Citrus Sinensis ID: 013522
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 441 | 2.2.26 [Sep-21-2011] | |||||||
| O65554 | 441 | CBL-interacting serine/th | yes | no | 0.954 | 0.954 | 0.761 | 0.0 | |
| Q9LWM4 | 461 | CBL-interacting protein k | yes | no | 0.956 | 0.915 | 0.605 | 1e-162 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.929 | 0.933 | 0.614 | 1e-154 | |
| Q6Z9F4 | 451 | CBL-interacting protein k | no | no | 0.922 | 0.902 | 0.632 | 1e-152 | |
| Q5W736 | 457 | CBL-interacting protein k | no | no | 0.922 | 0.890 | 0.594 | 1e-149 | |
| Q7X996 | 443 | CBL-interacting protein k | no | no | 0.931 | 0.927 | 0.576 | 1e-148 | |
| Q9SN43 | 489 | CBL-interacting serine/th | no | no | 0.959 | 0.865 | 0.545 | 1e-147 | |
| Q9FJ55 | 483 | CBL-interacting serine/th | no | no | 0.913 | 0.834 | 0.555 | 1e-142 | |
| Q9C562 | 479 | CBL-interacting serine/th | no | no | 0.925 | 0.851 | 0.536 | 1e-141 | |
| Q6ERS0 | 404 | Putative CBL-interacting | no | no | 0.866 | 0.945 | 0.570 | 1e-141 |
| >sp|O65554|CIPK6_ARATH CBL-interacting serine/threonine-protein kinase 6 OS=Arabidopsis thaliana GN=CIPK6 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 657 bits (1695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/432 (76%), Positives = 381/432 (88%), Gaps = 11/432 (2%)
Query: 5 NSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME 64
N + GG LLHG+YELGR+LGHGTFAKVY ARN+QTGKS+AMKVVGK+KV+KVGM++
Sbjct: 9 NGSDGGSS-TGLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVD 67
Query: 65 QIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF 124
QIKREISVM+MVKH +IVELHEVMASKSKIYFAM+LV+GGELF K+AKGRLREDVARVYF
Sbjct: 68 QIKREISVMRMVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYF 127
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
QQLISAVDFCHSRGVYHRDLKPENLLLDE+GNLKVTDFGLSAF+EHLKQDGLLHTTCGTP
Sbjct: 128 QQLISAVDFCHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTP 187
Query: 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF 244
AYVAPEVI KKGYDGAKAD+WSCGVIL+VLLAG+LPFQDDN+V+MYRKIYRGDFKCP W
Sbjct: 188 AYVAPEVILKKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWL 247
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK---------VVITKQEMEFEADK 295
SS+ARRL+TKLLDPNPN+RI I K+M+S WFKK A + + T+++++F K
Sbjct: 248 SSDARRLVTKLLDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHK 307
Query: 296 SSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAK-AV 354
S ++ ETLNAFHII+LSEGFDLSPLFEEKK+ E+ E+RFAT+RPASSVIS EE A+
Sbjct: 308 SKEETETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGN 367
Query: 355 KFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNEL 414
KF+V+ SESRVR++G+++GRKGKLA+ A+IFAV PS +VVEVKKD+GDTLEYN FCS L
Sbjct: 368 KFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTAL 427
Query: 415 RPALKDIVWMST 426
RPALKDI W ST
Sbjct: 428 RPALKDIFWTST 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 570 bits (1470), Expect = e-162, Method: Compositional matrix adjust.
Identities = 269/444 (60%), Positives = 346/444 (77%), Gaps = 22/444 (4%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
+ + ++L +YELGRMLG GTFAKVY ARNL + +S+A+KV+ K+KV++VGM++QIKREI
Sbjct: 2 EKKASILMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKREI 61
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
S+M++V+H +IV+LHEVMASKSKIYFAM+ V+GGELF+++A+GRL+ED AR YFQQLI A
Sbjct: 62 SIMRLVRHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIGA 121
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
VDFCHSRGVYHRDLKPENLL+DE+GNLKV+DFGLSAF E KQDGLLHTTCGTPAYVAPE
Sbjct: 122 VDFCHSRGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAPE 181
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
+I+K+GYDGAKADIWSCGVIL+VLLAG+LPF D N++ MYRKI +GD K P WF+++ RR
Sbjct: 182 IINKRGYDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVRR 241
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEME----------FEADK----- 295
L+++LLDPNPN RI + K++E WFKK V+ Q E F AD
Sbjct: 242 LLSRLLDPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNEG 301
Query: 296 ------SSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEE 349
SS +P +LNAF IISLS+GFDLS LFE K ++ + RF T +PAS+++S+ E+
Sbjct: 302 KAKEPASSLKPVSLNAFDIISLSKGFDLSGLFENDKE-QKADSRFMTQKPASAIVSKLEQ 360
Query: 350 VAKAVKFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQF 409
+A+ F VK + V+LQG + GRKG+LAI+A+IF VTPS VVEVKK GDTLEY +F
Sbjct: 361 IAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEYEKF 420
Query: 410 CSNELRPALKDIVWMSTADNPTLG 433
C+ LRP+L+DI W +++P+L
Sbjct: 421 CNKGLRPSLRDICWDGQSEHPSLA 444
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1406), Expect = e-154, Method: Compositional matrix adjust.
Identities = 260/423 (61%), Positives = 331/423 (78%), Gaps = 13/423 (3%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
D +L KYELGR+LG GTFAKVY ARN++TG+S+A+KV+ K KV KVG+++QIKREI
Sbjct: 2 DKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREI 61
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVM++V+H H+V LHEVMASK+KIYFAM+ VKGGELF+K++KG+L+E++AR YFQQLI A
Sbjct: 62 SVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGA 121
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
+D+CHSRGVYHRDLKPENLLLDE+G+LK++DFGLSA E +QDGLLHTTCGTPAYVAPE
Sbjct: 122 IDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPE 181
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI KKGYDGAKAD+WSCGV+LYVLLAGFLPF + N+V MYRKI +G+FKCP WF E ++
Sbjct: 182 VIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKK 241
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADK--------SSKQPET 302
L++++LDPNPNSRI I KIME+SWF+K K+ K + D S +P +
Sbjct: 242 LLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMS 301
Query: 303 LNAFHII-SLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAV-KFNVKT 360
NAF +I SLS+GFDLS LFE + ER E +F T + A ++S+FEE+A + +FN+
Sbjct: 302 YNAFDLISSLSQGFDLSGLFE---KEERSESKFTTKKDAKEIVSKFEEIATSSERFNLTK 358
Query: 361 SESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKD 420
S+ V+++ + GRKG LAI+ +IF VT S +VE KK GDT+EY QFC ELRP+LKD
Sbjct: 359 SDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKD 418
Query: 421 IVW 423
IVW
Sbjct: 419 IVW 421
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6Z9F4|CIPK6_ORYSJ CBL-interacting protein kinase 6 OS=Oryza sativa subsp. japonica GN=CIPK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1387), Expect = e-152, Method: Compositional matrix adjust.
Identities = 269/425 (63%), Positives = 336/425 (79%), Gaps = 18/425 (4%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
T+L G+YE+GR+LGHG F +V++AR+L+TG+S+A+KVV K+KV++ GMMEQIKREI+VMK
Sbjct: 17 TVLQGRYEMGRVLGHGNFGRVHVARDLRTGRSVAVKVVAKEKVVRAGMMEQIKREIAVMK 76
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDF 133
V H +IVELHEVMA++SKIY A++LV+GGELF +I + GR+RED AR YF+QL+SAVDF
Sbjct: 77 RVSHPNIVELHEVMATRSKIYLALELVRGGELFGRIVRLGRVREDAARHYFRQLVSAVDF 136
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
CHSRGVYHRDLKPENLLLDE GNLKV DFGLSA ++H + DGLLHT CGTP Y APEV+
Sbjct: 137 CHSRGVYHRDLKPENLLLDEAGNLKVVDFGLSALADHARADGLLHTLCGTPGYAAPEVLR 196
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 253
KGYDGAKAD+WSCGVILYVLLAG LPF DDNIV++YRK RGD++CP W S++ARRLI
Sbjct: 197 DKGYDGAKADLWSCGVILYVLLAGSLPFPDDNIVTLYRKAQRGDYRCPAWLSTDARRLIP 256
Query: 254 KLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ---------EMEFEADKSSKQPETLN 304
+LLDPNP +RI++++++E+ WFKK++ ++ + + EA+K +PETLN
Sbjct: 257 RLLDPNPTTRISVAQLVETPWFKKTSISRPVSIELPPAFADPAPAKEEAEKD--EPETLN 314
Query: 305 AFHIISLSEGFDLSPLFEEKKRAEREE--LRFATTRPASSVISRFEEVAK--AVKFNVKT 360
AFH+ISLSEGFDLSPLFE R + + FAT PAS VISR E VA + V
Sbjct: 315 AFHLISLSEGFDLSPLFEGDSAKGRRDGGMLFATREPASGVISRLEGVAARGGGRMRVTK 374
Query: 361 SESR-VRLQGQE-SGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPAL 418
S +R VRL+G E G KG+LA+ ADIF+V PS+LVV+VKKD GDTLEY FCS ELRPAL
Sbjct: 375 SGARGVRLEGAERGGAKGRLAVAADIFSVAPSVLVVDVKKDGGDTLEYRSFCSEELRPAL 434
Query: 419 KDIVW 423
+DIVW
Sbjct: 435 QDIVW 439
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5W736|CIPKI_ORYSJ CBL-interacting protein kinase 18 OS=Oryza sativa subsp. japonica GN=CIPK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 528 bits (1360), Expect = e-149, Method: Compositional matrix adjust.
Identities = 258/434 (59%), Positives = 330/434 (76%), Gaps = 27/434 (6%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
+L +YE+G++LG GTFAKVY RN+ T +S+A+KV+ KDK+ KVG+M+QIKREISVMK
Sbjct: 9 NILLRRYEIGKLLGQGTFAKVYHGRNIVTSQSVAIKVIDKDKIFKVGLMDQIKREISVMK 68
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+V+H +IV+L+EVMA+KSKIYF ++ VKGGELFNK+AKGRL+ED AR YFQQL+SAVDFC
Sbjct: 69 LVRHPNIVQLYEVMATKSKIYFVLEYVKGGELFNKVAKGRLKEDAARKYFQQLVSAVDFC 128
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
HSRGVYHRDLKPENLL+DE+GNLK+TDFGLSA +E +QDGLLHTTCGTPAYVAPEVIS+
Sbjct: 129 HSRGVYHRDLKPENLLVDENGNLKITDFGLSALAESRRQDGLLHTTCGTPAYVAPEVISR 188
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
KGYDG K D WSCGVIL+VL+AG+LPFQD N++ MYRKI + +FKCP WFSS+ R+L+++
Sbjct: 189 KGYDGVKVDTWSCGVILFVLMAGYLPFQDSNLMEMYRKIGKAEFKCPAWFSSDVRKLVSR 248
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ------------------------EME 290
+LDPNP SR+ I+KIME+ WFKK +I K +
Sbjct: 249 ILDPNPRSRMPITKIMETYWFKKGLDSKLILKNVETNEPVTALADVNVVFSSMGSSSSKK 308
Query: 291 FEADKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEV 350
E + + + LNAF IISLSEGFDLS LFEE + ++E RF +++ AS++IS+ E+V
Sbjct: 309 TEEKQDAGKLTNLNAFDIISLSEGFDLSGLFEETDK--KKEARFTSSQSASAIISKLEDV 366
Query: 351 AKAVKFNVKTSESRV-RLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQF 409
A K VK E V +++G GRKG LAI+A+IF VTPS +VE+KK+NGDTLEY
Sbjct: 367 ASCSKLTVKKKEGGVLKMEGASEGRKGVLAIDAEIFEVTPSFHLVEIKKNNGDTLEYQHL 426
Query: 410 CSNELRPALKDIVW 423
+++PALKDIVW
Sbjct: 427 WKEDMKPALKDIVW 440
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1351), Expect = e-148, Method: Compositional matrix adjust.
Identities = 248/430 (57%), Positives = 336/430 (78%), Gaps = 19/430 (4%)
Query: 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKRE 69
+ R +L KYE+G++LG GTFAKVY ARN +T +S+A+K++ K+KV+K G+M+QIKRE
Sbjct: 2 AEQRGNMLMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKRE 61
Query: 70 ISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
ISVMK+V+H +IV+L+EVMA+K+KIYF ++ VKGGELFNK+ +GRL+ED AR YFQQLI
Sbjct: 62 ISVMKLVRHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLIC 121
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
AVDFCHSRGVYHRDLKPENLLLDE+ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAP
Sbjct: 122 AVDFCHSRGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAP 181
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEAR 249
EVI+++GYDGAKADIWSCGVIL+VLLAG+LPF D N++ MY+KI + +FKCP WF+++ R
Sbjct: 182 EVINRRGYDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVR 241
Query: 250 RLITKLLDPNPNSRIAISKIMESSWFKKS----------APKVVI-TKQEMEFEADKSS- 297
RL+ ++LDPNP++RI++ KIME+ WF+K PK I +F++ S+
Sbjct: 242 RLLLRILDPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSAP 301
Query: 298 ---KQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAV 354
K+P LNAF IISLS G DLS +FEE ++++E +F +T AS++IS+ E++AK +
Sbjct: 302 TLEKKPSNLNAFDIISLSTGLDLSGMFEE---SDKKESKFTSTSTASTIISKIEDIAKGL 358
Query: 355 KFNV-KTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNE 413
+ + K ++++G + GRKG + I+A+IF VTP+ +VE+KK NGDTLEY + + E
Sbjct: 359 RLKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKTNGDTLEYRKVLNQE 418
Query: 414 LRPALKDIVW 423
+RPALKDIVW
Sbjct: 419 MRPALKDIVW 428
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SN43|CIPKC_ARATH CBL-interacting serine/threonine-protein kinase 12 OS=Arabidopsis thaliana GN=CIPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1339), Expect = e-147, Method: Compositional matrix adjust.
Identities = 251/460 (54%), Positives = 331/460 (71%), Gaps = 37/460 (8%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
L+ G+YE+G++LGHGTFAKVYLARN++T +S+A+KV+ K+KV+K G++ IKREIS+++
Sbjct: 20 ALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILR 79
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
V+H +IV+L EVMA+K+KIYF M+ V+GGELFNK+AKGRL+E+VAR YFQQLISAV FC
Sbjct: 80 RVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFC 139
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
H+RGVYHRDLKPENLLLDE+GNLKV+DFGLSA S+ ++QDGL HT CGTPAYVAPEV+++
Sbjct: 140 HARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLAR 199
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
KGYD AK DIWSCGVIL+VL+AG+LPF D N+++MY+KIYRG+F+CP WFS+E RL++K
Sbjct: 200 KGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSK 259
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKV-----------VITKQEME---FEADKSSK-- 298
LL+ NP R +IME+SWFKK + V+ E+E E+D+ S
Sbjct: 260 LLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDSAAS 319
Query: 299 -----------------QPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPAS 341
+P +LNAF IIS S+GFDLS LF++ + E RF + P S
Sbjct: 320 ESEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDD----DGEGSRFVSGAPVS 375
Query: 342 SVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNG 401
+IS+ EE+AK V F V+ + RV L+G G KG L I A+IF +TPSL+VVEVKK G
Sbjct: 376 KIISKLEEIAKVVSFTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSLVVVEVKKKGG 435
Query: 402 DTLEYNQFCSNELRPALKDIVWMSTADNPTLGLNLEEQQI 441
D EY FC+NEL+P L+++ P ++E I
Sbjct: 436 DKTEYEDFCNNELKPKLQNLTADDVVAEPVAVSAVDETAI 475
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ55|CIPKJ_ARATH CBL-interacting serine/threonine-protein kinase 19 OS=Arabidopsis thaliana GN=CIPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 246/443 (55%), Positives = 321/443 (72%), Gaps = 40/443 (9%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
L+ GKYE+GR+LGHGTFAKVYLARN Q+G+S+A+KV+ K+KV+K G++ IKREIS+++
Sbjct: 22 ALILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILR 81
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
V+H +IV+L EVMA+KSKIYF M+ VKGGELFNK+AKGRL+E++AR YFQQLISAV FC
Sbjct: 82 RVRHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAVSFC 141
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
H RGVYHRDLKPENLLLDE+GNLKV+DFGLSA S+ ++QDGL HT CGTPAYVAPEV+++
Sbjct: 142 HFRGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLAR 201
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
KGYDGAK DIWSCGVIL+VL+AGFLPF D N+++MY+KIYRGDF+CP WF E RL+ +
Sbjct: 202 KGYDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIR 261
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKV------------VITKQEME------------ 290
+L+ P R + IME+SWFKK + V E+E
Sbjct: 262 MLETKPERRFTMPDIMETSWFKKGFKHIKFYVEDDHQLCNVADDDEIESIESVSGRSSTV 321
Query: 291 -----FEA------DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRP 339
FE+ S +P +LNAF +IS S GFDLS LFE+ + E RF + P
Sbjct: 322 SEPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLSGLFED----DGEGSRFVSGAP 377
Query: 340 ASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGR-KGKLAINADIFAVTPSLLVVEVKK 398
+IS+ EE+A+ V F V+ + +V L+G G KG L+I A+IF +TP+L+VVEVKK
Sbjct: 378 VGQIISKLEEIARIVSFTVRKKDCKVSLEGSREGSMKGPLSIAAEIFELTPALVVVEVKK 437
Query: 399 DNGDTLEYNQFCSNELRPALKDI 421
GD +EY++FC+ EL+P L+++
Sbjct: 438 KGGDKMEYDEFCNKELKPKLQNL 460
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C562|CIPKA_ARATH CBL-interacting serine/threonine-protein kinase 10 OS=Arabidopsis thaliana GN=CIPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1293), Expect = e-141, Method: Compositional matrix adjust.
Identities = 242/451 (53%), Positives = 334/451 (74%), Gaps = 43/451 (9%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
+++P++L KY++GR+LG GTFAKVY R++ T +S+A+K++ K+KV+KVG++EQIKREI
Sbjct: 2 ENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREI 61
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVM++ +H ++VEL+EVMA+K++IYF M+ KGGELFNK+AKG+LR+DVA YF QLI+A
Sbjct: 62 SVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINA 121
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
VDFCHSR VYHRD+KPENLLLD++ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPE
Sbjct: 122 VDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 181
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI++KGYDG KADIWSCGV+L+VLLAG+LPF D N++ MYRKI + DFK P WF+ E RR
Sbjct: 182 VINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRR 241
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEME--------FEA--------- 293
L+ K+LDPNP +RI I++I ESSWF+K + + +++ME EA
Sbjct: 242 LLCKMLDPNPETRITIARIRESSWFRKG---LHMKQKKMEKRVKEINSVEAGTAGTNENG 298
Query: 294 -------------------DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRF 334
+ + +P LNAF +I+LS GFDL+ LF + + E RF
Sbjct: 299 AGPSENGAGPSENGDRVTEENHTDEPTNLNAFDLIALSAGFDLAGLFGDDNKRES---RF 355
Query: 335 ATTRPASSVISRFEEVAKAVKFNVKTSESRV-RLQGQESGRKGKLAINADIFAVTPSLLV 393
+ +PAS +IS+ EEVA+ +K +++ E+ + +L+ + GRKG L+++A+IF VTP+ +
Sbjct: 356 TSQKPASVIISKLEEVAQRLKLSIRKREAGLFKLERLKEGRKGILSMDAEIFQVTPNFHL 415
Query: 394 VEVKKDNGDTLEYNQFCSNELRPALKDIVWM 424
VEVKK NGDTLEY + + +LRPAL DIVW+
Sbjct: 416 VEVKKSNGDTLEYQKLVAEDLRPALSDIVWV 446
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ERS0|CIPKR_ORYSJ Putative CBL-interacting protein kinase 27 OS=Oryza sativa subsp. japonica GN=CIPK27 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1292), Expect = e-141, Method: Compositional matrix adjust.
Identities = 244/428 (57%), Positives = 304/428 (71%), Gaps = 46/428 (10%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM 75
+L G+YE+GR+LGHG F +V+ AR+++TG+++AMKVV KDKV + GM EQIKREI+VMKM
Sbjct: 6 VLEGRYEMGRVLGHGNFGRVHAARDVRTGRAVAMKVVSKDKVERAGMAEQIKREIAVMKM 65
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFC 134
V H +VELHEVMA+++K+Y A++LV+GGELF++IA+ GR+ E VAR YF+QL+SAVDFC
Sbjct: 66 VSHPSVVELHEVMATRTKVYLALELVRGGELFDRIARHGRVGEGVARRYFRQLVSAVDFC 125
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
H RGVYHRDLKPENLLLDE GNLKV DFGLSA + H + DGLLHT CGTPAYVAPEV++
Sbjct: 126 HGRGVYHRDLKPENLLLDEAGNLKVADFGLSALACHARPDGLLHTACGTPAYVAPEVLAG 185
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
GYDGAKAD+WSCGVILYVLLAG LPFQDDN+V MYRK+ RGDF CPPW +++AR+LI
Sbjct: 186 NGYDGAKADLWSCGVILYVLLAGALPFQDDNLVCMYRKMRRGDFCCPPWVTTDARKLIKS 245
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAP---KVVITKQEMEFE-----ADKSSKQPETLNAF 306
LLDPNP +RI ++ ++E+ WF+K+AP ++ + D + PE LNAF
Sbjct: 246 LLDPNPGTRITVAGLLETPWFRKTAPVPRPIIADPAAAPVDTRGNAGDDKDEPPEVLNAF 305
Query: 307 HIISLSEGFDLSPLFEE-------KKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 359
H+ISLSEGFDLSPLFE + A RFAT AS V++R E +A
Sbjct: 306 HLISLSEGFDLSPLFEHDPAASPGRATARAGGTRFATREAASGVVARLEALA-------- 357
Query: 360 TSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALK 419
+ G V PSLL+V+VKKD GD +EY F S ELRPALK
Sbjct: 358 -------MGGAR---------------VAPSLLMVDVKKDGGDAMEYRPFFSEELRPALK 395
Query: 420 DIVWMSTA 427
DIVW A
Sbjct: 396 DIVWSPAA 403
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 441 | ||||||
| 224091733 | 437 | predicted protein [Populus trichocarpa] | 0.970 | 0.979 | 0.843 | 0.0 | |
| 255586705 | 432 | CBL-interacting serine/threonine-protein | 0.945 | 0.965 | 0.876 | 0.0 | |
| 224104503 | 439 | predicted protein [Populus trichocarpa] | 0.970 | 0.974 | 0.834 | 0.0 | |
| 449457907 | 430 | PREDICTED: CBL-interacting serine/threon | 0.950 | 0.974 | 0.861 | 0.0 | |
| 449503175 | 430 | PREDICTED: CBL-interacting serine/threon | 0.950 | 0.974 | 0.859 | 0.0 | |
| 225445621 | 426 | PREDICTED: CBL-interacting serine/threon | 0.954 | 0.988 | 0.836 | 0.0 | |
| 166788445 | 438 | protein kinase [Phaseolus vulgaris] | 0.975 | 0.981 | 0.805 | 0.0 | |
| 356500647 | 430 | PREDICTED: CBL-interacting serine/threon | 0.963 | 0.988 | 0.771 | 0.0 | |
| 449442979 | 433 | PREDICTED: CBL-interacting serine/threon | 0.970 | 0.988 | 0.811 | 0.0 | |
| 166788439 | 433 | protein kinase [Phaseolus vulgaris] | 0.959 | 0.976 | 0.780 | 0.0 |
| >gi|224091733|ref|XP_002309336.1| predicted protein [Populus trichocarpa] gi|116265936|gb|ABJ91216.1| CBL-interacting protein kinase 9 [Populus trichocarpa] gi|222855312|gb|EEE92859.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 767 bits (1981), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/442 (84%), Positives = 400/442 (90%), Gaps = 14/442 (3%)
Query: 1 MATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV 60
MA S+G PTLLHGKYELGR+LGHGTFAKVY ARNLQ+GKS+AMKVVGK+KVIKV
Sbjct: 1 MAEKTSDG----HPTLLHGKYELGRLLGHGTFAKVYHARNLQSGKSVAMKVVGKEKVIKV 56
Query: 61 GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA 120
GMMEQ+KREISVMKMV+H HIVEL+EVMASKSKIYFAM+LV+GGELF+KIAKGRLREDVA
Sbjct: 57 GMMEQVKREISVMKMVRHPHIVELNEVMASKSKIYFAMELVRGGELFSKIAKGRLREDVA 116
Query: 121 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
RVYFQQLISA+DFCHSRGVYHRDLKPENLLLDEDG LKVTDFGLSAFSEHLKQDGLLHTT
Sbjct: 117 RVYFQQLISAIDFCHSRGVYHRDLKPENLLLDEDGKLKVTDFGLSAFSEHLKQDGLLHTT 176
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240
CGTPAYVAPEVI KKGYDGAKAD+WSCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKC
Sbjct: 177 CGTPAYVAPEVIGKKGYDGAKADLWSCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKC 236
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEA------- 293
P WFSSEARRLITKLLDPNP++RI SK+M+S+WFKKS PK V +K+EMEFEA
Sbjct: 237 PQWFSSEARRLITKLLDPNPSTRITTSKVMDSTWFKKSLPKTVRSKEEMEFEAFNGEEDA 296
Query: 294 --DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVA 351
DK +KQPETLNAFHIISLS+GFDLSPLFEEK R +EELRFATTRPASSVISR EEVA
Sbjct: 297 NGDK-AKQPETLNAFHIISLSQGFDLSPLFEEKTREGKEELRFATTRPASSVISRLEEVA 355
Query: 352 KAVKFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCS 411
KA FNVK S+S+VRLQGQE GRKGKLAI ADIFAVTPS LVVEVKKDNGDTLEYNQFCS
Sbjct: 356 KAGNFNVKKSDSKVRLQGQERGRKGKLAIAADIFAVTPSFLVVEVKKDNGDTLEYNQFCS 415
Query: 412 NELRPALKDIVWMSTADNPTLG 433
NELRPALKDIVW S A+N TL
Sbjct: 416 NELRPALKDIVWTSPAENSTLA 437
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586705|ref|XP_002533977.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223526040|gb|EEF28408.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/421 (87%), Positives = 395/421 (93%), Gaps = 4/421 (0%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM 75
LLHGKYELGR+LGHGTFAKVY RNLQTGKS+AMKVVGK+KVIKVGMMEQ+KREI+VMKM
Sbjct: 13 LLHGKYELGRLLGHGTFAKVYHGRNLQTGKSVAMKVVGKEKVIKVGMMEQVKREIAVMKM 72
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 135
VKH +IVELHEVMASKSKIYFAM+LV+GGELF+KIAKGRLREDVARVYFQQLISAVDFCH
Sbjct: 73 VKHPNIVELHEVMASKSKIYFAMELVRGGELFSKIAKGRLREDVARVYFQQLISAVDFCH 132
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF+EHLKQDGLLHTTCGTPAYVAPEVI KK
Sbjct: 133 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFAEHLKQDGLLHTTCGTPAYVAPEVIGKK 192
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255
GYDGAKAD+WSCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKCPPWFSSEARRLITKL
Sbjct: 193 GYDGAKADLWSCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKCPPWFSSEARRLITKL 252
Query: 256 LDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEA---DKSSKQPETLNAFHIISLS 312
LDPNP +RI ISKIM+SSW KKS PK V +K+EMEF+A DK SKQPETLNAFHIISLS
Sbjct: 253 LDPNPATRITISKIMDSSWIKKSVPKTVTSKEEMEFDAFNGDK-SKQPETLNAFHIISLS 311
Query: 313 EGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQES 372
EGFDLSPLFEEKKR E+EELRFATTRPASSVIS EEVAKA KF+VK SE++VR+QGQES
Sbjct: 312 EGFDLSPLFEEKKREEKEELRFATTRPASSVISTLEEVAKAGKFSVKKSETKVRMQGQES 371
Query: 373 GRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNPTL 432
GRKGKLAI A+IFAVTP+ LVVEVKKDNGDTLEYNQFCS ELRPALKDI+W S ADN T+
Sbjct: 372 GRKGKLAIAAEIFAVTPAFLVVEVKKDNGDTLEYNQFCSKELRPALKDILWTSPADNSTI 431
Query: 433 G 433
Sbjct: 432 A 432
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104503|ref|XP_002333931.1| predicted protein [Populus trichocarpa] gi|224142403|ref|XP_002324548.1| predicted protein [Populus trichocarpa] gi|116265932|gb|ABJ91214.1| CBL-interacting protein kinase 7 [Populus trichocarpa] gi|116265934|gb|ABJ91215.1| CBL-interacting protein kinase 8 [Populus trichocarpa] gi|222839165|gb|EEE77516.1| predicted protein [Populus trichocarpa] gi|222865982|gb|EEF03113.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/442 (83%), Positives = 401/442 (90%), Gaps = 14/442 (3%)
Query: 1 MATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV 60
MA + S+G PTLLHGKYELGR+LGHGTFAKVY ARNLQ+GKS+AMKVVGK+KVIKV
Sbjct: 1 MAETTSDG----HPTLLHGKYELGRLLGHGTFAKVYHARNLQSGKSVAMKVVGKEKVIKV 56
Query: 61 GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA 120
GMMEQIKREISVMKMVKH +IVELHEVMASKSKIYFAM+LV+GGELF+KI KGRLREDVA
Sbjct: 57 GMMEQIKREISVMKMVKHPNIVELHEVMASKSKIYFAMELVRGGELFSKIEKGRLREDVA 116
Query: 121 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
RVYFQQLISA+DFCHSRGVYHRDLKPENLLLDE+G LKVTDFGLSAF+EHLKQDGLLHTT
Sbjct: 117 RVYFQQLISAIDFCHSRGVYHRDLKPENLLLDENGKLKVTDFGLSAFTEHLKQDGLLHTT 176
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240
CGTPAYVAPEVI K+GYDGAKAD+WSCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKC
Sbjct: 177 CGTPAYVAPEVIGKQGYDGAKADLWSCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKC 236
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEA------- 293
PPWFSSEARRLITKLLDPNP++RI ISK+M+S+WFKKS PK V +K+EMEFEA
Sbjct: 237 PPWFSSEARRLITKLLDPNPSTRITISKVMDSTWFKKSVPKTVKSKEEMEFEAFNGDEDA 296
Query: 294 --DKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVA 351
DK SKQ ETLNAFHIISLS+GFDLSPLFEE+KR E+EELRFATTRPASSVISR EEV
Sbjct: 297 NGDK-SKQLETLNAFHIISLSQGFDLSPLFEERKREEKEELRFATTRPASSVISRLEEVG 355
Query: 352 KAVKFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCS 411
KA F+VK S+S+VRLQGQE GRKGKLAI ADIFAVTPS LVVEVKKDNGDTLE+NQFCS
Sbjct: 356 KAGNFSVKKSDSKVRLQGQERGRKGKLAIAADIFAVTPSFLVVEVKKDNGDTLEFNQFCS 415
Query: 412 NELRPALKDIVWMSTADNPTLG 433
LRPALKDIVW+S A+N TL
Sbjct: 416 KALRPALKDIVWISPAENSTLA 437
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457907|ref|XP_004146689.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/420 (86%), Positives = 391/420 (93%), Gaps = 1/420 (0%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
D +LHGKYELGR+LGHGTFAKVY ARNLQ+G SMAMKVVGK+KVIKVGMMEQIKREI
Sbjct: 7 DGSSGVLHGKYELGRLLGHGTFAKVYHARNLQSGTSMAMKVVGKEKVIKVGMMEQIKREI 66
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVMKMVKH +IVELHEVMASKSKIYFAM+LV+GGELF+KI+KGRLREDVARVYFQQLISA
Sbjct: 67 SVMKMVKHPNIVELHEVMASKSKIYFAMELVRGGELFSKISKGRLREDVARVYFQQLISA 126
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
+DFCHSRGVYHRDLKPENLLLD+DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE
Sbjct: 127 IDFCHSRGVYHRDLKPENLLLDDDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 186
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI KKGY+GAKAD+WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS EARR
Sbjct: 187 VIGKKGYNGAKADLWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSPEARR 246
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEF-EADKSSKQPETLNAFHII 309
L+TKLLDPNPN+RI SKIMESSWF+KS PK V+TK+E EF E+++ KQ ETLNAFHII
Sbjct: 247 LVTKLLDPNPNTRIPTSKIMESSWFRKSIPKTVVTKEEQEFIESNEKLKQSETLNAFHII 306
Query: 310 SLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQG 369
SLSEGFDLSPLFEEKKR E+EELRFATTRPASSVIS+ EEVAKA KF+VK SESRVRLQG
Sbjct: 307 SLSEGFDLSPLFEEKKREEKEELRFATTRPASSVISKLEEVAKAGKFSVKKSESRVRLQG 366
Query: 370 QESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADN 429
QE GRKGKL++ A+IFAVTPS LVVEVKKD+GDTLEYNQFCS ELRPALKDIVW S +N
Sbjct: 367 QECGRKGKLSVAAEIFAVTPSFLVVEVKKDHGDTLEYNQFCSKELRPALKDIVWTSPTEN 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503175|ref|XP_004161871.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/420 (85%), Positives = 391/420 (93%), Gaps = 1/420 (0%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
D +LHGKYELGR+LGHGTFAKVY ARNLQ+G SMAMKVVGK+KVIKVGMMEQ+KREI
Sbjct: 7 DGSSGVLHGKYELGRLLGHGTFAKVYHARNLQSGTSMAMKVVGKEKVIKVGMMEQVKREI 66
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVMKMVKH +IVELHEVMASKSKIYFAM+LV+GGELF+KI+KGRLREDVARVYFQQLISA
Sbjct: 67 SVMKMVKHPNIVELHEVMASKSKIYFAMELVRGGELFSKISKGRLREDVARVYFQQLISA 126
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
+DFCHSRGVYHRDLKPENLLLD+DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE
Sbjct: 127 IDFCHSRGVYHRDLKPENLLLDDDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 186
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI KKGY+GAKAD+WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS EARR
Sbjct: 187 VIGKKGYNGAKADLWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSPEARR 246
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEF-EADKSSKQPETLNAFHII 309
L+TKLLDPNPN+RI SKIMESSWF+KS PK V+TK+E EF E+++ KQ ETLNAFHII
Sbjct: 247 LVTKLLDPNPNTRIPTSKIMESSWFRKSIPKTVVTKEEQEFIESNEKLKQSETLNAFHII 306
Query: 310 SLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQG 369
SLSEGFDLSPLFEEKKR E+EELRFATTRPASSVIS+ EEVAKA KF+VK SESRVRLQG
Sbjct: 307 SLSEGFDLSPLFEEKKREEKEELRFATTRPASSVISKLEEVAKAGKFSVKKSESRVRLQG 366
Query: 370 QESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADN 429
QE GRKGKL++ A+IFAVTPS LVVEVKKD+GDTLEYNQFCS ELRPALKDIVW S +N
Sbjct: 367 QECGRKGKLSVAAEIFAVTPSFLVVEVKKDHGDTLEYNQFCSKELRPALKDIVWTSPTEN 426
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225445621|ref|XP_002262667.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6 [Vitis vinifera] gi|147782993|emb|CAN68670.1| hypothetical protein VITISV_026919 [Vitis vinifera] gi|229609807|gb|ACQ83519.1| CBL-interacting protein kinase 03 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/423 (83%), Positives = 389/423 (91%), Gaps = 2/423 (0%)
Query: 6 SNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ 65
++ G D P+LLHGKYELGR+LGHGTFAKVY ARNLQTGKS+AMKVVGKDKVIKVGM EQ
Sbjct: 2 ADSGKDSCPSLLHGKYELGRLLGHGTFAKVYHARNLQTGKSVAMKVVGKDKVIKVGMTEQ 61
Query: 66 IKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ 125
+KREISVMKMV+H +IVELHEVMASKSKIYFAM+LV+GGELF+KI+KGRLREDVARVYFQ
Sbjct: 62 VKREISVMKMVQHPNIVELHEVMASKSKIYFAMELVRGGELFSKISKGRLREDVARVYFQ 121
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
QLISAVDFCHSRGVYHRDLKPENLLLDE GNLKVTDFGLSA SEHLKQDGLLHTTCGTPA
Sbjct: 122 QLISAVDFCHSRGVYHRDLKPENLLLDESGNLKVTDFGLSALSEHLKQDGLLHTTCGTPA 181
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS 245
YVAPEVI K GYDGAKAD+WSCGVILYVLLAGFLPFQDDNIV+MYRKIYRGDFKCPPWFS
Sbjct: 182 YVAPEVIGKNGYDGAKADLWSCGVILYVLLAGFLPFQDDNIVAMYRKIYRGDFKCPPWFS 241
Query: 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKS--SKQPETL 303
E+RRL+TKLLDP PN+RI I+KI+ESSWFKKS PK ++TK+E EFE+ +KQPETL
Sbjct: 242 PESRRLVTKLLDPTPNTRITIAKIVESSWFKKSVPKTILTKEEQEFESFNCGKAKQPETL 301
Query: 304 NAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSES 363
NAFHIISLSEGFDLSPLFEEKKR ++EELRFATT+PASSVIS+ EEVAKA KF+VK SE+
Sbjct: 302 NAFHIISLSEGFDLSPLFEEKKREQKEELRFATTQPASSVISKLEEVAKAGKFSVKKSET 361
Query: 364 RVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVW 423
VRLQGQE GRKGKLAI A+IFAV PS LVVEVKK +GD+LEY+QFC+ ELRPALKDIVW
Sbjct: 362 IVRLQGQERGRKGKLAIGAEIFAVAPSFLVVEVKKHHGDSLEYDQFCNKELRPALKDIVW 421
Query: 424 MST 426
ST
Sbjct: 422 TST 424
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|166788445|dbj|BAG06678.1| protein kinase [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/437 (80%), Positives = 389/437 (89%), Gaps = 7/437 (1%)
Query: 1 MATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV 60
M S+ G + LLHGKYELGR+LGHGTFAKVY ARNL++GKS+AMKVVGK+KV+KV
Sbjct: 1 MMGEKSSTGEANNSLLLHGKYELGRLLGHGTFAKVYHARNLKSGKSVAMKVVGKEKVMKV 60
Query: 61 GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA 120
GMMEQIKREIS M MVKH IV+LHEVMASKSKIY AM+LV+GGELFNKIA+GRLRE+ A
Sbjct: 61 GMMEQIKREISAMNMVKHPSIVQLHEVMASKSKIYIAMELVRGGELFNKIARGRLREETA 120
Query: 121 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
R+YFQQL+SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS FSEHL+QDGLLHTT
Sbjct: 121 RLYFQQLVSAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSTFSEHLRQDGLLHTT 180
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240
CGTPAYVAPEVI KKGYDGAKADIWSCGVILYVLLAGFLPFQDDN+V++Y+KIYRGDFKC
Sbjct: 181 CGTPAYVAPEVIGKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNLVALYKKIYRGDFKC 240
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQP 300
PPWFSSEARRLITKLLDPNPN+RI ISKIMESSWFKK+ PK V+ + E + ++ KQ
Sbjct: 241 PPWFSSEARRLITKLLDPNPNNRITISKIMESSWFKKAVPKNVMGVKREELDLEEKIKQQ 300
Query: 301 E-----TLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVK 355
E T+NAFHIISLSEGFDLSPLFEEKK E +E+RFATTRPASSVISR EEVAKAVK
Sbjct: 301 EECKSSTMNAFHIISLSEGFDLSPLFEEKK-REEKEIRFATTRPASSVISRLEEVAKAVK 359
Query: 356 FNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELR 415
F+VK SE++VRLQGQE GRKGKLAI AD++AVTPS LVVEVKKDNGDTLEYNQFCSN+LR
Sbjct: 360 FDVKKSENQVRLQGQERGRKGKLAIAADLYAVTPSFLVVEVKKDNGDTLEYNQFCSNQLR 419
Query: 416 PALKDIVW-MSTADNPT 431
PALKDIVW S +NPT
Sbjct: 420 PALKDIVWRTSPPENPT 436
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500647|ref|XP_003519143.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/429 (77%), Positives = 385/429 (89%), Gaps = 4/429 (0%)
Query: 1 MATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV 60
M+ + + TLLHGKYELGR+LGHGTFAKVY ARNL TG+ +AMKVVGK+KVIKV
Sbjct: 1 MSEKEKGNNSEGQSTLLHGKYELGRVLGHGTFAKVYHARNLNTGQHVAMKVVGKEKVIKV 60
Query: 61 GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA 120
GMMEQ+KREISVMKMVKH++IVELHEVMASKSKIY AM+LV+GGELFNK++KGRL+EDVA
Sbjct: 61 GMMEQVKREISVMKMVKHQNIVELHEVMASKSKIYIAMELVRGGELFNKVSKGRLKEDVA 120
Query: 121 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
R+YFQQLISAVDFCHSRGVYHRDLKPENLLLDE GNLKV+DFGL+AFSEHLK+DGLLHTT
Sbjct: 121 RLYFQQLISAVDFCHSRGVYHRDLKPENLLLDEHGNLKVSDFGLTAFSEHLKEDGLLHTT 180
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240
CGTPAYV+PEVI+KKGYDGAKADIWSCGVILYVLLAGFLPFQDDN+V+MY+KIYRGDFKC
Sbjct: 181 CGTPAYVSPEVIAKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNLVAMYKKIYRGDFKC 240
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQP 300
PPWFS +AR+L+TKLLDPNPN+RI+ISK+MESSWFKK P+ + ++++ E +K Q
Sbjct: 241 PPWFSLDARKLVTKLLDPNPNTRISISKVMESSWFKKPVPR-KLAAEKVDLEEEKIESQL 299
Query: 301 ETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKT 360
ET+NAFHIISLSEGF+LSPLFE+K+ REE+RFAT S+VISR EEVAKA KF+V++
Sbjct: 300 ETINAFHIISLSEGFNLSPLFEDKR---REEMRFATAGTPSTVISRLEEVAKAGKFDVRS 356
Query: 361 SESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKD 420
SE++VRLQGQE GRKGKLAI ADI+AVTPS +VVEVKKDNGDTLEYNQFCS +LRPALKD
Sbjct: 357 SETKVRLQGQERGRKGKLAIAADIYAVTPSFMVVEVKKDNGDTLEYNQFCSKQLRPALKD 416
Query: 421 IVWMSTADN 429
I W S+ ++
Sbjct: 417 IFWNSSQNS 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442979|ref|XP_004139258.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like [Cucumis sativus] gi|449525178|ref|XP_004169595.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 6-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/434 (81%), Positives = 380/434 (87%), Gaps = 6/434 (1%)
Query: 1 MATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV 60
MA +GG +LL GKYELGR+LGHGTFAKVY ARNL+TGKS+AMKVVGK+K+IKV
Sbjct: 1 MADKGRDGG---HSSLLDGKYELGRLLGHGTFAKVYHARNLRTGKSVAMKVVGKEKIIKV 57
Query: 61 GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA 120
GMMEQIKREISVMKMVKH +IVELHEVMASKSKIYFAM+ V+GGELF+KIAKGRLREDVA
Sbjct: 58 GMMEQIKREISVMKMVKHPNIVELHEVMASKSKIYFAMEFVRGGELFSKIAKGRLREDVA 117
Query: 121 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
RVYFQQLISA+DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL+AFSEHLKQDGLLHTT
Sbjct: 118 RVYFQQLISAIDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLTAFSEHLKQDGLLHTT 177
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240
CGTPAYVAPEVI K GYDGAKAD+WSCGVILYVLLAGFLPFQDDN+V+MYRKIYRGDFKC
Sbjct: 178 CGTPAYVAPEVIGKHGYDGAKADLWSCGVILYVLLAGFLPFQDDNMVAMYRKIYRGDFKC 237
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEAD---KSS 297
P WFS EARRLITKLLDPNP +R I+KI SSWFKKS PK +ITK E E + KS
Sbjct: 238 PSWFSPEARRLITKLLDPNPVTRAGITKITSSSWFKKSVPKSLITKDEQEQTEENFTKSK 297
Query: 298 KQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFN 357
ETLNAFHIISLSEGFDLSPLFEEKKR E+EE+RFAT+ ASSVIS+ EEV KAVKF+
Sbjct: 298 PPAETLNAFHIISLSEGFDLSPLFEEKKREEKEEMRFATSSTASSVISKLEEVGKAVKFD 357
Query: 358 VKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPA 417
VK SE+ VRLQGQE GRKGKL I ADIFA+TPS +VVEVKKDNGDTLEYNQFC ELRPA
Sbjct: 358 VKKSETWVRLQGQEMGRKGKLTIAADIFAMTPSFVVVEVKKDNGDTLEYNQFCRKELRPA 417
Query: 418 LKDIVWMSTADNPT 431
LKDIVW S N T
Sbjct: 418 LKDIVWTSPTGNST 431
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|166788439|dbj|BAG06675.1| protein kinase [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/429 (78%), Positives = 383/429 (89%), Gaps = 6/429 (1%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR 68
G + TLLHGKYELGR+LGHGTFAKVY ARNL+TG+ +AMKVVGK+KVIKVGMMEQ+KR
Sbjct: 11 GVSEGSTLLHGKYELGRVLGHGTFAKVYHARNLKTGQHVAMKVVGKEKVIKVGMMEQVKR 70
Query: 69 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI 128
EISVMKMVKH +IVELHEVMASKSKIY AM+LV+GGELFNK++KGRL+EDVAR+YFQQLI
Sbjct: 71 EISVMKMVKHSNIVELHEVMASKSKIYIAMELVRGGELFNKVSKGRLKEDVARLYFQQLI 130
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
SAVDFCHSRGVYHRDLKPENLLLDE G LKV+DFGL+AF++HLK+DGLLHTTCGTPAYV+
Sbjct: 131 SAVDFCHSRGVYHRDLKPENLLLDEHGKLKVSDFGLTAFADHLKEDGLLHTTCGTPAYVS 190
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248
PEVI+KKGYDGAKADIWSCGVILYVLLAGFLPFQDDN+V+MY+KIYRGDFKCPPWFS EA
Sbjct: 191 PEVIAKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNLVAMYKKIYRGDFKCPPWFSVEA 250
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHI 308
RRL+T+LLDPNPN+RI+ISK++ESSWFKK P+ V EM+ E + + P T+NAFHI
Sbjct: 251 RRLVTRLLDPNPNTRISISKVVESSWFKKPVPRKVEDVAEMDLE--EKCETPATMNAFHI 308
Query: 309 ISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQ 368
ISLSEGFDLSPLFEEKK REE+RFAT SSVISR EEVAKA KF++K+SE++VRLQ
Sbjct: 309 ISLSEGFDLSPLFEEKK---REEMRFATAGTPSSVISRLEEVAKAGKFDMKSSETKVRLQ 365
Query: 369 GQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTAD 428
GQE GRKGKLAI ADI++VTPS +VVEVKKDNGDTLEYNQFCS +LRPALKDI W ++
Sbjct: 366 GQERGRKGKLAIAADIYSVTPSFMVVEVKKDNGDTLEYNQFCSKQLRPALKDIFW-NSPQ 424
Query: 429 NPTLGLNLE 437
N T + LE
Sbjct: 425 NSTPAIVLE 433
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 441 | ||||||
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.954 | 0.954 | 0.708 | 1.2e-161 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.943 | 0.947 | 0.573 | 2.5e-129 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.594 | 0.535 | 0.656 | 1.5e-123 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.682 | 0.578 | 0.578 | 8.4e-121 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.605 | 0.557 | 0.636 | 1.1e-120 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.616 | 0.527 | 0.626 | 7.5e-120 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.657 | 0.635 | 0.6 | 2.9e-118 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.621 | 0.568 | 0.608 | 6.8e-117 | |
| TAIR|locus:2040824 | 502 | CIPK13 "CBL-interacting protei | 0.668 | 0.587 | 0.57 | 5.5e-113 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.931 | 0.842 | 0.518 | 9.7e-112 |
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1574 (559.1 bits), Expect = 1.2e-161, P = 1.2e-161
Identities = 306/432 (70%), Positives = 352/432 (81%)
Query: 5 NSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXE 64
N + GG LLHG+YELGR+LGHGTFAKVY ARN+QTGKS+A +
Sbjct: 9 NGSDGGSSTG-LLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVD 67
Query: 65 QIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF 124
QIKREISVM+MVKH +IVELHEVMASKSKIYFAM+LV+GGELF K+AKGRLREDVARVYF
Sbjct: 68 QIKREISVMRMVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYF 127
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
QQLISAVDFCHSRGVYHRDLKPENLLLDE+GNLKVTDFGLSAF+EHLKQDGLLHTTCGTP
Sbjct: 128 QQLISAVDFCHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTP 187
Query: 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF 244
AYVAPEVI KKGYDGAKAD+WSCGVIL+VLLAG+LPFQDDN+V+MYRKIYRGDFKCP W
Sbjct: 188 AYVAPEVILKKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWL 247
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK---------VVITKQEMEFEADK 295
SS+ARRL+TKLLDPNPN+RI I K+M+S WFKK A + + T+++++F K
Sbjct: 248 SSDARRLVTKLLDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHK 307
Query: 296 SSKQPETLNAFHIISLSEGFDLSPXXXXXXXXXXXXXXXXTTRPASSVISRFEEVAKAV- 354
S ++ ETLNAFHII+LSEGFDLSP T+RPASSVIS EE A+
Sbjct: 308 SKEETETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGN 367
Query: 355 KFNVKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNEL 414
KF+V+ SESRVR++G+++GRKGKLA+ A+IFAV PS +VVEVKKD+GDTLEYN FCS L
Sbjct: 368 KFDVRKSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTAL 427
Query: 415 RPALKDIVWMST 426
RPALKDI W ST
Sbjct: 428 RPALKDIFWTST 439
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1269 (451.8 bits), Expect = 2.5e-129, P = 2.5e-129
Identities = 246/429 (57%), Positives = 312/429 (72%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREI 70
D +L KYELGR+LG GTFAKVY ARN++TG+S+A +QIKREI
Sbjct: 2 DKNGIVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREI 61
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVM++V+H H+V LHEVMASK+KIYFAM+ VKGGELF+K++KG+L+E++AR YFQQLI A
Sbjct: 62 SVMRLVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGA 121
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
+D+CHSRGVYHRDLKPENLLLDE+G+LK++DFGLSA E +QDGLLHTTCGTPAYVAPE
Sbjct: 122 IDYCHSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPE 181
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI KKGYDGAKAD+WSCGV+LYVLLAGFLPF + N+V MYRKI +G+FKCP WF E ++
Sbjct: 182 VIGKKGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKK 241
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKS--------SKQPET 302
L++++LDPNPNSRI I KIME+SWF+K K+ K + D S +P +
Sbjct: 242 LLSRILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMS 301
Query: 303 LNAFHIIS-LSEGFDLSPXXXXXXXXXXXXXXXXTTRPASSVISRFEEVA-KAVKFNVKT 360
NAF +IS LS+GFDLS T + A ++S+FEE+A + +FN+
Sbjct: 302 YNAFDLISSLSQGFDLS---GLFEKEERSESKFTTKKDAKEIVSKFEEIATSSERFNLTK 358
Query: 361 SESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKD 420
S+ V+++ + GRKG LAI+ +IF VT S +VE KK GDT+EY QFC ELRP+LKD
Sbjct: 359 SDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELRPSLKD 418
Query: 421 IVWMSTADN 429
IVW +N
Sbjct: 419 IVWKWQGNN 427
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 959 (342.6 bits), Expect = 1.5e-123, Sum P(2) = 1.5e-123
Identities = 172/262 (65%), Positives = 218/262 (83%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKM 75
L+ G+YE+G++LGHGTFAKVYLARN++T +S+A IKREIS+++
Sbjct: 21 LILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRR 80
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 135
V+H +IV+L EVMA+K+KIYF M+ V+GGELFNK+AKGRL+E+VAR YFQQLISAV FCH
Sbjct: 81 VRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAVTFCH 140
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
+RGVYHRDLKPENLLLDE+GNLKV+DFGLSA S+ ++QDGL HT CGTPAYVAPEV+++K
Sbjct: 141 ARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARK 200
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255
GYD AK DIWSCGVIL+VL+AG+LPF D N+++MY+KIYRG+F+CP WFS+E RL++KL
Sbjct: 201 GYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKL 260
Query: 256 LDPNPNSRIAISKIMESSWFKK 277
L+ NP R +IME+SWFKK
Sbjct: 261 LETNPEKRFTFPEIMENSWFKK 282
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 8.4e-121, Sum P(2) = 8.4e-121
Identities = 174/301 (57%), Positives = 226/301 (75%)
Query: 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISV 72
R +L GKYELG++LGHGTFAKVYLA+N+++G +A IKREIS+
Sbjct: 66 RNNILMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISI 125
Query: 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVD 132
++ V+H +IV L EVMA+KSKIYF M+ V GGELFN +AKGRL E+ AR YFQQLIS+V
Sbjct: 126 LRRVRHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVS 185
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
FCH RGVYHRDLKPENLLLD GNLKV+DFGLSA +E L+QDGL HT CGTPAY+APEV+
Sbjct: 186 FCHGRGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVL 245
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252
++KGYD AKAD+WSCGVIL+VL+AG +PF D NI+ MY+KIY+G+F+CP WFSS+ RL+
Sbjct: 246 TRKGYDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLL 305
Query: 253 TKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLS 312
T+LLD NP++RI I +IM++ WFKK V ++ + + ++ E ++ ++S
Sbjct: 306 TRLLDTNPDTRITIPEIMKNRWFKKGFKHVKFYIEDDKLCREDEDEEEEASSSGRSSTVS 365
Query: 313 E 313
E
Sbjct: 366 E 366
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
Identities = 170/267 (63%), Positives = 218/267 (81%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREI 70
+++P++L KY++GR+LG GTFAKVY R++ T +S+A EQIKREI
Sbjct: 2 ENKPSVLTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREI 61
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVM++ +H ++VEL+EVMA+K++IYF M+ KGGELFNK+AKG+LR+DVA YF QLI+A
Sbjct: 62 SVMRIARHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINA 121
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
VDFCHSR VYHRD+KPENLLLD++ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPE
Sbjct: 122 VDFCHSREVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 181
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI++KGYDG KADIWSCGV+L+VLLAG+LPF D N++ MYRKI + DFK P WF+ E RR
Sbjct: 182 VINRKGYDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRR 241
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKK 277
L+ K+LDPNP +RI I++I ESSWF+K
Sbjct: 242 LLCKMLDPNPETRITIARIRESSWFRK 268
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 7.5e-120, Sum P(2) = 7.5e-120
Identities = 171/273 (62%), Positives = 223/273 (81%)
Query: 5 NSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXE 64
N++ D P LL G++ELG++LGHGTFAKV+LA+N++TG+++A
Sbjct: 10 NNSFNKKDNPNLLLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVS 69
Query: 65 QIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF 124
IKREIS+++ V+H +IV+L EVMA+K+KIYF M+ V+GGELFNK+AKGRL+E+VAR YF
Sbjct: 70 HIKREISILRRVRHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYF 129
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
QQLI AV+FCH+RGV+HRD+KPENLLLDE+GNLKV+DFGLSA S+ +KQDGL HT CGTP
Sbjct: 130 QQLICAVEFCHARGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTP 189
Query: 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW 243
AYVAPEV+S+KGYDG K DIWSCGV+L+VL+AG+LPF D +N++ MY+KIY+GDF+CP W
Sbjct: 190 AYVAPEVLSRKGYDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRW 249
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
FS E L+T+LLD P +RI+I +IME+ WFK
Sbjct: 250 FSPELVNLLTRLLDTKPQTRISIPEIMENRWFK 282
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 2.9e-118, Sum P(2) = 2.9e-118
Identities = 174/290 (60%), Positives = 226/290 (77%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREI 70
+++P++L +YE+GR+LG GTFAKVY R+ T +S+A +QIKREI
Sbjct: 2 ENKPSVLTERYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREI 61
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
SVM++ KH ++VEL+EVMA+KS+IYF ++ KGGELFNK+AKG+L+EDVA YF QLISA
Sbjct: 62 SVMRIAKHPNVVELYEVMATKSRIYFVIEYCKGGELFNKVAKGKLKEDVAWKYFYQLISA 121
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
VDFCHSRGVYHRD+KPENLLLD++ NLKV+DFGLSA ++ +QDGLLHTTCGTPAYVAPE
Sbjct: 122 VDFCHSRGVYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPE 181
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250
VI++KGY+G KADIWSCGV+L+VLLAG+LPF D N++ MYRKI + DFKCP WF+ E +R
Sbjct: 182 VINRKGYEGTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKR 241
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQP 300
L+ K+LDPN +RI I+KI ESSWF+K ++ME + + + P
Sbjct: 242 LLCKMLDPNHETRITIAKIKESSWFRKGLHLKQKKMEKMEKQQVREATNP 291
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 6.8e-117, Sum P(2) = 6.8e-117
Identities = 171/281 (60%), Positives = 219/281 (77%)
Query: 4 SNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXX 63
S S+ GG R GKYELGR LG GTFAKV ARN++ G ++A
Sbjct: 18 SGSSSGGRTRV----GKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMI 73
Query: 64 EQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARV 122
QIKREIS MK++KH +++ + EVMASK+KIYF ++ V GGELF+KI+ GRL+ED AR
Sbjct: 74 AQIKREISTMKLIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARK 133
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
YFQQLI+AVD+CHSRGVYHRDLKPENLLLD +G LKV+DFGLSA + +++DGLLHTTCG
Sbjct: 134 YFQQLINAVDYCHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCG 193
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 242
TP YVAPEVI+ KGYDGAKAD+WSCGVIL+VL+AG+LPF+D N+ S+Y+KI++ +F CPP
Sbjct: 194 TPNYVAPEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPP 253
Query: 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS--APK 281
WFS+ A++LI ++LDPNP +RI ++++E+ WFKK APK
Sbjct: 254 WFSASAKKLIKRILDPNPATRITFAEVIENEWFKKGYKAPK 294
|
|
| TAIR|locus:2040824 CIPK13 "CBL-interacting protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 898 (321.2 bits), Expect = 5.5e-113, Sum P(2) = 5.5e-113
Identities = 171/300 (57%), Positives = 221/300 (73%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMK 74
++L KYE+G++LGHG+FAKVYLARN+ +G+ +A IKREIS+++
Sbjct: 51 SILMDKYEIGKLLGHGSFAKVYLARNIHSGEDVAIKVIDKEKIVKSGLAGHIKREISILR 110
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
V+H +IV L EVMA+K+KIY M+ V+GGEL+N +A+GRLRE AR YFQQLIS+V FC
Sbjct: 111 RVRHPYIVHLLEVMATKTKIYIVMEYVRGGELYNTVARGRLREGTARRYFQQLISSVAFC 170
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
HSRGVYHRDLK ENLLLD+ GN+KV+DFGLS SE LKQ+G+ T CGTPAY+APEV+++
Sbjct: 171 HSRGVYHRDLKLENLLLDDKGNVKVSDFGLSVVSEQLKQEGICQTFCGTPAYLAPEVLTR 230
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
KGY+GAKADIWSCGVIL+VL+AG+LPF D NI+ MY KIY+G FKCP WFS E RL+T+
Sbjct: 231 KGYEGAKADIWSCGVILFVLMAGYLPFDDKNILVMYTKIYKGQFKCPKWFSPELARLVTR 290
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEG 314
+LD NP++RI I +IM+ WFKK V + E DK ++ + + SLS G
Sbjct: 291 MLDTNPDTRITIPEIMKHRWFKKGFKHV-----KFYIENDKLCREDDDNDDDDSSSLSSG 345
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
Identities = 224/432 (51%), Positives = 292/432 (67%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAXXXXXXXXXXXXXXXEQIKREISVMKM 75
+L KYE+GR+LG GTF KVY + + TG+S+A EQIKREIS+M++
Sbjct: 38 VLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMRL 97
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 135
V+H +IVEL EVMA+K+KI+F M+ VKGGELF+KI KG+L+ED AR YFQQLISAVDFCH
Sbjct: 98 VRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIVKGKLKEDSARKYFQQLISAVDFCH 157
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
SRGV HRDLKPENLL+DE+G+LKV+DFGLSA E + QDGLLHT CGTPAYVAPEV+ KK
Sbjct: 158 SRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVAPEVLRKK 217
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255
GYDGAK DIWSCG+ILYVLLAGFLPFQD+N++ MYRKI++ +F+ PPWFS E++RLI+KL
Sbjct: 218 GYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPESKRLISKL 277
Query: 256 LDPNPNSRIAISKIMESSWFKKSAPKVVITK-QEMEFE--ADKSSK-------------Q 299
L +PN RI+I IM + WF+K+ + K E+E + D++
Sbjct: 278 LVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPTTTATTATTTTTPVS 337
Query: 300 PETLNAFHIISLSEGFDLSPXXXXXXXXXXXXXXXXTTR-PASSVISRFEEVAKAVKFNV 358
P+ NAF IS T+R AS ++ + E + K + V
Sbjct: 338 PKFFNAFEFIS---SMSSGFDLSSLFESKRKLRSMFTSRWSASEIMGKLEGIGKEMNMKV 394
Query: 359 K-TSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPA 417
K T + +V+L G+ GRKG++A+ A++F V P + VVE+ K GDTLEYN+ +RPA
Sbjct: 395 KRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYNRLYEEHVRPA 454
Query: 418 LKDIVWMSTADN 429
L++IVW DN
Sbjct: 455 LEEIVWSWHGDN 466
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O65554 | CIPK6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7615 | 0.9546 | 0.9546 | yes | no |
| Q9LWM4 | CIPK5_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6058 | 0.9569 | 0.9154 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | CIPK9 | SubName- Full=CBL-interacting protein kinase 9; (437 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | CBL1 | SubName- Full=Calcineurin B-like protein 1; (213 aa) | • | 0.649 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 441 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-106 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-89 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-81 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-81 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-70 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-66 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-66 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-65 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-61 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-57 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-54 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-54 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-53 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-52 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-52 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-51 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-51 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-50 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-50 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-49 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-49 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-48 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-48 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-48 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-48 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-48 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-48 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 6e-48 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-47 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-47 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-46 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-46 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-45 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-45 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-44 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-44 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-43 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-43 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-42 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-42 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-42 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-41 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-41 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-41 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-40 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-39 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-39 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-39 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-39 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-39 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-38 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-38 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-38 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-37 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-37 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-37 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-36 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-36 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-36 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-35 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-35 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-35 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-35 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-35 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-35 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-34 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-33 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-33 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-33 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-33 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-31 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-31 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-30 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-30 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-29 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-28 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-28 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-28 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-26 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-26 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-24 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-24 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 2e-24 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-19 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| cd12120 | 95 | cd12120, AMPKA_C_like, C-terminal regulatory domai | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 315 bits (809), Expect = e-106
Identities = 118/260 (45%), Positives = 169/260 (65%), Gaps = 11/260 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YE+ LG G+F KVYLAR+ +TGK +A+KV+ K K+ K E+I REI ++K +KH +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 139
IV L++V + K+Y M+ +GG+LF+ + +GRL ED AR Y +Q++SA+++ HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRDLKPEN+LLDEDG++K+ DFGL+ L L T GTP Y+APEV+ KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 200 AKADIWSCGVILYVLLAGFLPFQ-DDNIVSMYRKIYRGDFKCPPW---FSSEARRLITKL 255
DIWS GVILY LL G PF DD ++ +++KI + PP S EA+ LI KL
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 256 LDPNPNSRIAISKIMESSWF 275
L +P R+ + ++ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 8e-89
Identities = 105/263 (39%), Positives = 154/263 (58%), Gaps = 11/263 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YEL R LG G+F VY A++ TGK +A+K++ K K + +REI +++ + H +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
IV L + K +Y M+ +GG+LF+ +++ G L ED A+ Q++ +++ HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRDLKPEN+LLDE+G +K+ DFGL+ LK L T GTP Y+APEV+ G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK--LLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----DFKCPPW--FSSEARRLI 252
K D+WS GVILY LL G PF +NI+ + I R +F P W S EA+ LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 253 TKLLDPNPNSRIAISKIMESSWF 275
K L+ +P+ R +I++ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (644), Expect = 1e-81
Identities = 103/240 (42%), Positives = 149/240 (62%), Gaps = 6/240 (2%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G+F KV L R TGK AMKV+ K K+IK +E E +++ + H IV+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 145
++ K+Y ++ GGELF+ ++K GR E+ AR Y +++ A+++ HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 146 PENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADI 204
PEN+LLD DG++K+TDFGL+ L +G +T CGTP Y+APEV+ KGY A D
Sbjct: 121 PENILLDADGHIKLTDFGLAK---ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDW 176
Query: 205 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 264
WS GV+LY +L G PF ++ +Y KI + + P + S EAR LI+ LL +P R+
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL 236
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 250 bits (642), Expect = 7e-81
Identities = 105/262 (40%), Positives = 159/262 (60%), Gaps = 12/262 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E + LG G+F +V L R+ +GK A+K++ K K++K+ +E + E +++ ++H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
+V L+ S +Y M+ V GGELF+ + K GR E VAR Y Q++ A+++ HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPENLLLD DG +K+TDFG F++ +K G +T CGTP Y+APE+I KGY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFG---FAKRVK--GRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
A D W+ G+++Y +LAG+ PF DDN + +Y KI G + P +FS +A+ LI LL +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 260 PNSRIAISK-----IMESSWFK 276
R+ K I WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 1e-70
Identities = 90/264 (34%), Positives = 142/264 (53%), Gaps = 20/264 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM-----EQIKREISVMK 74
KYE+ + +G G+F KVYL R GK +K I + M E E+ ++K
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKE------IDLSNMSEKEREDALNEVKILK 54
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-----LREDVARVYFQQLIS 129
+ H +I++ +E K K+ M+ GG+L KI K + E+ +F QL
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
A+ + HSR + HRD+KP+N+ L +G +K+ DFG+S L T GTP Y++P
Sbjct: 115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSP 172
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEA 248
E+ K Y+ K+DIWS G +LY L PF+ +N++ + KI +G + P +SSE
Sbjct: 173 ELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSEL 231
Query: 249 RRLITKLLDPNPNSRIAISKIMES 272
R L++ LL +P R +I++I++S
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 1e-69
Identities = 93/249 (37%), Positives = 137/249 (55%), Gaps = 38/249 (15%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G F VYLAR+ +TGK +A+K++ K+ ++E++ REI ++K + H +IV+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 144
V ++ +Y M+ +GG L + + + G+L ED Q++ +++ HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 145 KPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
KPEN+LLD D G +K+ DFGLS K LL T GTPAY+APEV+ KGY K+D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
IWS GVILY L E + LI K+L +P R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 264 IAISKIMES 272
+ +I+E
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 1e-66
Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 13/259 (5%)
Query: 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89
G + +V+LA+ TG A+KV+ K +I+ ++Q+ E ++ + ++V+L+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 90 SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 148
K +Y M+ + GG+L + + G L EDVAR+Y +++ A+++ HS G+ HRDLKP+N
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123
Query: 149 LLLDEDGNLKVTDFGLSAF---SEHLKQDGLL---HTTCGTPAYVAPEVISKKGYDGAKA 202
+L+D +G+LK+TDFGLS + + GTP Y+APEVI +G+
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--PWFSSEARRLITKLLDPNP 260
D WS G ILY L G PF + +++ I G + P S EA LI+KLL P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242
Query: 261 NSRI---AISKIMESSWFK 276
R+ +I +I +FK
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 6e-66
Identities = 99/259 (38%), Positives = 141/259 (54%), Gaps = 14/259 (5%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G F +V L + ++ A+K V K +++ G E I E +++ H IV+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 87 VMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 145
K IY M+ GGEL+ + +G E AR Y ++ A ++ H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 146 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 205
PENLLLD +G +K+ DFG F++ LK T CGTP YVAPE+I KGYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 206 SCGVILYVLLAGFLPFQDDNIVSM--YRKIYRGDFKC--PPWFSSEARRLITKLLDPNPN 261
S G++LY LL G PF +D+ M Y I +G+ K P + A+ LI +LL NP
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 262 SRI-----AISKIMESSWF 275
R+ I I + WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 2e-65
Identities = 87/272 (31%), Positives = 153/272 (56%), Gaps = 21/272 (7%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHK 79
++ G+++G G+F+ V LA+ +T K A+K++ K ++IK ++ +K E V+ ++ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
I++L+ + +YF ++ GEL I K G L E R Y +++ A+++ HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAF------SEHLKQDGLLHTT------------ 180
+ HRDLKPEN+LLD+D ++K+TDFG + E K D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240
GT YV+PE++++K G +D+W+ G I+Y +L G PF+ N ++KI + ++
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 272
PP F +A+ LI KLL +P R+ +++ +
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 8e-62
Identities = 97/245 (39%), Positives = 149/245 (60%), Gaps = 7/245 (2%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+G LG G+F +V +A++ TG+ A+K + K +++K+ ++ + +E S++ + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
IV + ++++YF ++ V GGELF + K GR DVA+ Y +L+ A ++ HS+ +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPENLLLD G++KVTDFG F++ + T CGTP Y+APEVI KG+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFG---FAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGK 194
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
A D W+ GV+LY +AG+ PF DD +Y KI G K P WF AR L+ LL +
Sbjct: 195 A-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253
Query: 260 PNSRI 264
R+
Sbjct: 254 HTKRL 258
|
Length = 329 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 198 bits (507), Expect = 4e-61
Identities = 80/252 (31%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
++ G +LG G+F VYLA + TG+ MA+K V + +E ++REI ++ ++H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59
Query: 80 HIVEL--HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS 136
+IV E K+ + ++ V GG L + + K G+L E V R Y +Q++ + + HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
G+ HRD+K N+L+D DG +K+ DFG + ++ + GTP ++APEVI +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 197 YDGAKADIWSCGVILYVLLAGFLPF--QDDNIVSMYRKIYRGDFKCPP---WFSSEARRL 251
Y G ADIWS G + + G P+ + + ++Y+ G+ P S EA+
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE--PPEIPEHLSEEAKDF 236
Query: 252 ITKLLDPNPNSR 263
+ K L +P R
Sbjct: 237 LRKCLRRDPKKR 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-57
Identities = 93/263 (35%), Positives = 146/263 (55%), Gaps = 12/263 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
E + +G GTF +V+L R+ + A+KV+ +VI++ + + E V+K V H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 139
I+ L + +Y M+ V GGELF+ + GR Y +++ A+++ HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPEN+LLD++G++K+TDFG F++ L+ T CGTP Y+APEVI KG++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
A D W+ G+++Y +L G+ PF DDN +Y KI G + P A+ LI KLL +
Sbjct: 178 A-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 260 PNSRIAISK-----IMESSWFKK 277
R+ K + WFK
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 4e-54
Identities = 106/385 (27%), Positives = 167/385 (43%), Gaps = 32/385 (8%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH- 78
Y + R LG G+F +VYLAR+ K +A+KV+ K K +E+ REI ++ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARVYFQQLISAVDFC 134
+IV+L++ + +Y M+ V GG L KG L E A Q++SA+++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 135 HSRGVYHRDLKPENLLLDEDGN-LKVTDFGLSAF----SEHLKQDGLLHTTCGTPAYVAP 189
HS+G+ HRD+KPEN+LLD DG +K+ DFGL+ L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 190 EVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKC--- 240
EV+ Y + +DIWS G+ LY LL G PF+ + S + I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 241 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK----KSAPKVVITKQEME 290
P S A L+ KLL +P +R++ S + K + + K +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 291 FEADKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEV 350
S + SL+ L + E +++ SS +
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTAS 357
Query: 351 AKAVKFNVKTSESRVRLQGQESGRK 375
+K ++ S S ++
Sbjct: 358 SKRSSLPKISARSSPSSLSSSSRQQ 382
|
Length = 384 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 6e-54
Identities = 81/263 (30%), Positives = 139/263 (52%), Gaps = 14/263 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+EL R++G G F KV + + T K AMK + K K ++ G + + E +++ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 81 IVELHEVMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+V L + +Y +DL+ GG+L ++ K + E+ + + +++ A+++ HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRD+KP+N+LLDE G++ +TDF ++ + D L +T GTP Y+APEV+ ++GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-----PPWFSSEARRLITK 254
D WS GV Y L G P+ R R + P +S+EA I K
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235
Query: 255 LLDPNPNSRI--AISKIMESSWF 275
LL+ +P R+ + + +F
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 3e-53
Identities = 92/245 (37%), Positives = 142/245 (57%), Gaps = 8/245 (3%)
Query: 25 RMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGM-MEQIKREISVMKMVKHKH 80
++LG G + KV+ R + TGK AMKV+ K +++ K E ++++ VKH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
IV+L + K+Y ++ + GGELF + + G ED A Y ++ A++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPEN+LLD G++K+TDFGL E + + + HT CGT Y+APE++ + G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
D WS G ++Y +L G PF +N KI +G PP+ + EAR L+ KLL N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 260 PNSRI 264
P+SR+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-52
Identities = 92/257 (35%), Positives = 142/257 (55%), Gaps = 9/257 (3%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
++LG GTF KV L R TGK AMK++ K+ +I + E V++ +H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRD 143
+ ++ F M+ GGELF +++ R+ ED AR Y +++SA+ + HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LK ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 264 IA-----ISKIMESSWF 275
+ +IME +F
Sbjct: 238 LGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 2e-52
Identities = 93/242 (38%), Positives = 134/242 (55%), Gaps = 5/242 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVE 83
+++G G+F KV LA++ GK A+KV+ K ++K + I E +V+ K VKH +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH + K+YF +D V GGELF + + R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLKPEN+LLD G++ +TDFGL E ++ T CGTP Y+APEV+ K+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W G +LY +L G PF + MY I + P S AR L+ LL +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 263 RI 264
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-51
Identities = 87/242 (35%), Positives = 140/242 (57%), Gaps = 5/242 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
++LG G+F KV LA T + A+KV+ KD +++ +E E V+ + KH + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHR 142
LH +K +++F M+ V GG+L I + GR E AR Y +++ + F H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD +G++K+ DFG+ E + T CGTP Y+APE++S + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W+ GV+LY +LAG PF+ D+ +++ I + + P W S EA+ ++ L NP
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 263 RI 264
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 7e-51
Identities = 94/290 (32%), Positives = 146/290 (50%), Gaps = 35/290 (12%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +++G G F +V+L R+ TG+ AMKV+ K +IK + ++ E ++
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHSRGV 139
IV+L+ + +Y M+ + GG+L N I K E+ AR Y +L+ A+D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA---------------------------FSEHLK 172
HRD+KP+N+L+D DG++K+ DFGL +H +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK 232
+ ++T GTP Y+APEV+ Y + D WS GVILY +L GF PF D + Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 233 I--YRGDFKCPP--WFSSEARRLITKLLDPNPNSRI-AISKIMESSWFKK 277
I ++ + PP S EA LI +LL P R+ + +I +FK
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-50
Identities = 95/257 (36%), Positives = 147/257 (57%), Gaps = 9/257 (3%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
++LG GTF KV L R +GK AMK++ K+ +I + E V+K +H + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRD 143
+K ++ F M+ V GGELF +++ R+ ED R Y +++SA+D+ HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LK ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W GV++Y ++ G LPF + + ++ I D K P S++A+ L++ LL +PN R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 264 IA-----ISKIMESSWF 275
+ +IM S+F
Sbjct: 238 LGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 3e-50
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 27/270 (10%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM-----EQIKREISVMK 74
YE+ +G G+F V R GK + K I G M +Q+ E+++++
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKE------IDYGNMTEKEKQQLVSEVNILR 54
Query: 75 MVKHKHIVEL--HEVMASKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQL 127
+KH +IV + S +Y M+ +GG+L I K + E+ QL
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 128 ISAVDFCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
+ A+ CH+R V HRDLKP N+ LD + N+K+ DFGL+ H T G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVG 172
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-P 241
TP Y++PE ++ YD K+DIWS G ++Y L A PF N + + KI G F+ P
Sbjct: 173 TPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231
Query: 242 PWFSSEARRLITKLLDPNPNSRIAISKIME 271
+SSE +I +L+ +P+ R + ++++
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 1e-49
Identities = 91/244 (37%), Positives = 147/244 (60%), Gaps = 8/244 (3%)
Query: 25 RMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
++LG G+F KV+L R + G+ AMKV+ K +KV + K E ++ V H I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVY 140
V+LH ++ K+Y +D ++GG+LF +++K + E+ + Y +L A+D HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
+RDLKPEN+LLDE+G++K+TDFGLS E + + ++ CGT Y+APEV++++G+ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 260
AD WS GV+++ +L G LPFQ + I + P + S EA+ L+ L NP
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 261 NSRI 264
+R+
Sbjct: 238 ANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 85/249 (34%), Positives = 129/249 (51%), Gaps = 12/249 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+E+ +G G F +VY AR+ +TGK +A+KV+ K+ E+I EI ++K KH
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHP 57
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSR 137
+IV+ + K +++ M+ GG L + K L E ++L+ +++ HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
G+ HRD+K N+LL DG +K+ DFGLSA K +T GTP ++APEVI+ K Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGKPY 174
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 254
D KADIWS G+ L G P+ + + KI + P +S E + + K
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 255 LLDPNPNSR 263
L NP R
Sbjct: 234 CLQKNPEKR 242
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 6e-49
Identities = 86/241 (35%), Positives = 138/241 (57%), Gaps = 4/241 (1%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
++LG GTF KV L R TG+ AMK++ K+ +I + E V++ +H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRD 143
+ ++ F M+ GGELF +++ R+ E+ AR Y +++SA+++ HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
+K ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 264 I 264
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-48
Identities = 87/242 (35%), Positives = 131/242 (54%), Gaps = 4/242 (1%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+F KV R T + A+K + K ++ + E +V+ V IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 145
S K+Y + + GGELF+ + + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 146 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 205
PEN+LLD G++ + DFGL + +K D +T CGTP Y+APE++ GY A D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177
Query: 206 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 265
+ GV+LY +L G PF D+N+ MYRKI + + P F +A+ L+ LL +P R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 266 IS 267
+
Sbjct: 238 YN 239
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 90/272 (33%), Positives = 143/272 (52%), Gaps = 26/272 (9%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKM 75
+++ G +G GTF KVY A NL TG+ MA+K + K IK +I E+ V+++
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-----EIADEMKVLEL 55
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFC 134
+KH ++V+ + V + K+Y M+ GG L + GR L E V RVY QL+ + +
Sbjct: 56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF--SEHLKQDGLLHTTCGTPAYVAPEVI 192
HS G+ HRD+KP N+ LD +G +K+ DFG + + + + GTPAY+APEVI
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 193 SK---KGYDGAKADIWSCGVILYVLLAGFLPF--QDDNIVSMYRKIYRGDFKCPPW---- 243
+ KG+ A ADIWS G ++ + G P+ D+ M+ G PP
Sbjct: 176 TGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV---GAGHKPPIPDSL 231
Query: 244 -FSSEARRLITKLLDPNPNSRIAISKIMESSW 274
S E + + + L+ +P R S++++ +
Sbjct: 232 QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-48
Identities = 86/256 (33%), Positives = 132/256 (51%), Gaps = 16/256 (6%)
Query: 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVM 88
G F VYLA+ TG A+KV+ K +I + +K E ++M + ++ +L+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 89 ASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147
SK +Y M+ + GG+ + I G L ED A+ Y +++ V+ H RG+ HRD+KPE
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 148 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSC 207
NLL+D+ G+LK+TDFGLS K+ GTP Y+APE I G D +D WS
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDDKM-SDWWSL 179
Query: 208 GVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDPNPNSR 263
G +++ L G+ PF + +++ I P + S EA LI +LL +P R
Sbjct: 180 GCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
Query: 264 IA---ISKIMESSWFK 276
+ +I +FK
Sbjct: 240 LGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 4e-48
Identities = 93/296 (31%), Positives = 141/296 (47%), Gaps = 55/296 (18%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMV 76
YE LG GT+ VY AR+ +TG+ +A+K + D E I REIS++K +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-----EGIPSTALREISLLKEL 55
Query: 77 KHKHIVELHEVMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131
KH +IV+L +V+ ++ K+ Y MDL K + G L ++ + QL+ +
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMDLKK----YLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTT-CGTPAYVAP 189
+CHS + HRDLKP+N+L++ DG LK+ DFGL+ AF L+ +T T Y AP
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT----YTHEVVTLWYRAP 167
Query: 190 EVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--------------- 233
E++ K Y A DIWS G I ++ G F D+ + KI
Sbjct: 168 EILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226
Query: 234 -----YRGDF---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
Y+ F K P E L++K+L NP RI+ + ++ +F
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 4e-48
Identities = 97/273 (35%), Positives = 146/273 (53%), Gaps = 19/273 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV 76
+EL R+LG G + KV+L R + GK AMKV+ K ++ K E + E V++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 77 KHK-HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFC 134
+ +V LH + +K++ +D V GGELF + + E RVY +++ A+D
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHTTCGTPAYVAPEVIS 193
H G+ +RD+K EN+LLD +G++ +TDFGLS E L ++ ++ CGT Y+APEVI
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLS--KEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 194 KK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC----PPWFSSE 247
G+D A D WS GV+ + LL G PF D + +I R K P S+E
Sbjct: 180 GGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 248 ARRLITKLLDPNPNSRIA---ISKIMESSWFKK 277
AR I KLL+ +P R+ +I +F+
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 4e-48
Identities = 93/243 (38%), Positives = 137/243 (56%), Gaps = 5/243 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVE 83
+++G G+F KV LAR+ K A+KV+ K ++K + I E +V+ K VKH +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH + K+YF +D + GGELF + + R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLKPEN+LLD G++ +TDFGL E+++ +G T CGTP Y+APEV+ K+ YD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W G +LY +L G PF N MY I + P ++ AR L+ LL +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 263 RIA 265
R+
Sbjct: 238 RLG 240
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-48
Identities = 62/117 (52%), Positives = 84/117 (71%), Gaps = 2/117 (1%)
Query: 304 NAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSES 363
NAF +ISLS G DLS LFEE+ +RE RF + +PA +I + EE AK + F V+ +
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRET-RFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59
Query: 364 -RVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALK 419
V+L+GQ+ GRKG+LA++ ++F VTPSL+VVEVKK GDTLEY++F + LRP LK
Sbjct: 60 GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 87/288 (30%), Positives = 142/288 (49%), Gaps = 37/288 (12%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
++LG G +V+L R TGK A+KV+ K ++IK ++++ E ++ + H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELF---NKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
+ +++ + MD GGELF + L E+VAR Y +++ A+++ H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 142 RDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTT------------------ 180
RDLKPEN+LL E G++ ++DF LS L +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 181 ------CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 234
GT Y+APEVIS G+ A D W+ G++LY +L G PF+ N + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 235 RGDFKCP--PWFSSEARRLITKLLDPNPNSRIA----ISKIMESSWFK 276
+ + P P SS AR LI KLL +P+ R+ ++I + +F+
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 88/265 (33%), Positives = 134/265 (50%), Gaps = 25/265 (9%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G + +V+LA+ TG+ +A+K + K + K+ + + E ++ K + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 87 VMASKSKIYFAMDLVKGGE---LFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
+Y AM+ V GG+ L N G L ED AR Y ++ AVD H G HRD
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL---HTTCGTPAYVAPEVISKKGYDGA 200
LKPEN L+D G++K+TDFGLS G++ ++ G+P Y+APEV+ KGYD
Sbjct: 127 LKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-F 177
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--RGDFKCPPW------FSSEARRLI 252
D WS G +LY L GF PF + + + + P + S EA LI
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237
Query: 253 TKLLDPNPNSRIAISKIMESSWFKK 277
TKL++ ++ I +FK+
Sbjct: 238 TKLINDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 1e-46
Identities = 90/258 (34%), Positives = 146/258 (56%), Gaps = 10/258 (3%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
++LG GTF KV L + TG+ AMK++ K+ ++ + E V++ +H + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHS-RGVYHR 142
+ ++ F M+ GGELF +++ R+ ED AR Y +++SA+D+ HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK ENL+LD+DG++K+TDFGL E +K + T CGTP Y+APEV+ Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W GV++Y ++ G LPF + + ++ I + + P S EA+ L++ LL +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 263 RIA-----ISKIMESSWF 275
R+ +IM+ +F
Sbjct: 238 RLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 7e-46
Identities = 91/250 (36%), Positives = 136/250 (54%), Gaps = 6/250 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVE 83
+++G G+F KV LA+ G A+KV+ K ++K I E +V+ K +KH +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH + K+YF +D V GGELF + + R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLKPEN+LLD G++ +TDFGL E ++ + T CGTP Y+APEV+ K+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W G +LY +L G PF ++ MY I + P + A L+ LL +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 263 RI-AISKIME 271
R+ A + +E
Sbjct: 238 RLGAKADFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 93/243 (38%), Positives = 133/243 (54%), Gaps = 5/243 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVE 83
+++G G+F KV LA+ GK A+KV+ K V+ + I E +V+ K VKH +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH + K+YF +D V GGELF + + R E AR Y ++ SA+ + HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLKPEN+LLD G++ +TDFGL E + Q T CGTP Y+APEVI K+ YD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W G +LY +L G PF ++ MY I P S A ++ +LL+ +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 263 RIA 265
R+
Sbjct: 238 RLG 240
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 8e-45
Identities = 82/242 (33%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVE 83
R+LG G+F KV LAR ++G+ A+KV+ KD +++ +E E ++ + + H + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
L+ + +++F M+ V GG+L I K R E AR Y ++ SA+ F H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD +G+ K+ DFG+ E + T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W+ GV+LY +L G PF+ +N ++ I + P W S +A ++ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 263 RI 264
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 83/242 (34%), Positives = 134/242 (55%), Gaps = 5/242 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
++LG G+F KV LA T + A+KV+ KD +++ ++ E ++ + KH +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH +K +++F M+ V GG+L +I + R E +R Y ++ A+ F H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD +G+ K+ DFG+ E + T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W+ GV++Y ++AG PF+ DN ++ I D P W S EA ++ + NPN
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 263 RI 264
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-44
Identities = 86/244 (35%), Positives = 132/244 (54%), Gaps = 9/244 (3%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK---MVKHKHIVE 83
+G GTF +VY R T + AMKV+ K +++ + E +++ + + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHR 142
L + S +Y D + GGELF + K GR ED A+ Y +L+ A++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV-ISKKGYDGAK 201
DLKPEN+LLD G++ + DFGLS +L + +T CGT Y+APEV + +KGY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 202 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-WFSSEARRLITKLLDPNP 260
D WS GV+++ + G+ PF ++ MYR I G + P S E R+ + LL+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 261 NSRI 264
R+
Sbjct: 238 QHRL 241
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 6e-44
Identities = 80/260 (30%), Positives = 135/260 (51%), Gaps = 10/260 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
Y+LG ++G G F VY NL+TG +A+K + +K IK ++ I +EI ++K +KH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+IV+ + + +Y ++ + G L I K G E + VY Q++ + + H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V HRD+K N+L +DG +K+ DFG++ ++ + GTP ++APEVI G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---FSSEARRLITKL 255
+DIWS G + LL G P+ D N ++ +I + D PP S E + + +
Sbjct: 178 -TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--HPPLPEGISPELKDFLMQC 234
Query: 256 LDPNPNSRIAISKIMESSWF 275
+PN R ++++ W
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 22/264 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKM 75
+++ + LG G++ VY + L + A+K V +G M Q +R EI ++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV------DLGSMSQKEREDAVNEIRILAS 55
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-----LREDVARVYFQQLISA 130
V H +I+ E +K+ M+ G+L I+K + + E F QL+
Sbjct: 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
+ H + + HRDLK N+LL + +K+ D G+S + + + T GTP Y+APE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGTPHYMAPE 171
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEAR 249
V + Y K+DIWS G +LY + PF+ ++ + K+ RG + PP +S + +
Sbjct: 172 VWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 250 RLITKLLDPNPNSRIAISKIMESS 273
I +L P R KI+ S
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 86/300 (28%), Positives = 142/300 (47%), Gaps = 46/300 (15%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E +++G G F +V L + TG AMK + K ++++ + ++ E ++ +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+V+L+ ++ +Y M+ + GG++ + K E+ R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGL---------SAFSEHLKQD---------------- 174
HRD+KP+NLLLD G++K++DFGL + F L
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 175 -----------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD 223
L ++T GTP Y+APEV + GY + D WS GVI+Y +L G+ PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 224 DNIVSMYRKI--YRGDFKCPP--WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFK 276
DN YRKI ++ + P S EA+ LI +L R+ +++I +FK
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 93/297 (31%), Positives = 154/297 (51%), Gaps = 5/297 (1%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
++LG G+F KV LA T + A+K + KD V++ +E E V+ + +H +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
L +K ++F M+ + GG+L I + GR E AR Y ++I + F H +G+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD+DG++K+ DFG+ E++ +G T CGTP Y+APE++ + Y+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D WS GV+LY +L G PF ++ ++ I P W S EA+ ++KL + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237
Query: 263 RIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLSP 319
R+ + + F + + K+E+ K P + F +E LSP
Sbjct: 238 RLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSP 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 91/301 (30%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+ +G G F +V L R + T AMK + K V+ +K E ++ ++ +V+L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
+ K +YF MD + GG++ + I G ED+AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGL-SAF-----------SEHLKQDG---------------- 175
+KP+N+L+D DG++K+TDFGL + F +H +QD
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 176 -------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222
L H+ GTP Y+APEV+ + GY D WS GVILY +L G PF
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPFL 245
Query: 223 DDNIVSMYRKI--YRGDFKCPPW--FSSEARRLITKLLDPNPNSRIA---ISKIMESSWF 275
D K+ + P S EA LI +L R+ +I +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304
Query: 276 K 276
K
Sbjct: 305 K 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-42
Identities = 94/272 (34%), Positives = 152/272 (55%), Gaps = 18/272 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV 76
+EL ++LG G + KV+L R + TGK AMKV+ K ++ K +E + E +V++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 77 KHK-HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFC 134
+ +V LH +++K++ +D V GGE+F + + ED R Y ++I A++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVIS 193
H G+ +RD+K EN+LLD +G++ +TDFGLS F K+ ++ CGT Y+APE+I
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER--TYSFCGTIEYMAPEIIR 179
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEAR 249
KG G D WS G++++ LL G PF + + + R+I + D P + EA+
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239
Query: 250 RLITKLLDPNPNSRI-----AISKIMESSWFK 276
L+ KLL +P R+ S+I E +FK
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-42
Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 22/272 (8%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKV--VGKDKVIKVGMMEQIKREISVMKMVK 77
Y+ +G G +VY A + TGK +A+K + K E I EI +MK K
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN------KELIINEILIMKDCK 73
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLRED-VARVYFQQLISAVDFC 134
H +IV+ ++ +++ M+ + GG L + I R+ E +A V ++++ +++
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYL 132
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVI 192
HS+ V HRD+K +N+LL +DG++K+ DFG +A E K+ ++ GTP ++APEVI
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVI 188
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRG--DFKCPPWFSSEAR 249
+K Y K DIWS G++ + G P+ + + +++ +G K P +S E +
Sbjct: 189 KRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247
Query: 250 RLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ K L +P R + ++++ + KK+ PK
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 88/307 (28%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMK--VVGKDKVIKVGMMEQIKREISVMKMVK 77
+YE G+ LG GT+A VY AR+ +TG+ +A+K +G+ K K G+ REI +++ +K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCH 135
H +I+ L +V KS I + + +L I + A + Y + +++ H
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---------- 185
S + HRDLKP NLL+ DG LK+ DFGL+ + G+P
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVVTR 166
Query: 186 -YVAPEVISKKGYDGAKADIWSCGVILYVLLAG--FLPFQDDNIVSMYRKIYRG------ 236
Y APE++ + G D+WS G I LL FLP D + KI+
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTE 224
Query: 237 ----DFKCPPWF------------------SSEARRLITKLLDPNPNSRIAISKIMESSW 274
P + S +A L+ +LL NPN RI + +E +
Sbjct: 225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
Query: 275 FKKSAPK 281
F + P
Sbjct: 285 F-SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 78/257 (30%), Positives = 137/257 (53%), Gaps = 8/257 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV--GKDKVIKVGMMEQIKREISVMKMVK 77
++ G +LG G+F VY NL G A+K V D ++Q+++EI+++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS 136
H +IV+ + +Y ++LV GG L + K G E V R+Y +Q++ +++ H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
R HRD+K N+L+D +G +K+ DFG+ ++ + + + G+P ++APEVI+++G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGM---AKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-GDF-KCPPWFSSEARRLITK 254
G ADIWS G + + G P+ V+ KI R + P S EA+ I K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 255 LLDPNPNSRIAISKIME 271
L +P+ R ++++E
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 85/276 (30%), Positives = 150/276 (54%), Gaps = 21/276 (7%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E +++ +G + VYL R+ +T + AMK + K +I ++Q+ E ++ ++
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
+V + +K + M+ V+GG+ + G L D+AR+YF + + A+++ H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA----------FSEHLKQDG---LLHTTCGTPAY 186
HRDLKP+NLL+ G++K+TDFGLS + H+++D L CGTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW--- 243
+APEVI ++GY G D W+ G+ILY L G +PF D ++ ++ D + P
Sbjct: 183 IAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 244 FSSEARRLITKLLDPNPNSRIAIS---KIMESSWFK 276
++A+ LI++LL NP R+ ++ + +F
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 80/241 (33%), Positives = 133/241 (55%), Gaps = 5/241 (2%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVEL 84
+LG G+F KV LA T + A+K++ KD +I+ +E E V+ + + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
H + ++YF M+ V GG+L I + G+ +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y G D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W+ GV+LY +LAG PF ++ +++ I + P S EA + LL +P R
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
Query: 264 I 264
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 86/267 (32%), Positives = 139/267 (52%), Gaps = 14/267 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+++ +++G G F +V L R+ + + AMK++ K ++IK E +M +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
IV+LH +Y M+ + GG+L N ++ + E AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH--TTCGTPAYVAPEVISKKGYD 198
HRD+KP+N+LLD+ G+LK+ DFG + +G++ T GTP Y++PEV+ +G D
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 199 ---GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRL 251
G + D WS GV LY +L G PF D++V Y KI ++ P S +A+ L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281
Query: 252 ITKLLDPNPN--SRIAISKIMESSWFK 276
I L R + +I +FK
Sbjct: 282 ICAFLTDREVRLGRNGVDEIKSHPFFK 308
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG----MMEQIKREISVMKMVK 77
E ++LG G+ VY R+ TGK A+K I V +Q+ RE+ ++ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS 136
++V+ + + +I ++ + GG L + + K G++ E V +Q++ +D+ H+
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 137 -RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
R + HRD+KP NLL++ G +K+ DFG+S E +T GT Y++PE I +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYMSPERIQGE 175
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPW----FSSEA 248
ADIWS G+ L G PF + + I G P FS E
Sbjct: 176 -SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPEF 232
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSA 279
R I+ L +P R + +++++ + KK+
Sbjct: 233 RDFISACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 80/259 (30%), Positives = 138/259 (53%), Gaps = 10/259 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY + +G G+F K L ++ + GK +K + K + E+ ++E++V+ +KH
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHS 136
+IV+ E +Y MD +GG+L+ KI R ED +F Q+ A+ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKK 195
R + HRD+K +N+ L +DG +K+ DFG++ L L TC GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLSPEICENR 176
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254
Y+ K+DIW+ G +LY + F+ N+ ++ KI RG + +S + R L+++
Sbjct: 177 PYNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235
Query: 255 LLDPNPNSRIAISKIMESS 273
L NP R +++ I+E +
Sbjct: 236 LFKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 81/245 (33%), Positives = 133/245 (54%), Gaps = 7/245 (2%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
+MLG G+F KV+LA T + A+K + KD V+ +E E V+ + +H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF--QQLISAVDFCHSRGVYH 141
L+ +K ++F M+ + GG+L I + D+ R F ++I + F HS+G+ +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 201
RDLK +N+LLD DG++K+ DFG+ E++ D T CGTP Y+APE++ + Y
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTS 176
Query: 202 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPN 261
D WS GV+LY +L G PF + +++ I + P W + EA+ ++ KL P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPE 236
Query: 262 SRIAI 266
R+ +
Sbjct: 237 RRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 17/270 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+++ ++G G F +V + R TG AMKV+ K ++ + + E ++ +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
I +L K +Y M+ GG+L + + + + ED+A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVI---- 192
HRD+KPEN+L+D G++K+ DFG +A L + ++++ GTP Y+APEV+
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 193 -SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSE 247
KG G + D WS GVI Y ++ G PF + Y I ++ K P P SS+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWFKK 277
LI LL R+ + +F K
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME----QIKREISVMKMV 76
YE +G GT+ +VY ARN +TG+ +A+K K+ E REI +++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 77 KHKHIVELHEVMASKSKI-------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
+H +IV L E++ SK K Y DL G L + K E + Y +QL+
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDL--TGLLDSPEVK--FTESQIKCYMKQLLE 111
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ + HS G+ HRD+K N+L++ DG LK+ DFGL+ + T Y P
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 190 EVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G--------D 237
E++ + + Y D+WS G IL L G FQ + KI+ G
Sbjct: 171 ELLLGATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228
Query: 238 FKCPPWF---------------------SSEARRLITKLLDPNPNSRIAISKIMESSWF 275
PWF A L+ KLL +P RI+ + ++ +F
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 78/258 (30%), Positives = 126/258 (48%), Gaps = 11/258 (4%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQI---KREISVMKMVKHKHIVE 83
LG G F KV LA +TG+ A+K + K +I +E + KR +H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
L ++ + F M+ GG+L I E A Y ++ + + H + +RD
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LK +NLLLD +G +K+ DFGL E + T CGTP ++APEV+++ Y A D
Sbjct: 127 LKLDNLLLDTEGFVKIADFGLC--KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-VD 183
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W GV++Y +L G PF D+ ++ I + + P + S EA ++ +LL NP R
Sbjct: 184 WWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERR 243
Query: 264 IAISK-----IMESSWFK 276
+ + + + +F+
Sbjct: 244 LGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 91/296 (30%), Positives = 152/296 (51%), Gaps = 5/296 (1%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
++LG G+F KV LA G+ A+K + KD V+ +E E V+ + ++ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
L+ +K ++F M+ + GG+L I KGR A Y +++ + F HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N++LD DG++K+ DFG+ E++ D T CGTP Y+APE++ Y +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-V 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D WS GV+LY +L G PF D+ ++ I P W + E++ ++ KL + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 263 RIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEGFDLS 318
R+ + + F K+ + K+E++ K P + F LSE LS
Sbjct: 238 RLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLS 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 84/258 (32%), Positives = 131/258 (50%), Gaps = 13/258 (5%)
Query: 25 RMLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 83
R LG G+F +V LA +A+K K K+IK ++ + E ++ + H V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVYHR 142
L+ +S +Y ++ V GGE F + + R DV Y Q++ ++ S + +R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLKPENLLLD+DG +K+TDFG + D +T CGTP Y+APE++ G+ G A
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGH-GKAA 209
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
D W+ G+ +Y +L G PF + + +Y+KI G P + + + L+ KLL +
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTK 269
Query: 263 RIAISK-----IMESSWF 275
R K + E WF
Sbjct: 270 RYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 84/268 (31%), Positives = 142/268 (52%), Gaps = 24/268 (8%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVM 73
G +++ + +G G F+ VY A L G+ +A+K KV MM+ R EI ++
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDLL 56
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI----AKGRLREDVAR-VYFQQLI 128
K + H ++++ +++ ++L G+L I + RL + YF QL
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYV 187
SA++ HS+ + HRD+KP N+ + G +K+ D GL FS + H+ GTP Y+
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGTPYYM 173
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPP--W 243
+PE I + GY+ K+DIWS G +LY + A PF D N+ S+ +KI + D+ P
Sbjct: 174 SPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADH 232
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIME 271
+S E R L+++ ++P+P R IS +++
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 85/288 (29%), Positives = 132/288 (45%), Gaps = 38/288 (13%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
Y+ +G GT+ VY AR+ TG+ +A+K + K + G+ + REI ++K + H +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHSR 137
I++L +V K +Y + + K+ K R L E + + Y QL+ + FCHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
G+ HRDLKPENLL++ +G LK+ DFGL A S H T Y APE++
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGL-ARSFGSPVRPYTHYVV-TRWYRAPELLLGDKG 175
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GD-----------------F 238
DIWS G I LL+ F + + KI+R G F
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 239 KCPPW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
P S +A L++++L +P+ RI + + +F
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-38
Identities = 82/272 (30%), Positives = 146/272 (53%), Gaps = 26/272 (9%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
R++G G++AKV L +T + AMKV+ K+ V ++ ++ E V + H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
LH ++S+++F ++ V GG+L F+ + +L E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD +G++K+TD+G+ E ++ T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSM------------YRKIYRGDFKCPPWFSSEARR 250
D W+ GV+++ ++AG PF +IV M ++ I + P S +A
Sbjct: 178 DWWALGVLMFEMMAGRSPF---DIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234
Query: 251 LITKLLDPNPNSRI------AISKIMESSWFK 276
++ L+ +P R+ I +F+
Sbjct: 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 5e-38
Identities = 85/259 (32%), Positives = 141/259 (54%), Gaps = 10/259 (3%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 84
+LG G+F KV LA T + A+K++ KD VI+ +E E V+ + K + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
H + ++YF M+ V GG+L I + G+ +E A Y ++ + F H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LK +N++LD +G++K+ DFG+ EH+ T CGTP Y+APE+I+ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W+ GV+LY +LAG PF ++ +++ I + P S EA + L+ +P+ R
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 264 IAISK-----IMESSWFKK 277
+ I E ++F++
Sbjct: 244 LGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 78/257 (30%), Positives = 136/257 (52%), Gaps = 19/257 (7%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVV-------GKDKVIKVGMMEQIKREISVMKMV 76
G ++G GT+ +VYLA N+ TG+ MA+K V G+ + M++ ++ EI +K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCH 135
H +IV+ ++ + ++ V GG + + + GR E + R + +Q++ + + H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--S 193
S+G+ HRDLK +NLL+D DG K++DFG+S S+ + + + G+ ++APEVI
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW-------FSS 246
+GY AK DIWS G ++ + AG P+ D+ ++ K+ PP S
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-SAPPIPPDVSMNLSP 243
Query: 247 EARRLITKLLDPNPNSR 263
A + NP++R
Sbjct: 244 VALDFLNACFTINPDNR 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 1e-37
Identities = 82/242 (33%), Positives = 136/242 (56%), Gaps = 5/242 (2%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 84
+LG G+F KV LA T + A+K++ KD VI+ +E E V+ + K + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
H + ++YF M+ V GG+L +I + GR +E A Y ++ + F HS+G+ +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y G D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 204 IWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
W+ GV+LY +LAG PF+ ++ +++ I + P S EA + L+ +P R
Sbjct: 184 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243
Query: 264 IA 265
+
Sbjct: 244 LG 245
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 82/263 (31%), Positives = 136/263 (51%), Gaps = 24/263 (9%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR---EISVMKMVKHKHIVE 83
LG G F KVY A++ +TG A K+ I++ E+++ EI ++ KH +IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66
Query: 84 LHEVMASKSKIYFAMDLVKGGELFN---KIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
L+E ++K++ ++ GG L + ++ +G L E R +Q++ A++F HS V
Sbjct: 67 LYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-----SKK 195
HRDLK N+LL DG++K+ DFG+SA ++ Q T GTP ++APEV+
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDN 183
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLI 252
YD KADIWS G+ L L P + N + + KI + + P +SS +
Sbjct: 184 PYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 253 TKLLDPNPNSRIAISKIMESSWF 275
L +P+ R +++++ +
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 85/245 (34%), Positives = 131/245 (53%), Gaps = 12/245 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YE+ +++G G F +V L R+ T K AMK++ K ++IK E +M
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
+V+L +Y M+ + GG+L N ++ + E AR Y +++ A+D HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH--TTCGTPAYVAPEVISKK--- 195
HRD+KP+N+LLD+ G+LK+ DFG + ++G++ T GTP Y++PEV+ +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRL 251
GY G + D WS GV LY +L G PF D++V Y KI ++ P S EA+ L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281
Query: 252 ITKLL 256
I L
Sbjct: 282 ICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-37
Identities = 75/273 (27%), Positives = 136/273 (49%), Gaps = 17/273 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+ L +G G+F +VY A + +T + +A+KV+ ++ +E I++EI + +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRSP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+I + + SK++ M+ GG + + G+L E ++++ +++ H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISKKGYD 198
HRD+K N+LL E+G++K+ DFG+S L +T GTP ++APEVI + GYD
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP------WFSSEARRLI 252
KADIWS G+ L G P D + M ++ K P FS + +
Sbjct: 177 E-KADIWSLGITAIELAKGEPPLSD--LHPM--RVLFLIPKNNPPSLEGNKFSKPFKDFV 231
Query: 253 TKLLDPNPNSRIAISKIMESSWFKKSAPKVVIT 285
+ L+ +P R + ++++ + KK+ +T
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKKAKKTSYLT 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 3e-37
Identities = 82/257 (31%), Positives = 146/257 (56%), Gaps = 14/257 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV 76
+EL ++LG G + KV+L R + +GK AMKV+ K ++ K E + E V++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 77 KHK-HIVELHEVMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFC 134
+ +V LH + +K++ +D + GGELF ++ + R +E ++Y +++ A++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS- 193
H G+ +RD+K EN+LLD +G++ +TDFGLS H + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 194 -KKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEA 248
G+D A D WS GV++Y LL G PF + ++ + R+I + + P S+ A
Sbjct: 181 GDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 249 RRLITKLLDPNPNSRIA 265
+ +I +LL +P R+
Sbjct: 240 KDIIQRLLMKDPKKRLG 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 41/291 (14%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+Y++ +G G V+ A++ +TG+++A+K V ++ G+ Q REI ++ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR--LREDVARVYFQQLISAVDFCHSR 137
++V+L +V S M+ + +L + L E + Y + L+ V + H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHT-TCGTPAYVAPEVI-SK 194
G+ HRDLKP NLL+ DG LK+ DFGL+ FSE ++ L++ T Y APE++
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSE---EEPRLYSHQVATRWYRAPELLYGA 175
Query: 195 KGYDGAKADIWSCGVILYVLLAG--FLPFQDD----NIV-----SM-------------Y 230
+ YD D+W+ G I LL G P ++D IV + Y
Sbjct: 176 RKYDPG-VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234
Query: 231 RKIYRGDFKCPPW------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
KI + K P S EA L+ LL +P+ R++ ++ + +F
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 8e-37
Identities = 90/281 (32%), Positives = 133/281 (47%), Gaps = 51/281 (18%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+ LG G F +V LAR + T AMK + K V+ + +K E ++ ++ +V L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
+ K +YF MD + GG++ + + + G ED+AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGL-SAF-----------SEHLKQDG---------------- 175
+KP+N+L+D DG++K+TDFGL + F +H++QD
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 176 -----------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF 218
L H+ GTP Y+APEV+ + GY D WS GVILY +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 245
Query: 219 LPFQDDNIVSMYRKI--YRGDFKCPPW--FSSEARRLITKL 255
PF + K+ ++ PP S EA LI KL
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 78/250 (31%), Positives = 132/250 (52%), Gaps = 9/250 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKH 78
+ G++LG G F +VYL ++ TG+ +A+K V D E ++ EI ++K ++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+ IV+ + + + M+ + GG + +++ A G L E V R Y +Q++ V++ HS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE--HLKQDGLLHTTCGTPAYVAPEVISKK 195
+ HRD+K N+L D GN+K+ DFG S + G+ T GTP +++PEVIS +
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGE 182
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPWFSSEARRLIT 253
GY G KAD+WS G + +L P+ + ++ KI + + P S +AR +
Sbjct: 183 GY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241
Query: 254 KLLDPNPNSR 263
+ N R
Sbjct: 242 RTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 81/256 (31%), Positives = 135/256 (52%), Gaps = 10/256 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KYE R++G G F V+L R K + +K + +++ K + E V+K++ H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHS 136
+I+E +E + M+ GG L I K L ED +F Q++ A+ H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 137 RGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
+ + HRDLK +N+LLD+ +K+ DFG+ S+ L +T GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGI---SKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITK 254
Y+ K+DIW+ G +LY L + F+ N+ ++ KI G F +S + R+LI
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 255 LLDPNPNSRIAISKIM 270
+L+ +P+ R +S+IM
Sbjct: 236 MLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 77/253 (30%), Positives = 126/253 (49%), Gaps = 23/253 (9%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+++ LG G++ VY A + +TG+ +A+KVV + +++I +EIS++K +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPY 59
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRG 138
IV+ + + ++ M+ G + + KI L E+ Q + +++ HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
HRD+K N+LL+E+G K+ DFG+S K++ T GTP ++APEVI + G
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN----TVIGTPFWMAPEVIQEIG 175
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------SSEARR 250
Y+ KADIWS G+ + G P+ D I M R I+ K PP S E
Sbjct: 176 YN-NKADIWSLGITAIEMAEGKPPYSD--IHPM-RAIFMIPNKPPPTLSDPEKWSPEFND 231
Query: 251 LITKLLDPNPNSR 263
+ K L +P R
Sbjct: 232 FVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 86/270 (31%), Positives = 144/270 (53%), Gaps = 18/270 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +++G G F +V + + TG+ AMK++ K +++K + E V+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
I LH ++ +Y MD GG+L ++K RL ED+AR Y +++ A+D H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK-- 194
HRD+KP+N+LLD++G++++ DFG S L DG + + GTP Y++PE++
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 195 --KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW---FSSE 247
KG G + D WS GV +Y +L G PF +++V Y KI ++ F+ PP S E
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 248 ARRLITKLLDPNPN--SRIAISKIMESSWF 275
A+ LI +L+ R + + +F
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 72/268 (26%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YEL ++G G A VY A L + +A+K + +K ++++++E+ M H +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPN 60
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFN----KIAKGRLREDVARVYFQQLISAVDFCHS 136
+V+ + +++ M + GG L + +G L E + ++++ +++ HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVIS- 193
G HRD+K N+LL EDG++K+ DFG+SA + + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW------FSSE 247
GYD KADIWS G+ L G P+ + + + D +S
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWF 275
R++I+ L +P+ R ++++ +F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 4e-36
Identities = 69/248 (27%), Positives = 117/248 (47%), Gaps = 10/248 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +G G+F V+ + AMK + K+ + E+ E V+ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSSY 60
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR----EDVARVYFQQLISAVDFCHS 136
I+ +E K K+ M+ + G+L + R R + V R + Q L+ + HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-GLAHLHS 119
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
+ + HRD+K NL LD N+K+ D G++ +T GTP Y++PE+ K
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKP 177
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255
Y+ K+D+W+ GV+LY G PF +N ++ KI RG F +S + +LI +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 256 LDPNPNSR 263
L + R
Sbjct: 237 LTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 5e-36
Identities = 81/252 (32%), Positives = 141/252 (55%), Gaps = 14/252 (5%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83
R++G G++AKV L R +T + AMKVV K+ V ++ ++ E V + H +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH ++S+++F ++ V GG+L + + R L E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD +G++K+TD+G+ E L+ T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 203 DIWSCGVILYVLLAGFLPFQ--------DDNIVS-MYRKIYRGDFKCPPWFSSEARRLIT 253
D W+ GV+++ ++AG PF D N +++ I + P S +A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 254 KLLDPNPNSRIA 265
L+ +P R+
Sbjct: 238 SFLNKDPKERLG 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 74/218 (33%), Positives = 121/218 (55%), Gaps = 8/218 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
Y++ +++G G F +V L R+ + K AMK++ K ++IK E +M
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
+V+L +Y M+ + GG+L N ++ + E A+ Y +++ A+D HS G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH--TTCGTPAYVAPEVISKK--- 195
HRD+KP+N+LLD+ G+LK+ DFG + + G++ T GTP Y++PEV+ +
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCM---KMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
GY G + D WS GV L+ +L G PF D++V Y KI
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 42/284 (14%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G GT+ VY AR+ TG+ +A+K + + G+ REIS++K + H +IV L +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 87 VMASKSKIYFA-----MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
V+ S++K+Y +DL K + L + + Y QL+ + +CHS V H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKK---YMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122
Query: 142 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
RDLKP+NLL+D +G LK+ DFGL+ AF ++ H T Y APE++
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGSRQYST 179
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC--PP 242
DIWS G I ++ F D+ + +I+R D+K P
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239
Query: 243 W-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
W + L++K+L +P RI+ ++ +F
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 74/267 (27%), Positives = 120/267 (44%), Gaps = 27/267 (10%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G V + TGK MA+K + + I + +QI RE+ ++ +IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 87 VMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRD 143
+ I M+ + GG L K +GR+ E + ++ + + H + HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGAK 201
+KP N+L++ G +K+ DFG+S Q + L T GT +Y+APE I Y K
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVS------GQLVNSLAKTFVGTSSYMAPERIQGNDY-SVK 179
Query: 202 ADIWSCGVILYVLLAGFLPF-----QDDNIVSMYRKIYRGDFKCPP-----WFSSEARRL 251
+DIWS G+ L L G P+ D I + + I PP FS + +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQDF 236
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKS 278
+ L +P R + +++E + KK
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 80/258 (31%), Positives = 132/258 (51%), Gaps = 9/258 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+Y + R++G G+F + L +++ + + AMK + K +E ++E ++ +KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRL-REDVARVYFQQLISAVDFCHS 136
+IV E + +Y M+ GG+L KI +G+L ED +F Q+ V H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
+ V HRD+K +N+ L ++G +K+ DFG + T GTP YV PE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255
Y+ K+DIWS G ILY L PFQ ++ ++ K+ +G +K P +S E R LI ++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 256 LDPNPNSRIAISKIMESS 273
NP SR + + I+
Sbjct: 236 FKRNPRSRPSATTILSRG 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 80/258 (31%), Positives = 136/258 (52%), Gaps = 11/258 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+YE+ + +G G+F K+YLA+ + +K + K + V E K+E+ ++ +KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHS 136
+IV +++ M+ GG+L +I + R ED +F Q+ + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 137 RGVYHRDLKPENLLLDEDGNL-KVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISK 194
R + HRD+K +N+ L ++G + K+ DFG++ L L TC GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLIT 253
+ Y+ K DIWS G +LY L PF+ +N+ + KI +G F P FS + R LI+
Sbjct: 177 RPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 254 KLLDPNPNSRIAISKIME 271
+L +P R +I+ I++
Sbjct: 236 QLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 87/281 (30%), Positives = 130/281 (46%), Gaps = 51/281 (18%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+ LG G F +V LA + T AMK + K V+ + +K E ++ ++ +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
+ K +YF MD + GG++ + + + E +AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGL-SAF-----------SEHLKQDG---------------- 175
+KP+N+L+D DG++K+TDFGL + F H++QD
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 176 -----------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF 218
L H+ GTP Y+APEV+ +KGY D WS GVIL+ +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 219 LPFQDDNIVSMYRKI--YRGDFKCPPW--FSSEARRLITKL 255
PF K+ + PP S EA LITKL
Sbjct: 246 PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 76/245 (31%), Positives = 119/245 (48%), Gaps = 11/245 (4%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G F +V + TGK A K + K ++ K + E +++ V + IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 87 VMASKSKIYFAMDLVKGGEL---FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
+K + M L+ GG+L + + E A Y Q+I ++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LKPEN+LLD+ GN++++D GL+ LK + GTP Y+APEV+ + YD D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 204 IWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
++ G LY ++AG PF+ + R+ + P FS EA+ L LL +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 260 PNSRI 264
P R+
Sbjct: 237 PEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 80/250 (32%), Positives = 138/250 (55%), Gaps = 12/250 (4%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVE 83
R++G G++AKV L R + + AMKVV K+ V ++ ++ E V + + +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHR 142
LH + S+++ ++ V GG+L + + R L E+ AR Y ++ A++F H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
DLK +N+LLD DG++K+TD+G+ E L T CGTP Y+APE++ + Y G
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 203 DIWSCGVILYVLLAGFLPFQ------DDNIVS-MYRKIYRGDFKCPPWFSSEARRLITKL 255
D W+ GV+++ ++AG PF D N +++ I + P + S +A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 256 LDPNPNSRIA 265
L+ +P R+
Sbjct: 238 LNKDPKERLG 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 78/249 (31%), Positives = 136/249 (54%), Gaps = 16/249 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +++G G F +V + + K AMK++ K +++K + E V+ ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
I LH ++ +Y MD GG+L ++K RL ED+AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK-- 194
HRD+KP+N+L+D +G++++ DFG L +DG + ++ GTP Y++PE++
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 195 --KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW---FSSE 247
KG G + D WS GV +Y +L G PF +++V Y KI ++ F+ P S +
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 248 ARRLITKLL 256
A+ LI +L+
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 7e-34
Identities = 83/284 (29%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G GT+ VY ARN TG+ +A+K + D + G+ REIS++K + H +IV+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 87 VMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
V+ +++K+Y DL K + + + + Y QL+ + FCHS V H
Sbjct: 67 VIHTENKLYLVFEFLHQDLKK---FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 142 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
RDLKP+NLL++ +G +K+ DFGL+ AF ++ H T Y APE++ Y
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYST 180
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------DFKC--PP 242
DIWS G I ++ F D+ + +I+R D+K P
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240
Query: 243 W-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
W + R L++++L +PN RI+ + +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 82/266 (30%), Positives = 137/266 (51%), Gaps = 21/266 (7%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKS-MAMKVV-------GKDKVIKVGMMEQIKREISV 72
Y + LG G F VY R G++ +A+K + GKDK + + I E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 73 MK-MVKHKHIVELHEVMASKSKIYFAMDLVKG---GELFN--KIAKGRLREDVARVYFQQ 126
+K ++H +IV ++ ++Y MDL++G GE FN K K R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 127 LISAVDFCH-SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
++ A+ + H + + HRDL P N++L ED + +TDFGL ++ + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL---AKQKQPESKLTSVVGTIL 178
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--W 243
Y PE++ + Y G KAD+W+ G ILY + PF N++S+ KI ++ P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 244 FSSEARRLITKLLDPNPNSRIAISKI 269
+S + +IT L P+ +R I ++
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 69/206 (33%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMA---MKVVGKDKVIKVGMMEQIKREISVMKM 75
KYE+ ++G G + V RN TG+ +A K D+ +K + RE+ V++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDF 133
++H++IV L E K ++Y + V+ EL G L D R Y QL+ A+ +
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVRSYIWQLLQAIAY 115
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEV 191
CHS + HRD+KPEN+L+ E G LK+ DFG F+ L+ T T Y APE+
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFG---FARALRARPASPLTDYVATRWYRAPEL 172
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAG 217
+ G D+W+ G I+ LL G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 23/268 (8%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVV--------GKDKVIKVGMMEQIKREISVMKM 75
G ++G G+F VYL N +G+ MA+K V KD+ K M++ + REI+++K
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDR--KRSMLDALAREIALLKE 62
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFC 134
++H++IV+ + ++ V GG + + G E + R + +Q++ +++
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLS----AFSEHLKQDGLLHTTCGTPAYVAPE 190
H+RG+ HRD+K N+L+D G +K++DFG+S A S K +G + G+ ++APE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF----SS 246
V+ + Y KADIWS G ++ +L G PF D + + I++ P SS
Sbjct: 183 VVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGENASPEIPSNISS 238
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSW 274
EA + K + + N R +++++ +
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 53/304 (17%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+++G G F +V L + TGK AMK + K ++ K + +K E V+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRD 143
+ +Y M+ + GG+L + K EDV R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 144 LKPENLLLDEDGNLKVTDFGLS---------AFSEHLKQDG------------------- 175
+KP+N+L+D G++K++DFGLS A+ + L Q
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 176 -----------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF 218
+ ++T GTP Y+APE+ ++GY G + D WS G I++ L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 219 LPFQDDNIVSMYRKI--YRGDFKCPP--WFSSEARRLITKLLDPNPN--SRIAISKIMES 272
PF +N YRKI +R P S EA LI +L+ N R +I
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSH 305
Query: 273 SWFK 276
+F+
Sbjct: 306 PFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 78/249 (31%), Positives = 134/249 (53%), Gaps = 16/249 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +++G G F +V + + T + AMK++ K +++K + E +V+ +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
I LH ++ +Y MD GG+L ++K RL ED+AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISK-- 194
HRD+KP+N+LLD +G++++ DFG + QDG + ++ GTP Y++PE++
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCL---KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 195 --KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPWF---SSE 247
G G + D WS GV +Y +L G PF +++V Y KI + F+ P S E
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 248 ARRLITKLL 256
A+ LI +L+
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 80/260 (30%), Positives = 135/260 (51%), Gaps = 16/260 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ + + +G G F++VY A L G +A+K V ++ +EI ++K + H +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCH 135
+++ + +++ ++L G+L I K + E YF QL SA++ H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
SR V HRD+KP N+ + G +K+ D GL F + H+ GTP Y++PE I +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHEN 181
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPW----FSSEAR 249
GY+ K+DIWS G +LY + A PF D N+ S+ +KI + D+ PP +S E R
Sbjct: 182 GYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELR 238
Query: 250 RLITKLLDPNPNSRIAISKI 269
+L+ ++P+P R I+ +
Sbjct: 239 QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 9e-33
Identities = 80/264 (30%), Positives = 140/264 (53%), Gaps = 16/264 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+++ + +G G F++VY A L K +A+K V +++ + +EI ++K + H +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 81 IVELHEVMASKSKIYFAMDLVKGGEL-----FNKIAKGRLREDVARVYFQQLISAVDFCH 135
+++ + +++ ++L G+L + K K + E YF QL SAV+ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
SR V HRD+KP N+ + G +K+ D GL F + H+ GTP Y++PE I +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERIHEN 181
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPW----FSSEAR 249
GY+ K+DIWS G +LY + A PF D N+ S+ +KI + D+ PP +S + R
Sbjct: 182 GYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY--PPLPTEHYSEKLR 238
Query: 250 RLITKLLDPNPNSRIAISKIMESS 273
L++ + P+P+ R I + + +
Sbjct: 239 ELVSMCIYPDPDQRPDIGYVHQIA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 72/268 (26%), Positives = 141/268 (52%), Gaps = 23/268 (8%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKRE-----ISVMKMVKHKHI 81
+G G+ V +A + TG+ +A+K K+ + +Q +RE + +M+ +H +I
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVK--------KMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
VE++ +++ M+ ++GG L + + R+ E+ ++ A+ F H++GV H
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIH 138
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
RD+K +++LL DG +K++DFG A S+ + + L GTP ++APEVIS+ Y G
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPEVISRLPY-GT 194
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----FKCPPWFSSEARRLITKLL 256
+ DIWS G+++ ++ G P+ ++ + ++I R + K S R + ++L
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-RDNLPPKLKNLHKVSPRLRSFLDRML 253
Query: 257 DPNPNSRIAISKIMESSWFKKSAPKVVI 284
+P R ++++ + K+ P I
Sbjct: 254 VRDPAQRATAAELLNHPFLAKAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 87/291 (29%), Positives = 135/291 (46%), Gaps = 56/291 (19%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG GT+A VY RN TG+ +A+K + D + G REIS+MK +KH++IV LH+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 87 VMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
V+ +++K+ Y DL K + +G L + + + QL+ + FCH V H
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 142 RDLKPENLLLDEDGNLKVTDFGL--------SAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
RDLKP+NLL+++ G LK+ DFGL + FS + T Y AP+V+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----------TLWYRAPDVLL 173
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKI---------------- 233
DIWS G I+ ++ G F +D ++ ++R +
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233
Query: 234 YRGDF-KCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
Y+ F + P P L+ +LL NP RI+ ++ WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 77/277 (27%), Positives = 142/277 (51%), Gaps = 30/277 (10%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVG----KDKVIKVGMMEQIKREISV 72
L+ + E ++G G + VY +++ TG+ +A+K++ D V I+RE+++
Sbjct: 2 LYQRLE---LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV------SDIQREVAL 52
Query: 73 MKMVKH---KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
+ ++ +I + + +++ M+ +GG + + G + E V ++++
Sbjct: 53 LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV 112
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVA 188
A+ + H GV HRD+K N+L+ GN+K+ DFG++A L Q+ +T GTP ++A
Sbjct: 113 ALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA---LLNQNSSKRSTFVGTPYWMA 169
Query: 189 PEVISK-KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----- 242
PEVI++ K YD KADIWS G+ +Y + G P+ D V +R + PP
Sbjct: 170 PEVITEGKYYD-TKADIWSLGITIYEMATGNPPYSD---VDAFRAMMLIPKSKPPRLEDN 225
Query: 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279
+S R + LD P R++ ++++S W K +
Sbjct: 226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 68/257 (26%), Positives = 118/257 (45%), Gaps = 26/257 (10%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-MMEQIK---REISVMKMVK 77
LG+ LG G F +VY + G ++V K +K +QI+ RE +M+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK--TLKEDASEQQIEEFLREARIMRKLD 59
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC-- 134
H ++V+L V + +Y M+ ++GG+L LR++ ++ L+S A+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDL-----LSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 135 ----HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-P-AYVA 188
S+ HRDL N L+ E+ +K++DFGL S L D G P ++A
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMA 171
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSS 246
PE + + + +K+D+WS GV+L+ + G P+ + + + G PP
Sbjct: 172 PESLKEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230
Query: 247 EARRLITKLLDPNPNSR 263
E L+ + +P R
Sbjct: 231 ELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 74/256 (28%), Positives = 132/256 (51%), Gaps = 10/256 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
Y R+LG G F + L R + + K V ++ + + + EI ++ +++H +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPN 60
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRL-REDVARVYFQQLISAVDFCHSR 137
I+ + + + M+ GG L++KI KG+L E++ Y Q++SAV + H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVISKKG 196
G+ HRD+K N+ L + G +K+ DFG+ S+ L + + T GTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGI---SKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255
Y+ K+DIW+ G +LY LL F N +++ KI +G++ +SSE L+ L
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 256 LDPNPNSRIAISKIME 271
L +P R ++++
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 86/290 (29%), Positives = 135/290 (46%), Gaps = 55/290 (18%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVK-HKHIVE 83
+G GTF++V A++ +TGK A+K + K + EQ+ REI ++ + H +I+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSL---EQVNNLREIQALRRLSPHPNILR 62
Query: 84 LHEVM-----ASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCH 135
L EV+ + ++ MD+ L+ I KGR L E + Y QL+ ++D H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDM----NLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVISK 194
G++HRD+KPEN+L+ +D LK+ DFG S + K +T T Y APE +
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFG-SCRGIYSKPP---YTEYISTRWYRAPECLLT 172
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------------------- 235
GY G K DIW+ G + + +L+ F F N + KI+
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 236 ----------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
G K P S+E L+ KLL +P+ RI + + +F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 87/293 (29%), Positives = 140/293 (47%), Gaps = 46/293 (15%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KYE +G GT+ V+ A+N +T + +A+K V D + G+ REI ++K +KHK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHK 59
Query: 80 HIVELHEVMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+IV L++V+ S K+ Y DL K + G + ++ + + QL+ + FC
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKK----YFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI- 192
HS V HRDLKP+NLL++++G LK+ DFGL+ AF ++ T Y P+V+
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVLF 172
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYR---------------- 235
K Y D+WS G I L P F +++ ++I+R
Sbjct: 173 GAKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 236 GDFKCPPWF-------------SSEARRLITKLLDPNPNSRIAISKIMESSWF 275
D+K P + +S R L+ LL NP RI+ + ++ +F
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 85/258 (32%), Positives = 132/258 (51%), Gaps = 24/258 (9%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
YEL + +G GT+ VY AR++ TG+ +A+KV+ K+ E I++EIS++K +H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLRED-VARVYFQQLISAVDFCHS 136
+IV + K++ M+ GG L + ++ +G L E +A V + L + + H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-KGLAYLHE 119
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVI--- 192
G HRD+K N+LL EDG++K+ DFG+SA + + + + GTP ++APEV
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR---KSFIGTPYWMAPEVAAVE 176
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-------WFS 245
K GYDG K DIW+ G+ L P D + + I + +F PP W S
Sbjct: 177 RKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKW-S 233
Query: 246 SEARRLITKLLDPNPNSR 263
I K L +P R
Sbjct: 234 PVFHDFIKKCLTKDPKKR 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-31
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK-----DKVIKVGMMEQIKREI-SVMK 74
Y++ + LG GTF VYLARN +TG+ +A+K + K ++ + + RE+ S+ K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-------REVKSLRK 53
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVD 132
+ +H +IV+L EV ++YF + ++G +L E V R Q++ +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
H G +HRDLKPENLL+ +K+ DFGL + ++ T Y APE++
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGL---AREIRSRPPYTDYVSTRWYRAPEIL 170
Query: 193 SKKGYDGAKADIWSCGVI---LYVL 214
+ + DIW+ G I LY L
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 76/311 (24%), Positives = 130/311 (41%), Gaps = 70/311 (22%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-------IKREISV 72
+YEL + +G G + V A + +TG+ +A+K K+ + I REI +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK--------KISNVFDDLIDAKRILREIKL 52
Query: 73 MKMVKHKHIVELHEVMASKSK-----IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQ 126
++ ++H++I+ L +++ S +Y +L +L I + L +D + + Q
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQYFLYQ 111
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEHLKQDGLLHTTCGTP 184
++ + + HS V HRDLKP N+L++ + +LK+ DFGL+ + ++ L
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE------ 165
Query: 185 AYV------APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-- 235
YV APE++ S Y A DIWS G I LL F + + I
Sbjct: 166 -YVVTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223
Query: 236 G-----DFKCP------------------PW------FSSEARRLITKLLDPNPNSRIAI 266
G D K P S EA L+ K+L +P RI
Sbjct: 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 267 SKIMESSWFKK 277
+ + + +
Sbjct: 284 DEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 27/258 (10%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-MMEQIK---REISVMKMVK 77
LG+ LG G F +VY G ++V K +K +QI+ RE +M+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK--TLKEDASEQQIEEFLREARIMRKLD 59
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC- 134
H +IV+L V + + M+ + GG+L LR+ + L+S A+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDL-----LDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 135 -----HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-P-AYV 187
S+ HRDL N L+ E+ +K++DFGL S L D G P ++
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWM 171
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFS 245
APE + + + +K+D+WS GV+L+ + G P+ + + + +G PP
Sbjct: 172 APESLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230
Query: 246 SEARRLITKLLDPNPNSR 263
E +L+ + +P R
Sbjct: 231 PELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 92/270 (34%), Positives = 132/270 (48%), Gaps = 26/270 (9%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKM 75
KY + R+LG G V A+ + G+ A+KVV + GM E K E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME-----GMSEADKNRAQAEVCCLLN 87
Query: 76 VKHKHIVELHEVMASK--------SKIYFAMDLVKGGELFNKIAKGR------LREDVAR 121
IV+ HE A K I +D G+L +I K R RE A
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEAG 146
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181
+ F Q++ AV HS+ + HRD+K N+LL +G +K+ DFG S D + T C
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-C 240
GTP YVAPE+ +K Y KAD++S GV+LY LL PF +N+ + K G +
Sbjct: 207 GTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIM 270
PP S E + ++T LL +P R + SK++
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 84/283 (29%), Positives = 133/283 (46%), Gaps = 25/283 (8%)
Query: 2 ATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV---GKDKVI 58
++S+S G + E +G G VY + TG+ A+KV+ +D V
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116
Query: 59 KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLRE 117
+ QI REI +++ V H ++V+ H++ +I ++ + GG L IA +
Sbjct: 117 R-----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA 171
Query: 118 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GL 176
DVAR Q++S + + H R + HRD+KP NLL++ N+K+ DFG+S L Q
Sbjct: 172 DVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDP 224
Query: 177 LHTTCGTPAYVAPEVI----SKKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVS 228
+++ GT AY++PE I + YDG DIWS GV + G PF Q D
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284
Query: 229 MYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
M + P S E R I+ L P R + ++++
Sbjct: 285 MCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 85/289 (29%), Positives = 140/289 (48%), Gaps = 40/289 (13%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E +++G G F +V L + TG AMK++ K +++ + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 139
+V++ K +Y M+ + GG++ + K L E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGL---------------------SAFS---------- 168
HRD+KP+NLLLD G++K++DFGL S FS
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 169 EHLKQD--GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI 226
E K++ L ++T GTP Y+APEV + GY+ D WS GVI+Y +L G+ PF +
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 227 VSMYRKI--YRGDFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIME 271
YRK+ ++ PP S +A+ LI + + N RI + + E
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSEN-RIGSNGVEE 289
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 80/277 (28%), Positives = 140/277 (50%), Gaps = 29/277 (10%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVK 77
G +EL ++G GT+ KVY AR+ +TG+ +A+K++ + + E+IK E +++ K
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61
Query: 78 HKHIVELHEVMASKS------KIYFAMDLVKGG---ELFNKIAK--GRLREDVARVYFQQ 126
H +I + K+ +++ M+L GG +L + K RL+E+ ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTCGTPA 185
+ + + H V HRD+K +N+LL ++ +K+ DFG+SA L G +T GTP
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTPY 178
Query: 186 YVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--- 237
++APEVI+ YD A++D+WS G+ L G P D + + KI R
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 274
K P +S + I++ L N R + +++E +
Sbjct: 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 79/246 (32%), Positives = 131/246 (53%), Gaps = 13/246 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKH 78
+ LG++LG G F +VYL + TG+ +A+K V D E ++ EI ++K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 79 KHIVE----LHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDF 133
+ IV+ L + M I+ M+ + GG + +++ + G L E+V R Y +Q++ V +
Sbjct: 64 ERIVQYYGCLRDPMERTLSIF--MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVI 192
HS + HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GDFKCPPWFSSEARR 250
S +GY G KADIWS G + +L P+ + ++ KI + PP S R
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 251 LITKLL 256
+ ++
Sbjct: 241 FLKRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-30
Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 19/262 (7%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
ELG+ LG G F +VY G+ KV V K +K G E+ + E S+MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAV---KTLKEGASEEEREEFLEEASIMKKL 58
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA-RVYF-QQLISAVDFC 134
H +IV L V +Y + + GG+L + + K + + + Q+ +++
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEV 191
S+ HRDL N L+ E+ +K++DFGLS + +D G ++APE
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRD---IYEDDYYRKRGGGKLPIKWMAPES 175
Query: 192 ISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249
+ + +K+D+WS GV+L+ + G P+ + + + G P E
Sbjct: 176 LKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY 234
Query: 250 RLITKLLDPNPNSRIAISKIME 271
L+ + +P R S+++E
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 69/265 (26%), Positives = 125/265 (47%), Gaps = 13/265 (4%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVG---KDKVIKVGMMEQIKREISVMKMVKHKH 80
G+ LG G F+ Y AR+++TG MA+K V + ++E +++EI +M + H H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
I+ + S ++ + GG + + ++K G +E V Y +QL+ + + H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 140 YHRDLKPENLLLDEDGN-LKVTDFGLSA-FSEHLKQDGLLH-TTCGTPAYVAPEVISKKG 196
HRD+K NLL+D G L++ DFG +A + G GT A++APEV+ +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-----GDFKCPPWFSSEARRL 251
Y G D+WS G ++ + P+ + + I++ P S R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 252 ITKLLDPNPNSRIAISKIMESSWFK 276
+ L+ P R ++++ F+
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 18/268 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ LG G F KVY A+N +TG A KV+ + +E EI ++ H +
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYMVEIEILATCNHPY 70
Query: 81 IVELHEVMASKSKIYFAMDLVKGGE---LFNKIAKGRLREDVARVYFQQLISAVDFCHSR 137
IV+L K++ ++ GG + ++ +G L E +V +Q++ A+ + HS
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHSM 129
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----- 192
+ HRDLK N+LL DG++K+ DFG+SA +++K + GTP ++APEV+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEAR 249
YD KADIWS G+ L + P + N + + KI + + P +S E R
Sbjct: 188 KDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246
Query: 250 RLITKLLDPNPNSRIAISKIMESSWFKK 277
+ LD +P +R + ++++E +
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 69/198 (34%), Positives = 116/198 (58%), Gaps = 9/198 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKH 78
+ LG++LG G F +VYL + TG+ +A+K V D + E ++ EI ++K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 79 KHIVELHEVM--ASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
IV+ + + + K+ ++ + GG + +++ A G L E+V R Y +Q++ V + H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISK 194
S + HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEVIS
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 195 KGYDGAKADIWS--CGVI 210
+GY G KAD+WS C V+
Sbjct: 184 EGY-GRKADVWSVACTVV 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 88/286 (30%), Positives = 141/286 (49%), Gaps = 45/286 (15%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G GT+ VY RN +TG+ +AMK + + + + G+ REIS++K ++H +IV L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 87 VMASKSKIYF-----AMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVY 140
V+ +S++Y +MDL K + + KG+ + ++ + Y Q++ + FCHSR V
Sbjct: 67 VLMQESRLYLIFEFLSMDLKK---YLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVL 123
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRDLKP+NLL+D G +K+ DFGL+ AF ++ H T Y APEV+
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVV-TLWYRAPEVLLGSPRYS 180
Query: 200 AKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYR----------------GDFKC-- 240
DIWS G I + +A P F D+ + +I+R D+K
Sbjct: 181 TPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 241 PPW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
P W + L+ K+L +P RI+ K + +F
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 78/266 (29%), Positives = 139/266 (52%), Gaps = 13/266 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY +G G VY A ++ TG+ +A+K + + K E I EI VM+ KH
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHP 76
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+IV + +++ M+ + GG L + + + + E ++ + A++F HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
HRD+K +N+LL DG++K+TDFG A E K+ T GTP ++APEV+++K Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEVVTRKAY 192
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITK 254
G K DIWS G++ ++ G P+ ++N + ++Y G + + P S+ R + +
Sbjct: 193 -GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAP 280
L+ + R + ++++ + K + P
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 39/273 (14%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E +++G G F +V L + TG AMK++ K +++ + I+ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 139
+V++ K +Y M+ + GG++ + K L E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGL---------SAFSEHLKQD---------------- 174
HRD+KP+NLLLD G++K++DFGL + F +L
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 175 --------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI 226
L +T GTP Y+APEV + GY+ D WS GVI+Y +L G+ PF +
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 227 VSMYRKI--YRGDFKCPPW--FSSEARRLITKL 255
Y+K+ ++ PP S +A+ LI +
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 87/304 (28%), Positives = 130/304 (42%), Gaps = 63/304 (20%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 82
L R +G GT+ VY AR+ +G+ +A+K V D + G+ REI+++ ++H +IV
Sbjct: 12 LNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIV 69
Query: 83 ELHEVMASKS--KIYFAM-----DLVKGGELFNKIAKGRLREDVARVY--------FQQL 127
EL EV+ K I+ M DL L +++ + QL
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDL------------ASLLDNMPTPFSESQVKCLMLQL 117
Query: 128 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
+ + + H + HRDLK NLLL + G LK+ DFGL+ + + T Y
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYR 175
Query: 188 APEVI-SKKGYDGAKADIWSCGVILYVLLAG--FLP-----FQDDNIVSMY----RKIYR 235
APE++ Y A D+W+ G IL LLA LP Q D I+ + I+
Sbjct: 176 APELLLGCTTYTTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234
Query: 236 GDFKCP-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
G P PW S RL+ LL +P R + +ESS+FK
Sbjct: 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
Query: 277 KSAP 280
+
Sbjct: 295 EKPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 84/265 (31%), Positives = 134/265 (50%), Gaps = 20/265 (7%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKVGMMEQIKREI--SVMKMVKHKHIV 82
++G G F +VY R TGK AMK + K ++ +K G + I S++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 83 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 141
+ + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDG 199
RDLKP N+LLDE G+++++D GL+ FS+ H + GT Y+APEV+ K YD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQKGVAYD- 174
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMY---RKIYRGDFKCPPWFSSEARRLITKLL 256
+ AD +S G +L+ LL G PF+ + R + P FS E R L+ LL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234
Query: 257 DPNPNSRIAI-----SKIMESSWFK 276
+ N R+ ++ E +F+
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 77/269 (28%), Positives = 141/269 (52%), Gaps = 9/269 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY +G G VY A ++ TG+ +A+K + + K E I EI VM+ K+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNP 76
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+IV + +++ M+ + GG L + + + + E ++ + A+DF HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRD+K +N+LL DG++K+TDFG A + + T GTP ++APEV+++K Y G
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITKLL 256
K DIWS G++ ++ G P+ ++N + ++Y G + + P S+ R + + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 257 DPNPNSRIAISKIMESSWFKKSAPKVVIT 285
+ + + R + ++++ + K + P +T
Sbjct: 254 EMDVDRRGSAKELLQHPFLKLAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 85/297 (28%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
YE +G GT+ KVY AR+ TGK +A+K + ++ + G+ REIS+++M+
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSES 60
Query: 80 -HIVELHEVMASKSKI----------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI 128
+IV L +V + K Y DL K + + L + + QL+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGN-LKVTDFGLS-AFSEHLKQDGLLHTTCGTPAY 186
V CH GV HRDLKP+NLL+D+ LK+ D GL AFS +K H T Y
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV-TLWY 177
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------- 235
APEV+ + DIWS G I + F D+ + I++
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 236 GDFKCPPW-----------------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
G K W S E L+ K+L +P RI+ + +F
Sbjct: 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 70/216 (32%), Positives = 122/216 (56%), Gaps = 7/216 (3%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMVKHKHI 81
G++LG G F +VYL ++ TG+ +A K V D E ++ EI ++K ++H+ I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 82 VELHEVMASKSK--IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 138
V+ + + +++ + M+ + GG + +++ A G L E V R Y +Q++ + + HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTTCGTPAYVAPEVISKKGY 197
+ HRD+K N+L D GN+K+ DFG S + + G + + GTP +++PEVIS +GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
G KAD+WS G + +L P+ + ++ KI
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 52/297 (17%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMV 76
YE +G G + VY AR+L TG+ +A+K V ++ G+ REI+++K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-----GIPLSTLREIALLKQL 55
Query: 77 K---HKHIVELHEV-----MASKSKIYFAMDLVKG--GELFNKIAKGRLREDVARVYFQQ 126
+ H +IV L +V + K+ + V +K K L + + +Q
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA 185
L+ VDF HS + HRDLKP+N+L+ DG +K+ DFGL+ +S + L + T
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LTSVVVTLW 171
Query: 186 YVAPEVISKKGYDGAKADIWSCGVI---LYVLLAGF-----------------LPFQDD- 224
Y APEV+ + Y D+WS G I L+ F LP +++
Sbjct: 172 YRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230
Query: 225 --NIV---SMYRKIYRGDFK-CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
N+ S + FK P E L+ K+L NP+ RI+ + ++ +F
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 81/264 (30%), Positives = 133/264 (50%), Gaps = 18/264 (6%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKVGMMEQIKREI--SVMKMVKHKHIV 82
++G G F +VY R TGK AMK + K ++ +K G + I S++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 83 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 141
+ + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
RDLKP N+LLDE G+++++D GL+ FS+ H + GT Y+APEV+ K +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASVGTHGYMAPEVLQKGTAYDS 175
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMY---RKIYRGDFKCPPWFSSEARRLITKLLD 257
AD +S G +L+ LL G PF+ + R + + P FS E + L+ LL
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 258 PNPNSRIAI-----SKIMESSWFK 276
+ + R+ ++ E +FK
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 76/263 (28%), Positives = 130/263 (49%), Gaps = 18/263 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-----QIKREISVMK 74
+Y L + LG G+F VYL ++ + +KV+ K I VG + Q +E ++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVL---KEIPVGELNPNETVQANQEAQLLS 57
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLIS 129
+ H IV+ H + + +G +L K+ L E+ +F QL+
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
V + H R + HRDLK +N+ L ++ LK+ DFG+S + L T GTP Y++P
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSP 174
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEA 248
E + +GYD +K+DIWS G ILY + F+ N +S+ +I G P +S +
Sbjct: 175 EALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233
Query: 249 RRLITKLLDPNPNSRIAISKIME 271
++ +L+ +P+ R + ++I+
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 6e-28
Identities = 77/271 (28%), Positives = 142/271 (52%), Gaps = 13/271 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY +G G VY A ++ TG+ +A++ + + K E I EI VM+ K+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNP 77
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+IV + +++ M+ + GG L + + + + E ++ + A++F HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
HRD+K +N+LL DG++K+TDFG A E K+ ++ GTP ++APEV+++K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAY 193
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITK 254
G K DIWS G++ ++ G P+ ++N + ++Y G + + P S+ R + +
Sbjct: 194 -GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKVVIT 285
LD + R + ++++ + K + P +T
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 84/267 (31%), Positives = 131/267 (49%), Gaps = 19/267 (7%)
Query: 29 HGTFAKVYLARNLQTGKSMAMK-VVGKDKVIKVGMMEQIKR-------EISVMKMVKHKH 80
H + RN T +A + K+KV+ +M +R E+ + H
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFG 126
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDV------ARVYFQQLISAVDFC 134
IV+ + S K+ M+ GG+L NK K RL+E + + F Q++ A+D
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDL-NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVIS 193
HSR + HRDLK N+ L G +K+ DFG S +S+ + D + + CGTP Y+APE+
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWE 244
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLI 252
+K Y KAD+WS GVILY LL PF+ + + +++ G + P SS + L+
Sbjct: 245 RKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303
Query: 253 TKLLDPNPNSRIAISKIMESSWFKKSA 279
LL NP R +++ + + K A
Sbjct: 304 DPLLSKNPALRPTTQQLLHTEFLKYVA 330
|
Length = 478 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 84/281 (29%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
EL R LG G V R TG A+K + D + +QI RE+ + K K +I
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL--QKQILRELEINKSCKSPYI 61
Query: 82 VELHE--VMASKSKIYFAMDLVKGGEL---FNKIAK--GRLREDVARVYFQQLISAVDFC 134
V+ + + S S I AM+ +GG L + K+ K GR+ E V + ++ + +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
HSR + HRD+KP N+LL G +K+ DFG+S G T GT Y+APE I
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVNSLAG---TFTGTSFYMAPERIQG 177
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDN------------IVSMYRKIYRGDFKCPP 242
K Y +D+WS G+ L + PF + IV+M + +
Sbjct: 178 KPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236
Query: 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 283
+S E + I + L+ +P R ++E W K K V
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 43/293 (14%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+YE +G GT+ VY AR+ T +++A+K + ++ + G+ REIS++K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHG 61
Query: 80 HIVELHEVMASKSKIYFA-----MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+IV L +V+ S+ ++Y +DL K + AK + + Y Q++ + +C
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN---PRLIKTYLYQILRGIAYC 118
Query: 135 HSRGVYHRDLKPENLLLDEDGN-LKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI 192
HS V HRDLKP+NLL+D N LK+ DFGL+ AF ++ H T Y APE++
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYRAPEIL 175
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------G 236
+ DIWS G I ++ F D+ + KI+R
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235
Query: 237 DFKC--PPW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
D+K P W L++K+L +P+ RI +E +FK
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 76/269 (28%), Positives = 140/269 (52%), Gaps = 9/269 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY +G G V+ A ++ TG+ +A+K + K K E I EI VMK +K+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNP 76
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+IV + +++ M+ + GG L + + + + E ++ + A++F H+ V
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRD+K +N+LL DG++K+TDFG A + + T GTP ++APEV+++K Y G
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKCPPWFSSEARRLITKLL 256
K DIWS G++ ++ G P+ ++N + ++Y G + + P S R + + L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253
Query: 257 DPNPNSRIAISKIMESSWFKKSAPKVVIT 285
+ + R + ++++ + K + P +T
Sbjct: 254 EMDVEKRGSAKELLQHPFLKLAKPLSSLT 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 70/266 (26%), Positives = 144/266 (54%), Gaps = 18/266 (6%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+ V +AR +G+ +A+K++ K + E + E+ +M+ +H+++VE+++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYK 85
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+++ M+ ++GG L + +++ RL E+ + ++ A+ + HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 147 ENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIW 205
+++LL DG +K++DFG A S+ + + L GTP ++APEVIS+ Y G + DIW
Sbjct: 146 DSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 206 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------SSEARRLITKLLDPN 259
S G+++ ++ G P+ D+ V +++ PP S R + ++L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKISPVLRDFLERMLTRE 258
Query: 260 PNSRIAISKIMESSW-FKKSAPKVVI 284
P R ++++ + + P+ ++
Sbjct: 259 PQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 66/216 (30%), Positives = 113/216 (52%), Gaps = 11/216 (5%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVG---KDKVIKVGMMEQIKREISVMKMVKHKH 80
G +LG G + VY G+ +A+K V + + E+++ E+ ++K +KH +
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
IV+ + I M+ V GG + + + + G L E V Y +Q++ V + H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 140 YHRDLKPENLLLDEDGNLKVTDFG----LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
HRD+K N++L +G +K+ DFG L+ H +L + GTP ++APEVI++
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMY 230
GY G K+DIWS G ++ + G P D + +M+
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 73/266 (27%), Positives = 137/266 (51%), Gaps = 19/266 (7%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+ V +A TGK +A+K K + K E + E+ +M+ H+++V+++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+++ M+ ++GG L + + R+ E+ ++ A+ + H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 147 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
+++LL DG +K++DFG A E K+ L+ GTP ++APEVIS+ Y G + DI
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPY-GTEVDI 201
Query: 205 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------SSEARRLITKLLDP 258
WS G+++ ++ G P+ ++ + R+I PP SS R + +L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 259 NPNSRIAISKIMESSWFKKSAPKVVI 284
P+ R ++++ + K + P I
Sbjct: 259 EPSQRATAQELLQHPFLKLAGPPSCI 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
K+++ +G GT+ +VY AR+ TG+ +A+K V D K G REI +++ + H+
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHR 66
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-------GRLR-------EDVARVYFQ 125
+IV L E++ K A+D K F + + G L ED + + +
Sbjct: 67 NIVNLKEIVTDKQD---ALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTP 184
QL+ +++CH + HRD+K N+LL+ G +K+ DFGL+ ++ +T T
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPYTNKVITL 181
Query: 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---------------- 228
Y PE++ + G D+WSCG IL L FQ + ++
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 229 -----------------MYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
YR+ R +F P + A L+ +L +P+ R + +
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIP---TPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 272 SSW 274
S W
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 22/266 (8%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G + VY + TG +MAMK + + + QI E+ ++ +IV+ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 87 VMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSR-GVY 140
+ +Y M+ + G L +K+ A + EDV R ++ + F +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
HRD+KP N+L++ +G +K+ DFG+S L T G +Y+APE I G +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 201 -----KADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGD-FKCPPWFSSEARRL 251
++D+WS G+ + + G P+ NI + I GD P +S +A+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKK 277
+ K L+ PN R ++++E W K
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 32/214 (14%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REI 70
KYE +G GTF +V+ AR+ +T + +A+K V +ME K REI
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV---------LMENEKEGFPITALREI 62
Query: 71 SVMKMVKHKHIVELHEVMASKSK--------IYFAMDLVK---GGELFNKIAKGRLREDV 119
+++++KH+++V L E+ +K+ Y + + G L NK K L E +
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE-I 121
Query: 120 ARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLH 178
+V + L++ + + H + HRD+K N+L+ +DG LK+ DFGL+ AFS +
Sbjct: 122 KKV-MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 179 TT-CGTPAYVAPEVISKKGYDGAKADIWSCGVIL 211
T T Y PE++ + G D+W G I+
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 40/271 (14%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ LG G F +VY + L+ A+K + +D + + +E VMK + H +
Sbjct: 1 KKLGEGAFGEVYKGK-LKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPN 57
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE--------DVARVYFQQLIS-AV 131
+V L V + +Y ++ ++GG+L LR+ + + + + L+S A+
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDL-----LDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 132 DFC------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
S+ HRDL N L+ ED +K++DFGL S + D G
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKL 169
Query: 186 YV---APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF---QDDNIVSMYRKIYRGDF 238
+ APE + + +K+D+WS GV+L+ + G P+ ++ ++ RK YR
Sbjct: 170 PIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR--L 226
Query: 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKI 269
P + E L+ +P R S++
Sbjct: 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 78/250 (31%), Positives = 122/250 (48%), Gaps = 18/250 (7%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G F +V + TGK A K + K ++ K E E ++ V + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 87 VMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
+K+ + M ++ GG+L I E A Y Q+IS ++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKGYDG 199
RDLKPEN+LLD DGN++++D GL+ LK DG T GTP ++APE++ + YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV---ELK-DGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 200 AKADIWSCGVILYVLLAGFLPFQD-----DNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
+ D ++ GV LY ++A PF+ +N + ++I P FS ++
Sbjct: 177 S-VDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILNDSVTYPDKFSPASKSFCEA 234
Query: 255 LLDPNPNSRI 264
LL +P R+
Sbjct: 235 LLAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 50/137 (36%), Positives = 81/137 (59%), Gaps = 1/137 (0%)
Query: 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89
G F KVYL R K A+KVV K +I M+ Q++ E + + K IV L+ +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 90 SKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 148
S + +Y M+ + GG++ + + G E++A Y ++ A+D+ H G+ HRDLKP+N
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 149 LLLDEDGNLKVTDFGLS 165
+L+ +G++K+TDFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-24
Identities = 32/57 (56%), Positives = 45/57 (78%)
Query: 303 LNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 359
LNAF +ISLS G DLS LFEE+K+++++E RF + +PAS +IS+ EE+AK + F VK
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVK 57
|
Length = 58 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 31/275 (11%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKMVKHKHI 81
+G GT +VY R +TG MA+K ++ + G E+ KR ++ V+K +I
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDV-VLKSHDCPYI 76
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR- 137
V+ + + S ++ M+L+ +K+ K G + ED+ ++ A+ + +
Sbjct: 77 VKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT-TCGTPAYVAPEVI---- 192
GV HRD+KP N+LLD GN+K+ DFG+S D T + G AY+APE I
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGR----LVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFKCPPW---FSSEA 248
YD +AD+WS G+ L L G P+++ + KI + + P FS +
Sbjct: 191 PNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 283
+ L + R ++++ + ++ V
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 75/263 (28%), Positives = 134/263 (50%), Gaps = 20/263 (7%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ LG G F KVY A+N +TG A KV+ + +E EI ++ H +
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPN 63
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR--LREDVARVYFQQLISAVDFCHSRG 138
IV+L + ++ ++ ++ GG + + + L E RV +Q + A+++ H
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL--KQDGLLHTTCGTPAYVAPEVI---- 192
+ HRDLK N+L DG++K+ DFG+SA + ++D + GTP ++APEV+
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCET 179
Query: 193 -SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEA 248
+ YD KAD+WS G+ L + P + N + + KI + + P +SSE
Sbjct: 180 SKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238
Query: 249 RRLITKLLDPNPNSRIAISKIME 271
+ + K L+ N ++R +++++
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 10/202 (4%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+ +G G F V AR+ TG+++A+K + K V + ++ RE+ ++K ++H++I+ L
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHENIISL 74
Query: 85 HEVMASKSK-IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
++ S + IYF +L+ G +L + L + + + Q++ + + HS GV HRD
Sbjct: 75 SDIFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
LKP N+L++E+ +LK+ DFGL+ QD + T Y APE++ + D
Sbjct: 134 LKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVD 188
Query: 204 IWSCGVILYVLLAG--FLPFQD 223
IWS G I +L G P +D
Sbjct: 189 IWSAGCIFAEMLEGKPLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 71/253 (28%), Positives = 119/253 (47%), Gaps = 21/253 (8%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
R+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 85 HEVMASKSKIYFAMDLVKGGEL---FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
+K + + L+ GG+L + + E A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 201
RDLKPEN+LLD+ G+++++D GL+ H+ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 202 ADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------GDFKCPPWFSSEARRLI 252
D W+ G +LY ++AG PFQ +KI R + FS +AR L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRK-----KKIKREEVERLVKEVQEEYSEKFSPDARSLC 236
Query: 253 TKLLDPNPNSRIA 265
LL +P R+
Sbjct: 237 KMLLCKDPKERLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 76/307 (24%), Positives = 126/307 (41%), Gaps = 55/307 (17%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVV-----------GKDKVIKVGMMEQIKREIS 71
G LG GT+ KV A + TGK +A+K V + V G+ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAMDLVKG--GELFNKIAKGRLREDVARVYFQQLIS 129
+M +KH++I+ L +V I MD++ ++ + K RL E + Q+++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKCILLQILN 130
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS------------AFSEHLKQDGLL 177
++ H HRDL P N+ ++ G K+ DFGL+ + E +++ +
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--R 235
+ T Y APE++ D+WS G I LL G F +N + +I+
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 236 G--------DFKCPPWF------------------SSEARRLITKLLDPNPNSRIAISKI 269
G K P + S +A L+ LL NP RI+ +
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310
Query: 270 MESSWFK 276
++ +FK
Sbjct: 311 LKHEYFK 317
|
Length = 335 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 68/261 (26%), Positives = 135/261 (51%), Gaps = 9/261 (3%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+ V +A +GK +A+K K + K E + E+ +M+ +H+++VE++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+++ M+ ++GG L + + R+ E+ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 147 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 206
+++LL DG +K++DFG A + K+ + GTP ++APE+IS+ Y G + DIWS
Sbjct: 145 DSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 207 CGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
G+++ ++ G P+ ++ + M R K S + + +LL +P R
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261
Query: 264 IAISKIMESSWFKKSAPKVVI 284
+++++ + K+ P I
Sbjct: 262 ATAAELLKHPFLAKAGPPSCI 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 74/257 (28%), Positives = 131/257 (50%), Gaps = 18/257 (7%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVG-KDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+LG GT+ VY AR+L T +A+K + +D + E EI++ +KH++IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSYLKHRNIVQY 70
Query: 85 HEVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
+ M+ V GG L +K + E Y +Q++ + + H +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 141 HRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK--KGY 197
HRD+K +N+L++ G +K++DFG S + + T GT Y+APEVI K +GY
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYR-KIYRGDFKCPPWFSSEARRLITK 254
GA ADIWS G + + G PF + + +M++ +++ + P S+EA+ I +
Sbjct: 189 -GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247
Query: 255 LLDPNPNSRIAISKIME 271
+P+P+ R + +++
Sbjct: 248 CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+F +VY + +T + +A+K++ ++ +E I++EI+V+ +I +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+K++ M+ + GG + + G L E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 147 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
N+LL E G++K+ DFG++ +K++ T GTP ++APEVI + YD KADI
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 205 WSCGVILYVLLAGFLPFQD 223
WS G+ L G P D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 46/285 (16%)
Query: 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE-VM 88
GT+ VY AR+ +TG+ +A+K + +K K G REI+++ ++H +IV + E V+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQHPNIVTVKEVVV 74
Query: 89 ASKS-KIYFAMDLV----KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRD 143
S KIY M+ V K L + K + + QL+S V H + HRD
Sbjct: 75 GSNLDKIYMVMEYVEHDLKS--LMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131
Query: 144 LKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKA 202
LK NLLL+ G LK+ DFGL+ + LK L T Y APE++
Sbjct: 132 LKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLW---YRAPELLLGAKEYSTAI 188
Query: 203 DIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------------------GDFKCP 241
D+WS G I LL F + + KI++ F
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248
Query: 242 PWFSSEAR-----------RLITKLLDPNPNSRIAISKIMESSWF 275
P+ + L+ +LL +P RI+ ++ +F
Sbjct: 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 65/241 (26%), Positives = 117/241 (48%), Gaps = 21/241 (8%)
Query: 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS 71
+RP ++ L R LG G F +V+ + +A+K++ D ++K + +E+
Sbjct: 2 ERP---REEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQ---KEVQ 54
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQ-QLI 128
+K ++HKH++ L V + +Y +L++ G L F + +G++ + + Q+
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVA 114
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP-AYV 187
+ + + HRDL N+L+ ED KV DFGL+ +K+D L + P +
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWT 171
Query: 188 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG-----DFKCP 241
APE S + K+D+WS G++LY + G +P+ N +Y +I G KCP
Sbjct: 172 APEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP 230
Query: 242 P 242
Sbjct: 231 Q 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-23
Identities = 75/263 (28%), Positives = 131/263 (49%), Gaps = 17/263 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ--IKREISVMKMVKH 78
Y R++G G++ +V L R+ GK +K K + E+ ++E ++ +KH
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIK---KLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 79 KHIVELHEVMASKS-KIYFAMDLVKGGELFNKIA--KGRL-REDVARVYFQQLISAVDFC 134
+IV E + +Y M +GG+L++K+ KG+L E+ +F Q+ A+ +
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
H + + HRDLK +N+ L +KV D G++ E+ Q + T GTP Y++PE+ S
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSN 176
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW---FSSEARRL 251
K Y+ K+D+W+ G +Y + F ++ S+ +I G K PP +S E L
Sbjct: 177 KPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLPPMPKDYSPELGEL 233
Query: 252 ITKLLDPNPNSRIAISKIMESSW 274
I +L P R ++ I+ +
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 66/261 (25%), Positives = 132/261 (50%), Gaps = 16/261 (6%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+F +V+ + +T K +A+K++ ++ +E I++EI+V+ ++ + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+K++ M+ + GG + + G L E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129
Query: 147 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
N+LL E G +K+ DFG++ +K++ + GTP ++APEVI + YD +KADI
Sbjct: 130 ANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYD-SKADI 184
Query: 205 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW----FSSEARRLITKLLDPNP 260
WS G+ L G P + + + + I + + PP +S + + L+ P
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKEP 241
Query: 261 NSRIAISKIMESSWFKKSAPK 281
+ R ++++ + + A K
Sbjct: 242 SFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 24/227 (10%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMK-VVGKDKVIKVGMMEQIKREISVMKM 75
L +Y R LG G+ V+ A + K +A+K +V D ++ REI +++
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ----SVKHALREIKIIRR 58
Query: 76 VKHKHIVELHEVMASKSK--------------IYFAMDLVKGGELFNKIAKGRLREDVAR 121
+ H +IV+++EV+ +Y + ++ +L N + +G L E+ AR
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHAR 117
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSE-HLKQDGLLHT 179
++ QL+ + + HS V HRDLKP N+ ++ ED LK+ DFGL+ + H G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 180 TCGTPAYVAPE-VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN 225
T Y +P ++S Y A D+W+ G I +L G F +
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAH 223
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 16/223 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKM 75
KYE ++G G++ V ++ +TG+ +A+K V K+ M REI ++K
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-----REIRMLKQ 56
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDF 133
++H+++V L EV K ++Y + V + + + K L E R Y Q++ ++F
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVI 192
CHS + HRD+KPEN+L+ + G +K+ DFG F+ L G ++T T Y APE++
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFG---FARTLAAPGEVYTDYVATRWYRAPELL 172
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 235
G DIW+ G ++ +L G F D+ + I +
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 81/294 (27%), Positives = 135/294 (45%), Gaps = 47/294 (15%)
Query: 20 KYE-LGRMLGHGTFAKVYLARNLQTGKSMAMKVV---GKDKVIKVGMMEQIKREISVMKM 75
KYE L + +G G++ V+ RN +TG+ +A+K D VIK + REI ++K
Sbjct: 2 KYEKLSK-IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQ 56
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDF 133
+KH ++V L EV K K++ + L K +G + ++ +Q L AV+F
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTL-QAVNF 115
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYVAPEVI 192
CH HRD+KPEN+L+ + G +K+ DFG F+ L G +T T Y APE++
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFG---FARILTGPGDDYTDYVATRWYRAPELL 172
Query: 193 SKKGYDGAKADIWSCGVILYVLLAG--FLPFQDD------------NIVSMYRKIYRGD- 237
G D+W+ G + LL G P + D +++ +++I+ +
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232
Query: 238 ----FKCP------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
P P SS A + L +P R++ +++E +F
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 74/264 (28%), Positives = 129/264 (48%), Gaps = 23/264 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMV 76
+EL + +G GT+ VY ARN+ TG+ A+KV+ G+D +++EI +MK
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-------FAVVQQEIIMMKDC 63
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
KH +IV + K++ M+ GG L + G L E ++ + + + H
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPEV--I 192
S+G HRD+K N+LL ++G++K+ DFG+SA + + + + GTP ++APEV +
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR---KSFIGTPYWMAPEVAAV 180
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW-----FSSE 247
+KG DIW+ G+ L P D + + + + +F+ P +S+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240
Query: 248 ARRLITKLLDPNPNSRIAISKIME 271
+ L NP R K+++
Sbjct: 241 FHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-23
Identities = 69/261 (26%), Positives = 134/261 (51%), Gaps = 16/261 (6%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G+F +V+ + +T + +A+K++ ++ +E I++EI+V+ ++ + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+K++ M+ + GG + + G E ++++ +D+ HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 129
Query: 147 ENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
N+LL E G++K+ DFG++ +K++ T GTP ++APEVI + YD +KADI
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 205 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW----FSSEARRLITKLLDPNP 260
WS G+ L G P D + + + I + + PP FS + I L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDP 241
Query: 261 NSRIAISKIMESSWFKKSAPK 281
+ R ++++ + K+A K
Sbjct: 242 SFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 22/220 (10%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
G +EL ++G+GT+ +VY R+++TG+ A+KV+ + E+IK EI+++K H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 79 -KHIVELHEVMASKS------KIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLI 128
++I + KS +++ M+ G + + + + L+ED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ H+ V HRD+K +N+LL E+ +K+ DFG+SA + + G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 189
Query: 189 PEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQD 223
PEVI+ YD ++DIWS G+ + G P D
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G F +V + TGK A K + K ++ K + E +++ V IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 87 VMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARV--YFQQLISAVDFCHSRGVYHRD 143
SK+ + M L+ GG+L ++ G ++ RV Y Q+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKAD 203
+KPEN+LLD+ GN +++D GL+ LK + GT Y+APE++ ++ Y D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVD 176
Query: 204 IWSCGVILYVLLAGFLPFQD 223
++ G +Y ++AG PF+D
Sbjct: 177 WFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 65/196 (33%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
K+E+ ++G G + V R+ +T + +A+K KD + E RE+ +++ +K +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 80 HIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 137
+IVEL E + K+Y + V+ EL ++ G E V R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCHKN 119
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKK 195
+ HRD+KPENLL+ + LK+ DFG F+ +L + + T T Y +PE++
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFG---FARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 196 GYDGAKADIWSCGVIL 211
Y G D+WS G IL
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISV 72
+ +Y+ +G G + V A + ++GK +A+K K+ + + RE+ +
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKI 57
Query: 73 MKMVKHKHIVELHEVMASKSK----IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQL 127
++ KH +I+ + +++ +Y MDL+ +L + I + L E+ R + QL
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 128 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPA 185
+ + + HS V HRDLKP NLL++ED L++ DFG+ S + + T
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 186 YVAPEVI-SKKGYDGAKADIWSCGVIL 211
Y APE++ S Y A D+WS G I
Sbjct: 177 YRAPELLLSLPEYTTA-IDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 12/194 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YEL + +G GT+ VY ARNL TG+ A+K++ + +++Q EI ++K KH +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCN 67
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGV 139
IV S+ K++ M+ GG L + G L E ++ + + + HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEV--ISKK 195
HRD+K N+LL ++G++K+ DFG++A + K+ + GTP ++APEV + K
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI----GTPYWMAPEVAAVEKN 183
Query: 196 GYDGAKADIWSCGV 209
G DIW+ G+
Sbjct: 184 GGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 65/248 (26%), Positives = 118/248 (47%), Gaps = 11/248 (4%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
R+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 85 HEVMASKSKIYFAMDLVKGGEL-FNKIAKGR--LREDVARVYFQQLISAVDFCHSRGVYH 141
+K + + ++ GG+L F+ G E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 201
RDLKPEN+LLD+ G+++++D GL+ + + + GT Y+APEV++ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 202 ADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
D W G ++Y ++ G PF+ + R++ + FS EA+ + LL
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 258 PNPNSRIA 265
+P R+
Sbjct: 242 KDPKQRLG 249
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 64/247 (25%), Positives = 115/247 (46%), Gaps = 11/247 (4%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
R+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 85 HEVMASKSKIYFAMDLVKGGEL---FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
+K + + L+ GG+L + E+ A Y ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 142 RDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 201
RDLKPEN+LLD+ G+++++D GL+ + + + GT Y+APEV+ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 202 ADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
D W G ++Y ++ G PF+ + R++ + FS AR + +LL
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 258 PNPNSRI 264
+P R+
Sbjct: 242 KDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 27/273 (9%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVV---GKDKVIKVGMMEQIKREISVMKMVKHKHI 81
R +GHG+F VY AR+++T + +A+K + GK K + I +E+ ++ ++H +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK---WQDIIKEVRFLQQLRHPNT 77
Query: 82 VELHEVMASKSKIYFAMDLVKG--GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+E + + M+ G ++ K L+E + + + HS
Sbjct: 78 IEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHER 136
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKG 196
HRD+K N+LL E G +K+ DFG ++ ++ GTP ++APEVI +
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQ 190
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS-----EARRL 251
YDG K D+WS G+ L P + N +S I + D P SS R
Sbjct: 191 YDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNF 246
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKSAPKVVI 284
+ L P R + ++++ + + P VI
Sbjct: 247 VDSCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 77/315 (24%), Positives = 124/315 (39%), Gaps = 73/315 (23%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI----KVGMMEQIKREISVMKMV 76
YE+ LG GTF +VY AR ++TG+ +A+K K++ K G REI ++K +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64
Query: 77 KHKHIVELHEVMASKSKI-------------YFAMDLVKGGELFNKIAKGRLREDVARVY 123
KH ++V L ++ + Y DL G L N +L E + Y
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENP--SVKLTESQIKCY 120
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183
QL+ +++ H + HRD+K N+L+D G LK+ DFGL+ + + GT
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 184 PAYV---------APE-VISKKGYDGAKADIWSCGVILYVLLAG---------------- 217
Y PE ++ ++ Y A DIW G + +
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 218 ----------------FLP-FQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 260
LP + + + Y + F E L++KLL +P
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK---LGPEGLDLLSKLLSLDP 296
Query: 261 NSRIAISKIMESSWF 275
R+ S +E +F
Sbjct: 297 YKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (245), Expect = 5e-22
Identities = 87/306 (28%), Positives = 149/306 (48%), Gaps = 40/306 (13%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
DD + L+ +YE+ + +G+G F +V+L ++ +T + K + + +K Q+ E+
Sbjct: 6 DDGESRLN-EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEV 63
Query: 71 SVMKMVKHKHIVELHEVMASKS--KIYFAMDLVKGGELFNKIAK-----GRLREDVARVY 123
+VM+ +KHK+IV + +K+ K+Y M+ G+L I K G++ E
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 124 FQQLISAVDFCHS-------RGVYHRDLKPENLLLD-----------EDGNL------KV 159
+QL+ A+ +CH+ V HRDLKP+N+ L + NL K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 160 TDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAG 217
DFGLS +++ + + H+ GTP Y +PE++ K YD K+D+W+ G I+Y L +G
Sbjct: 184 GDFGLS---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSG 239
Query: 218 FLPFQD-DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
PF +N + ++ RG S E LI LL+ + R + + + K
Sbjct: 240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299
Query: 277 KSAPKV 282
P V
Sbjct: 300 NVGPPV 305
|
Length = 1021 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 58/290 (20%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVMK 74
Y+ +G G + V A + TG +A+K K+ E + REI +++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK--------KISPFEHQTFCQRTLREIKILR 58
Query: 75 MVKHKHIVELHEVMASKS-----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
KH++I+ + +++ S +Y +L++ +L+ I L D + + Q++
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR 117
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYV 187
+ + HS V HRDLKP NLLL+ + +LK+ DFGL A EH G L T Y
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYR 176
Query: 188 APEV-ISKKGYDGAKA-DIWSCGVILYVLLA------------------GFL--PFQDD- 224
APE+ ++ KGY KA DIWS G IL +L+ G L P Q+D
Sbjct: 177 APEIMLNSKGY--TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234
Query: 225 -NIVSMYRKIY-RGDFKCP--PW------FSSEARRLITKLLDPNPNSRI 264
I+S+ + Y + P PW +A L+ K+L NP+ RI
Sbjct: 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 93/328 (28%), Positives = 147/328 (44%), Gaps = 53/328 (16%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+Y++ ++G G++ V A + TG+ +A+K + D V +I REI ++++++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59
Query: 80 HIVELHEVMASKSK-----IYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDF 133
IVE+ +M S+ IY +L+ +L I A L + + + QL+ A+ +
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEV- 191
H+ V+HRDLKP+N+L + D LK+ DFGL+ + + + T T Y APE+
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178
Query: 192 ---ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--------------- 233
SK Y A DIWS G I +L G F N+V I
Sbjct: 179 GSFFSK--YTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235
Query: 234 -------YRGDF--KCPPWFSSE-------ARRLITKLLDPNPNSRIAISKIMESSWFKK 277
Y K P FS + A RL+ +LL +P R + + +FK
Sbjct: 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295
Query: 278 SAPKV------VITKQEMEFEADKSSKQ 299
A ITK E EFE + +K+
Sbjct: 296 LAKVEREPSAQPITKLEFEFERRRLTKE 323
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 74/271 (27%), Positives = 135/271 (49%), Gaps = 26/271 (9%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
G +EL ++G+GT+ +VY R+++TG+ A+KV+ + E+IK+EI+++K H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 79 -KHIVELHEVMASKS------KIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLI 128
++I + K+ +++ M+ G + + I + L+E+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ H V HRD+K +N+LL E+ +K+ DFG+SA + + G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 179
Query: 189 PEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKC 240
PEVI+ YD K+D+WS G+ + G P D + + I R K
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIME 271
W S + + I L N + R ++M+
Sbjct: 239 KKW-SKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 64/264 (24%), Positives = 115/264 (43%), Gaps = 28/264 (10%)
Query: 25 RMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ LG G F KV L R TG+ +A+K + + +REI +++ + H++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHEN 67
Query: 81 IVELHEVM--ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHS 136
IV+ V + M+ + G L + + + R + ++ R+ + Q+ +D+ S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISKK 195
+ HRDL N+L++ + +K++DFGL+ K + +P + APE +
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 196 GYDGAKADIWSCGVILYVLL----------AGFL----PFQDDNIVS-MYRKIYRGD-FK 239
+ + +D+WS GV LY L A FL Q IV+ + + G+
Sbjct: 188 KFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP 246
Query: 240 CPPWFSSEARRLITKLLDPNPNSR 263
PP E L+ + P R
Sbjct: 247 RPPSCPDEVYDLMKLCWEAEPQDR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 45/298 (15%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKH 78
KYE+ + LG G + V+ A + +T + +A+K + D ++ REI ++ + H
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFREIMFLQELGDH 66
Query: 79 KHIVELHEVM-ASKSK-IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS 136
+IV+L V+ A K IY + ++ +L I L + R QL+ A+ + HS
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHS 125
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHL--KQDGLLHTTCGTPAYVAPEVI- 192
V HRDLKP N+LL+ D +K+ DFGL+ + SE ++ +L T Y APE++
Sbjct: 126 GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL 185
Query: 193 -SKKGYDGAKA-DIWSCGVILYVLLAGFLPF-------QDDNIV---------------- 227
S + Y K D+WS G IL +L G F Q + I+
Sbjct: 186 GSTR-Y--TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242
Query: 228 ----SMYRKIYRGDFKCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
+M + K P S +A L+ KLL NPN R+ + +E + +
Sbjct: 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 69/264 (26%), Positives = 119/264 (45%), Gaps = 33/264 (12%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
+LG +G G F V L G+ +A+K + D + E SVM ++H ++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDD----STAAQAFLAEASVMTTLRHPNL 62
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC------H 135
V+L V+ + +Y + + G L + + R R QQL A+D C
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISK 194
+ HRDL N+L+ ED KV+DFGL+ K+ + P + APE + +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALRE 173
Query: 195 KGYDGAKADIWSCGVILYVLLA-GFLPFQD---DNIVSMYRKIYRGDF--KCPPWFSSEA 248
K + K+D+WS G++L+ + + G +P+ ++V K YR + CPP E
Sbjct: 174 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP----EV 228
Query: 249 RRLITKLLDPNPNSRIAISKIMES 272
+++ + +P R ++ E
Sbjct: 229 YKVMKDCWELDPAKRPTFKQLREQ 252
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 44/294 (14%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-- 77
+YE +G G + VY AR+ +G +A+K V + + + G+ RE++++K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 78 -HKHIVELHEVMAS-----KSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLIS 129
H +IV L +V A+ ++K+ + V +K+ L + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVA 188
+DF H+ + HRDLKPEN+L+ G +K+ DFGL+ +S + ++ T Y A
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YRA 175
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-------------- 234
PEV+ + Y D+WS G I + F ++ KI+
Sbjct: 176 PEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234
Query: 235 ----RGDF---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
RG F P +L+ ++L NP+ RI+ + ++ +F
Sbjct: 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YE LG G++A VY ++ GK +A+KV+ + + G RE S++K +KH +
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHAN 64
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
IV LH+++ +K + + V +L + K G L + +++ QL+ + + H R
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
+ HRDLKP+NLL+ + G LK+ DFGL+ + H + ++ T Y P+V+
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLGS 178
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPF 221
D+W G I ++ G F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 73/279 (26%), Positives = 137/279 (49%), Gaps = 30/279 (10%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVK 77
+E+ +G GT+ KVY N + G A+K++ D + V E+I+ E ++++ +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVD--EEIEAEYNILQSLPN 77
Query: 78 HKHIVELHEVM-----ASKSKIYFAMDLVKGGELFNKIAKG------RLREDVARVYFQQ 126
H ++V+ + + +++ ++L GG + ++ KG RL E +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYG 136
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTP 184
+ + H+ + HRD+K N+LL +G +K+ DFG+SA S L+++ T+ GTP
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTP 192
Query: 185 AYVAPEVIS-KKGYD---GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---D 237
++APEVI+ ++ YD A+ D+WS G+ L G P D + V KI R
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
P + I++ L + +R +++ ++E + K
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 51/151 (33%), Positives = 80/151 (52%), Gaps = 25/151 (16%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK-------REISVMKMVKHK 79
LG G++A VY R+ TG+ +A+K + +E + RE S++K +KH
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI---------RLEHEEGAPFTAIREASLLKDLKHA 63
Query: 80 HIVELHEVMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+IV LH+++ +K + Y DL + + L R++ QL+ + +C
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVRLFLFQLLRGLAYC 119
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
H R V HRDLKP+NLL+ E G LK+ DFGL+
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG GT+A V+ R+ T +A+K + + + G RE+S++K +KH +IV LH+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 87 VMASKSKIYFAMD-LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 145
++ + + + L K + + + +++ Q++ + +CH R V HRDLK
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 146 PENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
P+NLL++E G LK+ DFGL+ A S K T Y P+V+ + D+
Sbjct: 132 PQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 205 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC-------- 240
W G I + + +G F + I+R +FK
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP 248
Query: 241 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282
P +E L+TK L RI+ + M+ ++F+ ++
Sbjct: 249 QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI 296
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 32/273 (11%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HK 79
+E+ +G GT+ KV+ N + G A+K++ D + + E+I+ E +++K + H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDID--EEIEAEYNILKALSDHP 75
Query: 80 HIVELHEVMASKS-----KIYFAMDLVKGGELFNKIAKG------RLREDVARVYFQQLI 128
++V+ + + K +++ ++L GG + + KG R+ E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAY 186
+ H HRD+K N+LL +G +K+ DFG+SA S L+++ T+ GTP +
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPFW 190
Query: 187 VAPEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DF 238
+APEVI+ YD A+ D+WS G+ L G P D + + KI R
Sbjct: 191 MAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTL 249
Query: 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
P +S+E I K L + R +S +++
Sbjct: 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 89/324 (27%), Positives = 146/324 (45%), Gaps = 53/324 (16%)
Query: 21 YELGRMLGHGTFAKVYLARNLQT--GKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMV 76
YEL + LG G + V ARN +T +++A+K + K I + ++ RE+ +++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI---LAKRALRELKLLRHF 58
Query: 77 K-HKHIVELHE---VMASK-SKIYFAMDLVKGGELFNKIAKGRLREDVARVYF-QQLISA 130
+ HK+I L++ V +++Y +L++ +L I G+ D F Q++
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSE-HLKQDGLLHTTCGTPAYVA 188
+ + HS V HRDLKP NLL++ D LK+ DFGL+ FSE + G + T Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 189 PEV-ISKKGYDGAKADIWSCGVILYVLLAGFLPFQ------------------DDNIVSM 229
PE+ +S + Y A D+WS G IL LL F+ D+ +S
Sbjct: 178 PEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 230 YRKIYRGDF--------KCP-----PWFSSEARRLITKLLDPNPNSRIAISKIME----S 272
++ K P P + A L+ KLL +P RI++ + +E +
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 273 SWFKKSAPKVVITKQEMEFEADKS 296
W V + FE++ S
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESEDS 320
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 45/249 (18%)
Query: 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEV 87
G KV L + +T ++ +K + K + + I + H ++V LH+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILK-----GLRKSSEYSRERLTI-----IPHCVPNMVCLHKY 53
Query: 88 MASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146
+ S+ ++ + +GG+L++ I+K + E+ + + +++ A+D H G+ RDL P
Sbjct: 54 IVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113
Query: 147 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA----YVAPEV--ISKKGYDGA 200
N+LLD+ G++++T F +SE + +C A Y APEV IS+ +
Sbjct: 114 NNILLDDRGHIQLTYFS--RWSE-------VEDSCDGEAVENMYCAPEVGGISE---ETE 161
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-----DFKCPPWFSSEARRLITKL 255
D WS G IL+ LL G ++ G P W S EAR L+ +L
Sbjct: 162 ACDWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQL 212
Query: 256 LDPNPNSRI 264
L NP R+
Sbjct: 213 LQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 22/242 (9%)
Query: 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELHEVM 88
G F KV + ++ T K + V K+IK I E V + M + + ++L+ +
Sbjct: 27 GKFGKVSVLKHKPTQK---LFVQ---KIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSV 78
Query: 89 ASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147
+ MD +K G+LF+ + +G+L E + +QL+ A++ H + H D+K E
Sbjct: 79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138
Query: 148 NLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWS 206
N+L D + + D+GL + + GT Y +PE I YD D W+
Sbjct: 139 NVLYDRAKDRIYLCDYGL---CKIIGTPSCYD---GTLDYFSPEKIKGHNYD-VSFDWWA 191
Query: 207 CGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262
GV+ Y LL G PF++D + K + S A + +L N N
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251
Query: 263 RI 264
R+
Sbjct: 252 RL 253
|
Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 85
+LGHG VY A +L T + +A+KV+ D I V + +QI E+ ++ +I+ +
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 86 EVMASKSKIYFAMDLVKGGEL--FNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHR 142
+++I + + GG L + KI + L R VA ++ + + S + HR
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA------VVKGLTYLWSLKILHR 119
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGA 200
D+KP N+L++ G +K+ DFG+S Q + + T GT AY+APE IS + Y G
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVS------TQLVNSIAKTYVGTNAYMAPERISGEQY-GI 172
Query: 201 KADIWSCGVILYVLLAGFLPF 221
+D+WS G+ L G P+
Sbjct: 173 HSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
LG G V +++ TG MA KVV K + +QI RE+ +M + +IV
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSF 68
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDV----ARVYFQQLISAVDFCHSRG 138
+ +++ I M+ + G L ++I K G + ++ A + L +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--- 124
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ HRD+KP N+L++ G +K+ DFG+S E + + + T GT Y++PE I Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSG--ELI--NSIADTFVGTSTYMSPERIQGGKYT 180
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVS 228
K+D+WS G+ + L G PF NI
Sbjct: 181 -VKSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 31/229 (13%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME---------QIKREI 70
+Y+ +G G + +V A + +TG+ +A+K + + RE+
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK----------KLSRPFQSAIHAKRTYREL 65
Query: 71 SVMKMVKHKHIVELHEVMASKS------KIYFAMDLVKGGELFNKIAKGRLREDVARVYF 124
++K + H++++ L +V S +Y L+ G +L N + +L +D +
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLV 124
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
Q++ + + HS G+ HRDLKP N+ ++ED LK+ DFGL+ ++ + T
Sbjct: 125 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD-----EMTGYVATR 179
Query: 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
Y APE++ + DIWS G I+ LL G F + + ++I
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 66/248 (26%), Positives = 117/248 (47%), Gaps = 13/248 (5%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
R+LG G F +V + TGK A K + K ++ K E +++ V + +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 85 HEVMASKSKIYFAMDLVKGGEL----FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
+K + + ++ GG+L +N G E A Y +L ++ +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
+RDLKPEN+LLD+ G+++++D GL+ + + + GT Y+APEVI+ + Y +
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFKCPPWFSSEARRLITKLL 256
D W G ++Y ++ G PF+ + R++ + FS +A+ + LL
Sbjct: 182 -PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240
Query: 257 DPNPNSRI 264
NP R+
Sbjct: 241 TKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 92/326 (28%), Positives = 140/326 (42%), Gaps = 80/326 (24%)
Query: 20 KYELGRMLGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
KYE+ +G GT+ +VY A+ N + GK A+K DK G+ + REI++++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 78 HKHIVELHEVMASKS--KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ---------Q 126
H+++V L EV + +Y D + +L+ I R RV Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHR---QAKRVSIPPSMVKSLLWQ 116
Query: 127 LISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLS-AFSEHLKQ----DGLL 177
+++ V + HS V HRDLKP N+L+ E G +K+ D GL+ F+ LK D ++
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 178 HTTCGTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAG---F----------LPFQD 223
T Y APE++ + Y A DIW+ G I LL F PFQ
Sbjct: 177 VTIW----YRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 224 D------------------NIVSM--YRKIYRGDFKC--------PPWF------SSEAR 249
D +I M Y + + DFK W S+
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMK-DFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 250 RLITKLLDPNPNSRIAISKIMESSWF 275
L+ KLL+ +P RI + +E +F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-19
Identities = 70/288 (24%), Positives = 134/288 (46%), Gaps = 56/288 (19%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+Y++ R++G G +VYLA + + +A+K + +D + ++ RE + + H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY------------FQQ 126
IV ++ + + +Y+ M ++G L + + +E +++ F +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD---------GLL 177
+ + +++ HS+GV HRDLKP+N+LL G + + D+G + F + ++D +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 178 HTT-------CGTPAYVAPEVISKKGYDGA-KADIWSCGVILYVLLAGFLPFQ------- 222
+++ GTP Y+APE G + DI++ GVILY +L P++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 223 --DDNI-----VSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263
D I V+ YR+I PP+ S ++ K L +P R
Sbjct: 240 SYRDVILSPIEVAPYREI-------PPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 57/222 (25%), Positives = 111/222 (50%), Gaps = 17/222 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVK 77
+Y+ +G G + V A + + + +A+K + + +I + RE+ ++K +K
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMK 72
Query: 78 HKHIVELHEVMASK------SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131
H++++ L +V +++Y +L+ G +L N + +L ++ + QL+ +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
+ HS G+ HRDLKP N+ ++ED L++ DFGL+ + D + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEI 186
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
+ + DIWS G I+ LL G F ++ + ++I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG GT+A VY R+ T +A+K + + + G RE+S++K +KH +IV LH+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 87 VMASKSKIYFAMD-LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLK 145
++ ++ + + L K + + + +++ QL+ +++CH R V HRDLK
Sbjct: 72 IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 146 PENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
P+NLL++E G LK+ DFGL+ A S K T Y P+++ + D+
Sbjct: 132 PQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 205 WSCGVILYVLLAGFLPFQDDNIVSMYRKIYR----------------GDFKC-------- 240
W G I Y + G F + I+R +FK
Sbjct: 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRA 248
Query: 241 ------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
P S+ L++KLL RI+ + M+ +F
Sbjct: 249 DCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 65/242 (26%), Positives = 110/242 (45%), Gaps = 22/242 (9%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+G G + V A + +TG +A+K + + +I ++ RE+ ++K +KH++++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGL 81
Query: 85 HEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 138
+V +Y L+ G +L N + +L +D + Q++ + + HS
Sbjct: 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ HRDLKP NL ++ED LK+ DFGL+ + D + T Y APE++ +
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIMLNWMHY 195
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF-----SSEARRLIT 253
DIWS G I+ LL G F + + + I R S AR I
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255
Query: 254 KL 255
L
Sbjct: 256 SL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 15/215 (6%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG GT+A V+ R+ T +A+K + + + G RE+S++K +KH +IV LH+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 87 VMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYH 141
++ ++ + Y DL + + +V +++ QL+ + +CH R + H
Sbjct: 71 IIHTERCLTLVFEYLDSDL---KQYLDNCGNLMSMHNV-KIFMFQLLRGLSYCHKRKILH 126
Query: 142 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
RDLKP+NLL++E G LK+ DFGL+ A S K T Y P+V+
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGSTEYST 183
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 235
D+W G ILY + G F + I+R
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-18
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G++A VY + G+ +A+KV+ + G+ RE S++K +KH +IV LH+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 144
++ +K + F + + +L + + G L R++ QL+ + + H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 145 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
KP+NLL+ G LK+ DFGL+ Q + T Y P+V+ + DI
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 205 WSCGVILYVLLAG 217
W G I +L G
Sbjct: 188 WGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 44/270 (16%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKH 80
+G G F VY L+ +A+K + + +KR E ++K H +
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDF 133
IV+L V K IY M+LV GG L LR+ R+ ++L+ + +++
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTTCGTPAYVAPE 190
S+ HRDL N L+ E+ LK++DFG+S + DGL + APE
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPE 165
Query: 191 VISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD-------DNIVSMYRKIYRGDFKCPP 242
++ Y +++D+WS G++L+ G P+ + I S YR P
Sbjct: 166 ALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR------MPAPQ 218
Query: 243 WFSSEARRLITKLLDPNPNSRIAISKIMES 272
E RL+ + +P +R + S+I
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 31/267 (11%)
Query: 42 QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM-DL 100
TG +A+K++ D + + +RE ++ + H +IV L + + + FA+ +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 101 VKGGELFNKIA-KGRLR-EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--- 155
V G L +A G L + R+ Q L A+ H++G+ HRDLKP+N+++ + G
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVL-DALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 156 NLKVTDFGLSA----FSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVI 210
+ KV DFG+ + GTP Y APE + + +D+++ G+I
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLI 178
Query: 211 LYVLLAGFLPFQDDNIVS-MYRKIYRGDFKCPPWFSSEARRL---ITKLLDPNPNSRIAI 266
L G Q ++ +Y+++ D PPW L + K L+ +P R A
Sbjct: 179 FLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKDPRQRAA- 235
Query: 267 SKIMESSWFKKSAPKVVITKQEMEFEA 293
SAP + + +E A
Sbjct: 236 -----------SAPALAERFRALELCA 251
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 55/294 (18%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-GMMEQIKREISVMKMV---K 77
E R +G+G F V+ + + GK +A+K K+ V + KR +KM+ K
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK-----KMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 78 HKHIVELHEVMASK-----SKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAV 131
H +++ +++ +IY +L++ +L I + L D +V+ Q++ +
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAP 189
+ HS G+ HRD+KP NLL++ + LK+ DFGL+ E D H T T Y AP
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE---PDESKHMTQEVVTQYYRAP 173
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ----------------DDNIVSMY--- 230
E++ + + DIWS G I LL + FQ ++ +M
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233
Query: 231 ----RKIYRGDFKCPPWFSS----------EARRLITKLLDPNPNSRIAISKIM 270
I RG K PP EA L+ ++L +P+ RI+ + +
Sbjct: 234 EGARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 17/268 (6%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
R +GHG+F VY AR+++T + +A+K + + I +E+ ++ +KH + +E
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 85 HEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
+ + M+ G +L ++ K L+E + + + HS + HR
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYDG 199
D+K N+LL E G +K+ DFG ++ + ++ GTP ++APEVI + YDG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDG 203
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLL 256
K D+WS G+ L P + N +S I + + + W S R + L
Sbjct: 204 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW-SDYFRNFVDSCL 261
Query: 257 DPNPNSRIAISKIMESSWFKKSAPKVVI 284
P R ++++ + + P+ V+
Sbjct: 262 QKIPQDRPTSEELLKHMFVLRERPETVL 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVK 77
KY + +G G + V A+N +T + +A+K + D I ++ REI +++ +
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLD 62
Query: 78 HKHIVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAV 131
H++++ + ++M + +Y +L+ +L I + L +D + + QL+ +
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
+ HS V HRDLKP NLLL+ + +LK+ DFGL+ + ++ + T Y APE+
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWYRAPEL 179
Query: 192 I-SKKGYDGAKADIWSCGVILYVLL 215
+ + Y D+WS G I LL
Sbjct: 180 LLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 71/281 (25%), Positives = 124/281 (44%), Gaps = 19/281 (6%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
DD + G +E+G HG+F VY A N T + +A+K + + I +E+
Sbjct: 17 DDPEEIFVGLHEIG----HGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV 72
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG-GELFNKIAKGRLREDVARVYFQQLIS 129
++ +KH + +E + + M+ G ++ K L+E +
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 132
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ + HS + HRD+K N+LL E G +K+ DFG ++ S ++ GTP ++AP
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAP 186
Query: 190 EVI---SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPW 243
EVI + YDG K D+WS G+ L P + N +S I + D + W
Sbjct: 187 EVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW 245
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVI 284
+ R + L P R A ++++ + ++ P V+
Sbjct: 246 -TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 14/222 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+Y + +G G + V A + +TG+ +A+K + + ++ ++ RE++++K ++H+
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHE 74
Query: 80 HIVELHEVMASKS------KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 133
+++ L +V S Y M ++ KI L ED + Q++ + +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKY 132
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
HS G+ HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEVI
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVIL 187
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR 235
+ DIWS G I+ +L G F+ + + +I +
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 63/259 (24%), Positives = 125/259 (48%), Gaps = 31/259 (11%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKD--KVIKVGMMEQIKREISVMKMVKHKHIVE 83
+LG G F +V+ L+ +A+K +D + +K+ + + + ++K H +IV+
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLSEAR----ILKQYDHPNIVK 56
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVD------FCHS 136
L V + IY M+LV GG+ + LR+ + +QL+ A+D + S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLS-----FLRKKKDELKTKQLVKFALDAAAGMAYLES 111
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP----AYVAPEVI 192
+ HRDL N L+ E+ LK++DFG+S ++D ++++ G + APE +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 193 SKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250
+ Y +++D+WS G++L+ + G P+ ++ +G CP + +
Sbjct: 167 NYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225
Query: 251 LITKLLDPNPNSRIAISKI 269
++ + D P +R S++
Sbjct: 226 VMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 16/226 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK- 77
+YE +G G + KV+ AR+L+ G + +A+K V + + + GM RE++V++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 78 --HKHIVELHEVMA-----SKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLI 128
H ++V L +V ++K+ + V +K+ + + + + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+DF HS V HRDLKP+N+L+ G +K+ DFGL+ L + T Y A
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRA 177
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 234
PEV+ + Y D+WS G I + F+ + V KI
Sbjct: 178 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 74/275 (26%), Positives = 134/275 (48%), Gaps = 33/275 (12%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR-----EISVMKMVKHKHI 81
LG G + V R++ TG MA+K + V EQ KR +IS M+ V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRA----TVNSQEQ-KRLLMDLDIS-MRSVDCPYT 62
Query: 82 VELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLR--EDVARVYFQQLISAVDFCHSR 137
V + + + ++ M+++ + + K+ L ED+ ++ A+++ HS+
Sbjct: 63 VTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 138 -GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVI--- 192
V HRD+KP N+L++ +G +K+ DFG+S +L D + T G Y+APE I
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISG---YL-VDSVAKTIDAGCKPYMAPERINPE 178
Query: 193 -SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW-----FSS 246
++KGYD K+D+WS G+ + L G P+ D+ + ++++ + + P FS
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPAEKFSP 235
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
E + + K L N R ++++ +F+ K
Sbjct: 236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/268 (24%), Positives = 118/268 (44%), Gaps = 17/268 (6%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
R +GHG+F VY AR+++ + +A+K + + I +E+ ++ ++H + ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 85 HEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
+ + M+ G +L ++ K L+E + + + HS + HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI---SKKGYDG 199
D+K N+LL E G +K+ DFG ++ + GTP ++APEVI + YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLL 256
K D+WS G+ L P + N +S I + + + W S R + L
Sbjct: 194 -KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCL 251
Query: 257 DPNPNSRIAISKIMESSWFKKSAPKVVI 284
P R +++ + + P VI
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 20 KYELGRMLGHGTFAKVY--LARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKM 75
K L R LG G+F VY LA+ + G +V K M E+I+ E SVMK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKG-EPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY--------FQ-- 125
H+V L V+++ M+L+ G+L + + R + Q
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 126 -QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDG--LLHT 179
++ + + ++ HRDL N ++ ED +K+ DFG++ +++ ++ G LL
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183
Query: 180 TCGTPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQ 222
P ++APE + K G K+D+WS GV+L+ + P+Q
Sbjct: 184 ----PVRWMAPESL-KDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 55/219 (25%), Positives = 105/219 (47%), Gaps = 16/219 (7%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
+ LG G F V+L + + +A+K + + + + +E+ K VM + H +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
+ V + +Y + ++ G L N + +G+L +D+ Q + +++ HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVISKKGYDG 199
DL N L+ G +KV+DFG++ + D ++ G + PEV + Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 200 AKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD 237
+K+D+WS GV+++ V G +PF+ + + I RG
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 18/240 (7%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G + V A + +TG +A+K + + ++ ++ RE+ ++K +KH++++ L +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHENVIGLLD 81
Query: 87 VMASKSKI------YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
V + Y M + G +L + +L ED + Q++ + + H+ G+
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEVI +
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQ 195
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF-----SSEARRLITKL 255
DIWS G I+ +L G F+ + + +I + F S +A+ + KL
Sbjct: 196 TVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 25/258 (9%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
+G G F +V+ R +A+K + + + + +E ++K H +IV L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFCHSRGV 139
V K IY M+LV+GG+ LR + R+ ++LI + +++ S+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLT-----FLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP----AYVAPEVISKK 195
HRDL N L+ E LK++DFG+S E DG+ +T G + APE ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEE----DGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 196 GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLIT 253
Y +++D+WS G++L+ + G +P+ + + I +G CP RL+
Sbjct: 172 RYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLME 230
Query: 254 KLLDPNPNSRIAISKIME 271
+ + +P R + S + +
Sbjct: 231 RCWEYDPGQRPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 81/336 (24%), Positives = 143/336 (42%), Gaps = 63/336 (18%)
Query: 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKRE 69
D T+L +Y+ + +G G V A + G ++A+K + + ++ RE
Sbjct: 13 ADSTFTVLK-RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRE 70
Query: 70 ISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVY 123
+ ++K V HK+I+ L V + +Y M+L+ ++ L +
Sbjct: 71 LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL 128
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + + ++ T
Sbjct: 129 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVT 185
Query: 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---------- 233
Y APEVI GY DIWS G I+ L+ G + FQ + + + K+
Sbjct: 186 RYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244
Query: 234 ------------------YRG-DFK--CPPWF-----------SSEARRLITKLLDPNPN 261
Y G F+ P W +S+AR L++K+L +P+
Sbjct: 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304
Query: 262 SRIAISKIME----SSWF---KKSAPKVVITKQEME 290
RI++ + + + W+ + AP I ++E
Sbjct: 305 KRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLE 340
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 74/257 (28%), Positives = 127/257 (49%), Gaps = 28/257 (10%)
Query: 22 ELGRMLGHGTFAKVYLA--RNLQTGK-SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
LGR +G G F VY + + K ++A+K V E+ +E +M+ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDH 66
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHS 136
HIV+L V+ +++ ++ M+L GEL + + + D+A + Y QL +A+ + S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT-P-AYVAPEVISK 194
+ HRD+ N+L+ +K+ DFGLS + L+ + + G P ++APE I+
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINF 182
Query: 195 KGYDGAKADIWSCGVILY-VLLAGFLPFQ--DDNIVSMYRKIYRGDF-----KCPPWFSS 246
+ + A +D+W GV ++ +L+ G PFQ +N V +I G+ CPP S
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIG--RIENGERLPMPPNCPPTLYS 239
Query: 247 EARRLITKLLDPNPNSR 263
L+TK +P+ R
Sbjct: 240 ----LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 66/280 (23%), Positives = 123/280 (43%), Gaps = 48/280 (17%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMK-----VVGKDKVIKVGMMEQIKREI-SVMKMVKHKH 80
+G G F V + +G MA+K V K+ +++ ++ VM+ +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-------QKRLLMDLDVVMRSSDCPY 64
Query: 81 IVELHEVMASKSKIYFAMDLVKGG-ELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG- 138
IV+ + + + + M+L+ + F K L+ + ++++ + +
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP----EEILGKIAVATVKAL 120
Query: 139 --------VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAP 189
+ HRD+KP N+LLD +GN+K+ DFG+S L D + T G Y+AP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QL-VDSIAKTRDAGCRPYMAP 176
Query: 190 EVI---SKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPP--- 242
E I ++ GYD ++D+WS G+ LY + G P+ +++ ++ +GD PP
Sbjct: 177 ERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---PPILS 232
Query: 243 -----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
FS I L + + R +++E + K
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 16/233 (6%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR 68
GD T+L +Y+ + +G G V A + TG+++A+K + + V ++ R
Sbjct: 7 VGDSTFTVLK-RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYR 64
Query: 69 EISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARV 122
E+ +MK+V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMDLDHERMSY 122
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-C 181
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + T
Sbjct: 123 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYV 178
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 234
T Y APEVI GY DIWS G I+ ++ G + F + + + KI
Sbjct: 179 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G V + +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDV-ARVYFQQLISAVDFCHSRGVYHRD 143
S +I M+ + GG L +++ K GR+ E++ ++ L + HRD
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGAK 201
+KP N+L++ G +K+ DFG+S Q D + ++ GT +Y++PE + Y +
Sbjct: 126 VKPSNILVNSRGEIKLCDFGVSG------QLIDSMANSFVGTRSYMSPERLQGTHY-TVQ 178
Query: 202 ADIWSCGVILYVLLAGFLP 220
+DIWS G+ L + G P
Sbjct: 179 SDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 66/257 (25%), Positives = 123/257 (47%), Gaps = 23/257 (8%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G + +VY + ++A+K + +D + +E+ +E +VMK +KH ++V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ---QLISAVDFCHSRGVYHRD 143
V + Y + + G L + + + +E A V Q+ SA+++ + HRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HTTCGTP-AYVAPEVISKKGYDGAK 201
L N L+ E+ +KV DFGLS + D H P + APE ++ + K
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IK 185
Query: 202 ADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKI---YRGDFK--CPPWFSSEARRLITKL 255
+D+W+ GV+L+ + G P+ ++ +Y + YR + CPP + L+
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP----KVYELMRAC 241
Query: 256 LDPNPNSRIAISKIMES 272
NP+ R + ++I ++
Sbjct: 242 WQWNPSDRPSFAEIHQA 258
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 73/261 (27%), Positives = 120/261 (45%), Gaps = 27/261 (10%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
K LG ++G G F V TG+ +A+K + D V +E E +VM + HK
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLE----ETAVMTKLHHK 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARV--YFQQLISAVDFCHS 136
++V L V+ +Y M+L+ G L N + +GR V ++ + + +++ S
Sbjct: 60 NLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
+ + HRDL N+L+ EDG KV+DFGL+ + L + APE + K
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKK 173
Query: 197 YDGAKADIWSCGVILY-VLLAGFLPFQD---DNIVSMYRKIYRGD--FKCPPWFSSEARR 250
+ +K+D+WS GV+L+ V G P+ + K YR + CP +
Sbjct: 174 FS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA----DVYV 228
Query: 251 LITKLLDPNPNSRIAISKIME 271
L+T + P R + K+ E
Sbjct: 229 LMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 41/269 (15%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV----IKVGMM--EQIKREISVMKMV 76
+ LG G F V+L K GK V I+ G M + E VM +
Sbjct: 8 FLKELGSGQFGVVHLG-----------KWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL 56
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFC 134
H ++V+L+ V + I+ + + G L N + KG+L + + A+++
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEV 191
S G HRDL N L+ ED +KV+DFGL+ + D ++ GT + PEV
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSSQGTKFPVKWAPPEV 172
Query: 192 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD-------DNIVSMYRKIYRGDFKCPPW 243
+ +K+D+WS GV+++ V G +P++ +++ + YR +YR P
Sbjct: 173 FDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-LYR-----PKL 225
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIMES 272
+E ++ P R A K++
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 12/172 (6%)
Query: 68 REISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVAR 121
RE+ +MK V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMS 129
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + ++
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 186
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
T Y APEVI GY DIWS G I+ ++ G + F + + + K+
Sbjct: 187 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 25 RMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
R+LG G F KV L N TG+ +A+K + ++ K+EI+++K + H++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHEN 67
Query: 81 IVELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 138
IV+ + + + M+ V G L + + K +L ++ QQ+ + + HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLS-AFSE-----HLKQDGLLHTTCGTPAY-VAPEV 191
HRDL N+LLD D +K+ DFGL+ A E +++DG +P + A E
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVEC 181
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222
+ + + A +D+WS GV LY LL Q
Sbjct: 182 LKENKFSYA-SDVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G V+ + +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDL 144
S +I M+ + GG L + K GR+ E + +I + + + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 145 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 205 WSCGVILYVLLAGFLP 220
WS G+ L + G P
Sbjct: 186 WSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 67/266 (25%), Positives = 123/266 (46%), Gaps = 30/266 (11%)
Query: 21 YELGRMLGHGTFAKV---YLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
+ LGRMLG G F V L + + +A+K++ K + +E+ RE + MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 78 HKHIVELHEV-MASKSKIYFAMDLV-----KGGELFNKIAKGRLREDVARVYFQQLI--- 128
H ++++L V + S++K + +V K G+L + R+ E+ + Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 129 ----SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCG 182
S +++ S+ HRDL N +L+E+ + V DFGLS +S + G C
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG-----CA 174
Query: 183 TP---AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD- 237
+ ++A E ++ Y +D+W+ GV ++ ++ G P+ +Y + +G+
Sbjct: 175 SKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSR 263
K PP + L+ + P P R
Sbjct: 234 LKQPPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 12/172 (6%)
Query: 68 REISVMKMVKHKHIVELHEVMASK------SKIYFAMDLVKGGELFNKIAKGRLREDVAR 121
RE+ +MK V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMS 122
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + ++
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 179
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
T Y APEVI GY DIWS G I+ ++ + F + + + K+
Sbjct: 180 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86
LG G V ++ +G MA K++ + IK + QI RE+ V+ +IV +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 87 VMASKSKIYFAMDLVKGGELFNKIAKGRL--REDVARVYFQQLISAVDFCHSRGVYHRDL 144
S +I M+ + GG L + + + E + +V L + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 145 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADI 204
KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE + Y ++DI
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 205 WSCGVILYVLLAGFLP 220
WS G+ L L G P
Sbjct: 186 WSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 21/234 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+G+ V+LA++ T +A+K + D K ++ +++EI + ++H +
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPN 60
Query: 81 IVELHEVMASKSKIYFAMDLVKGG---ELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 137
I+ S++Y L+ G +L L E + +++A+D+ HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-------VAPE 190
G HR +K ++LL DG KV GL +K P ++PE
Sbjct: 121 GFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 191 VISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 242
V+ + +GY+ K+DI+S G+ L G +PF+D M + RG P
Sbjct: 179 VLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRG---TVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 66/251 (26%), Positives = 119/251 (47%), Gaps = 30/251 (11%)
Query: 3 TSNSNGGGDDRPTL-------LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKD 55
+N+ D+ + + Y+LG ++G+G+F VY A + T + +A+K V +D
Sbjct: 43 NNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD 102
Query: 56 KVIKVGMMEQIKREISVMKMVKHKHIVELHE------VMASKSKIYFAMDLVKGGELFNK 109
K RE+ +MK + H +I+ L + ++ I+ + + + +K
Sbjct: 103 PQYK-------NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155
Query: 110 IAKGRLREDVA------RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-LKVTDF 162
K R + A ++Y QL A+ + HS+ + HRDLKP+NLL+D + + LK+ DF
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
Query: 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222
G SA + Q + + + Y APE++ D+WS G I+ ++ G+ F
Sbjct: 216 G-SAKNLLAGQRSVSYIC--SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272
Query: 223 DDNIVSMYRKI 233
+ V +I
Sbjct: 273 GQSSVDQLVRI 283
|
Length = 440 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 30/273 (10%)
Query: 25 RMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
R LG G F KV L R TG+ +A+K + + + +K+EI +++ + H++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHEN 67
Query: 81 IVELHEVMASK--SKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHS 136
IV+ + + I M+ + G L + + + + ++ + Y Q+ +D+ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-VAPE-VISK 194
R HRDL N+L++ + +K+ DFGL+ E K+ + +P + APE +I
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 195 KGYDGAKADIWSCGVILYVLL----------AGFL----PFQDDNIVSMYRKIYRGD--F 238
K Y +D+WS GV LY LL FL P V+ ++
Sbjct: 188 KFY--IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245
Query: 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
PP E +L+ K + P+ R ++E
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKH 80
L R LG G F +V++ T K +A+K +K G M E +E +MK ++H
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK-VAVKT------LKPGTMSPEAFLQEAQIMKKLRHDK 62
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR-VYFQQLI-------SAVD 132
+V+L+ V + + IY + + G L + L+ + + QL+ +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD-----FLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAP 189
+ SR HRDL N+L+ E+ K+ DFGL+ L +D G + AP
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIKWTAP 173
Query: 190 EVISKKGYDGAKADIWSCGVILY 212
E + G K+D+WS G++L
Sbjct: 174 EAAN-YGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 40/236 (16%)
Query: 56 KVIKVGMM--EQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG 113
K+IK G M ++ E VM + H+ +V+L+ V + IY + + G L N
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN----- 88
Query: 114 RLREDVARVYFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166
LRE R QL+ + + S+ HRDL N L+D+ G +KV+DFGLS
Sbjct: 89 YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 167 FSEHLKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQ 222
+ D ++ G+ V PEV+ + +K+D+W+ GV+++ V G +P++
Sbjct: 149 YV----LDDEYTSSVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYE 203
Query: 223 DDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278
N K+ +G P +SE + IM S W +K+
Sbjct: 204 RFNNSETVEKVSQGLRLYRPHLASE-----------------KVYAIMYSCWHEKA 242
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 84
+G G F V+L L+ K K I+ G M E E VM + H +V+L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAI-------KTIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 85 HEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
+ V +S I + ++ G L + + +G+ ++ + + + S V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAPEVISKKGYDG 199
DL N L+ E+ +KV+DFG++ F D ++ GT + +PEV S Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVKWSSPEVFSFSKYS- 179
Query: 200 AKADIWSCGVILY-VLLAGFLPFQD 223
+K+D+WS GV+++ V G P+++
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 29/234 (12%)
Query: 27 LGHGTFAKV----YLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 82
LGHG F V YL ++ + +A+K + ++ + ++ RE SVM + H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE-VEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIV 59
Query: 83 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA--RVYFQQLISAVDFCHSRGVY 140
L V + + M+L G L K K R V+ + Q+ + + S+
Sbjct: 60 RLIGVCKGEP-LMLVMELAPLGPL-LKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLS----AFSEHLKQDGLLHTTCGT-P-AYVAPEVISK 194
HRDL N+LL K++DFG+S A S++ + TT G P + APE I+
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-----TTAGRWPLKWYAPECINY 172
Query: 195 KGYDGAKADIWSCGVILYVLLA-GFLPFQD---DNIVSMYRKIYRGDF--KCPP 242
+ +K+D+WS GV L+ + G P+ + +++M R +CP
Sbjct: 173 GKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ 225
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 51/167 (30%), Positives = 92/167 (55%), Gaps = 12/167 (7%)
Query: 65 QIKREISVMKMVKHKHIVELHEVMASKSKIY-----FAMDLVK--GGELFNKIAKGRLRE 117
Q++ EI + + H++I+++ E++ S++ Y + DL E F+ + L++
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 118 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177
R +QL+ AV++ H + + HRD+K EN+ L+ DG + + DFG + E +++
Sbjct: 269 --TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK-EREAFD 325
Query: 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQD 223
+ GT A +PE+++ GY DIWSCG+IL +L+ F P D
Sbjct: 326 YGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
+L + +G G F V L G +A+K + D + + E SVM ++H ++
Sbjct: 9 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEA-----SVMTQLRHSNL 61
Query: 82 VELHEVMAS-KSKIYFAMDLVKGGELFNKI-AKGR--LREDVARVYFQQLISAVDFCHSR 137
V+L V+ K +Y + + G L + + ++GR L D + + A+++ +
Sbjct: 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPEVISKKG 196
HRDL N+L+ ED KV+DFGL+ K+ T P + APE + +K
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAPEALREKK 175
Query: 197 YDGAKADIWSCGVILYVLLA-GFLPFQD---DNIVSMYRKIYRGDFK--CPP 242
+ K+D+WS G++L+ + + G +P+ ++V K Y+ D CPP
Sbjct: 176 FS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 36/259 (13%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKH 78
+L R LG G F +V+ N T +A+K +K G M + E +MK ++H
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT--PVAVKT------LKPGTMDPKDFLAEAQIMKKLRH 60
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-------DVARVYFQQLISAV 131
+++L+ V + IY +L+K G L + G R D+A Q+ S +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQVASGM 116
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVA 188
+ ++ HRDL N+L+ E+ KV DFGL+ +K+D + G + A
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTA 172
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF---QDDNIVSMYRKIYRGDFKCPPWF 244
PE + K+D+WS G++L ++ G +P+ + ++ + YR CPP
Sbjct: 173 PEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--MPCPPGC 229
Query: 245 SSEARRLITKLLDPNPNSR 263
E ++ +P+ R
Sbjct: 230 PKELYDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 57 VIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI-----YFAMDLVKGGELFNKIA 111
V+K+G E +++ V H ++ + + + S + +++ DL +
Sbjct: 95 VLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYT----YLTKR 150
Query: 112 KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171
L D A + +Q++ + + H++ + HRD+K EN+ +++ + + D G + F
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210
Query: 172 KQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA 216
GL GT APEV+++ Y+ +KADIWS G++L+ +LA
Sbjct: 211 PAFLGL----AGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 20 KYELGRMLGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
+YE G +G GT+ VY A+ + + K A+K ++ G+ REI++++ +K
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALK-----QIEGTGISMSACREIALLRELK 56
Query: 78 HKHIVELHEVMASKS--KIYFAMDLVKGGEL----FNKIAKG-----RLREDVARVYFQQ 126
H +++ L +V S S K++ D + F++ +K +L + + Q
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 127 LISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSA-FSEHLKQDGLLHTTC 181
++ + + H+ V HRDLKP N+L+ E G +K+ D G + F+ LK L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 215
T Y APE++ + DIW+ G I LL
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 26 MLGHGTFAKVYLAR--NLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
LG G F V L R LQ TG+ +A+K + + +REI ++K ++H +I
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNI 67
Query: 82 VELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSR 137
V+ V S + + M+ + G L + + K R R D ++ Y Q+ +++ S+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-VAPEVISKKG 196
HRDL N+L++ + +K+ DFGL+ K+ + +P + APE +++
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK 187
Query: 197 YDGAKADIWSCGVILYVL 214
+ A +D+WS GV+LY L
Sbjct: 188 FSVA-SDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 3/155 (1%)
Query: 68 REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQ 126
REI ++K + H+ I+ L KS + M K +LF + G L + A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
L+ A+ + H RG+ HRD+K EN+ LDE N + DFG + + + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF 221
+PE+++ Y AK DIWS G++L+ + +
Sbjct: 254 NSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 27 LGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 83
LG G+F V +G +A+K + DK+ + M+ +E ++M + H++++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARV--YFQQLISAVDFCHSRGVY 140
L+ V+ + + +L G L +++ K L ++ + Y Q+ + + + S+
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLS----------AFSEHLKQDGLLHTTCGTP-AYVAP 189
HRDL N+LL D +K+ DFGL EHLK P A+ AP
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK----------VPFAWCAP 169
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLA-GFLPF 221
E + + + A +D+W GV L+ + G P+
Sbjct: 170 ESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMVKHKH 80
+++G G F +V R GK + K +K G ++ + E S+M H +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAI---KTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDF 133
I+ L V+ + + ++ G L LRE+ + QL+ S + +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSL-----DKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG--TPA-YVAPE 190
HRDL N+L++ + KV+DFGLS E + +TT G P + APE
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT---YTTKGGKIPIRWTAPE 178
Query: 191 VISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
I+ + + A +D+WS G++++ V+ G P+ D
Sbjct: 179 AIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 20 KYELGRMLGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
+YE G +G GT+ VY A+ + + + A+K ++ G+ REI++++ +K
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELK 56
Query: 78 HKHIVELHEVMASKS--KIYFAMDLVKGGEL----FNKIAKG-----RLREDVARVYFQQ 126
H +++ L +V S + K++ D + F++ +K +L + + Q
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 127 LISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSA-FSEHLKQDGLLHTTC 181
++ + + H+ V HRDLKP N+L+ E G +K+ D G + F+ LK L
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 215
T Y APE++ + DIW+ G I LL
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKHI 81
++G G F +V R GK + K +K G E+ +R E S+M H +I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAI---KTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDFC 134
+ L V+ + + ++ G L LR++ + QL+ + + +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGAL-----DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---YVAPEV 191
HRDL N+L++ + KV+DFGLS F E D ++ G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 192 ISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 242
I+ + + A +D+WS G++++ V+ G P+ D + + I + D++ PP
Sbjct: 183 IAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-DYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMM 63
D R + + LG+ LG G F +V +A + K +A+K++ D K +
Sbjct: 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK--DL 67
Query: 64 EQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV 122
+ E+ +MKM+ KHK+I+ L +Y ++ G L + R R
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---RARRPPGME 124
Query: 123 Y-------------FQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 162
Y F+ L+S +++ S+ HRDL N+L+ ED +K+ DF
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 184
Query: 163 GLSAFSEHLKQDGLLHTTCGT-PA-YVAPEVISKKGYDGAKADIWSCGVILY 212
GL+ H+ D TT G P ++APE + + Y ++D+WS GV+L+
Sbjct: 185 GLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 233
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGK-------SMAMKVVGKDKVIKVGMMEQIKREISV 72
K LG+ LG G F +V +A L K ++A+K++ D K + + E+ +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEM 73
Query: 73 MKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-----DVARV---- 122
MKM+ KHK+I+ L +Y ++ G L + R D+ARV
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 123 -YFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174
F+ L+S +++ S+ HRDL N+L+ E+ +K+ DFGL+ ++ D
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--D 191
Query: 175 GLLHTTCGT-PA-YVAPEVISKKGYDGAKADIWSCGVILY 212
TT G P ++APE + + Y ++D+WS GV+++
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 74/289 (25%), Positives = 129/289 (44%), Gaps = 56/289 (19%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMMEQIKREISVMKM 75
LG+ LG G F +V A KS +A+K++ KD + + I E+ +MK+
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 76 V-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE--------------DVA 120
+ KHK+I+ L V + +Y ++ AKG LRE D+
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYA---------AKGNLREFLRARRPPGPDYTFDIT 124
Query: 121 RVY-----FQQLISAV-------DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168
+V F+ L+S ++ SR HRDL N+L+ ED +K+ DFGL+
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184
Query: 169 EHLKQDGLLHTTCG-TPA-YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD-- 223
+ D T+ G P ++APE + + Y ++D+WS G++++ + G P+
Sbjct: 185 HDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIP 241
Query: 224 -DNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ + + R+ +R D P + E L+ + P R +++E
Sbjct: 242 VEELFKLLREGHRMD--KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKM 75
+ LG+ LG G F +V A + K++K E+ + E+ +MKM
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 76 V-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR----------LREDVARVYF 124
+ KHK+I+ L V + +Y ++ G L + + R R +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 125 QQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177
+ L+S ++F S+ HRDL N+L+ ED +K+ DFGL+ H D
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYR 189
Query: 178 HTTCG-TPA-YVAPEVISKKGYDGAKADIWSCGVILY 212
TT G P ++APE + + Y ++D+WS GV+L+
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 50/238 (21%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGK-------SMAMKVVGKDKVIKVGMM 63
D + L + LG+ LG G F +V +A + K ++A+K++ D K +
Sbjct: 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK--DL 61
Query: 64 EQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE----- 117
+ E+ +MKM+ KHK+I+ L +Y L +KG LRE
Sbjct: 62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV---------LVEYASKGNLREYLRAR 112
Query: 118 ---------DVARV-----YFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGN 156
D ++ F+ L+S +++ S+ HRDL N+L+ ED
Sbjct: 113 RPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172
Query: 157 LKVTDFGLSAFSEHLKQDGLLHTTCGT-PA-YVAPEVISKKGYDGAKADIWSCGVILY 212
+K+ DFGL+ ++ D TT G P ++APE + + Y ++D+WS GV+L+
Sbjct: 173 MKIADFGLARDVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 54/226 (23%), Positives = 107/226 (47%), Gaps = 24/226 (10%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHK 79
+L + LG G F +V++ + K K +K G M + E ++MK ++H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTKVAV-------KTLKPGTMSVQAFLEEANLMKTLQHD 61
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI---AKGRLREDVARVYFQQLISAVDFCHS 136
+V L+ V+ + IY + + G L + + G++ + Q+ + +
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVIS 193
+ HRDL+ N+L+ E K+ DFGL+ +E+ ++G + APE I+
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAIN 177
Query: 194 KKGYDGAKADIWSCGVILY-VLLAGFLPF---QDDNIVSMYRKIYR 235
+ K+D+WS G++LY ++ G +P+ + +++S ++ YR
Sbjct: 178 FGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR 222
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 67/271 (24%), Positives = 116/271 (42%), Gaps = 28/271 (10%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM-----MEQIKREISVMKMVK 77
LG++LG G F V + Q S V K +K+ + +E+ E + MK
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAV---KTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 78 HKHIVELHEV---MASKSKIYFAM---DLVKGGELFNKIAKGRLREDVARVYFQQLI--- 128
H ++++L V +S KI M +K G+L + + RL ++ Q L+
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 129 ----SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEHLKQDGLLHTTCG 182
+++ +R HRDL N +L ED + V DFGLS +S + G
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG--RIAKM 177
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKC 240
++A E ++ + Y +K+D+W+ GV ++ + G P+ +Y + G+ K
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236
Query: 241 PPWFSSEARRLITKLLDPNPNSRIAISKIME 271
P E L+ +P R +K+ E
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 63/224 (28%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHK 79
+L + LG G F +V++A K + V K +K G M E E +VMK ++H
Sbjct: 9 KLEKKLGAGQFGEVWMA---TYNKHTKVAV----KTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQ-QLISAVDFCHS 136
+V+LH V+ +K IY + + G L F K +G + + F Q+ + F
Sbjct: 62 KLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVIS 193
R HRDL+ N+L+ K+ DFGL+ +E+ ++G + APE I+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI----KWTAPEAIN 176
Query: 194 KKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG 236
+ K+D+WS G++L ++ G +P+ + + R + RG
Sbjct: 177 FGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 25 RMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHK 79
+++G G F +V R L + + + + K +K G E+ +R E S+M H
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAI----KTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVD 132
+I+ L V+ + + ++ G L LR+ + QL+ S +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSL-----DAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---YVAP 189
+ G HRDL N+L++ + KV+DFGLS E + +TT G + AP
Sbjct: 121 YLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAP 178
Query: 190 EVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
E I+ + + A +D+WS G++++ V+ G P+ +
Sbjct: 179 EAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 30/88 (34%), Positives = 51/88 (57%), Gaps = 1/88 (1%)
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
+QL+SA+D+ H G+ HRD+K EN+L++ ++ + DFG + F+ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 185 AYVAPEVISKKGYDGAKADIWSCGVILY 212
APEV++ Y DIWS G++++
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 58/277 (20%), Positives = 104/277 (37%), Gaps = 47/277 (16%)
Query: 27 LGHGTFAKVYLARNLQ-TGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIV- 82
LG G F KVY + A V K + + + ++ ++E +M ++H +IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 83 ---------------------ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR 121
+LHE + S V + D
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPH----SDVGAESGDETVKSSLDCSDFLH 128
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLH 178
+ Q + + +++ S HRDL N L+ E +K++DFGLS +++ +
Sbjct: 129 IAIQ-IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV---QS 184
Query: 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP---FQDDNIVSMYRK-- 232
+ ++ PE I G ++DIWS GV+L+ + + G P F + ++ M R
Sbjct: 185 KSLLPVRWMPPEAI-LYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 233 IYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKI 269
+ CP + L+ + + P R I
Sbjct: 244 LLPCPEDCPARVYA----LMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 23 LGRMLGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
L R LG G F KV+LA NL K + V K + + +RE ++ ++H+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNK-----------IAKGRLREDVARVYFQQLI- 128
IV+ + V + + +K G+L NK + G+ R+ + Q++
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 129 ------SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHT 179
S + + S+ HRDL N L+ + +K+ DFG+S +++ + G HT
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HT 185
Query: 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILY 212
++ PE I + + ++D+WS GVIL+
Sbjct: 186 MLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 64/256 (25%), Positives = 110/256 (42%), Gaps = 31/256 (12%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHK 79
+L + LG+G F +V++ K K +K G M E E +MK ++H
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTKVAV-------KTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-------DVARVYFQQLISAVD 132
+V+L+ V+ S+ IY + + G L + + G R D+A Q+ + +
Sbjct: 62 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMA 116
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP---AYVAP 189
+ HRDL+ N+L+ + K+ DFGL+ L +D G + AP
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLA----RLIEDNEYTARQGAKFPIKWTAP 172
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247
E + G K+D+WS G++L L+ G +P+ N + ++ RG CP
Sbjct: 173 EA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
Query: 248 ARRLITKLLDPNPNSR 263
L+ + +P R
Sbjct: 232 LHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHK 79
+L + LG G F +V++ K +A+K +K G M E E ++MK ++H
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHTK-VAIKS------LKQGSMSPEAFLAEANLMKQLQHP 61
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKG-RLREDVARVYFQQLISAVDFCHS 136
+V L+ V+ ++ IY + ++ G L F K +G +L + Q+ + F
Sbjct: 62 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVIS 193
+ HRDL+ N+L+ E K+ DFGL+ +E+ ++G + APE I+
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAIN 176
Query: 194 KKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRL 251
G K+D+WS G++L ++ G +P+ + + + RG P E L
Sbjct: 177 -YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235
Query: 252 ITKLLDPNPNSR 263
+ P R
Sbjct: 236 MRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 39/162 (24%), Positives = 76/162 (46%), Gaps = 4/162 (2%)
Query: 57 VIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR 116
VIK G E +++ + H I++L + K +L+ +A R
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNI 179
Query: 117 EDVARVYFQQ-LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175
+ ++ ++ A+ + H + HRD+K EN+ ++ G++ + DFG + F + +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG 217
+ GT A APE++++ Y G DIWS G++L+ +
Sbjct: 240 -YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 23 LGRMLGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
L R LG G F KV+LA NL + + V K + RE ++ ++H+H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNK-----------IAKGRLREDVARVYF----Q 125
IV+ + V + + +K G+L NK +A+G ++ + Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHTTCG 182
Q+ + + + S+ HRDL N L+ E+ +K+ DFG+S +++ + G HT
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLP 185
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILY 212
++ PE I + + ++D+WS GV+L+
Sbjct: 186 I-RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 31/251 (12%)
Query: 27 LGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVE 83
LG G F +V++ N T ++ K +K G M E +E VMK ++H+ +V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAI--------KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKGR----LREDVARVYFQQLISAVDFCHSRGV 139
L+ V+ S+ IY + + G L + + KG LR Q+ S + +
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
HRDL+ N+L+ E+ KV DFGL+ +E+ + G + APE + G
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI----KWTAPEA-ALYG 178
Query: 197 YDGAKADIWSCGVILYVLLA-GFLPFQ---DDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252
K+D+WS G++L L G +P+ + ++ + YR CPP L+
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLM 236
Query: 253 TKLLDPNPNSR 263
+ P R
Sbjct: 237 CQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 56/227 (24%), Positives = 105/227 (46%), Gaps = 13/227 (5%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMK 74
+ E ++LG G F VY + G+ +A+KV+ ++ K ++I E VM
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMA 64
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVD 132
V H H+V L + S S++ L+ G L + + K + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP-AYVAPEV 191
+ + + HRDL N+L+ ++K+TDFGL+ + + + P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD-VDEKEYHAEGGKVPIKWMALES 182
Query: 192 ISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD 237
I + Y K+D+WS GV ++ L+ G P++ V + + +G+
Sbjct: 183 ILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 65/281 (23%), Positives = 118/281 (41%), Gaps = 28/281 (9%)
Query: 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM 73
P L + ++G G F +V AR + G M + + E+ V+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 74 -KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----------VARV 122
K+ H +I+ L + +Y A++ G L + + K R+ E + +
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 123 YFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175
QQL+ +D+ + HRDL N+L+ E+ K+ DFGLS Q+
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEV 176
Query: 176 LLHTTCGT-PA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRK 232
+ T G P ++A E ++ Y +D+WS GV+L+ +++ G P+ +Y K
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 233 IYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272
+ +G + P E L+ + P R + ++I+ S
Sbjct: 236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 33/275 (12%)
Query: 23 LGRMLGHGTFAKVYLA--RNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMV 76
L R LG G F KV+L +L+ + V K +K + RE ++
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAV---KTLKETASNDARKDFEREAELLTNF 65
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGEL---------------FNKIAKGRLREDVAR 121
+H++IV+ + V + ++ G+L G L
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLH 178
Q+ S + + S+ HRDL N L+ D +K+ DFG+S +++ + G
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG--- 182
Query: 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD 237
T ++ PE I + + ++D+WS GV+L+ + G P+ + + I +G
Sbjct: 183 HTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241
Query: 238 FK-CPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
P SE ++ +P RI I I E
Sbjct: 242 LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 61/251 (24%), Positives = 108/251 (43%), Gaps = 31/251 (12%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQIKREISVMKMVKHKHIVEL 84
LG G F +V++ T K K +K G M E +E +MK ++H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAI-------KTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL 66
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-------DVARVYFQQLISAVDFCHSR 137
+ V+ S+ IY + + G L + + +G + D+A Q+ + +
Sbjct: 67 YAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA----AQIADGMAYIERM 121
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVAPEVISK 194
HRDL+ N+L+ ++ K+ DFGL+ +E+ + G + APE +
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA-AL 176
Query: 195 KGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLI 252
G K+D+WS G++L L+ G +P+ + ++ RG CP L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236
Query: 253 TKLLDPNPNSR 263
+P+ R
Sbjct: 237 KLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHKH 80
+++G G F +V+ G+ + K +K G E+ ++ E S+M H +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAI---KTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI-------SAVDF 133
I+ L V+ + ++ G L LR+ QL+ + + +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGAL-----DKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA---YVAPE 190
HRDL N+L++ + KV+DFGLS E + +TT G + APE
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPE 180
Query: 191 VISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
I+ + + A +D+WS G++++ V+ G P+ D
Sbjct: 181 AIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
Y Q+ ++F SR HRDL N+LL E+ +K+ DFGL A + D + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 183 TP-AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--F 238
P ++APE I K Y ++D+WS GV+L+ + + G P+ I + + +
Sbjct: 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ P + E R++ +P R S ++E
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 37/125 (29%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL--LHTTCGT 183
Q+ + + H RGV H+D+ N ++DE+ +K+TD +A S L L
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNENR 181
Query: 184 P-AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMY---RKIYR--G 236
P ++A E + K Y A +D+WS GV+L+ L+ G P+ + + M + YR
Sbjct: 182 PVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240
Query: 237 DFKCP 241
CP
Sbjct: 241 PINCP 245
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 27 LGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
LG G F KV+LA NL + + V K + +RE ++ +++H+HIV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 85 HEVMASKSKIYFAMDLVKGGELFN---------KIAKGRLREDVARVYFQQLISAVDFCH 135
+ V + + ++ G+L KI G ++ Q+++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 136 SRGVY-------HRDLKPENLLLDEDGNLKVTDFGLS--AFSEHLKQDGLLHTTCGTPAY 186
S VY HRDL N L+ + +K+ DFG+S +S + G T +
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG--GRTMLPIRW 190
Query: 187 VAPEVISKKGYDGAKADIWSCGVILY 212
+ PE I + + ++DIWS GV+L+
Sbjct: 191 MPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 65/300 (21%), Positives = 124/300 (41%), Gaps = 57/300 (19%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV--IKVGMMEQ---------IKR 68
LG+ LG G F KV K+ A ++ G+ + V M+++ +
Sbjct: 1 NLVLGKTLGEGEFGKVV--------KATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS 52
Query: 69 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFN------KIAKGRLREDVAR- 121
E +++K V H H+++L+ + + ++ K G L + K+ L D R
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 122 ------------------VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163
+ Q+ + + + HRDL N+L+ E +K++DFG
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 164 LSAFSEHLKQDGLLHTTCG-TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP 220
LS + ++D + + G P ++A E + Y ++D+WS GV+L+ ++ G P
Sbjct: 173 LS--RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNP 229
Query: 221 F---QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
+ + + ++ + YR + P S E L+ P+ R + I S +K
Sbjct: 230 YPGIAPERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADI--SKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 28/164 (17%)
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
Y Q+ ++F SR HRDL N+LL E+ +K+ DFGL + + +D
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKD-------- 226
Query: 183 TPAYV------------APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSM 229
P YV APE I K Y ++D+WS GV+L+ + + G P+ I
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
Query: 230 Y-RKIYRGDFKCPPWFSS-EARRLITKLLDPNPNSRIAISKIME 271
+ R++ G P +++ E ++ NP R S+++E
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 27/241 (11%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHK 79
LG+ LG G F V +KV K I + ME E MK H
Sbjct: 3 LGKTLGEGEFGSV--MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 80 HIVELHEV--MASKSKIYFA----MDLVKGGELFNKIAKGRLREDVARVYFQQLI----- 128
+++ L V +S+ Y + + +K G+L + + RL + + Q L+
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 129 --SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQDGLLHTTCGT 183
S +++ S+ HRDL N +L+E+ N+ V DFGLS ++ +Q +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178
Query: 184 PAYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCP 241
++A E ++ + Y K+D+WS GV ++ + G P+ +Y + +G+ K P
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236
Query: 242 P 242
P
Sbjct: 237 P 237
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 59/266 (22%), Positives = 113/266 (42%), Gaps = 32/266 (12%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK---------REISVMKMVK 77
LG G F +V+LA K+ ++ G + ++ V +++ K RE+ + + +
Sbjct: 13 LGRGEFGEVFLA------KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLRED-------VARVYF-QQL 127
HK++V L + Y ++ G+L F + K + + +V Q+
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 128 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-Y 186
+D + HRDL N L+ +KV+ LS + + P +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRW 184
Query: 187 VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS 245
+APE + + + K+D+WS GV+++ V G LPF + + ++ G + P
Sbjct: 185 LAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 246 --SEARRLITKLLDPNPNSRIAISKI 269
S +L+T+ NP R + S++
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 59/247 (23%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 27 LGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
LG F KVY T +++A+K + KDK + + E+ K E + ++H +I
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV-----------------YF 124
V L V+ + + +L + DV
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLLHTTCG 182
Q+ + ++F S V H+DL N+L+ + N+K++D GL F E D L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL--FREVYAADYYKLMGNSLL 188
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP---FQDDNIVSMY--RKIYRG 236
+++PE I G +DIWS GV+L+ + + G P + + +++ M R++
Sbjct: 189 PIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247
Query: 237 DFKCPPW 243
CP W
Sbjct: 248 PDDCPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 35/262 (13%)
Query: 25 RMLGHGTFAKVYLARNL-QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 83
R++G G F VY + G+ + V +++ + +EQ +E +MK H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 84 LHEVM-ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSRGVY 140
L + S+ + +K G+L N I V + + Q+ +++ S+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSA-------FSEHLKQDGLLHTTCGTPAYVAPEVIS 193
HRDL N +LDE +KV DFGL+ +S H L ++A E +
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-----WMALESLQ 175
Query: 194 KKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252
+ + K+D+WS GV+L+ L+ G P+ D + + + +G RRL+
Sbjct: 176 TQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG------------RRLL 222
Query: 253 TKLLDPNPNSRIAISKIMESSW 274
P+P + ++M S W
Sbjct: 223 QPEYCPDP-----LYEVMLSCW 239
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 20 KYELGRMLGHGTFAKVY--LARNLQTGKS---MAMKVVGKDKVIKVGMMEQIK--REISV 72
K L R LG G+F VY AR++ G++ +A+K V + ++ E+I+ E SV
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEASV 62
Query: 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-------------LREDV 119
MK H+V L V++ M+L+ G+L + + R L+E +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 120 ARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA---FSEHLKQ--D 174
++ + + +++ HRDL N ++ D +K+ DFG++ +++ ++
Sbjct: 123 QMA--AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILY 212
GLL ++APE + K G +D+WS GV+L+
Sbjct: 181 GLLPVR-----WMAPESL-KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 36/270 (13%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVM-KMVKHKH 80
++G G F +V A + G M + K++K E R E+ V+ K+ H +
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----------VARVYFQQLIS- 129
I+ L ++ +Y A++ G L + + K R+ E + + QQL+
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 130 AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE-HLKQDGLLHTTCG 182
A D + + HRDL N+L+ E+ K+ DFGLS E ++K+ T
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK-----TMGR 179
Query: 183 TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFK 239
P ++A E ++ Y K+D+WS GV+L+ +++ G P+ +Y K+ +G +
Sbjct: 180 LPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 240 CPPWFSSEARRLITKLLDPNPNSRIAISKI 269
P E L+ + P R ++I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
Y Q+ ++F SR HRDL N+LL E+ +K+ DFGL A + D +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 183 TP-AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMY-RKIYRGD-F 238
P ++APE I + Y ++D+WS GV+L+ + + G P+ I + R++ G
Sbjct: 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ P + + E + + P+ R S+++E
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 24/242 (9%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMA-MKVVGK------DKVIKVGMMEQIKREISVMK 74
G+ LG G F KV A KS A MKV K + +M ++K +M
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK----IMS 93
Query: 75 MV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR---LREDVARVYFQQLISA 130
+ H++IV L I + G+L N + + R L + + Q+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGTPA-YV 187
+ F S+ HRDL N+LL +K+ DFGL + + D ++ P ++
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL---ARDIMNDSNYVVKGNARLPVKWM 210
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRGDFKCPPWFS 245
APE I Y ++D+WS G++L+ + + G P+ + S Y+ I G P +
Sbjct: 211 APESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269
Query: 246 SE 247
Sbjct: 270 PA 271
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 35/236 (14%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVM-KMVKHKH 80
++G G F +V AR + G M + K +K + R E+ V+ K+ H +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAI----KRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----------VARVYFQQLI-- 128
I+ L + +Y A++ G L + + K R+ E + + QQL+
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 129 -----SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE-HLKQDGLLHTTCG 182
+D+ + HRDL N+L+ E+ K+ DFGLS E ++K+ T
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-----TMGR 172
Query: 183 TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG 236
P ++A E ++ Y +D+WS GV+L+ +++ G P+ +Y K+ +G
Sbjct: 173 LPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 22 ELGRMLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
EL ++G G V LAR TG+ + ++ + + M+ ++ E+ V K+ H
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHP 59
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHS 136
+IV + ++++ + G + I + E Q ++ A+D+ H
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY-------VAP 189
G HR +K ++L+ DG KV GL + + L P Y ++P
Sbjct: 120 MGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177
Query: 190 EVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQD 223
EV+ + +GYD AK+DI+S G+ L G +PF+D
Sbjct: 178 EVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 56/246 (22%), Positives = 112/246 (45%), Gaps = 15/246 (6%)
Query: 27 LGHGTFAKVY--LARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
LG G F V + + ++ K++A+K++ K+ + +++ RE +VM+ + + +IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRD 143
+ ++S + M+L + G L + K + + E Q+ + + HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP----AYVAPEVISKKGYDG 199
L N+LL K++DFGL S+ L D + + APE ++ +
Sbjct: 121 LAARNVLLVTQHYAKISDFGL---SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 200 AKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 257
+K+D+WS GV+++ + G P++ + + I G+ +CP E L+
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 258 PNPNSR 263
+ R
Sbjct: 237 YGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 64/266 (24%), Positives = 107/266 (40%), Gaps = 32/266 (12%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV--GMMEQIKREISV--------MKMV 76
LG GT ++Y A L +K IKV +++ R+IS+ M+ V
Sbjct: 3 LGRGTRTQIY-AGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV 61
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFC 134
HKHIV L+ V + + V+ G +LF L +QL SA+ +
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYL 121
Query: 135 HSRGVYHRDLKPENLLLDEDG-------NLKVTDFG--LSAFSEHLKQDGLLHTTCGTPA 185
+ + H ++ +N+LL +G +K++D G ++ S + +
Sbjct: 122 EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--------P 173
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF 244
++APE + AD WS G L+ + G +P +D + R Y G
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPS 232
Query: 245 SSEARRLITKLLDPNPNSRIAISKIM 270
E L+T ++ +PN R IM
Sbjct: 233 CKELADLMTHCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 20 KYELGRMLGHGTFAKVY--LARNL---QTGKSMAMKVVGKDKVIKVGMMEQIK--REISV 72
K + R LG G+F VY +A+ + + +A+K V + M E+I+ E SV
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASV 62
Query: 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRED----VARVYFQQLI 128
MK H+V L V++ M+L+ G+L + + R + A +++I
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 129 S-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQ--DGL 176
+ + ++ HRDL N ++ ED +K+ DFG++ +++ ++ GL
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILY 212
L +++PE + K G +D+WS GV+L+
Sbjct: 183 LPVR-----WMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 10/100 (10%)
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP 241
GTP Y+APE++ K + A D W+ GV L+ L G PF D+ +++ I D
Sbjct: 542 GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 242 PW------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
PW S A+ I LL +P R + ++ + F
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++LG G F VY + G+ + A+K + + K ++I E VM V + H
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 70
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-------AVDF 133
+ L + + S + L+ G L + + RE + Q L++ +++
Sbjct: 71 VCRLLGICLT-STVQLITQLMPFGCLLDYV-----REHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG-TP-AYVAPEV 191
R + HRDL N+L+ ++K+TDFGL+ +++ H G P ++A E
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKWMALES 182
Query: 192 ISKKGYDGAKADIWSCGVILYVLLA-GFLPF 221
I + Y ++D+WS GV ++ L+ G P+
Sbjct: 183 ILHRIYT-HQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 52/212 (24%)
Query: 84 LHEVMASKSKIYFA--MDLVKGGELFNKIAKGRLRED-VARVYFQQLISAVDFCHSRGVY 140
L ++M SK Y L K +L KG RE+ + + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPYLLGKVQDL----PKGLERENKIIQTIMRQILFALDGLHSTGIV 277
Query: 141 HRDLKPENLLLDE-DGNLKVTDFGLSA----FSEHLKQDGLLHTTCGTPAYVAPE--VIS 193
HRD+KP+N++ E G+ K+ D G +A ++ ++ LL P Y APE ++S
Sbjct: 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL-----DPRYAAPEQYIMS 332
Query: 194 KKGYDGAKA-------------------DIWSCGVILYVLLAGFLPF--QDDNIVSMYRK 232
+ A DI+S G+I L P D N++ R+
Sbjct: 333 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI---FLQMAFPNLRSDSNLIQFNRQ 389
Query: 233 IYRGDFKCPPWFSSEARRLITKLLDPNPNSRI 264
+ R D+ W KL++P + +
Sbjct: 390 LKRNDYDLVAW---------RKLVEPRASPDL 412
|
Length = 566 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 25 RMLGHGTFAKVYLARNLQ-----TGKS-MAMKVVGKDKVIKVGMMEQIK--REISVMKMV 76
LG G F +VY +G +A+K + K + E+ + +E +M
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ----EKKEFLKEAHLMSNF 56
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRL-REDVARVYFQQLIS-AVDFC 134
H +IV+L V Y M+L++GG+L + + R+ R + ++L+ +D
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 135 HSRGVY-------HRDLKPENLLLDEDGN-----LKVTDFGLSAFSEHLKQD-------G 175
VY HRDL N L+ E G +K+ DFGL+ + K D G
Sbjct: 117 KG-CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--RDIYKSDYYRKEGEG 173
Query: 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 215
LL ++APE + G ++D+WS GV+++ +L
Sbjct: 174 LLPVR-----WMAPESLL-DGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 21/197 (10%)
Query: 27 LGHGTFA----KVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 82
LG G F VY R Q ++ + +K ++ MM RE +M + + +IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM----REAEIMHQLDNPYIV 58
Query: 83 ELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARV--YFQQLISAVDFCHSRGV 139
+ V +++ + M++ GG L NK G+ E V+ V Q+ + + +
Sbjct: 59 RMIGVCEAEA-LMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT--TCGT-P-AYVAPEVISKK 195
HRDL N+LL K++DFGL S+ L D + + G P + APE I+ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGL---SKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 196 GYDGAKADIWSCGVILY 212
+ +++D+WS G+ ++
Sbjct: 174 KFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++LG G F VY + G+++ A+K++ + K + + E +M + H H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRG 138
+V L V S + I L+ G L + + K + + + Q+ + + R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ HRDL N+L+ ++K+TDFGL+ E +++ ++A E I + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 199 GAKADIWSCGVILYVLL 215
++D+WS GV ++ L+
Sbjct: 190 -HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
E+GR G VYLAR+ TG + +++ + + ++ ++ E+ + +H +I
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNI 61
Query: 82 VELHEVMASKSKIYFAMDLVKGGE----LFNKIAKGRLREDVARVYFQQLISAVDFCHSR 137
+ V + S ++ + G L +G + E + + +++ H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--------DGLLHTTCGTPAYVAP 189
G HR++K ++L+ DG V+ GLS ++ D +T P +++P
Sbjct: 121 GYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSP 177
Query: 190 EVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQD 223
E++ + GY+ K+DI+S G+ L G +PFQD
Sbjct: 178 ELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 84
+G+G F KV L G S A +VV K+ EQ+ +E+ + + H ++++
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE------DVARVYFQQLISAVDFCHSRG 138
++ G+L N + R DV + ++ S + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTP-AYVAPEVISKKG 196
H DL N L D ++K+ D+GL A ++ +D + C P ++APE++ +G
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALEQY-PEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 197 YD------GAKADIWSCGVILYVLL-AGFLPFQD 223
D K++IWS GV ++ L A P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 28/221 (12%)
Query: 22 ELGRMLGHGTFAKVY--LARNLQTGKS-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
L R LGHG F +VY L R + + V + E +M H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR-EDVARVYFQQLIS-AVDF--- 133
++IV L V + + ++L+ GG+L + + + R R E + + + L+ A D
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 134 CH---SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSA---FSEHLKQDGLLHTTCGTP 184
C HRD+ N LL G K+ DFG++ + + ++ G
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAMLPI 185
Query: 185 AYVAPEVISKKGYDG---AKADIWSCGVILY-VLLAGFLPF 221
++ PE DG +K D+WS GV+L+ + G++P+
Sbjct: 186 KWMPPEAF----LDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 65/263 (24%), Positives = 109/263 (41%), Gaps = 44/263 (16%)
Query: 27 LGHGTFAKVYLARNLQTG---KSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHI 81
LG GTF K++ + G + +V+ K DK + E S+M + HKH+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHL 61
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGR------LREDVARVYFQQLISAVDFCH 135
V + V + + VK G L + K + + +VA+ QL A+ F
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAK----QLAWALHFLE 117
Query: 136 SRGVYHRDLKPENLLLDEDGN--------LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
+G+ H ++ +N+LL + + +K++D G+S L ++ LL +V
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV--LPKEILLERI----PWV 171
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY---RKIY----RGDFKC 240
PE I AD WS G L+ + +G D +S +K+ R
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLSALDSQKKLQFYEDRHQLPA 226
Query: 241 PPWFSSEARRLITKLLDPNPNSR 263
P W +E LI + +D P+ R
Sbjct: 227 PKW--TELANLINQCMDYEPDFR 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 19/46 (41%), Positives = 31/46 (67%)
Query: 118 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163
+V + +Q+++ + H G+ HRD+KPENLL+ DG +K+ DFG
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV------GKDKVIKVGMMEQIKR---- 68
++++ +LG GTF KV A + + + A+K+V +D I++ ME++++
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188
Query: 69 -EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQL 127
+MK+ ++ H + +D + F+ +A++ FQ
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFS-------HRHLAQIIFQTG 241
Query: 128 ISAVDFCHSR-GVYHRDLKPENLLLD----------------EDGNLKVTDFGLSAFSEH 170
+ A+D+ H+ + H DLKPEN+L++ + +++ D G H
Sbjct: 242 V-ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH 300
Query: 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 219
+ T Y +PEV+ G+ D+WS G I+Y L G L
Sbjct: 301 SRT-----AIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKL 343
|
Length = 467 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 36/115 (31%), Positives = 46/115 (40%), Gaps = 26/115 (22%)
Query: 117 EDVARVYFQQL----ISAV--DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170
D+ V + L I AV + HR K N+LL DG
Sbjct: 4 ADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDG--------------L 49
Query: 171 LKQDGLLHTTC-----GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP 220
LK DG + P ++APEVI + Y KADI+S G+ LY L LP
Sbjct: 50 LKLDGSVAFKTPEQSRPDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 37/266 (13%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
LG F K+Y G A V K + + ++E S+M + H +IV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ------------------Q 126
V+ + + + + G+L + DV + Q
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL-----SAFSEHLKQDGLLHTTC 181
+ + +++ S H+DL N+L+ E ++K++D GL SA ++ LL
Sbjct: 133 IAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR- 191
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLP---FQDDNIVSMYRKIYRGD 237
++ PE I + + +DIWS GV+L+ + + G P F + ++ M RK R
Sbjct: 192 ----WMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSR 263
C L+T+ P+ R
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 40/182 (21%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 69 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQ 126
E + H +IV L V+ + + + + G L F + +G+L
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL--LHTTCG-- 182
L S + + G H+ L +L++ D K++ F L++D ++TT
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGK 169
Query: 183 TPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKC 240
+P + APE I + A +D+WS G++++ +++ G P+ D + + + + G F+
Sbjct: 170 SPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRL 227
Query: 241 PP 242
P
Sbjct: 228 PA 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 59/264 (22%), Positives = 98/264 (37%), Gaps = 45/264 (17%)
Query: 27 LGHGTFAKVYLARNLQTGK----------SMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
LG GTF +Y S+ +KV+G D S+M +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS----LAFFETASLMSQL 58
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFC 134
HKH+V+L+ V I + VK G L F K + +QL SA+ +
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 135 HSRGVYHRDLKPENLLLDEDGN-------LKVTDFG--LSAFSEHLKQDGLLHTTCGTPA 185
+ + H ++ +N+L+ G +K++D G ++ S + + +
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------P 169
Query: 186 YVAPEVISKKGYDGAK-----ADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGDFK 239
++APE I +G AD WS G L + G P + R Y+ +
Sbjct: 170 WIAPECIR----NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHR 224
Query: 240 CPPWFSSEARRLITKLLDPNPNSR 263
P +E LI + +P R
Sbjct: 225 LPMPDCAELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
Q+ ++F S+ HRDL N+LL + +K+ DFGL+ H +T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRG-DFKCPP 242
++APE I Y +D+WS G++L+ + + G P+ + S Y KI G P
Sbjct: 305 WMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363
Query: 243 WFSSEARRLITKLLDPNPNSR---IAISKIMES 272
+ E ++ K + P R + +S I+ES
Sbjct: 364 HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGT 183
Q+ + F S+ HRDL N+LL K+ DFGL + ++ D ++
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL---ARDIRNDSNYVVKGNARL 278
Query: 184 PA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFK-- 239
P ++APE I Y ++D+WS G++L+ + + G P+ + S + K+ + ++
Sbjct: 279 PVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 240 CPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
P SE ++ D +P R +I++
Sbjct: 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 42/237 (17%)
Query: 19 GKYELGRMLGHGTFAKVYLAR--NLQTGKSMAMKVVGKDKVIKVG----MMEQIKREISV 72
E R +G G F +V+ AR L + M V K++K M +RE ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAAL 61
Query: 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFN-----------KIAKGRLREDVAR 121
M H +IV+L V A + + + G+L ++
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 122 VYFQQLISAVDFCHSRGV------------YHRDLKPENLLLDEDGNLKVTDFGLSA--- 166
+ L C ++ V HRDL N L+ E+ +K+ DFGLS
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 167 FSEHLKQDGLLHTTCGTPA-YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF 221
+++ K P ++ PE I Y ++D+W+ GV+L+ + + G P+
Sbjct: 182 SADYYKASE----NDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS----VMKMVKHK 79
++LG G F V+ + G S+ + V K I+ Q +EI+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVA--IKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV--YFQQLISAVDFCHSR 137
+IV L + S + L G L + + + R D R+ + Q+ + +
Sbjct: 70 YIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGTP-AYVAPEVISK 194
+ HR+L N+LL D +++ DFG+ ++ L D ++ TP ++A E I
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGV---ADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 195 KGYDGAKADIWSCGVILYVLLA 216
Y ++D+WS GV ++ +++
Sbjct: 186 GRYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++LG G F VY + G+++ A+KV+ ++ K ++I E VM V +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRG 138
+ L + + S + L+ G L + + K R+ + Q+ + +
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG-TP-AYVAPEVISKKG 196
+ HRDL N+L+ ++K+TDFGL+ + + + H G P ++A E I +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRR 187
Query: 197 YDGAKADIWSCGVILYVLLA-GFLPFQ 222
+ ++D+WS GV ++ L+ G P+
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA--RVYFQQLI 128
S+M V H H+ +H V S+ + V+ G L + K + R VA QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 129 SAVDFCHSRGVYHRDLKPENLLLD----EDGN---LKVTDFGLS--AFSEHLKQDGLLHT 179
SA+ + + + H ++ +N+LL +G +K++D G+S A S + + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 180 TCGTPAYVAPEVISKKGYDGAKADIWSCG-VILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238
++APE + AD WS G +L + G +P ++ S + Y
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEKERFYEKKH 238
Query: 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIM 270
+ P E LI++ L P R + I+
Sbjct: 239 RLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 30/149 (20%), Positives = 63/149 (42%), Gaps = 20/149 (13%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV-- 82
++L G +VYL + +K+ + +RE+++++++ K +
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVP 56
Query: 83 ELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVY--FQQLISAVDFCHSRG 138
++ S Y M+ ++G L ++ K + E +A + QL V CH
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV-LCH--- 112
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAF 167
DL P N+L+D+ L + D+ + +
Sbjct: 113 ---GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 25/164 (15%)
Query: 27 LGHGTFAKVYL--ARNLQTGKSM-AMKVVGKDKVIKVGMME---------QIKREISVMK 74
LG G F +V+L A L A + G+ ++ V M+ +EI +M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVAR------VYFQ--- 125
+K+ +I+ L V S + + ++ G+L +++ + V
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 126 ----QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
Q+ S + + S HRDL N L+ +K+ DFG+S
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 2/99 (2%)
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
Q+ + ++F S+ HRDL N+L+ E +K+ DFGL+ +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
++APE I Y +D+WS G++L+ + G P+ +
Sbjct: 307 WMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHKHIVEL 84
+G+G F KV L + +G + A +VV K+ + + EQ+K E + ++H ++++
Sbjct: 3 IGNGWFGKVILGE-VNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVA--RVYFQQL----ISAVDFCHSRG 138
+ M+ G+L + R E + Q++ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG---TP-AYVAPEVISK 194
H DL N LL D +K+ D+GLS H K + T P ++APE++ +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 195 KG-----YDGAK-ADIWSCGVILYVLL 215
D K +++WS GV ++ L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.002
Identities = 17/66 (25%), Positives = 33/66 (50%), Gaps = 5/66 (7%)
Query: 97 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 156
M+ + G EL + R+ ED V +++ + + G+ H DL N+L+D+D
Sbjct: 109 VMEYIDGVEL----YRVRVLEDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163
Query: 157 LKVTDF 162
+ + D+
Sbjct: 164 IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 27 LGHGTFAKVYL--ARNLQ--TGKSMAMKVVGKDKV-IKVGMMEQ---------IKREISV 72
LG G F +V+L A ++ K ++ V G V + V M+ + +EI +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-----DVARVYFQQL 127
M +K +I+ L V + + + ++ G+L +++ +E DV + + L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 128 I-------SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
I S + + S HRDL N L+ ++ +K+ DFG+S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 34/176 (19%), Positives = 64/176 (36%), Gaps = 32/176 (18%)
Query: 19 GKYELGRMLGHGTFAKVYLARNL----------QTGKS------MAMKVVGKDKVIKVGM 62
LG G F +V+L + +A+KV+ D
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAR 63
Query: 63 MEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV 122
+ +K E+ ++ + +I L V + M+ ++ G+L N+ + + E
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLA 121
Query: 123 YFQ-------------QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
Q+ S + + S HRDL N L+ ++ +K+ DFG+S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.002
Identities = 14/85 (16%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 331 ELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQ-ESGRKGK---LAINADIFA 386
EL + S + +V + N+ + + G+ + +++
Sbjct: 5 ELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIEVYE 64
Query: 387 VTPSLLVVEVKKDNGDTLEYNQFCS 411
V P L +V+ KK G T + + +
Sbjct: 65 VGPGLFMVDFKKKTGSTKTFTKLAT 89
|
This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 14/152 (9%)
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLLHTT 180
Q+ +DF S+ HRD+ N+LL + K+ DFGL+ + +K + L
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRG-D 237
++APE I Y ++D+WS G++L+ + + G P+ + S Y+ + RG
Sbjct: 280 -----WMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSRIAISKI 269
P + E ++ + P R S+I
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 441 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.37 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.34 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.14 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.84 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.58 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 97.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.25 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.23 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.11 | |
| PLN02236 | 344 | choline kinase | 97.11 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.03 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.02 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.45 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.35 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.11 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.68 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.56 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.55 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-65 Score=486.58 Aligned_cols=267 Identities=38% Similarity=0.726 Sum_probs=239.0
Q ss_pred CCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch----hhHHHHHHHHHHHHhCCCCCcceEE
Q 013522 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVMKMVKHKHIVELH 85 (441)
Q Consensus 10 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l~ 85 (441)
...++..+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.+.... .....+.+|++||++|+|||||+++
T Consensus 163 ~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 163 SKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred ccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 345566688999999999999999999999999999999999998776532 2345578999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC---CCeEEee
Q 013522 86 EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTD 161 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~---~~vkl~D 161 (441)
++|..++..|+||||+.||+|++++.. +.+.++..+.+++||+.|+.|||+.||+||||||+|||+..+ ..+||+|
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 999999999999999999999999976 789999999999999999999999999999999999999876 6799999
Q ss_pred cCccccccccccCCcccccccCCCccchhhhhccCC--CCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCC
Q 013522 162 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDF 238 (441)
Q Consensus 162 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~ 238 (441)
||+|.+.. ....+.|.||||.|+|||++.+.++ ++.++|+||+||+||.+++|.+||.+.... .+.++|.+|.+
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99999754 5678899999999999999987653 345789999999999999999999887555 49999999998
Q ss_pred CCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 KCPP--W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 ~~~~--~--~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+-+ | ++.++++||.+||..||++|||+.++|+||||+...
T Consensus 400 ~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 400 AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 7743 3 799999999999999999999999999999998543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-63 Score=490.07 Aligned_cols=261 Identities=57% Similarity=0.999 Sum_probs=246.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch--hhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV--GMMEQIKREISVMKMVK-HKHIVELHEVMASK 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~ 91 (441)
....++|.+++.||+|+||+|++|.+..++..||+|++++...... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4678899999999999999999999999999999998877633311 35678889999999998 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~~ 169 (441)
..+|+|||||.||+|++++.+ +++.|.+++.+|+||++||+|||++||+||||||||||+|.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 999999999999999999999999999999999999999999 999999999998764
Q ss_pred ccccCCcccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCC-CHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF-SSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~ 247 (441)
.....+.+.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 4567889999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+++||++||.+||.+|+|+.+|++||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-63 Score=498.23 Aligned_cols=261 Identities=40% Similarity=0.777 Sum_probs=248.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
....|-|+++++||.|+.|.|.+|++..||+.+|||++.+...........+.+||.||+.+.||||+++|+++++..++
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 34568899999999999999999999999999999999988655556677899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+|+||++||+||+++.+ |++++.++.++|+||+.|+.|||..+||||||||||+|+|..+++||+|||+|.+- ..
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~ 164 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VP 164 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cC
Confidence 999999999999999975 99999999999999999999999999999999999999999999999999999863 35
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
+..+.|.||+|.|.|||++.+.+|+|.++||||||||||.||+|.+||+++|...++.++.+|.+.+|..+++++++||+
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+||+.||++|+|.++|++|||+...
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcC
Confidence 9999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-62 Score=487.48 Aligned_cols=262 Identities=37% Similarity=0.672 Sum_probs=248.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|..++.||+|||++||.+++..+|+.||+|++.+..+.+....+.+.+||+|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 47999999999999999999999999999999999998888888999999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|+|+.++|..+.++ +.++|.+++.|++||+.||.|||+++|+|||||..|+|++++.+|||+|||||+.... .+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999999985 7899999999999999999999999999999999999999999999999999997654 33556
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
.|.||||.|+|||++.+.++ +..+||||+||+||.||.|++||...+..+.|.+|...++.+|..++.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 79999999999999998887 59999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccCccCCccc
Q 013522 258 PNPNSRIAISKIMESSWFKKSAPKVV 283 (441)
Q Consensus 258 ~dP~~R~t~~eil~hpwf~~~~~~~~ 283 (441)
+||.+|||+++||.|+||..+..+..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPAR 280 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCC
Confidence 99999999999999999976655443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-59 Score=445.01 Aligned_cols=264 Identities=39% Similarity=0.723 Sum_probs=244.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..-.++|++++.||+|+||+|+.++.+.+++.+|+|++.+..+......++.+.|..||..++||+||+++..|++..++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34568899999999999999999999999999999999999988777789999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+|+||+.||+|+..+++ +.++|..++.|+..|+.||.|||++||+||||||||||+|.+|.++|+|||+++..- ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cC
Confidence 999999999999999985 899999999999999999999999999999999999999999999999999998432 33
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC-CCCCHHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-PWFSSEARRLI 252 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~li 252 (441)
+....+.|||+.|||||++.+.+|+ ..+|.||||+++|+|++|.+||.+.+...++++|.++....+ ..++.++++||
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 4556778999999999999999996 889999999999999999999999999999999999995554 45999999999
Q ss_pred HHhcCCCCCCCC----CHHHHhcCcccCccCCc
Q 013522 253 TKLLDPNPNSRI----AISKIMESSWFKKSAPK 281 (441)
Q Consensus 253 ~~~L~~dP~~R~----t~~eil~hpwf~~~~~~ 281 (441)
+++|..||++|. ++.+|.+||||......
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 999999999996 68999999999865443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-59 Score=429.37 Aligned_cols=262 Identities=41% Similarity=0.744 Sum_probs=247.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.-.++|+++++||.|+||.|.+++++.+|..+|+|++++..+.+....++..+|..+|+.+.||+++++++.+.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45678999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||++||+|+.++++ +++++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||.|... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999998743 2
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
+...|.||||.|+|||++..++|+ .++|.|||||++|||++|++||.+.+...+|++|..++..+|+.+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 347899999999999999999996 8899999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCcccCccCCccc
Q 013522 255 LLDPNPNSRI-----AISKIMESSWFKKSAPKVV 283 (441)
Q Consensus 255 ~L~~dP~~R~-----t~~eil~hpwf~~~~~~~~ 283 (441)
+|+.|-.+|. ...+|.+||||+.......
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 9999999995 4678999999996654433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=453.01 Aligned_cols=264 Identities=34% Similarity=0.639 Sum_probs=245.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
..-..+|.+++.||.|+|++|++|+++.+++.||||++.+.-+.++...+-+.+|-.+|.+| +||.|++||..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999999999999999999999888888888899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+|+|+||+++|+|.++|.+ |.+++..++.|+.||+.||+|||++|||||||||||||+|.++.+||+|||.|.++....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999987 999999999999999999999999999999999999999999999999999998765432
Q ss_pred cC-----------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC
Q 013522 173 QD-----------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP 241 (441)
Q Consensus 173 ~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~ 241 (441)
.. +...+.+||..|++||+|..... +..+|+|+||||||.|++|.+||.+.+.--++++|..-++.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 22 11245789999999999987655 5899999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+.+++.+++||+++|..||++|+|+++|.+||||....
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 99999999999999999999999999999999998643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-58 Score=436.38 Aligned_cols=266 Identities=39% Similarity=0.703 Sum_probs=250.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
...+..||++.++||+|+||+|.+|.....|+.||||.++++++.....+-++++||+||..|+||||+++|++|++.+.
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 34678899999999999999999999999999999999999999888888999999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+.|||||..||+|+++|.+ +.++|.+++.+|+||.+|+.|||.++|+|||||.+|||+|.|+++||+|||++.++.
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~--- 204 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--- 204 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---
Confidence 9999999999999999986 899999999999999999999999999999999999999999999999999998754
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
....+.+.||+|.|.+||++++.+|.++.+|-|||||+||-|+.|..||++.+...+.++|.+|.+.-|+. +.++.-||
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLI 283 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLI 283 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999998877764 67789999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCccCCccc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKSAPKVV 283 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~ 283 (441)
+.||..||++|.|+.+|-.|-|.+=++...+
T Consensus 284 RwmLmVNP~RRATieDiAsHWWvNwgy~~~V 314 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHWWVNWGYNMPV 314 (668)
T ss_pred HHHHhcCcccchhHHHHhhhheeeccccccc
Confidence 9999999999999999999999976554433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-56 Score=421.59 Aligned_cols=257 Identities=30% Similarity=0.515 Sum_probs=233.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-KI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~ 94 (441)
+...+.+.++.||+|+.|+||+++|+.|++.+|+|++... .+....+++.+|++|++.++|||||++|+.|.++. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 4445788899999999999999999999999999999433 34466789999999999999999999999999998 49
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+|+||||+||+|.+.+.. |+++|....+++.+++.||.|||+ ++|+||||||+|||++..|.|||||||.|+...
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv--- 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV--- 230 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh---
Confidence 999999999999999987 899999999999999999999995 999999999999999999999999999987543
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-----cHHHHHHHHHcCCC-CCCCC-CC
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRGDF-KCPPW-FS 245 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~~-~~~~~-~~ 245 (441)
++...+.+||..|||||.+.+..| +.++||||||+.++|+.+|+.||... +..+++..|..+.+ ..|.. +|
T Consensus 231 -nS~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 231 -NSIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred -hhhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 236688999999999999999887 48899999999999999999999875 67788999998655 45665 99
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++++||..||++||.+|||+.|+++|||+++..
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999999999998654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-56 Score=424.12 Aligned_cols=258 Identities=38% Similarity=0.687 Sum_probs=237.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+.+.. ....+-+..||.||+.++|||||++++++.+++.+|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 568999999999999999999999999999999999887653 3556788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC------CCeEEeecCcccccc
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED------GNLKVTDFGLSAFSE 169 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~------~~vkl~DFGla~~~~ 169 (441)
|||||.||+|.++|++ ++++|..++.++.||+.||++||+++|+||||||.|||++.+ -.+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999987 799999999999999999999999999999999999999875 358999999998755
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCCH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---CPPWFSS 246 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~ 246 (441)
......+.||+|.|||||++....|+ .|+|+||+|+|||++++|++||+..+..++...+.++... .|.++++
T Consensus 167 ---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 167 ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred ---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 56778999999999999999988887 8999999999999999999999999999999988887543 3556888
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...+|+...|..+|..|.+..+-+.|++.....
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 899999999999999999999999999987554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-56 Score=434.37 Aligned_cols=266 Identities=36% Similarity=0.627 Sum_probs=239.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+-.++|++++.||+|+||.||+|+.+.||+.+|+|++.++.....+..++++.|-.||....+|+||++|..|.+.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc-
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK- 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~- 172 (441)
||||||++||++..++.+ +.|+++.++.|+.+++.|++-+|+.|++||||||+|+|||..|.+||+||||++......
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999986 889999999999999999999999999999999999999999999999999985332100
Q ss_pred -------------------cC-------------------------CcccccccCCCccchhhhhccCCCCCcccHHHHH
Q 013522 173 -------------------QD-------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCG 208 (441)
Q Consensus 173 -------------------~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlG 208 (441)
.+ ......+|||.|+|||++.+.+|. ..+|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHH
Confidence 00 012345699999999999999985 889999999
Q ss_pred HHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccCccCCc
Q 013522 209 VILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP--WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKSAPK 281 (441)
Q Consensus 209 vil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~~~~ 281 (441)
||+||||.|++||...++.+.+++|..-+ +.+|. .++++++|||.+||. ||++|.- ++||..||||+...+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 99999999999999999999999998765 55665 478999999999999 9999985 9999999999876544
Q ss_pred c
Q 013522 282 V 282 (441)
Q Consensus 282 ~ 282 (441)
.
T Consensus 455 ~ 455 (550)
T KOG0605|consen 455 H 455 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=406.41 Aligned_cols=249 Identities=33% Similarity=0.595 Sum_probs=224.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEE-EEEe-C
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE-VMAS-K 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~~-~ 91 (441)
+......|+|.++||+|+||+||++++..+|..+|.|.+.-... +......+..|+.+|++|+|||||++|+ .|.+ .
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 44556789999999999999999999999999999999975443 3355678899999999999999999998 4444 4
Q ss_pred CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhh--cC--cEeccCCCCcEEeCCCCCeEEeec
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHS--RG--VYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~--~g--i~HrDLkp~NILl~~~~~vkl~DF 162 (441)
..++||||||.+|+|...|+. ..++|..++++|.||+.||.+||+ .. |.||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 459999999999999999963 569999999999999999999999 45 999999999999999999999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CC
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CP 241 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~ 241 (441)
|++++++. .....++.+|||+||+||.+...+|+ .+|||||+||++|||++-.+||.+.+..++..+|..++++ +|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998765 33456788999999999999999997 9999999999999999999999999999999999999886 66
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCH
Q 013522 242 -PWFSSEARRLITKLLDPNPNSRIAI 266 (441)
Q Consensus 242 -~~~~~~~~~li~~~L~~dP~~R~t~ 266 (441)
..+|.++..||..|+.+||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 5789999999999999999999997
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=399.88 Aligned_cols=260 Identities=36% Similarity=0.685 Sum_probs=236.3
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
....+.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++..++... ..+.+.+|+.|.+.|+||||+++++.+.+..
T Consensus 5 ~~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 5 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred cccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 345678899999999999999999999999999999999987776543 5688999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC---CCeEEeecCccccc
Q 013522 93 KIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFS 168 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~-~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~---~~vkl~DFGla~~~ 168 (441)
..|+|+|++.|++|+.-|. +--++|..+..+++||++||+|||.+||+|||+||+|+|+-+. .-+||+|||+|.-.
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999999999977765 4568999999999999999999999999999999999999543 35999999998744
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----CC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WF 244 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~ 244 (441)
. .........|||.|||||++.+.+| +.++|||+||||||-|+.|++||.+.+...+|+.|.++.+.+|+ .+
T Consensus 164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~i 239 (355)
T KOG0033|consen 164 N---DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTV 239 (355)
T ss_pred C---CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcC
Confidence 3 4556677889999999999998888 58899999999999999999999999999999999999887765 38
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
++++++||++||..||.+|+|+.|+|+|||+++
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 999999999999999999999999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=390.98 Aligned_cols=257 Identities=36% Similarity=0.673 Sum_probs=243.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
-..++|++++.||+|-||.||+|+...++-.||+|++.++.+.......++++|++|...|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34588999999999999999999999999999999999998877777889999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+++||..+|+++..+.. +++++..+..|+.|++.||.|||.++|+||||||+|+|++..|.+||+|||.+...
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~---- 174 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---- 174 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec----
Confidence 99999999999999984 56999999999999999999999999999999999999999999999999998743
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
+.+.-.+.|||..|.|||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+.++.+|+.++.+++|||
T Consensus 175 p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 175 PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 25567899999999999999999987 88999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+||..+|.+|.+..|++.|||+..
T Consensus 254 ~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 254 SRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHhccCccccccHHHHhhhHHHHh
Confidence 9999999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=416.15 Aligned_cols=267 Identities=34% Similarity=0.612 Sum_probs=235.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------hhHHHHHHHHHHHHhCCCCCcc
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----------GMMEQIKREISVMKMVKHKHIV 82 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~hpnIv 82 (441)
.....+.|++++.||+|.||+|.+|++..+++.||||++.+...... .-.+++++||.||++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34556789999999999999999999999999999999987654321 1246899999999999999999
Q ss_pred eEEEEEEeC--CEEEEEEeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 83 ELHEVMASK--SKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 83 ~l~~~~~~~--~~~~lv~E~~~gg~L~~~i~~~~-l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
+|+++..++ +.+|+|+|||..|.+...-..+. +++.++++|+++++.||+|||.+||+||||||.|+|++++|.+||
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 999999764 68999999999998866555555 999999999999999999999999999999999999999999999
Q ss_pred eecCcccccccc---ccCCcccccccCCCccchhhhhc---cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Q 013522 160 TDFGLSAFSEHL---KQDGLLHTTCGTPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233 (441)
Q Consensus 160 ~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i 233 (441)
+|||.+..+... ..+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|++||.+....+++.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 999998765222 12234556789999999999977 567789999999999999999999999999999999999
Q ss_pred HcCCCCCCCC--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 234 YRGDFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 234 ~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
......+|.. +.+++++||.+||++||++|+++.+|..|||......
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 9998888865 7899999999999999999999999999999976643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=398.07 Aligned_cols=255 Identities=26% Similarity=0.473 Sum_probs=221.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|+.+.++|+|+||+||+++++.||+.||||.+-.+. .+....+-..|||++|++|+|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 67999999999999999999999999999999995443 22334566789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|||+. ++.+.+++ ..++++.+++|+.|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... ++..
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 99987 55555554 4599999999999999999999999999999999999999999999999999987654 5567
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--------------C-----
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--------------D----- 237 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------~----- 237 (441)
.+..+.|.||+|||.+.+...+|.++||||+||++.||++|.+.|++.+..+....|.+. .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 788899999999999999666689999999999999999999999998877666555331 1
Q ss_pred CCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 238 FKCP------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 238 ~~~~------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
..+| +.++.-+.+|+++||..||.+|++++++|.||||..
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 0111 225677899999999999999999999999999943
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-53 Score=427.01 Aligned_cols=264 Identities=32% Similarity=0.611 Sum_probs=246.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 93 (441)
..-...|++++.||+|+||+|++|..+.+++.+|||++.|..+......+....|..|+...+ ||.++.++..|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345678999999999999999999999999999999999999988888999999999999884 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+|+||||+.||++...++.+.+++..++.|+..++.||.|||++||+|||||.+|||+|.+|.+||+|||+++ +....
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK--e~m~~ 521 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK--EGMGQ 521 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc--ccCCC
Confidence 9999999999997777777999999999999999999999999999999999999999999999999999987 33445
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
+....|.||||.|+|||++.+..|. .++|.|||||+||+||.|..||.+++..+++..|...++..|.|+|.++.++++
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 6678899999999999999998884 999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCcccCccCCc
Q 013522 254 KLLDPNPNSRIA-----ISKIMESSWFKKSAPK 281 (441)
Q Consensus 254 ~~L~~dP~~R~t-----~~eil~hpwf~~~~~~ 281 (441)
++|..||++|.- +.+|..||||+.-...
T Consensus 601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred HHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 999999999986 5789999999875543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-54 Score=416.31 Aligned_cols=265 Identities=39% Similarity=0.673 Sum_probs=246.3
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.....+.|-|.+.++||+|-|+.|.+|++.-||+.||||++++.+... -...++.+|+..|+.++|||||++|++..+.
T Consensus 11 i~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 11 IYDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ 89 (864)
T ss_pred ccccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence 344568899999999999999999999999999999999999988754 3456888999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-CCCCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-~~~~vkl~DFGla~~~ 168 (441)
..+|+|+|+-.||+|+++|-. ..++|+.+++||.||+.|+.|||+..|+|||||||||.+- .-|-|||+|||++..+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999999999965 4599999999999999999999999999999999998775 4588999999998754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
. ++..+.+.||+..|-|||++.+..|+.+++||||||||||.|+||.+||...+..+.+-.|....+..|..++.++
T Consensus 170 ~---PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eC 246 (864)
T KOG4717|consen 170 Q---PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKEC 246 (864)
T ss_pred C---CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHH
Confidence 3 5667899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
++||..||..||++|.|.++|..++|++....
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999999999987654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=418.09 Aligned_cols=260 Identities=30% Similarity=0.523 Sum_probs=228.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKS- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~- 92 (441)
..+.+||.++++||.|+||.||+|+...+|+.||||.+.+.... ....-. .||+..|++|+ |||||+|.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 45788999999999999999999999999999999999765433 222222 47999999998 999999999998877
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
.+|+|||||+. +|+++++. ..+++..++.|+.||++||+|+|++|++|||+||||||+..+..+||+|||+|+-
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe--- 159 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE--- 159 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc---
Confidence 99999999965 89999975 5699999999999999999999999999999999999999999999999999984
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--C------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G------------ 236 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~------------ 236 (441)
......++.++.|.||+|||++.+.++++.+.|||++|||++|+.+-++.|.+.+..+.+.+|.. |
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 44556678889999999999999999999999999999999999999999999988877776643 1
Q ss_pred -----CCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 237 -----DFKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 237 -----~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
.+.+| +..++++.+||.+||.+||.+|||+.++|+||||+....
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 12222 236789999999999999999999999999999987543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=412.95 Aligned_cols=260 Identities=33% Similarity=0.554 Sum_probs=230.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SK 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~ 93 (441)
.....|+.+++||+|+||.||+|++..+|+.||+|.++.+.. +.+......|||.||++|+||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 445679999999999999999999999999999999987654 345667788999999999999999999998776 78
Q ss_pred EEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
+|+|+|||+. +|.-++... +|++.+++.|++||+.||+|||++||.|||||..|||||.+|.+||+|||||+++...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999987 888888874 7999999999999999999999999999999999999999999999999999987754
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--C-----C---CCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D-----F---KCP 241 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~-----~---~~~ 241 (441)
. ...++..+-|.||.|||.+.+..-++.++|+||+||||.||++|++.|.+.+..+...+|.+- . + .+|
T Consensus 272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 3 334777889999999999999888889999999999999999999999999999888888652 1 1 112
Q ss_pred -------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 -------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 -------------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
..+++.+.+|+..||..||.+|.|+.++|+|+||...
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 1257889999999999999999999999999999543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=412.82 Aligned_cols=260 Identities=37% Similarity=0.739 Sum_probs=236.0
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
......++|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 33445688999999999999999999999999999999998765444445678899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.||+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~- 170 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD- 170 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-
Confidence 99999999999999999976 6799999999999999999999999999999999999999999999999999875322
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 251 (441)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+...+|.++++.+++|
T Consensus 171 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 ----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDL 245 (329)
T ss_pred ----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHH
Confidence 2235689999999999988776 48999999999999999999999999888899999999999999999999999
Q ss_pred HHHhcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 252 ITKLLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 252 i~~~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
|.+||+.||.+||+ ++++++||||...
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999997 7999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=407.05 Aligned_cols=260 Identities=32% Similarity=0.549 Sum_probs=223.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--KIY 95 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~ 95 (441)
..+|..++.||+|+||+||++.+..+|...|+|.+..... ...+.+.+|+.+|++|+|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 4568999999999999999999999999999999976632 12677999999999999999999999754444 699
Q ss_pred EEEeccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEeecCcccccccc-
Q 013522 96 FAMDLVKGGELFNKIAK-G-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHL- 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~-~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~~~~~~- 171 (441)
++|||++||+|.+++.+ + ++++..++.|.+|+++||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999987 4 7999999999999999999999999999999999999999 799999999998765431
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHHcCC--CCCCCCCCHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD--FKCPPWFSSEA 248 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~ 248 (441)
..........|||.|||||++........++||||+||++.||+||+.||.. .........+.... +.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122344677999999999998633333589999999999999999999988 45555455555444 57789999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
++||.+||..||++|||+.++|+|||.+....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999976543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=412.79 Aligned_cols=260 Identities=42% Similarity=0.770 Sum_probs=238.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~ 93 (441)
..+...|++++.||+|.||.||.++++.+|+.+|+|++.+.........+.+.+|+.||+++. ||||+.++++|++.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 456778999999999999999999999999999999999887765455678999999999998 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC----CCeEEeecCcccccc
Q 013522 94 IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED----GNLKVTDFGLSAFSE 169 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~----~~vkl~DFGla~~~~ 169 (441)
+|+|||+|.||+|++.|....++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999976459999999999999999999999999999999999999643 479999999998655
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC--CC--CC
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--PW--FS 245 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~--~~ 245 (441)
. .....+.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+......++..+++.++ +| ++
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 3 5678899999999999999887774 899999999999999999999999999999999999987653 34 78
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
..++++|++||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=378.05 Aligned_cols=257 Identities=33% Similarity=0.536 Sum_probs=226.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|...+.||+|+||.||+|++..||+.||||.+..... +++......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 589999999999999999999999999999999987654 3355567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||++. +|...|+. ..++...++.|+.+++.||+|||++.|.||||||.|+|++++|.+||+|||+|+++..... .
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--I 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--c
Confidence 99976 89999986 5689999999999999999999999999999999999999999999999999998765433 3
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC---CCC----------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF---KCP---------- 241 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~---~~~---------- 241 (441)
....+-|.||.|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+....|.+. .+ .+|
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 333478999999999999888889999999999999999999999999888777777552 11 011
Q ss_pred -------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 242 -------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 242 -------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+..++++.+|+.+||..||.+|+|+.|+|+|+||....
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 11467889999999999999999999999999998743
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-53 Score=414.56 Aligned_cols=255 Identities=31% Similarity=0.589 Sum_probs=238.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++.... ....+.+++|++|++.|+||||+.++++|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 6799999999999999999999999999999999887643 345678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|||.| +|+..++. +.++|+.++.+..|++.||.|||+.+|.|||+||.|||++.+|.+|+||||+|+.... .....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cceee
Confidence 99988 99999986 8999999999999999999999999999999999999999999999999999987554 34456
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
....|||.|||||.+.+.+|+ ..+|+||+|||+||+++|++||-......+.+.|.....+.|+..+..+..|+..+|.
T Consensus 158 tsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~ 236 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLI 236 (808)
T ss_pred eeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhh
Confidence 677899999999999998887 8899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccCcc
Q 013522 258 PNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~t~~eil~hpwf~~~ 278 (441)
+||.+|+|..+++.|||.+..
T Consensus 237 kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 237 KDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred cChhhcccHHHHhcChHHhhh
Confidence 999999999999999998753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-52 Score=401.07 Aligned_cols=254 Identities=35% Similarity=0.643 Sum_probs=231.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999976 6799999999999999999999999999999999999999999999999999875432 22
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
.+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+...+|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 34679999999999987776 48899999999999999999999999998999999999999999999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCcccCcc
Q 013522 258 PNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
.||.+||+ ++++++||||+..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCC
Confidence 99999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=405.54 Aligned_cols=263 Identities=31% Similarity=0.596 Sum_probs=235.8
Q ss_pred CCCCCccccCCeEEeeeecccCceEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 10 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
+.....+..++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred cccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 33445566788999999999999999999976554 68999999776554444567788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
.+.+..|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 999999999999999999999976 6799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHH
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSE 247 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 247 (441)
... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+....+..+..+...+|+.+++.
T Consensus 181 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 254 (340)
T PTZ00426 181 VDT-----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254 (340)
T ss_pred cCC-----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 432 2345689999999999987666 5899999999999999999999999998889999999988899999999
Q ss_pred HHHHHHHhcCCCCCCCC-----CHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
+.++|++||+.||++|+ |++++++||||...
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999996 89999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-53 Score=381.55 Aligned_cols=258 Identities=36% Similarity=0.656 Sum_probs=231.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMV-KHKHIVELHEVMAS 90 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 90 (441)
+-..|.-.+.||.|..++|..+.+..+|+.+|+|++...... .....+.-.+|+.||+++ .||+|+++.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 456788889999999999999999999999999999754322 123456677899999998 79999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
+...++|+|.|+.|+|+|++.+ -.++|.+.+++++||++|+.|||.++|+||||||+|||+|++.++||+|||+|+...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999987 579999999999999999999999999999999999999999999999999998544
Q ss_pred ccccCCcccccccCCCccchhhhhcc-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC--CC
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PP 242 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~ 242 (441)
.+..+...||||+|+|||.+... +.++..+|+|+||||||-|+.|.+||......-+.+.|..|++.+ |.
T Consensus 175 ---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 175 ---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 45678889999999999998532 223578999999999999999999999999999999999998776 56
Q ss_pred C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 243 W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 243 ~--~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
| +|..+++||++||+.||.+|+|+.++|.||||..
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 6 7899999999999999999999999999999953
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-51 Score=402.22 Aligned_cols=251 Identities=36% Similarity=0.656 Sum_probs=226.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445567889999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccC
Q 013522 105 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183 (441)
Q Consensus 105 ~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 183 (441)
+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99999876 6799999999999999999999999999999999999999999999999999864221 22334567899
Q ss_pred CCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013522 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 184 ~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (441)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+...+|..+++++.+||++||..||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999987776 48999999999999999999999999888888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCcccCcc
Q 013522 264 I-----AISKIMESSWFKKS 278 (441)
Q Consensus 264 ~-----t~~eil~hpwf~~~ 278 (441)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-52 Score=411.94 Aligned_cols=261 Identities=40% Similarity=0.767 Sum_probs=246.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.-.+-|.+.++||+|.|++|.+|++..++..||||+++++..... ....+.+|+.+|+.|+|||||+++.++.....+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 456789999999999999999999999999999999998876543 3455899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||+.+|++++++.. +++.+..++.+|.|+.+|++|||+++|+|||||++|||++.+-++||+|||++.++. ..
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---cc
Confidence 99999999999999987 899999999999999999999999999999999999999999999999999999866 46
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
..+.+.||+|.|.|||++.+..|+++.+|+||+|++||.|++|.+||++.+..++......+.+.+|-.++.++.+||++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+|.++|.+|+++++++.|+|......
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhh
Confidence 99999999999999999999976543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=388.93 Aligned_cols=266 Identities=32% Similarity=0.541 Sum_probs=233.7
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
....-.+.|++...||.|..++||+|+...+++.||||+++.++... ..+.+++|+..|+.++||||++++..|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34556788999999999999999999999999999999999887654 3789999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+|+||.|+.+|++++.+.. ..++|..+..++++++.||.|||.+|-+|||||+.|||++.+|.|||+|||.+...-
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999999975 349999999999999999999999999999999999999999999999999876443
Q ss_pred ccccCC--cccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC---
Q 013522 170 HLKQDG--LLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--- 242 (441)
Q Consensus 170 ~~~~~~--~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--- 242 (441)
..+... .+.+..|||+|||||++.. .+|+ .|+||||||++..||.+|..||....+..++..-.++.++.+.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 322111 1256789999999999643 4675 9999999999999999999999999888887777777766432
Q ss_pred -------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 243 -------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 243 -------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
.++..++.+|..||+.||.+|||++++|+|+||+....+
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 267789999999999999999999999999999876543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=395.50 Aligned_cols=249 Identities=35% Similarity=0.653 Sum_probs=225.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999765444444567788999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCC
Q 013522 107 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185 (441)
Q Consensus 107 ~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 185 (441)
.+++.. +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999965 6799999999999999999999999999999999999999999999999999874322 1223445689999
Q ss_pred ccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 013522 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI- 264 (441)
Q Consensus 186 y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~- 264 (441)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+...+|..+++++++||.+||.+||++||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988776 488999999999999999999999999989999999988899999999999999999999999997
Q ss_pred --CHHHHhcCcccCcc
Q 013522 265 --AISKIMESSWFKKS 278 (441)
Q Consensus 265 --t~~eil~hpwf~~~ 278 (441)
++.++++||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-51 Score=384.12 Aligned_cols=261 Identities=27% Similarity=0.462 Sum_probs=224.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----C
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-----K 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~ 91 (441)
+..+|...+.||+|+||.|+.|.+..+|+.||||.+... +.....+++..||+.+|+.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 456777789999999999999999999999999998633 2344567889999999999999999999999855 4
Q ss_pred CEEEEEEeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~-l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+.+|+|+|++ +-+|...|+.+. ++++.++.++.||+.||.|+|+.||+||||||.|+|++.++.+||+|||+|+..+.
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 558999999876 99999999999999999999999999999999999999999999999999997765
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------- 236 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 236 (441)
....+.++..+.|.||.|||++.....++...||||+||||.||++|++.|.+.+....+..|..-
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 444566778889999999999977666679999999999999999999999988766555444221
Q ss_pred ---------CCCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 ---------DFKCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ---------~~~~~--------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
-+..| +..++.+.+|+++||..||.+|+|++|+|.|||+..-.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 11111 34689999999999999999999999999999997543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=400.58 Aligned_cols=259 Identities=30% Similarity=0.568 Sum_probs=224.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445678889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc----
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ---- 173 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 173 (441)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999975 7899999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC
Q 013522 174 -----------------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD 224 (441)
Q Consensus 174 -----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~ 224 (441)
.....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112346899999999999887775 8999999999999999999999999
Q ss_pred cHHHHHHHHHcC--CCCCCCC--CCHHHHHHHHHhcCCCCC---CCCCHHHHhcCcccCccC
Q 013522 225 NIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDPNPN---SRIAISKIMESSWFKKSA 279 (441)
Q Consensus 225 ~~~~~~~~i~~~--~~~~~~~--~~~~~~~li~~~L~~dP~---~R~t~~eil~hpwf~~~~ 279 (441)
+....+.++... ...+|+. +++++++||.+|+. +|. .||++++|++||||+...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 888888888763 3445543 68999999999875 444 468999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=403.39 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=229.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..+|...++||+|+.|.||.|+...+++.||||.++.....+ .+-+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 356899999999999999999999999999999998876544 46788999999999999999999999888999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|||++||+|.|.+....++|.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||+++..... ...-
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSKR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--cCcc
Confidence 99999999999999988999999999999999999999999999999999999999999999999998765542 2255
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH-cCC--CCCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-RGD--FKCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~~--~~~~~~~~~~~~~li~~ 254 (441)
.+.+|||+|||||++.++.| ++++||||||++++||+-|++||-..++......|. .|. .+.|..+|+.+++|+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67889999999999999888 599999999999999999999998776654444443 343 45577899999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||+.||++|+|+.++|+||||+...
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhhcC
Confidence 9999999999999999999996443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=393.76 Aligned_cols=255 Identities=29% Similarity=0.551 Sum_probs=228.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM---KMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
|++.+.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866543334456777787765 456799999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|||+.|++|...+..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999863221 22233
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
.+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|..+++.+.+||.+||.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 46789999999999987766 48899999999999999999999999988888999888888999999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccCcc
Q 013522 258 PNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
.||.+|| ++.++++||||+..
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=395.12 Aligned_cols=251 Identities=37% Similarity=0.669 Sum_probs=225.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445677889999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccC
Q 013522 105 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183 (441)
Q Consensus 105 ~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 183 (441)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99998875 6799999999999999999999999999999999999999999999999999864221 12234456899
Q ss_pred CCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013522 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 184 ~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (441)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||++||.+||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987766 58999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCcccCcc
Q 013522 264 I-----AISKIMESSWFKKS 278 (441)
Q Consensus 264 ~-----t~~eil~hpwf~~~ 278 (441)
+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 7 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=392.38 Aligned_cols=251 Identities=33% Similarity=0.653 Sum_probs=224.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+...........+..|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999866543334556777888888876 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999999875 6799999999999999999999999999999999999999999999999999864221 2223445679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++..+..+....|.++++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987766 4889999999999999999999999999999999999888899999999999999999999999
Q ss_pred CCCH------HHHhcCcccCcc
Q 013522 263 RIAI------SKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~------~eil~hpwf~~~ 278 (441)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCC
Confidence 9998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=393.18 Aligned_cols=251 Identities=35% Similarity=0.662 Sum_probs=225.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccC
Q 013522 105 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183 (441)
Q Consensus 105 ~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 183 (441)
+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcccc--CCCCccccccCC
Confidence 99998875 679999999999999999999999999999999999999999999999999986421 122233456799
Q ss_pred CCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013522 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 184 ~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (441)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||..||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999987766 48899999999999999999999999888888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCcccCcc
Q 013522 264 I-----AISKIMESSWFKKS 278 (441)
Q Consensus 264 ~-----t~~eil~hpwf~~~ 278 (441)
+ ++.++++||||...
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=393.47 Aligned_cols=254 Identities=33% Similarity=0.589 Sum_probs=225.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765443345677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6799999999999999999999999999999999999999999999999999875432 33
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCC------CCCHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP------WFSSEAR 249 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~~~~~~ 249 (441)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+....+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 456799999999999887664 88999999999999999999999988877777665432 22232 3589999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+||.+||..+|.+|||+.++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=389.97 Aligned_cols=256 Identities=32% Similarity=0.594 Sum_probs=228.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~ 98 (441)
+|++.+.||+|+||+||+|++..+++.||+|++.+.........+.+..|+.+++.++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444566788899999999765 6888999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999863211 12234
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
...+||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+....+..+......+|..+++++.++|.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 456799999999999887764 8899999999999999999999999988999999998888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCcccCcc
Q 013522 258 PNPNSRIAI-----SKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~t~-----~eil~hpwf~~~ 278 (441)
+||.+|++. +++++||||...
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999986 899999999764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=397.99 Aligned_cols=258 Identities=33% Similarity=0.605 Sum_probs=224.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC---
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--- 174 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~--- 174 (441)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999875 67999999999999999999999999999999999999999999999999998643211100
Q ss_pred ---------------------------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCC
Q 013522 175 ---------------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF 221 (441)
Q Consensus 175 ---------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf 221 (441)
....+.+||+.|+|||++.+.++. .++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011245799999999999887774 8999999999999999999999
Q ss_pred CCCcHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccCcc
Q 013522 222 QDDNIVSMYRKIYRGD--FKCPP--WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKS 278 (441)
Q Consensus 222 ~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~ 278 (441)
.+.+....+..+.... ...|. .+++++++||++||. +|.+|++ +.++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988888777776543 33344 368999999999997 9999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=398.50 Aligned_cols=258 Identities=33% Similarity=0.560 Sum_probs=221.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555566789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc-----
Q 013522 100 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ----- 173 (441)
Q Consensus 100 ~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~----- 173 (441)
|++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999876 6799999999999999999999999999999999999999999999999999753211000
Q ss_pred ----------------------------------------CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHH
Q 013522 174 ----------------------------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYV 213 (441)
Q Consensus 174 ----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ 213 (441)
.....+.+||+.|+|||++.+..+. .++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHHH
Confidence 0012345799999999999887774 88999999999999
Q ss_pred HhhCCCCCCCCcHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHhc--CCCCCCCCCHHHHhcCcccCcc
Q 013522 214 LLAGFLPFQDDNIVSMYRKIYR--GDFKCPP--WFSSEARRLITKLL--DPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L--~~dP~~R~t~~eil~hpwf~~~ 278 (441)
|++|..||...+......++.. .....|+ .+++++.+||.+|| ..+|..|+++.++++||||...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999998877766666653 2344454 47899999999965 4555569999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=390.52 Aligned_cols=251 Identities=33% Similarity=0.632 Sum_probs=225.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556677899998866 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
++|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999998865 6799999999999999999999999999999999999999999999999999864221 2233445679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+..+..+....|.++++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999987776 4889999999999999999999999999999999999998899999999999999999999999
Q ss_pred CC-------CHHHHhcCcccCcc
Q 013522 263 RI-------AISKIMESSWFKKS 278 (441)
Q Consensus 263 R~-------t~~eil~hpwf~~~ 278 (441)
|| ++.++++||||...
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCCC
Confidence 99 89999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=382.66 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=220.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999976654333334567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+.+|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999888753 3589999999999999999999999999999999999999999999999999875322 222
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH----HHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
.....||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+. ......+.......+..+++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999877764 889999999999999999999987543 23334444555567778999999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 253 TKLLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 253 ~~~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
++||+.||++||| ++++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=397.31 Aligned_cols=262 Identities=32% Similarity=0.556 Sum_probs=229.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44578999999999999999999999999999999997654433344566789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccccCCCccchhhhhccC---CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CCCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP--WFSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~ 248 (441)
...+.+||+.|+|||++.+.. ..+.++|||||||++|+|++|.+||.+.+....+.++.... ..+|. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 224567999999999986543 34689999999999999999999999999888888887653 44454 479999
Q ss_pred HHHHHHhcCCCCCC--CCCHHHHhcCcccCcc
Q 013522 249 RRLITKLLDPNPNS--RIAISKIMESSWFKKS 278 (441)
Q Consensus 249 ~~li~~~L~~dP~~--R~t~~eil~hpwf~~~ 278 (441)
.+||++||..+|.+ |+|+.++++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999998 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=398.87 Aligned_cols=257 Identities=32% Similarity=0.591 Sum_probs=221.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444445678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC---
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--- 174 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~--- 174 (441)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999976 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHH
Q 013522 175 ------------------------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILY 212 (441)
Q Consensus 175 ------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 212 (441)
......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 00013579999999999987776 48899999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCcccCc
Q 013522 213 VLLAGFLPFQDDNIVSMYRKIYRG--DFKCPP--WFSSEARRLITKLLDPNPNSR---IAISKIMESSWFKK 277 (441)
Q Consensus 213 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~L~~dP~~R---~t~~eil~hpwf~~ 277 (441)
+|++|.+||.+.+....+..+... ...+|. .++.++++||.+||. +|.+| +|+.+++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988887777777653 344454 478999999999998 67665 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=396.58 Aligned_cols=262 Identities=32% Similarity=0.556 Sum_probs=227.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999997654444344567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+||||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-ce
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccccCCCccchhhhhccC---CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCC--CCCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP--WFSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~ 248 (441)
...+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+..+.... ..+|. .+++.+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 234668999999999997643 34689999999999999999999999998888888887643 44454 468999
Q ss_pred HHHHHHhcCCCCCC--CCCHHHHhcCcccCcc
Q 013522 249 RRLITKLLDPNPNS--RIAISKIMESSWFKKS 278 (441)
Q Consensus 249 ~~li~~~L~~dP~~--R~t~~eil~hpwf~~~ 278 (441)
+++|.+||..+|.+ |+|+.++++||||+..
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999866654 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=372.32 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=226.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--K 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 91 (441)
+....+.|+.+..|++|+||.||+|++..|++.||+|.++.++ .+.+.--.-.|||.+|.+++|||||.+-++... -
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 3455678999999999999999999999999999999997665 233444456799999999999999999998854 4
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
+.+|+|||||.. +|...+.. .++...+++.+..|++.|++|||.+.|+||||||+|+|++..|.+||+|||+|+-++
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 679999999977 89888876 579999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--C----------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D---------- 237 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~---------- 237 (441)
.. -..++..+-|.||.|||.+.+...++.++|+||+|||+.||+++++.|.+....+...+|.+- .
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 43 334566778999999999999887889999999999999999999999999888877777541 0
Q ss_pred -------CCCCC-----------C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 -------FKCPP-----------W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 -------~~~~~-----------~--~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..++. + +++...+|+..+|.+||.+|.|+.+.|+|+||.+..
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 11111 1 357889999999999999999999999999998754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=397.73 Aligned_cols=258 Identities=35% Similarity=0.607 Sum_probs=222.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765444455678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc-----
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK----- 172 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----- 172 (441)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999876 678999999999999999999999999999999999999999999999999975321100
Q ss_pred ----------------------------------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHH
Q 013522 173 ----------------------------------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILY 212 (441)
Q Consensus 173 ----------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~ 212 (441)
......+.+||+.|+|||++.+.+++ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011245799999999999888775 8899999999999
Q ss_pred HHhhCCCCCCCCcHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccCcc
Q 013522 213 VLLAGFLPFQDDNIVSMYRKIYRG--DFKCP--PWFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKS 278 (441)
Q Consensus 213 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~ 278 (441)
+|++|++||...+......++... ....| ..+++++.+||.+|+ .||++|++ ++++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999988877766666543 23344 357999999999987 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-49 Score=386.64 Aligned_cols=251 Identities=32% Similarity=0.615 Sum_probs=222.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||.||+|++..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999865433233455677788888754 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|..++.. +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999999876 6799999999999999999999999999999999999999999999999999863211 1223456789
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...+...+.......|.+++.++++||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999877764 889999999999999999999999988888888888888889999999999999999999999
Q ss_pred CCCH-HHHhcCcccCcc
Q 013522 263 RIAI-SKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~-~eil~hpwf~~~ 278 (441)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=380.97 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=213.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||.|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 36799999999999999999999999999999999754321 2235677999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.| +|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999986 89888864 3578999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------ 237 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 237 (441)
......||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 33456789999999998765544689999999999999999999998877655544432210
Q ss_pred -CCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 -FKC-----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 -~~~-----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
..+ .+.+++++++||.+||++||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001 12367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=391.11 Aligned_cols=251 Identities=35% Similarity=0.660 Sum_probs=225.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 105 ELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 105 ~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
+|..++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998875 679999999999999999999997 7999999999999999999999999999864221 2223345679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999987766 4899999999999999999999999888888888888888889999999999999999999999
Q ss_pred CC-----CHHHHhcCcccCcc
Q 013522 263 RI-----AISKIMESSWFKKS 278 (441)
Q Consensus 263 R~-----t~~eil~hpwf~~~ 278 (441)
|+ ++.++++||||...
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=380.48 Aligned_cols=264 Identities=30% Similarity=0.481 Sum_probs=236.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
-...|++++.||.|.-|+||+++...++..+|+|++++..........++..|-.||+.++||.++.||..|+++...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34568999999999999999999999999999999999988777778889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc---
Q 013522 97 AMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH--- 170 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~--- 170 (441)
|||||+||+|..+.++ +.+++..++.|+..++.||+|||-.|||+||||||||||-++|.+.|+||.|+.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999999999875 5699999999999999999999999999999999999999999999999998732100
Q ss_pred ------------------------------ccc---------------------CCcccccccCCCccchhhhhccCCCC
Q 013522 171 ------------------------------LKQ---------------------DGLLHTTCGTPAYVAPEVISKKGYDG 199 (441)
Q Consensus 171 ------------------------------~~~---------------------~~~~~~~~gt~~y~APE~l~~~~~~~ 199 (441)
... +......+||-.|+|||++.+.++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg- 313 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG- 313 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-
Confidence 000 0011234588899999999999885
Q ss_pred CcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHhcCCCCCCCCC----HHHHhcCc
Q 013522 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--WFSSEARRLITKLLDPNPNSRIA----ISKIMESS 273 (441)
Q Consensus 200 ~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t----~~eil~hp 273 (441)
.++|.|+|||.||||+.|..||.+.+..+.+.+|......+|. .++..++|||+++|.+||.+|.. +.||.+||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHP 393 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCc
Confidence 8999999999999999999999999999999999998888875 47899999999999999999998 99999999
Q ss_pred ccCccCCc
Q 013522 274 WFKKSAPK 281 (441)
Q Consensus 274 wf~~~~~~ 281 (441)
||+...+.
T Consensus 394 FF~gVnWa 401 (459)
T KOG0610|consen 394 FFEGVNWA 401 (459)
T ss_pred cccCCChh
Confidence 99876554
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=394.08 Aligned_cols=258 Identities=36% Similarity=0.667 Sum_probs=227.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444345677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc-----
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK----- 172 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----- 172 (441)
||+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999976 689999999999999999999999999999999999999999999999999987543322
Q ss_pred ----------------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHH
Q 013522 173 ----------------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY 230 (441)
Q Consensus 173 ----------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~ 230 (441)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0112345679999999999988766 48999999999999999999999998888888
Q ss_pred HHHHc--CCCCCCCC--CCHHHHHHHHHhcCCCCCCCCC-HHHHhcCcccCcc
Q 013522 231 RKIYR--GDFKCPPW--FSSEARRLITKLLDPNPNSRIA-ISKIMESSWFKKS 278 (441)
Q Consensus 231 ~~i~~--~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t-~~eil~hpwf~~~ 278 (441)
.++.. .....|.. +++++.+||.+||. ||.+||+ +.++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 87776 44445443 59999999999998 9999999 9999999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=379.53 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=212.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999765332 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||+.++.+..+... +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc-ccccc
Confidence 99998776655543 56999999999999999999999999999999999999999999999999998754321 11223
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-------------------C
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------F 238 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 238 (441)
....||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34579999999999987776 489999999999999999999998766544332222110 0
Q ss_pred CC-------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 KC-------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 ~~-------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.. ...+++++.+||.+||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01 11267889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=375.46 Aligned_cols=264 Identities=35% Similarity=0.642 Sum_probs=246.0
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.++..++|+.++.||+|+||+|.+++.+.+++.+|||+++++.+.......+-..|-++|+..+||.+..+...|...++
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 35677899999999999999999999999999999999999988776667777789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+|+||||+.||+|+-.+.+ ..++++.++.|-..|++||.|||+++|+.||||.+|+|+|.+|.+||+|||++. +...
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK--E~I~ 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK--EEIK 320 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch--hccc
Confidence 9999999999999999976 669999999999999999999999999999999999999999999999999986 3455
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
.+....+.||||.|+|||++....| +.++|.|.+||+||||+||++||...+...++.-|...+..+|..++++++.|+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 5667889999999999999998888 599999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCcccCccCC
Q 013522 253 TKLLDPNPNSRIA-----ISKIMESSWFKKSAP 280 (441)
Q Consensus 253 ~~~L~~dP~~R~t-----~~eil~hpwf~~~~~ 280 (441)
..+|.+||.+|.. +.+|++|+||....+
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 9999999999984 889999999986543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=386.48 Aligned_cols=256 Identities=32% Similarity=0.597 Sum_probs=228.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+|++.+.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544434455677788888877 5899999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||++||+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999999875 7799999999999999999999999999999999999999999999999999864221 12234
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
...+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+...++..+......+|..+++++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 456799999999999887774 8999999999999999999999999999999999998888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCcccCcc
Q 013522 258 PNPNSRIAI-----SKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~t~-----~eil~hpwf~~~ 278 (441)
.||.+|+++ .++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999984 899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=385.69 Aligned_cols=251 Identities=33% Similarity=0.652 Sum_probs=221.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+.........+....|..++.. .+||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987654333445556677777765 4899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|..++.. +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999999875 6799999999999999999999999999999999999999999999999999874322 1233445689
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++..+.......|.+++.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 4889999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCHH-HHhcCcccCcc
Q 013522 263 RIAIS-KIMESSWFKKS 278 (441)
Q Consensus 263 R~t~~-eil~hpwf~~~ 278 (441)
||++. ++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99864 88899999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=387.98 Aligned_cols=251 Identities=30% Similarity=0.600 Sum_probs=219.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544444566788999999988 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 999998865 789999999999999999999999999999999999999999999999999986321 12233456789
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------cHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------NIVSMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
|+.|+|||++.+..++ .++|+|||||++|+|++|+.||... ........+.......|..++..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999887764 8899999999999999999999631 22345566777788889999999999999
Q ss_pred HhcCCCCCCCCC------HHHHhcCcccCcc
Q 013522 254 KLLDPNPNSRIA------ISKIMESSWFKKS 278 (441)
Q Consensus 254 ~~L~~dP~~R~t------~~eil~hpwf~~~ 278 (441)
+||..||.+|+| ++++++||||...
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999997 7899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=381.94 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=211.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999999754321 2234677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 578777764 5689999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHHc--CCC--------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYR--GDF-------------- 238 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~~~-------------- 238 (441)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+.. +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987655556889999999999999999999987432 222222211 000
Q ss_pred -----C--CCC---------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 -----K--CPP---------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 -----~--~~~---------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. .|. .+++++.+||.+||++||++|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0 000 1356789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=396.16 Aligned_cols=258 Identities=34% Similarity=0.592 Sum_probs=221.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433344577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc-----
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK----- 172 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----- 172 (441)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999976 678999999999999999999999999999999999999999999999999975321100
Q ss_pred ------------------------------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh
Q 013522 173 ------------------------------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA 216 (441)
Q Consensus 173 ------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~ 216 (441)
........+||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011235799999999999887774 89999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHcCC--CCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCcccCcc
Q 013522 217 GFLPFQDDNIVSMYRKIYRGD--FKCPP--WFSSEARRLITKLLDPNPNSRI---AISKIMESSWFKKS 278 (441)
Q Consensus 217 G~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~~ 278 (441)
|+.||.+.+.......+.... ...|. .+++++.+||.+|+ .+|.+|+ |+.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999988777666665432 23333 57899999999977 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=385.96 Aligned_cols=252 Identities=37% Similarity=0.696 Sum_probs=223.6
Q ss_pred eeeecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 24 GRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
++.||+|+||.||++++. .+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 57889999999765432 12334567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 100 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 100 ~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
|+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999975 6789999999999999999999999999999999999999999999999999864321 222344
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCC
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 258 (441)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|+.+++.+.+||.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5679999999999987766 488999999999999999999999999888888999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccCcc
Q 013522 259 NPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 259 dP~~R~-----t~~eil~hpwf~~~ 278 (441)
||++|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=384.66 Aligned_cols=251 Identities=35% Similarity=0.674 Sum_probs=225.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544444566778899999888 799999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|...+.+ +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999999876 5899999999999999999999999999999999999999999999999999864211 2223345679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+.......|..+++.+.+||++||..||++
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887774 889999999999999999999999988888888888888888899999999999999999999
Q ss_pred CCCH-----HHHhcCcccCcc
Q 013522 263 RIAI-----SKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~-----~eil~hpwf~~~ 278 (441)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=392.10 Aligned_cols=258 Identities=31% Similarity=0.606 Sum_probs=224.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+.|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998655444455678889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc----
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ---- 173 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 173 (441)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999864321110
Q ss_pred -----------------------------CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC
Q 013522 174 -----------------------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD 224 (441)
Q Consensus 174 -----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~ 224 (441)
.....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|++||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0112245799999999999887775 8899999999999999999999999
Q ss_pred cHHHHHHHHHcC--CCCCCCC--CCHHHHHHHHHhcCCCCCCCC---CHHHHhcCcccCcc
Q 013522 225 NIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDPNPNSRI---AISKIMESSWFKKS 278 (441)
Q Consensus 225 ~~~~~~~~i~~~--~~~~~~~--~~~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~~ 278 (441)
+....+.++... ...+|+. +++++++||.+|+. ||.+|+ ++.++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 888888887753 3344543 78999999999875 999998 48999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=382.68 Aligned_cols=252 Identities=32% Similarity=0.608 Sum_probs=221.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+..............|..+++. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999986543322344566778888876 4999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 6799999999999999999999999999999999999999999999999999863211 1223345679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|.+++.++++||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999987776 4899999999999999999999999888888888888888888899999999999999999999
Q ss_pred CCCHH-HHhcCcccCccC
Q 013522 263 RIAIS-KIMESSWFKKSA 279 (441)
Q Consensus 263 R~t~~-eil~hpwf~~~~ 279 (441)
||++. ++++||||+...
T Consensus 238 R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 238 RLGVKGDIRQHPFFREID 255 (316)
T ss_pred cCCChHHHHcCcccCCCC
Confidence 99996 899999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=384.75 Aligned_cols=258 Identities=36% Similarity=0.620 Sum_probs=222.2
Q ss_pred CeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
+|++++.||+|+||+||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47899999999765432 223456788999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999999865 67999999999999999999999999999999999999999999999999998753321 1
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEAR 249 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~ 249 (441)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335679999999999987654568899999999999999999999642 3445566677777788888999999
Q ss_pred HHHHHhcCCCCCCCC-----CHHHHhcCcccCcc
Q 013522 250 RLITKLLDPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 250 ~li~~~L~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
+||.+||..||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.28 Aligned_cols=251 Identities=37% Similarity=0.637 Sum_probs=221.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333445555555 56789999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI--EHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc--cCCCccccccC
Confidence 999999875 679999999999999999999999999999999999999999999999999986421 12233445679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+..+....++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999887764 889999999999999999999999998899999998888888889999999999999999999
Q ss_pred CCCH----HHHhcCcccCcc
Q 013522 263 RIAI----SKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~----~eil~hpwf~~~ 278 (441)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9997 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=382.32 Aligned_cols=256 Identities=32% Similarity=0.598 Sum_probs=227.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+..|+.+++.+. ||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444445567788999998885 578889999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999976 7799999999999999999999999999999999999999999999999999864221 12233
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.......|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999987776 48899999999999999999999999988889999988888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCcccCcc
Q 013522 258 PNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
.||.+|++ ..++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 4789999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=370.54 Aligned_cols=259 Identities=31% Similarity=0.498 Sum_probs=222.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKS---- 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~---- 92 (441)
...|..+++||+|+||+||+|+++.+|+.||+|.++.+.-. ++.-....+|+.+|+.|+|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688888999999999999999999999999999876432 334456789999999999999 999999998877
Q ss_pred --EEEEEEeccCCCchHHHHhc-C----CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 93 --KIYFAMDLVKGGELFNKIAK-G----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 93 --~~~lv~E~~~gg~L~~~i~~-~----~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
.+|+|+||++. +|..++.. + .++...++.+++||+.||+|||++||+||||||.|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89888875 2 3777899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---------
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--------- 236 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 236 (441)
+.... +...+...++|.+|.|||++.+...++...||||+|||++||+++++.|.+....+....|.+-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85442 2334677789999999999999877789999999999999999999999999887777776441
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 237 ---------DFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 237 ---------~~~~~~~------------~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
...+|.| .+++..+++.+||+++|.+|.|+..+|.||||.....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 1122222 2358899999999999999999999999999987543
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=384.55 Aligned_cols=251 Identities=31% Similarity=0.609 Sum_probs=219.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544445566788999998876 899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999864221 2223345689
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC---------CcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---------DNIVSMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.. .........+......+|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999877764 889999999999999999999952 122345566777788889999999999999
Q ss_pred HhcCCCCCCCCC------HHHHhcCcccCcc
Q 013522 254 KLLDPNPNSRIA------ISKIMESSWFKKS 278 (441)
Q Consensus 254 ~~L~~dP~~R~t------~~eil~hpwf~~~ 278 (441)
+||+.||++||| +.++++||||+..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=386.43 Aligned_cols=258 Identities=31% Similarity=0.550 Sum_probs=223.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765434445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 99999999999976 579999999999999999999999999999999999999999999999999987543211 112
Q ss_pred ccccccCCCccchhhhhc-----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCC--CCCCHH
Q 013522 177 LHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP--PWFSSE 247 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~ 247 (441)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ..+| +.++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233588999999999999999999999888877777776542 2233 457999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+||.+||. ||.+|||+.++++||||...
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=388.43 Aligned_cols=263 Identities=33% Similarity=0.553 Sum_probs=226.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34457999999999999999999999999999999999765443334456688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 95 YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Cc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998754321 11
Q ss_pred CcccccccCCCccchhhhhccC---CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCC--CCCCHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP--PWFSSE 247 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~ 247 (441)
....+.+||+.|+|||++.+.. ..+.++|||||||++|+|++|.+||...+....+..+.... ..+| ..+++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1234567999999999997543 34689999999999999999999999999888888887643 3344 358999
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNS--RIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~--R~t~~eil~hpwf~~~ 278 (441)
+++||.+||..++.+ |+++.++++||||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=387.88 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=229.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
...|+..+.||+|+||.||+|.+..+++.||+|+++.+... ...+.+.+|+.+|..+++|||.++|+.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 34688889999999999999999999999999999877543 3578899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAKGRL-REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l-~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||.||++.+.++.+.+ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.+|++|||.+....... ..
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh--hc
Confidence 999999999999998665 999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHh
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 255 (441)
..+.+|||.|||||++...+|+ .++||||||++.+||++|.+||.+..++....-|-+..++ ....+++.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 3788999999999999988886 8999999999999999999999998886655555554433 2346899999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccCccC
Q 013522 256 LDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|++||+.|||+.++|+|+|++...
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999998743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=380.73 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=216.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcE-EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKS-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 92 (441)
.+......+.+.||+|+||+||.|.+ .|+. ||+|++......... .+.+.+|+.+|++++|||||++++++.++.
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34445567778899999999999999 5556 999999876554433 779999999999999999999999998887
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC-cEeccCCCCcEEeCCCC-CeEEeecCcccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRG-VYHRDLKPENLLLDEDG-NLKVTDFGLSAF 167 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~g-i~HrDLkp~NILl~~~~-~vkl~DFGla~~ 167 (441)
..++||||+++|+|.+++.. +.++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999965 67999999999999999999999999 99999999999999998 999999999985
Q ss_pred ccccccCCcccccccCCCccchhhhh--ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH-cC-CCCCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-RG-DFKCPPW 243 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~-~~~~~~~ 243 (441)
..... .......||+.|||||++. ...|+ .++||||||++||||+||+.||.+.........+. .+ .+.+|..
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 44321 2333468999999999998 45665 99999999999999999999999988765555554 33 4556777
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+++.+..||.+||..||++||++.+|+.
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=380.00 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=208.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----SKI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~ 94 (441)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864322 223345788999999999999999999988543 358
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 689888875 6799999999999999999999999999999999999999999999999999875332211
Q ss_pred -CCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc---------------
Q 013522 174 -DGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--------------- 235 (441)
Q Consensus 174 -~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 235 (441)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 112245679999999999865 344 5889999999999999999999987654332211110
Q ss_pred -----------CCCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 236 -----------GDFKC-----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 236 -----------~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
...+. .+.+++.+.++|.+||+.||++|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00001 12367889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=382.21 Aligned_cols=251 Identities=37% Similarity=0.626 Sum_probs=220.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433333445556655 46789999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999998875 6799999999999999999999999999999999999999999999999999864211 2223345679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+.......++..+..+.++|++||..||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887775 889999999999999999999999998899999988888888889999999999999999999
Q ss_pred CCCH----HHHhcCcccCcc
Q 013522 263 RIAI----SKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~----~eil~hpwf~~~ 278 (441)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCCCCCCHHHHhcCCCcCCC
Confidence 9986 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=371.39 Aligned_cols=249 Identities=29% Similarity=0.478 Sum_probs=214.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||+|+||+||++.+..+++.||+|.+.+.........+.+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999766544333456778899999999999999999999999999999999999999
Q ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccc
Q 013522 107 FNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181 (441)
Q Consensus 107 ~~~i~-----~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 181 (441)
...+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 88773 246899999999999999999999999999999999999999999999999998654321 12233457
Q ss_pred cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 182 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ......+.......|+.+++.+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999887764 889999999999999999999976532 3344455555566777899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccCcc
Q 013522 258 PNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 258 ~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
.||++|| |++++++||||+..
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 9999999 88999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=384.47 Aligned_cols=250 Identities=34% Similarity=0.608 Sum_probs=218.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
||+|+||+||+|++..+++.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344555677777665 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999998875 7799999999999999999999999999999999999999999999999999864221 2233456789
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHhcCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-WFSSEARRLITKLLDPNPN 261 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li~~~L~~dP~ 261 (441)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+...++..+..+...+|. .+++++.+||++||.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999976554468999999999999999999999999988889999888877775 4799999999999999999
Q ss_pred CCC----CHHHHhcCcccCcc
Q 013522 262 SRI----AISKIMESSWFKKS 278 (441)
Q Consensus 262 ~R~----t~~eil~hpwf~~~ 278 (441)
+|| ++.++++||||...
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HCCCCCCCHHHHhcCccccCC
Confidence 998 79999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=379.52 Aligned_cols=251 Identities=35% Similarity=0.610 Sum_probs=220.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+. +++.++||||+++++++.+.+..|+||||+.|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998655433333445555654 67889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCC--CCCCccccccC
Confidence 999988875 679999999999999999999999999999999999999999999999999986421 12233445679
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+......+|+..+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877765 789999999999999999999999998888899988888888889999999999999999999
Q ss_pred CCCH----HHHhcCcccCcc
Q 013522 263 RIAI----SKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~----~eil~hpwf~~~ 278 (441)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred cCCCCCCHHHHhCCCCcCCC
Confidence 9975 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=381.43 Aligned_cols=250 Identities=37% Similarity=0.679 Sum_probs=222.3
Q ss_pred eeecccCceEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 013522 25 RMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
+.||+|+||+||++++. .+|+.||+|++.+.... ......+.+|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 57899999999765432 223456778999999999999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccc
Q 013522 102 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180 (441)
Q Consensus 102 ~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 180 (441)
.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 99999999975 6799999999999999999999999999999999999999999999999999874322 12234456
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 260 (441)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.......|..+++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 79999999999987766 48899999999999999999999999888888889888888999999999999999999999
Q ss_pred CCCCC-----HHHHhcCcccCcc
Q 013522 261 NSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 261 ~~R~t-----~~eil~hpwf~~~ 278 (441)
++||| +.+++.||||...
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=379.72 Aligned_cols=251 Identities=37% Similarity=0.641 Sum_probs=219.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998654332223334444544 56889999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999976 6789999999999999999999999999999999999999999999999999864221 2233456789
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+....+..+.......++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887764 889999999999999999999999998888888888888888889999999999999999999
Q ss_pred CCCHH----HHhcCcccCcc
Q 013522 263 RIAIS----KIMESSWFKKS 278 (441)
Q Consensus 263 R~t~~----eil~hpwf~~~ 278 (441)
|+++. ++++|+||...
T Consensus 238 R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCCCHHHHhcCcccCCC
Confidence 99876 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=378.64 Aligned_cols=252 Identities=31% Similarity=0.609 Sum_probs=219.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554445567788999999888 699999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999998875 6799999999999999999999999999999999999999999999999999864221 2233456789
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC-------CcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-------DNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 255 (441)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. ......+..+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987776 4899999999999999999999953 22334566666777788888999999999999
Q ss_pred cCCCCCCCCC------HHHHhcCcccCccC
Q 013522 256 LDPNPNSRIA------ISKIMESSWFKKSA 279 (441)
Q Consensus 256 L~~dP~~R~t------~~eil~hpwf~~~~ 279 (441)
|..||++|++ +.++++||||+...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 9999999998 56999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=374.56 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=218.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++.+.||+|+||.||+|++..++..+|+|++.... .......+.+|+.+|+.++||||+++++++.+.+.+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999997542 22345689999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||||++|++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 9999999999999976 6799999999999999999999986 699999999999999999999999999864322
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH--------------------
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-------------------- 234 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-------------------- 234 (441)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..++...+.
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 22345579999999999987766 489999999999999999999998765544322211
Q ss_pred --------------------------cCC-CCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 235 --------------------------RGD-FKCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 235 --------------------------~~~-~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... ...+ ..+++++++||.+||++||++|||+.++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 111 1111 13678999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=376.92 Aligned_cols=259 Identities=31% Similarity=0.573 Sum_probs=220.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986433211 111
Q ss_pred ccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCC---CCCCHH
Q 013522 177 LHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP---PWFSSE 247 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~ 247 (441)
....+||+.|+|||++.. ....+.++||||+||++|+|++|+.||.+.+....+..+.... ..+| +.++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223569999999999963 2344678999999999999999999999988877777776543 2333 347899
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNS--RIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~--R~t~~eil~hpwf~~~ 278 (441)
+++||++||..++++ |+++.++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999765444 8899999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=368.49 Aligned_cols=255 Identities=26% Similarity=0.461 Sum_probs=219.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976544333334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+.||+|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999988753 4589999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH----HHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+.......++.+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 345579999999999987666 488999999999999999999998765533 233344445556677899999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCcccCcc
Q 013522 253 TKLLDPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 253 ~~~L~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
.+||..||.+|| ++.++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=394.60 Aligned_cols=262 Identities=33% Similarity=0.516 Sum_probs=229.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 92 (441)
....++|++.+.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 45668999999999999999999999999999999999766543 344567889999999999999999998775332
Q ss_pred ------EEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEee
Q 013522 93 ------KIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 161 (441)
Q Consensus 93 ------~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~D 161 (441)
.+++||||+.+|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 47899999999999998863 4589999999999999999999999999999999999999999999999
Q ss_pred cCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CC
Q 013522 162 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KC 240 (441)
Q Consensus 162 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~ 240 (441)
||+++............+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+..+.. +.
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 9999765443333445567899999999999887764 899999999999999999999999988888888777654 46
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
|+.+++++.+||.+||..||.+|||+.++++|||++..
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 77899999999999999999999999999999998753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=391.22 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=207.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
..++|++++.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3468999999999999999999999999999999885432 2345799999999999999999887432
Q ss_pred ---CEEEEEEeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeec
Q 013522 92 ---SKIYFAMDLVKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDF 162 (441)
Q Consensus 92 ---~~~~lv~E~~~gg~L~~~i~-----~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DF 162 (441)
..+++||||+++ +|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 257799999976 6766654 25699999999999999999999999999999999999999765 6999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC------
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------ 236 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------ 236 (441)
|+|..... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99975432 222345678999999999876554568999999999999999999999987665544443321
Q ss_pred -----------CC------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 -----------DF------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 -----------~~------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.. .+|...++++.+||.+||++||.+|||+.++++||||...
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 01 1234467899999999999999999999999999999753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=367.16 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=207.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMA----- 89 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----- 89 (441)
.+|++.+.||+|+||+||+|++.. +++.||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999864 46889999987543322 2334566788877766 6999999999885
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
....+++||||+. ++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999997 488888864 458999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC--------
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------- 238 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------- 238 (441)
.... ........||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..+.+..+.....
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2334456799999999999877664 889999999999999999999998877666665543210
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 -------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 -------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
...+.+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=378.50 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=214.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34577999999999999999999999999999999986543 2234567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+||||+.+++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MD 223 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cc
Confidence 99999999998653 34677888999999999999999999999999999999999999999999998754321 11
Q ss_pred cccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHHc-CCCCCCCCCCHH
Q 013522 176 LLHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---VSMYRKIYR-GDFKCPPWFSSE 247 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~-~~~~~~~~~~~~ 247 (441)
......||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+.. .....+..++.+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2345679999999998743 34556789999999999999999999974332 222233322 234456678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++||.+||..||++|||+.++++||||....
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999999999999998753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=359.06 Aligned_cols=251 Identities=37% Similarity=0.668 Sum_probs=221.6
Q ss_pred cccCCeEEe-eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe---
Q 013522 16 LLHGKYELG-RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS--- 90 (441)
Q Consensus 16 ~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--- 90 (441)
-+.++|++- ++||-|-.|+|-.+.++.||+.+|+|++... ...++|+++.-.. .|||||.++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 467889885 6899999999999999999999999998533 4677999986655 79999999999864
Q ss_pred -CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEeecC
Q 013522 91 -KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFG 163 (441)
Q Consensus 91 -~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~DFG 163 (441)
..++.+|||.+.||+|+.+|+. +.++|.++..+++||..|+.|||+.+|.||||||||+|... |..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4678999999999999999986 35999999999999999999999999999999999999975 4469999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHHHHcCCCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFK 239 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~ 239 (441)
+|+... ....+.+.|-||+|+|||++....|+ ..+|+||+||++|.|+||++||-... ...+..+|..|.+.
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 997533 35678899999999999999888886 88999999999999999999996543 34678889999888
Q ss_pred CCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 240 CPP--W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 240 ~~~--~--~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+|. | +|++++++|+++|..+|.+|.|+.+++.|||+...
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 764 4 79999999999999999999999999999999754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=363.91 Aligned_cols=255 Identities=40% Similarity=0.765 Sum_probs=231.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||.|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997765544455678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||+++++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|.||+++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999975 77999999999999999999999999999999999999999999999999998754322 3
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..+++.++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 45579999999999877655 48899999999999999999999988887888888888888899999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccCccC
Q 013522 258 PNPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 258 ~dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
.||.+|+ +++++++||||+...
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999 999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=368.19 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=214.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 36799999999999999999999999999999999755322 2234577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.+ +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--cc
Confidence 999976 78887764 45899999999999999999999999999999999999999999999999998643221 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------- 236 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 236 (441)
......+|+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2334568999999999876555568999999999999999999999887655443333211
Q ss_pred CCCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 DFKC-----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.... .+.+++++++||.+||..||.+|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0111 123678999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=380.15 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=236.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK-IYF 96 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~l 96 (441)
.+.|..++.+|+|+||.+++++++.+++.+++|.++...... .......+|+.+++++.|||||.+++.|..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 467999999999999999999999999999999998877654 334478899999999999999999999988888 999
Q ss_pred EEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 97 AMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||+||+||++.+.|.+ .-++|+.+..||.|++.||.|||++.|.|||||+.|||++.++.|||+|||+|+.... .
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--E 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--c
Confidence 9999999999999976 3489999999999999999999999999999999999999999999999999987654 2
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLI 252 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 252 (441)
.+...+..|||.|+.||++.+.+|+ .++|||||||++|||++-+++|...+...+..+|.++. .+.|..++.+++.||
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 3467889999999999999999996 99999999999999999999999999999999999987 677889999999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+.||..+|..||++.++|.+|....
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999988764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=378.57 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=212.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++.+.||+|+||.||.|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 357899999999999999999999999999999999975432 223456788999999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999976 67777654 48899999999999999999999999999999999999999999999999987533
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------ 237 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 237 (441)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2233456799999999999887764 88999999999999999999998877655554443210
Q ss_pred ----------CCC--------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 238 ----------FKC--------------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 238 ----------~~~--------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
... ....+..+++||.+||+.||.+|||+.++|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 01124678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=372.61 Aligned_cols=259 Identities=30% Similarity=0.545 Sum_probs=220.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654433344566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999975 67899999999999999999999999999999999999999999999999998643211 1112
Q ss_pred ccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCC---CCCHH
Q 013522 177 LHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP---WFSSE 247 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~ 247 (441)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++.... ..+|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234579999999999863 2334688999999999999999999999998888888886653 23333 47899
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNS--RIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~--R~t~~eil~hpwf~~~ 278 (441)
+++||++||..+|.+ |+++.++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999765554 7899999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=375.77 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=210.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 467899999999999999999999999999999999975432 223456788999999999999999999998644
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 357999999976 56666643 48899999999999999999999999999999999999999999999999986432
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-------------- 235 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 235 (441)
.........||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 ---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 22233456789999999999887775 889999999999999999999987654332222111
Q ss_pred --------CCCC---------CCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 236 --------GDFK---------CPP-----------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 236 --------~~~~---------~~~-----------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.... ++. ..++.+++||.+||.+||++|||+.++|+||||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 1111 011 1357889999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=362.91 Aligned_cols=251 Identities=31% Similarity=0.491 Sum_probs=213.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C---
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--S--- 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~--- 92 (441)
.-.|+-.+.+|.|+||.||.|....+++.||||.+-.++-.+ .+|+.+|+.++|||||++..+|... +
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 346899999999999999999999999999999886554332 2899999999999999999888532 2
Q ss_pred EEEEEEeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCccc
Q 013522 93 KIYFAMDLVKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSA 166 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~-----~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~ 166 (441)
+..+||||++. +|...++ +.+++...++-|..||+.||+|||+.|||||||||.|+|+|.+ |.+||||||.|+
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 45689999976 8999887 4679999999999999999999999999999999999999977 899999999998
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC----------
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---------- 236 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------- 236 (441)
.... +....+...|..|+|||.+.+...++.+.||||+||++.||+-|.+.|.+.+..+....|.+-
T Consensus 175 ~L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 7654 233356678999999999999887789999999999999999999999998877665554331
Q ss_pred -------CCCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 -------DFKCP------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 -------~~~~~------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+..+| ...++++.+|+.++|.++|.+|.++.+++.||||..-.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 11111 23589999999999999999999999999999998644
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=387.40 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=224.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQT-GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
...|.+.+.||+|+||.||.|.+..+ ++.||+|.+.... ......+++|+.+|+.++||||+++++++...+..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 7889999775432 2345677889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 97 AMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
||||++||+|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987742 46899999999999999999999999999999999999999999999999999765433
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARR 250 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ 250 (441)
.......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...+...+..+.. +.|..+++++++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 22233456789999999999987766 5889999999999999999999999888888888777655 356678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
||.+||..||++|||+.+++.|||++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=379.24 Aligned_cols=251 Identities=18% Similarity=0.320 Sum_probs=206.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 44689999999999999999999999999999996532 346789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|+|++. ++|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 999995 588888865 679999999999999999999999999999999999999999999999999987533221 22
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc-------HHHHHHHH---------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-------IVSMYRKI--------------- 233 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i--------------- 233 (441)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 3345689999999999987776 589999999999999999998764321 00111111
Q ss_pred -----------HcCCC----CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 234 -----------YRGDF----KCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 234 -----------~~~~~----~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..... ..|. .++.++.+||.+||++||.+|||+.++|+||||+...
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11100 1111 1456899999999999999999999999999998643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=384.20 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=217.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-C-----CCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H-----KHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~ 88 (441)
..+..||++.+.||+|+||.|.+|.+..|++.||||+++... ....+...|+.||..|+ | -|+|+++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 456669999999999999999999999999999999997654 45678889999999997 4 3999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC--CeEEeecC
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--NLKVTDFG 163 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~--~vkl~DFG 163 (441)
...++.|||+|.+. -+|+++++. ..++...++.+++||+.||.+||+.||||+|||||||||.+.+ .+||+|||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999999995 599999986 4588999999999999999999999999999999999997654 69999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------- 236 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 236 (441)
.|++... ...+.+.+..|+|||+|.+.+|+ .+.||||||||+.||++|.+.|.+.+..+.+..|..-
T Consensus 337 SSc~~~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 337 SSCFESQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccCC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9986442 23488899999999999999997 8899999999999999999999998877766555321
Q ss_pred ---------------------------------------------CCCCCCC-----------CCHHHHHHHHHhcCCCC
Q 013522 237 ---------------------------------------------DFKCPPW-----------FSSEARRLITKLLDPNP 260 (441)
Q Consensus 237 ---------------------------------------------~~~~~~~-----------~~~~~~~li~~~L~~dP 260 (441)
....|+. -...+.+||.+||++||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0001100 12357899999999999
Q ss_pred CCCCCHHHHhcCcccCcc
Q 013522 261 NSRIAISKIMESSWFKKS 278 (441)
Q Consensus 261 ~~R~t~~eil~hpwf~~~ 278 (441)
.+|+|+.++|+||||...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999843
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.01 Aligned_cols=259 Identities=30% Similarity=0.534 Sum_probs=220.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||++++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433344566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 578999999999999999999999999999999999999999999999999986543211 112
Q ss_pred ccccccCCCccchhhhhcc----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCC---CCCHH
Q 013522 177 LHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP---WFSSE 247 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~ 247 (441)
....+||+.|+|||++.+. +..+.++|||||||++|+|++|+.||...+....+.++.... +++|+ .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 233588999999999999999999999988888887776643 33443 36899
Q ss_pred HHHHHHHhcCCCCCC--CCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNS--RIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~--R~t~~eil~hpwf~~~ 278 (441)
+++||.+||..++.+ |++++++++||||+..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 999999999876655 5789999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.14 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=214.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 94 (441)
.|++++.||+|+||+||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999999999999999864321 2234567889999999999999999999998776 89
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999996 478887765 67999999999999999999999999999999999999999999999999998754322 1
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc------------------
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------------------ 235 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 235 (441)
........+|+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 22234456899999999998766556899999999999999999999988776554444321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 236 -----GDF---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 236 -----~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... ......++++.+||.+||+.||.+|||+.++++||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234578999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=374.19 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=213.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+.++|++.+.||.|+||+||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 567899999999999999999999999999999998754321 22345677899999999999999999987543
Q ss_pred -CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 -SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 -~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
...|+++|++ |++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 77999888888899999999999999999999999999999999999999999999999999875332
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------- 237 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 237 (441)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 171 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred -----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 23456799999999999775555689999999999999999999998776554444332210
Q ss_pred ----------CCCC--------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 ----------FKCP--------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 ----------~~~~--------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...| ...++.+.+||.+||.+||.+|||+.++++||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0011 12466789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-47 Score=358.63 Aligned_cols=252 Identities=35% Similarity=0.636 Sum_probs=214.0
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++++.||+|+||+||+|++..+++.||+|++....... .......+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999998775433 2233445699999999999999999999999999999999
Q ss_pred cCCCchHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 101 VKGGELFNKIA-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 101 ~~gg~L~~~i~-~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
+.+++|.+++. .+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999998 588999999999999999999999999999999999999999999999999998643 122334556
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---cHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPP----WFSSEARRLI 252 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~----~~~~~~~~li 252 (441)
..+|+.|+|||++......+.++||||||+++|+|++|..||... +......+........+. ..++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 778999999999873444569999999999999999999999987 333333333332221111 1238999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCccc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=368.26 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=216.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999987542 2234567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||+.|++|.+++.. +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---
Confidence 99999999999999976 6789999999999999999999975 799999999999999999999999999875432
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHH---------------------
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK--------------------- 232 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~--------------------- 232 (441)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......+...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 12234579999999999987665 4889999999999999999999986554332211
Q ss_pred -----------------------HHcCC-CCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 233 -----------------------IYRGD-FKCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 233 -----------------------i~~~~-~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+.... ...+ ..+++++++||.+||+.||++|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 11111 1111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.89 Aligned_cols=256 Identities=29% Similarity=0.536 Sum_probs=220.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.|++.+.||+|++|.||.|.+..+++.+|+|.+....... ......+.+|+.++++++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987553321 1234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|+||++|++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999875 678999999999999999999999999999999999999999999999999987543321111
Q ss_pred -cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q 013522 176 -LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLI 252 (441)
Q Consensus 176 -~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 252 (441)
......|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1134568899999999987665 58999999999999999999999887666555554433 3456677899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCccc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=360.44 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=215.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999976554433344567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999988853 3589999999999999999999999999999999999999999999999999864322 122
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH---HHHHHH-HcCCCCCCCCCCHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---SMYRKI-YRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i-~~~~~~~~~~~~~~~~~li 252 (441)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|..||...... ...... .......+..+++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234579999999999987766 48899999999999999999999864321 111111 2222345667899999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCcccCc
Q 013522 253 TKLLDPNPNSRIA-----ISKIMESSWFKK 277 (441)
Q Consensus 253 ~~~L~~dP~~R~t-----~~eil~hpwf~~ 277 (441)
++||+.||++||| +.++++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=358.40 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=208.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||+|+||+||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.+....|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443323344566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccC
Q 013522 107 FNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183 (441)
Q Consensus 107 ~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 183 (441)
.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 988854 3488999999999999999999999999999999999999999999999999875432 1223345799
Q ss_pred CCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHHHHcCCCCCC-CCCCHHHHHHHHHhcCC
Q 013522 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCP-PWFSSEARRLITKLLDP 258 (441)
Q Consensus 184 ~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~L~~ 258 (441)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.... ...............+ ..+++++++||.+||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 589999999999999999999997643 2334444444444333 35899999999999999
Q ss_pred CCCCCCCH----HHHhcCcccCc
Q 013522 259 NPNSRIAI----SKIMESSWFKK 277 (441)
Q Consensus 259 dP~~R~t~----~eil~hpwf~~ 277 (441)
||++||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=359.55 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=206.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMAS-----K 91 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~ 91 (441)
+|++.+.||+|+||+||+|++..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 699999999999999999999999999999998754322 12234556788777765 79999999998864 3
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
..++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 88888865 34899999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-----------
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----------- 237 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 237 (441)
.. ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+......++....
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 222344578999999999987766 489999999999999999999998876655544443210
Q ss_pred C----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 F----------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~----------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. .+.+.++..+.+||.+||++||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=371.42 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=210.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 466899999999999999999999999999999999875432 223456788999999999999999999998543
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 67666654 48899999999999999999999999999999999999999999999999987432
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------- 236 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 236 (441)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2233456799999999999887764 8899999999999999999999887654433322110
Q ss_pred ---------CC-----C---------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 ---------DF-----K---------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 ---------~~-----~---------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.. . .+...+.++++||.+||..||++|||+.++|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 0 011235678999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=360.33 Aligned_cols=257 Identities=27% Similarity=0.489 Sum_probs=215.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||.|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 46899999999999999999999999999999998754322 2234677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~~ 159 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 159 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CCC
Confidence 999974 88888864 5689999999999999999999999999999999999999999999999999864322 112
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------- 236 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 236 (441)
......+++.|+|||++.+....+.++|||||||++|+|++|++||...+.......+...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2334567999999999877655568999999999999999999999887765444333211
Q ss_pred CCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 DFKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
....| +.+++++++||.+||.+||.+|||+.++++||||+.-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00111 24688899999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=381.03 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=229.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.+-|+|+..||.|+||+||+|.++.++-..|.|+|... ....++++.-||.||..+.||+||+|++.|.-.+.+|++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 34588999999999999999999999999999998644 345678899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
.|||.||-+...+-. ..+.+.+++.+++|++.||+|||+++|+|||||..|||++-+|.++|+|||.+..... .-.
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence 999999998888765 5699999999999999999999999999999999999999999999999999864322 122
Q ss_pred cccccccCCCccchhhhh-----ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC---CCCCCHH
Q 013522 176 LLHTTCGTPAYVAPEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC---PPWFSSE 247 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~ 247 (441)
.-.+..|||+|||||+.. ..+|+ .++||||||++|.+|..+.+|...-+++..+.+|.+.+++. |..++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 345678999999999974 45776 89999999999999999999999999999999998887653 6778999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
+.|++.+||.+||..||+++++|+||||++....
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 9999999999999999999999999999865443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=351.42 Aligned_cols=263 Identities=32% Similarity=0.626 Sum_probs=226.5
Q ss_pred ccCCeEEe-eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 17 LHGKYELG-RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 17 ~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
+.+-|++. +.||+|+|+.|-.+.+..+|..||||++++... ....++.+|++++.++ .|+||++++++|++++..
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 34446664 689999999999999999999999999987732 3467899999999998 699999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~DFGla~~~~~ 170 (441)
|+|||.+.||.|...|.. ..++|.++..+.+.|+.||.|||.+||.||||||+|||..... -+||+||.++.-...
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 999999999999999986 6699999999999999999999999999999999999997654 489999998754322
Q ss_pred c-----ccCCcccccccCCCccchhhhh----ccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------------cH
Q 013522 171 L-----KQDGLLHTTCGTPAYVAPEVIS----KKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------------NI 226 (441)
Q Consensus 171 ~-----~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---------------~~ 226 (441)
. .....+.++||+..|||||+.. ...++..++|.||||||||.||+|++||.+. -.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 1233467889999999999863 2233448899999999999999999999753 23
Q ss_pred HHHHHHHHcCCCCCCC--C--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCcc
Q 013522 227 VSMYRKIYRGDFKCPP--W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282 (441)
Q Consensus 227 ~~~~~~i~~~~~~~~~--~--~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~~ 282 (441)
..++..|..|.+.+|. | +|.++++||+.+|..|+.+|.++.++++|||++...+..
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek 371 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK 371 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence 5788999999999986 3 899999999999999999999999999999998765443
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.76 Aligned_cols=256 Identities=25% Similarity=0.465 Sum_probs=220.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|+..+.||.|+||+||.|.+..+++.+|+|.+.............+.+|+.+|+.++|+||+.+++.+...+..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999976654433344567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999999864332 122
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH----HHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||....... +...+.......++.+++.+.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 345579999999999987666 488999999999999999999998765433 333344445566677899999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCcccCccC
Q 013522 253 TKLLDPNPNSRIA-----ISKIMESSWFKKSA 279 (441)
Q Consensus 253 ~~~L~~dP~~R~t-----~~eil~hpwf~~~~ 279 (441)
.+||+.||++||| +.++++|+||+...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 9999999999999 88999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=383.23 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=202.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH------KHIVELHEVMASK 91 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~ 91 (441)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123456678888877755 4588899988764
Q ss_pred -CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCC-------------
Q 013522 92 -SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDG------------- 155 (441)
Q Consensus 92 -~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~------------- 155 (441)
.++|+|||++ |++|.+++.. +.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 7788888865 789999999999999999999998 5999999999999998765
Q ss_pred ---CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Q 013522 156 ---NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK 232 (441)
Q Consensus 156 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 232 (441)
.+||+|||++.... ......+||+.|+|||++.+..|. .++|||||||++|+|++|++||.+.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 223456899999999999887775 889999999999999999999988765443332
Q ss_pred HHcCCCCCC-----------------------C-------------------CCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 013522 233 IYRGDFKCP-----------------------P-------------------WFSSEARRLITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 233 i~~~~~~~~-----------------------~-------------------~~~~~~~~li~~~L~~dP~~R~t~~eil 270 (441)
+......+| + ..++.+.+||.+||.+||++|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 221100000 0 0135578999999999999999999999
Q ss_pred cCcccCccC
Q 013522 271 ESSWFKKSA 279 (441)
Q Consensus 271 ~hpwf~~~~ 279 (441)
+||||....
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998644
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=346.79 Aligned_cols=252 Identities=27% Similarity=0.518 Sum_probs=219.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFAM 98 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~ 98 (441)
+|++.+.||.|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999754432 2345678899999999999999999998864 45789999
Q ss_pred eccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 99 DLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 99 E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999999864 3589999999999999999999999999999999999999999999999999876532 222
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 254 (441)
......|++.|+|||++.+..+. .++||||+||++|+|++|..||...+.......+..+.. ..+..+++.+.++|.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 34456789999999999877664 889999999999999999999998877777666666654 4566789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 013522 255 LLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf 275 (441)
||++||++|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=366.50 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=206.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
.+-.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 345678999999999999999999852 345789999986432 223456788999999999 899999999988
Q ss_pred EeC-CEEEEEEeccCCCchHHHHhcC------------------------------------------------------
Q 013522 89 ASK-SKIYFAMDLVKGGELFNKIAKG------------------------------------------------------ 113 (441)
Q Consensus 89 ~~~-~~~~lv~E~~~gg~L~~~i~~~------------------------------------------------------ 113 (441)
... ..+|++|||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 654 4689999999999999988641
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCC
Q 013522 114 ---------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184 (441)
Q Consensus 114 ---------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~ 184 (441)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+..+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 36678889999999999999999999999999999999999999999999987543211111122344678
Q ss_pred CccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH-HHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCC
Q 013522 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPN 261 (441)
Q Consensus 185 ~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~ 261 (441)
.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .....+..+. ...|..+++++.+||.+||..||.
T Consensus 241 ~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 241 KWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 8999999987766 489999999999999997 99999876543 3333444432 345667899999999999999999
Q ss_pred CCCCHHHHhc
Q 013522 262 SRIAISKIME 271 (441)
Q Consensus 262 ~R~t~~eil~ 271 (441)
+|||+.++++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=355.25 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=221.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
....+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++.+......|
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 4557999999999999999999999999999999999765432 3467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+||||++|++|.+++..+.+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++...... ..
T Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~ 171 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS 171 (296)
T ss_pred EeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998753321 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLI 252 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li 252 (441)
......|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+.... ...|..+++.+.+||
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (296)
T ss_pred ccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHH
Confidence 2234578999999999987655 589999999999999999999998876644333333222 223556889999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.+||.+||++|||+.++++||||...
T Consensus 251 ~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=353.22 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=209.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||+|+||.||+|++..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22344678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 100 LVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 100 ~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 997 578888754 46899999999999999999999999999999999999999999999999998643321 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------ 237 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 237 (441)
......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 22344678999999998765544688999999999999999999998765433222211100
Q ss_pred C-----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 F-----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~-----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. .....+++++.+||++||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 0122368899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=371.45 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=208.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.++..+|++++.||.|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||+++++++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 456678999999999999999999864 356789999885432 3458999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
..|+|||++. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 588888864 67999999999999999999999999999999999999999999999999998754433
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHHc----C--------
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---VSMYRKIYR----G-------- 236 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~----~-------- 236 (441)
..........||+.|+|||++.+..|. .++|||||||++|+|++|..||.+... ...+..+.+ .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222233456799999999999877774 889999999999999999999966432 111111111 0
Q ss_pred -----------------CCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 -----------------DFKCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 -----------------~~~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+..|+ .++.++.+||.+||..||++|||+.++|.||||.+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 011111 2467889999999999999999999999999997643
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=348.95 Aligned_cols=255 Identities=30% Similarity=0.541 Sum_probs=219.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK------VGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+|.++..||.|+||.||.|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999999899999999987553321 1234678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
.+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 678999999999999999999999999999999999999999999999999987554211
Q ss_pred c----CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 013522 173 Q----DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247 (441)
Q Consensus 173 ~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 247 (441)
. ........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111223468899999999987666 47899999999999999999999887665555555443 34556678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=360.06 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=194.3
Q ss_pred eeeecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 013522 24 GRMLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMD 99 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E 99 (441)
+++||+|+||+||+|++. .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999975 4678999999865432 2457789999999999999999999854 467899999
Q ss_pred ccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe----CCCCCeEEeecCcc
Q 013522 100 LVKGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLS 165 (441)
Q Consensus 100 ~~~gg~L~~~i~~----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl----~~~~~vkl~DFGla 165 (441)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78877742 248899999999999999999999999999999999999 45678999999999
Q ss_pred ccccccc-cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH---------HHHHHHHHc
Q 013522 166 AFSEHLK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---------VSMYRKIYR 235 (441)
Q Consensus 166 ~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~---------~~~~~~i~~ 235 (441)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 112234567899999999998766556899999999999999999999964321 111111111
Q ss_pred C----------------------------CCCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 236 G----------------------------DFKC----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 236 ~----------------------------~~~~----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. .... ....+..+.+||.+||++||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01134678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=356.21 Aligned_cols=259 Identities=33% Similarity=0.575 Sum_probs=226.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998766544345678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC-
Q 013522 99 DLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD- 174 (441)
Q Consensus 99 E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 174 (441)
||+.|++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999875 46899999999999999999999999999999999999999999999999998644321100
Q ss_pred --------------------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH
Q 013522 175 --------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS 228 (441)
Q Consensus 175 --------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~ 228 (441)
.......||..|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999987766 589999999999999999999999888877
Q ss_pred HHHHHHcCCCCCCCC--CCHHHHHHHHHhcCCCCCCCCC----HHHHhcCcccCcc
Q 013522 229 MYRKIYRGDFKCPPW--FSSEARRLITKLLDPNPNSRIA----ISKIMESSWFKKS 278 (441)
Q Consensus 229 ~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t----~~eil~hpwf~~~ 278 (441)
.+..+......++.. +++.++++|.+||..||++||| +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666655554 6899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.87 Aligned_cols=252 Identities=31% Similarity=0.515 Sum_probs=209.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||.|+||+||+|++..+|+.+|+|.+..... .......+.+|+.+++.++||||+++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999975432 22234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 100 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 100 ~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|+.+ +|.+.+.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 78777753 67999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCC-CCCcHHHHHHHHHcCC-------------------
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF-QDDNIVSMYRKIYRGD------------------- 237 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~------------------- 237 (441)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877655568999999999999999988875 4444444443332110
Q ss_pred C----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 F----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. ...+.+++++++||.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=353.29 Aligned_cols=256 Identities=28% Similarity=0.488 Sum_probs=222.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4679999999999999999999999999999999975432 2356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
+||+.|++|..++....+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccC
Confidence 999999999999988889999999999999999999999999999999999999999999999999987533221 122
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~ 254 (441)
....|++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+.... ...|..+++.+.+||++
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 34568999999999977665 488999999999999999999998877655444444332 23455688999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||..||.+|||+.+++.||||+...
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.72 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=222.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765433 3446778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999999865 46889999999999999999999999999999999999999999999999998754322 222
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHh
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 255 (441)
....+|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+......++..+..+ .+..++..+.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3455789999999999877664 8899999999999999999999988887777777776543 3446889999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 013522 256 LDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf 275 (441)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.25 Aligned_cols=255 Identities=27% Similarity=0.490 Sum_probs=220.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654322 4678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 99 DLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 99 E~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||+.|++|.+++.. +.+++..++.++.||+.||+|||+.|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999975 35899999999999999999999999999999999999999999999999998765443222
Q ss_pred --CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CC-----CCCCH
Q 013522 175 --GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CP-----PWFSS 246 (441)
Q Consensus 175 --~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~~~ 246 (441)
.......|++.|+|||++......+.++|+|||||++|+|++|..||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12344568999999999877644568999999999999999999999887776666665554332 11 24678
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.27 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=214.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......++.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986542 2334567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999976 779999999999999999999997 5999999999999999999999999999864322 22
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--------------------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------- 236 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------- 236 (441)
....+|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999876655 58899999999999999999999765544333222111
Q ss_pred ----------------C-CCCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 ----------------D-FKCPP-WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 ----------------~-~~~~~-~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
. +..|. .++.++++||.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0 11111 267889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=366.59 Aligned_cols=245 Identities=26% Similarity=0.458 Sum_probs=213.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+-...+++++.||+|-||+||.|.+. ....||+|.+...... .+.+.+|+++|++|+|+|||++++++..+..+|
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 33444667789999999999999993 2348999998654332 357779999999999999999999999988999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|||||++.|+|.++++. +.+.......++.||++|++||+++++|||||-..||||+++..+||+|||||+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~--- 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG--- 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC---
Confidence 99999999999999986 568999999999999999999999999999999999999999999999999998322
Q ss_pred cCCccccccc---CCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 013522 173 QDGLLHTTCG---TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247 (441)
Q Consensus 173 ~~~~~~~~~g---t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 247 (441)
+.......| ..-|.|||.+....+. .+||||||||+||||+| |+.||.+.+..+..+.+.+| +.+.|+.+|+.
T Consensus 355 -d~~Y~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 355 -DDEYTASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred -CCceeecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence 222222222 2349999999988774 99999999999999999 99999999999999999988 57889999999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHh
Q 013522 248 ARRLITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil 270 (441)
+.+++..||..+|++|||++.+.
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999998664
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=351.63 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=221.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||.|+||+||+|.+..++..+|+|++... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998644 234456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 999999999999875 56999999999999999999999999999999999999999999999999988653321 11
Q ss_pred cccccccCCCccchhhhhcc----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~ 248 (441)
......|++.|+|||.+... ...+.++|+|||||++|+|++|.+||...+......++..+.. ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345689999999998532 1224689999999999999999999998887777777766543 3456789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.++|.+||+.||.+|||+.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=354.71 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=221.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++......|
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence 355889999999999999999999999999999999975433 23466889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+||||++|++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... ..
T Consensus 93 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~ 170 (297)
T cd06656 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS 170 (297)
T ss_pred EeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998653321 11
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-C--CCCCCCCCHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-D--FKCPPWFSSEARRLI 252 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~~~~li 252 (441)
......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... . ...|..+++.+++||
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFL 249 (297)
T ss_pred CcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHH
Confidence 2234578999999999987665 48899999999999999999999876654332222222 1 223456788999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
.+||..||++|||+.++++||||+.....
T Consensus 250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 250 NRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred HHHccCChhhCcCHHHHhcCchhcccccc
Confidence 99999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=348.42 Aligned_cols=252 Identities=32% Similarity=0.616 Sum_probs=223.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665444567889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 100 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 100 ~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
|+.|++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 9999999999976 4899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLITKL 255 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 255 (441)
...|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+ ...............|+.++.++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5668999999999987665 588999999999999999999998776 334443333356677888899999999999
Q ss_pred cCCCCCCCCCH--HHHhcCccc
Q 013522 256 LDPNPNSRIAI--SKIMESSWF 275 (441)
Q Consensus 256 L~~dP~~R~t~--~eil~hpwf 275 (441)
|..||.+||++ .++++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=391.12 Aligned_cols=264 Identities=29% Similarity=0.481 Sum_probs=218.7
Q ss_pred CCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
...+....++|++++.||+|+||+||+|++..++..||+|++...... ......+.+|+.+|+.|+||||++++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 344566778999999999999999999999999999999999765432 2445778899999999999999999998854
Q ss_pred --CCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc-------CcEeccCCCCcEEeCCC--
Q 013522 91 --KSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-------GVYHRDLKPENLLLDED-- 154 (441)
Q Consensus 91 --~~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~-------gi~HrDLkp~NILl~~~-- 154 (441)
...+|+||||+.+++|.++|.. +.+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4679999999999999999864 5799999999999999999999984 49999999999999642
Q ss_pred ---------------CCeEEeecCccccccccccCCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhhCC
Q 013522 155 ---------------GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGF 218 (441)
Q Consensus 155 ---------------~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~G~ 218 (441)
+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 3489999999875432 2233456799999999998643 23458899999999999999999
Q ss_pred CCCCCCcHH-HHHHHHHcCCCCCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 219 LPFQDDNIV-SMYRKIYRGDFKCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 219 ~Pf~~~~~~-~~~~~i~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.||...+.. .+...+..+ +..| ...++++.+||..||..+|.+|||+.++|.|||+....
T Consensus 241 ~PF~~~~~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999765543 333334333 3333 45789999999999999999999999999999997543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.02 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=212.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998654321 123456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||++++.|..++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999888887765 579999999999999999999999999999999999999999999999999987543321 122
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------------CC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------DF 238 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~~ 238 (441)
....++..|+|||.+.+....+.++||||+||++|+|++|..||.+.+..+....+... ..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34457899999999876555568999999999999999999999876654333322110 00
Q ss_pred CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 KCP------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 ~~~------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
..| +.++..+.+||.+||++||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=348.19 Aligned_cols=257 Identities=27% Similarity=0.486 Sum_probs=224.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 99 DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 99 E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
||+++++|.+++..+++++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999987654321 2233
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCC-CCHHHHHHHHHhc
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPW-FSSEARRLITKLL 256 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~~~~~~~li~~~L 256 (441)
...|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+..... ..+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4568999999999987765 5899999999999999999999988776666655555433 33444 7899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCccCC
Q 013522 257 DPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
..||++|||++++++||||.+...
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCCc
Confidence 999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=395.02 Aligned_cols=263 Identities=35% Similarity=0.563 Sum_probs=236.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+-.++|+|++.||+|+||.|.+++++.+++.||+|++++-...+......+..|-.||..-+.+-|+.++..|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 34578999999999999999999999999999999999876666666788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||++||+|..++.+ +++|++.++.|+..|+.||+-+|+.|+|||||||+|||+|..|.+||+|||.+-..... ..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GT 230 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC-Cc
Confidence 99999999999999987 67999999999999999999999999999999999999999999999999987544321 12
Q ss_pred CcccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCC--CCCCH
Q 013522 175 GLLHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCP--PWFSS 246 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~~~ 246 (441)
-...+.+|||.|++||++.. .+.+|..+|.||+||++|||+.|..||..++..+.|.+|... .+.+| ..+|+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 23456789999999999953 256689999999999999999999999999999999999876 56777 45899
Q ss_pred HHHHHHHHhcCCCCCCCCC---HHHHhcCcccCccCC
Q 013522 247 EARRLITKLLDPNPNSRIA---ISKIMESSWFKKSAP 280 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~~~ 280 (441)
++++||++++.. |+.|.. ++++..||||.+..+
T Consensus 311 eakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 311 EAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCCh
Confidence 999999999875 899998 999999999986543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=349.50 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=215.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 100 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 100 ~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|+ |++|.+++.. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999864 5689999999999999999999999999999999999999999999999999875443211 223
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-------------------C
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------F 238 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 238 (441)
....|++.|+|||.+.+....+.++||||+||++|+|++|.+||...+....+..+...- .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 455789999999998766555689999999999999999999998776555444432210 0
Q ss_pred C-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 239 K-----------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 239 ~-----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
. ..+..+..+.+||.+||.+||.+|||+.++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.53 Aligned_cols=260 Identities=32% Similarity=0.627 Sum_probs=223.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999987664433344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc-----
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK----- 172 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~----- 172 (441)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999976 778999999999999999999999999999999999999999999999999886311000
Q ss_pred --------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC--
Q 013522 173 --------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-- 242 (441)
Q Consensus 173 --------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~-- 242 (441)
.........|++.|+|||.+....+ +.++|+|||||++|+|++|..||.+.+...+...+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123467889999999877665 58999999999999999999999988888888877766544332
Q ss_pred -CCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccCccC
Q 013522 243 -WFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKSA 279 (441)
Q Consensus 243 -~~~~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~~ 279 (441)
.+++++.++|.+||+.||++||| +.++++||||....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 47899999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=345.12 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=216.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc---chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI---KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+|++++.||+|+||+||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 58899999998754321 22345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc---
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK--- 172 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~--- 172 (441)
++||++|++|.+++.+ +.+++..+..++.|++.||+|||+.||+|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 678999999999999999999999999999999999999999999999999987542211
Q ss_pred -cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHH
Q 013522 173 -QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEA 248 (441)
Q Consensus 173 -~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 248 (441)
.........|++.|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122334568999999999987666 48899999999999999999999876655444444333 234566789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.++|++||..+|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=341.62 Aligned_cols=252 Identities=31% Similarity=0.589 Sum_probs=221.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||+|+||+||.+.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998754432 2345678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 9999999999864 357899999999999999999999999999999999999999999999999987543221 11
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHh
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 255 (441)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+....+..+..+ .|..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223458899999999877655 48899999999999999999999988888888777766543 5667899999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 013522 256 LDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf 275 (441)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.15 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=211.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe------
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS------ 90 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~------ 90 (441)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 477999999999999999999999999999999987543 2245788999999998 79999999999865
Q ss_pred CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
...+|++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 3468999999999999999875 3589999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCcccccccCCCccchhhhhc-----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC--C
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--C 240 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~ 240 (441)
.... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...........+...... .
T Consensus 161 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 161 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred cccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 4321 123345679999999999863 234 47899999999999999999999876655444444333221 2
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 33578899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=369.42 Aligned_cols=250 Identities=19% Similarity=0.314 Sum_probs=205.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|++++||||+++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35589999999999999999999999999999996421 235689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|||++. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 588888864 46999999999999999999999999999999999999999999999999999765432222
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC--------CcHHHHHHHHHcCCC--------
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--------DNIVSMYRKIYRGDF-------- 238 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~-------- 238 (441)
......+||+.|+|||++.+..++ .++|||||||+||+|++|..|+-. .....+.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 223356799999999999887764 889999999999999998765422 112222322222111
Q ss_pred ---------------------CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 239 ---------------------KCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 239 ---------------------~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
..+. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 13568999999999999999999999999999974
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.03 Aligned_cols=248 Identities=38% Similarity=0.687 Sum_probs=219.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||.|+||.||+|++..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+.++...|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876654445567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCC
Q 013522 107 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185 (441)
Q Consensus 107 ~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 185 (441)
.+++.+ ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 568999999999999999999999999999999999999999999999999987543221 2234578999
Q ss_pred ccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHH--cCCCCCCCCCCHHHHHHHHHhcCCCCC
Q 013522 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIY--RGDFKCPPWFSSEARRLITKLLDPNPN 261 (441)
Q Consensus 186 y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~ 261 (441)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... ....+..+. ......|...+++++++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877666 488999999999999999999998776 666777776 445667777899999999999999999
Q ss_pred CCCC-----HHHHhcCcccCcc
Q 013522 262 SRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 262 ~R~t-----~~eil~hpwf~~~ 278 (441)
+||| +.++++||||+..
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hCcCCcccCHHHHhcChhhhCC
Confidence 9999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=344.35 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=215.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc-------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-------VGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+|.+.+.||.|+||+||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6899999999999999999999999999999986432211 113457889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+++||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999976 78999999999999999999999999999999999999999999999999998754332
Q ss_pred ccCCcccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCC----CC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPP----WF 244 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~ 244 (441)
..........|+..|+|||.+.... ..+.++|+||||+++|++++|..||...+.......+... ....+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234456899999999987654 2358899999999999999999999776555444433322 222332 35
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+..+.++|.+||.+||.+|||+.++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=348.46 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=219.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...+.|++++.||+|+||.||+|++..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 34577999999999999999999999999999999986542 234677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||++|++|...+.+ +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..... .
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~ 163 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--T 163 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--c
Confidence 99999999999888753 5689999999999999999999999999999999999999999999999998764322 1
Q ss_pred CCcccccccCCCccchhhhhcc----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSS 246 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~ 246 (441)
........+++.|+|||.+... ...+.++|+|||||++|+|++|.+||...+....+.++..... ..+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 1122345689999999998532 1124789999999999999999999988776666666655432 23456788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++.++|.+||..||++||++.++++||||....
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999999999999999999999997543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=346.95 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=217.2
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++.+.||.|+||+||+|.+..++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 788999999999999999999999999999986542 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 101 VKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 101 ~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
+.+++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... .....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 999999888754 66899999999999999999999999999999999999999999999999998643221 12233
Q ss_pred ccccCCCccchhhhhcc----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHH
Q 013522 179 TTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRL 251 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~l 251 (441)
...|++.|+|||++... ...+.++|||||||++|+|++|.+||...+.......+..... ..|..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 45689999999998421 2224789999999999999999999988777666666654432 3455688999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|.+||..||.+|||+.++++||||....
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.23 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=206.4
Q ss_pred Eeeeeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 23 LGRMLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 23 i~~~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
++.+||+| +|++||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7899999999999999999999765432 34456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc----
Q 013522 101 VKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ---- 173 (441)
Q Consensus 101 ~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~---- 173 (441)
+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999864 4589999999999999999999999999999999999999999999999986532211110
Q ss_pred -CCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC------------
Q 013522 174 -DGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK------------ 239 (441)
Q Consensus 174 -~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------ 239 (441)
........++..|+|||++.+. ...+.++|||||||++|+|++|+.||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 0111234577889999999753 22358899999999999999999999875544333222222111
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 240 ----------------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 240 ----------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
....+++.+.+||.+||++||++|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 011246789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.42 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=212.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999865432 2345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cccc
Confidence 999999999999875 7899999999999999999999999999999999999999999999999999864432 1122
Q ss_pred ccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC-----CCCCHHHH
Q 013522 177 LHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-----PWFSSEAR 249 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~ 249 (441)
.....|++.|+|||++.. ....+.++|+|||||++|+|++|..||...................+ ..++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 234578999999999842 22235789999999999999999999976554433333333332222 23678899
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
++|.+||..||++|||++++++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=345.86 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=211.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987543 2234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 99 DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 99 E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999988654 4578999999999999999999999999999999999999999999999999864332 2334
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-------HHHHHHHHcCCCC-C-CCCCCHHHH
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-------VSMYRKIYRGDFK-C-PPWFSSEAR 249 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~-~-~~~~~~~~~ 249 (441)
..+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||..... ......+...... . ....++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5679999999999987766 5899999999999999999999965321 1222333322222 2 234788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++|.+||+.||++||++.++++||||...
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=345.23 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=211.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34679999999999999999999999999999999965432 234568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+.+++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 9999999999998864 67899999999999999999999999999999999999999999999999998754321 11
Q ss_pred cccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-----CCCCCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-----PPWFSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~ 248 (441)
......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...+.......+....+.. +..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 2234568999999999853 2223478999999999999999999997655443333332322222 22367899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
.+||++||..||++|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=349.67 Aligned_cols=260 Identities=31% Similarity=0.467 Sum_probs=217.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
+|++.+.||.|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999999765433 123345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+ +++|.+++... .+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 88999999763 5999999999999999999999999999999999999999999999999998754332 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-----------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------------- 238 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 238 (441)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 233345788999999986655556899999999999999999999987776555544432100
Q ss_pred ------C-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCcc
Q 013522 239 ------K-----CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282 (441)
Q Consensus 239 ------~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~~ 282 (441)
. .....+..+.++|.+||.+||++|||+.++++||||.+...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 0 0122467899999999999999999999999999999866443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=363.70 Aligned_cols=251 Identities=33% Similarity=0.680 Sum_probs=222.7
Q ss_pred CeEE--eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 20 KYEL--GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 20 ~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
-|+| .+.||.|.||+||-|+++.+|+.||||++++.++.. ...+++++|++||+.+.||.||.+--.|++++.+|+|
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV 641 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV 641 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence 3666 379999999999999999999999999999988754 3458999999999999999999999999999999999
Q ss_pred EeccCCCchHHHH-h--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEeecCcccccccc
Q 013522 98 MDLVKGGELFNKI-A--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSEHL 171 (441)
Q Consensus 98 ~E~~~gg~L~~~i-~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~DFGla~~~~~~ 171 (441)
||.+.|. ..+.| . .|++++...+.++.||+.||.|||-+||+|+||||||||+.+.. .+||||||+|++..+
T Consensus 642 MEKl~GD-MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE- 719 (888)
T KOG4236|consen 642 MEKLHGD-MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE- 719 (888)
T ss_pred ehhhcch-HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch-
Confidence 9999874 55555 3 38999999999999999999999999999999999999997654 699999999997654
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC--C--CCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP--W--FSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~~~~ 247 (441)
.+.-.+.+|||.|+|||++.+++|+ ..-|+||.|||+|.-++|..||..+. ++.++|....+-+|+ | ++++
T Consensus 720 --ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 720 --KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred --hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHH
Confidence 4556788999999999999999997 77999999999999999999997653 456677777766654 4 8999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+||..+|+..-.+|+|+++.|.|||+++-
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.42 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=214.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999899999999986544322 34567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||+.++.|..+... +.+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999988887765 56899999999999999999999999999999999999999999999999998754322 1223
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-------------------C
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------F 238 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 238 (441)
....+++.|+|||++.+....+.++|||||||++|+|++|++||......+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345688999999999765555688999999999999999999998766544333332100 0
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 ------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 ------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
..++.++..+.+|+.+||.+||++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=346.32 Aligned_cols=248 Identities=31% Similarity=0.499 Sum_probs=204.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK---MVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
.||+|+||.||++.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++.+...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997665432222233344544444 4479999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccc
Q 013522 103 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181 (441)
Q Consensus 103 gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 181 (441)
|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999998875 67999999999999999999999999999999999999999999999999998643321 223457
Q ss_pred cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCC
Q 013522 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 182 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 258 (441)
||+.|+|||.+.+....+.++||||+||++|+|++|..||.... ...............|+.++++++++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998644434588999999999999999999997542 222223333345566778999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccCc
Q 013522 259 NPNSRI-----AISKIMESSWFKK 277 (441)
Q Consensus 259 dP~~R~-----t~~eil~hpwf~~ 277 (441)
||.+|| |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=348.25 Aligned_cols=255 Identities=27% Similarity=0.494 Sum_probs=217.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986432 2234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 99 DLVKGGELFNKIAKG----RLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 99 E~~~gg~L~~~i~~~----~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999888764 79999999999999999999996 599999999999999999999999999986432
Q ss_pred CCcccccccCCCccchhhhhccCC-----CCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHH---HHcCC-CCCCCCC
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGY-----DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK---IYRGD-FKCPPWF 244 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~-~~~~~~~ 244 (441)
.....+..|++.|+|||.+.+... .+.++|+|||||++|+|++|..||...+....... +..+. ...|+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223345668999999999854432 25789999999999999999999977655443333 33332 3456678
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++++.++|.+||..+|++||++.++++||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=356.67 Aligned_cols=262 Identities=29% Similarity=0.490 Sum_probs=233.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..+.|+.-+.||+|+||.||-++-..||+.+|+|.+.+.++.+........+|-.||.+++.|.||.+-..|++++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34556788999999999999999999999999999999988776555556678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
++||..|.||+|.-.|-+ | .+++..++.|+.+|+.||.+||+.+|+.|||||+|||+|+.|+++|+|+|||.-..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~-- 338 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP-- 338 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC--
Confidence 999999999999888865 3 69999999999999999999999999999999999999999999999999998543
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHHHHcCCCCCCCCCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 247 (441)
........+||..|||||++.+..|+ ..+|.|||||+||+|+.|..||.... ..++-+.+......+|..+|++
T Consensus 339 -~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 339 -EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred -CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 34445666999999999999988875 88999999999999999999997642 3456667777778889999999
Q ss_pred HHHHHHHhcCCCCCCCCC-----HHHHhcCcccCccCC
Q 013522 248 ARRLITKLLDPNPNSRIA-----ISKIMESSWFKKSAP 280 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t-----~~eil~hpwf~~~~~ 280 (441)
+++|.+.+|+.||++|.. ++++.+||||+....
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 999999999999999985 679999999987543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=337.77 Aligned_cols=252 Identities=28% Similarity=0.509 Sum_probs=222.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++||||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 445678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|++|++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999975 358999999999999999999999999999999999999999999999999987543322 13
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-CCCCCHHHHHHHHHh
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEARRLITKL 255 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~ 255 (441)
.....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+..+....+..+.+.. ++.++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999877665 478999999999999999999999988888887877765443 456789999999999
Q ss_pred cCCCCCCCCCHHHHhcCccc
Q 013522 256 LDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf 275 (441)
|..||.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.74 Aligned_cols=256 Identities=27% Similarity=0.484 Sum_probs=215.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc---hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
.|+.++.||+|+||.||.|.+..+++.+|+|++....... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4889999999999999999999999999999997543211 2245788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCcccccccccc-
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQ- 173 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~~- 173 (441)
|+||+.|++|.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999976 6789999999999999999999999999999999999998876 599999999875443211
Q ss_pred -CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHH---H--cCCCCCCCCCCHH
Q 013522 174 -DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---Y--RGDFKCPPWFSSE 247 (441)
Q Consensus 174 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~--~~~~~~~~~~~~~ 247 (441)
........|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+ . ......|+.++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223468899999999977666 48899999999999999999999765433222222 1 2234556678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+.+++.+||..||.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=346.54 Aligned_cols=239 Identities=15% Similarity=0.218 Sum_probs=208.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDL 100 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~ 100 (441)
..||+|++|.||+|.+ +|+.||+|.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 799999999976654443446788899999999999999999999876 4578999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 101 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 101 ~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
++||+|.+++.. +.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 999999999976 6689999999999999999999984 999999999999999999999999999875432 123
Q ss_pred ccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Q 013522 179 TTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITK 254 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 254 (441)
...||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+...++..+... .++.|..+++.+.+||.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999976 344 58999999999999999999999998888888877554 345565789999999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 013522 255 LLDPNPNSRIAISKIME 271 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~ 271 (441)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999985
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=352.24 Aligned_cols=263 Identities=33% Similarity=0.604 Sum_probs=240.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
.+-..+|..+..||+|+||+|-+|..+.+.+.+|||++.++.+......+--..|-++|... +-|.+++++..|.+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45567899999999999999999999999999999999998887666666666788888876 57899999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+|+||||+.||+|.-.|+. |++.|..+..|+..|+-||=+||++||+.||||..||++|.+|.+||+|||++. +..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK--Eni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccc--cccc
Confidence 9999999999999999987 999999999999999999999999999999999999999999999999999986 2333
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
......+.||||.|+|||++...+| +.++|.||+||+||||++|.+||++.+..++++.|......+|..+|.++.+++
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 4556788999999999999999888 588999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCH-----HHHhcCcccCccCC
Q 013522 253 TKLLDPNPNSRIAI-----SKIMESSWFKKSAP 280 (441)
Q Consensus 253 ~~~L~~dP~~R~t~-----~eil~hpwf~~~~~ 280 (441)
+..|.+.|.+|..+ .+|..||||+...+
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 99999999999864 58999999986543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=340.86 Aligned_cols=256 Identities=28% Similarity=0.505 Sum_probs=214.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKI 94 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 94 (441)
..|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3689999999999999999999999999999998754321 12345678899999999999999999998865 4678
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc-
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK- 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~- 172 (441)
++++||+++++|.+++.. +.+++.....++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 678999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 250 (441)
.........++..|+|||.+.+..+ +.++||||+||++|+|++|+.||...........+... ....|..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1122234568999999999987665 48899999999999999999999877655444443322 34456678899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+| +||..+|++|||+.++++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=345.97 Aligned_cols=256 Identities=33% Similarity=0.660 Sum_probs=228.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 97 (441)
++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544455678889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC--
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-- 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-- 174 (441)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999976 58999999999999999999999999999999999999999999999999998755432211
Q ss_pred ----------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC
Q 013522 175 ----------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238 (441)
Q Consensus 175 ----------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 238 (441)
.......|++.|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12233457899999999876654 5889999999999999999999998887777777777788
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCccc
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAI----SKIMESSWF 275 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~----~eil~hpwf 275 (441)
..|..+++.+.++|.+||+.||.+|||+ .++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=344.12 Aligned_cols=257 Identities=26% Similarity=0.529 Sum_probs=220.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 96 (441)
.|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 48889999999999999999999999999999865432 234567889999999996 9999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 97 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||++|++|.+++..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCC-CCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPP-WFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~~~~~~~li~~ 254 (441)
.....|++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+..... .++. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 33456899999999987655556899999999999999999999988776655544433322 2222 278899999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
||..||++|||+.++++||||++...
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=349.36 Aligned_cols=259 Identities=30% Similarity=0.459 Sum_probs=214.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKI 94 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 94 (441)
..++|++.+.||.|+||.||+|.+..+|+.||+|.+....... .....+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 4578999999999999999999999999999999987543221 2233566899999999999999999998754 578
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78888764 568999999999999999999999999999999999999999999999999987544321
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC----------------
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---------------- 236 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 236 (441)
.......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+....+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 22233346888999999876555568999999999999999999999988877666555431
Q ss_pred ---CCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 ---DFKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ---~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+..+ .++++.+.+||.+||.+||++|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 01111 23578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.04 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=214.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKI 94 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 94 (441)
..|++.+.||+|+||+||.|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999998643221 12345688899999999999999999998866 3578
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|++|||++|++|.+++.+ +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999876 6789999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHH
Q 013522 174 -DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARR 250 (441)
Q Consensus 174 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 250 (441)
........|+..|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|+.++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112334568999999999987665 58899999999999999999999876655444444432 23346667889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+|++|+. +|++|||++++++|||++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.05 Aligned_cols=246 Identities=22% Similarity=0.375 Sum_probs=199.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..+|++.+.||+|+||+||+|++..+++.||+|+.... ....|+.+++.++||||+++++++......|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999985433 234699999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 478888764 5689999999999999999999999999999999999999999999999999874321 22
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCC-CCCCCCcH----------HHHHHHHHc---CCCCCC
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNI----------VSMYRKIYR---GDFKCP 241 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~-~Pf~~~~~----------~~~~~~i~~---~~~~~~ 241 (441)
......||+.|+|||++.+..+ +.++|||||||++|+|+++. .+|..... ..+...+.. ....+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2345679999999999988776 48999999999999999854 44443211 011111110 000011
Q ss_pred ------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 242 ------------------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 242 ------------------------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667888999999999999999999999999974
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=344.70 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=212.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443333455667899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccC
Q 013522 107 FNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183 (441)
Q Consensus 107 ~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 183 (441)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 999865 3 689999999999999999999999999999999999999999999999999875432 2223345688
Q ss_pred CCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH----HHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCC
Q 013522 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259 (441)
Q Consensus 184 ~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 259 (441)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ..+...+.......|+.+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877665 5889999999999999999999977543 333334444455667778999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccCcc
Q 013522 260 PNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 260 P~~R~-----t~~eil~hpwf~~~ 278 (441)
|.+|| ++.++++||||...
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88899999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=347.98 Aligned_cols=251 Identities=19% Similarity=0.258 Sum_probs=204.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQ----------------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 80 (441)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45789999999999999999998632 34579999986543 2234567889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCcE
Q 013522 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKG--------------------RLREDVARVYFQQLISAVDFCHSRGVY 140 (441)
Q Consensus 81 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--------------------~l~~~~~~~~~~qll~aL~ylH~~gi~ 140 (441)
|+++++++.+.+..|+||||+.+|+|.+++... .++...+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988642 256678899999999999999999999
Q ss_pred eccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh--CC
Q 013522 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GF 218 (441)
Q Consensus 141 HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~--G~ 218 (441)
||||||+|||++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999875432211112233456788999999877666 589999999999999986 67
Q ss_pred CCCCCCcHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 013522 219 LPFQDDNIVSMYRKIYR--------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 270 (441)
.||...+.......+.. .....|+.+++.+.+||.+||..||++|||+.+|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 88887665554443321 11234566889999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=343.64 Aligned_cols=250 Identities=31% Similarity=0.505 Sum_probs=209.0
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKRE---ISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
.||+|+||+||+|.+..+++.||+|.+.+..............| +.+++...||||+++++++.+.+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987544322212223333 344555689999999999999999999999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccc
Q 013522 103 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181 (441)
Q Consensus 103 gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 181 (441)
|++|..++.. +.+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999998865 6799999999999999999999999999999999999999999999999999864332 1223557
Q ss_pred cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---cHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCC
Q 013522 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 182 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 258 (441)
|++.|+|||.+.+....+.++||||+||++|+|++|..||.+. ........+.......|..+++.+.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999975433458899999999999999999999876 4444444555556667777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccCccC
Q 013522 259 NPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 259 dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
||.+|| ++.++++||||+...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=337.32 Aligned_cols=251 Identities=31% Similarity=0.490 Sum_probs=216.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999975532 2457889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 999999999998865 57999999999999999999999999999999999999999999999999998754321 11
Q ss_pred cccccccCCCccchhhhhcc---CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-----CCCCCCHH
Q 013522 176 LLHTTCGTPAYVAPEVISKK---GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-----CPPWFSSE 247 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~ 247 (441)
......+++.|+|||.+... .++ .++|+|||||++|+|++|.+||...+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22345689999999998765 554 7899999999999999999999887665555444444222 12335788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
+.++|++||..||..|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.48 Aligned_cols=253 Identities=30% Similarity=0.527 Sum_probs=218.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
+|+..+.||+|+||+||+|.+..+++.|++|.+...... .....+.+.+|+.+++.++||||+++++++.+....|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688899999999999999999889999999998754321 123456789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
+||++|++|.+++.+ +.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---cc
Confidence 999999999999976 55899999999999999999999999999999999999999999999999998754322 12
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--CCCCCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~ 254 (441)
.....|++.|+|||.+......+.++|+|||||++|+|++|..||...........+.. .....|+.+++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34566899999999987655245889999999999999999999987765554444443 2334566789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 013522 255 LLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf 275 (441)
||..+|.+|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=360.56 Aligned_cols=254 Identities=23% Similarity=0.366 Sum_probs=208.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
..-.++|++++.||+|+||.||+|++..+| ..||+|++..... ......+.+|+.+++.+ +||||+++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 344568999999999999999999865443 5799999975432 23456788999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc--------------------------------------------------------
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK-------------------------------------------------------- 112 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~-------------------------------------------------------- 112 (441)
......|+||||+++|+|.+++..
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 999999999999999999998853
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 113 ---------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 113 ---------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13678889999999999999999999999999999999999999999999998754322111111
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 254 (441)
.+..+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||........+...... ....|...++++.++|.+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 350 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM 350 (374)
T ss_pred cCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence 22335667999999977666 589999999999999997 99999876554333333333 344567789999999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 013522 255 LLDPNPNSRIAISKIME 271 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~ 271 (441)
||+.||.+|||+.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.24 Aligned_cols=248 Identities=31% Similarity=0.575 Sum_probs=217.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||.|+||.||++.+..+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++.+.+.+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 2345778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||++++++.++++|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999998864 45899999999999999999999999999999999999999999999999998754332 122
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHHHh
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITKL 255 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~ 255 (441)
.....|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+... .|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568999999999977665 48899999999999999999999998887777777666543 5667889999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 013522 256 LDPNPNSRIAISKIMES 272 (441)
Q Consensus 256 L~~dP~~R~t~~eil~h 272 (441)
|+.||++|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.25 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=214.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC---
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK--- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--- 91 (441)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35688999999999999999999999999999999986542 2235678899999998 899999999998653
Q ss_pred --CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
...|+||||+.|++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 468999999999999998752 5689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccC----CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC--
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG----YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-- 238 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 238 (441)
+........ ......|++.|+|||.+.... ..+.++|||||||++|+|++|++||...+.......+.+...
T Consensus 175 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 175 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred chhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 875432111 123456899999999986432 135789999999999999999999988776655555554422
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 239 -KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 239 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
..+..++..+.+||.+||+.||++|||+.++++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=339.51 Aligned_cols=250 Identities=36% Similarity=0.672 Sum_probs=220.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++||||+++++.+......|+++||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999766544445567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc------CCcccc
Q 013522 107 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ------DGLLHT 179 (441)
Q Consensus 107 ~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~------~~~~~~ 179 (441)
.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 7799999999999999999999999999999999999999999999999999875332211 112234
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHhcC
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF--SSEARRLITKLLD 257 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~li~~~L~ 257 (441)
..+++.|+|||.+....+ +.++||||||+++|+|++|..||........+..+..+....|... ++.+.++|.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568899999999877664 5889999999999999999999999888888888887777776665 8999999999999
Q ss_pred CCCCCCCCH---HHHhcCcccCc
Q 013522 258 PNPNSRIAI---SKIMESSWFKK 277 (441)
Q Consensus 258 ~dP~~R~t~---~eil~hpwf~~ 277 (441)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=343.12 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=221.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
...|+..+.||.|+||.||.|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568889999999999999999999999999999875432 23457889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|||+.|++|.+++..+++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999986543211 122
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhc
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLL 256 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L 256 (441)
....++..|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+..+. ...+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33468889999999977665 488999999999999999999998877666555554432 2334457889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCccC
Q 013522 257 DPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+|++||++.++++||||....
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcc
Confidence 99999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.07 Aligned_cols=258 Identities=24% Similarity=0.401 Sum_probs=227.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|.-++.||+|+||.||.|++..+.+.||||.+..+.-.......++..|+..|++++|||++.+.++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 37778999999999999999999999999999987766666667889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 100 LVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 100 ~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||-| +-.|.+. +.++-+.++..+..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.+... .
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------A 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------A 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------h
Confidence 9966 6777765 46799999999999999999999999999999999999999999999999999886443 4
Q ss_pred cccccCCCccchhhhh--ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC--CCCCHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--PWFSSEARRLIT 253 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~--~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~ 253 (441)
.+.+|||+|||||++. ..+.++-++||||||++..+|...++|+-..|.+..+..|...+.+.. +.+|..++.|+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 5678999999999985 233334789999999999999999999999999988888877765442 347899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCccCCcccc
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKSAPKVVI 284 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~~~~~~~ 284 (441)
.||++-|..|||.+++|+|+|.....++.++
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 9999999999999999999999877665543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=343.84 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=214.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 2234578899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||+.++.+..+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99998777666654 5699999999999999999999999999999999999999999999999999876543221 133
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---------------------
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--------------------- 236 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 236 (441)
....+++.|+|||++.+....+.++||||+|+++|+|++|.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678999999999987744568999999999999999999999876654433332210
Q ss_pred CC-----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 237 DF-----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 237 ~~-----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.. ..+..+++++++||++||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.71 Aligned_cols=252 Identities=29% Similarity=0.483 Sum_probs=212.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS---- 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---- 92 (441)
.++|++.+.||+|+||+||+|.+..+++.+++|++..... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4899999999999999999999998999999999875532 346788999999999 7999999999996544
Q ss_pred --EEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 93 --KIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 93 --~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
.+|+||||+.+++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999988753 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhcc----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--- 238 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--- 238 (441)
...... ........|++.|+|||++... ...+.++|||||||++|+|++|..||...+.......+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 654321 1223445689999999998542 2234789999999999999999999987666555555555432
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
..+..+++++++||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.79 Aligned_cols=251 Identities=31% Similarity=0.517 Sum_probs=219.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999765433 2346788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCccccccccccCC
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~~~~ 175 (441)
|++|++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 9999999999975 2489999999999999999999999999999999999998655 5799999998754321 2
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 254 (441)
......|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+.......+..+.. +.+..+++++.++|.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234568999999999977655 4889999999999999999999998887777777665543 4566789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 013522 255 LLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf 275 (441)
||.+||++|||+.+++.||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.92 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=208.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 92 (441)
....++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 44567899999999999999999999999999999998654322 123345678999999999999999999986543
Q ss_pred ------EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 93 ------KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 93 ------~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
..|+||||+.+ +|.+.+.. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999965 78887765 3689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccC--CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--CC---
Q 013522 165 SAFSEHLKQD--GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GD--- 237 (441)
Q Consensus 165 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~--- 237 (441)
+......... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.. +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8755332211 1223456788999999987655446889999999999999999999987765433322221 00
Q ss_pred --------------CCCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 --------------FKCP-------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 --------------~~~~-------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
...| ...++.+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=347.78 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=221.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..+.|.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3455677788999999999999999999999999986533 2345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 97 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||+++++|.+++..+++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 97 v~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~ 174 (292)
T cd06658 97 VMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPK 174 (292)
T ss_pred EEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999998643321 222
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLIT 253 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~ 253 (441)
.....|++.|+|||.+.+..+ +.++||||+||++|+|++|+.||...+.......+.... ...+..++..+.++|.
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred CceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 344678999999999977666 488999999999999999999998877665555544332 2223347889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
+||..||.+|||+.++++||||.....+
T Consensus 254 ~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 254 LMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHccCChhHCcCHHHHhhChhhhccCCc
Confidence 9999999999999999999999866544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.52 Aligned_cols=253 Identities=30% Similarity=0.514 Sum_probs=206.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||.|+||+||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 47899999999999999999999989999999998754321 1224566899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--Cc
Confidence 999985 89988865 46899999999999999999999999999999999999999999999999998643221 11
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHcC------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG------------------ 236 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~------------------ 236 (441)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||...+ ..+....+.+.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 22334578899999998765444688999999999999999999997665 22222222110
Q ss_pred -C--CCC---------CCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 237 -D--FKC---------PPWFS--SEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 237 -~--~~~---------~~~~~--~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. ... .+.++ .++.++|.+||.+||++|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=352.54 Aligned_cols=260 Identities=26% Similarity=0.457 Sum_probs=212.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4579999999999999999999999999999999986422 223456678899999999999999999987544
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
...|+++||+.+ +|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999965 8888888888999999999999999999999999999999999999999999999999998754322
Q ss_pred cc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc---------------
Q 013522 172 KQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--------------- 235 (441)
Q Consensus 172 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 235 (441)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 12233457899999999986654456899999999999999999999987654332221110
Q ss_pred C-----------CCC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 236 G-----------DFK-----CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 236 ~-----------~~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. ... ..+.+++++.++|.+||+.||++|||+.++++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000 1134578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=358.92 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=207.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
..-.++|++++.||+|+||+||+|++ ..++..||+|++..... ....+.+.+|+.+|+.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 33456899999999999999999974 34677899999864432 23356788999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhcC-------------------------------------------------------
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAKG------------------------------------------------------- 113 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~~------------------------------------------------------- 113 (441)
.+.+..|+||||++||+|.+++...
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 9999999999999999999988531
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 114 ---------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 114 ---------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 36778889999999999999999999999999999999999999999999987543222
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH-HHHHHHHcCC-CCCCCCCCHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
.........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... .....+..+. ...|...+.+++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY 347 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence 1111222335667999999987766 489999999999999998 99999876543 3334444332 334566789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
+||.+||+.||++|||+.++++.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=343.21 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=215.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 457999999999999999999986555 689999986442 2234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 93 KIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
..|++|||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999864 3477889999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999875332221222334457889999999877666 489999999999999998 999999988888888877
Q ss_pred cCCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 235 RGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 235 ~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.. ..|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6543 4567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=335.69 Aligned_cols=252 Identities=31% Similarity=0.560 Sum_probs=220.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--SKSKIYFA 97 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv 97 (441)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++.+. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876543 2344577889999999999999999999875 34678999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh-----hcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 98 MDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCH-----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH-----~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
|||+++++|.+++.. +++++..++.++.||+.||+||| +.+++|+||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999864 56899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCH
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSS 246 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~ 246 (441)
..... .......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+...+...+..+.. ..|..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54322 11344578999999999977665 4889999999999999999999999887777777777654 35667889
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+.+++.+||..+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=336.90 Aligned_cols=249 Identities=28% Similarity=0.467 Sum_probs=215.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||.|+||.||+|.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999998899999999865421 578999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.+++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999864 568999999999999999999999999999999999999999999999999987543321 12
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLIT 253 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~ 253 (441)
.....|++.|+|||++.+..+ +.++||||+||++|+|++|..||...........+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 234458899999999987766 48899999999999999999999877655444333322 22334457889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 013522 254 KLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf 275 (441)
+||+.||++|||+.+++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=349.07 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=193.0
Q ss_pred eeeecccCceEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEe
Q 013522 24 GRMLGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--SKSKIYFAMD 99 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E 99 (441)
+..||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999754 668899999865432 245778999999999999999999984 4568899999
Q ss_pred ccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe----CCCCCeEEeecCcc
Q 013522 100 LVKGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLS 165 (441)
Q Consensus 100 ~~~gg~L~~~i~~----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl----~~~~~vkl~DFGla 165 (441)
|+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9965 77777642 247899999999999999999999999999999999999 56678999999999
Q ss_pred cccccccc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH---------HHHHHHHc
Q 013522 166 AFSEHLKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------SMYRKIYR 235 (441)
Q Consensus 166 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 235 (441)
........ ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76433211 122345578999999999977655568999999999999999999999653211 00111000
Q ss_pred ----------------------------CCC----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 236 ----------------------------GDF----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 236 ----------------------------~~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
... ......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=338.21 Aligned_cols=250 Identities=17% Similarity=0.260 Sum_probs=211.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 457999999999999999999865 4567899999875432 23346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999875422111
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 250 (441)
........+++.|+|||.+.+..+ +.++||||+||++|++++ |..||.+.+.......+..+. .+.|..++..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 111112335678999999987766 489999999999999775 999999888887777776653 3556678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+||+.+|.+|||+.+|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=353.48 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=211.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 367899999999999999999999999999999999865432 223456778899999999999999999988543
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888887655 8999999999999999999999999999999999999999999999999987533
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------- 236 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 236 (441)
. ........|++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+..+...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223445689999999999887774 8899999999999999999999876654433333210
Q ss_pred ---------CCC--------------C-------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 ---------DFK--------------C-------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ---------~~~--------------~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... . +...++.+++||.+||+.||++|||+.++|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence 000 0 112356789999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=343.34 Aligned_cols=252 Identities=30% Similarity=0.516 Sum_probs=209.9
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||.|+||.||+|++..+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865432 22334578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+. ++|.+++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 578888754 56899999999999999999999999999999999999999999999999998644321 122
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-C-----------------C
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-D-----------------F 238 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~-----------------~ 238 (441)
.....+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+......++... . .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 334457899999999876665568899999999999999999999876654333322210 0 0
Q ss_pred C-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 K-----------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 ~-----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. ..+.++++++++|.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.10 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=210.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE------
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA------ 89 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------ 89 (441)
-.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 4578999999999999999999999999999999986543 2345788999999998 7999999999984
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
....+|++|||+.+|+|.+++.. ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 34678999999999999999865 458899999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccccCCCccchhhhhc-----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-C-
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-K- 239 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~- 239 (441)
..... ........|++.|+|||.+.. ..+ +.++|+|||||++|+|++|..||...........+..... .
T Consensus 170 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 54321 122345678999999999853 234 4789999999999999999999977665444443333322 1
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 240 CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+..++.++.+||.+||..||.+|||+.+|++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.75 Aligned_cols=256 Identities=24% Similarity=0.436 Sum_probs=221.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
-|++.+.||.|+||.||+|.+..+++.+|+|++..... ......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37888999999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
|+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 9999999999988889999999999999999999999999999999999999999999999999986443211 11233
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhcCC
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~ 258 (441)
..|+..|+|||.+..... +.++|+||+||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 468899999999876655 4789999999999999999999988776666666654433 35566889999999999999
Q ss_pred CCCCCCCHHHHhcCcccCccCC
Q 013522 259 NPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 259 dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+|.+||++.++++||||.+...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.19 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=206.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASK--SKIYFA 97 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv 97 (441)
|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ......+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999986543211 1223457888898885 99999999999887 899999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.+ +|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++. +.+||+|||++..... ..
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence 999975 78888764 56899999999999999999999999999999999999999 9999999999875432 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC------------------C
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------D 237 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 237 (441)
......+++.|+|||.+....+.+.++||||+||++|+|++|.+||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568999999998866666678999999999999999999999887765554443221 1
Q ss_pred CCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 FKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+.+| +.++..+.+||.+||.+||++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.19 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=212.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45899999999999999999999999999999999866543 3356788999999999999999999876543
Q ss_pred ---------CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEee
Q 013522 92 ---------SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTD 161 (441)
Q Consensus 92 ---------~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~D 161 (441)
...|+||||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+|++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 36899999997 48999888888999999999999999999999999999999999999974 55789999
Q ss_pred cCcccccccccc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC---
Q 013522 162 FGLSAFSEHLKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--- 237 (441)
Q Consensus 162 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 237 (441)
||++........ .+......|++.|+|||.+.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432211 1222334689999999988665555689999999999999999999998776554444332211
Q ss_pred ----------------------C-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 238 ----------------------F-----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 238 ----------------------~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
. .+.+.++.++.+||.+||++||.+|||+.+++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123467889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=334.11 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=216.3
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
||++.+.||+|+||.||.|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999989999999999766433 3457889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC-c-
Q 013522 100 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-L- 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~- 176 (441)
|+++++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||++++++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999987 468999999999999999999999999999999999999999999999999987644322111 1
Q ss_pred ccccccCCCccchhhhhccC--CCCCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHcC-CCCCCCCC--CHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG-DFKCPPWF--SSEARR 250 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~--~~~~~~ 250 (441)
.....+++.|+|||.+.+.. ..+.++||||||+++|++++|..||.... .......+..+ ....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22456889999999987654 23588999999999999999999997652 22223233322 33455554 899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+|.+||+.||.+|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.95 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=211.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE----
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA---- 89 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~---- 89 (441)
....++|++.+.||+|+||+||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 346789999999999999999999999999999999886432 1235678899999999 7999999999873
Q ss_pred -eCCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecC
Q 013522 90 -SKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163 (441)
Q Consensus 90 -~~~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFG 163 (441)
+....|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 45679999999999999988742 468899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhcc----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-- 237 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-- 237 (441)
++...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...........+....
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 170 VSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred ceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 98754321 1122345699999999998532 223578999999999999999999998776554444433322
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 -FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
...|..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 12344568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=341.21 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=208.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSK---- 93 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~---- 93 (441)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999865432 2233457888999999995 6999999999877665
Q ss_pred -EEEEEeccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEeecCcc
Q 013522 94 -IYFAMDLVKGGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLS 165 (441)
Q Consensus 94 -~~lv~E~~~gg~L~~~i~~------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~DFGla 165 (441)
.|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78888753 24799999999999999999999999999999999999998 889999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--C-----
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--F----- 238 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~----- 238 (441)
...... ........+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+......++...- .
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 643221 1222334578999999998765545689999999999999999999998876655444433210 0
Q ss_pred ----------CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 239 ----------KC-----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 239 ----------~~-----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
.. .+.+++.+.+||.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 124688899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=339.29 Aligned_cols=255 Identities=26% Similarity=0.469 Sum_probs=220.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|.-.+.||.|++|.||+|.+..+++.+++|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45666899999999999999999999999998864332 234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
|+.|++|.+++..+++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+...... ......
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~ 174 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKS 174 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999987643321 112234
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC---CCCCCHHHHHHHHHhc
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC---PPWFSSEARRLITKLL 256 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~~L 256 (441)
..|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.....+. +..++..+.++|.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 568999999999987666 488999999999999999999998887777776666553322 2337889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCccCC
Q 013522 257 DPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
.+||++|||+.++++||||++..+
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ccChhhCcCHHHHccCcccccCCC
Confidence 999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.98 Aligned_cols=254 Identities=29% Similarity=0.423 Sum_probs=213.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIY 95 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 95 (441)
.+.|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999755432 23345677899999999999999999998877 8999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||+.+ +|.+.+.. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 89888865 358999999999999999999999999999999999999999999999999987544321
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC----------------
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---------------- 237 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 237 (441)
.......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+......++....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 223345678999999998766555688999999999999999999998877665554432210
Q ss_pred ---------------CCCCCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 ---------------FKCPPW-FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ---------------~~~~~~-~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
..++.. +++.+.++|++||+.||++|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 012222 57889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=349.63 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=216.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--- 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 92 (441)
.+.++|++.+.||+|+||.||+|.+..++..||+|.+.+... .......+.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 367899999999999999999999999999999999865422 2234567889999999999999999999986543
Q ss_pred ---EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 ---KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ---~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+++||||+ |++|.+++..+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799999888889999999999999999999999999999999999999999999999999987432
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-----------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------- 238 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 238 (441)
. ......+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+....+..+.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 223446799999999987644456889999999999999999999988765544444332111
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 --------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...+.+++.+.++|.+||..||++|||+.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 01235678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=337.73 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=216.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+......|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999876532 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||+.|++|.+++.. ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 99999999999975 678999999999999999999999 999999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-----cHHHHHHHHHcCC-CCCCCC-CCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRGD-FKCPPW-FSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~~~~~ 248 (441)
.....|++.|+|||.+.+..+ +.++|||||||++|+|++|..||... ........+.... ...+.. +++++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122678999999999987766 48899999999999999999999764 2334444444433 233444 78999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.++|.+||..||++|||+.+++.||||+.
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=335.48 Aligned_cols=247 Identities=34% Similarity=0.589 Sum_probs=210.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+|+||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433223333445555544 456899999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 6789999999999999999999999999999999999999999999999998864322 234568
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHhcCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDP 258 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~ 258 (441)
++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+....+..+..+....+ ..+++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987664 5899999999999999999999999888877777766554332 35789999999999999
Q ss_pred CCCCCC---CHHHHhcCcccCcc
Q 013522 259 NPNSRI---AISKIMESSWFKKS 278 (441)
Q Consensus 259 dP~~R~---t~~eil~hpwf~~~ 278 (441)
||++|| ++++++.||||.+.
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhcC
Confidence 999999 45799999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=338.98 Aligned_cols=251 Identities=32% Similarity=0.517 Sum_probs=211.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||.|++|+||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999975532 1234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 100 LVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 100 ~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|+.+ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 88888764 35899999999999999999999999999999999999999999999999998754321 11
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------------ 237 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 237 (441)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998766555689999999999999999999998877665544432210
Q ss_pred CC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 FK-----------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~~-----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.. ..+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=344.43 Aligned_cols=256 Identities=25% Similarity=0.431 Sum_probs=219.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
..|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457888999999999999999999999999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 99 DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 99 E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
||+++++|.+++..+.+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 99999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhcC
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~ 257 (441)
...|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+..+.. ..+..++.++.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3468899999999987765 4889999999999999999999987665554444443322 2344578899999999999
Q ss_pred CCCCCCCCHHHHhcCcccCccC
Q 013522 258 PNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 258 ~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+|++|||+.++++||||....
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.63 Aligned_cols=255 Identities=29% Similarity=0.440 Sum_probs=206.5
Q ss_pred CeEEeeeecccCceEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIY 95 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~ 95 (441)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999874422233456778999999999999999999999888 8899
Q ss_pred EEEeccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC----CCCeEEeecCcc
Q 013522 96 FAMDLVKGGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE----DGNLKVTDFGLS 165 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~----~~~vkl~DFGla 165 (441)
+||||+.+ +|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 67666642 36899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH---------HHHHHH-
Q 013522 166 AFSEHLKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---------MYRKIY- 234 (441)
Q Consensus 166 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i~- 234 (441)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|.+||.+.+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543222 1122345689999999998765545688999999999999999999997644321 000000
Q ss_pred -------------------------cCCCCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 235 -------------------------RGDFKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 235 -------------------------~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
......+ ...+..+.++|.+||.+||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 0356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=343.56 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=218.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 4799999999999999999999988999999999864432 2346788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
+||+++++|.+++.+..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--ccc
Confidence 999999999999988789999999999999999999999999999999999999999999999999886443221 222
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-CC--CCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-DF--KCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~--~~~~~~~~~~~~li~~ 254 (441)
....|++.|+|||.+....+ +.++|+|||||++|++++|..||...+.......+... .. ..+..++..++++|++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34468999999999877665 58899999999999999999999877654433333322 22 2233467889999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||..+|.+||++.+++.||||+...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=333.24 Aligned_cols=252 Identities=31% Similarity=0.580 Sum_probs=217.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||+|+||.||+|.+..+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+.+.+..|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 689999999999999999999999999999999765332 2335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC-eEEeecCccccccccccCC
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~-vkl~DFGla~~~~~~~~~~ 175 (441)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||++++++. +||+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 9999999999865 24789999999999999999999999999999999999998864 699999998754321 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 254 (441)
......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+.. ..++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2234568999999999877665 4889999999999999999999998877766666655443 3455678999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 013522 255 LLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf 275 (441)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=329.95 Aligned_cols=252 Identities=35% Similarity=0.626 Sum_probs=223.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||.|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 689999999999999999999989999999999765432 2445678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 100 LVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 100 ~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|++|++|.+.+.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999999865 568999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLIT 253 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~ 253 (441)
......+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+...+...+..... ..|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 23345678999999999877665 4889999999999999999999998887777777766543 445578999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 013522 254 KLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf 275 (441)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=334.08 Aligned_cols=251 Identities=31% Similarity=0.556 Sum_probs=213.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987644444455667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 99 DLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 99 E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 99999999988852 448899999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHHcCCC-CCC-CCCCHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIYRGDF-KCP-PWFSSEAR 249 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~~-~~~~~~~~ 249 (441)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+..... +.+ ..++..+.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 -TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred -HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 12234568999999999987766 488999999999999999999996543 3445555544332 222 35778999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
++|.+||..+|++|||+.++++.
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=339.43 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=204.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 6799999999999999999999999999999998654321 22345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ...
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CCC
Confidence 9996 577776653 56788999999999999999999999999999999999999999999999998743321 122
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHc--C------------CC---
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYR--G------------DF--- 238 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~--~------------~~--- 238 (441)
.....+++.|+|||.+.+....+.++|||||||++|+|++|..||...+.. +....+.. + ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 334567999999999876544457899999999999999999999765432 22111110 0 00
Q ss_pred -----CC-CC---------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 -----KC-PP---------WFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 -----~~-~~---------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.. +. ..++.+.+++.+||..||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=338.72 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=214.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
+-.++|++.+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456799999999999999999997642 345899998864432 2234467889999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
....|+||||+++|+|.+++.. ..++...+..++.|++.||.|||++||+||||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999999964 12356778899999999999999999999999999999999999999
Q ss_pred eecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-
Q 013522 160 TDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD- 237 (441)
Q Consensus 160 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~- 237 (441)
+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999874332111111222345678999999877665 489999999999999998 899999888877777776553
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------CcccCc
Q 013522 238 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME------SSWFKK 277 (441)
Q Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~------hpwf~~ 277 (441)
...+..+++.+.+++.+||+.||++|||+.++++ ||||+.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 3456677899999999999999999999999987 899875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=309.58 Aligned_cols=256 Identities=32% Similarity=0.541 Sum_probs=220.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|.-.++||+|+||+|++|++..+++.||+|.++.+.- .++.-....+||.+|+.++|.|||+++++..++..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 357778899999999999999999999999999987653 2345567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|||.. +|..+..+ |.+..+.++.++.|++.||.|||++++.||||||.|+|++.+|.+|++|||+|+-+.-. -..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence 99975 78777764 88999999999999999999999999999999999999999999999999999865532 223
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC--CC---CC------C---
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG--DF---KC------P--- 241 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~---~~------~--- 241 (441)
....+-|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|++.+..+...+|.+. .+ .+ |
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 4455679999999999998888899999999999999986 89999999988888777542 11 11 1
Q ss_pred ---------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 ---------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 ---------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
|.++..-++|++++|.-+|.+|++++++++||||...
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1134456899999999999999999999999999764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=337.54 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=212.2
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
.+..++|++.+.||+|+||+||.|.+.. ++..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3567889999999999999999998642 456799998854321 223456889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeE
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAKG-----------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLK 158 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~~-----------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vk 158 (441)
.....++||||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999998641 246678889999999999999999999999999999999999999
Q ss_pred EeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC
Q 013522 159 VTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD 237 (441)
Q Consensus 159 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 237 (441)
|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999864322111111123346788999999987665 588999999999999999 799999888877777766654
Q ss_pred C-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 238 F-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 238 ~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
. ..+..+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 4566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=359.74 Aligned_cols=259 Identities=32% Similarity=0.579 Sum_probs=240.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+-....+++.+||-|+||.|=++........+|+|++++..+......+++..|-.||..++.|.||++|-.|.+...+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34456788899999999999999986666679999999988888888899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+.||-|-||+|...++. |.+.+..++.|+..+++|++|||++||+.|||||||+++|.+|-+||.|||+|... ..+
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki---~~g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI---GSG 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh---ccC
Confidence 99999999999999985 89999999999999999999999999999999999999999999999999999854 456
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLI 252 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li 252 (441)
....|.||||.|+|||++.+++++ .++|.||||+++|||++|.+||.+.+++..|..|.+| .+.+|..++..+.+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 677899999999999999999998 8899999999999999999999999999999999998 4678999999999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 253 TKLLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 253 ~~~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
+++...+|..|.. +.+|.+|.||..-
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 9999999999986 8999999999754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=350.17 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=217.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK-- 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 93 (441)
.+.++|++.+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 367889999999999999999999999999999999865422 22345667889999999999999999988765544
Q ss_pred ----EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 94 ----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 94 ----~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.|+|+||+ |++|.+++..+++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6699999988889999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC----------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---------- 239 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 239 (441)
. ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 1344568999999999876545568999999999999999999999887766555544332100
Q ss_pred ---------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 ---------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 ---------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
....+++.+.++|.+||..||++|||+.++++||||.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=340.96 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=217.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
....+|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34567999999999999999999999999999999987554444445567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+|+||+.| ++.+.+. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--- 167 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence 99999975 6767665 36789999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CC-CCCCCHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KC-PPWFSSEAR 249 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~~ 249 (441)
.....|++.|+|||++.+ ....+.++||||||+++|+|++|..||.+.+.......+..... .. +..++..+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 234568899999998742 23335789999999999999999999988776665555544332 22 234678999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++|.+||..||++|||+.+++.||||....
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=338.88 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=216.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 367999999999999999999999999999999986543 223457889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+++++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 999999999999876 679999999999999999999997 6999999999999999999999999999764322 1
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-----------HHHHHHHHcCC-CCCCCC
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-----------VSMYRKIYRGD-FKCPPW 243 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-----------~~~~~~i~~~~-~~~~~~ 243 (441)
.....+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||..... ......+.... ..++..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 2234579999999999877655 4889999999999999999999986543 12333333332 222333
Q ss_pred -CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 244 -FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 244 -~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++.++.+||.+||.+||.+|||+.++++||||....
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=352.26 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=211.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
+-...|++++.||+||.++||++... +.+.||+|.+.... .+...+.-+.+||..|.+| .|.+||+||++-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 44557999999999999999999974 44566666554332 2445678899999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||-. .+|...+..+ -++...++.|..|++.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|.......
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 99999975 4899998863 34445899999999999999999999999999999999 56899999999998766555
Q ss_pred cCCcccccccCCCccchhhhhccCCC----------CCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHcCC--CC
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYD----------GAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRGD--FK 239 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~----------~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~--~~ 239 (441)
..-...+.+||+.|||||.+....+. +.++||||||||||+|+.|++||..-. ...-+..|...+ ++
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE 593 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence 55566788999999999999654332 578999999999999999999997643 334444454442 35
Q ss_pred CCCCCCHH-HHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 240 CPPWFSSE-ARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 240 ~~~~~~~~-~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+|..-+.. +.++++.||..||++|||+.++|+|||++.
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 55544444 999999999999999999999999999975
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=341.91 Aligned_cols=254 Identities=26% Similarity=0.488 Sum_probs=218.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
-|+....||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++.+...+..|+++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 35556689999999999999999999999999865432 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
|+++++|...+....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... ......
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 176 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccccc
Confidence 999999999888888999999999999999999999999999999999999999999999999998643321 112234
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHhc
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKLL 256 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~L 256 (441)
.+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+..... ..+..+++.+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 678999999999987666 5889999999999999999999988776666655544322 223457889999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCccC
Q 013522 257 DPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+.+|.+|||+.++++||||.+..
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCC
Confidence 99999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=337.71 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=212.5
Q ss_pred cCCeEEeeeecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
...|.+.+.||+|+||+||++.+ ..++..+|+|.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 35799999999999999999985 2355679999886542 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-C-------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeE
Q 013522 93 KIYFAMDLVKGGELFNKIAK-G-------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLK 158 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~-------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vk 158 (441)
..|+||||+.+++|.+++.. + .+++..+..++.|++.||+|||++|++||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999999864 2 389999999999999999999999999999999999999999999
Q ss_pred EeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC
Q 013522 159 VTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD 237 (441)
Q Consensus 159 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 237 (441)
|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875432211112223446788999999977655 489999999999999998 999999888888888887775
Q ss_pred C-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 238 F-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 238 ~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
. ..+..+++++.+|+.+||++||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 345568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=337.67 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=214.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998743 467899999865432 224578899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCe
Q 013522 93 KIYFAMDLVKGGELFNKIAK---------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 157 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~v 157 (441)
..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999864 237888999999999999999999999999999999999999999
Q ss_pred EEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC
Q 013522 158 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG 236 (441)
Q Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 236 (441)
||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999864322111112233446788999999987766 488999999999999998 99999888888888888777
Q ss_pred CCCC-CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 237 DFKC-PPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 237 ~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.... +..++..+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6544 4568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.85 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=219.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFA 97 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv 97 (441)
+|++.+.||+|++|.||.|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+.+. ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999999765432 24567889999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
+||+.+++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999976 4799999999999999999999999999999999999999999999999999876554322112
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYR--GDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~~~~~~~~~~~~~~~li~ 253 (441)
.....++..|+|||.+....+ +.++||||||+++|+|++|..||.... .......+.. .....|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999876654 588999999999999999999998765 3333333332 334556678999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 013522 254 KLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf 275 (441)
+||..||++||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=337.83 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=210.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||.|++|+||+|.+..+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 6899999999999999999999999999999998654322 233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEeecCccccccccccC
Q 013522 99 DLVKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~~~~~~~~~ 174 (441)
||+.+ +|.+.+.. . .+++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++...... .
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~ 157 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--V 157 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--c
Confidence 99964 78877754 2 3678889999999999999999999999999999999985 457999999998643321 1
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--C---------------
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D--------------- 237 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~--------------- 237 (441)
.......|++.|+|||.+.+....+.++||||+||++|+|++|.+||...+..+...++... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 22234567899999999876555568999999999999999999999877665544443221 0
Q ss_pred ----CC--------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 238 ----FK--------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 238 ----~~--------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.. ..+.+++.+.++|.+||+.||++||++.++++||||.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 123467889999999999999999999999999999764
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=335.88 Aligned_cols=246 Identities=26% Similarity=0.417 Sum_probs=204.5
Q ss_pred ccCCeEEeeee--cccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 17 LHGKYELGRML--GHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 17 ~~~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
..+.|++.+.+ |.|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34677787776 99999999999999999999999987543221 122222222 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~ 171 (441)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999999977 5799999999999999999999999999999999999999998 999999999864332
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH----HHHHHcCCCCCCCCCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM----YRKIYRGDFKCPPWFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 247 (441)
.....|++.|+|||++.+..+. .++|||||||++|+|++|..||........ ...........++.+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 1234689999999999877764 889999999999999999999976543221 222223344556678999
Q ss_pred HHHHHHHhcCCCCCCCCC-HHHHhcCcccCc
Q 013522 248 ARRLITKLLDPNPNSRIA-ISKIMESSWFKK 277 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t-~~eil~hpwf~~ 277 (441)
+.+||.+||++||.+||+ ++++|+||||.+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999996 699999999963
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.66 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=214.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+....|++.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++||||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 34567999999999999999999999999999999986542 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999864 358899999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 250 (441)
. .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 159 Y-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred e-eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1 11112234667999999877766 488999999999999998 99999988888777777664 44566778999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
+|.+||..||++|||+.++++
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=343.73 Aligned_cols=252 Identities=20% Similarity=0.343 Sum_probs=210.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
-..+|++.+.||+|+||+||+|++..+++. ||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999998766664 8999986432 223456788999999999999999999998764
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..++++||+.+|+|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 57899999999999999975 4688999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 248 (441)
...........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.....+...+..+ ..+.|+.++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 2221112223356789999999877664 89999999999999997 99999987766655444443 345567789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.99 Aligned_cols=259 Identities=28% Similarity=0.497 Sum_probs=220.4
Q ss_pred cccCCeEEe-----eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 16 LLHGKYELG-----RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 16 ~~~~~y~i~-----~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
.+.=.|+.. -.||+|+||+||.|++..|...+|||.+.... .....-+..||.+.++|+|.|||++++.+..
T Consensus 567 ~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se 643 (1226)
T KOG4279|consen 567 KIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSE 643 (1226)
T ss_pred ceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCC
Confidence 344455554 37999999999999999999999999985432 2345678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-CCCCeEEeecCcc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK--GRL--REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLS 165 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~--~~l--~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-~~~~vkl~DFGla 165 (441)
++.+-|.||-++||+|.++++. |++ +|...-.|.+||++||.|||++.|+|||||-+|||++ -.|.+||+|||-+
T Consensus 644 nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 644 NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccc
Confidence 9999999999999999999986 777 8999999999999999999999999999999999996 4689999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhc-cCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cH-HHHHHH-HHcCCCCCC
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISK-KGYDGAKADIWSCGVILYVLLAGFLPFQDD-NI-VSMYRK-IYRGDFKCP 241 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~-~~~~~~-i~~~~~~~~ 241 (441)
+.... -+....+..||.-|||||++-. ...+|.++|||||||++.||.||++||... ++ ..+++- ..+..+++|
T Consensus 724 KRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 724 KRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred hhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 75443 3445678889999999999954 334479999999999999999999999653 22 233322 234456778
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..++.+++.+|.+|+.+||.+||++.++|.+||++...
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 88999999999999999999999999999999998763
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=348.34 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=213.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA----SKS 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 92 (441)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 34789999999999999999999999999999999875432 2234567788999999999999999999875 345
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999996 589888865 66999999999999999999999999999999999999999999999999998654322
Q ss_pred cc--CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--------------
Q 013522 172 KQ--DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-------------- 235 (441)
Q Consensus 172 ~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 235 (441)
.. ........|+..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 12223457899999999987644456899999999999999999999987765433222111
Q ss_pred ------------CCCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 236 ------------GDFKC-----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 236 ------------~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..... .+..++++.++|.+||+.||++|||+.+++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00011 133688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.74 Aligned_cols=251 Identities=30% Similarity=0.495 Sum_probs=209.7
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++.+.||.|++|+||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999999765432 23345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 101 VKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 101 ~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
+. ++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 5899988753 5899999999999999999999999999999999999999999999999998644321 1122
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--------------------
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------- 237 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------- 237 (441)
....+++.|+|||++.+....+.++|||||||++|+|++|.+||...+......++.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578999999998765544688999999999999999999998776544333322210
Q ss_pred ---------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 ---------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
....+.++..+.++|.+||++||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=341.91 Aligned_cols=253 Identities=28% Similarity=0.438 Sum_probs=222.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|.++.+||+|+||.||+|.++.+|+.+|||.+.-+ ..+..+..||.||+++..|++|++|+.+-....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 88999999999999999999999999999988654 3467899999999999999999999999889999999999
Q ss_pred cCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 101 VKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 101 ~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
|..|++.+.++ +..++++++..+++.-+.||.|||...-+|||||..|||++.+|..||+|||.|..... .-....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN 187 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN 187 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence 99999999986 37799999999999999999999999999999999999999999999999999864322 112235
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHHHHHh
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITKL 255 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~~ 255 (441)
+..|||.|||||++..-+|+ .++||||||++..||..|++||.+-.++.....|-...+ .-|..+|.++.++|++|
T Consensus 188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 67899999999999999998 889999999999999999999998877654444433322 23445789999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 256 LDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
|.++|++|.|+.++++|||.++....
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 99999999999999999999876543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.97 Aligned_cols=261 Identities=23% Similarity=0.403 Sum_probs=217.4
Q ss_pred CCCCCCccccCCeEEeeeecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCC
Q 013522 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKH 80 (441)
Q Consensus 9 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpn 80 (441)
.......+..++|.+++.||+|+||.||.|++.. ++..+|+|.+.... .......+.+|+.+++.+ +|||
T Consensus 8 ~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~ 85 (307)
T cd05098 8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 85 (307)
T ss_pred CCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence 3444567778999999999999999999998743 23579999997542 223356788899999999 7999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEecc
Q 013522 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRD 143 (441)
Q Consensus 81 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrD 143 (441)
|+++++++...+..|+||||+.+|+|.+++... .++...+..++.|++.||+|||++|++|||
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 165 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRD 165 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 999999999999999999999999999999642 378889999999999999999999999999
Q ss_pred CCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCC
Q 013522 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQ 222 (441)
Q Consensus 144 Lkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~ 222 (441)
|||+||+++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.
T Consensus 166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999875432211111122234578999999977665 588999999999999998 999999
Q ss_pred CCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 223 DDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 223 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..+...+...+..+. ...|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 245 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888877777766654 35567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=330.58 Aligned_cols=244 Identities=24% Similarity=0.432 Sum_probs=204.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||+|+||.||+|++..+++.+|+|.+.... .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999999999999999886432 2344567899999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 105 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 105 ~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 4589999999999999999999999999999999999999999999999999864322111111111123
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP 260 (441)
+..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+... ....|..++..+.+|+.+||.+||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999977665 588999999999999997 99999877766655555443 345566789999999999999999
Q ss_pred CCCCCHHHHhc
Q 013522 261 NSRIAISKIME 271 (441)
Q Consensus 261 ~~R~t~~eil~ 271 (441)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=329.53 Aligned_cols=246 Identities=42% Similarity=0.749 Sum_probs=221.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||.|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+.+...+|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999889999999999877655545677899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCC
Q 013522 107 FNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185 (441)
Q Consensus 107 ~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 185 (441)
.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999986 478999999999999999999999999999999999999999999999999987543221 23345568999
Q ss_pred ccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 013522 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIA 265 (441)
Q Consensus 186 y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 265 (441)
|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+.....++|..++..+.++|++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999877655 4889999999999999999999988887788888888888888889999999999999999999999
Q ss_pred H---HHHhcCccc
Q 013522 266 I---SKIMESSWF 275 (441)
Q Consensus 266 ~---~eil~hpwf 275 (441)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=347.00 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=212.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+..+|.+.+.||+|+||+||.|++..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 457899999999999999999999999999999998754322 22345677899999999999999999987544
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
...|+|+||+. ++|.+++.. +++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 588888865 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc---------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--------------- 235 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 235 (441)
. ........++..|+|||.+......+.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 12334556899999999987644456899999999999999999999987654332222211
Q ss_pred --------C-----CC---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 236 --------G-----DF---KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 236 --------~-----~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
. .. ...+.+++++.+||++||++||++|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 0123578899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.66 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=213.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998644 4579999986543 223456788899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 578999999999999999999999999999999999999999999999999998654211
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 250 (441)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111112334678999999987666 488999999999999998 99999887777777777655 33456678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 013522 251 LITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+||+.||++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=326.23 Aligned_cols=252 Identities=30% Similarity=0.557 Sum_probs=220.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+++++.++|||++++++++.+.+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999766532 2456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 100 LVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 100 ~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
|+.+++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence 9999999999876 789999999999999999999999999999999999999999999999999987654322 1234
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHhcC
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY-RGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
...|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......+.. ......|+.+++.+.++|.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4568999999999877664 588999999999999999999998766544444443 34455667789999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 013522 258 PNPNSRIAISKIMESSWF 275 (441)
Q Consensus 258 ~dP~~R~t~~eil~hpwf 275 (441)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.56 Aligned_cols=247 Identities=29% Similarity=0.507 Sum_probs=206.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
...||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 357999999999999999999999999886543 23456789999999999999999999999999999999999999
Q ss_pred CchHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEeecCccccccccccCCccc
Q 013522 104 GELFNKIAK--GRL--REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 104 g~L~~~i~~--~~l--~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
++|.+++.. +.+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 999999975 445 88889999999999999999999999999999999986 678999999998654321 12233
Q ss_pred ccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCcHH--HHHHH-HHcCCCCCCCCCCHHHHHHHHH
Q 013522 179 TTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIV--SMYRK-IYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~~~~~~~~~~~li~~ 254 (441)
...|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||...... ..... ........|..+++++++++.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 446899999999986543 2458899999999999999999999754322 22211 2233345677789999999999
Q ss_pred hcCCCCCCCCCHHHHhcCccc
Q 013522 255 LLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf 275 (441)
||+.+|.+|||+.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.37 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=211.4
Q ss_pred CCeEEeeeecccCceEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNL----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..|++.+.||+|+||+||+|.+. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 57999999999999999999853 456789999986432 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC
Q 013522 95 YFAMDLVKGGELFNKIAK------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 156 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~------------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~ 156 (441)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 999999999999999852 23678889999999999999999999999999999999999999
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHc
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYR 235 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 235 (441)
+||+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875432222222334456778999999977665 589999999999999998 9999988777666666655
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 236 GD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 236 ~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.. .+.+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 43 44566789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=344.56 Aligned_cols=265 Identities=27% Similarity=0.383 Sum_probs=216.5
Q ss_pred cccCCeEE-eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----------hHHHHHHHHHHHHhCCCCCcce
Q 013522 16 LLHGKYEL-GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----------MMEQIKREISVMKMVKHKHIVE 83 (441)
Q Consensus 16 ~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~ 83 (441)
.+.+||.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 46688875 57799999999999999999999999998654332100 1225778999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeec
Q 013522 84 LHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 84 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DF 162 (441)
+++++...+..|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999997 589988875 67999999999999999999999999999999999999999999999999
Q ss_pred Cccccccccc------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHH
Q 013522 163 GLSAFSEHLK------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY 230 (441)
Q Consensus 163 Gla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~ 230 (441)
|++....... .........+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987543110 1112233457889999999876555568999999999999999999999988766555
Q ss_pred HHHHcCC--C--------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 231 RKIYRGD--F--------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 231 ~~i~~~~--~--------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
..+.... . ...+..+.++.++|.+||+.||++|||+++++.||||+.....
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 4443210 0 0012357889999999999999999999999999999876443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=333.26 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=207.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------KS 92 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~ 92 (441)
|.+++.||+|+||.||+|.+..++. .+|+|.+..... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578899999999999999877775 699998865432 23446788899999999999999999997642 23
Q ss_pred EEEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
..+++|||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999888742 34789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCC
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPW 243 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 243 (441)
................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.......++..+..+.. ..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76432211111223346778999999977665 589999999999999999 8999998887777777776543 45667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++..+.++|.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.69 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=214.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
+..++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999998644 3789999986443 22334578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
....|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 9999999999999999999864 23677889999999999999999999999999999999999999999
Q ss_pred eecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-
Q 013522 160 TDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD- 237 (441)
Q Consensus 160 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~- 237 (441)
+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.......+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999875433222122334457889999999876665 588999999999999998 999999888777777766543
Q ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 238 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
...|..++..+.++|.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4557778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=333.79 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=211.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
-.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999977 77899999885432 223345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEe
Q 013522 92 SKIYFAMDLVKGGELFNKIAKG--------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVT 160 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~--------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~ 160 (441)
...|+||||+.|++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 9999999999999999998652 478899999999999999999999999999999999998765 59999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CC
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DF 238 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 238 (441)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875422111111112233567999999987666 589999999999999997 99999988777777666543 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..|..++..+.+++.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5567789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.79 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=206.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
++|++.+.||+|+||.||+|++..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++...+..|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653221 23345556665 6777999999999999999999999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 98 MDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
|||+. ++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 477666643 3689999999999999999999997 999999999999999999999999999875432
Q ss_pred ccCCcccccccCCCccchhhhhcc---CCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHHcC-CCCCC-CCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKK---GYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRG-DFKCP-PWFS 245 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~-~~~~~-~~~~ 245 (441)
........|++.|+|||.+.+. ...+.++|+|||||++|+|++|..||... +.......+..+ ....| ..++
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1122335689999999988642 12357899999999999999999999753 222333333332 33333 3478
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.++.++|.+||..+|.+|||+.++++||||....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.27 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=211.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 568999999999999999999999999999999998754321 22346678899999999999999999988543
Q ss_pred -CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 -SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 -~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
...|++++++ |++|.+.+..+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478888887 77999888888899999999999999999999999999999999999999999999999999874321
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------------ 238 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 238 (441)
......|++.|+|||.+.+....+.++||||+||++|+|++|+.||...+.......+.....
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 173 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 223456899999999987644446889999999999999999999987655443333222100
Q ss_pred -----------CC--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 -----------KC--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 -----------~~--------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.. ....++++.+||.+||++||.+|||+.++++||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 00 112578899999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=332.07 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=208.7
Q ss_pred eEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 013522 21 YELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK---- 93 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---- 93 (441)
|.+++.||+|+||.||.|....+ +..||+|.+...... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999997653 478999998754332 2345678999999999999999999998865443
Q ss_pred --EEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 94 --IYFAMDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 94 --~~lv~E~~~gg~L~~~i~~-------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
.++++||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999988843 2588999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCC
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPP 242 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~ 242 (441)
+................+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.+....+..+..+ ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875432221111222345678999999876655 589999999999999999 99999888877777777665 345677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=328.75 Aligned_cols=254 Identities=30% Similarity=0.512 Sum_probs=220.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
..|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765421 34578999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+++++|.+++.. +.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 99999999999976 779999999999999999999999 999999999999999999999999999987543221 12
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---cHHHHHHHHHcCC-CCCCCC-CCHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGD-FKCPPW-FSSEARRL 251 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~-~~~~~~-~~~~~~~l 251 (441)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ........+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 235568999999999877644 58899999999999999999999776 4455555555433 334555 78999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
|.+||.++|++|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=328.00 Aligned_cols=255 Identities=28% Similarity=0.499 Sum_probs=215.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV--IKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKI 94 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 94 (441)
..|++.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1223456889999999999999999999998664 568
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
++++||++|++|.+++.+ +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999876 6789999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHH
Q 013522 174 -DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARR 250 (441)
Q Consensus 174 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ 250 (441)
........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||..........++... ....|+.+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112234568999999999987665 48899999999999999999999887666555555433 23457788999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+|.+||. +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=332.78 Aligned_cols=255 Identities=30% Similarity=0.435 Sum_probs=211.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIYF 96 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l 96 (441)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.++||||+++++++.+ .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999875432 2345778999999999999999999998854 457899
Q ss_pred EEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 97 AMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
||||++|++|.+++.. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999887642 5589999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-----cHHHHHHHHHcCCC-CCC----
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRGDF-KCP---- 241 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~~-~~~---- 241 (441)
.......++..|+|||.+.+..++ .++|||||||++|+|++|..||... ...+....+..... ..+
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 112245678899999999776664 8899999999999999999999865 22344444443221 111
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 242 --PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 242 --~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
..+++.+.++|.+||.+||++|||+.++++||||++...
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 124678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.22 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=208.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKS--MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
+-.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3446899999999999999999999877765 466665422 2233456788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 93 KIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
.+|+||||+++++|.+++... .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999998642 478999999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.+||+|||++....... ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999999986322111 1111224667999999877665 588999999999999998 999998887777777665
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 235 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+. ...|..+++++.+||.+||+.+|++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 542 33455678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.82 Aligned_cols=246 Identities=23% Similarity=0.406 Sum_probs=209.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 46899999999999999999874 456899998864432 2357889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||++||+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999999864 5689999999999999999999999999999999999999999999999999874321111 11
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 254 (441)
.....++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+.......+..+.. ..|...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 112234567999999977666 488999999999999999 9999999888888888877643 3455678899999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 013522 255 LLDPNPNSRIAISKIME 271 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~ 271 (441)
||..||.+|||+.++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=327.42 Aligned_cols=250 Identities=31% Similarity=0.586 Sum_probs=213.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999987654444444678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 99 DLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 99 E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999998853 45899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHHcCCC-CCCC-CCCHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIYRGDF-KCPP-WFSSEAR 249 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~~~~~~ 249 (441)
........|++.|+|||.+.+..+. .++|+|||||++|+|++|..||.... .......+..+.. +.|. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 1223345689999999999877664 88999999999999999999996543 3345555554433 3343 6788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=327.46 Aligned_cols=245 Identities=24% Similarity=0.401 Sum_probs=213.9
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 013522 25 RMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
+.||+|+||.||+|.+... +..+|+|++...... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 899999999765432 24678999999999999999999999999999999999999
Q ss_pred CCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 102 KGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 102 ~gg~L~~~i~~----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999975 56899999999999999999999999999999999999999999999999998765433
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 249 (441)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+ ....|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 22122344567889999999977655 588999999999999999 69999998888888887754 3456778899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++.+||..||++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.47 Aligned_cols=258 Identities=27% Similarity=0.497 Sum_probs=212.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 92 (441)
+...++|++.+.||.|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678999999999999999999999999999999999754322 223456778999999999999999999987654
Q ss_pred --------EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeec
Q 013522 93 --------KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 93 --------~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DF 162 (441)
.+|+|+||+.+ ++...+.. ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999986 67777764 46899999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC--
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF-- 238 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~-- 238 (441)
|++........ .......+++.|+|||.+.+....+.++|||||||++|+|++|++||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99875443221 12223356888999999876544468899999999999999999999887665555444331 00
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 --------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 --------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.....+++.+.++|.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=335.67 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=213.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.+|++.+.||.|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 4688999999999999999987543 5789999987543 22345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC
Q 013522 94 IYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 156 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~ 156 (441)
.++++||+.+++|.+++.. ..++...+..++.|++.||.|||++||+||||||+||++++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 9999999999999999852 24788889999999999999999999999999999999999999
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHc
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYR 235 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 235 (441)
+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999875433222222334456789999999977665 588999999999999998 8999998888888888877
Q ss_pred CCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 236 GDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 236 ~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.. +.|..++..+.+|+.+||+.+|.+|||+.+|+..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 654 4567799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.97 Aligned_cols=259 Identities=32% Similarity=0.597 Sum_probs=218.6
Q ss_pred CeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
.|++.+.||.|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999975 47899999999764332 223456788999999999 699999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+|+||+++++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999875 668999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
........|++.|+|||.+... ...+.++||||||+++|+|++|..||... ....+...+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223356689999999998653 23357899999999999999999999743 234455555556667777889999
Q ss_pred HHHHHHhcCCCCCCCC-----CHHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
.+++.+||..||++|| ++.++++||||+...
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.44 Aligned_cols=250 Identities=30% Similarity=0.561 Sum_probs=212.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||.|+||.||+|++..+++.+|+|.+.............+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887654444445568889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 99 DLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 99 E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||+.|++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998862 45899999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH--HHHHHHHHcCCCC-C-CCCCCHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI--VSMYRKIYRGDFK-C-PPWFSSEAR 249 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~~~~~~ 249 (441)
.......+|++.|+|||.+.+..+. .++|+||||+++|+|++|..||.+... ......+.....+ . +..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 1223455789999999999776664 789999999999999999999976533 3444455443332 2 235789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
++|.+||..||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=345.06 Aligned_cols=262 Identities=29% Similarity=0.420 Sum_probs=214.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe--C
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS--K 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~ 91 (441)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+... .......+.+|+.+++++ +||||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 3467899999999999999999999998999999998865322 122345677899999999 99999999999864 3
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
...|+||||+.+ +|..++..+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 478999999975 9999998878899999999999999999999999999999999999999999999999998754332
Q ss_pred ccC---CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-----------
Q 013522 172 KQD---GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----------- 237 (441)
Q Consensus 172 ~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 237 (441)
... .......||+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 233445689999999998765555688999999999999999999998765444333221110
Q ss_pred ----------------C----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 238 ----------------F----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 238 ----------------~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
. ...+.++.++.++|.+||+.||++|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 0112368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.25 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=208.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
..++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 368999999999999999999999999999999998654322 12234567899999999999999999987443
Q ss_pred ---CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 92 ---SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 92 ---~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
..+|+|+||+.+ +|...+.. ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999975 67776654 579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccC---------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC
Q 013522 167 FSEHLKQD---------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD 237 (441)
Q Consensus 167 ~~~~~~~~---------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 237 (441)
........ .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54332211 112234578999999998765545688999999999999999999999887766555443210
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 F-----------------------KCP-------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~-----------------------~~~-------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
. ..+ ..+++.+.++|.+||..||++|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 001 1234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=369.59 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=206.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...........+++.+|+.+++.++||||+++++++.+.+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 37999999999999999999999999999999999765433334567789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 98 MDLVKGGELFNKIAK------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
|||++|++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998853 12455677889999999999999999999999999999999999999999999
Q ss_pred cccccccc----------------CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH
Q 013522 166 AFSEHLKQ----------------DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM 229 (441)
Q Consensus 166 ~~~~~~~~----------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~ 229 (441)
........ .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521110 001123569999999999987776 5899999999999999999999987655433
Q ss_pred HHHHHcC-CCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 230 YRKIYRG-DFKCP--PWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 230 ~~~i~~~-~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....... ....+ ..+++.+.+++.+||..||++||+..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3221111 11111 247889999999999999999988665543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.25 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=209.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999985 5678999998654322 346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||++|++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...... ...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccc
Confidence 99999999999864 568999999999999999999999999999999999999999999999999987532111 001
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~ 254 (441)
.....++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+ ....|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111123457999999987666 488999999999999998 89999887777777777655 345566789999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 013522 255 LLDPNPNSRIAISKIMES 272 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~h 272 (441)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=335.84 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=216.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|+....||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 344568999999999999999999999999885432 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccc
Q 013522 101 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180 (441)
Q Consensus 101 ~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 180 (441)
+++++|.+.+..+++++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... .......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--ccccccc
Confidence 99999999988888999999999999999999999999999999999999999999999999987643321 1122345
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHHHHHHHhcC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~L~ 257 (441)
.|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+.... ......+++.+.++|.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 68999999999876655 588999999999999999999998877665555443332 22334578999999999999
Q ss_pred CCCCCCCCHHHHhcCcccCccCCc
Q 013522 258 PNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 258 ~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
.||.+||++.+++.||||.....+
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCC
Confidence 999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.82 Aligned_cols=244 Identities=34% Similarity=0.561 Sum_probs=216.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 95 (441)
+...|++...+|.|+|+.|..+.+..+++..++|++.+... +..+|+.++... +||||+++++++.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 56789999999999999999999999999999999987622 334677666655 8999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe-CCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL-DEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl-~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+|||++.|+.+.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999999999999988666668888999999999999999999999999999999 58899999999998743321
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
..+.|-|..|+|||++...+|+ .++|+||||++||+||+|+.||...... ++..++..+.+. .++|+.+++||+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQ 544 (612)
T ss_pred --hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHH
Confidence 6677889999999999988886 9999999999999999999999765444 677777665544 889999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 013522 254 KLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf 275 (441)
+||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.66 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=208.5
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHE 86 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 86 (441)
..+.-.++|++++.||+|+||+||+|.+... +..||+|++.... .....+.+.+|+.+|+.++ ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3445567899999999999999999987533 3469999986543 2234567889999999996 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhc------------------------------------------------------
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAK------------------------------------------------------ 112 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~------------------------------------------------------ 112 (441)
++.+...+|+|||||++|+|.+++..
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 99999999999999999999988753
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcE
Q 013522 113 -------------------------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 149 (441)
Q Consensus 113 -------------------------------------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NI 149 (441)
..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367778889999999999999999999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH-
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV- 227 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~- 227 (441)
|++.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999999875432222222233457788999999987666 489999999999999997 99999876443
Q ss_pred HHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 SMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..+..+..+ ....+..++.++.++|.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333344433 23456678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=332.57 Aligned_cols=252 Identities=30% Similarity=0.496 Sum_probs=211.8
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKIYFAM 98 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 98 (441)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++.+. ...|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998664 2233456788999999999999999999999888 8999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.+ +|.+.+.. ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 4799999999999999999999999999999999999999999999999999875543221 12
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC------------------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------------------ 238 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------------ 238 (441)
.....+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 33446788999999876654456899999999999999999999988776655554433100
Q ss_pred -----CC-------CCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 239 -----KC-------PPW-FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 239 -----~~-------~~~-~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.. ... +++.+.++|++||..||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 011 37889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=386.78 Aligned_cols=262 Identities=32% Similarity=0.537 Sum_probs=225.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.+.-||.-+.+||.|.||.||.|.+..+|+..|+|-+...... ......+.+|..++..++|||+|++|++-.+.+..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3556889999999999999999999999999999998765443 345678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc--
Q 013522 96 FAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK-- 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~-l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~-- 172 (441)
|.||||.||+|.+.++.|+ .+|...+.|..|++.|++|||++||+||||||+||+++.+|.+|++|||.|.......
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999999865 6777788899999999999999999999999999999999999999999987543321
Q ss_pred cCCcccccccCCCccchhhhhccC--CCCCcccHHHHHHHHHHHhhCCCCCCCC--cHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
-.+.+....|||.|||||++.+.. ..+-++|||||||++.||+||+.||... +..-+|.--.-..+++|..+|++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 123456778999999999997643 3356899999999999999999999764 333444433334677898999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++||.+||+.||++|+++.|+++|.|-+..
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999999999987644
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.43 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=213.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
-..+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999977 89999999876532 235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 97 AMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||||+++++|.+++.. ..++...+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-- 157 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-- 157 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence 9999999999999975 45899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRL 251 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l 251 (441)
........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+.+..+..+ ..+.|..+++.+.++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred cccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 111223345678999999977666 488999999999999998 89999988877777777654 345567789999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 013522 252 ITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~ 271 (441)
|.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=334.41 Aligned_cols=256 Identities=24% Similarity=0.423 Sum_probs=215.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEV 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 87 (441)
..+-.++|++.+.||+|+||.||+|.+... ...+|+|.+..... ......+.+|+.+++.+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 445567899999999999999999998643 37899999875432 23446788999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEE
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 150 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NIL 150 (441)
+...+..|++|||+.+|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999999999999853 35889999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHH
Q 013522 151 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSM 229 (441)
Q Consensus 151 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~ 229 (441)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 99999999999999875443221111222335677999999877666 488999999999999997 9999998888777
Q ss_pred HHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 230 YRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 230 ~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+..+..+. ...|..++..+.+|+.+||.+||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77766653 34566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=363.38 Aligned_cols=247 Identities=33% Similarity=0.556 Sum_probs=206.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEE-EEe---C-
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEV-MAS---K- 91 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~-~~~---~- 91 (441)
..+++|.+.|-+|||+.||+|++...|..||+|.+-.. +...++.+++||++|+.|+ |||||.+++. ... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34678899999999999999999888899999988544 4456889999999999995 9999999993 221 1
Q ss_pred --CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
-.++|.||||.||.|.|++.. .+|+|.++.+||.|+++||++||... |||||||-|||||+.+|..||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 247899999999999999974 56999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc--CC--c---ccccccCCCccchhhhh---ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH
Q 013522 165 SAFSEHLKQ--DG--L---LHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 165 a~~~~~~~~--~~--~---~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 234 (441)
|+-.-.... .. . .-...-||.|+|||.+. +.+. +.|+|||+|||+||-|+....||...... .|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL----AIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce----eEE
Confidence 863211110 00 0 01123699999999973 4444 59999999999999999999999887432 477
Q ss_pred cCCCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 235 RGDFKCPP--WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 235 ~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.+.+|+ .++..+.+||+.||++||++||++.+++.+
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 88888876 589999999999999999999999998765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=327.98 Aligned_cols=267 Identities=31% Similarity=0.584 Sum_probs=238.6
Q ss_pred CCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013522 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA 89 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 89 (441)
...+.+-..+|++++.||+|+|++|.+++.+.|.+.+|+|++.++-+...+..+-+..|-.+..+- +||.+|.++.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 345566678999999999999999999999999999999999988877767777788888887665 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
+++.+++|.||++||+|.-.+++ .+++|+.++.|...|+-||+|||++||+.||||..|+|+|..|.+|++|+|+.+
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck-- 399 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-- 399 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh--
Confidence 99999999999999999877766 679999999999999999999999999999999999999999999999999986
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC--------CcHHHHHHHHHcCCCCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--------DNIVSMYRKIYRGDFKC 240 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~~~ 240 (441)
+...+.....+.||||.|+|||++.+..| +..+|.|+|||+|+||++|+.||+- .+...+++-|......+
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 34556677889999999999999998877 6999999999999999999999952 23445677788888999
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCcccCccCC
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIA------ISKIMESSWFKKSAP 280 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t------~~eil~hpwf~~~~~ 280 (441)
|..+|-.+..+++..|.+||..|.. ..++..|+||+...+
T Consensus 479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 9999999999999999999999975 679999999986543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.25 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=206.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
.+-.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ....+.+.+|+.+++++ +||||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3445789999999999999999997543 457899999865432 23346778899999999 899999999987
Q ss_pred Ee-CCEEEEEEeccCCCchHHHHhc-------------------------------------------------------
Q 013522 89 AS-KSKIYFAMDLVKGGELFNKIAK------------------------------------------------------- 112 (441)
Q Consensus 89 ~~-~~~~~lv~E~~~gg~L~~~i~~------------------------------------------------------- 112 (441)
.. ...++++|||+++++|.+++..
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 54 4678999999999999998853
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCC
Q 013522 113 -------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185 (441)
Q Consensus 113 -------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~ 185 (441)
..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++................+++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 1578889999999999999999999999999999999999999999999999875432221111223445778
Q ss_pred ccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHH-HHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCC
Q 013522 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS-MYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 186 y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+|||++.+..+. .++|||||||++|+|++ |..||.+....+ ....+..+ ....|..+++++.+++.+||+.+|++
T Consensus 241 y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~ 319 (337)
T cd05054 241 WMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED 319 (337)
T ss_pred ccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence 9999999887775 88999999999999998 999998754333 33333333 23345667899999999999999999
Q ss_pred CCCHHHHhcC
Q 013522 263 RIAISKIMES 272 (441)
Q Consensus 263 R~t~~eil~h 272 (441)
|||+.++++|
T Consensus 320 RPs~~ell~~ 329 (337)
T cd05054 320 RPTFSELVEI 329 (337)
T ss_pred CcCHHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=335.57 Aligned_cols=255 Identities=22% Similarity=0.391 Sum_probs=213.1
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELH 85 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 85 (441)
.....++|.+++.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556899999999999999999998632 34579999986542 223456788999999999 699999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCc
Q 013522 86 EVMASKSKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 148 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~N 148 (441)
+++.+...+|++|||+++|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 999999999999999999999999864 237888899999999999999999999999999999
Q ss_pred EEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH
Q 013522 149 LLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV 227 (441)
Q Consensus 149 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~ 227 (441)
||++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875432221111222334568999999987665 488999999999999999 99999988888
Q ss_pred HHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 SMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..+..+..+. ...|..++.++.++|.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7777776654 3456678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=327.86 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=209.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||+|+||+||+|++..+ ..||+|.+..... ..+.+.+|+.+++.++||||+++++.+. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 4567899999999999999999998655 4699999875432 2357889999999999999999999875 45689
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+||||+.+++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999975 357899999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 250 (441)
. .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+. .+.+..++..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1 11223446778999999877666 489999999999999999 899998887777777765542 3455668899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
+|.+||++||++|||+.++++
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=334.43 Aligned_cols=256 Identities=24% Similarity=0.378 Sum_probs=216.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..+.|...+.||+|+||+||+|++..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 44558888999999999999999999999999999976554444455678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||||+.| ++.+.+.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 9999965 77777754 568999999999999999999999999999999999999999999999999875321
Q ss_pred CcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC--CCCCCHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFSSEARR 250 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 250 (441)
......|++.|+|||.+.. ....+.++|||||||++|+|++|..||...+.......+.....+. .+.++..+++
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 2234578999999999842 2333578999999999999999999998877666555555443322 2346788999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||.+||+++|.+||++.+++.||||+...
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=333.85 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=211.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999864 3456799998854432 33467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 93 KIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
..++||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378899999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999875432221122233456888999999987665 488999999999999998 999998888777777777
Q ss_pred cCCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 235 RGDFK-CPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 235 ~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+... .+..++..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66543 45567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=326.19 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=210.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 44578999999999999999999974 457899999865432 2456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++|||+.|++|.+++.. ..++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999975 258999999999999999999999999999999999999999999999999987654211
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 250 (441)
.. ......++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ..+.+..++..+.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 11 1111123457999999877665 488999999999999999 99999988877777776554 23456668899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+||..||.+||++.++++
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.74 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=210.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCC----------------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTG----------------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 81 (441)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ....+.+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 5589999875532 2456788999999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHhc-C-----------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcE
Q 013522 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAK-G-----------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 149 (441)
Q Consensus 82 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~-----------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NI 149 (441)
+++++++......+++|||+.+++|.+++.. . .+++..++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999999875 2 589999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh--CCCCCCCCcHH
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIV 227 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~--G~~Pf~~~~~~ 227 (441)
+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875432222222334456788999999877655 589999999999999998 78899877666
Q ss_pred HHHHHHHcC--------CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 SMYRKIYRG--------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ~~~~~i~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.....+... ....++.++.++.++|.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665555432 12345567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=334.96 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=218.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
....|+..+.||+|+||.||+|++..++..+|+|.+.............+.+|+.+++.++|||++++++++.+....|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 33458899999999999999999999999999999976544444556788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||||+.| +|.+.+.. .++++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9999975 77777643 6689999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC--CCCCCHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFSSEARR 250 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 250 (441)
.....|++.|+|||.+.. .+..+.++|||||||++|+|++|..||...+.......+....... +..+++.+++
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 234568999999999842 2334588999999999999999999998877666666665544322 2347889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
+|.+||+.+|.+|||+.++++|+|+......
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 9999999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=326.95 Aligned_cols=249 Identities=20% Similarity=0.362 Sum_probs=210.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+-.++|++.++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+.+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34578999999999999999999974 567899998765332 2467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++|||+++++|.+++.. ..++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999864 458889999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 250 (441)
. .......++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+..+. .+.+..++.++.+
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD 235 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 11122335678999999877665 478999999999999998 999999887777777766542 3334567899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+||..||++|||++++++
T Consensus 236 li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 236 IMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=360.87 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=196.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-CcEEEEEE--------------eecccccchhhHHHHHHHHHHHHhCCCCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQT-GKSMAMKV--------------VGKDKVIKVGMMEQIKREISVMKMVKHKH 80 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~hpn 80 (441)
.+.++|++++.||+|+||+||+|..... +...+.|. +.+...........+.+|+.+|+.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 4567899999999999999999876432 22222221 11111111223567889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC
Q 013522 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKG------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED 154 (441)
Q Consensus 81 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~ 154 (441)
|+++++++.+.+..|+|+|++. ++|..++..+ ......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 4787777542 23466788999999999999999999999999999999999
Q ss_pred CCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCC-CCCCC--cHHHHHH
Q 013522 155 GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL-PFQDD--NIVSMYR 231 (441)
Q Consensus 155 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~-Pf~~~--~~~~~~~ 231 (441)
+.+||+|||++....... .......+||+.|+|||++.+..+. .++|||||||++|+|++|.. ||... +....+.
T Consensus 304 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999997554221 1222346799999999999887774 88999999999999999875 44322 1111111
Q ss_pred HHHc----------------------CCC-----CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 232 KIYR----------------------GDF-----KCP-----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 232 ~i~~----------------------~~~-----~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++.. ..+ ..+ ..++.++.++|.+||.+||.+|||+.|+|.||||....
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 1111 000 000 12456788899999999999999999999999997653
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=333.73 Aligned_cols=248 Identities=22% Similarity=0.360 Sum_probs=208.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 95 (441)
++|++.+.||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+.+++++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 4688877532 1223456788999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeE
Q 013522 96 FAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLK 158 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vk 158 (441)
+++||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998642 478899999999999999999999999999999999999999999
Q ss_pred EeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC
Q 013522 159 VTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD 237 (441)
Q Consensus 159 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 237 (441)
|+|||++........ ......+..|+|||++.+..+ +.++|||||||++|+|++ |..||...+......++..+.
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999863221100 111223456999999877666 489999999999999997 999999988888777776653
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 238 -FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 238 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
...|..+++.+.+||.+||..||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566689999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=326.33 Aligned_cols=247 Identities=21% Similarity=0.362 Sum_probs=208.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++.+.||+|+||+||.|.+. .+..+|+|.+..... ..+.+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 57999999999999999999874 345699998865432 2356889999999999999999999999889999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999999975 4689999999999999999999999999999999999999999999999999864322111 01
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~ 254 (441)
.....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+... .+...++.+++++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 111234567999999977666 478999999999999998 99999988877777777665433 355578999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 013522 255 LLDPNPNSRIAISKIMES 272 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~h 272 (441)
||.+||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=324.54 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=220.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+|++.+.||+|+||.||++++..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999999765432 2345667789999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 100 LVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 100 ~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 56899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CCCCCCHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWFSSEARRLIT 253 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~ 253 (441)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...+.......+..+..+ .+..++.+++++|.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 3344568999999999987666 47899999999999999999999998887777777666543 45568899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCccc
Q 013522 254 KLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf 275 (441)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=328.79 Aligned_cols=252 Identities=20% Similarity=0.337 Sum_probs=210.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
+...+|++.+.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345689999999999999999999877776 48999986442 223456788999999999999999999998754
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..++++||+++|+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999999975 568999999999999999999999999999999999999999999999999987554
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 247 (441)
............+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+. .+.++.++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence 32111112223356789999999877664 88999999999999998 999998877666666665543 3456678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.++|.+||..||++|||+.++++
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=352.25 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=221.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+.+..+...++..||+|+||+||+|+|-. .||||++.-+.... ..++.+++|+.++++-+|.||+-+.+++..+..
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 45666778889999999999999999954 59999998766544 588999999999999999999999999988877
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.||..+|.|.+|+.++.- -++.-...+.|++|+++|+.|||.++|+|||||..|||+.+++.|||+||||++.....
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 899999999999999964 56888999999999999999999999999999999999999999999999999876666
Q ss_pred ccCCcccccccCCCccchhhhhc---cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-----CCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-----PPW 243 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~ 243 (441)
.....+....|...|||||++.. .+| +..+|||||||++|||+||.+||...+...++..+.+|.... ...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 66666777889999999999964 344 588999999999999999999999888888888877774321 234
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
++.++++|+..||..++++||++.+||.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6779999999999999999999999986
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.88 Aligned_cols=248 Identities=33% Similarity=0.530 Sum_probs=214.2
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988999999999976543 346788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 100 LVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 100 ~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 9999999999876 3789999999999999999999999999999999999999999999999999875443221 3
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-CCCC--CCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-FKCP--PWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~~~li~~ 254 (441)
....|+..|+|||.+....+ +.++|+||||+++|+|++|..||...+............ ...+ ..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999976654 588999999999999999999998875544443333322 2222 2248899999999
Q ss_pred hcCCCCCCCCCHHHHhcCcc
Q 013522 255 LLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpw 274 (441)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=366.80 Aligned_cols=149 Identities=34% Similarity=0.616 Sum_probs=139.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999876555555567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
|||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999975 678999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=337.48 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=212.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIY 95 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~ 95 (441)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 57889999999999999999999999999999999865432 22345678899999999999999999999865 56789
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+++||+ +++|...+..+++++..+..++.||++||.|||+.||+||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999999 56899888888899999999999999999999999999999999999999999999999999874321
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-------------------- 235 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------------- 235 (441)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223456789999999986644446899999999999999999999987654322211110
Q ss_pred ------CCCCC-----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 236 ------GDFKC-----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 236 ------~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..... .+.+++.++++|++||+.+|++|||+++++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00011 134678999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=349.45 Aligned_cols=234 Identities=24% Similarity=0.427 Sum_probs=208.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
++-||.|+-|.||+|+. .++.||||.++.- -..+|+.|++|+||||+.+.++|.....+|||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 46799999999999997 7789999977422 22578899999999999999999999999999999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
|.|...++. ..+.......|..+|+.|++|||.+.|||||||.-||||+.+..|||+|||-++-... .......+|
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhhhhh
Confidence 999999987 5688999999999999999999999999999999999999999999999999874433 355677899
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHhcCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP 260 (441)
|..|||||++.+.+.. .|+|||||||+|||||||..||.+-+...++.-+...- .+.|..+++.++-||++||.-.|
T Consensus 274 TVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 9999999999988875 99999999999999999999999988777666555543 46678899999999999999999
Q ss_pred CCCCCHHHHhcCc
Q 013522 261 NSRIAISKIMESS 273 (441)
Q Consensus 261 ~~R~t~~eil~hp 273 (441)
.+||++.+||.|-
T Consensus 353 RNRPSFrqil~Hl 365 (904)
T KOG4721|consen 353 RNRPSFRQILLHL 365 (904)
T ss_pred CCCccHHHHHHHH
Confidence 9999999999983
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=334.05 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=211.5
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHE 86 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 86 (441)
......++|.+.+.||+|+||.||+|.+ ..++..+|+|.+..... ....+.+.+|+.+++++ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 3456677899999999999999999985 23556899999865432 23456789999999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecC
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFG 163 (441)
++...+..|++|||+.+|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++++|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 999999999999999999999999752 38999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC--CCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKC 240 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~ 240 (441)
++................+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||...+............ ...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 9875432211111222346788999999977766 488999999999999998 999998776554444443332 234
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+...++.+.+++.+||.++|++|||+.++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5668899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=333.26 Aligned_cols=257 Identities=22% Similarity=0.410 Sum_probs=216.0
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNL-------QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVEL 84 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l 84 (441)
...+...+|.+++.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 45677889999999999999999999853 234579999986442 223456789999999999 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCC
Q 013522 85 HEVMASKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147 (441)
Q Consensus 85 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~ 147 (441)
++++......|++|||+.+++|.+++... .++...+..++.||+.||.|||++|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999998642 3677888999999999999999999999999999
Q ss_pred cEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcH
Q 013522 148 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI 226 (441)
Q Consensus 148 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~ 226 (441)
||+++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999998754432222222334467789999999776664 88999999999999998 8999998888
Q ss_pred HHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 227 VSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 227 ~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..+...+..+. ...|..++..+.+||.+||.++|.+|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 88887776553 34466788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=326.35 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=209.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..++|++.+.||+|+||.||+|.+. ++..+|+|.+...... .+.+.+|+.++++++||||+++++++. ....
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 345678999999999999999999875 5677999998765432 356889999999999999999999875 4568
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
|++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999999864 35899999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 249 (441)
. ........++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.+..+....+..+ ..+.+...+..+.
T Consensus 156 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05070 156 E-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233 (260)
T ss_pred c-cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 111112235567999999876665 488999999999999999 99999988877777777654 3455667889999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
+|+.+||.+||++|||+.++.+
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=340.83 Aligned_cols=254 Identities=19% Similarity=0.340 Sum_probs=203.8
Q ss_pred eeeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 25 RMLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 25 ~~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
..||.| +||+||+|.+..+|+.||+|++...... ....+.+++|+.+++.++||||+++++++..++..|+|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765432 2445789999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC----
Q 013522 103 GGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG---- 175 (441)
Q Consensus 103 gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~---- 175 (441)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999999875 348999999999999999999999999999999999999999999999998653221111100
Q ss_pred -cccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC--------------
Q 013522 176 -LLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-------------- 239 (441)
Q Consensus 176 -~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 239 (441)
......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||..................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011223567799999987642 2358899999999999999999999876554443333222110
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 ---------------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 ---------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+..+++.+.+||++||..||++|||+.++++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 1122567899999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=330.10 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=211.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
...+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3467899999999999999999743 356789999875432 24467899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 92 SKIYFAMDLVKGGELFNKIAKG----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
...+++|||+++++|.+++... .+++..+..++.||+.||+|||++|++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999999999998652 378899999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...........+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 9999999998643321111112233457889999999877764 88999999999999998 999998877777777666
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 235 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+. ...|..+++.+.++|.+||+.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 653 3456678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.43 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=217.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 94 (441)
+|++.+.||.|+||.||+|++..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999998999999999875432 2234567889999999999999999999987765 79
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|++|||+.+ +|.+.+.+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999975 88888876 5799999999999999999999999999999999999999999999999999876543221
Q ss_pred -CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-------------
Q 013522 174 -DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK------------- 239 (441)
Q Consensus 174 -~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 239 (441)
........+++.|+|||++.+....+.++|+||+||++|+|++|.+||...+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012344568999999999987744468999999999999999999999988876665555431100
Q ss_pred ------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 ------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 ------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+.+++.+.+||.+||++||++|||+.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1123678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=330.34 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=219.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..+.|++.+.||+|+||.||.|.+..++..+|+|++..... ....+.+|+.+++.++||||+++++.+...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 44569999999999999999999988899999999975432 35678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
++||+.|++|.+++... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999999874 79999999999999999999999999999999999999999999999999876443221
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CC--CCCCCHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KC--PPWFSSEARRL 251 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~--~~~~~~~~~~l 251 (441)
.......+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+..... .. +..++..+.++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 12234458899999999887666 4889999999999999999999998776655555544332 22 23378899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
|.+||+.+|.+|||+.++++||||.+.
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.30 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=209.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS---- 90 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 90 (441)
.+-.+||+|.+.||.|||+.||++++..+++.||+|.+.... ....+...+|++..++++||||++++++...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 345679999999999999999999999999999999986654 2456788999999999999999999887533
Q ss_pred -CCEEEEEEeccCCCchHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCCeEEeec
Q 013522 91 -KSKIYFAMDLVKGGELFNKIAK----G-RLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 91 -~~~~~lv~E~~~gg~L~~~i~~----~-~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~vkl~DF 162 (441)
....|+++.|...|+|.+.++. | .++|.++..||.++++||.+||+.. ++||||||.|||+++.+.+++.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 3459999999999999999974 3 5899999999999999999999998 999999999999999999999999
Q ss_pred CccccccccccCCc-------ccccccCCCccchhhhhccCC--CCCcccHHHHHHHHHHHhhCCCCCCCCcH--HHHHH
Q 013522 163 GLSAFSEHLKQDGL-------LHTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNI--VSMYR 231 (441)
Q Consensus 163 Gla~~~~~~~~~~~-------~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~~ll~G~~Pf~~~~~--~~~~~ 231 (441)
|.++...-.-.+.. ......|..|.|||.+.-+.+ -+.++|||||||+||.|+.|.-||+.... ..+..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99875432211110 122346899999999864432 25899999999999999999999964321 12222
Q ss_pred HHHcCCCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 232 KIYRGDFKCPP--WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 232 ~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+..+.+.+|. .+|+.+.+||+.||++||.+||++.+++.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 34455555554 489999999999999999999999999864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=325.01 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=204.3
Q ss_pred eecccCceEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 26 MLGHGTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
.||+|+||+||+|.+ ..++..+|+|++..... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 46788999999865432 2345678899999999999999999999875 4567899999999
Q ss_pred CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC-Ccccccc
Q 013522 104 GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLLHTTC 181 (441)
Q Consensus 104 g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~~ 181 (441)
++|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999965 67899999999999999999999999999999999999999999999999998754322111 0112223
Q ss_pred cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCC
Q 013522 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 259 (441)
Q Consensus 182 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~d 259 (441)
+++.|+|||.+....+ +.++|+|||||++|+|++ |..||.+.+.......+..+. ++.|..+++++.++|.+||++|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 478999999999999998 999999888777777777654 4567779999999999999999
Q ss_pred CCCCCCHHHHhc
Q 013522 260 PNSRIAISKIME 271 (441)
Q Consensus 260 P~~R~t~~eil~ 271 (441)
|++|||+++|.+
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=339.93 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=209.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+.++|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 45799999999999999999999999999999999875432 223345678999999999999999999998654
Q ss_pred -CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 -SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 -~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..+|+|+||+.+ +|.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred CceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999964 666654 34689999999999999999999999999999999999999999999999999864321
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------- 237 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 237 (441)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 22345678999999998764444689999999999999999999998877555444333210
Q ss_pred ----------CCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 ----------FKC--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 ----------~~~--------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... .+..++.+.+||.+||+.||++|||+++++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 001 123577899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=330.52 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=208.6
Q ss_pred CeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
+|++.+.||+|+||+||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235799998865432 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcE
Q 013522 95 YFAMDLVKGGELFNKIAK-------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 149 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-------------------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NI 149 (441)
|+++||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2367888999999999999999999999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHH
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS 228 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~ 228 (441)
|+++++.+||+|||++...............+++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875432221112233456778999999876655 488999999999999998 999999888877
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 229 MYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 229 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+...+..+ ....|..++.++.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 77666554 33446678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=324.45 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=210.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..++|++++.||+|+||.||+|.+ .+++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 45678899999999999999999986 4678899999875543 2357889999999999999999999874 4678
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
|++|||+.+++|.+++.. ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999999999864 46889999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 249 (441)
. ........++..|+|||++....+ +.++||||||+++|++++ |++||.+.+.......+..+ ..+.+..++.++.
T Consensus 156 ~-~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 156 E-YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233 (260)
T ss_pred C-cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 111122345678999999876665 488999999999999999 99999988877777766554 2345566789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
++|.+||..||++|||+++++.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=332.26 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=206.0
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv 97 (441)
.+|+..+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4567788999999999999999999999999998754322 34567889999999996 99999999999999999999
Q ss_pred EeccCCCchHH---HHh---cCCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 98 MDLVKGGELFN---KIA---KGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 98 ~E~~~gg~L~~---~i~---~~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
|||+.+ ++.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 4433 322 26799999999999999999999974 999999999999999999999999999864332
Q ss_pred cccCCcccccccCCCccchhhhhcc--CCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHHcCCC-CCC----C
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDF-KCP----P 242 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~~----~ 242 (441)
........|++.|+|||++.+. ...+.++||||+||++|+|++|++||..... ......+..+.. ..+ .
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1222344689999999999765 2345889999999999999999999976542 122223332222 121 2
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.++.++.+||.+||.+||++|||+.++++||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 378899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.54 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=202.3
Q ss_pred cCCe-EEeeeecccCceEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 013522 18 HGKY-ELGRMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-- 90 (441)
Q Consensus 18 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 90 (441)
.+|| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998865 335788999999865422 2235678899999999999999999998765
Q ss_pred CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
....|++|||+.+++|.+++....+++..++.++.|++.||.|||++||+||||||+|||+++++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccCC-cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH--H-------------HHHHHH
Q 013522 171 LKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV--S-------------MYRKIY 234 (441)
Q Consensus 171 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~--~-------------~~~~i~ 234 (441)
..... ......++..|+|||.+....+ +.++|||||||++|+|++|..||...... . ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 21111 1122345677999999877665 48999999999999999999998653311 1 111111
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 235 RG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 235 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+ ..+.|..++..+.+++.+||++||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 22345667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=328.87 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=204.4
Q ss_pred EEeeeecccCceEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 22 ELGRMLGHGTFAKVYLARNL----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
++.+.||.|+||.||+|.+. ..+..|+||.+... ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 45678999999442 2233468899999999999999999999999988889999
Q ss_pred EeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 98 MDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||+++|+|.+++... .++......++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999998754221111
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLI 252 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li 252 (441)
.......+...|+|||.+....+ +.++||||||+++||+++ |+.||.+.+......++..+.. ..|..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 22233456778999999987765 589999999999999999 7899999888888888866543 45667899999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 013522 253 TKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~ 271 (441)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=337.31 Aligned_cols=258 Identities=22% Similarity=0.401 Sum_probs=215.4
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQT-------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 83 (441)
...++...+|++++.||+|+||.||.|++... +..||+|.+.... .......+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 45667778999999999999999999986532 2368999886432 223456888999999999 8999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCC
Q 013522 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146 (441)
Q Consensus 84 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp 146 (441)
+++++...+.+|+++||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999999999999998641 366788889999999999999999999999999
Q ss_pred CcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCc
Q 013522 147 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDN 225 (441)
Q Consensus 147 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~ 225 (441)
+|||++.++.+||+|||+++...............+++.|+|||++.+..+. .++|||||||++|+|++ |..||...+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998754332211122223345679999999876664 88999999999999998 899999988
Q ss_pred HHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 226 IVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 226 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.......+..+. ...|..++..+.+||.+||+.+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888887776653 34566788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.06 Aligned_cols=251 Identities=21% Similarity=0.345 Sum_probs=211.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+.|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+..|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3579999999999999999999877665 59999986542 233457899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++||||+.+++|.+++.. +.++...++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999875 568999999999999999999999999999999999999999999999999987543322
Q ss_pred cCCcccccc---cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 013522 173 QDGLLHTTC---GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247 (441)
Q Consensus 173 ~~~~~~~~~---gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 247 (441)
......... .+..|+|||.+.+..+ +.++|||||||++|++++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 2457999999987766 488999999999999886 99999888777777776543 23445667899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+++.+||..+|.+||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=327.21 Aligned_cols=251 Identities=18% Similarity=0.296 Sum_probs=207.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
-.++|++.+.||+|+||+||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 346899999999999999999999887774 6666664321 1223467788899999999999999999875 45
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..++++||+++|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999964 5689999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 248 (441)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+.. ..+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 222222334457788999999977666 489999999999999998 9999998877666665655543 3355578899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+++.+||..||++|||+.++++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=324.70 Aligned_cols=263 Identities=28% Similarity=0.417 Sum_probs=212.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 92 (441)
...|++.+.||+|+||.||+|....++. .+|||.+..++-. .+.....-+|+.+++.++||||+.+..+|.+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3579999999999999999997655443 6899999765432 2344567799999999999999999999977 88
Q ss_pred EEEEEEeccCCCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC----CCeEEeec
Q 013522 93 KIYFAMDLVKGGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED----GNLKVTDF 162 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~----~~vkl~DF 162 (441)
.+++++||++. +|...|+- ..++...++.++.||+.|++|||++-|.||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999976 78888852 348999999999999999999999999999999999999877 89999999
Q ss_pred CccccccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH---------HHHHHH
Q 013522 163 GLSAFSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---------VSMYRK 232 (441)
Q Consensus 163 Gla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~---------~~~~~~ 232 (441)
|+|+++...-.. ......+-|.+|.|||.+.+...++.+.|||+.|||+.||++-.+.|.+... .+...+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987643322 2344566799999999999998889999999999999999999888865321 122333
Q ss_pred HHc--CCC---------CCCCC--------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 233 IYR--GDF---------KCPPW--------------------------FSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 233 i~~--~~~---------~~~~~--------------------------~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
|.. |.+ ..|.+ -++.+.+|+.+||++||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 322 110 11111 14568999999999999999999999999999
Q ss_pred CccCCcc
Q 013522 276 KKSAPKV 282 (441)
Q Consensus 276 ~~~~~~~ 282 (441)
.++.-++
T Consensus 341 ~~d~lpp 347 (438)
T KOG0666|consen 341 TEDPLPP 347 (438)
T ss_pred ccCCCCC
Confidence 9876553
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.93 Aligned_cols=259 Identities=35% Similarity=0.596 Sum_probs=216.8
Q ss_pred CeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
.|++.+.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999999754332 223456788999999999 699999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+.|++|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 999999999999999875 668999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHHHHcCCCCCCCCCCHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
.......+|++.|+|||.+.+.. ..+.++||||||+++|+|++|..||.... ...+...+.....+.|..+++++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223456899999999986543 24578999999999999999999996432 33444555666677788899999
Q ss_pred HHHHHHhcCCCCCCCCC---HHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRIA---ISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t---~~eil~hpwf~~~~ 279 (441)
.++|.+||+.||++||| +.++|+||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999998 56779999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=322.76 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=207.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3457899999999999999999998554 4699998865432 2356889999999999999999999885 45689
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999965 247899999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 250 (441)
........++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.........+..+ ..+.+..++..+.+
T Consensus 157 -~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred -ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 111122345678999999876665 588999999999999999 99999988877777776654 33456678899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
++++||.+||++|||++++++
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=332.34 Aligned_cols=256 Identities=22% Similarity=0.368 Sum_probs=215.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
...+|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999875443333445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||||+.| ++.+.+.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 9999974 77776643 5689999999999999999999999999999999999999999999999999865332
Q ss_pred CcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC--CCCCCHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFSSEARR 250 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 250 (441)
.....|++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..+..+. +..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 234568999999999853 2233578999999999999999999998776655555554443322 3357889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||++||..+|++||++.++++|||+....
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 99999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.26 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=213.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
...++|++.+.||+|+||+||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999877665 589998865532 2345678899999999999999999999987
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
...++||||+.+|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999999999999975 468999999999999999999999999999999999999999999999999987544
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 247 (441)
............+++.|+|||.+....+. .++|+|||||++|++++ |..||.......+...+..+. .+.|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID 239 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 22111111122245679999998766664 88999999999999998 999999988887777777654 4556678899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+++.+||..||..|||+.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.42 Aligned_cols=251 Identities=23% Similarity=0.353 Sum_probs=211.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4689999999999999999999753 67899999986543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcE
Q 013522 93 KIYFAMDLVKGGELFNKIAKG-----------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 149 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~-----------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NI 149 (441)
..|+++||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999998631 367888899999999999999999999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHH
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS 228 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~ 228 (441)
+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999864322211111222335677999999887766 488999999999999997 889998888777
Q ss_pred HHHHHHcCCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 229 MYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 229 ~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....+..+.. ..|..++..+.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777776654 456678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=323.83 Aligned_cols=251 Identities=21% Similarity=0.351 Sum_probs=210.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3679999999999999999999865443 79999986543 223456889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||++|++|.+++.. +.++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999975 468999999999999999999999999999999999999999999999999987654321
Q ss_pred cCCc-ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 173 QDGL-LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 173 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
.... .....+++.|+|||.+.+..+ +.++|+|||||++|++++ |..||...........+..+. .+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1111 111223567999999987665 589999999999999886 999998877766776666542 344456789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
+++.+||+.+|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=329.10 Aligned_cols=251 Identities=31% Similarity=0.515 Sum_probs=211.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999999999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 101 VKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 101 ~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
+.+ +|.+.+.. +.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88888765 478999999999999999999999999999999999999999999999999987544322 1223
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-------------------CC
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-------------------FK 239 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~~ 239 (441)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+...++...- ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34588899999998776445689999999999999999999998877655544442210 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 240 -----------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 240 -----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=325.28 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=214.1
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
||.+.+.||+|+||+||++.+..++..+++|++...... ......++.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999888888888877543321 122344677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 98 MDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988752 56899999999999999999999999999999999999975 5799999999875432
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRL 251 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l 251 (441)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+.......+..+.. ..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 12233345689999999998776664 789999999999999999999988877777777665543 3456688999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCccc
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf 275 (441)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.77 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=204.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCC--------------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTG--------------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE 83 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~--------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~ 83 (441)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 359999987542 2234567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEE
Q 013522 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKG-------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 150 (441)
Q Consensus 84 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NIL 150 (441)
+++++...+..|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 2678888999999999999999999999999999999
Q ss_pred eCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh--CCCCCCCCcHHH
Q 013522 151 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIVS 228 (441)
Q Consensus 151 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~--G~~Pf~~~~~~~ 228 (441)
++.++.+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875332111111223345678999999877665 589999999999999988 778998766655
Q ss_pred HHHHHHc-----C---CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 229 MYRKIYR-----G---DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 229 ~~~~i~~-----~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....+.. + ....++.+++.+.+||.+||+.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4444321 1 12335567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=320.86 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=212.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||+|+||+||+|.+. ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45689999999999999999999975 557899999875432 2467889999999999999999999999989999
Q ss_pred EEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+||||+++++|.+++.. ..++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999975 358999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 250 (441)
........++..|+|||.+.+..+ +.++|+||+||++|+|++ |+.||.+.+.......+..+ ..+.|...+.++.+
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111112234578999999987655 588999999999999998 99999988877777777665 33456667899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 013522 251 LITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+||..||++||++.++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=339.03 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=204.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA 89 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 89 (441)
.-.++|++++.||+|+||+||+|.+ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 3457899999999999999999985 34678999999965432 23356788999999999 6899999999875
Q ss_pred e-CCEEEEEEeccCCCchHHHHhcC-------------------------------------------------------
Q 013522 90 S-KSKIYFAMDLVKGGELFNKIAKG------------------------------------------------------- 113 (441)
Q Consensus 90 ~-~~~~~lv~E~~~gg~L~~~i~~~------------------------------------------------------- 113 (441)
. ...++++|||+.+|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45789999999999999988531
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccc
Q 013522 114 -------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180 (441)
Q Consensus 114 -------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 180 (441)
.++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 2567778889999999999999999999999999999999999999999998754221111112233
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH-HHHHHHHcC-CCCCCCCCCHHHHHHHHHhcC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRG-DFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~ 257 (441)
.+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+
T Consensus 242 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 320 (343)
T cd05103 242 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 320 (343)
T ss_pred CCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence 45678999999977666 488999999999999997 99999875433 233333333 345566788999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 013522 258 PNPNSRIAISKIMES 272 (441)
Q Consensus 258 ~dP~~R~t~~eil~h 272 (441)
.||++|||+.++++|
T Consensus 321 ~~p~~Rps~~eil~~ 335 (343)
T cd05103 321 GEPSQRPTFSELVEH 335 (343)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=320.76 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=204.1
Q ss_pred eeecccCceEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 013522 25 RMLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876555 78999999765432 34567889999999999999999999876 45689999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC-cccc
Q 013522 102 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG-LLHT 179 (441)
Q Consensus 102 ~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~~ 179 (441)
.+++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 559999999999999999999999999999999999999999999999999987543221110 0111
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcC
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~ 257 (441)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+.... ...|..+++.++++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999977665 489999999999999998 999999888777777766553 35667789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 013522 258 PNPNSRIAISKIME 271 (441)
Q Consensus 258 ~dP~~R~t~~eil~ 271 (441)
+||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.05 Aligned_cols=251 Identities=18% Similarity=0.269 Sum_probs=204.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcC----------------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQ----------------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 81 (441)
.++|++.+.||+|+||+||++.+.. ++..+|+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999986532 34579999986542 22345688999999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcE
Q 013522 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKG------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 149 (441)
Q Consensus 82 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NI 149 (441)
+++++++...+..|++|||+.+++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999998652 256778999999999999999999999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh--CCCCCCCCcHH
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA--GFLPFQDDNIV 227 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~--G~~Pf~~~~~~ 227 (441)
|++.++.++|+|||++................+++.|+|||...+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875432111111222344678999999877665 589999999999999998 78999876655
Q ss_pred HHHHHHHc--------CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 SMYRKIYR--------GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ~~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
........ ...+.|+.+++.+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54443211 123445668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.06 Aligned_cols=259 Identities=34% Similarity=0.584 Sum_probs=223.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..-|..++.||-|+||+|.+++..+|...||+|.+++..+.......+++.|-.||..-..+-||+||..|.+++++|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34588899999999999999999999999999999998887777888999999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC--
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-- 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-- 174 (441)
|+|++||++..++-+ |-+.|+.++.|+..|.+|+++.|+.|+|||||||+|||||.+|.+||+||||++-+...+..
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999998866 89999999999999999999999999999999999999999999999999998654322110
Q ss_pred --------------------------------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh
Q 013522 175 --------------------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA 216 (441)
Q Consensus 175 --------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~ 216 (441)
-..+..+||+.|+|||++.+.+|. ..+|.||.|||||+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhh
Confidence 012445699999999999999986 88999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHc--CCCCCC--CCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCcccCcc
Q 013522 217 GFLPFQDDNIVSMYRKIYR--GDFKCP--PWFSSEARRLITKLLDPNPNSRIA---ISKIMESSWFKKS 278 (441)
Q Consensus 217 G~~Pf~~~~~~~~~~~i~~--~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~~ 278 (441)
|.+||.+++..+...++.. ..+.+| ..+++++.+||.++.. +++.|.. ++++..||||+.-
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence 9999988776554444322 223333 3589999999999764 4788874 6789999999853
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=327.64 Aligned_cols=251 Identities=31% Similarity=0.513 Sum_probs=211.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++.+.||+|+||.||.|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997654 2223456778899999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 101 VKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 101 ~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
+.+ +|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 975 899999764 7999999999999999999999999999999999999999999999999998754332 11233
Q ss_pred ccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC------------------CCCC
Q 013522 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------DFKC 240 (441)
Q Consensus 179 ~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 240 (441)
...+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+....+.++... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456888999999877645568999999999999999999999887766555444321 0001
Q ss_pred -----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 241 -----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 241 -----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+.++..+.++|++||..||++||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 11247789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.19 Aligned_cols=256 Identities=24% Similarity=0.480 Sum_probs=223.1
Q ss_pred ccCCe-EEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 013522 17 LHGKY-ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK- 93 (441)
Q Consensus 17 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~- 93 (441)
-.+|| +....||+|+|-+||+|.|..+|..||.-.+....+. .....+++..|+.+|+.|+||||+++|+.+.+..+
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 45666 5678999999999999999999999998766544443 34567899999999999999999999999987665
Q ss_pred -EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc--CcEeccCCCCcEEeCCC-CCeEEeecCccccc
Q 013522 94 -IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR--GVYHRDLKPENLLLDED-GNLKVTDFGLSAFS 168 (441)
Q Consensus 94 -~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~--gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~ 168 (441)
+.+|.|.+.+|+|+.+.++ ++.+-..++.|++||+.||.|||++ .|+|||||.+||||+.+ |.|||+|+|||++.
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8899999999999999988 8899999999999999999999998 59999999999999865 89999999999975
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCC-CCcHHHHHHHHHcCCCCC--CCCCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ-DDNIVSMYRKIYRGDFKC--PPWFS 245 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~~~~~~~--~~~~~ 245 (441)
.. .......|||.|||||... ..|+ ..+||||||+.|.||+|+..||. ..+...+|+++..|..+- ..--.
T Consensus 197 r~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 197 RK----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred hc----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 54 2334478999999999986 5676 89999999999999999999996 588999999999986432 22237
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++++++|.+||.. .+.|+|+.|+|+||||....
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 8999999999999 99999999999999998753
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.52 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=210.1
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHE 86 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~ 86 (441)
.+.+-.++|.+++.||+|+||.||+|++. .+++.||+|++..... ......+.+|+.+|..+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 35566678999999999999999999964 3456899999975432 233457889999999997 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC-----------------------------------------------------
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAKG----------------------------------------------------- 113 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~~----------------------------------------------------- 113 (441)
++...+.+|+||||+++|+|.+++...
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 999999999999999999999998542
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCC
Q 013522 114 ----------------------------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147 (441)
Q Consensus 114 ----------------------------------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~ 147 (441)
.++...+..++.||+.||.|||+.|++||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2456677889999999999999999999999999
Q ss_pred cEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcH
Q 013522 148 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI 226 (441)
Q Consensus 148 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~ 226 (441)
|||++.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999875432211112223457888999999987665 588999999999999998 8999987654
Q ss_pred HHHH-HHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 227 VSMY-RKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 227 ~~~~-~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.. ..+..+ ....|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4443 333333 244567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=319.48 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=202.1
Q ss_pred eecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 013522 26 MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKG 103 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g 103 (441)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 445679999986542 2234567899999999999999999999885 4578999999999
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc-cccc
Q 013522 104 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL-LHTT 180 (441)
Q Consensus 104 g~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~~ 180 (441)
++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999864 5789999999999999999999999999999999999999999999999999875432211111 1112
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~ 258 (441)
.+++.|+|||.+....+ +.++|||||||++|++++ |..||.+.........+..+. ..+|+.+++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23578999999877665 488999999999999996 999999888777777776653 456778899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 013522 259 NPNSRIAISKIME 271 (441)
Q Consensus 259 dP~~R~t~~eil~ 271 (441)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.39 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=206.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQT--GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS----KS 92 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~ 92 (441)
+|++.+.||+|+||.||+|.+..+ +..||+|.+..... .......+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 89999999864321 222356778899999999 59999999987532 25
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 589888865 67899999999999999999999999999999999999999999999999998754322
Q ss_pred cc--CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------
Q 013522 172 KQ--DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------- 236 (441)
Q Consensus 172 ~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 236 (441)
.. ........||+.|+|||.+.+....+.++||||+||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112334578999999998866433458999999999999999999999876543333222110
Q ss_pred ------------C---CC---CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 ------------D---FK---CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ------------~---~~---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. .. ..+..+..+.+|+.+||+.||++|||+.+++.||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 0 00 1123578899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=318.96 Aligned_cols=242 Identities=23% Similarity=0.443 Sum_probs=210.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ...++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 46799999999999999999997 588999999965532 457888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 98 MDLVKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|||+++++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence 999999999999975 2 5899999999999999999999999999999999999999999999999998754221
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLI 252 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li 252 (441)
.....++..|+|||.+....+ +.++||||||+++|+|++ |..||...+...+...+..+ ....|..+++.+.++|
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred --cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 112334567999999876655 488999999999999997 99999988877777766654 3345667899999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 013522 253 TKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~ 271 (441)
.+||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=324.12 Aligned_cols=249 Identities=31% Similarity=0.487 Sum_probs=206.7
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMASKSK---- 93 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~---- 93 (441)
|++.+.||.|+||.||+|++..+++.||+|.+..... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975433 223344566788877766 59999999999987776
Q ss_pred -EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 94 -IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 94 -~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
++++|||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888865 358999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-----CCC----
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD-----FKC---- 240 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-----~~~---- 240 (441)
.. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||.+.+..+.+.++.... ...
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 22234457899999999987665 488999999999999999999999887766665554310 000
Q ss_pred ------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 241 ------------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 241 ------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01245778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=320.14 Aligned_cols=251 Identities=20% Similarity=0.325 Sum_probs=210.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
...|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876654 79999886542 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||+++++|.+++.. +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999864 578999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcc-cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 173 QDGLL-HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 173 ~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
..... .....++.|+|||++....+ +.++|||||||++|+|++ |..||...+.......+..+. .+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11123457999999987666 488999999999999997 999998887777777776542 233445789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
+++.+||..||++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=321.85 Aligned_cols=241 Identities=23% Similarity=0.378 Sum_probs=201.1
Q ss_pred eeecccCceEEEEEEEcCCCc--EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 013522 25 RMLGHGTFAKVYLARNLQTGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988776 46888775322 223456788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 102 KGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 102 ~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCC
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPP 242 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~ 242 (441)
+....... .......++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 85322111 1112234567999999876665 488999999999999997 999998888777777766542 34455
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.++.++.+|+.+||..||.+|||+.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=318.11 Aligned_cols=241 Identities=24% Similarity=0.438 Sum_probs=206.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM-ASKSKIYF 96 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~l 96 (441)
..+|++.+.||+|+||.||+|.. .|..+|+|.+.... ..+.+.+|+.+++.++|||++++++++ ...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 46799999999999999999987 57889999985432 245788999999999999999999975 45678999
Q ss_pred EEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 97 AMDLVKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+|||+++++|.+++.. + .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--- 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---
Confidence 9999999999999875 2 378999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRL 251 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 251 (441)
......++..|+|||++....+ +.++|||||||++|+|++ |++||...+.......+..+. ...++.+++.+.++
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 --TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred --cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 1123345678999999877665 488999999999999997 999999888877777766553 34466789999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 013522 252 ITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~ 271 (441)
|.+||..||++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=322.41 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=210.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQ----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-K 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~ 91 (441)
-.++|++.+.||+|+||.||.|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 45789999999999999999999875 35889999886432 33446778899999999999999999998755 5
Q ss_pred CEEEEEEeccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeec
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DF 162 (441)
...++++||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 778999999999999999864 34789999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCC
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKC 240 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~ 240 (441)
|+++...............++..|+|||++.+..+ +.++|||||||++|++++ |.+||...+...+...+..+. +..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence 99874432111111123346678999999977666 488999999999999999 999999888777776665542 344
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+..+++++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=316.86 Aligned_cols=243 Identities=26% Similarity=0.389 Sum_probs=205.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 999999998765432 34568899999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 105 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 105 ~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
+|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999964 5688999999999999999999999999999999999999999999999999874331111111112234
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP 260 (441)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 589999999999999998 89999888776666666554 334566788999999999999999
Q ss_pred CCCCCHHHHhc
Q 013522 261 NSRIAISKIME 271 (441)
Q Consensus 261 ~~R~t~~eil~ 271 (441)
.+|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=330.76 Aligned_cols=253 Identities=23% Similarity=0.410 Sum_probs=200.2
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
+++.+| ++|.||.+++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|++|||+.
T Consensus 6 i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhc--CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 344444 445566666667999999999976532 23456789999999999999999999999999999999999999
Q ss_pred CCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc-----C
Q 013522 103 GGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-----D 174 (441)
Q Consensus 103 gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-----~ 174 (441)
+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........ .
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9999999875 4589999999999999999999999999999999999999999999999998764321111 1
Q ss_pred CcccccccCCCccchhhhhcc--CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC--------------
Q 013522 175 GLLHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------------- 238 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-------------- 238 (441)
.......++..|+|||++... .+ +.++|+||+||++|+|++|..||..............+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 122344578889999998653 34 5789999999999999999999987654333221111110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 --------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+..++.++.+||.+||..||++|||+.++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00112356789999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=316.51 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=211.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTG----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+++.+.||.|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357789999999999999998766 8999999965432 1246789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcC-C--CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 97 AMDLVKGGELFNKIAKG-R--LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~-~--l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+|||+++++|.+.+... . +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999752 2 99999999999999999999999999999999999999999999999999875443211
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRL 251 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~l 251 (441)
... ....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+.. ..+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 01236789999999865555 589999999999999998 8999998888777777766543 4466689999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 013522 252 ITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~ 271 (441)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.75 Aligned_cols=238 Identities=24% Similarity=0.324 Sum_probs=198.1
Q ss_pred eeecccCceEEEEEEEcCCCcE-------EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
+.||+|+||+||+|.+..++.. +|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3699999999999998665544 8888875432 23456788899999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC--------eEEeecCcccc
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--------LKVTDFGLSAF 167 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~--------vkl~DFGla~~ 167 (441)
|||+.+|+|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999975 34899999999999999999999999999999999999987765 69999998763
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcHHHHHHHHHcCCCCCCCCCCH
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRGDFKCPPWFSS 246 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 246 (441)
.. ......+++.|+|||++.+....+.++|||||||++|+|++| .+||...+..... .........|...+.
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 32 123456889999999998655446889999999999999998 5677665554433 334445667777789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+||.+||+.||++|||++++++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=316.52 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=209.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999885 4778999998654332 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.+++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccc
Confidence 99999999999864 568999999999999999999999999999999999999999999999999986432211 111
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 254 (441)
.....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+...+...+..+.. ..|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 112234568999999977665 478999999999999998 9999998888777777766533 3355578999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 013522 255 LLDPNPNSRIAISKIMES 272 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~h 272 (441)
||..+|++|||+.++++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=317.46 Aligned_cols=243 Identities=23% Similarity=0.408 Sum_probs=205.4
Q ss_pred eeecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 013522 25 RMLGHGTFAKVYLARNLQ-TGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
+.||+|+||.||+|.+.. +++ .||+|.+...... ...+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999776543 456789999999999999999999999988 8999999999
Q ss_pred CCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC-Ccc
Q 013522 102 KGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-GLL 177 (441)
Q Consensus 102 ~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~ 177 (441)
.+++|.+.+.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999976 35899999999999999999999999999999999999999999999999998765332111 111
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG--DFKCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~ 254 (441)
....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+... ....|..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457788999999877666 488999999999999998 99999888777777666542 233455678999999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 013522 255 LLDPNPNSRIAISKIME 271 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~ 271 (441)
||..+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=324.65 Aligned_cols=249 Identities=31% Similarity=0.476 Sum_probs=206.9
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 99 (441)
|++.+.||+|+||+||+|.+..+++.||+|.+...... .......+|+..++.++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999989999999998654321 11234457899999998 9999999999999999999999
Q ss_pred ccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 100 LVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 100 ~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|+ +++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 7799988865 2689999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------------C
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------------------D 237 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 237 (441)
.....|+..|+|||++.+....+.++|+||||+++++|++|.+||...+....+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 334568899999999865554568999999999999999999999887665544433221 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 238 FK-----------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 238 ~~-----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
.. ..+..+.++.++|++||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.10 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=208.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
++..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 467789999999999999999999864 55679999886542 234678899999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
|++|||+++++|.+++.. ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999999999965 35788889999999999999999999999999999999999999999999998654321
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
. ........++..|+|||++....+ +.++|+|||||++|++++ |.+||...+.......+..+. .+.+...+.++.
T Consensus 156 ~-~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 156 E-YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233 (260)
T ss_pred C-cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHH
Confidence 1 111122335677999999976655 578999999999999998 999999887777776665543 234566889999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 013522 250 RLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~ 271 (441)
+++.+||++||++||++.++++
T Consensus 234 ~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 234 NIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=313.84 Aligned_cols=242 Identities=23% Similarity=0.435 Sum_probs=203.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999986 478899999986543 2233456889999999999999999999999999999999999999
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccccc
Q 013522 105 ELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182 (441)
Q Consensus 105 ~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~g 182 (441)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 99999865 458899999999999999999999999999999999999999999999999986432111 111112334
Q ss_pred CCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCC
Q 013522 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 183 t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP 260 (441)
++.|+|||++.+..+ +.++|||||||++|++++ |..||...+.......+..+. ...+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999976655 588999999999999998 999998887777666666553 35566789999999999999999
Q ss_pred CCCCCHHHHhc
Q 013522 261 NSRIAISKIME 271 (441)
Q Consensus 261 ~~R~t~~eil~ 271 (441)
++|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=320.85 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=211.4
Q ss_pred CCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.+|++.+.||.|+||+||+|++.. +.+.+|+|.+..... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999753 356799998865432 2245778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecC
Q 013522 94 IYFAMDLVKGGELFNKIAK-G---------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~---------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFG 163 (441)
.|+||||+++++|.+++.. . .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999975 3 48999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCCC--C
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFK--C 240 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~--~ 240 (441)
++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+... .
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 97643211 1112233456788999999876665 488999999999999998 89999887777777777655543 3
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+..++..+.+++.+||..||++|||+.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=318.09 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=209.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
-..+|.+.+.||+|+||.||+|.+... ...||+|....... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999997544 34699998864431 2345688999999999999999999998875 45
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.|+||||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999999999999975 35899999999999999999999999999999999999999999999999998754332
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
... ......+++.|+|||.+....+ +.++|||||||++|++++ |..||...+.......+..+. ...|+.+++.+.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SYY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 111 1112234567999999876665 488999999999999986 999999887777776666653 455677899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
++|.+||.++|.+|||+.+++..
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.46 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=209.5
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
...-.+.|++.+.||+|+||+||+|.+..+++.||+|.+.+.... .....+.+|+.++..+ .||||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 345568899999999999999999999988999999999754321 2344566677766666 5999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..|++|||+.+ .|.+.+.. +.+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999854 67666654 578999999999999999999997 699999999999999999999999999986543
Q ss_pred ccccCCcccccccCCCccchhhhhccC---CCCCcccHHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHHcCCC-CCCC--
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKG---YDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDF-KCPP-- 242 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~~~-- 242 (441)
. ........+++.|+|||.+.+.. ..+.++||||||+++|+|++|+.||..... .+.+..+..... ..+.
T Consensus 167 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 167 D---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred C---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 2 11223345788999999986543 234789999999999999999999976332 344444444432 2222
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.++.++.+||.+||..||.+|||+.++++||||...
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 368899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.34 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=194.8
Q ss_pred eeecccCceEEEEEEEcCC------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 25 RMLGHGTFAKVYLARNLQT------------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+.||+|+||.||+|+.... ...+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999985422 2358888875532 234557888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC-------eEEeecC
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-------LKVTDFG 163 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~-------vkl~DFG 163 (441)
..++||||+.+++|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 56899999999999999999999999999999999999987664 8999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHh-hCCCCCCCCcHHHHHHHHHcCCCCCCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYRGDFKCPP 242 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 242 (441)
++..... .....|++.|+|||.+......+.++|||||||++|+|+ +|..||......+.. ....+......
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8764321 123457889999999875454568999999999999997 589999876654433 23334444444
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=317.42 Aligned_cols=228 Identities=28% Similarity=0.444 Sum_probs=193.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHH
Q 013522 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNK 109 (441)
Q Consensus 30 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 109 (441)
|+||+||++++..+++.||+|.+.+.. ...+|...+....||||+++++++.+....|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997643 223455555566799999999999999999999999999999999
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccc
Q 013522 110 IAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188 (441)
Q Consensus 110 i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 188 (441)
+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+..... ......+++.|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 865 5799999999999999999999999999999999999999999999999998754332 1234456788999
Q ss_pred hhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH--
Q 013522 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAI-- 266 (441)
Q Consensus 189 PE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~-- 266 (441)
||.+.+..+ +.++|+||+||++|+|++|+.||....... ........|+++++.++++|.+||+.||++|||+
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876666 488999999999999999999886532211 0112345788899999999999999999999986
Q ss_pred ---HHHhcCccc
Q 013522 267 ---SKIMESSWF 275 (441)
Q Consensus 267 ---~eil~hpwf 275 (441)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=339.14 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=218.5
Q ss_pred CCCCccccCCeEEeeeecccCceEEEEEEEcCCCc---E-EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEE
Q 013522 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGK---S-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 86 (441)
...+.+.+.+-.+.++||+|+||.||+|+....+. . ||+|....+..........+.+|.++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34456667777888999999999999998765422 3 8999987644444566788999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
+......+|+|||+|.||+|.++++. +.++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence 99999999999999999999999987 3499999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccc-cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC--CC
Q 013522 165 SAFSEHLKQDGLLHTTC-GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF--KC 240 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~-gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~ 240 (441)
|+.-... ......+ -...|+|||.+....| +.++||||+||++||+++ |..||.+........+|....+ +.
T Consensus 309 s~~~~~~---~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 309 SRAGSQY---VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred ccCCcce---eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 8753311 1111122 3456999999988755 599999999999999999 8899999999999999966544 45
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
|+..+.++..++.+|+..||++|||+.++.+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 6667889999999999999999999999864
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.69 Aligned_cols=244 Identities=18% Similarity=0.253 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 25 RMLGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999997532 34578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCchHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 103 GGELFNKIAKG------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 103 gg~L~~~i~~~------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
+|+|.+++... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246778899999999999999999999999999999999999999999999864221111111
Q ss_pred ccccccCCCccchhhhhcc------CCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH-cCCCCC-----CCC
Q 013522 177 LHTTCGTPAYVAPEVISKK------GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY-RGDFKC-----PPW 243 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~------~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~-~~~~~~-----~~~ 243 (441)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||............. ....+. +..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233456789999998542 233578999999999999999 899998876655554443 332222 335
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+++.+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=310.15 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=211.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+.+++..||.|+.|.|++++.+.+|...|||.+.+.. +....+++.+.+.++-..+ .|+||+.+++|......++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3456678999999999999999999999999998764 3345678888888877664 899999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|.+.- -+..++.+ ++++|..+-++...+++||.||.+ +||+|||+||+|||+|+.|++|+||||+|...-. ..
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---Sk 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SK 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec---cc
Confidence 99853 34444443 779999999999999999999985 5999999999999999999999999999875432 22
Q ss_pred cccccccCCCccchhhhhc---cCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHHcCCCCCCC---CCCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDFKCPP---WFSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~~---~~~~~~ 248 (441)
......|-+.|||||.+.- ..|+ .++||||||+.|+||.||..||.+- ...+..-++....++..+ .+|+++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 3345569999999999853 3455 8899999999999999999999884 455777777776665432 389999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++|+..||.+|+.+||...++|+|||+..-
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 999999999999999999999999998754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.67 Aligned_cols=251 Identities=21% Similarity=0.352 Sum_probs=207.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.++|++.+.||+|+||.||+|.+..+|. .+|+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999987776 468888764432 22344688999999999999999999998754 4
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.++++||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999875 35899999999999999999999999999999999999999999999999999754432
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
..........+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ++.++.++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22112223446778999999877665 488999999999999997 999998876655555554433 344566789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++.+||..||++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=320.92 Aligned_cols=237 Identities=24% Similarity=0.330 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEEcCC------------------------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc
Q 013522 26 MLGHGTFAKVYLARNLQT------------------------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI 81 (441)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999985322 2358888885432 2334567889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----
Q 013522 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---- 155 (441)
Q Consensus 82 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---- 155 (441)
+++++++.+....|+||||+++|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999864 6789999999999999999999999999999999999997654
Q ss_pred ---CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHH-hhCCCCCCCCcHHHHHH
Q 013522 156 ---NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVL-LAGFLPFQDDNIVSMYR 231 (441)
Q Consensus 156 ---~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~l-l~G~~Pf~~~~~~~~~~ 231 (441)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+| ++|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 12345788999999987654446899999999999998 47999998776554433
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 232 KIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 232 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333445555567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=360.30 Aligned_cols=257 Identities=28% Similarity=0.481 Sum_probs=212.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE------
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA------ 89 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------ 89 (441)
....+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..|.+|+|||||++|..+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 35567888999999999999999999999999999997664 3355778999999999999999999874320
Q ss_pred --------------------------------------------------e----------------------C------
Q 013522 90 --------------------------------------------------S----------------------K------ 91 (441)
Q Consensus 90 --------------------------------------------------~----------------------~------ 91 (441)
. .
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred -----------------------------------CEEEEEEeccCCCchHHHHhcCCCC--HHHHHHHHHHHHHHHHHH
Q 013522 92 -----------------------------------SKIYFAMDLVKGGELFNKIAKGRLR--EDVARVYFQQLISAVDFC 134 (441)
Q Consensus 92 -----------------------------------~~~~lv~E~~~gg~L~~~i~~~~l~--~~~~~~~~~qll~aL~yl 134 (441)
..+||-||||....+.+.+.++.+. ...++++|+||++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 1378999999998888888887665 889999999999999999
Q ss_pred hhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc----c------------cccCCcccccccCCCccchhhhhccC--
Q 013522 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE----H------------LKQDGLLHTTCGTPAYVAPEVISKKG-- 196 (441)
Q Consensus 135 H~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APE~l~~~~-- 196 (441)
|+.||+||||||.|||+|+++.|||+|||+|+... . ....+..+...||..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998621 0 11122456778999999999998765
Q ss_pred CCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 197 YDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPWF----SSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 197 ~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~----~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+..|+|+||||||||||+. ||.- ........++.++.++.|+.+ -+.-..+|++||+.||.+|||+.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 23499999999999999994 5654 345566777777777777433 245678999999999999999999999
Q ss_pred CcccCc
Q 013522 272 SSWFKK 277 (441)
Q Consensus 272 hpwf~~ 277 (441)
+.||..
T Consensus 871 s~llpp 876 (1351)
T KOG1035|consen 871 SELLPP 876 (1351)
T ss_pred ccCCCc
Confidence 999974
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.61 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=202.9
Q ss_pred eeecccCceEEEEEEEcCCC------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQTG------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+.||+|+||.||+|++.... +.+|+|.+..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 6899998865421 233567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-----CeEEeecCcc
Q 013522 99 DLVKGGELFNKIAK--------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-----NLKVTDFGLS 165 (441)
Q Consensus 99 E~~~gg~L~~~i~~--------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-----~vkl~DFGla 165 (441)
||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999864 2377899999999999999999999999999999999999887 8999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCC
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPW 243 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 243 (441)
................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 64432111111223345788999999977665 589999999999999998 99999887777666666543 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
++..+.++|.+||..+|.+|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.17 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=206.2
Q ss_pred eEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 013522 21 YELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----- 92 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 92 (441)
|++.+.||+|+||+||+|.+. .+++.||+|++..... .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 3578999999965432 2344677889999999999999999999886532
Q ss_pred -EEEEEEeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 93 -KIYFAMDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 93 -~~~lv~E~~~gg~L~~~i~~-------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
..++++||+.+|+|.+++.. ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999887642 2478899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCC
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPP 242 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~ 242 (441)
+................+++.|++||.+....+. .++|||||||++|+|++ |.+||...+....+..+..+. ...++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754321111112233456789999999776664 78999999999999999 999999888777777766553 44566
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+++.+.+++.+||..+|++|||+.+++.+
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=312.91 Aligned_cols=240 Identities=26% Similarity=0.464 Sum_probs=204.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||.||.+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 46799999999999999999975 78899999986432 235788999999999999999999998654 47999
Q ss_pred EeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 98 MDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999975 34789999999999999999999999999999999999999999999999998643211
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLI 252 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li 252 (441)
......++.|+|||.+.+..+ +.++|+|||||++|+|++ |.+||...+.......+.++. ...+..+++.+.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 122234567999999876665 488999999999999997 999999888877777766553 233556889999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 013522 253 TKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~ 271 (441)
.+||..+|.+|||++++++
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.12 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=200.8
Q ss_pred eEEeeeecccCceEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 013522 21 YELGRMLGHGTFAKVYLARN----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--SKI 94 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~ 94 (441)
|++.+.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999984 4578899999986443 223456799999999999999999999998765 678
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++||||++|++|.+++.+ ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999999999865 358999999999999999999999999999999999999999999999999987543221
Q ss_pred cC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---------------HHHHHHHHHcC
Q 013522 173 QD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---------------IVSMYRKIYRG 236 (441)
Q Consensus 173 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~~i~~~ 236 (441)
.. .......|+..|+|||++.+..+ +.++|||||||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 11234557778999999877665 488999999999999999876653211 11111122222
Q ss_pred -CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 237 -DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 237 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..+.+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233455688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=317.24 Aligned_cols=249 Identities=23% Similarity=0.390 Sum_probs=199.1
Q ss_pred CCeEEeeeecccCceEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 013522 19 GKYELGRMLGHGTFAKVYLARN----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KS 92 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 92 (441)
.+|++.+.||+|+||+||.|.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5799999999999999999984 4578899999986542 2345678899999999999999999998743 45
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
.+++|+||+++++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 78999999999999999965 4689999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCcc-cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH----------------HHHHH
Q 013522 171 LKQDGLL-HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----------------MYRKI 233 (441)
Q Consensus 171 ~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~----------------~~~~i 233 (441)
....... ....++..|+|||.+.+..+ +.++|||||||++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 2111111 11223456999999977665 488999999999999999887764432210 11111
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 234 YRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 234 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..+ ..+.+..++.++.+||.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 22345568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=312.98 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=199.3
Q ss_pred eeecccCceEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 013522 25 RMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA-SKSKIYFAMDL 100 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~ 100 (441)
+.||+|+||+||+|.+.. ++..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998753 34579999875322 2234567889999999999999999999765 45668999999
Q ss_pred cCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc--CCc
Q 013522 101 VKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGL 176 (441)
Q Consensus 101 ~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~--~~~ 176 (441)
+.+++|.+++.. ..++...+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999975 4467788889999999999999999999999999999999999999999999864322110 011
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~ 254 (441)
.....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+...+...+..+.. ..+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123345778999999877666 489999999999999999 5778888777777777666543 3455678999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 013522 255 LLDPNPNSRIAISKIMES 272 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~h 272 (441)
||..+|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=314.85 Aligned_cols=244 Identities=18% Similarity=0.220 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 25 RMLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
+.||+|+||.||+|.+. .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 3556799998865432 2234578889999999999999999999999999999999999
Q ss_pred CCchHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 103 GGELFNKIAK------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 103 gg~L~~~i~~------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
+|+|.+++.. ...+...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999999864 1356677889999999999999999999999999999999999999999999864322111111
Q ss_pred ccccccCCCccchhhhhccC------CCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHc-CCCCCC-----CC
Q 013522 177 LHTTCGTPAYVAPEVISKKG------YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYR-GDFKCP-----PW 243 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~------~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~~~-----~~ 243 (441)
.....|++.|+|||++.+.. ..+.++|||||||++|+|++ |..||...+.......... .....+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22345788899999986432 12578999999999999996 9999987665544333222 222221 23
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.++.+.+++++|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=313.02 Aligned_cols=270 Identities=27% Similarity=0.401 Sum_probs=222.5
Q ss_pred CCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 10 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
...+.....+.|+-..++|+|.||.||+|+...+|+.||+|++-.+. .+.+.-....+|+.+|..|+|+|++.++++|.
T Consensus 8 ~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 8 MYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred ccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 34566677889999999999999999999999999999998764332 13345566779999999999999999998874
Q ss_pred e--------CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 90 S--------KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 90 ~--------~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
. ...+|+|+.+|.. +|+..+.. -+++..+++++++++++||.|+|+..|+|||+||+|+|++.+|.+||
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 3 2358999999976 88888876 57999999999999999999999999999999999999999999999
Q ss_pred eecCcccccccccc--CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--
Q 013522 160 TDFGLSAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR-- 235 (441)
Q Consensus 160 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-- 235 (441)
+|||+++.+..... ....+.++-|.+|.+||.+.+..-++++.|||..||||.+|.+|.+-+.+.+.......|..
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 99999965543322 22345566799999999999988889999999999999999999999988776655444422
Q ss_pred CCC--------------------CCCC-------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 236 GDF--------------------KCPP-------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 236 ~~~--------------------~~~~-------------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
|.. +.|. .-++++.+|+.++|..||.+|++++++++|.||.....+
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 110 0111 014588999999999999999999999999999876654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=312.31 Aligned_cols=249 Identities=29% Similarity=0.533 Sum_probs=210.4
Q ss_pred CeEEeeeecccCceEEEEEEEcC-CCcEEEEEEeecccc-------cchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKV-------IKVGMMEQIKREISVMKM-VKHKHIVELHEVMAS 90 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~ 90 (441)
.|++.+.||+|+||.||.|.+.. +++.+|+|.+..... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999998864321 122345567788888875 799999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
.+..|++|||+.|++|.+.+.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988732 468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-CC-
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PP- 242 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~- 242 (441)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+.... +.
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 8754322 13445678999999999987665 589999999999999999999999888777777766654432 22
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+++.+.++|.+||+.||++|||+.++..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=323.46 Aligned_cols=253 Identities=28% Similarity=0.468 Sum_probs=208.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CC----CcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HK----HIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hp----nIv~l~~~~ 88 (441)
-.+.+||.+..+||+|+||+|-.+.+..++..||+|+++.-. ...+..+-|+.+|.++. .| -++++.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 356889999999999999999999999999999999996432 23456678999999994 33 377888999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC------------
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE------------ 153 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~------------ 153 (441)
.-.++++||+|.+ |.++++++.+ .+++-..++.+..||+.+++|||+.+++|-||||||||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 7799999986 46899999999999999999999999999999999999931
Q ss_pred --------CCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc
Q 013522 154 --------DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN 225 (441)
Q Consensus 154 --------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~ 225 (441)
+-.++|+|||.|++-...+ .+.+.|..|.|||++.+-++. .++||||+||||+||.+|...|...+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCC
Confidence 2358999999998644322 567789999999999999996 88999999999999999999997654
Q ss_pred HH---HHHHHHHc------------------CCCCCCCCC-------------------------CHHHHHHHHHhcCCC
Q 013522 226 IV---SMYRKIYR------------------GDFKCPPWF-------------------------SSEARRLITKLLDPN 259 (441)
Q Consensus 226 ~~---~~~~~i~~------------------~~~~~~~~~-------------------------~~~~~~li~~~L~~d 259 (441)
.. ++.+.|.. +...+|... -..+.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 32 24444322 111111110 124789999999999
Q ss_pred CCCCCCHHHHhcCcccCcc
Q 013522 260 PNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 260 P~~R~t~~eil~hpwf~~~ 278 (441)
|.+|+|+.|+|.||||...
T Consensus 394 P~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARL 412 (415)
T ss_pred ccccccHHHHhcCHHhhcC
Confidence 9999999999999999754
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.94 Aligned_cols=255 Identities=13% Similarity=0.177 Sum_probs=194.1
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhh--------HHHHHHHHHHHHhCCCCCcc
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGM--------MEQIKREISVMKMVKHKHIV 82 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~hpnIv 82 (441)
..+..++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......+...++.+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 345668999999999999999999998877 6778888754332110000 01122334455677999999
Q ss_pred eEEEEEEeCC----EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCe
Q 013522 83 ELHEVMASKS----KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 157 (441)
Q Consensus 83 ~l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~v 157 (441)
++++++.... ..++++|++.. ++.+.+.. ...++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9999765443 45788888754 56666655 347888999999999999999999999999999999999999999
Q ss_pred EEeecCcccccccccc-----CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-H----
Q 013522 158 KVTDFGLSAFSEHLKQ-----DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-V---- 227 (441)
Q Consensus 158 kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~---- 227 (441)
+|+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+... .
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999875432111 112233469999999999987776 5899999999999999999999987632 1
Q ss_pred ----HHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 ----SMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ----~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+....+..+.... +..++.+.+++..|+..+|++||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2233344443333 346889999999999999999999999975
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=310.20 Aligned_cols=235 Identities=23% Similarity=0.275 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEEcCCC----------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 25 RMLGHGTFAKVYLARNLQTG----------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 3578887654321 15678899999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-------CeEEeecCcc
Q 013522 95 YFAMDLVKGGELFNKIAK-G-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-------NLKVTDFGLS 165 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~-~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-------~vkl~DFGla 165 (441)
++||||+++|+|.+++.. + .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999975 3 589999999999999999999999999999999999999887 7999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCCCCCCC
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPW 243 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 243 (441)
..... .....+++.|+|||++... ...+.++|||||||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 74332 2234577889999998765 344688999999999999999 688887765443333332 22222322
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3488999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.70 Aligned_cols=244 Identities=15% Similarity=0.232 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEEcCC--CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 25 RMLGHGTFAKVYLARNLQT--GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
+.||+|+||+||+|....+ ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23466676654322 2345688899999999999999999999999999999999999
Q ss_pred CCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 103 GGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 103 gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
+|+|.+++.. ...++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999999874 23567778899999999999999999999999999999999999999999997532211111122
Q ss_pred cccccCCCccchhhhhccC------CCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC------CCCCCCC
Q 013522 178 HTTCGTPAYVAPEVISKKG------YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD------FKCPPWF 244 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~------~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~------~~~~~~~ 244 (441)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+..+. ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999985321 12468999999999999996 688998777766666554432 1233447
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+.+++..|+ .+|++|||+.++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.48 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=203.2
Q ss_pred CCeEEeeeecccCceEEEEEEEc----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 013522 19 GKYELGRMLGHGTFAKVYLARNL----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KS 92 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~ 92 (441)
..|++.+.||+|+||.||+|.+. .++..+|+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56888999999999999999864 34789999999755432 346789999999999999999999999877 56
Q ss_pred EEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..+++|||+++++|.+++... .++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999999763 499999999999999999999999999999999999999999999999999875442
Q ss_pred cccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH---------------HHHHHHH
Q 013522 171 LKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------------SMYRKIY 234 (441)
Q Consensus 171 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~i~ 234 (441)
.... .......++..|+|||.+....+ +.++|||||||++|+|++|..||...... .+...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 01112334567999999877665 48899999999999999999998654321 1222222
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 235 RG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 235 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+ ..+.+..++..+.+|+.+||.+||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23345567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.47 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=213.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGK-----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
+-...-++.+.||+|+||.||.|....... .||+|.+.+. .+.....++.+|..+|+.++|||||++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 334567888999999999999998764332 3888877543 455677899999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeec
Q 013522 91 KSKIYFAMDLVKGGELFNKIAKG--------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~~--------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DF 162 (441)
....+|++|||.||+|..+|++. .++..+...++.|+++|+.||+++++|||||..+|+|+++...+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999863 3788999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCcccccccC--CCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHH-HcCCC
Q 013522 163 GLSAFSEHLKQDGLLHTTCGT--PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKI-YRGDF 238 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt--~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i-~~~~~ 238 (441)
|+|+.... .+.......+. ..|||||.+....+ +.++|||||||+|||+++ |..||.+.+..++...+ ..++.
T Consensus 847 GlArDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 847 GLARDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred chhHhhhh--chheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 99983221 11111111122 35999999988666 599999999999999999 99999998887777744 44577
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.|..++..+.++|..||+.+|++||++..|++
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 888999999999999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=340.05 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=214.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
+-...-+..+.||+|+||+||+|+... +...||||.++... ......+|+||+++|..|+|||||+|++++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 445566778999999999999998542 34579999986543 23367899999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-C----------C----CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-G----------R----LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~----------~----l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
++.+|+|+||+..|+|.+++.. + . ++..+...++.||+.|+.||-++.++||||-..|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 9999999999999999999863 1 2 67888999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.|||+||||++..-............-...|||||.|....|. .+|||||+||+|||+++ |+.||.+....+..+.|.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 9999999999743211111111111224569999999988885 88999999999999998 999999999999999998
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 013522 235 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKI 269 (441)
Q Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 269 (441)
++. +++|..+|.++.+|+..||+.+|++||++.+|
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 886 57899999999999999999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=333.88 Aligned_cols=241 Identities=32% Similarity=0.489 Sum_probs=197.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS------ 92 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------ 92 (441)
+-|...+.||+||||.||+++++.+|+.||||.+++.... ...+..-+|+++|++|+|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 5678889999999999999999999999999999876533 34678889999999999999999999865443
Q ss_pred EEEEEEeccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC--CC--CeEEeecCc
Q 013522 93 KIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DG--NLKVTDFGL 164 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~--~~--~vkl~DFGl 164 (441)
...+|||||.||+|+..+++ ..+++.+...++..+..||.|||++||+||||||.||++-. +| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46799999999999999975 35999999999999999999999999999999999999843 23 479999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-----cHHHHHHHHHcC---
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-----NIVSMYRKIYRG--- 236 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~--- 236 (441)
|+-. ..+....+..||+.|.+||.+.+.++++..+|.||+||++|+++||.+||-.. +..-++.-+.+.
T Consensus 171 Arel---~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 AREL---DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccC---CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 9854 35567889999999999999987666678999999999999999999999542 222233222211
Q ss_pred -----------------CCCCCCCCCHH----HHHHHHHhcCCCCCCCC
Q 013522 237 -----------------DFKCPPWFSSE----ARRLITKLLDPNPNSRI 264 (441)
Q Consensus 237 -----------------~~~~~~~~~~~----~~~li~~~L~~dP~~R~ 264 (441)
.++.|...++. +-.++..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 12333344443 34677889999999999
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=317.24 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=196.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-KIYF 96 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~l 96 (441)
.+.|.-...||+|+||.||+|.- .+|..||||.+....... ..++.+|+.++.+++|||+|+|+++|.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 35677778999999999999996 455899999776543221 345999999999999999999999999988 5999
Q ss_pred EEeccCCCchHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHhhcC---cEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 97 AMDLVKGGELFNKIAK--G-RLREDVARVYFQQLISAVDFCHSRG---VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~-~l~~~~~~~~~~qll~aL~ylH~~g---i~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
|+||++.|+|.+.+.. + .+++....+|+.+++.||+|||+.. |+||||||+|||+|++.+.||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999975 3 7899999999999999999999854 99999999999999999999999999964332
Q ss_pred cccCCccccc-ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc------HHHHH-HHHHcCC-----
Q 013522 171 LKQDGLLHTT-CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN------IVSMY-RKIYRGD----- 237 (441)
Q Consensus 171 ~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~------~~~~~-~~i~~~~----- 237 (441)
. .....+. .||..|+|||.+... ..+.++|||||||+|.||++|+.|.+... ..... ..+.++.
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 1 2222233 899999999999764 44689999999999999999998887532 12221 1222221
Q ss_pred -CCCC-CCCC--HH---HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 238 -FKCP-PWFS--SE---ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 238 -~~~~-~~~~--~~---~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..+. ..++ .. +..+..+|++.+|..||++.++++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 1223 22 456778999999999999999743
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.28 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=223.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA----- 89 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~----- 89 (441)
.-.+.|+|.++||.|.+|+||+++++.+++..|+|+...... .-+.++.|..||+.+ .|||++.+|++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 345679999999999999999999999999999999876543 346788999999988 7999999999985
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
.++.+|||||||.||+..|+++. .++.|+.+..+++.++.|+.+||++.++|||||-.|||++.+|.||++|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35789999999999999999986 679999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccccCCCccchhhhhc-----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC- 240 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~- 240 (441)
.... .-+...|..|||.|||||++.. ..|+ ..+|+||||++..||..|.+|+-+..+...+.+|-+..++-
T Consensus 172 Qlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 172 QLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 5443 2334567789999999999953 2344 78999999999999999999999998887777766554322
Q ss_pred --CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 241 --PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 241 --~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|..++..+.++|..||.+|..+||+..++|+|||..+..
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 445789999999999999999999999999999998543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.78 Aligned_cols=272 Identities=27% Similarity=0.423 Sum_probs=224.8
Q ss_pred CCCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch----hhHHHHHHHHHHHHhCCCCCcceE
Q 013522 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVMKMVKHKHIVEL 84 (441)
Q Consensus 9 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~Ei~il~~l~hpnIv~l 84 (441)
+.......+.+||-++.+||+|+|+.||+|.+....+.||+|+-...+.+++ ...+..-+|..|.+.|.||.||++
T Consensus 453 SQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 453 SQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred hhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 3334456789999999999999999999999999999999999866554432 345678899999999999999999
Q ss_pred EEEEE-eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc--CcEeccCCCCcEEeCC---CCCe
Q 013522 85 HEVMA-SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR--GVYHRDLKPENLLLDE---DGNL 157 (441)
Q Consensus 85 ~~~~~-~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~--gi~HrDLkp~NILl~~---~~~v 157 (441)
|++|. +.+.+|-|+|||+|.+|.-+++. ..++|.+++.|+-||+.||.||.+. .|+|-||||.|||+-. -|.+
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 99995 55678899999999999999987 5689999999999999999999976 6999999999999943 4689
Q ss_pred EEeecCccccccccccC-----CcccccccCCCccchhhhhc---cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-H
Q 013522 158 KVTDFGLSAFSEHLKQD-----GLLHTTCGTPAYVAPEVISK---KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-S 228 (441)
Q Consensus 158 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~ 228 (441)
||+|||++.+++....+ .+.....||-||++||.+.- .+-.+.++||||+|||+|..+.|+.||...... +
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 99999999987654433 13345569999999999852 344568999999999999999999999765332 2
Q ss_pred HH--HHHHcC-CCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 229 MY--RKIYRG-DFKCP--PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 229 ~~--~~i~~~-~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
++ ..|.+. +..+| |.+++++++||++||++--++|+...++-.||||.....
T Consensus 693 ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 22 223332 34444 568999999999999999999999999999999986543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=335.18 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=181.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCC----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE--
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQT----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV-- 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-- 87 (441)
+....++|++.+.||+|+||+||+|++..+ +..||+|.+..... .+....| .++...+.++..++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhh
Confidence 334567899999999999999999999988 99999998754321 1111111 1122223333322221
Q ss_pred ----EEeCCEEEEEEeccCCCchHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHhhcCcEec
Q 013522 88 ----MASKSKIYFAMDLVKGGELFNKIAKGRL---------------------REDVARVYFQQLISAVDFCHSRGVYHR 142 (441)
Q Consensus 88 ----~~~~~~~~lv~E~~~gg~L~~~i~~~~l---------------------~~~~~~~~~~qll~aL~ylH~~gi~Hr 142 (441)
......+++|+||+.+++|.+++....+ .+..+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2456689999999999999998875321 134467899999999999999999999
Q ss_pred cCCCCcEEeCC-CCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCC---------------------CC
Q 013522 143 DLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD---------------------GA 200 (441)
Q Consensus 143 DLkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~---------------------~~ 200 (441)
||||+|||++. ++.+||+|||+|+..... ........+||+.|+|||.+...... +.
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~ 358 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 358 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence 99999999986 579999999999754321 12233566899999999976433221 23
Q ss_pred cccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC---------------------CCCCCHHHHHHHHHhcCCC
Q 013522 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC---------------------PPWFSSEARRLITKLLDPN 259 (441)
Q Consensus 201 ~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~~~~~~~li~~~L~~d 259 (441)
++|||||||+||+|+++..|++... ......+....... ....+....+||.+||++|
T Consensus 359 k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 359 RFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 5699999999999999877754331 11222221111110 1112334568999999999
Q ss_pred CCCCCCHHHHhcCcccCccCC
Q 013522 260 PNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 260 P~~R~t~~eil~hpwf~~~~~ 280 (441)
|++|||+.++|+||||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999986543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=291.25 Aligned_cols=249 Identities=24% Similarity=0.482 Sum_probs=204.1
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASK--SKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~ 94 (441)
.++|++.+++|+|.|++|+.|++..+++.++||++..- ..+.+++|+.||+.|. ||||++++++..++ ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 46899999999999999999999999999999998543 2468999999999996 99999999998765 357
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~~~~~~ 173 (441)
.+++||+...+...+. ..++...++.|+.+|+.||.|||+.||.|||+||.|+++|.. ..++|+|+|+|.++..
T Consensus 111 aLiFE~v~n~Dfk~ly--~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp--- 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY--PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 185 (338)
T ss_pred hhHhhhhccccHHHHh--hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC---
Confidence 7999999886655443 348888999999999999999999999999999999999965 4699999999987653
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCC-CCcHHHHHHHH-------------HcCCCC
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ-DDNIVSMYRKI-------------YRGDFK 239 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i-------------~~~~~~ 239 (441)
......++.+..|--||.+.....+...-|+|||||+|..|+..+.||- +.+..+..-+| .+-...
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 3445667789999999999887766688999999999999999988873 32222222111 111111
Q ss_pred CC-------------CC-----------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 240 CP-------------PW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 240 ~~-------------~~-----------~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+ +| .++++.+|+.++|.+|..+|+|+.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11 11 4799999999999999999999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.20 Aligned_cols=239 Identities=47% Similarity=0.814 Sum_probs=208.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 013522 31 TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI 110 (441)
Q Consensus 31 ~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i 110 (441)
+||.||+|.+..+|+.+|+|++....... ..+.+.+|+..++.++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999999899999999997654322 1578999999999999999999999999999999999999999999999
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccch
Q 013522 111 AKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189 (441)
Q Consensus 111 ~~~-~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 189 (441)
... .++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......+++.|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 764 3899999999999999999999999999999999999999999999999998754432 134456689999999
Q ss_pred hhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHhcCCCCCCCCC
Q 013522 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW---FSSEARRLITKLLDPNPNSRIA 265 (441)
Q Consensus 190 E~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~t 265 (441)
|.+....++ .++||||||++++++++|..||.. .+.......+..+....+.. ++.++.+++.+||..||++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999866664 799999999999999999999988 66666666666655544332 8899999999999999999999
Q ss_pred HHHHhcCccc
Q 013522 266 ISKIMESSWF 275 (441)
Q Consensus 266 ~~eil~hpwf 275 (441)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=299.45 Aligned_cols=254 Identities=29% Similarity=0.475 Sum_probs=214.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--- 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 91 (441)
.....||.-++.+|.|+- .|..|.+.-+++.||+|.+.... ......++..+|..++..++|+||++++.+|.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 345678999999999999 89999999999999999987763 3345567888999999999999999999998433
Q ss_pred ---CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 ---SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ---~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
...|+||||+.. +|...+. -.++...+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 468999999965 8888887 45889999999999999999999999999999999999999999999999999743
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC-----------
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD----------- 237 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 237 (441)
. ..-.++..+.|..|.|||++.+.+| ...+||||+||++.||++|+..|.+.+..+.+.++...-
T Consensus 169 ~---~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 169 D---TDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred C---cccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 2 2345677789999999999999886 588999999999999999999998877665555442210
Q ss_pred ----------------CC----CCCC-----------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 238 ----------------FK----CPPW-----------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 238 ----------------~~----~~~~-----------~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
.. +|.+ -+..+++|+.+||..||++|+|++++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 01 1111 134689999999999999999999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=314.89 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=214.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC------CCcceEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH------KHIVELHEV 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~ 87 (441)
++++.++|.+....|+|-||+|..|.+..-|..||||+|....+ +.+.=.+|+.||++|+. -|+++|+-.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 35788999999999999999999999999999999999987653 45666789999999963 489999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeec
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK-G---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDF 162 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~-~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DF 162 (441)
|...+++|+|+|.+. .+|.+.++. | .+....++.|++||+-||..|-.+||+|.||||.|||++++. .+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999995 589999975 3 377889999999999999999999999999999999999875 5899999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 242 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 242 (441)
|.|.+... ...+.+.-+..|.|||++.+.+|+ .+.|+||+||+||||.||+..|++.+...++.-...-.-++|.
T Consensus 582 GSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99876543 233444556779999999999997 8899999999999999999999998776666544332222221
Q ss_pred C-----------------------------------------------------CC-------HHHHHHHHHhcCCCCCC
Q 013522 243 W-----------------------------------------------------FS-------SEARRLITKLLDPNPNS 262 (441)
Q Consensus 243 ~-----------------------------------------------------~~-------~~~~~li~~~L~~dP~~ 262 (441)
. ++ ..+++|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 11 24789999999999999
Q ss_pred CCCHHHHhcCcccCc
Q 013522 263 RIAISKIMESSWFKK 277 (441)
Q Consensus 263 R~t~~eil~hpwf~~ 277 (441)
|.|+.++|.||||..
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=314.54 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=217.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-C--cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQT-G--KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+-.++-.+.++||+|+||.|+.|.|... | -.||||++....... ...+|.+|+.+|.+|+|||+++||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 3345677889999999999999998743 3 369999997765432 67899999999999999999999999987 7
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+.+|+|++.+|+|.+.+.. ..|.......|+.||+.|+.||.+++.|||||-..|+|+-....|||+||||.+-..
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78899999999999999976 558888999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccc-cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCH
Q 013522 170 HLKQDGLLHT-TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSS 246 (441)
Q Consensus 170 ~~~~~~~~~~-~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 246 (441)
.....-.+.. ..-...|+|||.+....+ +.++|||++||++|||++ |+.||.+-....++++|.+++ .+-|+.+++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 3222111111 112335999999987777 489999999999999998 899999999999999987653 567889999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
++.+++..||..+|.+|||+..|.+.-+.
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999999999754333
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=310.07 Aligned_cols=243 Identities=28% Similarity=0.489 Sum_probs=205.6
Q ss_pred eEEeeeecccCceEEEEEEEcC--CC--cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQ--TG--KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~--~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
-.+.+.||.|-||.||.|.... .| -.||||....+-. ....+.+..|..+|+.++||||+++++++.+ ...||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 3445789999999999998643 23 3588898765432 2347889999999999999999999999965 57899
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|||.++-|+|..+++. ..++......|+.||+.||+|||+..++||||-..|||+.+..-|||+|||+|+..+. .
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed---~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED---D 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc---c
Confidence 9999999999999986 5688899999999999999999999999999999999999999999999999986554 2
Q ss_pred CcccccccCC--CccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHH
Q 013522 175 GLLHTTCGTP--AYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARR 250 (441)
Q Consensus 175 ~~~~~~~gt~--~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ 250 (441)
.......|.. -|||||.++-..+ +.++|||-|||.+||++. |..||.+-...+..-.+.+| +.++|+.+++.+..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred chhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 3333334433 4999999987766 588999999999999887 99999987666666666666 57899999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHh
Q 013522 251 LITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil 270 (441)
|+.+||++||.+||++.+|.
T Consensus 624 lmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHhccCcccCCcHHHHH
Confidence 99999999999999987763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.41 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=189.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc----------------CCCcEEEEEEeecccccc-----------hhhHHHHHH
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNL----------------QTGKSMAMKVVGKDKVIK-----------VGMMEQIKR 68 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vAiK~i~~~~~~~-----------~~~~~~~~~ 68 (441)
.-.++|++.++||+|+||+||+|.+. ..++.||||.+....... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45678999999999999999999753 245679999986432110 001122334
Q ss_pred HHHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCchHHHHhc--C--------------------
Q 013522 69 EISVMKMVKHKHI-----VELHEVMAS--------KSKIYFAMDLVKGGELFNKIAK--G-------------------- 113 (441)
Q Consensus 69 Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~--~-------------------- 113 (441)
|+.++.+++|.++ +++++++.. ....|+|+||+.+++|.+++.. +
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777766654 566666642 3568999999999999988753 1
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchh
Q 013522 114 ---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190 (441)
Q Consensus 114 ---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 190 (441)
.++...++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....... ........+||.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChh
Confidence 13456788899999999999999999999999999999999999999999986433211 11111223589999999
Q ss_pred hhhccC--------------------CC-CCcccHHHHHHHHHHHhhCCC-CCCCCc-----------HHHHHHHHHcCC
Q 013522 191 VISKKG--------------------YD-GAKADIWSCGVILYVLLAGFL-PFQDDN-----------IVSMYRKIYRGD 237 (441)
Q Consensus 191 ~l~~~~--------------------~~-~~~~DiwSlGvil~~ll~G~~-Pf~~~~-----------~~~~~~~i~~~~ 237 (441)
.+.... |. ..+.||||+||++|+|++|.+ ||.+.. ....++.+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 985422 11 124799999999999999986 775421 111222233334
Q ss_pred CCCC--CCCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCcccCc
Q 013522 238 FKCP--PWFSSEARRLITKLLDPNP---NSRIAISKIMESSWFKK 277 (441)
Q Consensus 238 ~~~~--~~~~~~~~~li~~~L~~dP---~~R~t~~eil~hpwf~~ 277 (441)
+.++ +..++.+++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 4443 3478999999999999766 78999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.57 Aligned_cols=247 Identities=23% Similarity=0.419 Sum_probs=215.1
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+++-..+-...++||-|.||.||.|.|+.-.-.||||.+..+.. ..+.+..|..+|+.++|||+|+|+++|..+..
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 44444455667899999999999999999999999999865432 36789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+|||.|||..|+|.+++++ ..++......++.||.+|+.||..+++|||||-..|+|+.++..|||+||||++++..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999999999986 3467777788999999999999999999999999999999999999999999997653
Q ss_pred cccCCccccccc---CCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCC
Q 013522 171 LKQDGLLHTTCG---TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFS 245 (441)
Q Consensus 171 ~~~~~~~~~~~g---t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 245 (441)
. .++...| ..-|.|||.+..+.+ +.++|||+|||+|||+.| |-.||.+.+....|.-+.++ ++.-|..|+
T Consensus 418 D----TYTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 418 D----TYTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred C----ceecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCC
Confidence 2 2223333 335999999987776 489999999999999998 99999999998888877766 456789999
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHH
Q 013522 246 SEARRLITKLLDPNPNSRIAISKI 269 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~ei 269 (441)
+.+.+|++.||+++|.+||++.+|
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHH
Confidence 999999999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=289.39 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=208.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
....+-+..||.|+||+|++-.++.+|+..|||.++.... +....++..|.... +.-+.||||++|+..-.++.-|+
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3344556789999999999999999999999999987654 23456777887764 45589999999999989999999
Q ss_pred EEeccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 97 AMDLVKGGELFNKIA------KGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 97 v~E~~~gg~L~~~i~------~~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.||++.- +|..+.. ..+++|..+-.+.-..+.||+||-. ..|+|||+||+|||+|..|.+||||||++....
T Consensus 141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9999954 5544332 3679999999999999999999985 599999999999999999999999999986432
Q ss_pred ccccCCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHHcCCCCCC---C-
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDFKCP---P- 242 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~~~---~- 242 (441)
. .-..+...|-.+|||||.+.. .+|+ .+|||||||++|||+.||..|+..= +..+....+..|+++.. .
T Consensus 220 ~---SiAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 220 D---SIAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred H---HHHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence 1 122344568999999999953 4565 8999999999999999999999763 45566677777776542 2
Q ss_pred --CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 243 --WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 243 --~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.++..+..+|.-||.+|-+.||+..+++++||++...
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 2788999999999999999999999999999997543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.80 Aligned_cols=131 Identities=30% Similarity=0.549 Sum_probs=115.8
Q ss_pred ccc-CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----C---CCcceEEE
Q 013522 16 LLH-GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----H---KHIVELHE 86 (441)
Q Consensus 16 ~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~ 86 (441)
.+. +||-+.++||.|-|++||+|.|..+.+.||+|+++.... ..+....||.+|++++ | .+||+|++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 456 899999999999999999999999999999999965543 3466778999999883 3 37999999
Q ss_pred EEE----eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEe
Q 013522 87 VMA----SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLL 151 (441)
Q Consensus 87 ~~~----~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl 151 (441)
.|. ++.++++|+|++ |.+|..+|.. ..++...++.|++|++.||.|||+ +||+|-||||+|||+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 995 467999999999 8899999975 459999999999999999999996 599999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=290.59 Aligned_cols=257 Identities=25% Similarity=0.459 Sum_probs=212.4
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-----KI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~ 94 (441)
+-+-.+.||.|+||.||.+.+..+|+.||+|.+..-. .+....+++-+|+++|..++|.|++..+++..... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4556789999999999999999999999999885432 23345678889999999999999999999876543 47
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|++.|.+.. +|...|.+ ..++.+.++.++.||+.||.|||+.||.||||||.|+|+++|+.+||||||+|+..+. ..
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d~ 210 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-RD 210 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch-hh
Confidence 888898865 78888765 7899999999999999999999999999999999999999999999999999997553 23
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH-------------------
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY------------------- 234 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~------------------- 234 (441)
...++..+-|.+|.|||++.+...++.+.||||.|||+.||+..+..|...++....+.|.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 3344555678999999999998888899999999999999999999998776655444332
Q ss_pred ----cCCCCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 235 ----RGDFKCPP-----------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 235 ----~~~~~~~~-----------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++..+.|. .-..+..+++.++|.+||++|++..+++.|++..++.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 22222221 1234678999999999999999999999999987653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.12 Aligned_cols=250 Identities=21% Similarity=0.360 Sum_probs=219.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
..-.|.+.||.|.||.|+.|+-+..| ..||||.+...- .+....++..|..||.+++||||++|-++......+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 34578899999999999999987666 469999986432 3345678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
||.|||..|+|..+++. |.+...+..-+++.|+.|+.||.+.|++||||-..|||++.+-.+||+|||++++.+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999999999975 889999999999999999999999999999999999999999999999999999876533
Q ss_pred CCcccccccC--CCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 013522 174 DGLLHTTCGT--PAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEAR 249 (441)
Q Consensus 174 ~~~~~~~~gt--~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 249 (441)
....++..|. ..|.|||.+...++ +.+|||||+|++|||.++ |+.||.+.+.++..+.|..+ +.+.|..++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 3444555554 35999999998877 488999999999998776 99999999999999998877 4566668999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
+|+..||++|-..||++.+|+.+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=297.20 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=207.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
+.-..+..++++||+|-||.|.++.- ..+..||+|.++..... .....+.+||++|.+|+||||++++++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 44556788999999999999999995 34689999999766432 3457899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCC---CHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 95 YFAMDLVKGGELFNKIAKGRL---REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~~l---~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
++++||+..|+|..++..... .-.....++.||++|++||.+.+++||||.+.|+|+|.++++||+|||+|+-.-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999999999987422 34455679999999999999999999999999999999999999999999732211
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHh--hCCCCCCCCcHHHHHHHHHc---C-----CCCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL--AGFLPFQDDNIVSMYRKIYR---G-----DFKCP 241 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll--~G~~Pf~~~~~~~~~~~i~~---~-----~~~~~ 241 (441)
.....-...+-...|||||.+....+ +.++|+|+||++|||++ +...||...+.....+.... . -+..|
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 11111111223467999999988777 48999999999999876 58899988777666655432 1 23457
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+-++..+.+||.+|+..|.++|||++++-.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 789999999999999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=301.24 Aligned_cols=200 Identities=29% Similarity=0.574 Sum_probs=181.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhCC---CCCcceEEEEEEe
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----MMEQIKREISVMKMVK---HKHIVELHEVMAS 90 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~ 90 (441)
..|..++.||.|+||+|++|.++.+...|+||.+.++++.-.. .+-.+-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4599999999999999999999999999999999988775322 2234667999999997 9999999999999
Q ss_pred CCEEEEEEeccC-CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 KSKIYFAMDLVK-GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 ~~~~~lv~E~~~-gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.+++||+||-.. |.+||++|+. .+++|.++..+|+|+..|+++||+.||+|||||-||+.++.+|-+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999764 5699999986 67999999999999999999999999999999999999999999999999998743
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~ 222 (441)
..+.+.+..||..|.|||++.+.+|-|.+-|||++|++||-++....||.
T Consensus 721 ----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 ----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 45778899999999999999999999999999999999999998888874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.02 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=201.7
Q ss_pred eEEeeeecccCceE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 013522 21 YELGRMLGHGTFAK-VYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 21 y~i~~~LG~G~fg~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
|.--+.+|.|+-|+ ||+|.. .|+.||||.+-. +..+.+.+||..|+.- .|||||++|+.-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33447899999985 799998 889999997743 3456788999999988 6999999999999999999999
Q ss_pred eccCCCchHHHHhcC-C----CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CC--CeEEeecCccccc
Q 013522 99 DLVKGGELFNKIAKG-R----LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DG--NLKVTDFGLSAFS 168 (441)
Q Consensus 99 E~~~gg~L~~~i~~~-~----l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~--~vkl~DFGla~~~ 168 (441)
|.|.. +|.++++.. . ......+..+.|+++||++||+.+|+||||||.||||+. ++ .++|+|||++...
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99965 999999862 1 122456888999999999999999999999999999976 34 6899999999765
Q ss_pred ccccc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcHHHHHHHHHcCCCCCC---CC
Q 013522 169 EHLKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRGDFKCP---PW 243 (441)
Q Consensus 169 ~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~~---~~ 243 (441)
..... -....+..||-+|+|||++....- ..++||+|+||++|+.++| .+||.+.-.. ..+|..+....- +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccC
Confidence 43221 123456679999999999987655 4789999999999998885 9999876432 235666654331 11
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCcccc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVI 284 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~~ 284 (441)
-..++.+||.+||.+||..||++.++|.||+|....++...
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~F 779 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSF 779 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHH
Confidence 12289999999999999999999999999999987655443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.97 Aligned_cols=237 Identities=22% Similarity=0.316 Sum_probs=188.1
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
..|.....||+|+||+||+|++..++..||+|.+..... ....|++++++++||||+++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 456777899999999999999999999999998864322 1235688999999999999999999999999999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 99 DLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH---SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 99 E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH---~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999999964 888999999999999999999 6799999999999999999888776 665543211
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc-----HHHHHHHHHcC-------CCCC---
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-----IVSMYRKIYRG-------DFKC--- 240 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~~-------~~~~--- 240 (441)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||+... .....+..... +...
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 123368999999999987766 489999999999999999999996431 11111111100 0011
Q ss_pred ---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 241 ---PPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 241 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.....++.+++.+||+.||++|||+.++++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11112356789999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=282.41 Aligned_cols=249 Identities=22% Similarity=0.419 Sum_probs=198.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMASK 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~ 91 (441)
+..+.++-.+.+.||+|.||.||+|.+ -|+.||||+|.... ...+.+|.+|.+. |+|+||+.+++.-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 356778899999999999999999999 78899999996442 3568889998875 5999999998865322
Q ss_pred ----CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------cCcEeccCCCCcEEeCCCCCeEE
Q 013522 92 ----SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS--------RGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 92 ----~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~--------~gi~HrDLkp~NILl~~~~~vkl 159 (441)
..+|||.+|.+.|+|+|++.+..++-+...+++..+++||+|||- -.|+|||||..|||+..+|.+.|
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 479999999999999999999999999999999999999999994 25999999999999999999999
Q ss_pred eecCccccccccc--cCCcccccccCCCccchhhhhcc----CCCC-CcccHHHHHHHHHHHhhC----------CCCCC
Q 013522 160 TDFGLSAFSEHLK--QDGLLHTTCGTPAYVAPEVISKK----GYDG-AKADIWSCGVILYVLLAG----------FLPFQ 222 (441)
Q Consensus 160 ~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~----~~~~-~~~DiwSlGvil~~ll~G----------~~Pf~ 222 (441)
+|+|||-...... -+-.....+||..|||||++... .+.+ ..+||||||.++||+... .+||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999996544322 12234678899999999998542 1222 358999999999999852 57885
Q ss_pred C-----CcHHHHHHHH--HcCCCCCCC-CCCH----HHHHHHHHhcCCCCCCCCCHHHHh
Q 013522 223 D-----DNIVSMYRKI--YRGDFKCPP-WFSS----EARRLITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 223 ~-----~~~~~~~~~i--~~~~~~~~~-~~~~----~~~~li~~~L~~dP~~R~t~~eil 270 (441)
+ ++.+++.+-+ .+-++..|+ |-+. .+..|++-||..||.-|.|+--|.
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3 4455555443 333455555 3333 345789999999999999987664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=299.52 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=220.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.-.++|++++.+|.|+||.||+|+++.+++..|+|+++.+.. ....-+.+||-+++.++||||+.+++.+......+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 345789999999999999999999999999999999976643 34567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
++||||.||+|.+...- |.+++.++....+..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+..... .-
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti 166 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI 166 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence 99999999999988764 8999999999999999999999999999999999999999999999999999864332 11
Q ss_pred CcccccccCCCccchhhhh---ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC-----CCCCH
Q 013522 175 GLLHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-----PWFSS 246 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~~~ 246 (441)
.......|||+|||||+-. ..+|. ..+|||++|+...|+---.+|..+..++.......+..++.| ...++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2334667999999999863 34554 899999999999999888888777666655555555544433 24688
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.+.+|++.+|..+|++|||++.+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 89999999999999999999999999998754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=277.34 Aligned_cols=244 Identities=21% Similarity=0.331 Sum_probs=199.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMASKS--- 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~--- 92 (441)
...-++.+.+|+|.||.||+|.. +++.||||++... ....+..|-+|.+. +.|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45567789999999999999997 6799999999643 34677888888775 58999999999876555
Q ss_pred -EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------cCcEeccCCCCcEEeCCCCCeEEeec
Q 013522 93 -KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS---------RGVYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 93 -~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~---------~gi~HrDLkp~NILl~~~~~vkl~DF 162 (441)
.++||+||.+.|+|.+++....++.....+++..++.||+|||+ ..|+|||||..|||+..++...|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 79999999999999999999999999999999999999999996 36999999999999999999999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCC-----CCcccHHHHHHHHHHHhhCC------------CCCC---
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD-----GAKADIWSCGVILYVLLAGF------------LPFQ--- 222 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DiwSlGvil~~ll~G~------------~Pf~--- 222 (441)
|+|..+......+.....+||..|||||++.+.--. -.+.||||+|.+|||+++.. +||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999888877777777779999999999999754221 13589999999999999853 3342
Q ss_pred --CCcHHHHHHHHHc--CCCCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 013522 223 --DDNIVSMYRKIYR--GDFKCPPW-----FSSEARRLITKLLDPNPNSRIAISKI 269 (441)
Q Consensus 223 --~~~~~~~~~~i~~--~~~~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~ei 269 (441)
.++..++...+.+ .++.+|.. -...+++.+.-||+.||+-|.|+.=+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2344444444433 34555542 23567899999999999999998644
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.59 Aligned_cols=254 Identities=23% Similarity=0.413 Sum_probs=211.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEc----C---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNL----Q---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELH 85 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~----~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 85 (441)
+.+-.....+.+.||+|+||+|++|.-. . ....||||.+...... ...+.+..|+.+|+.+ .||||+.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 3444455567789999999999999732 1 1457999998655432 4578899999999998 599999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCc
Q 013522 86 EVMASKSKIYFAMDLVKGGELFNKIAKGR-----------------LREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 148 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------------l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~N 148 (441)
+++...+..++|+||+..|+|.++++..+ ++..+...+..||+.|++||++.+++||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998766 8899999999999999999999999999999999
Q ss_pred EEeCCCCCeEEeecCccccccccccCCcccccccCCC--ccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCc
Q 013522 149 LLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA--YVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDN 225 (441)
Q Consensus 149 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~--y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~ 225 (441)
||+..+..+||+|||+|+........ ......|+.+ |||||.+....| +.++||||+||+|||+++ |..||.+-.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999843221111 1111223334 999999988655 589999999999999998 999998854
Q ss_pred -HHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 226 -IVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 226 -~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..+++..+..|. ...|..+++++.++++.||..+|++||++.++.+
T Consensus 527 ~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 556677777774 4778899999999999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.14 Aligned_cols=255 Identities=25% Similarity=0.475 Sum_probs=204.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 91 (441)
.+...|.++.+||.|+|++||+|.+.. .++.||+|.+..... ..++.+|+++|..+ .+.||+++.+++...
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 466789999999999999999999877 788999999876543 35789999999998 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~~~ 170 (441)
+...+|+||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|+|||+|...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888877765 6688999999999999999999999999999999999854 6789999999862111
Q ss_pred cc-------------------------------cCCcc-----------cccccCCCccchhhhhccCCCCCcccHHHHH
Q 013522 171 LK-------------------------------QDGLL-----------HTTCGTPAYVAPEVISKKGYDGAKADIWSCG 208 (441)
Q Consensus 171 ~~-------------------------------~~~~~-----------~~~~gt~~y~APE~l~~~~~~~~~~DiwSlG 208 (441)
.. +.+.. ....|||+|.|||++.+.+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00001 1234999999999999988888999999999
Q ss_pred HHHHHHhhCCCCCCCCc-----HHHHH--------HHH--HcCC---------------------------CCC------
Q 013522 209 VILYVLLAGFLPFQDDN-----IVSMY--------RKI--YRGD---------------------------FKC------ 240 (441)
Q Consensus 209 vil~~ll~G~~Pf~~~~-----~~~~~--------~~i--~~~~---------------------------~~~------ 240 (441)
||+..++++..||-... ..++. ++. .-|. .+.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999983211 00000 000 0000 000
Q ss_pred ----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 241 ----PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 241 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
...++..+.+|+.+||+.||.+|+|++++|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0124568999999999999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=247.65 Aligned_cols=212 Identities=43% Similarity=0.762 Sum_probs=186.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 013522 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGEL 106 (441)
Q Consensus 27 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 106 (441)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 346789999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEeecCccccccccccCCcccccccC
Q 013522 107 FNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183 (441)
Q Consensus 107 ~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~gt 183 (441)
.+++... .++...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999864 7899999999999999999999999999999999999999 89999999999875433211 23345578
Q ss_pred CCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013522 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 184 ~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (441)
..|++||.+......+.++|+|++|++++++ ..+.+++.+|+..||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987653446889999999999998 678899999999999999
Q ss_pred CCHHHHhcCc
Q 013522 264 IAISKIMESS 273 (441)
Q Consensus 264 ~t~~eil~hp 273 (441)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.36 Aligned_cols=247 Identities=20% Similarity=0.329 Sum_probs=211.3
Q ss_pred eEEeeeecccCceEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
.+..++||+|+||+||+|.+...|+ +||||++...... .....+..|+-+|..|+|||+++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4456899999999999999986665 5888888655432 34577889999999999999999999997765 889
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
|++|+++|.|.++++. +.+.......|..||++|+.|||.+.++||||-..|||+.+...+||+|||+|.........
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999975 67889999999999999999999999999999999999999999999999999876654332
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLI 252 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li 252 (441)
-....-.-.+.|||=|.+....| +.++||||+||.+||++| |..|+++....++-+.+..+ +.+.|+.++-++..++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 22222222456999999988777 489999999999999998 99999999888887777666 4678999999999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 013522 253 TKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~ 271 (441)
.+||..|+..||++.++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999988743
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=246.34 Aligned_cols=211 Identities=26% Similarity=0.471 Sum_probs=174.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 97 (441)
+...-+..||+|+||.|-+.++..+|...|+|.+...- +....+++.+|+.+..+. ..|.+|.+|+.+..+..+++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 34445678999999999999999999999999996543 234566788888886554 799999999999999999999
Q ss_pred EeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 98 MDLVKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 98 ~E~~~gg~L~~~i~-----~~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
||.+.- +|..+.. .+..+|..+-+++..++.||.|||++ .|+|||+||.|||++.+|++|+||||.+....
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-- 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-- 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence 999964 6655543 26799999999999999999999986 89999999999999999999999999987543
Q ss_pred ccCCcccc-cccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHHcCC
Q 013522 172 KQDGLLHT-TCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD 237 (441)
Q Consensus 172 ~~~~~~~~-~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~ 237 (441)
++...+ ..|-..|||||.+.. .+|+ .+|||||||+.++||.+++.||+. .++.+.+.++....
T Consensus 201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 201 --DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred --hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 233333 668899999999853 3564 899999999999999999999975 45556666666543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=250.15 Aligned_cols=219 Identities=44% Similarity=0.719 Sum_probs=188.0
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++.+.||.|++|+||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999999765432 2467899999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccc
Q 013522 101 VKGGELFNKIAKG-R-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLH 178 (441)
Q Consensus 101 ~~gg~L~~~i~~~-~-l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 178 (441)
+.+++|.+++... . +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 9999999999863 3 8999999999999999999999999999999999999999999999999987654322 11334
Q ss_pred ccccCCCccchhhh-hccCCCCCcccHHHHHHHHHHHhhCCCCCCC--CcHHHHHHHHHcCCCCCCCC
Q 013522 179 TTCGTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRGDFKCPPW 243 (441)
Q Consensus 179 ~~~gt~~y~APE~l-~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~~~~ 243 (441)
...++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.+...+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 56788999999998 444454 689999999999999999999987 45557888888876555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=258.56 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=203.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEV-MASKSK 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~ 93 (441)
.+.+.|.|.+.||+|-||++.+++++.++..+++|.+.+... ...++.+|..---.| .|.||+.-|++ |.+.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 477889999999999999999999999999999999987653 356788888765555 58999998886 577888
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC--CCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED--GNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~--~~vkl~DFGla~~~~~~ 171 (441)
+++++||++-|+|..-+....+.|...++++.|+++|+.|||+++++|||||.+|||+-.. -++||||||+++..
T Consensus 97 YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--- 173 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--- 173 (378)
T ss_pred EEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc---
Confidence 9999999999999999988779999999999999999999999999999999999999433 37999999987632
Q ss_pred ccCCcccccccCCCccchhhhhccC---C-CCCcccHHHHHHHHHHHhhCCCCCCCCcH----HHHHHHHHcCC-CCCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKG---Y-DGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGD-FKCPP 242 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~---~-~~~~~DiwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~-~~~~~ 242 (441)
+......--+..|.|||.+.... + ..+.+|+|.||+++|.+++|.+||+.... -..+.++..+. +..|.
T Consensus 174 --g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 --GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred --CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 22333344577899999874321 1 13568999999999999999999975322 22334444443 34444
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCcccCc
Q 013522 243 ---WFSSEARRLITKLLDPNPNSR---IAISKIMESSWFKK 277 (441)
Q Consensus 243 ---~~~~~~~~li~~~L~~dP~~R---~t~~eil~hpwf~~ 277 (441)
.+++.+..+.++-|.++|++| .++......-|...
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 378999999999999999999 66777777777653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=296.59 Aligned_cols=261 Identities=29% Similarity=0.502 Sum_probs=212.1
Q ss_pred cCCe-EEeeeecccCceEEEEEEEcCCCcEEEEEEeecc--cc-cchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 18 HGKY-ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKD--KV-IKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 18 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
...| .....+|.|++|.|+.+......+.++.|.+... .. ........+..|+.+-..+.|||++..+..+.+...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 4556 5678999999999999998888887888776522 11 111122237778888899999999887776666666
Q ss_pred EEEEEeccCCCchHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~-~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
.+..||||++ +|+.++.+. ++...++..+++||+.||+|||+.||.|||+||+|++++.+|.+||+|||.+..+....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 6666999999 999999884 89999999999999999999999999999999999999999999999999998776655
Q ss_pred cC--CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHH--HH-------HHcCCCCCC
Q 013522 173 QD--GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY--RK-------IYRGDFKCP 241 (441)
Q Consensus 173 ~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~--~~-------i~~~~~~~~ 241 (441)
.. ......+|+.+|+|||++.+..|+....||||+|++++.|.+|+.||......+.. .. +..+.....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLL 554 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHH
Confidence 54 55677899999999999999999999999999999999999999999765433211 11 111111122
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..++...+.+|.+||++||.+|+|+++|++++||+...
T Consensus 555 ~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 555 SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 23678899999999999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=296.32 Aligned_cols=200 Identities=16% Similarity=0.216 Sum_probs=147.7
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccC
Q 013522 75 MVKH-KHIVELHEVM-------ASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 144 (441)
Q Consensus 75 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDL 144 (441)
.++| +||++++++| .....+++++||+ +++|++++.. +.+++.++..++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5888888877 2334678889988 5699999975 45999999999999999999999999999999
Q ss_pred CCCcEEeCCC-------------------CCeEEeecCcccccccccc--------------CCcccccccCCCccchhh
Q 013522 145 KPENLLLDED-------------------GNLKVTDFGLSAFSEHLKQ--------------DGLLHTTCGTPAYVAPEV 191 (441)
Q Consensus 145 kp~NILl~~~-------------------~~vkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APE~ 191 (441)
||+|||++.. +.+|++|||+++....... .......+||++|+|||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 4456666666543211000 000112468999999999
Q ss_pred hhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 013522 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 192 l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 270 (441)
+.+..| +.++|||||||+||||++|.+|+..... ....+..... +.+....+...+++.+||.+||.+|||+.+++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 988877 5899999999999999999998764321 1122211111 11111245678999999999999999999999
Q ss_pred cCcccCcc
Q 013522 271 ESSWFKKS 278 (441)
Q Consensus 271 ~hpwf~~~ 278 (441)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=239.07 Aligned_cols=253 Identities=19% Similarity=0.257 Sum_probs=207.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCC-----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE-
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTG-----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA- 89 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~- 89 (441)
+-..|+++.-.+-+|+||.||.|.+++.. +.|-+|.+... .+.-....+..|-..+..+.|||+..+.++..
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34557888889999999999999876432 23445544322 12234567788888999999999999999874
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEe
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~---------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
+....++++.+..-|+|..++.- ..++..+...++.|++.|++|||++||+|.||-..|+++|+.-++||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45678888899988999998871 236677888899999999999999999999999999999999999999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-C
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-F 238 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 238 (441)
|=.+|+..-..+..-..........|||||.+....|. .++|+|||||+||||+| |+.|+..-++.+++..+.+|. .
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 99998765443333333344456679999999988775 88999999999999998 999999999999999988874 5
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.-|-++|+++..++.-||..+|++||+.+|+..
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 568889999999999999999999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=230.10 Aligned_cols=254 Identities=36% Similarity=0.607 Sum_probs=212.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK-HIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E 99 (441)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999876554433567899999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCccccccccccC
Q 013522 100 LVKGGELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 100 ~~~gg~L~~~i~~~----~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 174 (441)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777763 699999999999999999999999999999999999999998 6999999998754432222
Q ss_pred C----cccccccCCCccchhhhhcc--CCCCCcccHHHHHHHHHHHhhCCCCCCCCcH----HHHHHHHHcCCCC-CCCC
Q 013522 175 G----LLHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNI----VSMYRKIYRGDFK-CPPW 243 (441)
Q Consensus 175 ~----~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 243 (441)
. .....+||+.|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 35678899999999999874 4556889999999999999999999887763 4555555554433 2222
Q ss_pred CC--------HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 244 FS--------SEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 244 ~~--------~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.. ..+.+++.+++..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 47899999999999999999999988866543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=242.46 Aligned_cols=172 Identities=22% Similarity=0.216 Sum_probs=136.6
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcC-CCcEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCcce-EEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKV--IKVGMMEQIKREISVMKMVKHKHIVE-LHEVM 88 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~ 88 (441)
+-..+.++|++.+.||+|+||+||+|++.. +++.+|||.+..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 335688999999999999999999999876 678889998753311 12234567999999999999999985 5442
Q ss_pred EeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccC-CCCcEEeCCCCCeEEeecCcccc
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL-KPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDL-kp~NILl~~~~~vkl~DFGla~~ 167 (441)
+..|+||||+.|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999732 11 11 2568899999999999999999999 99999999999999999999986
Q ss_pred ccccccCCc------ccccccCCCccchhhhhc
Q 013522 168 SEHLKQDGL------LHTTCGTPAYVAPEVISK 194 (441)
Q Consensus 168 ~~~~~~~~~------~~~~~gt~~y~APE~l~~ 194 (441)
......... ..+.++++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 654332222 246678999999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=222.89 Aligned_cols=157 Identities=25% Similarity=0.298 Sum_probs=128.1
Q ss_pred CchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccc
Q 013522 104 GELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181 (441)
Q Consensus 104 g~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 181 (441)
|+|.+++.. +.+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 688999974 45999999999999999999999999 999999999999999 9998764331 236
Q ss_pred cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCC-------CCCCCH--HHHHH
Q 013522 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKC-------PPWFSS--EARRL 251 (441)
Q Consensus 182 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~-------~~~~~~--~~~~l 251 (441)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||...... .....+....... +..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887775 8999999999999999999999765432 3333333221111 122333 69999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
|.+||..||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=252.74 Aligned_cols=239 Identities=35% Similarity=0.623 Sum_probs=207.9
Q ss_pred eecccCceEEEEEEE---cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 013522 26 MLGHGTFAKVYLARN---LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
.+|.|+||+|++++. .+.|.-+|+|+..+........ ..-..|..++..++ ||.+++++..+..+...|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998763 3567889999997765432222 25667888888886 999999999999999999999999
Q ss_pred CCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccc
Q 013522 102 KGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180 (441)
Q Consensus 102 ~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 180 (441)
.||+|+..+.. ..+.+...+.+...++-+++++|+.||+|||+|++||+++.+|.+++.|||+++..-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999999876 56788889999999999999999999999999999999999999999999998754322 122
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP 260 (441)
|||.-|||||+++ ++. ..+|.||+|+++|+|++|..||.. +....|.+..+..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 443 789999999999999999999988 677788888999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCcccCcc
Q 013522 261 NSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 261 ~~R~t-----~~eil~hpwf~~~ 278 (441)
.+|.- ..++++|++|+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99985 4799999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=221.92 Aligned_cols=248 Identities=26% Similarity=0.340 Sum_probs=195.0
Q ss_pred CeEEeeeecccCceEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH----KHIVELHEVM-ASKSK 93 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~ 93 (441)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+........ ...+..|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997774 689999887653222 1267889999999873 6999999999 57888
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-----CCeEEeecCcc
Q 013522 94 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-----GNLKVTDFGLS 165 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-----~~vkl~DFGla 165 (441)
-|+||+.+ |.+|.++... ++++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 7899998753 679999999999999999999999999999999999999765 35999999999
Q ss_pred ccccccccCC-------c-ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH---HHHHHHH
Q 013522 166 AFSEHLKQDG-------L-LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---SMYRKIY 234 (441)
Q Consensus 166 ~~~~~~~~~~-------~-~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~ 234 (441)
+.+......+ . .....||..|+++.+..+... +.+.|+||++.++.+|+.|.+||...... ..+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8333211111 1 123449999999999887765 58999999999999999999999765532 2222222
Q ss_pred cCCCC--CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 235 RGDFK--CPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 235 ~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..... .....+..+.++...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22111 223355778888888888999999998888654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=241.27 Aligned_cols=228 Identities=33% Similarity=0.623 Sum_probs=182.1
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
...-...+|+.++++..|+||.||+++++.+.+.+|+| +++..+.- ++ |+.....|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------Rn---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------RN---ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------hc---cccccCCccee----------
Confidence 44456678999999999999999999999999999995 44443211 11 44444555554
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
|+-...++. |.++.+. +.+++|+|+.||+|||+||+|++++.-|.+|++|||++..-...
T Consensus 136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 456666665 5666544 78999999999999999999999999999999999998532111
Q ss_pred c-------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC
Q 013522 172 K-------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238 (441)
Q Consensus 172 ~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 238 (441)
. ..-.-...||||.|+|||++...+| +.++|.|++|+|+|+++-|..||.++++++++..+.....
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 0 0011234589999999999999988 5899999999999999999999999999999999888777
Q ss_pred CCCCC---CCHHHHHHHHHhcCCCCCCCC---CHHHHhcCcccCccCCc
Q 013522 239 KCPPW---FSSEARRLITKLLDPNPNSRI---AISKIMESSWFKKSAPK 281 (441)
Q Consensus 239 ~~~~~---~~~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~~~~~ 281 (441)
.+|.. ++++++++|.++|+.+|..|. .+-++.+|+||+.....
T Consensus 276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 66643 789999999999999999996 46688999999865544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=198.86 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=200.8
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEe
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMAS 90 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~ 90 (441)
...-+..++|+++++||.|+||.+|+|....+|+.||||+-....- ..++..|..+.+.|++ +.|..+..+..+
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 3445678899999999999999999999999999999998754432 3477889999999964 788888888888
Q ss_pred CCEEEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC---CCeEEeecCcc
Q 013522 91 KSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLS 165 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~---~~vkl~DFGla 165 (441)
...-.+||+.+ |.+|.++.. +.+++-..+.-++-|++.-++|+|.++++||||||+|+|+.-+ ..+-++|||+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88999999999 778988876 3679999999999999999999999999999999999999644 35899999999
Q ss_pred ccccccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCC
Q 013522 166 AFSEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGD 237 (441)
Q Consensus 166 ~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~ 237 (441)
..+...... ..-....||..|.+--...+... +.+.|+-|+|.+|.++.-|.+||++.. ...-+++|....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 866543322 12234569999998777655433 477899999999999999999998854 345567777766
Q ss_pred CCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHH
Q 013522 238 FKCPP-----WFSSEARRLITKLLDPNPNSRIAIS 267 (441)
Q Consensus 238 ~~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~ 267 (441)
...|. .+|.++.-.+.-|-..--++-|...
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 66553 4788888888888777666666643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=203.33 Aligned_cols=246 Identities=20% Similarity=0.345 Sum_probs=200.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
.+..-.|+++++||+|+||.++.|.+.-+++.||||.-.... .+.+++.|....+.| ..++|...|.+...+-+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 455668999999999999999999999999999999865432 356899999999998 57999999999888888
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-----CeEEeecCccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-----NLKVTDFGLSA 166 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-----~vkl~DFGla~ 166 (441)
-.+|+|++ |.+|.|+..- .+++...+.-++.|++.-++|+|++..|.|||||+|+||...+ .+-++|||+|.
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88999999 7788888763 5699999999999999999999999999999999999997544 48899999998
Q ss_pred cccccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC---CcHHHHHHHHHcCCC
Q 013522 167 FSEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDF 238 (441)
Q Consensus 167 ~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~ 238 (441)
.+...... .......||..||+--...+... +.+.|+-|||-+++++|-|.+||.+ ++...-|++|....-
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 76543321 22345679999999887776654 4789999999999999999999986 456677888866544
Q ss_pred CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHH
Q 013522 239 KCP-----PWFSSEARRLITKLLDPNPNSRIAIS 267 (441)
Q Consensus 239 ~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~ 267 (441)
..| ..+|.++..-++-.-..+-..-|..+
T Consensus 257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 333 34677777666666666666666644
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=205.59 Aligned_cols=176 Identities=15% Similarity=0.200 Sum_probs=138.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHH------HHHHHHHHHhCCCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ------IKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
..+.++|++.+.||.|+||.||++.. ++..+|+|++............. +.+|+..+.++.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 35789999999999999999999765 57789999997654433333333 68999999999999999999886
Q ss_pred EeC--------CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEe
Q 013522 89 ASK--------SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 89 ~~~--------~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
... +..+++|||++|.+|.+... +++ ....+++.+|..||+.|++|||+||.||+++.+| ++|+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 543 35889999999999987732 333 2456999999999999999999999999999988 9999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHh
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 215 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll 215 (441)
|||.+........ ...++....|+ .++|+||||+.+..+.
T Consensus 177 Dfg~~~~~~e~~a--------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKA--------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhh--------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 9998764321110 01134455676 7899999999887554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=198.39 Aligned_cols=141 Identities=21% Similarity=0.268 Sum_probs=112.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----------------------hHHHHHHHHHHHHhCCCCC
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----------------------MMEQIKREISVMKMVKHKH 80 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn 80 (441)
...||+|+||.||+|.+. +|+.||+|+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999765321111 0123456999999998887
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-hhcCcEeccCCCCcEEeCCCCCeE
Q 013522 81 IVELHEVMASKSKIYFAMDLVKGGELFNK-IAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLDEDGNLK 158 (441)
Q Consensus 81 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~-i~~~~l~~~~~~~~~~qll~aL~yl-H~~gi~HrDLkp~NILl~~~~~vk 158 (441)
+.....+... ..++||||+.|+++... +..+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7544333222 23899999999877655 4557899999999999999999999 799999999999999998 57899
Q ss_pred EeecCccccc
Q 013522 159 VTDFGLSAFS 168 (441)
Q Consensus 159 l~DFGla~~~ 168 (441)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=202.90 Aligned_cols=233 Identities=27% Similarity=0.356 Sum_probs=153.3
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC----------CCcceEEEEEE-
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH----------KHIVELHEVMA- 89 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~- 89 (441)
+..++.||.|+++.||.+++.+||+.+|+|++...........+++++|.-....+.+ -.++--++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4667899999999999999999999999999986664444567888888766555432 12222233221
Q ss_pred --------eC---C-----EEEEEEeccCCCchHHHHhc----CCC---CHHHH-HHHHHHHHHHHHHHhhcCcEeccCC
Q 013522 90 --------SK---S-----KIYFAMDLVKGGELFNKIAK----GRL---REDVA-RVYFQQLISAVDFCHSRGVYHRDLK 145 (441)
Q Consensus 90 --------~~---~-----~~~lv~E~~~gg~L~~~i~~----~~l---~~~~~-~~~~~qll~aL~ylH~~gi~HrDLk 145 (441)
.. + +.+++|+-+. ++|.+.+.. ... ....+ ..+..|++..+++||+.|++|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 1 2367788875 478777642 222 12223 3345899999999999999999999
Q ss_pred CCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccC-------CCCCcccHHHHHHHHHHHhhCC
Q 013522 146 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG-------YDGAKADIWSCGVILYVLLAGF 218 (441)
Q Consensus 146 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~~~~~~DiwSlGvil~~ll~G~ 218 (441)
|+|++++.+|.+.|+||+.....+. .......+..|.+||...... ..+.+.|.|+||+++|.|.||.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999987653222 111134567799999875431 1247789999999999999999
Q ss_pred CCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCC
Q 013522 219 LPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 219 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (441)
+||........... .--.|. .+++.++.||+++|++||.+|
T Consensus 248 lPf~~~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99987654321111 111344 789999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=232.54 Aligned_cols=240 Identities=24% Similarity=0.330 Sum_probs=185.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccc-ccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDK-VIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..|...+.||.+.|=+|.+|++. .|. |.||++-+.. ........+..+|++ ...++|||++.+..+.......|+|
T Consensus 23 ~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 23 VECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred cceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 37889999999999999999983 444 9999997654 333333344445555 5567999999999998888899999
Q ss_pred EeccCCCchHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc--ccccccC
Q 013522 98 MDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF--SEHLKQD 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~-l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~--~~~~~~~ 174 (441)
-+|+.. +|+|++...+ +...+.+.|+.||+.||..||+.||+|||||.||||++.-+-+.|+||..-+. ..+.++.
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999976 8999998755 66778888999999999999999999999999999999999999999986421 1222222
Q ss_pred C---cccccccCCCccchhhhhccC----------CCCCcccHHHHHHHHHHHhh-CCCCCCCCc-----------HHHH
Q 013522 175 G---LLHTTCGTPAYVAPEVISKKG----------YDGAKADIWSCGVILYVLLA-GFLPFQDDN-----------IVSM 229 (441)
Q Consensus 175 ~---~~~~~~gt~~y~APE~l~~~~----------~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~-----------~~~~ 229 (441)
. .+.|...-.+|+|||.+.... .-+++.||||+||++.||++ |++||.-.. ....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 1 234445566799999986522 12467899999999999998 799995322 2222
Q ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 230 YRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 230 ~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.++| -+..++.||..|++.||++|.++++.|+.
T Consensus 259 Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2222 14578999999999999999999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-26 Score=238.70 Aligned_cols=259 Identities=32% Similarity=0.537 Sum_probs=219.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIY 95 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 95 (441)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... .......++..|..+-+.+. |+|++++++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6779999999999999999998754 34567777775543 22345667778999999887 999999999999999999
Q ss_pred EEEeccCCCchHHHH-hcC--CCCHHHHHHHHHHHHHHHHHHh-hcCcEeccCCCCcEEeCCCC-CeEEeecCccccccc
Q 013522 96 FAMDLVKGGELFNKI-AKG--RLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEH 170 (441)
Q Consensus 96 lv~E~~~gg~L~~~i-~~~--~l~~~~~~~~~~qll~aL~ylH-~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~ 170 (441)
+.++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++.++ .++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 552 5788899999999999999999 99999999999999999999 999999999988776
Q ss_pred -cccCCccccccc-CCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHHcC--CCCCC--CC
Q 013522 171 -LKQDGLLHTTCG-TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY-RKIYRG--DFKCP--PW 243 (441)
Q Consensus 171 -~~~~~~~~~~~g-t~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~--~~~~~--~~ 243 (441)
.+........|| ++.|+|||...+..|.+...|+||+|+++..+++|..||......... ..+... ..... ..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 555667778899 999999999998888899999999999999999999999876543321 222221 11222 34
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
++....+++.++|..+|..|.+..++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7889999999999999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=190.93 Aligned_cols=143 Identities=18% Similarity=0.255 Sum_probs=115.3
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------------------hhHHHHHHHHHHHHhCCCC
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----------------------GMMEQIKREISVMKMVKHK 79 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~hp 79 (441)
+...||+|+||+||+|.+. +|+.||||+++....... ......++|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999999986532100 0123346899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCe
Q 013522 80 HIVELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNL 157 (441)
Q Consensus 80 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~v 157 (441)
+|.....+.... .|+||||+.|+++.. .+..+++++..+..++.|++.+|.+||+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886554443332 489999999885544 3556778999999999999999999999 9999999999999998 8899
Q ss_pred EEeecCcccccc
Q 013522 158 KVTDFGLSAFSE 169 (441)
Q Consensus 158 kl~DFGla~~~~ 169 (441)
+|+|||+|...+
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-23 Score=185.14 Aligned_cols=192 Identities=20% Similarity=0.251 Sum_probs=144.0
Q ss_pred EEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh-hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 013522 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-MMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.+...|++|+||+||++.. .+..++.+.+......... ....+++|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998876 7778887777554432111 1235789999999995 5889999886 45699999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccC-CCCcEEeCCCCCeEEeecCccccccccccC----
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDL-KPENLLLDEDGNLKVTDFGLSAFSEHLKQD---- 174 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDL-kp~NILl~~~~~vkl~DFGla~~~~~~~~~---- 174 (441)
|+.|.+|...+..+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999987654221 2357889999999999999999999 799999999999999999999754432210
Q ss_pred C-------cccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCc
Q 013522 175 G-------LLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDN 225 (441)
Q Consensus 175 ~-------~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~ 225 (441)
. ...-...+|.|++|+.-.-.. ..-...+.++.|+-+|.++|+..|+..++
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 011223688899998654321 11256788999999999999998875543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=198.31 Aligned_cols=195 Identities=26% Similarity=0.417 Sum_probs=147.8
Q ss_pred CCCCcceEEEEEEe---------------------------CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHH
Q 013522 77 KHKHIVELHEVMAS---------------------------KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129 (441)
Q Consensus 77 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~ 129 (441)
+|||||++...|.+ +..+|+||...+. +|+.++-....+-...+-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999877632 2358999998865 8999998888888999999999999
Q ss_pred HHHHHhhcCcEeccCCCCcEEeC--CCC--CeEEeecCccccccccc-----cCCcccccccCCCccchhhhhccC----
Q 013522 130 AVDFCHSRGVYHRDLKPENLLLD--EDG--NLKVTDFGLSAFSEHLK-----QDGLLHTTCGTPAYVAPEVISKKG---- 196 (441)
Q Consensus 130 aL~ylH~~gi~HrDLkp~NILl~--~~~--~vkl~DFGla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~~---- 196 (441)
|+.|||++||.|||+|.+|||+. +++ .+.|+|||.+- .+... ..+......|.-.-||||+....+
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL-Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL-ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee-eccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999994 333 48999999652 22221 111223455888899999986432
Q ss_pred -CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHH-HHc-CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCH---HHHh
Q 013522 197 -YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK-IYR-GDFKCPPWFSSEARRLITKLLDPNPNSRIAI---SKIM 270 (441)
Q Consensus 197 -~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~-i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~---~eil 270 (441)
.+-.++|.|++|.+.||+++...||.....+.+-.. ..+ .-+..|..+++.+++|+..+|+.||++|+|. ..++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 223589999999999999999999977433221111 122 2345677899999999999999999999984 4555
Q ss_pred cCc
Q 013522 271 ESS 273 (441)
Q Consensus 271 ~hp 273 (441)
+..
T Consensus 512 ~Ls 514 (598)
T KOG4158|consen 512 NLS 514 (598)
T ss_pred HHH
Confidence 543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=191.03 Aligned_cols=241 Identities=20% Similarity=0.322 Sum_probs=195.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.+...+..+|...-.|+.|+|++ .|..++.|++.-.... .....++..|.-.|+.+.||||+.+++.+..+.++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 34556777899999999999999 5556777887654432 23446788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCCeEEe--ecCccccccc
Q 013522 98 MDLVKGGELFNKIAKGR---LREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVT--DFGLSAFSEH 170 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~---l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~vkl~--DFGla~~~~~ 170 (441)
..|++-|+|+..+..+. .+..++.+++.+++.|++|||+.. |..--|....+++|++-+.+|+ |--++. .
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--q- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--e-
Confidence 99999999999998743 678889999999999999999863 4444788999999998876654 322211 0
Q ss_pred cccCCcccccccCCCccchhhhhccCCCC--CcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCCCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDG--AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~--~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 246 (441)
.....-+|.||+||.+.+++-+. .++|+|||.+++|||.|.+.||.+-.+.+.--+|.-. +..+||.+++
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 11223478999999998876553 4699999999999999999999998887766555433 5678999999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHh
Q 013522 247 EARRLITKLLDPNPNSRIAISKIM 270 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil 270 (441)
.+..|+.-|+..||.+||.++.|+
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999988764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=184.40 Aligned_cols=134 Identities=20% Similarity=0.235 Sum_probs=109.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-----KHKHIVELHEVMASKS---KIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~~~ 95 (441)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++|+++.++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7777666 6999876432 2346799999999999 5799999999998863 444
Q ss_pred -EEEec--cCCCchHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhcCcEeccCCCCcEEeCCC----CCeEEeecCcc
Q 013522 96 -FAMDL--VKGGELFNKIAKGRLREDVARVYFQQLISAV-DFCHSRGVYHRDLKPENLLLDED----GNLKVTDFGLS 165 (441)
Q Consensus 96 -lv~E~--~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL-~ylH~~gi~HrDLkp~NILl~~~----~~vkl~DFGla 165 (441)
+|+|| +.+++|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 557999999988777766 35678888777 99999999999999999999743 37999995543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=180.34 Aligned_cols=142 Identities=18% Similarity=0.200 Sum_probs=114.5
Q ss_pred eEEeeeecccCceEEEEEE-EcCCCcEEEEEEeecccccch---------------------hhHHHHHHHHHHHHhCCC
Q 013522 21 YELGRMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKV---------------------GMMEQIKREISVMKMVKH 78 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAiK~i~~~~~~~~---------------------~~~~~~~~Ei~il~~l~h 78 (441)
|++.+.||+|+||.||+|. +..+|+.||+|++........ .....+.+|+.+++.+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8999999999999999999 668999999999975432100 011346789999999976
Q ss_pred C--CcceEEEEEEeCCEEEEEEeccCCCchHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcC-cEeccCCCCcEEeCCC
Q 013522 79 K--HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG-VYHRDLKPENLLLDED 154 (441)
Q Consensus 79 p--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i-~~~~l~~~~~~~~~~qll~aL~ylH~~g-i~HrDLkp~NILl~~~ 154 (441)
. .+.++++. ...|+||||+.|++|.... ....+....+..++.|++.+|.+||+.| |+||||||+||+++ +
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3 34444543 2358999999998887665 3455677778899999999999999999 99999999999999 8
Q ss_pred CCeEEeecCcccc
Q 013522 155 GNLKVTDFGLSAF 167 (441)
Q Consensus 155 ~~vkl~DFGla~~ 167 (441)
+.++|+|||.|..
T Consensus 185 ~~i~LiDFg~a~~ 197 (237)
T smart00090 185 GKVVIIDVSQSVE 197 (237)
T ss_pred CCEEEEEChhhhc
Confidence 8999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-20 Score=169.57 Aligned_cols=137 Identities=21% Similarity=0.324 Sum_probs=115.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
+.||+|++|.||+|.+ +|..+++|+......... .....+.+|+.++..+.|++|.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999997 778899998654322111 123467889999999999999887777777788899999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875422 7889999999999999999999999999999999 78999999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.5e-20 Score=196.39 Aligned_cols=235 Identities=20% Similarity=0.326 Sum_probs=177.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~ 92 (441)
+-..+|.|.+.||+|+||+||.|.+.. |+.||+|+-.....+.--...++ +.+|+ -+.|..++..+.-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHccCC
Confidence 445689999999999999999999866 99999999766554432222333 33333 244555555555556
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-------CCCCeEEeecCc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-------EDGNLKVTDFGL 164 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-------~~~~vkl~DFGl 164 (441)
.-++|+||.+.|+|.+++.. +.+++..+..+..|++.-|++||..||||+||||+|+||. ++--++|+|||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 67899999999999999986 6699999999999999999999999999999999999993 233599999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-----C
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-----K 239 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~ 239 (441)
|-.+.-......+...++|-.+--+|...+.++. ..+|.|.++-+++.||.|+.. + ...|.. .
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~----------q-~~~g~~~~~~~~ 915 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM----------E-VKNGSSWMVKTN 915 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH----------H-hcCCcceecccc
Confidence 8665544445567788899999999999999995 899999999999999998532 1 222211 1
Q ss_pred CCCCCC-HHHHHHHHHhcCCCCCCCCCHHHH
Q 013522 240 CPPWFS-SEARRLITKLLDPNPNSRIAISKI 269 (441)
Q Consensus 240 ~~~~~~-~~~~~li~~~L~~dP~~R~t~~ei 269 (441)
++..+. +...+++..+|..|-..=|.+.++
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 222222 334578888998555555555554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=165.03 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=108.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
.||+|+||+||+|.+ +|..+++|......... .....++.+|+.+++.+.|+++....-++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999995 67889999865432211 11246778999999999988766555555566677999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 101 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 101 ~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=164.46 Aligned_cols=137 Identities=19% Similarity=0.287 Sum_probs=109.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch-------------------hhHHHHHHHHHHHHhCCCCC-
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------------------GMMEQIKREISVMKMVKHKH- 80 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn- 80 (441)
|.+.+.||+|+||.||.|.+ .+|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88999999999999999987 4899999999865431000 01123678999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 81 -IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 81 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
+...++ ....++||||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2455899999999988765431 345678899999999999999999999999999999999999
Q ss_pred eecCcccc
Q 013522 160 TDFGLSAF 167 (441)
Q Consensus 160 ~DFGla~~ 167 (441)
+|||++..
T Consensus 167 iDfg~~~~ 174 (198)
T cd05144 167 IDWPQMVS 174 (198)
T ss_pred EECCcccc
Confidence 99999853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-20 Score=184.03 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=170.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEE-------
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE------- 86 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~------- 86 (441)
....+.+.+..+..+++.+...+-..+ .+.+.-+..+.+. ........+++-.+....|-+..-+.+
T Consensus 242 ~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~ 318 (516)
T KOG1033|consen 242 ESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE 318 (516)
T ss_pred ccccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence 344566667777777777765553322 3344444333222 122344455666555554444433333
Q ss_pred EE-----EeCCEEEEEEeccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCe
Q 013522 87 VM-----ASKSKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 157 (441)
Q Consensus 87 ~~-----~~~~~~~lv~E~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~v 157 (441)
.+ ....++||.|++|...+|.+++.+ ...+......++.|+..|+.| +|.+|+|+||.||+...++.+
T Consensus 319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~ 395 (516)
T KOG1033|consen 319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQL 395 (516)
T ss_pred hccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhh
Confidence 11 113368999999999999999974 236678889999999999999 999999999999999999999
Q ss_pred EEeecCccccccccc----cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHH
Q 013522 158 KVTDFGLSAFSEHLK----QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRK 232 (441)
Q Consensus 158 kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~ 232 (441)
||.|||+.+-..... .....+...||++||+||.+.+..|. .++||||||+||+||+. +|... ........
T Consensus 396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d 471 (516)
T KOG1033|consen 396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLI---QFSTQFERIATLTD 471 (516)
T ss_pred hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHH---HhccHHHHHHhhhh
Confidence 999999986544322 11234566799999999999998885 99999999999999996 22211 11222333
Q ss_pred HHcCCCCCCCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 233 IYRGDFKCPPWF-SSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 233 i~~~~~~~~~~~-~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
+..+.++..-+. .+.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 472 ~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 472 IRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 444443311121 3456799999999999999987777777664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=179.36 Aligned_cols=199 Identities=21% Similarity=0.349 Sum_probs=157.4
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCc-EeccCCCCcE
Q 013522 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGV-YHRDLKPENL 149 (441)
Q Consensus 73 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi-~HrDLkp~NI 149 (441)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.|.+... .++.--...++++|+.||.|+|+..| +|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46789999999999999999999999999999999999873 46666677889999999999998766 9999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCC------CCCcccHHHHHHHHHHHhhCCCCCCC
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY------DGAKADIWSCGVILYVLLAGFLPFQD 223 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~------~~~~~DiwSlGvil~~ll~G~~Pf~~ 223 (441)
++|..-.+||+|||+..+..............-...|.|||.+..... -+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876543111111222223456999999976422 24679999999999999999999976
Q ss_pred C----cHHHHHHHHHc-CCCCCCCC------CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 224 D----NIVSMYRKIYR-GDFKCPPW------FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 224 ~----~~~~~~~~i~~-~~~~~~~~------~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
. ...++...+.+ +...+.|. +++++..++..||..+|.+||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 3 22455556666 33333332 3457899999999999999999999843
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-19 Score=184.29 Aligned_cols=138 Identities=17% Similarity=0.250 Sum_probs=112.6
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.|...+.||+|+||+||+|.+. +..+++|+....... .....+.+.+|+.+++.++|++++..+.+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4566889999999999999874 344555543222111 111245688999999999999999888777777788
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 95 YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
++||||++|++|.+.+. ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 457789999999999999999999999999999 678999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-18 Score=155.41 Aligned_cols=137 Identities=20% Similarity=0.315 Sum_probs=100.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHH---------------------HHHHHHHHHHhCCCCC--
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME---------------------QIKREISVMKMVKHKH-- 80 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hpn-- 80 (441)
++.||+|+||+||.|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 8999999998754322111111 1145666666664443
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHH-HHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeE
Q 013522 81 IVELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLK 158 (441)
Q Consensus 81 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vk 158 (441)
+.+.++. ...++||||++|+.+.. .+..... ...++.++.+++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4455543 23589999999954432 1221111 16788999999999999999 9999999999999999 89999
Q ss_pred EeecCcccc
Q 013522 159 VTDFGLSAF 167 (441)
Q Consensus 159 l~DFGla~~ 167 (441)
|+|||.+..
T Consensus 155 liDfg~a~~ 163 (187)
T cd05119 155 IIDVPQAVE 163 (187)
T ss_pred EEECccccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=157.20 Aligned_cols=137 Identities=18% Similarity=0.309 Sum_probs=107.3
Q ss_pred eeec-ccCceEEEEEEEcCCCcEEEEEEeecccc----c------chhhHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 013522 25 RMLG-HGTFAKVYLARNLQTGKSMAMKVVGKDKV----I------KVGMMEQIKREISVMKMVKHKHI--VELHEVMASK 91 (441)
Q Consensus 25 ~~LG-~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~ 91 (441)
..|| .|+.|+||.+.. .+..+++|.+..... . .......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 788888888876 478899998864322 0 11223568899999999998875 6677664332
Q ss_pred -C---EEEEEEeccCC-CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 92 -S---KIYFAMDLVKG-GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 92 -~---~~~lv~E~~~g-g~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
. ..++|||+++| .+|.+++..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999998 6898888877676654 5789999999999999999999999999999999999999876
Q ss_pred c
Q 013522 167 F 167 (441)
Q Consensus 167 ~ 167 (441)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 4
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=142.08 Aligned_cols=132 Identities=20% Similarity=0.312 Sum_probs=112.9
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~ 100 (441)
+.+.||.|.++.||++.. ++..+++|.+..... ...+.+|+.+++.+.| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 457899999999999998 347899999865432 3578899999999976 5999999998888899999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---CcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 101 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---GVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 101 ~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~---gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
+.|+.+... +......++.+++.+++++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5566677899999999999984 799999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.4e-18 Score=180.78 Aligned_cols=267 Identities=26% Similarity=0.425 Sum_probs=216.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...+.+.+.+-+-+|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|-++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 35567888899999999999999988888888888776544333233444555555555556677776666666678899
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc---
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL--- 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~--- 171 (441)
++++|+.|++|...+.. +..+.+-++.++..+..+++|||+..+.|+|++|.|+|...+|..+++|||........
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999999987 66888899999999999999999999999999999999999999999999833211000
Q ss_pred -------------------c-------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc
Q 013522 172 -------------------K-------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN 225 (441)
Q Consensus 172 -------------------~-------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~ 225 (441)
. .........||+.|.+||.+.+... +..+|.|++|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0011234569999999999988766 588999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCC---CCHHHHHHHHHhcCCCCCCCCCHH---HHhcCcccCccCCccc
Q 013522 226 IVSMYRKIYRGDFKCPPW---FSSEARRLITKLLDPNPNSRIAIS---KIMESSWFKKSAPKVV 283 (441)
Q Consensus 226 ~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~t~~---eil~hpwf~~~~~~~~ 283 (441)
....++.+..+..++|.. .+..+++++.++|..+|.+|..+. +.-.||+|+...+...
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 999999999988877653 789999999999999999999987 8899999987665433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.2e-16 Score=155.53 Aligned_cols=261 Identities=19% Similarity=0.224 Sum_probs=195.4
Q ss_pred CCCCccccCCeEEeeeecc--cCceEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEE
Q 013522 11 DDRPTLLHGKYELGRMLGH--GTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELH 85 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~ 85 (441)
......+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-..... ......+=.+|+.-.+.+ .|+|.++.+
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccC
Confidence 3344567778889999999 99999999998 88999999997332211 001112233566666666 599999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhc-C-CCCHHHHHHHHHHHHH----HHHHHhhcCcEeccCCCCcEEeCCC-CCeE
Q 013522 86 EVMASKSKIYFAMDLVKGGELFNKIAK-G-RLREDVARVYFQQLIS----AVDFCHSRGVYHRDLKPENLLLDED-GNLK 158 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~gg~L~~~i~~-~-~l~~~~~~~~~~qll~----aL~ylH~~gi~HrDLkp~NILl~~~-~~vk 158 (441)
..++..+..|+-+|+|. .+|..+... . -+++..++..+.+... ||.++|+.+++|-|+||.||+...+ ...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 99999999999999995 688888775 3 3899999999999999 9999999999999999999999999 8899
Q ss_pred EeecCccccccccccCCc---ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHH-HHHHHH
Q 013522 159 VTDFGLSAFSEHLKQDGL---LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIV-SMYRKI 233 (441)
Q Consensus 159 l~DFGla~~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~-~~~~~i 233 (441)
++|||+........-... .....|...|++||.+.+. .+...|++|+|.+..+-.+|-.+.... +.. ...+.+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 999999765443321111 1222578889999998643 468899999999999888876554332 111 001111
Q ss_pred HcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 234 YRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
. ....+-...+.++...+..|++.+|..|++++.++.|++..
T Consensus 342 ~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 342 Y-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred c-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 1 01111223456677799999999999999999999999886
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-14 Score=145.37 Aligned_cols=185 Identities=17% Similarity=0.282 Sum_probs=138.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|++ ....-++.+..-.|..+.++.+|.|.+.+...- .....+++-++-|+.++||||+++++.++..+.+|+|.|.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTEr 90 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTER 90 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeec
Confidence 555 333333333322567778999999999876543 4456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 101 VKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 101 ~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH-~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
+. .|..++++ ++.......+.||+.||.||| +++++|++|.-..|+++..|..||++|.++...+.... ....
T Consensus 91 V~--Pl~~~lk~--l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~ 164 (690)
T KOG1243|consen 91 VR--PLETVLKE--LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKS 164 (690)
T ss_pred cc--cHHHHHHH--hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--cccc
Confidence 96 46666654 336777778899999999997 67899999999999999999999999998754332221 1111
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCC
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF 218 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~ 218 (441)
..---.|..|+.+.... -..|.|-|||++++++.|.
T Consensus 165 ~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred chhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcc
Confidence 11222366676553322 2479999999999999993
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=147.85 Aligned_cols=142 Identities=23% Similarity=0.308 Sum_probs=96.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccch-------------------------------hhHH------HHH
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------------------------------GMME------QIK 67 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------------------~~~~------~~~ 67 (441)
+.||.|++|.||+|+. .+|+.||||+.+....... .... ++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999996 5899999999854310000 0000 234
Q ss_pred HHHHHHHhC----C-CCCcceEEEEE-EeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHH-HHHHHhhcCcE
Q 013522 68 REISVMKMV----K-HKHIVELHEVM-ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCHSRGVY 140 (441)
Q Consensus 68 ~Ei~il~~l----~-hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~-aL~ylH~~gi~ 140 (441)
+|...+.++ . +|+| .+-.++ ...+..++||||++|++|.+......... ....++.+++. .+..+|..|++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence 455555544 2 3333 222222 22345789999999999988764311111 22345556655 47889999999
Q ss_pred eccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 141 HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
|+|+||.||+++.+|.++++|||++....
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.3e-15 Score=154.49 Aligned_cols=145 Identities=22% Similarity=0.376 Sum_probs=100.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-h----hhHHH
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--------------------------K-V----GMMEQ 65 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------------------------~-~----~~~~~ 65 (441)
+...|+. +.||.|++|.||.|+...+|+.||||+.+..... + . +..+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 7899999999999999888999999999754100 0 0 11222
Q ss_pred HH------HHHHHHHhC----CCCCcceEEEEEEe-CCEEEEEEeccCCCchHHH--Hhc-C----CCCHHHHHHHHHHH
Q 013522 66 IK------REISVMKMV----KHKHIVELHEVMAS-KSKIYFAMDLVKGGELFNK--IAK-G----RLREDVARVYFQQL 127 (441)
Q Consensus 66 ~~------~Ei~il~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~-~----~l~~~~~~~~~~ql 127 (441)
+. +|...+.++ .+.+.+.+-.++.+ .+..++||||+.|+.+.+. +.. + .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 33 344333333 24444444444432 4567899999999999764 322 3 25555566666666
Q ss_pred HHHHHHHhhcCcEeccCCCCcEEeCCCC----CeEEeecCcccccc
Q 013522 128 ISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSE 169 (441)
Q Consensus 128 l~aL~ylH~~gi~HrDLkp~NILl~~~~----~vkl~DFGla~~~~ 169 (441)
+ ..|++|+|+||.||+++.+| .++++|||++...+
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5 59999999999999999988 99999999986543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-13 Score=122.04 Aligned_cols=141 Identities=18% Similarity=0.215 Sum_probs=104.6
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEeeccccc-------------------chhhHHHH----HHHHHHHH
Q 013522 24 GRMLGHGTFAKVYLARNLQ------TGKSMAMKVVGKDKVI-------------------KVGMMEQI----KREISVMK 74 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~-------------------~~~~~~~~----~~Ei~il~ 74 (441)
...||.|--+.||.|.... .+..+|+|+.+..... +......+ ++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998643 3579999998532110 01112233 38999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEeccCCCchH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCcEeccCCCCcEE
Q 013522 75 MVKH--KHIVELHEVMASKSKIYFAMDLVKGGELF-NKIAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLL 150 (441)
Q Consensus 75 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~-~~i~~~~l~~~~~~~~~~qll~aL~yl-H~~gi~HrDLkp~NIL 150 (441)
++.. -++..++++ ..-++||||+.+..+. ..+....+++..+..++.+++.+|..| |+.|++|+||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9853 566677765 4568999999775442 234444566777788899999999999 8999999999999999
Q ss_pred eCCCCCeEEeecCcccccc
Q 013522 151 LDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 151 l~~~~~vkl~DFGla~~~~ 169 (441)
++ ++.+.|+|||.|...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 4789999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=122.43 Aligned_cols=127 Identities=21% Similarity=0.291 Sum_probs=97.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeccC
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV-ELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~E~~~ 102 (441)
.+.|+.|.++.||.++. .+..|++|+...... ......+|+.+++.+.+.+++ +++.... +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999997 478899999754421 123467899999998665544 4555433 34579999999
Q ss_pred CCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCc-----EeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 103 GGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV-----YHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 103 gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi-----~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
|.++... ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11123467899999999999985 9999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1e-13 Score=130.48 Aligned_cols=204 Identities=17% Similarity=0.263 Sum_probs=143.8
Q ss_pred HHHHHhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--
Q 013522 70 ISVMKMVKHKHIVELHEVMASK-----SKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-- 137 (441)
Q Consensus 70 i~il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~-- 137 (441)
..-|-++-|.|||+++.++.+. ....++.||+..|++..++++ ..+.....++|+.||++||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3344556799999999998553 458899999999999999975 3578888899999999999999987
Q ss_pred CcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC--cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHh
Q 013522 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG--LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLL 215 (441)
Q Consensus 138 gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll 215 (441)
-|+|+++....|++..+|-+|+.----..+........ ......|-++|.|||.=..... ..++|||++|+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHH
Confidence 59999999999999999988876322221111111111 1122346788999997443333 36799999999999998
Q ss_pred hCCCCC-CCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 216 AGFLPF-QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 216 ~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.|..-- ........-..+...-+... ...-+.+|.+||+..|..||++.+++.||..-+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 876542 22222222222222111111 223467899999999999999999999997644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.3e-14 Score=141.09 Aligned_cols=251 Identities=19% Similarity=0.182 Sum_probs=189.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNL-QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
...++|..+..||.|.|+.|+..... .++..|++|...+.......... -..|+-+...+ .|.++++++..+....+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 45678999999999999999987755 78889999988655443322222 22456666555 69999999999988888
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~~~~ 171 (441)
.|+-.|||.++++...+.- ..+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++-..-
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~- 419 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF- 419 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence 9999999999988776643 558889999999999999999999999999999999999876 7889999998762111
Q ss_pred ccCCcccccccCCCcc-chhhhhccCCCCCcccHHHHHHHHHHHhhCCC-CCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYV-APEVISKKGYDGAKADIWSCGVILYVLLAGFL-PFQDDNIVSMYRKIYRGDFKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~-Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 249 (441)
......+.-++. .+|++........++|++|||..+.+.++|.. ++.... ...+..+..+..+..+..+.
T Consensus 420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~~~~~q 491 (524)
T KOG0601|consen 420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGLKLQLQ 491 (524)
T ss_pred ----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCCchHHhhh
Confidence 011112233334 35555444444588999999999999998854 333322 23456666677676678899
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
.+.+.++.+|+..|+.+.++..|.=|.
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhh
Confidence 999999999999999999998876553
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.2e-12 Score=110.11 Aligned_cols=136 Identities=19% Similarity=0.281 Sum_probs=100.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----MMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
..+++|+-+.+|.+.+ -|..+.+|.=.+....... ...+-.+|..++.++.--.|...+=+..++....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999976 4445666643322222211 23456779999998865555544444556777789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
|+.|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++... ++.++||||+.+..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~ 142 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD 142 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence 99998888888766 24566677778888999999999999999999665 49999999987533
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.3e-13 Score=96.63 Aligned_cols=61 Identities=56% Similarity=0.904 Sum_probs=48.7
Q ss_pred ccccchhhhhccCCCCCCChhhHHhhHH-HhhhhcccccCCchhhHHHHHHHHHHcCcEEEe
Q 013522 300 PETLNAFHIISLSEGFDLSPLFEEKKRA-EREELRFATTRPASSVISRFEEVAKAVKFNVKT 360 (441)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 360 (441)
|..+|||++|++|+|+|||+||++.... .++++||+|+.|++.+++++|++|+.++++|++
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 6789999999999999999999876542 457899999999999999999999999999974
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.1e-11 Score=112.80 Aligned_cols=140 Identities=19% Similarity=0.320 Sum_probs=108.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASK---SKIYFAMD 99 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E 99 (441)
+.||.|.++.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999873 3688999997654321 124578899999999975 4467777776654 36789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS------------------------------------------- 136 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~------------------------------------------- 136 (441)
|++|.++.+.+..+.+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999888776543456777777788888888888873
Q ss_pred -------------cCcEeccCCCCcEEeCC--CCCeEEeecCcccc
Q 013522 137 -------------RGVYHRDLKPENLLLDE--DGNLKVTDFGLSAF 167 (441)
Q Consensus 137 -------------~gi~HrDLkp~NILl~~--~~~vkl~DFGla~~ 167 (441)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.9e-11 Score=104.00 Aligned_cols=143 Identities=20% Similarity=0.219 Sum_probs=108.6
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
....|-+|+-+.|+.+.+ .|+.+.||.=.......+ -...+.++|+.+|.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999999998 888888885332222211 1245678899999998765665555566666777899
Q ss_pred EeccCC-CchHHHHhc--CCCCHHH-HHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC---eEEeecCcccc
Q 013522 98 MDLVKG-GELFNKIAK--GRLREDV-ARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAF 167 (441)
Q Consensus 98 ~E~~~g-g~L~~~i~~--~~l~~~~-~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~---vkl~DFGla~~ 167 (441)
|||++| .++.+++.. ..-.++. ...++++|-+.+.-||..+++|+||..+||++.++|. +-++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999988 477777764 2223333 3788999999999999999999999999999977663 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.9e-10 Score=114.75 Aligned_cols=210 Identities=18% Similarity=0.262 Sum_probs=159.0
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCC-Cch
Q 013522 32 FAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KSKIYFAMDLVKG-GEL 106 (441)
Q Consensus 32 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~lv~E~~~g-g~L 106 (441)
-.+.|++....+|..|++|.+...+.... ...-.-+++++++.|+|||++.++|.. ...+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 46789999999999999999955443322 123345778999999999999999863 4578999999987 467
Q ss_pred HHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 107 FNKIA----------------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 107 ~~~i~----------------~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
.++.- ....+|..+|.|+.||..||.++|+.|...+-|.|.+||++.+.+++|+..|...+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 66542 12377899999999999999999999999999999999999999999999887665432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCC-CCCCcHHHH-HHHHHcCCCCCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSM-YRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 248 (441)
.. . |-+... .+-|.=-||.+++.|.||..- +........ .+.|. +.++.++
T Consensus 446 d~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~ 498 (655)
T KOG3741|consen 446 DP--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDL 498 (655)
T ss_pred CC--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHH
Confidence 11 0 112221 456899999999999999654 222233322 23332 3468899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++|.-+...+++. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999997 688888866
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.1e-10 Score=103.46 Aligned_cols=127 Identities=20% Similarity=0.324 Sum_probs=85.7
Q ss_pred EEEEEEEcCCCcEEEEEEeeccccc-----------------------chhhHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 013522 34 KVYLARNLQTGKSMAMKVVGKDKVI-----------------------KVGMMEQIKREISVMKMVKHK--HIVELHEVM 88 (441)
Q Consensus 34 ~Vy~a~~~~~~~~vAiK~i~~~~~~-----------------------~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~ 88 (441)
.||.|.. .+|..+|+|+....... ........++|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899987 57789999998542110 001234678899999999765 567777553
Q ss_pred EeCCEEEEEEeccC--CCchHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 89 ASKSKIYFAMDLVK--GGELFNKIAKGRLREDVARVYFQQLISAVDF-CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 89 ~~~~~~~lv~E~~~--gg~L~~~i~~~~l~~~~~~~~~~qll~aL~y-lH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
.-+|||||+. |..+. .+....++.+....++.+++..+.. +|+.|++|+||.+.|||++++ .+.|+|||.+
T Consensus 80 ----~~~ivME~I~~~G~~~~-~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLP-RLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp ----TTEEEEE--EETTEEGG-CHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred ----CCEEEEEecCCCccchh-hHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2369999998 54444 3443334456677888889886666 579999999999999999887 9999999988
Q ss_pred cc
Q 013522 166 AF 167 (441)
Q Consensus 166 ~~ 167 (441)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 64
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.6e-09 Score=100.97 Aligned_cols=131 Identities=17% Similarity=0.112 Sum_probs=92.4
Q ss_pred EEEEEEEcCCCcEEEEEEeeccccc---ch-----hhHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEEEEE
Q 013522 34 KVYLARNLQTGKSMAMKVVGKDKVI---KV-----GMMEQIKREISVMKMVKHKHI--VELHEVMAS-----KSKIYFAM 98 (441)
Q Consensus 34 ~Vy~a~~~~~~~~vAiK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~-----~~~~~lv~ 98 (441)
.|..+.. .|+.|.||........ +. .-...+.+|...+..|..-+| ..++.+.+. ....++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555554 6778999966332210 00 001136788888877743222 233333332 23578999
Q ss_pred eccCCC-chHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-------CCCeEEeecCccc
Q 013522 99 DLVKGG-ELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------DGNLKVTDFGLSA 166 (441)
Q Consensus 99 E~~~gg-~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-------~~~vkl~DFGla~ 166 (441)
|+++|. +|.+++.. ...++.....++.+++..+.-||..||+|+|+++.|||++. +..+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 78888753 45667788899999999999999999999999999999975 4579999999875
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=8.8e-11 Score=120.96 Aligned_cols=153 Identities=20% Similarity=0.364 Sum_probs=112.9
Q ss_pred HHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCccccccccccC-----C--cccccccCCCccchhhhhccCC
Q 013522 126 QLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD-----G--LLHTTCGTPAYVAPEVISKKGY 197 (441)
Q Consensus 126 qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~-----~--~~~~~~gt~~y~APE~l~~~~~ 197 (441)
+...|+.|+|.. +++|++|.|++|.++.+|.+||+.|+.+......... . ......-.+.|.|||++... .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 344899999975 8999999999999999999999999987543321110 0 00111235569999999874 4
Q ss_pred CCCcccHHHHHHHHHHHh-hCCCCCCCCcHHHHHHHHHc----CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 198 DGAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYR----GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 198 ~~~~~DiwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.++|++|+||++|.+. .|+.-+...+....+..-.. +....+..+++++++=+.++|..++..||++..++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 568999999999999998 45555554433322222111 1233456789999999999999999999999999999
Q ss_pred cccCccC
Q 013522 273 SWFKKSA 279 (441)
Q Consensus 273 pwf~~~~ 279 (441)
|||....
T Consensus 266 ~ff~D~~ 272 (700)
T KOG2137|consen 266 PFFSDPG 272 (700)
T ss_pred cccCCch
Confidence 9998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-09 Score=100.10 Aligned_cols=137 Identities=23% Similarity=0.354 Sum_probs=106.1
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--c-----------------hhhHHHHHHHHHHHHhCCCC--
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--K-----------------VGMMEQIKREISVMKMVKHK-- 79 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~-----------------~~~~~~~~~Ei~il~~l~hp-- 79 (441)
+.++..||-|--|.||.|.+. .|.++|+|.=+.-... + .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999974 7899999965321110 0 01123577899999999654
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 80 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
.|.+.+++ +...+||||+.|-.|... +++.+.+..++..|+.-+.-+-..||+|+|+++-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 77777765 566899999999777554 2345666677777777777777999999999999999999999999
Q ss_pred eecCccc
Q 013522 160 TDFGLSA 166 (441)
Q Consensus 160 ~DFGla~ 166 (441)
+||-.+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.3e-08 Score=96.01 Aligned_cols=235 Identities=17% Similarity=0.210 Sum_probs=151.9
Q ss_pred EEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEE------EEeC-CE
Q 013522 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEV------MASK-SK 93 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~------~~~~-~~ 93 (441)
..++.||+|+-+.+|..-.. +..| -|++....... .. +-+..|... .||-+-.-+.+ ..+. ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~V-AKIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQV-AKIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hchh-heeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 34678999999999976532 2234 48887654321 11 122233333 56644331111 1222 33
Q ss_pred EEEEEeccCCCc-hHHHHhc----C---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 94 IYFAMDLVKGGE-LFNKIAK----G---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 94 ~~lv~E~~~gg~-L~~~i~~----~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
+-+.|..++|.. +..+... . ....+-+.+..+.|+.+.+-||+.|.+-+|+.++|+|+++++.+.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 889999998853 2333321 1 2557778889999999999999999999999999999999999999975432
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCC----CCCcccHHHHHHHHHHHhhC-CCCCCCCcH----HHHHH-HHHc
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY----DGAKADIWSCGVILYVLLAG-FLPFQDDNI----VSMYR-KIYR 235 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~----~~~~~-~i~~ 235 (441)
.+ ...+......+|.+.|.+||.-.-..+ .+...|.|.||+++|+|+.| +.||.+-.. ...++ .|..
T Consensus 165 qi---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QI---NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ee---ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 22 123334556679999999997541211 13568999999999998886 999975311 01111 2222
Q ss_pred CC-----------CCC---CCC--CCHHHHHHHHHhcCC--CCCCCCCHHH
Q 013522 236 GD-----------FKC---PPW--FSSEARRLITKLLDP--NPNSRIAISK 268 (441)
Q Consensus 236 ~~-----------~~~---~~~--~~~~~~~li~~~L~~--dP~~R~t~~e 268 (441)
+. .+. +|| +++++..|..+|+.. ++.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 21 111 122 689999999999975 3668999754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.5e-08 Score=89.53 Aligned_cols=105 Identities=22% Similarity=0.377 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHHhCCCC--CcceEEEEEEeC----CEEEEEEeccCCC-chHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 013522 63 MEQIKREISVMKMVKHK--HIVELHEVMASK----SKIYFAMDLVKGG-ELFNKIAK-GRLREDVARVYFQQLISAVDFC 134 (441)
Q Consensus 63 ~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~-~~l~~~~~~~~~~qll~aL~yl 134 (441)
.....+|...+..|..- .+.+.+.+.... ...++|+|+++|. +|.+.+.. ...+......++.++...++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34677888887777422 233444444432 3468999999984 78888876 4467778889999999999999
Q ss_pred hhcCcEeccCCCCcEEeCCCC---CeEEeecCcccc
Q 013522 135 HSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAF 167 (441)
Q Consensus 135 H~~gi~HrDLkp~NILl~~~~---~vkl~DFGla~~ 167 (441)
|+.||+|+|++|.|||++.++ .+.++||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-07 Score=85.58 Aligned_cols=141 Identities=18% Similarity=0.258 Sum_probs=94.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHH------HHHHHHHHHHhC---CCCCcceEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVMKMV---KHKHIVELHE 86 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~------~~~~Ei~il~~l---~hpnIv~l~~ 86 (441)
++.+.|.+.+.+-......|.+..- +|+.+.+|..+........... ...+++..+..+ .-.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 5678999999999988888888875 7889999988654322211111 122333333333 2223333333
Q ss_pred EEE-----eCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEee
Q 013522 87 VMA-----SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 161 (441)
Q Consensus 87 ~~~-----~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~D 161 (441)
+.. -....+++|||++|.+|.+... +++ .+...+.+++.-+|+.|++|+|..|.|++++.+ .++++|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence 222 2234568999999988866532 333 244567788999999999999999999999855 599999
Q ss_pred cCccc
Q 013522 162 FGLSA 166 (441)
Q Consensus 162 FGla~ 166 (441)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.7e-07 Score=85.40 Aligned_cols=137 Identities=14% Similarity=0.122 Sum_probs=99.2
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeeccccc--c-hhhHHHHHHHHHHHHhCCCC--CcceEEEEE--Ee--CCEEEEEE
Q 013522 28 GHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--K-VGMMEQIKREISVMKMVKHK--HIVELHEVM--AS--KSKIYFAM 98 (441)
Q Consensus 28 G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~-~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~--~~--~~~~~lv~ 98 (441)
|+||-+.|+.... .|+.+-+|.-...... . ..-...+.+|+..+..|..- .+.+..... .. .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888988775 4556778865311110 0 12346788999999888432 244444221 11 22478999
Q ss_pred eccCC-CchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC--eEEeecCccc
Q 013522 99 DLVKG-GELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--LKVTDFGLSA 166 (441)
Q Consensus 99 E~~~g-g~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~--vkl~DFGla~ 166 (441)
|-+.| .+|.+++..+ +.++.....++.+++..+.-||+.|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98865 5888888663 4577778899999999999999999999999999999987777 9999998664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-09 Score=111.24 Aligned_cols=241 Identities=20% Similarity=0.161 Sum_probs=169.5
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv 97 (441)
..|...+-+++|+++++++.+...+...+ .+.+... ...+-++++|.+++||| .+..++-+..+...+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34667788999999999999976555444 6665433 34567899999999999 77777777788899999
Q ss_pred EeccCCC-chHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 98 MDLVKGG-ELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 98 ~E~~~gg-~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
++++.++ +...... .-.+.+.+.....+.-..+++|+|+.-=+|+| ||+..+ +..+..||+...-....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc---
Confidence 9999887 2222211 12244555556667778899999998778998 887755 68999999987643322
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCC---CCCCCHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKC---PPWFSSEAR 249 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~~~~~~ 249 (441)
....+..+|+.++|||+.....++ ...|.|++|+--.++.-|.+|-..+... ...+..+. +.. ..|-+..-+
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCccccc
Confidence 234567799999999999888887 7799999999777787777775432110 00000000 000 011112223
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++...|+..-|..|+....++.|.+|+...
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 577889999999999999999998887654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5e-07 Score=83.61 Aligned_cols=139 Identities=17% Similarity=0.222 Sum_probs=98.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchh---------------------hHHHHHHHHHHHHhCC--CCCc
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG---------------------MMEQIKREISVMKMVK--HKHI 81 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--hpnI 81 (441)
..|+.|--+.||+|.. .++..+|+|++......-.. ...-..+|+.-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666777778999986 67899999999653321100 0112456787787773 4555
Q ss_pred ceEEEEEEeCCEEEEEEeccCCC-chHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEE
Q 013522 82 VELHEVMASKSKIYFAMDLVKGG-ELFNKIAKGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 82 v~l~~~~~~~~~~~lv~E~~~gg-~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl 159 (441)
.+.+.+.. -.+||||+... .-.-.++.-.+..+++..+..+++..+.-|-. .|++|+||+.=|||+. ++.+.|
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 56666543 36999999553 11222333234444788999999999998876 8999999999999998 889999
Q ss_pred eecCcccccc
Q 013522 160 TDFGLSAFSE 169 (441)
Q Consensus 160 ~DFGla~~~~ 169 (441)
+|||.|....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999987544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.4e-07 Score=84.13 Aligned_cols=132 Identities=16% Similarity=0.160 Sum_probs=84.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH--IVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~ 102 (441)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+.+..+.+...+|||++.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999983 24467788875422 2346789999999886433 4677888878888899999999
Q ss_pred CCc-hHHH---------------------HhcC---CCCHHH-HHHHHHHH----------HH-HHHHHh----hcCcEe
Q 013522 103 GGE-LFNK---------------------IAKG---RLREDV-ARVYFQQL----------IS-AVDFCH----SRGVYH 141 (441)
Q Consensus 103 gg~-L~~~---------------------i~~~---~l~~~~-~~~~~~ql----------l~-aL~ylH----~~gi~H 141 (441)
|.+ +... +..- ..+... ...+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 1111 1110 011000 01111111 11 112222 135789
Q ss_pred ccCCCCcEEeCCCCCeEEeecCccc
Q 013522 142 RDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 142 rDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-06 Score=81.28 Aligned_cols=136 Identities=20% Similarity=0.292 Sum_probs=82.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEVM---ASKSKIYFAM 98 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~ 98 (441)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999999743 58999986543 2356788999998888533 355666644 2344689999
Q ss_pred eccCCCchHH----------------HHh---cC--C---CCHHH--HHHH-------------------HHHHHH-HHH
Q 013522 99 DLVKGGELFN----------------KIA---KG--R---LREDV--ARVY-------------------FQQLIS-AVD 132 (441)
Q Consensus 99 E~~~gg~L~~----------------~i~---~~--~---l~~~~--~~~~-------------------~~qll~-aL~ 132 (441)
++++|..+.. .+. .- . +.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 00 0 01000 0000 011222 233
Q ss_pred HHh-------hcCcEeccCCCCcEEeC-CCCCeEEeecCccc
Q 013522 133 FCH-------SRGVYHRDLKPENLLLD-EDGNLKVTDFGLSA 166 (441)
Q Consensus 133 ylH-------~~gi~HrDLkp~NILl~-~~~~vkl~DFGla~ 166 (441)
.++ ...++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24699999999999999 56667899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.2e-07 Score=92.28 Aligned_cols=136 Identities=20% Similarity=0.337 Sum_probs=89.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccc---------------------------h----hhHH------HHH
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---------------------------V----GMME------QIK 67 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---------------------------~----~~~~------~~~ 67 (441)
..|+.++-|.||.|+. .+|+.||||+.+..-... . ...+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6789999999999997 459999999985421100 0 0011 234
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHHH--hcCCCC-----HHHHHHHHHHHHHHHHHHh
Q 013522 68 REISVMKMVK-----HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI--AKGRLR-----EDVARVYFQQLISAVDFCH 135 (441)
Q Consensus 68 ~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i--~~~~l~-----~~~~~~~~~qll~aL~ylH 135 (441)
+|..-+.+++ .|+|.--.=+++-.+.-.++|||+.|-.+.+.. .....+ +.-+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4555444442 343322222223345668999999998887774 333344 222333333333
Q ss_pred hcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 136 ~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
..|++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 489999999999999999999999999987643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.3e-06 Score=80.75 Aligned_cols=133 Identities=14% Similarity=0.117 Sum_probs=83.5
Q ss_pred ecccCc-eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 013522 27 LGHGTF-AKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 27 LG~G~f-g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~gg 104 (441)
|-.|.. +.||.... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 344444 78999975 34678888875432 235678999998883 444667888777767789999999997
Q ss_pred chHHHH----------------hc-CCCCH------HHHHHHHHH-----------------------HHHHHHHH----
Q 013522 105 ELFNKI----------------AK-GRLRE------DVARVYFQQ-----------------------LISAVDFC---- 134 (441)
Q Consensus 105 ~L~~~i----------------~~-~~l~~------~~~~~~~~q-----------------------ll~aL~yl---- 134 (441)
++.... .. ..++. ......+.+ +...+..|
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 665321 00 00110 000000000 11111222
Q ss_pred ---hhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 135 ---HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 135 ---H~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
....++|+|+.|.|||+++++.+.|+||+.+.+
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999977788999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.2e-06 Score=92.31 Aligned_cols=202 Identities=15% Similarity=0.208 Sum_probs=141.6
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCc
Q 013522 65 QIKREISVMKMVKHKHIVELHEVMASKSK----IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139 (441)
Q Consensus 65 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi 139 (441)
...-|+..+....|+|++.++.+-..... ..+..|+|++.++...+.. +..+....+.+..++++||.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34456667788899999999988754433 2345689999999999987 889999999999999999999999866
Q ss_pred EeccCCCC---cEEeCCCCCeEEe--ecCccccccccccCCcccccccCCCccchhhhhccCCC-CCcccHHHHHHHHHH
Q 013522 140 YHRDLKPE---NLLLDEDGNLKVT--DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYV 213 (441)
Q Consensus 140 ~HrDLkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~~DiwSlGvil~~ 213 (441)
.|.-|... +-..+..+.+.++ ||+.+....... ......-+..+.|||....+.+. +...|+|.+|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 55555444 3444555666766 888776443322 12223345668888887655443 123699999999999
Q ss_pred HhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 214 LLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+..|..+-...-... .+ .+..+.....+++.+|+.-++++|+++.+++.|||.+..
T Consensus 385 ~~~~~~i~~~~~~~~---~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPV---SL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccccchh---hh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 988754422111100 00 111122267889999999999999999999999998643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.3e-06 Score=91.22 Aligned_cols=80 Identities=16% Similarity=0.340 Sum_probs=57.7
Q ss_pred eeeecccCceEEEEEEEcCCC--cEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTG--KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHI--VELHEVMASK---SKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~~ 95 (441)
.+.|+.|.++.+|+......+ ..+++|......... ....+.+|+.+|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998864332 467777654332211 2357889999999995 6665 7788877664 4689
Q ss_pred EEEeccCCCc
Q 013522 96 FAMDLVKGGE 105 (441)
Q Consensus 96 lv~E~~~gg~ 105 (441)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=4.7e-06 Score=73.23 Aligned_cols=127 Identities=20% Similarity=0.349 Sum_probs=92.8
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce-EEEEEEeCCEEEEEEecc
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE-LHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~lv~E~~ 101 (441)
..+.||+|.+|.||++.+ .|..+|+|+-..+.. ...+..|.++|..+.-.++-. +|.+. ..++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhh
Confidence 457899999999999998 677999998765532 457889999999998777654 44443 234569999
Q ss_pred CCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCC--CcEEeCCCCCeEEeecCcccc
Q 013522 102 KGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP--ENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 102 ~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp--~NILl~~~~~vkl~DFGla~~ 167 (441)
.|.+|.+.-..+ . ++-+..++++---|-..||-|+.|.- .||++ .++.+-|+||..|++
T Consensus 95 ~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence 998887664432 1 33344566665556778999999864 45555 555999999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.30 E-value=2e-05 Score=71.39 Aligned_cols=128 Identities=20% Similarity=0.264 Sum_probs=93.3
Q ss_pred CCeEEeeeecccCc-eEEEEEEEcCCCcEEEEEEeecccc----------cc-h-------hhHHHHHHHHHHHHhC---
Q 013522 19 GKYELGRMLGHGTF-AKVYLARNLQTGKSMAMKVVGKDKV----------IK-V-------GMMEQIKREISVMKMV--- 76 (441)
Q Consensus 19 ~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAiK~i~~~~~----------~~-~-------~~~~~~~~Ei~il~~l--- 76 (441)
.+++.++.||.|+- |.||+++- +|+.+|+|++..-.. .. . ...+-+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999997 888999999432110 00 0 1234577788876666
Q ss_pred CCCCc--ceEEEEEEeC------------------CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 013522 77 KHKHI--VELHEVMASK------------------SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS 136 (441)
Q Consensus 77 ~hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~ 136 (441)
.+.++ ++.++++.-. ....||.||++... .....-+.+|++-+..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHHHHHHHHHHHHHH
Confidence 45566 8999987211 12467888887643 1123345678888899999
Q ss_pred cCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 137 ~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
.||+-+|+++.|.. +-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999987 5689999964
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.7e-05 Score=70.93 Aligned_cols=133 Identities=20% Similarity=0.304 Sum_probs=98.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccc-------------cchhhHHHHHHHHHHHHhCC------CCCcceEE
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-------------IKVGMMEQIKREISVMKMVK------HKHIVELH 85 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l~ 85 (441)
..||+|+.-.||.-- ......||++..... .......+..+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 568999999998743 445678899876650 01123567778887777666 78999999
Q ss_pred EEEEeCCEEEEEEeccCC------CchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----
Q 013522 86 EVMASKSKIYFAMDLVKG------GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---- 155 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---- 155 (441)
++.++.--.-+|+|.+.. .+|.+++..+.+++ . +...+-.-..||-+.+|+.+|++|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 999999999999998753 36888888877777 3 334445566788899999999999999996432
Q ss_pred CeEEee-cCc
Q 013522 156 NLKVTD-FGL 164 (441)
Q Consensus 156 ~vkl~D-FGl 164 (441)
.+.|+| ||-
T Consensus 160 ~lvlIDG~G~ 169 (199)
T PF10707_consen 160 RLVLIDGLGE 169 (199)
T ss_pred EEEEEeCCCC
Confidence 477777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-05 Score=81.95 Aligned_cols=138 Identities=21% Similarity=0.240 Sum_probs=87.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccc----------------------------hhhHHH------HHHHH
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK----------------------------VGMMEQ------IKREI 70 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~----------------------------~~~~~~------~~~Ei 70 (441)
+.||.-+.|.||+|+-+ +|+.||||+-+..-... ++..+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 67999999999999975 59999999875421100 011111 22222
Q ss_pred H----HHHhCCCCC------cceEEEEEEeCCEEEEEEeccCCCchHHH--HhcCCCCHHHHHHHHHHHHHHHH-HHhhc
Q 013522 71 S----VMKMVKHKH------IVELHEVMASKSKIYFAMDLVKGGELFNK--IAKGRLREDVARVYFQQLISAVD-FCHSR 137 (441)
Q Consensus 71 ~----il~~l~hpn------Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~--i~~~~l~~~~~~~~~~qll~aL~-ylH~~ 137 (441)
+ +.+.+.|-+ |.++|-.+ .+...++||||.|..+.|. |.+..++...+.. .+.++.. -+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~---~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILN---KLVEAYLEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHH---HHHHHHHHHHHhc
Confidence 2 233344555 44444333 3456899999999876554 4454465554333 2333222 22357
Q ss_pred CcEeccCCCCcEEeCC----CCCeEEeecCccccc
Q 013522 138 GVYHRDLKPENLLLDE----DGNLKVTDFGLSAFS 168 (441)
Q Consensus 138 gi~HrDLkp~NILl~~----~~~vkl~DFGla~~~ 168 (441)
|++|+|-+|.||++.. ++.+.+-|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 8999999999999984 567999999997643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=4e-07 Score=101.09 Aligned_cols=209 Identities=16% Similarity=0.088 Sum_probs=149.0
Q ss_pred HHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhc-
Q 013522 66 IKREISVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKGGELFNKIAKG-----RLREDVARVYFQQLISAVDFCHSR- 137 (441)
Q Consensus 66 ~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~-----~l~~~~~~~~~~qll~aL~ylH~~- 137 (441)
...|..-++...|+++...+.-... ....|.+++|+.+|.+++.|-+| .+.+.-+....++.+.+..-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666789998887766543 34578999999999999999753 244445555555657788888864
Q ss_pred ----CcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHH
Q 013522 138 ----GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYV 213 (441)
Q Consensus 138 ----gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ 213 (441)
-.+|++||+-|.++..+.++|+.++|+.++..+ .........++|.|++|++.+.-.+. .++|+|+.|+.+|.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYL 1432 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHH
Confidence 278999999999999999999999999884222 22344566789999999998877774 56999999999999
Q ss_pred HhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 214 LLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+..|..+|-.-....+...+..+.. ..+...|.++-.....+|-+.-..||.-...+.-+.|..
T Consensus 1433 rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9988887744333222222222222 233334556666666777777788898888888777653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.3e-05 Score=72.49 Aligned_cols=72 Identities=10% Similarity=0.117 Sum_probs=45.0
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEE
Q 013522 25 RMLGHGTFA-KVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK---HIVELHEVMASK---SKIYFA 97 (441)
Q Consensus 25 ~~LG~G~fg-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~lv 97 (441)
+.|+.|+.. .||... ..+.+|+.... .....+.+|..+|+.+... -+.+.++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456766666 588752 34667765432 1245788999999887531 344445443332 245889
Q ss_pred EeccCCCch
Q 013522 98 MDLVKGGEL 106 (441)
Q Consensus 98 ~E~~~gg~L 106 (441)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00014 Score=67.95 Aligned_cols=135 Identities=16% Similarity=0.248 Sum_probs=80.8
Q ss_pred eeeecccCceEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEecc
Q 013522 24 GRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~ 101 (441)
++.|..|-...+|++.... .++.|.+|+...... ..-...+|+.+++.+...+ ..+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 3567888889999997533 357899998754321 1123457999999885433 344544332 2 4799999
Q ss_pred CCCchHHH----------H----h---c--CCCC-----------HHHHHHHHHHH----------------------HH
Q 013522 102 KGGELFNK----------I----A---K--GRLR-----------EDVARVYFQQL----------------------IS 129 (441)
Q Consensus 102 ~gg~L~~~----------i----~---~--~~l~-----------~~~~~~~~~ql----------------------l~ 129 (441)
+|.++... + . . .... ...+..+...+ ..
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665211 1 1 1 0110 11222222111 11
Q ss_pred HHHHH----h----hcCcEeccCCCCcEEeCC-CCCeEEeecCccc
Q 013522 130 AVDFC----H----SRGVYHRDLKPENLLLDE-DGNLKVTDFGLSA 166 (441)
Q Consensus 130 aL~yl----H----~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~ 166 (441)
.+..| . ..+++|+|+.|.|||++. ++.+.++||..|.
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11111 1 236999999999999998 5789999999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00031 Score=68.34 Aligned_cols=76 Identities=8% Similarity=0.079 Sum_probs=55.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH---KHIVELHEVMAS---KSKIYFA 97 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~lv 97 (441)
.+.||.|..+.||.... ++..+.+|.... .. ....+..|...|+.|.- ..+.++++++.. .+..++|
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~-~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARS-FS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecc-cc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 46799999999999975 223567777432 11 12478899999998843 367788887754 3668999
Q ss_pred EeccCCCch
Q 013522 98 MDLVKGGEL 106 (441)
Q Consensus 98 ~E~~~gg~L 106 (441)
||++.|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00011 Score=71.17 Aligned_cols=135 Identities=16% Similarity=0.166 Sum_probs=83.2
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEV------MASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~ 95 (441)
.+.|..|....+|+... ++..+++|+.... ....+..|+.++..|.+- .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56788888889999875 4457888987531 134677888888877432 24444431 23345678
Q ss_pred EEEeccCCCchHH--------------HHhc--CCCCH--------HHHH------------HHHHHHHHHHHHHhh---
Q 013522 96 FAMDLVKGGELFN--------------KIAK--GRLRE--------DVAR------------VYFQQLISAVDFCHS--- 136 (441)
Q Consensus 96 lv~E~~~gg~L~~--------------~i~~--~~l~~--------~~~~------------~~~~qll~aL~ylH~--- 136 (441)
++++|++|..+.. .+.. ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866421 0110 00000 0000 011112233444443
Q ss_pred ----cCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 137 ----RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 137 ----~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999987777899999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.84 E-value=8.7e-05 Score=70.53 Aligned_cols=132 Identities=15% Similarity=0.178 Sum_probs=78.3
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg 104 (441)
.+..|-.+.+|+... +++.+++|+...... ...-...+|..+++.+...++ .+++.... -++|+||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 456788889998873 667888887543211 110134689999998854333 34444332 26899999986
Q ss_pred chHH--------------H---HhcCC-----CC-HHHHHHHHHHHH---------HHHHHHhh--------cCcEeccC
Q 013522 105 ELFN--------------K---IAKGR-----LR-EDVARVYFQQLI---------SAVDFCHS--------RGVYHRDL 144 (441)
Q Consensus 105 ~L~~--------------~---i~~~~-----l~-~~~~~~~~~qll---------~aL~ylH~--------~gi~HrDL 144 (441)
.+.. . +...+ ++ ...+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 1 11111 11 122223332221 11222211 25899999
Q ss_pred CCCcEEeCCCCCeEEeecCcccc
Q 013522 145 KPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 145 kp~NILl~~~~~vkl~DFGla~~ 167 (441)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 88999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00052 Score=69.15 Aligned_cols=80 Identities=14% Similarity=0.181 Sum_probs=55.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccc-cc---hhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IK---VGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~---~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 96 (441)
.+.||.|.+..||.+.....++.+.||.-..... .. .-..++...|...|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 3679999999999999854446899998531100 00 123567778888888763 3467777777 4456789
Q ss_pred EEeccCCCc
Q 013522 97 AMDLVKGGE 105 (441)
Q Consensus 97 v~E~~~gg~ 105 (441)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=8.4e-05 Score=67.26 Aligned_cols=98 Identities=16% Similarity=0.243 Sum_probs=79.6
Q ss_pred HHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCchHHH----HhcCCCCHHHHHHHHHHHHHHHHHHhh---cC
Q 013522 67 KREISVMKMVKH-KHIVELHEVMASKSKIYFAMDLVKGGELFNK----IAKGRLREDVARVYFQQLISAVDFCHS---RG 138 (441)
Q Consensus 67 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~----i~~~~l~~~~~~~~~~qll~aL~ylH~---~g 138 (441)
..|.-+|+.+.+ +++.+++|.|-. ++|.||...+++... ..-...++....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368889999976 699999999833 578999987766421 122346889999999999999999997 45
Q ss_pred cEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 139 i~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
+.-.|++|+|+-++++|++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777899999999999999999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=2.2e-05 Score=75.35 Aligned_cols=135 Identities=17% Similarity=0.296 Sum_probs=98.6
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--c---------------hhhH--HHHHHHHHHHHhCCC--C
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--K---------------VGMM--EQIKREISVMKMVKH--K 79 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~---------------~~~~--~~~~~Ei~il~~l~h--p 79 (441)
|.+++.||-|.-+-||.+-+ ..|++.++|.-+.-+.. + .-.+ -...+|...|+.|.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67899999999999999997 57889999965432211 0 0001 124568888888843 2
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 80 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
-|.+.++ .+..++|||++.|-.|...-. ...+..+...++.-+--|..+|+||+|..-=||++++++.+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 3444444 356789999999977765421 2234456667777788899999999999999999999999999
Q ss_pred eecCcc
Q 013522 160 TDFGLS 165 (441)
Q Consensus 160 ~DFGla 165 (441)
+||-..
T Consensus 244 IDFPQm 249 (465)
T KOG2268|consen 244 IDFPQM 249 (465)
T ss_pred eechHh
Confidence 999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0003 Score=68.81 Aligned_cols=136 Identities=18% Similarity=0.201 Sum_probs=81.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEV------MASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~~~ 95 (441)
.+.++.|....+|.+.. . +..+.+|+..... ..+.+..|+.++..|... .+.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677888889999874 3 3467789875421 124556777777777322 23444332 12245678
Q ss_pred EEEeccCCCchH-----------H---HHhc--CCCCH-------HHHH----------------HHHHHHHHHHHHHh-
Q 013522 96 FAMDLVKGGELF-----------N---KIAK--GRLRE-------DVAR----------------VYFQQLISAVDFCH- 135 (441)
Q Consensus 96 lv~E~~~gg~L~-----------~---~i~~--~~l~~-------~~~~----------------~~~~qll~aL~ylH- 135 (441)
+++||++|.++. . .+.. ..++. ...+ .....+...++++.
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 0 1110 00100 0000 00112233455553
Q ss_pred ------hcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 136 ------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 136 ------~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2689999999999999988777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00064 Score=66.16 Aligned_cols=74 Identities=14% Similarity=0.240 Sum_probs=48.4
Q ss_pred eeecccCceEEEEEEEcC------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQ------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFA 97 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv 97 (441)
+.|..|-...||++.... +++.+++|+...... ......+|..+++.+...++ .+++..+.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 556677778999987533 257899999754321 12356788888888853333 345555532 358
Q ss_pred EeccCCCch
Q 013522 98 MDLVKGGEL 106 (441)
Q Consensus 98 ~E~~~gg~L 106 (441)
+||++|..+
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 999988665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0002 Score=48.93 Aligned_cols=42 Identities=21% Similarity=0.464 Sum_probs=35.2
Q ss_pred cceEEEEEEEEec-CceEEEEEEccCCChhhhHHHhhhhhhhhh
Q 013522 376 GKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFCSNELRPAL 418 (441)
Q Consensus 376 ~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~~~l~~~l 418 (441)
..+.|.+||+.+. ++++.|+|++.+||...|+++|. +|-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~-~il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCS-KILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHH-HHHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHH-HHHHHc
Confidence 4578999999997 89999999999999999999997 465544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0029 Score=62.04 Aligned_cols=134 Identities=15% Similarity=0.206 Sum_probs=74.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEEE------EEEeCCEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHE------VMASKSKIYF 96 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~l 96 (441)
+.|+.|...++|.... ++..+++|++.. . . .+.+..|+.+++.|... .+.+.+. +....+..++
T Consensus 28 ~~l~~G~~n~~y~v~t--~~g~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 28 KGIAEGIENSNFFLTT--TQGEYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred chhccccccceEEEEe--CCCcEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 5577788889999875 334688898751 1 1 23444566666555311 1333332 1233567899
Q ss_pred EEeccCCCchH-----------HHH---hc--CCC--------CH----HHHHH-----------HHHH-HHHHHHHHh-
Q 013522 97 AMDLVKGGELF-----------NKI---AK--GRL--------RE----DVARV-----------YFQQ-LISAVDFCH- 135 (441)
Q Consensus 97 v~E~~~gg~L~-----------~~i---~~--~~l--------~~----~~~~~-----------~~~q-ll~aL~ylH- 135 (441)
++||++|..+. ..+ .. ..+ .. ..... .+.+ +-..++.+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999986431 111 10 001 00 00000 1111 111122222
Q ss_pred ------hcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 136 ------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 136 ------~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
..|+||+|+.|.||+++.+...-|+||+.+.
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999866556899999865
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0014 Score=64.00 Aligned_cols=139 Identities=18% Similarity=0.272 Sum_probs=85.6
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEEEEEEeCC--EEEEEE
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEVMASKS--KIYFAM 98 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~--~~~lv~ 98 (441)
+++.+..|....+|.... +++.+.+. ... ............+|..+++.+.-- -+...++++.++. ..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344444444445566554 37777777 321 122234567788999999988542 3344555665555 779999
Q ss_pred eccCCCchHHHHhcCCCCHHHHHHHHH-HHHHHHHHHhh-----------------------------------------
Q 013522 99 DLVKGGELFNKIAKGRLREDVARVYFQ-QLISAVDFCHS----------------------------------------- 136 (441)
Q Consensus 99 E~~~gg~L~~~i~~~~l~~~~~~~~~~-qll~aL~ylH~----------------------------------------- 136 (441)
+|+.|..+.+.......+ ..+.. .+...|+-||+
T Consensus 105 ~~veGe~~~~~~~~~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 105 EWVEGEVVWSALPPESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EEecceeccCcCCcccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999985443322221111 11111 33444444442
Q ss_pred -----------------cCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 137 -----------------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 137 -----------------~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..++|+|+.+.|++++.++.+-|.||+++.+-+
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 358999999999999999999999999987543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0012 Score=67.31 Aligned_cols=162 Identities=20% Similarity=0.272 Sum_probs=105.7
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEec
Q 013522 64 EQIKREISVMKMVKHKHIVELHEVMASK-SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142 (441)
Q Consensus 64 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~Hr 142 (441)
.++.....+++.+.|+|...++++-... ....+|||++ +.+|.+....+.+-... ++ .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s-------~~-------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDES-------LL-------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhh-------hc-------cccccee
Confidence 4566778889999999999999987543 4578899999 56888887765321111 00 2222221
Q ss_pred cCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCC
Q 013522 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222 (441)
Q Consensus 143 DLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~ 222 (441)
| .++.+| -+++ . | |- ..++++||||+|.++.++.-|...|.
T Consensus 92 -----~-------~~~~td-~~~t---~---------------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLT---K---------------Y--PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----h-------hhhccc-cccc---c---------------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2 233333 1111 0 0 10 11248999999999999999988776
Q ss_pred CCcHHHHHHHHHcCCCCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 223 DDNIVSMYRKIYRGDFKCP------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 223 ~~~~~~~~~~i~~~~~~~~------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.....+....+.+-....- -.++....++..+|+-..|..||...++++++-|.+..
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 6555554444433211110 01456678899999999999999999999999997653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0034 Score=61.64 Aligned_cols=145 Identities=23% Similarity=0.322 Sum_probs=99.4
Q ss_pred EEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--------c--------------hhhH-HHHHHHHHHHHhCCC
Q 013522 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--------K--------------VGMM-EQIKREISVMKMVKH 78 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~--------------~~~~-~~~~~Ei~il~~l~h 78 (441)
.|-.+|..|--+-||.|.. .+|..+|||++..+-+. . ..+. --...|+.-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4456788888999999986 68888999998542211 0 0111 124567888887765
Q ss_pred CCcceEEEEEEeCCEEEEEEeccCC-CchHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCcEeccCCCCcEEeCCCCC
Q 013522 79 KHIVELHEVMASKSKIYFAMDLVKG-GELFNKIAKGRLREDVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLDEDGN 156 (441)
Q Consensus 79 pnIv~l~~~~~~~~~~~lv~E~~~g-g~L~~~i~~~~l~~~~~~~~~~qll~aL~yl-H~~gi~HrDLkp~NILl~~~~~ 156 (441)
..|.-.--+.. ....|||+++.+ |--.-.++.-.++...+..+-+|++.-+.-| |.++.+|.||.-=|+|+ -+|.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 44332111111 134689999953 2233344555688888999999999888877 56799999999999999 5578
Q ss_pred eEEeecCccccccc
Q 013522 157 LKVTDFGLSAFSEH 170 (441)
Q Consensus 157 vkl~DFGla~~~~~ 170 (441)
+.|+|.+.|.-.++
T Consensus 303 lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEccccccCCC
Confidence 99999998764333
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0079 Score=60.63 Aligned_cols=76 Identities=16% Similarity=0.146 Sum_probs=52.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKV---GMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l 96 (441)
.+.||.|....||+..+ .+..++||.-..... ... -...+...|...|+.+. ..++.++|.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 57789999999999987 345688997642111 110 12445566777777664 247888888876 34578
Q ss_pred EEeccCC
Q 013522 97 AMDLVKG 103 (441)
Q Consensus 97 v~E~~~g 103 (441)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999987
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0057 Score=60.82 Aligned_cols=135 Identities=15% Similarity=0.219 Sum_probs=80.8
Q ss_pred eeeecccCceEEEEEEEcC----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQ----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV-ELHEVMASKSKIYFAM 98 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~lv~ 98 (441)
...|-.|-...+|++.... +++.|.+|+..... ....+ -.+|..+++.+..-++. ++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3456568889999987532 34689999886532 11222 26799999888544443 455655432 578
Q ss_pred eccCCCchHH----------HH-------hcCC-------CCHHHHHHHHHHHH-----------------HHHHHH---
Q 013522 99 DLVKGGELFN----------KI-------AKGR-------LREDVARVYFQQLI-----------------SAVDFC--- 134 (441)
Q Consensus 99 E~~~gg~L~~----------~i-------~~~~-------l~~~~~~~~~~qll-----------------~aL~yl--- 134 (441)
||+.|.++.. .+ .... .....+..++.++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 9988766531 11 1101 11223333332221 111111
Q ss_pred -----hhcCcEeccCCCCcEEeCC-CCCeEEeecCccc
Q 013522 135 -----HSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSA 166 (441)
Q Consensus 135 -----H~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~ 166 (441)
+...++|+|+++.||++++ ++.+.++||..|.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1236899999999999986 4689999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0053 Score=60.81 Aligned_cols=76 Identities=11% Similarity=0.113 Sum_probs=49.7
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeecc-cccc---hhhHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKD-KVIK---VGMMEQIKREISVMKMVK--HK-HIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~ 98 (441)
.+|.|....||++.+...++.++||.-..- +... .-..++..-|...|+... -| .+.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999998544468999965311 1000 123456778888887763 34 45555554 445566999
Q ss_pred eccCC
Q 013522 99 DLVKG 103 (441)
Q Consensus 99 E~~~g 103 (441)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0063 Score=60.16 Aligned_cols=134 Identities=16% Similarity=0.229 Sum_probs=78.4
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEec
Q 013522 25 RMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~ 100 (441)
+.|..|-...+|+...... +..|.+|+...... . .-.-.+|..+++.+..-++ .++++++.. + +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehh
Confidence 4455588888998875432 34788998754321 1 1123578889888865554 355655532 2 58899
Q ss_pred cCCCchHH----------HH-------hcCCC-------CHHHHHHHHHHHH----------------------HHHHH-
Q 013522 101 VKGGELFN----------KI-------AKGRL-------REDVARVYFQQLI----------------------SAVDF- 133 (441)
Q Consensus 101 ~~gg~L~~----------~i-------~~~~l-------~~~~~~~~~~qll----------------------~aL~y- 133 (441)
+.|.+|.. .+ ....+ ....+..++.++- .-+..
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 88765421 11 11111 1223333333321 11111
Q ss_pred ---Hhhc----CcEeccCCCCcEEeCC-CCCeEEeecCccc
Q 013522 134 ---CHSR----GVYHRDLKPENLLLDE-DGNLKVTDFGLSA 166 (441)
Q Consensus 134 ---lH~~----gi~HrDLkp~NILl~~-~~~vkl~DFGla~ 166 (441)
+.+. -.+|+|+.|.|||+++ ++.++++||..|.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1112 2799999999999975 4689999999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.011 Score=57.53 Aligned_cols=29 Identities=34% Similarity=0.622 Sum_probs=25.6
Q ss_pred cCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 137 ~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0081 Score=57.80 Aligned_cols=30 Identities=30% Similarity=0.524 Sum_probs=25.5
Q ss_pred CcEeccCCCCcEEeCCCCC-eEEeecCcccc
Q 013522 138 GVYHRDLKPENLLLDEDGN-LKVTDFGLSAF 167 (441)
Q Consensus 138 gi~HrDLkp~NILl~~~~~-vkl~DFGla~~ 167 (441)
.++|+|++|.|||+++++. .-|+||+.+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.014 Score=53.68 Aligned_cols=31 Identities=35% Similarity=0.747 Sum_probs=22.2
Q ss_pred cCcEeccCCCCcEEe-CCCCCeEEeecCcccc
Q 013522 137 RGVYHRDLKPENLLL-DEDGNLKVTDFGLSAF 167 (441)
Q Consensus 137 ~gi~HrDLkp~NILl-~~~~~vkl~DFGla~~ 167 (441)
..++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.024 Score=56.93 Aligned_cols=78 Identities=15% Similarity=0.180 Sum_probs=52.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccc---hhhHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVMKMVK--HK-HIVELHEVMASKSKIYFA 97 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv 97 (441)
.+.||.|.-.-||++.+...++.|+||.-..---.. .-..++..-|..+|+.+. -| .+.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 578999999999999984446789998653111111 123577788889988773 34 45556554 44556789
Q ss_pred EeccCC
Q 013522 98 MDLVKG 103 (441)
Q Consensus 98 ~E~~~g 103 (441)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.075 Score=51.93 Aligned_cols=29 Identities=21% Similarity=0.247 Sum_probs=27.2
Q ss_pred CcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 138 gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
++||+|+.+.|+|++.++.+-++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.039 Score=53.33 Aligned_cols=73 Identities=12% Similarity=0.178 Sum_probs=48.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEec
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
.+.++.|....+|... .+++.+.+|+-.... ...+..|..-|+.|. --.+.+.+.+....+..|++|||
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 4678999999999988 588899999876221 246778888888883 34577888888777777999999
Q ss_pred cCCC
Q 013522 101 VKGG 104 (441)
Q Consensus 101 ~~gg 104 (441)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.048 Score=54.96 Aligned_cols=76 Identities=11% Similarity=0.207 Sum_probs=45.6
Q ss_pred EeeeecccCceEEEEEEEcCC-CcE-----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 013522 23 LGRMLGHGTFAKVYLARNLQT-GKS-----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIY 95 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~-~~~-----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 95 (441)
..+.|..|-...+|++..... +.. |.+.+..... ...-.-.+|+.+++.+..-++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~----~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN----SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC----ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345666688899999975432 122 4444321111 111123578999999965544 456666643 6
Q ss_pred EEEeccCCCch
Q 013522 96 FAMDLVKGGEL 106 (441)
Q Consensus 96 lv~E~~~gg~L 106 (441)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999998765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.017 Score=57.53 Aligned_cols=62 Identities=15% Similarity=0.153 Sum_probs=49.1
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCcEeccCCCCcEEeCCC
Q 013522 93 KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDED 154 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH-~~gi~HrDLkp~NILl~~~ 154 (441)
...++-+|..|..+..++.....++...+++..-...|+--|- -.+.+|.|+.|.||++-.+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 3567788999999999998766788777777777777766554 4689999999999999543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.068 Score=52.66 Aligned_cols=133 Identities=19% Similarity=0.267 Sum_probs=78.4
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCC---cceE----EEEEEeCCEEE
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKH---IVEL----HEVMASKSKIY 95 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpn---Iv~l----~~~~~~~~~~~ 95 (441)
.|.+ .-..||.... .+| .+++|+.+.. .. ..++.-|+..|..|. .|= +..+ +.....+.+.+
T Consensus 33 ~l~s-~eN~~f~~~~-~~g-~~iLki~~~~-~~----~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDG-RYILKIYRPG-WT----RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEe-cCC-CeEEEEecCC-CC----HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 4567888886 333 3489998765 22 356778888888773 221 2222 12222224788
Q ss_pred EEEeccCCCchHH---------------HHhc--CCC-----------CHH----HH---------HHHHHHHHHHHHHH
Q 013522 96 FAMDLVKGGELFN---------------KIAK--GRL-----------RED----VA---------RVYFQQLISAVDFC 134 (441)
Q Consensus 96 lv~E~~~gg~L~~---------------~i~~--~~l-----------~~~----~~---------~~~~~qll~aL~yl 134 (441)
-+.+|++|..+.. .+.. ..+ ... .. .....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 9999999977652 1100 001 111 00 01122344444444
Q ss_pred hh--------cC--cEeccCCCCcEEeCCCCC-eEEeecCccc
Q 013522 135 HS--------RG--VYHRDLKPENLLLDEDGN-LKVTDFGLSA 166 (441)
Q Consensus 135 H~--------~g--i~HrDLkp~NILl~~~~~-vkl~DFGla~ 166 (441)
.+ .+ +||+|+.|.||+++.+.. +-++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 43 34 999999999999999885 8999999764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.035 Score=54.63 Aligned_cols=88 Identities=25% Similarity=0.368 Sum_probs=62.1
Q ss_pred hCCCCCcceEEEEE-EeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeC
Q 013522 75 MVKHKHIVELHEVM-ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLD 152 (441)
Q Consensus 75 ~l~hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~ 152 (441)
....++..+.+-+- ...-..|++|++. |+.|. .+. .-..+++..+|.+.+.-++-+..+ ..-|||+...|||++
T Consensus 281 ~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId 356 (488)
T COG5072 281 ECGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIK--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID 356 (488)
T ss_pred hccchhhhcceEEecCCceEEEEEEecC-Cceee-eee--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence 33445555544443 2334567788876 44442 222 234567788899888888888765 789999999999999
Q ss_pred CCCCeEEeecCcccc
Q 013522 153 EDGNLKVTDFGLSAF 167 (441)
Q Consensus 153 ~~~~vkl~DFGla~~ 167 (441)
+|++-|+||-+++.
T Consensus 357 -~GnvtLIDfklsRl 370 (488)
T COG5072 357 -EGNVTLIDFKLSRL 370 (488)
T ss_pred -cCceEEEEeeeeec
Confidence 99999999999984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.39 Score=47.33 Aligned_cols=71 Identities=13% Similarity=0.097 Sum_probs=43.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEE---E--EEEeCCEEEEEEeccC
Q 013522 30 GTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELH---E--VMASKSKIYFAMDLVK 102 (441)
Q Consensus 30 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~---~--~~~~~~~~~lv~E~~~ 102 (441)
+.-..||.... .++..+++|+.+.... ....+..|+..+..|... .++... + +...++..+.+++++.
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34467888875 4567899998853321 235677788887766321 122211 1 1233567888999998
Q ss_pred CCc
Q 013522 103 GGE 105 (441)
Q Consensus 103 gg~ 105 (441)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.31 Score=55.51 Aligned_cols=136 Identities=13% Similarity=0.236 Sum_probs=76.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-------CCCCcceEE-----EEEEe-C
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-------KHKHIVELH-----EVMAS-K 91 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-------~hpnIv~l~-----~~~~~-~ 91 (441)
+.|+ |..-.+|+... .+|..+++|+.+.... ...+..|..+|..| .-|.+++-. ..... .
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~-----~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEP-----RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccc-----hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 5664 45678898874 5677899999875421 22344555566544 233333321 11221 2
Q ss_pred C--EEEEEEeccCCCchHHH-----------------Hhc--CCCC--------------------------HHHHHHHH
Q 013522 92 S--KIYFAMDLVKGGELFNK-----------------IAK--GRLR--------------------------EDVARVYF 124 (441)
Q Consensus 92 ~--~~~lv~E~~~gg~L~~~-----------------i~~--~~l~--------------------------~~~~~~~~ 124 (441)
+ +.+.+++|++|..+.+. +.. ..++ ....+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 56788999999766441 000 0000 01112223
Q ss_pred HHHHHHHHH-----Hh--hcCcEeccCCCCcEEeCCCC--CeE-EeecCcccc
Q 013522 125 QQLISAVDF-----CH--SRGVYHRDLKPENLLLDEDG--NLK-VTDFGLSAF 167 (441)
Q Consensus 125 ~qll~aL~y-----lH--~~gi~HrDLkp~NILl~~~~--~vk-l~DFGla~~ 167 (441)
.+++..+.- +. ..++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 333333221 11 25799999999999999875 555 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 441 | ||||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-59 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-59 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-59 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-59 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-59 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-59 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-58 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-57 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-57 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-57 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-57 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-56 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-56 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-56 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-55 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-55 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-54 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-53 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-52 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-48 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-47 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-47 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-47 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-47 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-46 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-44 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-44 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-43 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-43 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-43 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-43 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-43 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-43 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-43 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-43 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-42 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-42 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-42 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-42 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-41 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-41 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-41 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-41 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-41 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-41 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-41 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-41 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-41 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-41 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-41 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-41 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-41 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-41 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-41 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-41 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-41 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-41 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-40 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-40 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-40 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-40 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-40 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-40 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-40 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-40 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-40 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-40 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-40 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-40 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-40 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-40 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-40 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-40 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-40 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-40 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-40 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-40 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-40 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-40 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-40 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-40 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-39 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-39 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-39 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-39 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-39 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-39 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-39 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-39 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-39 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-39 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-39 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-39 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-39 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-39 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-39 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-39 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-39 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-39 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-39 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-39 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-39 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-39 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-39 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-39 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-39 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-39 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-39 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-39 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-39 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-39 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-39 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-39 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-39 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-39 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-38 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-38 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-38 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-38 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-38 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-38 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-38 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-38 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-38 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-38 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-38 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-38 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-38 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-38 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-38 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-38 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-38 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-38 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-38 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-38 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-38 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-38 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-38 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-38 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-38 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-38 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-38 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-38 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-38 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-38 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-38 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-38 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-38 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-38 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-38 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-38 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-38 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-38 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-38 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-38 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-38 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-38 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-38 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-38 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-38 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-37 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-37 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-37 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-37 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-37 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-37 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-37 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-37 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-37 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-37 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-37 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-37 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-37 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-37 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-37 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-37 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-37 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-37 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-37 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-37 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-37 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-37 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-37 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-37 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-37 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-37 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-37 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-37 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-37 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-37 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-37 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-37 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-37 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-37 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-37 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-37 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-37 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-37 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-37 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-37 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-37 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-36 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-36 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-36 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-36 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-36 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-36 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-36 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-36 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-35 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-35 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-35 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-35 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-34 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-34 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-34 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-33 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-33 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-33 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-33 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-33 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-33 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-33 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-33 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-33 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-33 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-33 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-33 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-33 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-32 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-32 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-32 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-32 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-32 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-32 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-32 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-32 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-32 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-32 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-32 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-32 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-32 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-32 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-32 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-32 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-31 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-31 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-31 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-30 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-30 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-30 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-30 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-30 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-30 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-30 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-29 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-29 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-29 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-29 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-29 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-28 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-28 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-28 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-28 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-27 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-27 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-26 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-26 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-26 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-26 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-25 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-25 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-23 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-23 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-23 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-23 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-23 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-23 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-22 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-22 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-22 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-22 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-22 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-22 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-22 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-21 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-20 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-20 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-20 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-16 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-16 | ||
| 2ehb_D | 143 | The Structure Of The C-Terminal Domain Of The Prote | 6e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-09 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-09 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-09 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-07 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 |
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 470 bits (1212), Expect = e-167
Identities = 116/277 (41%), Positives = 168/277 (60%), Gaps = 4/277 (1%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR 68
G + G Y LG LG GTF KV + + TG +A+K++ + K+ + ++ +IKR
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 69 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQL 127
EI +K+ +H HI++L++V+++ + + M+ V GGELF+ I GR+ E AR FQQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 128 ISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
+SAVD+CH V HRDLKPEN+LLD N K+ DFGLS + L T+CG+P Y
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSE 247
APEVIS + Y G + DIWSCGVILY LL G LPF D+++ ++++KI G F P + +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVI 284
L+ +L +P R I I E WFK+ P +
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLF 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 470 bits (1211), Expect = e-167
Identities = 92/267 (34%), Positives = 149/267 (55%), Gaps = 6/267 (2%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
++L + LG G + +V LA N T +++A+K+V + + E IK+EI + KM+ H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+++V+ + + Y ++ GGELF++I + E A+ +F QL++ V + H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
G+ HRD+KPENLLLDE NLK++DFGL+ + ++ LL+ CGT YVAPE++ ++ +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW--FSSEARRLITK 254
D+WSCG++L +LAG LP+ + Y PW S L+ K
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPK 281
+L NP++RI I I + W+ K K
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 470 bits (1212), Expect = e-167
Identities = 87/270 (32%), Positives = 148/270 (54%), Gaps = 6/270 (2%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-QIKREISVMKMVK 77
GKY +G +LG G++ KV + +T A+K++ K K+ ++ E +K+EI +++ ++
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 78 HKHIVELHEVM--ASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDF 133
HK++++L +V+ K K+Y M+ G E+ + + + R A YF QLI +++
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
HS+G+ H+D+KP NLLL G LK++ G++ D T+ G+PA+ PE+ +
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 194 -KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252
+ G K DIWS GV LY + G PF+ DNI ++ I +G + P L+
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLL 244
Query: 253 TKLLDPNPNSRIAISKIMESSWFKKSAPKV 282
+L+ P R +I +I + SWF+K P
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 471 bits (1213), Expect = e-167
Identities = 97/311 (31%), Positives = 161/311 (51%), Gaps = 13/311 (4%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
++L + LG G + +V LA N T +++A+K+V + + E IK+EI + KM+ H
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+++V+ + + Y ++ GGELF++I + E A+ +F QL++ V + H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
G+ HRD+KPENLLLDE NLK++DFGL+ + ++ LL+ CGT YVAPE++ ++ +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPPW--FSSEARRLITK 254
D+WSCG++L +LAG LP+ + Y PW S L+ K
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFHIISLSEG 314
+L NP++RI I I + W+ K K + + S+ P + +
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGA---KRPRVTSGGVSESPSGFSK----HIQSN 297
Query: 315 FDLSPLFEEKK 325
D SP+ +
Sbjct: 298 LDFSPVNSASR 308
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 468 bits (1207), Expect = e-164
Identities = 131/463 (28%), Positives = 212/463 (45%), Gaps = 78/463 (16%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
G Y LG LG GTF KV + ++ TG +A+K++ + K+ + ++ +I+REI +K+ +H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
HI++L++V+++ S I+ M+ V GGELF+ I GRL E +R FQQ++S VD+CH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
V HRDLKPEN+LLD N K+ DFGLS + L T+CG+P Y APEVIS + Y
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
G + DIWS GVILY LL G LPF DD++ ++++KI G F P + + L+ +L
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252
Query: 258 PNPNSRIAISKIMESSWFKKSAPKVV-------------------------ITKQEMEFE 292
+P R I I E WFK+ PK + +++E+
Sbjct: 253 VDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSC 312
Query: 293 ADKSSKQPETLNAFHII--------SLSEGFDLSPLFEEKKRAEREELRFATTRPASSVI 344
+ Q A+H+I + + + + P
Sbjct: 313 LYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAE 372
Query: 345 SRFE-------------------------------------EVAKAVK---FNVK-TSES 363
+ EV +A+K + K +
Sbjct: 373 TPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPY 432
Query: 364 RVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEY 406
+R++ + ++ ++ V +++ + + + LE
Sbjct: 433 YLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 464 bits (1195), Expect = e-163
Identities = 113/363 (31%), Positives = 173/363 (47%), Gaps = 35/363 (9%)
Query: 1 MATSNSNGGGDDRPTLL-HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK 59
M + G D P + +Y+ + +G G F L R+ T + +A+K + + I
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID 60
Query: 60 VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIA-KGRLRED 118
E ++REI + ++H +IV EV+ + + + M+ GGEL+ +I GR ED
Sbjct: 61 ----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED 116
Query: 119 VARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED--GNLKVTDFGLSAFSEHLKQDGL 176
AR +FQQL+S V +CHS + HRDLK EN LLD LK+ DFG S S
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQ 173
Query: 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK---- 232
+T GTPAY+APEV+ ++ YDG AD+WSCGV LYV+L G PF+D YRK
Sbjct: 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233
Query: 233 IYRGDFKCPP--WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEME 290
I + P S E LI+++ +P +RI+I +I SWF K+ P ++ +
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTG 293
Query: 291 ----------------FEADKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRF 334
+ + P N +++ DL ++ E+
Sbjct: 294 SQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDI 351
Query: 335 ATT 337
++
Sbjct: 352 DSS 354
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-159
Identities = 85/260 (32%), Positives = 135/260 (51%), Gaps = 4/260 (1%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+Y GR LG G FAK + + T + A K+V K ++K E++ EIS+ + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+H+V H ++ ++L + L + L E AR Y +Q++ + H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
V HRDLK NL L+ED +K+ DFGL+ E+ CGTP Y+APEV+SKKG+
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
+ D+WS G I+Y LL G PF+ + Y +I + ++ P + A LI K+L
Sbjct: 193 SF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 251
Query: 258 PNPNSRIAISKIMESSWFKK 277
+P +R I++++ +F
Sbjct: 252 TDPTARPTINELLNDEFFTS 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 452 bits (1166), Expect = e-159
Identities = 107/275 (38%), Positives = 173/275 (62%), Gaps = 5/275 (1%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
G Y + LG G+F KV LA + +T + +A+K + + + K M +++REIS +K+++H
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
HI++L++V+ + + I ++ GGELF+ I K R+ ED R +FQQ+I A+++CH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
+ HRDLKPENLLLD++ N+K+ DFGLS + L T+CG+P Y APEVI+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
G + D+WSCG++LYV+L G LPF D+ I ++++K+ + P + S A+ LI +++
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIV 244
Query: 258 PNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFE 292
+P RI I +I WF + P + +E++
Sbjct: 245 ADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGS 279
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 450 bits (1159), Expect = e-159
Identities = 82/265 (30%), Positives = 152/265 (57%), Gaps = 5/265 (1%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+++G +LG G+FA VY A ++ TG +A+K++ K + K GM+++++ E+ + +KH
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS 136
I+EL+ + +Y +++ GE+ + E+ AR + Q+I+ + + HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
G+ HRDL NLLL + N+K+ DFGL+ + +T CGTP Y++PE+ ++
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSA 188
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256
+ G ++D+WS G + Y LL G PF D + + K+ D++ P + S EA+ LI +LL
Sbjct: 189 H-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 257 DPNPNSRIAISKIMESSWFKKSAPK 281
NP R+++S +++ + +++
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSST 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-159
Identities = 85/260 (32%), Positives = 135/260 (51%), Gaps = 4/260 (1%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+Y GR LG G FAK + + T + A K+V K ++K E++ EIS+ + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+H+V H ++ ++L + L + L E AR Y +Q++ + H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
V HRDLK NL L+ED +K+ DFGL+ E+ CGTP Y+APEV+SKKG+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
+ D+WS G I+Y LL G PF+ + Y +I + ++ P + A LI K+L
Sbjct: 219 SF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQ 277
Query: 258 PNPNSRIAISKIMESSWFKK 277
+P +R I++++ +F
Sbjct: 278 TDPTARPTINELLNDEFFTS 297
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 447 bits (1153), Expect = e-158
Identities = 99/298 (33%), Positives = 156/298 (52%), Gaps = 31/298 (10%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------- 60
G + +Y L +G G++ V LA N AMKV+ K K+I+
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 61 ---------------GMMEQIKREISVMKMVKHKHIVELHEVM--ASKSKIYFAMDLVKG 103
G +EQ+ +EI+++K + H ++V+L EV+ ++ +Y +LV
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 104 GELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163
G + L ED AR YFQ LI +++ H + + HRD+KP NLL+ EDG++K+ DFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVIS--KKGYDGAKADIWSCGVILYVLLAGFLPF 221
+S + D LL T GTPA++APE +S +K + G D+W+ GV LY + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 222 QDDNIVSMYRKIYRGDFKCP--PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
D+ I+ ++ KI + P P + + + LIT++LD NP SRI + +I W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-158
Identities = 96/271 (35%), Positives = 151/271 (55%), Gaps = 6/271 (2%)
Query: 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV 72
+ +++GR LG G F VYLAR Q MA+KV+ K ++ K G+ Q++REI +
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 73 MKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAV 131
++H +I+ ++ + +IY ++ GEL+ ++ K GR E + + ++L A+
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
+CH R V HRD+KPENLL+ G LK+ DFG S + L+ T CGT Y+ PE+
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEM 183
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251
I K +D K D+W GV+ Y L G PF + +R+I D K PP+ S ++ L
Sbjct: 184 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282
I+KLL +P R+ + +ME W K ++ +V
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-154
Identities = 89/273 (32%), Positives = 150/273 (54%), Gaps = 6/273 (2%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+E+GR LG G F VYLAR Q+ +A+KV+ K ++ K G+ Q++RE+ + ++H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR 137
+I+ L+ +++Y ++ G ++ ++ K + E Y +L +A+ +CHS+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
V HRD+KPENLLL G LK+ DFG S + + CGT Y+ PE+I + +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMH 184
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
D K D+WS GV+ Y L G PF+ + Y++I R +F P + + AR LI++LL
Sbjct: 185 D-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 243
Query: 258 PNPNSRIAISKIMESSWFKKSAPKVVITKQEME 290
NP+ R + +++E W ++ K + +
Sbjct: 244 HNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 415 bits (1070), Expect = e-145
Identities = 88/309 (28%), Positives = 144/309 (46%), Gaps = 21/309 (6%)
Query: 2 ATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG 61
T GG DR +Y LG +LG G F V+ L +A+KV+ +++V+
Sbjct: 15 GTPTPPPGGKDREAFE-AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73
Query: 62 MMEQ---IKREISVMKMV----KHKHIVELHEVMASKSKIYFAMDL-VKGGELFNKIA-K 112
+ E++++ V H ++ L + ++ ++ + +LF+ I K
Sbjct: 74 PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK 133
Query: 113 GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHL 171
G L E +R +F Q+++A+ CHSRGV HRD+K EN+L+D G K+ DFG A
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---- 189
Query: 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 231
D GT Y PE IS+ Y A +WS G++LY ++ G +PF+ D +
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------Q 243
Query: 232 KIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEF 291
+I + P S + LI + L P P+SR ++ +I+ W + A V + +
Sbjct: 244 EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
Query: 292 EADKSSKQP 300
S P
Sbjct: 304 APLAWSLLP 312
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 414 bits (1066), Expect = e-144
Identities = 106/282 (37%), Positives = 167/282 (59%), Gaps = 6/282 (2%)
Query: 5 NSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME 64
NS D + G Y L + +G G FAKV LAR++ TG+ +A+K++ K + + ++
Sbjct: 2 NSIASCADEQPHI-GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQ 59
Query: 65 QIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVY 123
++ RE+ +MK++ H +IV+L EV+ ++ +Y M+ GGE+F+ + A GR++E AR
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183
F+Q++SAV +CH + + HRDLK ENLLLD D N+K+ DFG S G L CG
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGA 176
Query: 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW 243
P Y APE+ K YDG + D+WS GVILY L++G LPF N+ + ++ RG ++ P +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVIT 285
S++ L+ + L NP R + +IM+ W + +
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 409 bits (1052), Expect = e-142
Identities = 82/278 (29%), Positives = 140/278 (50%), Gaps = 16/278 (5%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-----QIKREISVM 73
KY LG G F V+ A + + K + +K + K+KV++ +E ++ EI+++
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDL-VKGGELFNKI-AKGRLREDVARVYFQQLISAV 131
V+H +I+++ ++ ++ M+ G +LF I RL E +A F+QL+SAV
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
+ + + HRD+K EN+++ ED +K+ DFG +A+ L++ L +T CGT Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTIEYCAPEV 200
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251
+ Y G + ++WS GV LY L+ PF + + P S E L
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSL 254
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEM 289
++ LL P P R + K++ W + T +E+
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEV 292
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-140
Identities = 85/305 (27%), Positives = 141/305 (46%), Gaps = 19/305 (6%)
Query: 2 ATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG 61
+ G ++ L +Y++G +LG G F VY + +A+K V KD++ G
Sbjct: 27 LHATKLAPGKEKEPLE-SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 62 MM---EQIKREISVMKMVKHK--HIVELHEVMASKSKIYFAMDLVKG-GELFNKIA-KGR 114
+ ++ E+ ++K V ++ L + ++ + +LF+ I +G
Sbjct: 86 ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 115 LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQ 173
L+E++AR +F Q++ AV CH+ GV HRD+K EN+L+D + G LK+ DFG A +
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LK 201
Query: 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
D + GT Y PE I Y G A +WS G++LY ++ G +PF+ D +I
Sbjct: 202 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEI 255
Query: 234 YRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEA 293
RG SSE + LI L P+ R +I W + + + +
Sbjct: 256 IRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315
Query: 294 DKSSK 298
SK
Sbjct: 316 PGPSK 320
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 391 bits (1005), Expect = e-135
Identities = 63/308 (20%), Positives = 127/308 (41%), Gaps = 51/308 (16%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--------------VGMME 64
Y + R L G F K+ L K A+K K + K +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 65 QIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---------GRL 115
K E+ ++ +K+++ + ++ + ++Y + ++ + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 116 REDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174
V + + ++++ + H+ + + HRD+KP N+L+D++G +K++DFG S + D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----D 204
Query: 175 GLLHTTCGTPAYVAPEVIS-KKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRK 232
+ + GT ++ PE S + Y+GAK DIWS G+ LYV+ +PF ++V ++
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264
Query: 233 IYRGDFKCP-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESS 273
I + + P + S+E + L NP RI ++
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324
Query: 274 WFKKSAPK 281
W + +
Sbjct: 325 WLADTNIE 332
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-114
Identities = 72/298 (24%), Positives = 130/298 (43%), Gaps = 37/298 (12%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+E +LG G F +V ARN + A+K + + + I E+ ++ + H+
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQ 62
Query: 80 HIVELHEV-------------MASKSKIYFAMDLVKGGELFNKIAKGR--LREDVARVYF 124
++V + + KS ++ M+ + G L++ I + D F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------------LK 172
+Q++ A+ + HS+G+ HRDLKP N+ +DE N+K+ DFGL+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK 232
L + GT YVA EV+ G+ K D++S G+I + ++ V++ +K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240
Query: 233 IYRGDFKCPPWF----SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITK 286
+ + PP F +++I L+D +PN R ++ S W VI +
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-112
Identities = 99/303 (32%), Positives = 156/303 (51%), Gaps = 22/303 (7%)
Query: 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKR 68
P L +Y + + LG G +V LA +T K +A+K++ K K + ++
Sbjct: 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64
Query: 69 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQL 127
EI ++K + H I+++ ++ Y ++L++GGELF+K+ RL+E ++YF Q+
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 128 ISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
+ AV + H G+ HRDLKPEN+LL +ED +K+TDFG S L + L+ T CGTP
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 180
Query: 185 AYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRG--DF 238
Y+APEV+ GY D WS GVIL++ L+G+ PF + VS+ +I G +F
Sbjct: 181 TYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 239
Query: 239 KCPPWF--SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKS 296
W S +A L+ KLL +P +R + + W + K E +
Sbjct: 240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTA 299
Query: 297 SKQ 299
Q
Sbjct: 300 LPQ 302
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-110
Identities = 94/269 (34%), Positives = 143/269 (53%), Gaps = 13/269 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
Y++ LG G F+ V + TG A K++ K+ ++++RE + + ++H
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHP 65
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 138
+IV LH+ + +S Y DLV GGELF I A+ E A QQ++ ++ +CHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 139 VYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
+ HR+LKPENLLL + +K+ DFGL+ + H GTP Y++PEV+ K
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRL 251
Y DIW+CGVILY+LL G+ PF D++ +Y +I G D+ P W + EA+ L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKSAP 280
I +L NP RI + ++ W
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRER 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-108
Identities = 98/273 (35%), Positives = 141/273 (51%), Gaps = 16/273 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
++ Y L +G G++ +V +A T A K + K V V ++ K+EI +MK +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSL 63
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
H +I+ L+E + IY M+L GGELF ++ K RE A + ++SAV +CH
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
V HRDLKPEN L D LK+ DFGL+A K ++ T GTP YV+P+V+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVL 180
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
+ Y G + D WS GV++YVLL G+ PF + KI G F W S +A
Sbjct: 181 -EGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
LI +LL +P RI + +E WF+K
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = e-107
Identities = 95/277 (34%), Positives = 145/277 (52%), Gaps = 13/277 (4%)
Query: 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS 71
+ T Y++ LG G F+ V + TG A K++ K+ ++++RE
Sbjct: 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREAR 80
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISA 130
+ + ++H +IV LH+ + +S Y DLV GGELF I A+ E A QQ++ +
Sbjct: 81 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 131 VDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
+ +CHS G+ HR+LKPENLLL + +K+ DFGL+ + H GTP Y+
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYL 197
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW-- 243
+PEV+ K Y DIW+CGVILY+LL G+ PF D++ +Y +I G D+ P W
Sbjct: 198 SPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 256
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280
+ EA+ LI +L NP RI + ++ W
Sbjct: 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-107
Identities = 96/286 (33%), Positives = 153/286 (53%), Gaps = 22/286 (7%)
Query: 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIK 67
P L +Y + + LG G +V LA +T K +A++++ K K + ++
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 68 REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQ 126
EI ++K + H I+++ ++ Y ++L++GGELF+K+ RL+E ++YF Q
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 127 LISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183
++ AV + H G+ HRDLKPEN+LL +ED +K+TDFG S L + L+ T CGT
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGT 304
Query: 184 PAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRG--D 237
P Y+APEV+ GY D WS GVIL++ L+G+ PF + VS+ +I G +
Sbjct: 305 PTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363
Query: 238 FKCPPWF--SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
F W S +A L+ KLL +P +R + + W + K
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-107
Identities = 90/297 (30%), Positives = 142/297 (47%), Gaps = 22/297 (7%)
Query: 3 TSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-- 60
T ++ G + YE +LG G + V + T K A+K++
Sbjct: 1 TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 61 ----GMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGR 114
+ E +E+ +++ V H +I++L + + + + DL+K GELF+ + K
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 115 LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174
L E R + L+ + H + HRDLKPEN+LLD+D N+K+TDFG S L
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPG 177
Query: 175 GLLHTTCGTPAYVAPEVI------SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS 228
L CGTP+Y+APE+I + GY G + D+WS GVI+Y LLAG PF +
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
Query: 229 MYRKIYRG--DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
M R I G F P W +S + L+++ L P R + + +F++ +
Sbjct: 237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-107
Identities = 91/278 (32%), Positives = 146/278 (52%), Gaps = 21/278 (7%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREIS 71
+ KY+ ++G G + V + TG A+K++ + E +RE
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 72 VMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLIS 129
+++ V H HI+ L + S S ++ DL++ GELF+ + K L E R + L+
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
AV F H+ + HRDLKPEN+LLD++ ++++DFG S L+ L CGTP Y+AP
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAP 268
Query: 190 EVI------SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCP 241
E++ + GY G + D+W+CGVIL+ LLAG PF + M R I G F P
Sbjct: 269 EILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 242 PW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
W SS + LI++LL +P +R+ + ++ +F++
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-106
Identities = 101/269 (37%), Positives = 152/269 (56%), Gaps = 16/269 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+ +LG G F++V+L + TGK A+K + K + ++ EI+V+K +KH+
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 138
+IV L ++ S + Y M LV GGELF++I +G E A + QQ++SAV + H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 139 VYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
+ HRDLKPENLL +E+ + +TDFGLS + +G++ T CGTP YVAPEV+++K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQK 182
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRL 251
Y D WS GVI Y+LL G+ PF ++ ++ KI G +F+ P W S A+
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKSAP 280
I LL+ +PN R K + W +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTA 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-106
Identities = 92/273 (33%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+Y + MLG G+F +V ++ T + A+KV+ K I RE+ ++K +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKL 78
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
H +I++L E++ S Y +L GGELF++I + R E A +Q+ S + + H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
+ HRDLKPEN+LL ++D ++K+ DFGLS +Q+ + GT Y+APEV+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL 195
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
+ Y K D+WS GVILY+LL+G PF N + +++ G F P W S +A
Sbjct: 196 -RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ LI K+L +P+ RI ++ +E W +K + +
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-105
Identities = 83/273 (30%), Positives = 136/273 (49%), Gaps = 18/273 (6%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ + R LG G F V+L +G +K + KD+ MEQI+ EI V+K +
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL 77
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAV 131
H +I+++ EV +Y M+ +GGEL +I L E +Q+++A+
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 132 DFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ HS+ V H+DLKPEN+L +K+ DFGL+ K D GT Y+A
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMA 194
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPWF-S 245
PEV K+ K DIWS GV++Y LL G LPF ++ + +K ++ +
Sbjct: 195 PEVF-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252
Query: 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278
+A L+ ++L +P R + ++++ WFK++
Sbjct: 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-103
Identities = 96/270 (35%), Positives = 149/270 (55%), Gaps = 14/270 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+Y+L LG G F+ V + G+ A ++ K+ ++++RE + +++KH
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHP 70
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 138
+IV LH+ ++ + Y DLV GGELF I A+ E A QQ++ AV CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 139 VYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDG-LLHTTCGTPAYVAPEVISK 194
V HR+LKPENLLL + +K+ DFGL+ ++ + GTP Y++PEV+ K
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIE---VEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARR 250
Y G D+W+CGVILY+LL G+ PF D++ +Y++I G DF P W + EA+
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246
Query: 251 LITKLLDPNPNSRIAISKIMESSWFKKSAP 280
LI K+L NP+ RI ++ ++ W +
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRST 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-101
Identities = 97/277 (35%), Positives = 145/277 (52%), Gaps = 18/277 (6%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
L +E+ LG G + VY + T K A+KV+ K + ++ EI V+ +
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-----KIVRTEIGVLLRL 105
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
H +I++L E+ + ++I ++LV GGELF++I KG E A +Q++ AV + H
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH 165
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
G+ HRDLKPENLL D LK+ DFGLS ++ L+ T CGTP Y APE++
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEIL 222
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRG--DFKCPPW--FSSE 247
Y G + D+WS G+I Y+LL GF PF D+ M+R+I F P W S
Sbjct: 223 RGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVI 284
A+ L+ KL+ +P R+ + ++ W A V
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-101
Identities = 89/279 (31%), Positives = 151/279 (54%), Gaps = 16/279 (5%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREIS 71
+++ YE+G LG G FA V R TGK A K + K ++ E+I+RE++
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISA 130
+++ ++H +I+ LH++ +K+ + ++LV GGELF+ + K L ED A + +Q++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 131 VDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
V + HS+ + H DLKPEN++L + +K+ DFG++ ++ GTP +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEF 177
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW- 243
VAPE+++ + G +AD+WS GVI Y+LL+G PF + I DF +
Sbjct: 178 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236
Query: 244 -FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
S A+ I +LL +P R+ I++ +E SW K +
Sbjct: 237 NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-101
Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 18/283 (6%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM--EQI 66
D L YEL ++G G F+ V N +TG+ A+K+V K + E +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 67 KREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLR----EDVAR 121
KRE S+ M+KH HIVEL E +S +Y + + G +L +I + E VA
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLH 178
Y +Q++ A+ +CH + HRD+KP +LL + +K+ FG++ + +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESGLVAG 191
Query: 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-- 236
GTP ++APEV+ ++ Y G D+W CGVIL++LL+G LPF ++ I +G
Sbjct: 192 GRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKY 249
Query: 237 DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
W S A+ L+ ++L +P RI + + + W K+
Sbjct: 250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 1e-99
Identities = 87/284 (30%), Positives = 146/284 (51%), Gaps = 16/284 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMM---EQIKREISVM 73
+ Y+ G LG G FA V R TG A K + K + E I+RE+S++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVD 132
K ++H +++ LHEV +K+ + ++LV GGELF+ + K L E+ A + +Q+++ V
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 133 FCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ HS + H DLKPEN++L +K+ DFGL+ + GTP +VA
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVA 185
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--F 244
PE+++ + G +AD+WS GVI Y+LL+G PF D + +F+ +
Sbjct: 186 PEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 288
S+ A+ I +LL +P R+ I ++ W K + ++++
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKA 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 300 bits (769), Expect = 2e-99
Identities = 89/318 (27%), Positives = 147/318 (46%), Gaps = 52/318 (16%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV--GMMEQIKREISVMK 74
L KY L +G G++ V +A QT A+K++ K+K+ ++ +E+IK E+ +MK
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---------------------- 112
+ H +I L+EV + I M+L GG L +K+
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 113 -------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL-- 151
RE + +Q+ SA+ + H++G+ HRD+KPEN L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 152 DEDGNLKVTDFGLSAFSEHLK--QDGLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCG 208
++ +K+ DFGLS L + + T GTP +VAPEV++ G K D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 209 VILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEARRLITKLLDPNPNSRI 264
V+L++LL G +PF N ++ F+ P + S AR L++ LL+ N + R
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 265 AISKIMESSWFKKSAPKV 282
+ ++ W + + K+
Sbjct: 324 DAMRALQHPWISQFSDKI 341
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 3e-99
Identities = 64/286 (22%), Positives = 125/286 (43%), Gaps = 20/286 (6%)
Query: 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV 72
++ Y + + +G G +KV+ N + + A+K V ++ ++ + EI+
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAY 79
Query: 73 MKMVKHK--HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLIS 129
+ ++ I+ L++ + IY M+ +L + + K + + Y++ ++
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
AV H G+ H DLKP N L+ DG LK+ DFG++ + + + GT Y+ P
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 190 EVISKKGYD----------GAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG- 236
E I K+D+WS G ILY + G PFQ + I ++ I
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257
Query: 237 DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282
+ + P + + ++ L +P RI+I +++ + + V
Sbjct: 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 4e-99
Identities = 60/312 (19%), Positives = 110/312 (35%), Gaps = 51/312 (16%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ + L +LG G A V+ R+ +TG A+KV ++ ++ RE V+K +
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 77 KHKHIVELHEVM--ASKSKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISA 130
HK+IV+L + + M+ G L+ + + L E + + ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 131 VDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
++ G+ HR++KP N++ D K+TDFG + L+ D + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEY 181
Query: 187 VAPEVISKKGYD-------GAKADIWSCGVILYVLLAGFLPFQD----DNIVSMYRKIYR 235
+ P++ + GA D+WS GV Y G LPF+ + KI
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 236 GDF-------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIM 270
G ++ +L+ + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 271 ESSWFKKSAPKV 282
+
Sbjct: 302 AETSDILHRGNS 313
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-99
Identities = 88/333 (26%), Positives = 156/333 (46%), Gaps = 31/333 (9%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKH 78
YE+ +G G+++ + T A+K++ K K EI ++ + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+I+ L +V +Y +L+KGGEL +KI + E A + V++ H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 138 GVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
GV HRDLKP N+L ++++ DFG + ++GLL T C T +VAPEV+
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLE 193
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPF---QDDNIVSMYRKIYRG--DFKCPPW--FSS 246
++GYD A DIWS GV+LY +L G+ PF DD + +I G W S
Sbjct: 194 RQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSWFKK--SAPKVVITKQEMEFEADKSSKQPETLN 304
A+ L++K+L +P+ R+ + ++ W P+ + +Q+ +
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD-----APHLVKGAMAA 307
Query: 305 AFHIISLSEGFDLSPLFEEKKRAEREELRFATT 337
+ ++ ++ L P+ A+R ++ T+
Sbjct: 308 TYSALNRNQSPVLEPV-GRSTLAQRRGIKKITS 339
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 7e-99
Identities = 86/284 (30%), Positives = 145/284 (51%), Gaps = 16/284 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVM 73
+ Y++G LG G FA V R TG A K + K + E+I+RE+S++
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVD 132
+ V H +++ LH+V +++ + ++LV GGELF+ + K L E+ A + +Q++ V+
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 133 FCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ H++ + H DLKPEN++L ++K+ DFGL+ ++ GTP +VA
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVA 186
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--F 244
PE+++ + G +AD+WS GVI Y+LL+G PF D I DF +
Sbjct: 187 PEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 288
S A+ I KLL R+ I + + W + + ++E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 2e-98
Identities = 92/273 (33%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+Y + MLG G+F +V ++ T + A+KV+ K I RE+ ++K +
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKL 78
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
H +I++L E++ S Y +L GGELF++I + R E A +Q+ S + + H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
+ HRDLKPEN+LL ++D ++K+ DFGLS +Q+ + GT Y+APEV+
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL 195
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
+ Y K D+WS GVILY+LL+G PF N + +++ G F P W S +A
Sbjct: 196 -RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ LI K+L +P+ RI ++ +E W +K + +
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 4e-98
Identities = 87/284 (30%), Positives = 145/284 (51%), Gaps = 16/284 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK---VGMMEQIKREISVM 73
+ Y++G LG G FA V R TG A K + K + E+I+RE+S++
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVD 132
+ V H +I+ LH+V +++ + ++LV GGELF+ + K L E+ A + +Q++ V+
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 133 FCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ H++ + H DLKPEN++L ++K+ DFGL+ ++ GTP +VA
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVA 186
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--F 244
PE+++ + G +AD+WS GVI Y+LL+G PF D I DF +
Sbjct: 187 PEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 288
S A+ I KLL R+ I + + W + + ++E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-97
Identities = 71/337 (21%), Positives = 135/337 (40%), Gaps = 20/337 (5%)
Query: 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
Y + + +G G +KV+ N + + A+K V ++ ++ + EI+ + ++
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKLQ 65
Query: 78 HK--HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFC 134
I+ L++ + IY M+ +L + + K + + Y++ ++ AV
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
H G+ H DLKP N L+ DG LK+ DFG++ + + + GT Y+ PE I
Sbjct: 125 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 195 KGYD----------GAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG-DFKCP 241
K+D+WS G ILY + G PFQ + I ++ I + + P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPE 301
+ + ++ L +P RI+I +++ + + V + E Q
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
Query: 302 TLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTR 338
LN+ + I + + F R
Sbjct: 304 GLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 340
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 2e-97
Identities = 96/311 (30%), Positives = 159/311 (51%), Gaps = 32/311 (10%)
Query: 20 KYELG---RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
Y+L + LG G+F+ + ++ ++ A+K++ K ++EI+ +K+
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLC 62
Query: 77 K-HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFC 134
+ H +IV+LHEV + + M+L+ GGELF +I K E A ++L+SAV
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 135 HSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
H GV HRDLKPENLL +++ +K+ DFG + + L T C T Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-------IVSMYRKIYRG--DFKCPP 242
+++ GYD D+WS GVILY +L+G +PFQ + V + +KI +G F+
Sbjct: 181 LNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 243 W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK--SAPKVVITKQEMEFEADKS-- 296
W S EA+ LI LL +PN R+ +S + + W + + ++ + +
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
Query: 297 SKQPETLNAFH 307
+ T +AF+
Sbjct: 300 TCVKATFHAFN 310
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 3e-97
Identities = 93/273 (34%), Positives = 150/273 (54%), Gaps = 13/273 (4%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+Y+ R+LG G+F +V L ++ TG+ A+KV+ K +V + E + RE+ ++K +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
H +I++L+E K Y ++ GGELF++I ++ R E A +Q++S + + H
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
+ HRDLKPENLLL +D N+++ DFGLS + + GT Y+APEV+
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEVL 200
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
Y K D+WS GVILY+LL+G PF N + +K+ +G F+ P W S A
Sbjct: 201 -HGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ LI K+L P+ RI+ ++ W + +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 304 bits (779), Expect = 5e-97
Identities = 80/340 (23%), Positives = 135/340 (39%), Gaps = 24/340 (7%)
Query: 8 GGGD--DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ 65
GGG PT G +E+ LG G F V + TG+ +A+K ++ K E+
Sbjct: 1 GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRER 58
Query: 66 IKREISVMKMVKHKHIVELHEVMASKSKI------YFAMDLVKGGELFNKIAK----GRL 115
EI +MK + H ++V EV K+ AM+ +GG+L + + L
Sbjct: 59 WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118
Query: 116 REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLK 172
+E R + SA+ + H + HRDLKPEN++L K+ D G +++ L
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELD 175
Query: 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYR 231
Q L GT Y+APE++ +K Y D WS G + + + GF PF + V +
Sbjct: 176 QGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234
Query: 232 KIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEF 291
K+ + + + + P PN I W + + +Q
Sbjct: 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC--MLMWHQRQRGTD 292
Query: 292 EADKSSKQPETLNAFHIISLSEGFDLSPLFEEKKRAEREE 331
+ + + L++ + L ++ E
Sbjct: 293 PQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENE 332
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = 8e-97
Identities = 68/324 (20%), Positives = 136/324 (41%), Gaps = 20/324 (6%)
Query: 3 TSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM 62
++ ++ ++ Y + + +G G +KV+ N + + A+K V ++
Sbjct: 40 DDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-T 97
Query: 63 MEQIKREISVMKMVKHK--HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDV 119
++ + EI+ + ++ I+ L++ + IY M+ +L + + K +
Sbjct: 98 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE 156
Query: 120 ARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179
+ Y++ ++ AV H G+ H DLKP N L+ DG LK+ DFG++ + + +
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 180 TCGTPAYVAPEVISKKGYD----------GAKADIWSCGVILYVLLAGFLPFQD--DNIV 227
G Y+ PE I K+D+WS G ILY + G PFQ + I
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
Query: 228 SMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITK 286
++ I + + P + + ++ L +P RI+I +++ + + V
Sbjct: 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMA 335
Query: 287 QEMEFEADKSSKQPETLNAFHIIS 310
+ E Q LN+ + I
Sbjct: 336 KGTTEEMKYVLGQLVGLNSPNSIL 359
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 3e-96
Identities = 60/314 (19%), Positives = 112/314 (35%), Gaps = 51/314 (16%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ + L +LG G A V+ R+ +TG A+KV ++ ++ RE V+K +
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 77 KHKHIVELHEVM--ASKSKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISA 130
HK+IV+L + + M+ G L+ + + L E + + ++
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 131 VDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
++ G+ HR++KP N++ D K+TDFG + L+ D + GT Y
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEY 181
Query: 187 VAPEVISKKGYD-------GAKADIWSCGVILYVLLAGFLPFQD----DNIVSMYRKIYR 235
+ P++ + GA D+WS GV Y G LPF+ + KI
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 236 GDF-------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIM 270
G ++ +L+ + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 271 ESSWFKKSAPKVVI 284
+ + +
Sbjct: 302 AETSDILHRMVIHV 315
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 4e-96
Identities = 87/309 (28%), Positives = 147/309 (47%), Gaps = 39/309 (12%)
Query: 8 GGGDDRPTLLHGKYELGR-MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQI 66
G D Y+L +LG G A+V NL T + A+K++ K ++
Sbjct: 1 GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRV 57
Query: 67 KREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYF 124
RE+ ++ + H++++EL E + + Y + ++GG + + I + E A V
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSE-----HLKQDGL 176
Q + SA+DF H++G+ HRDLKPEN+L ++ +K+ DF L + +
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 177 LHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS--- 228
L T CG+ Y+APEV+ YD + D+WS GVILY+LL+G+ PF
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 229 ------------MYRKIYRG--DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMES 272
++ I G +F W S A+ LI+KLL + R++ +++++
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296
Query: 273 SWFKKSAPK 281
W + AP+
Sbjct: 297 PWVQGCAPE 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 6e-96
Identities = 98/301 (32%), Positives = 152/301 (50%), Gaps = 23/301 (7%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM----------MEQI 66
+ Y R LG G + +V L + A+KV+ K + K E+I
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 67 KREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQ 125
EIS++K + H +I++L +V K Y + +GGELF +I + + E A +
Sbjct: 94 YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
Q++S + + H + HRD+KPEN+LL + N+K+ DFGLS+F +D L G
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLG 210
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKC 240
T Y+APEV+ KK Y K D+WSCGVI+Y+LL G+ PF N + +K+ +G F
Sbjct: 211 TAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 241 PPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSK 298
W S EA+ LI +L + N R + + S W KK A + + Q+ A + +
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMR 328
Query: 299 Q 299
+
Sbjct: 329 K 329
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 1e-95
Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 17/284 (5%)
Query: 17 LHGKYEL-GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM 75
+ Y L + LG G FA V + TG+ A K + K + + +I EI+V+++
Sbjct: 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AEILHEIAVLEL 84
Query: 76 VKH-KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAV 131
K ++ LHEV + S+I ++ GGE+F+ + E+ +Q++ V
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 132 DFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+ H + H DLKP+N+LL G++K+ DFG+S + L GTP Y+A
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLA 201
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--F 244
PE+++ D+W+ G+I Y+LL PF ++ Y I + D+ +
Sbjct: 202 PEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 288
S A I LL NP R + SW ++ + + +E
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 4e-95
Identities = 95/273 (34%), Positives = 149/273 (54%), Gaps = 14/273 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
L Y+ + LG G + +V L R+ T A+K++ K V ++ E++V+K++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL 93
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
H +I++L++ K Y M+ KGGELF++I + + E A V +Q++S V + H
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
+ HRDLKPENLLL ++D +K+ DFGLSA + + GT Y+APEV+
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVL 210
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
+K Y K D+WS GVIL++LLAG+ PF + RK+ +G F P W S A
Sbjct: 211 -RKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ LI ++L + RI+ + +E W K+ K
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 1e-94
Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 16/274 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
L+ KY + LG G F V+ + K+ K V + +K+EIS++ +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIA 58
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFC 134
+H++I+ LHE S ++ + + G ++F +I L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 135 HSRGVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
HS + H D++PEN++ +K+ +FG + LK P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVH 175
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
D+WS G ++YVLL+G PF + + I F + S EA
Sbjct: 176 QHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282
+ +LL SR+ S+ ++ W K+ +V
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-93
Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 15/273 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
++ Y++ LG G F V+ TG+ K + + +K EIS+M +
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQL 105
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFC 134
H ++ LH+ K ++ ++ + GGELF++IA ++ E Y +Q +
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 135 HSRGVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
H + H D+KPEN++ + ++K+ DFGL+ L D ++ T T + APE++
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIV 222
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
++ G D+W+ GV+ YVLL+G PF ++ + + + R +F + S EA
Sbjct: 223 DREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ I LL P R+ + +E W K
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-93
Identities = 84/296 (28%), Positives = 141/296 (47%), Gaps = 17/296 (5%)
Query: 13 RPTLLHGKYELGRM--LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREI 70
+ ++ Y + + LG G F +V+ TG +A K++ + E++K EI
Sbjct: 81 KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEI 137
Query: 71 SVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKG-RLREDVARVYFQQLI 128
SVM + H ++++L++ SK+ I M+ V GGELF++I + L E ++ +Q+
Sbjct: 138 SVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 129 SAVDFCHSRGVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
+ H + H DLKPEN+L + +K+ DFGL+ K L GTP +
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR---YKPREKLKVNFGTPEF 254
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW- 243
+APEV++ D+WS GVI Y+LL+G PF DN I D + +
Sbjct: 255 LAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ 313
Query: 244 -FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSK 298
S EA+ I+KLL + RI+ S+ ++ W ++ Q+ + +
Sbjct: 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQD 369
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 3e-93
Identities = 92/359 (25%), Positives = 145/359 (40%), Gaps = 24/359 (6%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ Y++ LG G F V+ TG + A K V E +++EI M ++
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVL 211
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFC 134
+H +V LH+ +++ + + GGELF K+A ++ ED A Y +Q+ +
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 135 HSRGVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
H H DLKPEN++ LK+ DFGL+A L + T GT + APEV
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVA 328
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPPW--FSSEA 248
K G D+WS GV+ Y+LL+G PF +N R + + + S +
Sbjct: 329 EGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVIT-------KQEMEFEADKSSKQPE 301
+ I KLL +PN+R+ I + +E W + + + K PE
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 447
Query: 302 TLNAF-HIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 359
L I + S P E R + A R ++ F +
Sbjct: 448 PLPPLGRISNYSSLRKHRPQ-EYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSANFYCR 505
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 4e-92
Identities = 86/264 (32%), Positives = 147/264 (55%), Gaps = 8/264 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++ G++LG G+F+ V LAR L T + A+K++ K +IK + + RE VM + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
V+L+ K+YF + K GEL I K G E R Y +++SA+++ H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
HRDLKPEN+LL+ED ++++TDFG + + ++ GT YV+PE++++K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
+ +D+W+ G I+Y L+AG PF+ N +++KI + ++ P F +AR L+ KLL +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 260 PNSRI------AISKIMESSWFKK 277
R+ + +F+
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 6e-92
Identities = 92/280 (32%), Positives = 140/280 (50%), Gaps = 33/280 (11%)
Query: 20 KYELGR-MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-K 77
Y+L + +LG G KV + +TG+ A+K++ + ++E+
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 78 HKHIVELHEV----MASKSKIYFAMDLVKGGELFNKI-AKGRLR--EDVARVYFQQLISA 130
HIV + +V K + M+ ++GGELF++I +G E A + + +A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 131 VDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
+ F HS + HRD+KPENLL ++D LK+TDFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYV 196
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRG--DFKCP 241
APEV+ + YD D+WS GVI+Y+LL GF PF + M R+I G F P
Sbjct: 197 APEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 242 PW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279
W S +A++LI LL +P R+ I++ M W +S
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 2e-91
Identities = 48/307 (15%), Positives = 107/307 (34%), Gaps = 54/307 (17%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-- 77
G +LG A + +TG+S + V + ++Q+K E+ +++++
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 78 -----------------------HKHIVELHEVMASKS--KIYFAMDLVK------GGEL 106
K ++ + +F ++ G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 107 FNKIAKGRLREDVARVY-FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
+ + + AR+ Q+I + H G+ H L+P +++LD+ G + +T F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 166 AFSEHLKQDGLLHTTCGTPAYVAPEVIS----------KKGYDGAKADIWSCGVILYVLL 215
+DG + + + PE+ + ++ D W+ G+++Y +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 216 AGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
LP D + I+R R L+ L R+ + ME+ +
Sbjct: 308 CADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 276 KKSAPKV 282
++ ++
Sbjct: 364 EQLRTEL 370
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 4e-91
Identities = 89/323 (27%), Positives = 149/323 (46%), Gaps = 33/323 (10%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHK 79
++LG G KV N +T + A+K++ + +RE+ + +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115
Query: 80 HIVELHEV----MASKSKIYFAMDLVKGGELFNKI-AKGRLR--EDVARVYFQQLISAVD 132
HIV + +V A + + M+ + GGELF++I +G E A + + A+
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 133 FCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ HS + HRD+KPENLL + LK+TDFG + L T C TP YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYYVAP 232
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRG--DFKCPPW 243
EV+ + YD D+WS GVI+Y+LL G+ PF ++ ++ M +I G +F P W
Sbjct: 233 EVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291
Query: 244 --FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS--APKVVITKQEMEFEADKSSKQ 299
S E + LI LL P R+ I++ M W +S P+ + + E + +
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351
Query: 300 PETLNAFHIISLSEGFDLSPLFE 322
+ + ++ ++ + +
Sbjct: 352 VKEEMTSALATMRVDYEQIKIKK 374
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 2e-86
Identities = 90/263 (34%), Positives = 158/263 (60%), Gaps = 14/263 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+++ R LG G+F +V+L R+ G+ AMKV+ K+ V+++ +E E ++ +V H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
I+ + +I+ MD ++GGELF+ + K R VA+ Y ++ A+++ HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HTTCGTPAYVAPEVISKKGYD 198
+RDLKPEN+LLD++G++K+TDFG + K + +T CGTP Y+APEV+S K Y+
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFA------KYVPDVTYTLCGTPDYIAPEVVSTKPYN 181
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
+ D WS G+++Y +LAG+ PF D N + Y KI + + PP+F+ + + L+++L+
Sbjct: 182 KS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 240
Query: 259 NPNSRIAISK-----IMESSWFK 276
+ + R+ + + WFK
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFK 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-85
Identities = 91/262 (34%), Positives = 145/262 (55%), Gaps = 12/262 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++ + LG G+F +V L ++ ++G AMK++ K KV+K+ +E E +++ V
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
+V+L S +Y M+ V GGE+F+ + + GR E AR Y Q++ ++ HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPENLL+D+ G ++VTDFG + + G T CGTP +APE+I KGY+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
A D W+ GV++Y + AG+ PF D + +Y KI G + P FSS+ + L+ LL +
Sbjct: 218 A-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 260 PNSRI-----AISKIMESSWFK 276
R ++ I WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 2e-85
Identities = 91/344 (26%), Positives = 144/344 (41%), Gaps = 51/344 (14%)
Query: 1 MATSNSNGGGDDRP---------TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKV 51
MA S GG R L + + R+L G FA VY A+++ +G+ A+K
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 52 VGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELH-------EVMASKSKIYFAMDLVKG 103
+ ++ I +E+ MK + H +IV+ E + + + +
Sbjct: 61 LLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 104 GELFNKI----AKGRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNL 157
G+L + ++G L D F Q AV H + + HRDLK ENLLL G +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177
Query: 158 KVTDFGLSAFSEH-------LKQDGLLH---TTCGTPAYVAPEVIS--KKGYDGAKADIW 205
K+ DFG + H ++ L+ T TP Y PE+I G K DIW
Sbjct: 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIW 237
Query: 206 SCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW--FSSEARRLITKLLDPNPNSR 263
+ G ILY+L PF+D + +I G + PP + LI +L NP R
Sbjct: 238 ALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293
Query: 264 IAISKIMESSW----FKKSAPKVVIT---KQEMEFEADKSSKQP 300
++I++++ + PK IT +Q + + S+ P
Sbjct: 294 LSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 1e-84
Identities = 79/287 (27%), Positives = 144/287 (50%), Gaps = 8/287 (2%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY + +G G+F K L ++ + G+ +K + + + E+ +RE++V+ +KH
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHS 136
+IV+ E +Y MD +GG+LF +I +ED +F Q+ A+ H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
R + HRD+K +N+ L +DG +++ DFG++ + L GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKP 201
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEARRLITKL 255
Y+ K+DIW+ G +LY L F+ ++ ++ KI G F +S + R L+++L
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 256 LDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPET 302
NP R +++ I+E + K K + + E K+ + +
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS 307
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 2e-83
Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 17/271 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
YE+ +G G++ + R GK + K + + + + E+++++ +KH
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHP 65
Query: 80 HIVELHE--VMASKSKIYFAMDLVKGGELFNKIAKGR-----LREDVARVYFQQLISAVD 132
+IV ++ + + + +Y M+ +GG+L + I KG L E+ QL A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 133 FCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
CH R V HRDLKP N+ LD N+K+ DFGL+ H T GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYM 183
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSS 246
+PE +++ Y+ K+DIWS G +LY L A PF + + KI G F+ P +S
Sbjct: 184 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSWFKK 277
E +IT++L+ R ++ +I+E+ +
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 4e-83
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 25/289 (8%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
Y + LG G F+ V L L G A+K + + E+ +RE + ++ H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHP 86
Query: 80 HIVELHEV----MASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISA 130
+I+ L +K + + + K G L+N+I L ED +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-------LKQDGLLHTTCGT 183
++ H++G HRDLKP N+LL ++G + D G + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 184 PAYVAPEVISKKGYD--GAKADIWSCGVILYVLLAGFLPFQDDNIVSM-YRKIYRGDFKC 240
+Y APE+ S + + + D+WS G +LY ++ G P+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 241 PPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWF-KKSAPKVVITK 286
P SS +L+ ++ +P+ R I ++ + AP T+
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 9e-83
Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++ ++G G F +V+ A++ GK+ +K V + E+ +RE+ + + H +
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVN 65
Query: 81 IVELHE----------------VMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVAR 121
IV + + ++ M+ G L I K +L + +A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 122 VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181
F+Q+ VD+ HS+ + +RDLKP N+ L + +K+ DFGL LK DG +
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRSK 182
Query: 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP 241
GT Y++PE IS + Y + D+++ G+IL LL + + + + G
Sbjct: 183 GTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGII--S 237
Query: 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
F + + L+ KLL P R S+I+ + K +P+
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 1e-82
Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 11/269 (4%)
Query: 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS 71
+ ++ LGHG++ +V+ R+ + G+ A+K ++ S
Sbjct: 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLIS 129
K+ +H V L + +Y +L G L L E Y + +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
A+ HS+G+ H D+KP N+ L G K+ DFGL L G G P Y+AP
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAP 225
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248
E++ + Y AD++S G+ + + LP + + + +F SSE
Sbjct: 226 ELL-QGSYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSEL 281
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKK 277
R ++ +L+P+P R ++ ++
Sbjct: 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-81
Identities = 77/263 (29%), Positives = 138/263 (52%), Gaps = 12/263 (4%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
E+ R +G G+F KV + + T K AMK + K K ++ + + +E+ +M+ ++H +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVY 140
V L + ++ +DL+ GG+L + + +E+ +++ +L+ A+D+ ++ +
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK---GY 197
HRD+KP+N+LLDE G++ +TDF ++A L ++ + T GT Y+APE+ S + GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 198 DGAKADIWSCGVILYVLLAGFLPF---QDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254
A D WS GV Y LL G P+ + + P +S E L+ K
Sbjct: 195 SFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 255 LLDPNPNSRI-AISKIMESSWFK 276
LL+PNP+ R +S + +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 248 bits (637), Expect = 8e-80
Identities = 92/266 (34%), Positives = 145/266 (54%), Gaps = 13/266 (4%)
Query: 22 ELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVK 77
EL R+LG G + KV+ R + TGK AMKV+ K ++ K E ++++ VK
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS 136
H IV+L + K+Y ++ + GGELF ++ + G ED A Y ++ A+ H
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
+G+ +RDLKPEN++L+ G++K+TDFGL E + + HT CGT Y+APE++ + G
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256
++ A D WS G ++Y +L G PF +N KI + PP+ + EAR L+ KLL
Sbjct: 198 HNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 257 DPNPNSRI-----AISKIMESSWFKK 277
N SR+ ++ +F+
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-79
Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 56/308 (18%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHK 79
++LG G KV N +T + A+K++ + +RE+ + + +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 80 HIVELHEV----MASKSKIYFAMDLVKGGELFNKI-AKGRLR--EDVARVYFQQLISAVD 132
HIV + +V A + + M+ + GGELF++I +G E A + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 133 FCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ HS + HRD+KPENLL + LK+TDFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRG--DFKCPPW 243
E + YD D+WS GVI+Y+LL G+ PF ++ ++ M +I G +F P W
Sbjct: 169 ETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 244 --FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK--SAPKVVITKQEM--EFEADKSS 297
S E + LI LL P R+ I++ M W + P+ + + E +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 286
Query: 298 KQPETLNA 305
+ E +A
Sbjct: 287 VKEEMTSA 294
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 5e-79
Identities = 92/261 (35%), Positives = 138/261 (52%), Gaps = 9/261 (3%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKH 80
+++G G+F KV LAR+ A+KV+ K ++K + I E +V+ K VKH
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
+V LH + K+YF +D + GGELF + + E AR Y ++ SA+ + HS +
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPEN+LLD G++ +TDFGL E+++ + T CGTP Y+APEV+ K+ YD
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
D W G +LY +L G PF N MY I + P ++ AR L+ LL +
Sbjct: 219 T-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 260 PNSRIA----ISKIMESSWFK 276
R+ +I +F
Sbjct: 278 RTKRLGAKDDFMEIKSHVFFS 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 9e-79
Identities = 88/262 (33%), Positives = 143/262 (54%), Gaps = 9/262 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
++ ++LG GTF KV L R TG+ AMK++ K+ +I + E V++ +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
+ L + ++ F M+ GGELF +++ E+ AR Y +++SA+++ HSR V
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RD+K ENL+LD+DG++K+TDFGL E + + T CGTP Y+APEV+ Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
A D W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL +
Sbjct: 185 A-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 260 PNSRIAISK-----IMESSWFK 276
P R+ +ME +F
Sbjct: 244 PKQRLGGGPSDAKEVMEHRFFL 265
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 245 bits (629), Expect = 1e-78
Identities = 94/265 (35%), Positives = 151/265 (56%), Gaps = 13/265 (4%)
Query: 22 ELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
EL ++LG G+F KV+L + + + AMKV+ K +KV + K E ++ V H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-TLKVRDRVRTKMERDILVEVNH 85
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR 137
IV+LH ++ K+Y +D ++GG+LF +++K E+ + Y +L A+D HS
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
G+ +RDLKPEN+LLDE+G++K+TDFGLS E + + ++ CGT Y+APEV++++G+
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
+ AD WS GV+++ +L G LPFQ + I + P + S EA+ L+ L
Sbjct: 204 TQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 262
Query: 258 PNPNSRIAISK-----IMESSWFKK 277
NP +R+ I S+F
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-77
Identities = 87/264 (32%), Positives = 140/264 (53%), Gaps = 11/264 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHK 79
+E R+LG G+F KV LAR +TG A+KV+ KD +++ +E E ++ + H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+ +L + +++F M+ V GG+L I K R E AR Y ++ISA+ F H +G
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ +RDLK +N+LLD +G+ K+ DFG+ E + T CGTP Y+APE++ + Y
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
A D W+ GV+LY +L G PF+ +N ++ I + P W +A ++ +
Sbjct: 203 PA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261
Query: 259 NPNSRI------AISKIMESSWFK 276
NP R+ I+ +FK
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFK 285
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 244 bits (623), Expect = 2e-77
Identities = 48/301 (15%), Positives = 91/301 (30%), Gaps = 48/301 (15%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
K +L L G + V+L R+++ + A+KV +E++ + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 80 HIVEL--------------------------HEVMASKSKIYFAM-----DLVKGGELFN 108
E + + + M DL +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 109 KI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166
+ +G + QLI S+G+ H P+NL + DG L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQDDN 225
K + Y E ++ + W G+ +Y + FLPF
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 226 --IVSMYRKIYRG-------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
I +++ F + LI + L+ + R+ + ME+ F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 277 K 277
+
Sbjct: 358 Q 358
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-77
Identities = 83/259 (32%), Positives = 138/259 (53%), Gaps = 6/259 (2%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHK 79
+ L +MLG G+F KV+LA +T + A+K + KD V+ +E E V+ + +H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+ + +K ++F M+ + GG+L I + A Y ++I + F HS+G
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ +RDLK +N+LLD+DG++K+ DFG+ E++ D +T CGTP Y+APE++ + Y+
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKYN 196
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
+ D WS GV+LY +L G PF + ++ I + P W EA+ L+ KL
Sbjct: 197 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255
Query: 259 NPNSRI-AISKIMESSWFK 276
P R+ I + F+
Sbjct: 256 EPEKRLGVRGDIRQHPLFR 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-77
Identities = 79/281 (28%), Positives = 139/281 (49%), Gaps = 16/281 (5%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+ + + +G G F++VY A L G +A+K V ++ +EI ++K + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-----AKGRLREDVARVYFQQLISAVDF 133
++++ + +++ ++L G+L I K + E YF QL SA++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
HSR V HRD+KP N+ + G +K+ D GL F + H+ GTP Y++PE I
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIH 209
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKCPPW----FSSE 247
+ GY+ K+DIWS G +LY + A PF D N+ S+ +KI + D+ PP +S E
Sbjct: 210 ENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEE 266
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQE 288
R+L+ ++P+P R ++ + + + + +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 6e-77
Identities = 72/329 (21%), Positives = 126/329 (38%), Gaps = 49/329 (14%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KM 75
L ++LG+G+ V G+ +A+K + D + EI ++ +
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTES 65
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--------GRLREDVARVYFQQL 127
H +++ + + +Y A++L L + + +E +Q+
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 128 ISAVDFCHSRGVYHRDLKPENLLLD-------------EDGNLKVTDFGLSAF--SEHLK 172
S V HS + HRDLKP+N+L+ E+ + ++DFGL S
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 173 QDGLLHTTCGTPAYVAPEVISKKGYD------GAKADIWSCGVILYVLL-AGFLPFQDDN 225
L+ GT + APE++ + DI+S G + Y +L G PF D
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 226 IVSMYRKIYRG-----DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278
S I RG + KC +EA LI++++D +P R K++ F
Sbjct: 245 --SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302
Query: 279 APKVV-ITKQEMEFEADKSSKQPETLNAF 306
+ K+ + K E + L F
Sbjct: 303 SKKLEFLLKVSDRLEIENRDPPSALLMKF 331
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-76
Identities = 87/282 (30%), Positives = 147/282 (52%), Gaps = 12/282 (4%)
Query: 2 ATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG 61
+ N G DR L + +LG G+F KV L+ T + A+K++ KD VI+
Sbjct: 5 VSKFDNNGNRDRMKLTD--FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD 62
Query: 62 MMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDV 119
+E E V+ + K + +LH + ++YF M+ V GG+L I + GR +E
Sbjct: 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 122
Query: 120 ARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179
A Y ++ + F S+G+ +RDLK +N++LD +G++K+ DFG+ E++ T
Sbjct: 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKT 180
Query: 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK 239
CGTP Y+APE+I+ + Y + D W+ GV+LY +LAG PF+ ++ +++ I +
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 239
Query: 240 CPPWFSSEARRLITKLLDPNPNSRI-----AISKIMESSWFK 276
P S EA + L+ +P R+ I E ++F+
Sbjct: 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 4e-76
Identities = 62/331 (18%), Positives = 120/331 (36%), Gaps = 31/331 (9%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KH 78
+ +LGHG + R + + +A+K + + RE+ +++ +H
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC------FSFADREVQLLRESDEH 77
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS 136
+++ + Y A++L L + + QQ S + HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 137 RGVYHRDLKPENLLLDEDGN-----LKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYVAPE 190
+ HRDLKP N+L+ ++DFGL + GT ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 191 VIS---KKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDFKCPPWF-- 244
++S K+ DI+S G + Y +++ G PF + C
Sbjct: 197 MLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 245 -SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ-----EMEFEADKSSK 298
AR LI K++ +P R + +++ +F ++ + E E K
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVK 315
Query: 299 QPETLNAFHIISLSEGFDLSPLFEEKKRAER 329
Q E ++ + +++ + R R
Sbjct: 316 QLER-GGRAVVKMDWRENITVPLQTDLRKFR 345
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 1e-75
Identities = 83/285 (29%), Positives = 151/285 (52%), Gaps = 22/285 (7%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR 68
G D L ++L R++G G++AKV L R +T + AMKVV K+ V ++ ++
Sbjct: 1 GAMDPLGLQD--FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 58
Query: 69 EISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQ 126
E V + H +V LH ++S+++F ++ V GG+L + + +L E+ AR Y +
Sbjct: 59 EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 118
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
+ A+++ H RG+ +RDLK +N+LLD +G++K+TD+G+ E L+ T CGTP Y
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNY 176
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF---------QDDNIVSMYRKIYRGD 237
+APE++ + Y + D W+ GV+++ ++AG PF + +++ I
Sbjct: 177 IAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSRI------AISKIMESSWFK 276
+ P S +A ++ L+ +P R+ + I +F+
Sbjct: 236 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-75
Identities = 89/268 (33%), Positives = 140/268 (52%), Gaps = 16/268 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YE+ +++G G F +V L R+ T K AMK++ K ++IK E +M
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
+V+L +Y M+ + GG+L N ++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEVISKKGYD 198
HRD+KP+N+LLD+ G+LK+ DFG + ++G++ T GTP Y++PEV+ +G D
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 199 ---GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP--PWFSSEARRL 251
G + D WS GV LY +L G PF D++V Y KI ++ P S EA+ L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 252 ITKLLDPNPNSRIA---ISKIMESSWFK 276
I L + R+ + +I +FK
Sbjct: 308 ICAFLT-DREVRLGRNGVEEIKRHLFFK 334
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 5e-75
Identities = 50/309 (16%), Positives = 104/309 (33%), Gaps = 46/309 (14%)
Query: 15 TLLHGKYEL---GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS 71
+ L + G +LG A + +TG+S + V + ++Q+K E+
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 72 VMK----------------------MVKHKHIVELHEVMASKSKIYFAMDLV-------- 101
++ +VK ++ V + ++
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 102 ---KGGELFNKIAKGRLREDVARVYF-QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 157
G L + + + AR+ Q+I + H G+ H L+P +++LD+ G +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 250
Query: 158 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK----ADIWSCGVILYV 213
+T F + + P A ++ + D W+ G+ +Y
Sbjct: 251 FLTGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309
Query: 214 LLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESS 273
+ LP DD + I+R P R L+ L R+ + ME+
Sbjct: 310 IWCADLPNTDDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 274 WFKKSAPKV 282
+++ ++
Sbjct: 366 EYEQLRTEL 374
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 5e-75
Identities = 89/263 (33%), Positives = 144/263 (54%), Gaps = 10/263 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E ++LG GTF KV L + TG+ AMK++ K+ ++ + E V++ +H
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RG 138
+ L + ++ F M+ GGELF +++ ED AR Y +++SA+D+ HS +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V +RDLK ENL+LD+DG++K+TDFGL E +K + T CGTP Y+APEV+ Y
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
A D W GV++Y ++ G LPF + + ++ I + + P EA+ L++ LL
Sbjct: 328 RA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 386
Query: 259 NPNSRIAISK-----IMESSWFK 276
+P R+ IM+ +F
Sbjct: 387 DPKQRLGGGSEDAKEIMQHRFFA 409
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-74
Identities = 46/315 (14%), Positives = 109/315 (34%), Gaps = 41/315 (13%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKRE 69
L + +LG G FA+VY A + + + +KV + + Q+
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMER 120
Query: 70 ISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK------GRLREDVARVY 123
+K ++ + ++ +L G L N I + + + +
Sbjct: 121 ---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLL-----------DEDGNLKVTDFGLSAFSEHLK 172
+++ ++ H + H D+KP+N +L D L + D G S +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYR 231
+ + C T + E++S K ++ + D + +Y +L G ++ +++
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 232 KIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI----AISKIMESSWFKKSAPKVVITKQ 287
++R W +L+ + + + ++ F++ + +
Sbjct: 297 GLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLK-KVFQQHYTNKIRALR 350
Query: 288 ----EMEFEADKSSK 298
+ E +S K
Sbjct: 351 NRLIVLLLECKRSRK 365
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 3e-74
Identities = 79/273 (28%), Positives = 148/273 (54%), Gaps = 20/273 (7%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHK 79
++L R++G G++AKV L R +T + AM+VV K+ V ++ ++ E V + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+V LH ++S+++F ++ V GG+L + + +L E+ AR Y ++ A+++ H RG
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ +RDLK +N+LLD +G++K+TD+G+ E L+ T CGTP Y+APE++ + Y
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231
Query: 199 GAKADIWSCGVILYVLLAGFLPF---------QDDNIVSMYRKIYRGDFKCPPWFSSEAR 249
+ D W+ GV+++ ++AG PF + +++ I + P S +A
Sbjct: 232 FS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290
Query: 250 RLITKLLDPNPNSRI------AISKIMESSWFK 276
++ L+ +P R+ + I +F+
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-74
Identities = 88/274 (32%), Positives = 152/274 (55%), Gaps = 21/274 (7%)
Query: 22 ELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMVK 77
EL ++LG G + KV+L R + TGK AMKV+ K ++ K E + E V++ ++
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 78 HKH-IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCH 135
+V LH +++K++ +D + GGELF +++ R E ++Y +++ A++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL-HTTCGTPAYVAPEVI-- 192
G+ +RD+K EN+LLD +G++ +TDFGLS E + + + CGT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYRGDFKCPPWFSSEA 248
G+D A D WS GV++Y LL G PF + ++ + R+I + + P S+ A
Sbjct: 235 GDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293
Query: 249 RRLITKLLDPNPNSRI-----AISKIMESSWFKK 277
+ LI +LL +P R+ +I E +F+K
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-73
Identities = 81/273 (29%), Positives = 138/273 (50%), Gaps = 22/273 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +++G G F +V + + K AMK++ K +++K + E V+ K
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
I LH + +Y MD GG+L ++K RL E++AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEVI---- 192
HRD+KP+N+L+D +G++++ DFG L +DG + GTP Y++PE++
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 193 -SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW---FSS 246
K Y G + D WS GV +Y +L G PF +++V Y KI ++ F+ P S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 247 EARRLITKLLDPNPNSRI---AISKIMESSWFK 276
A+ LI +L+ + R+ I + +F
Sbjct: 312 NAKDLIRRLICSREH-RLGQNGIEDFKKHPFFS 343
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 5e-73
Identities = 71/289 (24%), Positives = 111/289 (38%), Gaps = 40/289 (13%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME----QIKREISVMKM 75
+E + LG G F V+ A+N + A+K I++ E ++ RE+ +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR------IRLPNRELAREKVMREVKALAK 59
Query: 76 VKHKHIVELHEV------------MASKSKIYFAMDLVKGGELFNKIAKGR----LREDV 119
++H IV + K +Y M L + L + + V
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 120 ARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA----------FSE 169
F Q+ AV+F HS+G+ HRDLKP N+ D +KV DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM 229
+ GT Y++PE I Y K DI+S G+IL+ LL F V
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLYPF--STQMERVRT 236
Query: 230 YRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
+ F ++ +L P+P R I+E++ F+
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-72
Identities = 80/274 (29%), Positives = 135/274 (49%), Gaps = 22/274 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ +++G G F++V + + QTG+ AMK++ K ++K G + + E V+ +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
I +LH ++ +Y M+ GG+L ++K R+ ++AR Y +++ A+D H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYVAPEVISKKG 196
HRD+KP+N+LLD G++++ DFG L+ DG + GTP Y++PE++ G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 197 YD------GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCP---PWFS 245
G + D W+ GV Y + G PF D+ Y KI Y+ P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 246 SEARRLITKLLDPNPNSRI---AISKIMESSWFK 276
EAR I +LL P +R+ +F
Sbjct: 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 5e-72
Identities = 82/263 (31%), Positives = 141/263 (53%), Gaps = 10/263 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHK 79
+ +LG G+F KV L+ T + A+K++ KD VI+ +E E V+ + K
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+ +LH + ++YF M+ V GG+L I + GR +E A Y ++ + F S+G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ +RDLK +N++LD +G++K+ DFG+ E++ T CGTP Y+APE+I+ + Y
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEIIAYQPYG 520
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
+ D W+ GV+LY +LAG PF+ ++ +++ I + P S EA + L+
Sbjct: 521 KS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579
Query: 259 NPNSRIAISK-----IMESSWFK 276
+P R+ I E ++F+
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFFR 602
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-71
Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 17/269 (6%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
R+LG G F +V+ + TGK A K + K ++ K + E ++ V + I
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHS 136
V L +K+ + M ++ GG++ I +E A Y Q++S ++ H
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
R + +RDLKPEN+LLD+DGN++++D GL+ E GTP ++APE++ +
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVS----MYRKIYRGDFKCPPWFSSEARRLI 252
YD + D ++ GV LY ++A PF+ + +++ P FS ++
Sbjct: 366 YDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFC 424
Query: 253 TKLLDPNPNSRIAISK-----IMESSWFK 276
LL +P R+ + F+
Sbjct: 425 EALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-69
Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 16/268 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ R+LG G F +V + TGK A K + K ++ K E +++ V +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELF---NKIAKGRLREDVARVYFQQLISAVDFCHSR 137
+V L +K + + L+ GG+L + + E A Y ++ ++ H
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
+ +RDLKPEN+LLD+ G+++++D GL + H+ + + GT Y+APEV+ + Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGL---AVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEARRLIT 253
+ D W+ G +LY ++AG PFQ + R + + FS +AR L +
Sbjct: 363 TFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 254 KLLDPNPNSRI-----AISKIMESSWFK 276
+LL +P R+ + ++ E FK
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 3e-67
Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 18/269 (6%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---H 78
+ R++G G F +VY R TGK AMK + K ++ E ++ +V
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR 137
IV + + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+R
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-G 196
V +RDLKP N+LLDE G+++++D GL+ H + GT Y+APEV+ K
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVA 367
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---MYRKIYRGDFKCPPWFSSEARRLIT 253
YD + AD +S G +L+ LL G PF+ + R + P FS E R L+
Sbjct: 368 YDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 254 KLLDPNPNSRIAISK-----IMESSWFKK 277
LL + N R+ + ES +F+
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-62
Identities = 47/293 (16%), Positives = 100/293 (34%), Gaps = 24/293 (8%)
Query: 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR 68
G + ++ +G G F V+ G A+K K V ++
Sbjct: 1 GAMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 69 EISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVY 123
+ + +H H+V A + + GG L + I++ +E +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE-------------H 170
Q+ + + HS + H D+KP N+ + H
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 171 LKQDGLLHTTCGTPAYVAPEVIS-KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM 229
+ + G ++A EV+ + KADI++ + + ++ +
Sbjct: 181 VTRISSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGD---Q 236
Query: 230 YRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ +I +G + P S E L+ ++ P+P R + +++ S ++ K
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-57
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 26/297 (8%)
Query: 1 MATSNSNGGGDDRPTLLHGKYEL-----GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKD 55
M ++ GD LL YE +LG GT+ VY R+L +A+K +
Sbjct: 2 MRSTEE---GDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--- 55
Query: 56 KVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELF----NKIA 111
+ + EI++ K +KHK+IV+ + I M+ V GG L +K
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 112 KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEH 170
+ E Y +Q++ + + H + HRD+K +N+L++ G LK++DFG S
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 171 LKQDGLLHTTCGTPAYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIV 227
+ T GT Y+APE+I +GY G ADIWS G + + G PF +
Sbjct: 176 INP--CTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQ 232
Query: 228 SMYRKIYRGDFKCPP---WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ K+ P S+EA+ I K +P+P+ R + ++ + K S+ K
Sbjct: 233 AAMFKVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 23/254 (9%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+G G+F +V+ ++ QTG A+K KV + E+ +
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPR 111
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGV 139
IV L+ + + M+L++GG L I + G L ED A Y Q + +++ H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 140 YHRDLKPENLLLDEDGNL-KVTDFGLSAFSEHLKQDGLLHTTC------GTPAYVAPEVI 192
H D+K +N+LL DG+ + DFG + L+ DGL + GT ++APEV+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEAR 249
K D AK DIWS ++ +L G P+ + KI + PP +
Sbjct: 229 MGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 250 RLITKLLDPNPNSR 263
+ I + L P R
Sbjct: 288 QAIQEGLRKEPVHR 301
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-53
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 18/231 (7%)
Query: 62 MMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR----LRE 117
M+ +I M K+ V + + K +Y M L + L + + +
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 118 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------- 170
V F Q+ AV+F HS+G+ HRDLKP N+ D +KV DFGL +
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 171 ---LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV 227
+ GT Y++PE I Y K DI+S G+IL+ LL F V
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM--ERV 280
Query: 228 SMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
+ + F + ++ +L P+P R + I+E++ F+
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 15/67 (22%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+E + +G G F V+ A+N + A+K + + E++ RE+ + ++H
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHP 64
Query: 80 HIVELHE 86
IV
Sbjct: 65 GIVRYFN 71
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 61/271 (22%), Positives = 127/271 (46%), Gaps = 19/271 (7%)
Query: 19 GKYE-LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
G++ +G G+F VY + +T +A + K+ K ++ K E ++K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 78 HKHIVELH----EVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVD 132
H +IV + + K I +L+ G L + + ++ V R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 133 FCHSRG--VYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
F H+R + HRDLK +N+ + G++K+ D GL+ LK+ GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 199
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD--FKCPPWFSS 246
E+ ++ YD D+++ G+ + + P+ + N +YR++ G
Sbjct: 200 EMY-EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSWFKK 277
E + +I + N + R +I ++ ++F++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 1e-50
Identities = 84/303 (27%), Positives = 138/303 (45%), Gaps = 64/303 (21%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REIS 71
KYE +G GT+ V+ A+N +T + +A+K ++ ++ REI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKR------VR---LDDDDEGVPSSALREIC 53
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQ 126
++K +KHK+IV LH+V+ S K+ DL K + G L ++ + + Q
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK----YFDSCNGDLDPEIVKSFLFQ 109
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA 185
L+ + FCHSR V HRDLKP+NLL++ +G LK+ +FGL+ AF ++ T
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVV-TLW 166
Query: 186 YVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYR------- 235
Y P+V+ +K Y + D+WS G I L P F +++ ++I+R
Sbjct: 167 YRPPDVLFGAKL-YSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224
Query: 236 ----GDFKCP------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESS 273
K P P ++ R L+ LL NP RI+ + ++
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 274 WFK 276
+F
Sbjct: 285 YFS 287
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-50
Identities = 49/133 (36%), Positives = 83/133 (62%), Gaps = 1/133 (0%)
Query: 298 KQPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFN 357
+ P +NAF +I+LS+G +LS LF+ ++ + + RF + R S +I+ E VA ++ F
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61
Query: 358 VKTSESRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPA 417
T + RL+G S + G+LA+ +I+ V PSL +V+V+K G+TLEY++F +L
Sbjct: 62 SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFY-KKLCSK 120
Query: 418 LKDIVWMSTADNP 430
L++I+W +T P
Sbjct: 121 LENIIWRATEGIP 133
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-50
Identities = 79/302 (26%), Positives = 122/302 (40%), Gaps = 61/302 (20%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REIS 71
+YE LG G FA VY AR+ T + +A+K K IK+G + K REI
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIK-----K-IKLGHRSEAKDGINRTALREIK 64
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQ 126
+++ + H +I+ L + KS I DL K L + Y
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV----IIKDNSLVLTPSHIKAYMLM 120
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTC-GTP 184
+ +++ H + HRDLKP NLLLDE+G LK+ DFGL+ +F + +T T
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA----YTHQVVTR 176
Query: 185 AYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------- 235
Y APE++ ++ Y D+W+ G IL LL D+ + +I+
Sbjct: 177 WYRAPELLFGARM-YGVG-VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234
Query: 236 ----GDFKCP-----------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSW 274
P + LI L NP +RI ++ ++ +
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
Query: 275 FK 276
F
Sbjct: 295 FS 296
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 81/309 (26%), Positives = 132/309 (42%), Gaps = 68/309 (22%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKM 75
+++ LG+GT+A VY N TG +A+K +K+ E REIS+MK
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59
Query: 76 VKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGR-LREDVARVYFQQLIS 129
+KH++IV L++V+ +++K+ DL K + R L ++ + + QL+
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA--- 185
+ FCH + HRDLKP+NLL+++ G LK+ DFGL+ AF + +
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--------FSSEVVT 171
Query: 186 --YVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G--- 236
Y AP+V+ S+ Y + DIWSCG IL ++ G F N + I+ G
Sbjct: 172 LWYRAPDVLMGSRT-YSTS-IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229
Query: 237 -----------DFK------------------CPPWFSSEARRLITKLLDPNPNSRIAIS 267
+ + LL NP+ R++
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK 289
Query: 268 KIMESSWFK 276
+ + WF
Sbjct: 290 QALHHPWFA 298
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-49
Identities = 86/307 (28%), Positives = 137/307 (44%), Gaps = 74/307 (24%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REIS 71
KY +G GT+ VY A+N G++ A+K I+ +E+ REIS
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKK------IR---LEKEDEGIPSTTIREIS 52
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQ 126
++K +KH +IV+L++V+ +K ++ DL K + +G L A+ + Q
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK----LLDVCEGGLESVTAKSFLLQ 108
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA 185
L++ + +CH R V HRDLKP+NLL++ +G LK+ DFGL+ AF ++ T
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHE 160
Query: 186 -----YVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI----- 233
Y AP+V+ SKK Y DIWS G I ++ G F + +I
Sbjct: 161 IVTLWYRAPDVLMGSKK-YSTT-IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 234 ---------------YRGDFKCP---------PWFSSEARRLITKLLDPNPNSRIAISKI 269
Y +F L++K+L +PN RI +
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 270 MESSWFK 276
+E ++FK
Sbjct: 279 LEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 86/314 (27%), Positives = 133/314 (42%), Gaps = 75/314 (23%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REIS 71
KY+ +G GT+ VY A++ G+ +A+K I+ ++ REIS
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKR------IR---LDAEDEGIPSTAIREIS 71
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQ 126
++K + H +IV L +V+ S+ + DL K K L++ ++Y Q
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK----VLDENKTGLQDSQIKIYLYQ 127
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA 185
L+ V CH + HRDLKP+NLL++ DG LK+ DFGL+ AF ++ T
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--------YTHE 179
Query: 186 -----YVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--- 235
Y AP+V+ SKK Y + DIWS G I ++ G F KI+
Sbjct: 180 VVTLWYRAPDVLMGSKK-YSTS-VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 236 --------GDFKCP-------------------PWFSSEARRLITKLLDPNPNSRIAISK 268
+ P P F E L++ +L +PN RI+
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 269 IMESSWFKKSAPKV 282
M +FK P++
Sbjct: 298 AMNHPYFKDLDPQI 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-49
Identities = 78/326 (23%), Positives = 132/326 (40%), Gaps = 60/326 (18%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKM 75
Y LG GT+A VY ++ T +A+K I++ E RE+S++K
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKE------IRLEHEEGAPCTAIREVSLLKD 56
Query: 76 VKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
+KH +IV LH+++ ++ + DL + + + +++ QL+
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQ----YLDDCGNIINMHNVKLFLFQLLRG 112
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAP 189
+ +CH + V HRDLKP+NLL++E G LK+ DFGL+ A S K + T Y P
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVV-TLWYRPP 169
Query: 190 EVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------------ 235
+++ S Y D+W G I Y + G F + I+R
Sbjct: 170 DILLGSTD-YSTQ-IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 236 ---------GDFKCP---------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK- 276
++ P S+ L+TKLL +RI+ M+ +F
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
Query: 277 --KSAPKVVITKQEMEFEADKSSKQP 300
+ K+ T + + K+
Sbjct: 288 LGERIHKLPDTTSIFALKEIQLQKEA 313
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-48
Identities = 84/312 (26%), Positives = 135/312 (43%), Gaps = 68/312 (21%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REIS 71
+Y LG GT+ +VY A + T +++A+K I+ +E + RE+S
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR------IR---LEHEEEGVPGTAIREVS 85
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQ 126
++K ++H++I+EL V+ +++ DL K +K + V + + Q
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKK---YMDK--NPDVSMRVIKSFLYQ 140
Query: 127 LISAVDFCHSRGVYHRDLKPENLLLD-----EDGNLKVTDFGLS-AFSEHLKQDGLLHTT 180
LI+ V+FCHSR HRDLKP+NLLL E LK+ DFGL+ AF ++Q H
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 181 CGTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G- 236
T Y PE++ + Y + DIWS I +L F D+ + KI+ G
Sbjct: 199 I-TLWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256
Query: 237 -------------DFK--------------CPPWFSSEARRLITKLLDPNPNSRIAISKI 269
D+K E L+T +L+ +P RI+
Sbjct: 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316
Query: 270 MESSWFKKSAPK 281
+E +F +
Sbjct: 317 LEHPYFSHNDFD 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 67/273 (24%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ +G G+F +V+ + +T K +A+K++ ++ +E I++EI+V+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPY 81
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
+ + + +K++ M+ + GG + + G L E ++++ +D+ HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 141 HRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
HRD+K N+LL E G +K+ DFG++ +K+ +T GTP ++APEVI + YD
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR----NTFVGTPFWMAPEVIKQSAYD 197
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW----FSSEARRLITK 254
+KADIWS G+ L G P + + + + I + + PP +S + +
Sbjct: 198 -SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEA 253
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ 287
L+ P+ R ++++ + ++A K +
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 70/328 (21%), Positives = 128/328 (39%), Gaps = 68/328 (20%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKM 75
KYE +G G++ V+ RN TG+ +A+K K ++ IK REI ++K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 76 VKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
+KH ++V L EV K +++ ++ + + E + + Q + A
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLH----ELDRYQRGVPEHLVKSITWQTLQA 114
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV-- 187
V+FCH HRD+KPEN+L+ + +K+ DFG + + + V
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YDD-----EVAT 165
Query: 188 ----APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR------- 235
+PE++ Y G D+W+ G + LL+G + + V I +
Sbjct: 166 RWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224
Query: 236 ------------GDFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIME 271
K P S A L+ L +P R+ +++
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284
Query: 272 SSWFKKSAPKVVITKQEMEFEADKSSKQ 299
+F ++ ++ +E + A+ Q
Sbjct: 285 HPYF-ENIREIEDLAKEHDKPAENLYFQ 311
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-46
Identities = 39/125 (31%), Positives = 65/125 (52%), Gaps = 6/125 (4%)
Query: 300 PETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVK 359
+NAF IIS S GF+LS LF + ++ +R E RF + A V+ R EE+ A V
Sbjct: 3 ARRMNAFDIISGSPGFNLSGLFGDARKYDRVE-RFVSAWTAERVVERLEEIVSAENLTVA 61
Query: 360 TSES-RVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPAL 418
E+ ++++G +KG A+ +I +T L+++EV+K ++ LRP
Sbjct: 62 KKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFF 117
Query: 419 KDIVW 423
++V
Sbjct: 118 VELVH 122
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 72/310 (23%), Positives = 124/310 (40%), Gaps = 61/310 (19%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV--GKDKVIKVGMMEQIKREISVMKMVK 77
+YE +G G + VY AR+ +G +A+K V G+ RE+++++ ++
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 78 ---HKHIVELHEVMASKS-----KIYFAM-----DLVKGGELFNKIAKGRLREDVARVYF 124
H ++V L +V A+ K+ DL +K L + +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT---YLDKAPPPGLPAETIKDLM 126
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGT 183
+Q + +DF H+ + HRDLKPEN+L+ G +K+ DFGL+ +S + T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL---------T 177
Query: 184 PA-----YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--- 235
P Y APEV+ + Y D+WS G I + F ++ KI+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 236 --------GDFKCP----------------PWFSSEARRLITKLLDPNPNSRIAISKIME 271
D P P +L+ ++L NP+ RI+ + ++
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
Query: 272 SSWFKKSAPK 281
S+ K
Sbjct: 297 HSYLHKDEGN 306
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-46
Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 53/298 (17%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKM 75
KYE ++G G++ V RN TG+ +A+K K ++ + +K REI ++K
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 76 VKHKHIVELHEVMASKSKIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
++H+++V L EV K + Y ++ ++ L V + Y Q+I+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILD----DLELFPNGLDYQVVQKYLFQIING 136
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAP 189
+ FCHS + HRD+KPEN+L+ + G +K+ DFG + + + T Y AP
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVA-TRWYRAP 193
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--G----------- 236
E++ G D+W+ G ++ + G F D+ + I G
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253
Query: 237 ---DFKC---PPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
F P S L K L +P+ R ++++ +F+
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 66/249 (26%), Positives = 132/249 (53%), Gaps = 13/249 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+ +G G+ V LAR +G+ +A+K++ K + E + E+ +M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHF 102
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
++VE+++ +++ M+ ++GG L + +++ RL E+ + ++ A+ + H++GV
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
HRD+K +++LL DG +K++DFG A + K+ + GTP ++APEVIS+ Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK----SLVGTPYWMAPEVISRSLY 218
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 254
+ DIWS G+++ ++ G P+ D+ V +++ K S R + +
Sbjct: 219 A-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER 277
Query: 255 LLDPNPNSR 263
+L +P R
Sbjct: 278 MLVRDPQER 286
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 18/277 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+E+ LG G F KVY A+N +TG A KV+ ++ E EI ++ H
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHP 76
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSR 137
+IV+L K++ ++ GG + L E +V +Q++ A++F HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVI---- 192
+ HRDLK N+L+ +G++++ DFG+SA + + GTP ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 193 -SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEA 248
YD KADIWS G+ L + P + N + + KI + D P +S E
Sbjct: 194 MKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF 252
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVIT 285
R + LD NP +R + ++++E + +
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-44
Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 18/275 (6%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHK 79
E +G GT +V+ R +TG +A+K + + ++I ++ V +K
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 80 HIVELHEVMASKSKIYFAMDLVKGG-ELFNKIAKGRLREDVARVYFQQLISAVDFCHS-R 137
+IV+ + + ++ AM+L+ E K +G + E + ++ A+ +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----- 192
GV HRD+KP N+LLDE G +K+ DFG+S L D + G AY+APE I
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD---FKCPPWFSSEA 248
+K YD +AD+WS G+ L L G P+++ + K+ + + FS +
Sbjct: 202 TKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF 260
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 283
+ + L + R +K++E S+ K+ V
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 20/253 (7%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ +G G+F V+ A + G +A+K++ ++ + + RE+++MK ++H +
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC------ 134
IV + + + + G L+ + K RE + ++L A D
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD--ERRRLSMAYDVAKGMNYL 153
Query: 135 HSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
H+R + HR+LK NLL+D+ +KV DFGLS + GTP ++APEV+
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVL 211
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARR 250
+ + K+D++S GVIL+ L P+ + N + + + P + +
Sbjct: 212 RDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270
Query: 251 LITKLLDPNPNSR 263
+I P R
Sbjct: 271 IIEGCWTNEPWKR 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 13/249 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY +G G VY A ++ TG+ +A++ + + K E I EI VM+ K+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+IV + +++ M+ + GG L + + + + E ++ + A++F HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
HRD+K +N+LL DG++K+TDFG A E K+ T GTP ++APEV+++K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR----STMVGTPYWMAPEVVTRKAY 193
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLITK 254
K DIWS G++ ++ G P+ ++N + I + P S+ R + +
Sbjct: 194 GP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 255 LLDPNPNSR 263
L+ + R
Sbjct: 253 CLEMDVEKR 261
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 38/267 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
E+ ++G G F V A+ K +A+K + + + E+ + V H +I
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNI 63
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC------H 135
V+L A + + M+ +GG L+N + + + H
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYT--AAHAMSWCLQCSQGVAYLH 119
Query: 136 SR---GVYHRDLKPENLLLDEDGN-LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
S + HRDLKP NLLL G LK+ DFG + + G+ A++APEV
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEV 174
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYRKIYRG-----DFKCPPWF 244
Y K D++S G+IL+ ++ PF + + ++ G P
Sbjct: 175 FEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 245 SSEARRLITKLLDPNPNSRIAISKIME 271
L+T+ +P+ R ++ +I++
Sbjct: 234 ----ESLMTRCWSKDPSQRPSMEEIVK 256
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-43
Identities = 73/290 (25%), Positives = 136/290 (46%), Gaps = 26/290 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
YEL ++G G A V A + +A+K + +K M+++ +EI M H +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPN 74
Query: 81 IVELHEVMASKSKIYFAM---------DLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131
IV + K +++ M D++K + G L E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF---SEHLKQDGLLHTTCGTPAYVA 188
++ H G HRD+K N+LL EDG++++ DFG+SAF + ++ + T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 189 PEVISK-KGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYR---------KIYRGD 237
PEV+ + +GYD KADIWS G+ L G P+ + + + D
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 238 FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ 287
+ + R++I+ L +P R ++++ +F+K+ K + ++
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 64/257 (24%), Positives = 115/257 (44%), Gaps = 12/257 (4%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
+++ +Y++ LG G + VYLA + +A+K + K +++ +RE+
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIA-KGRLREDVARVYFQQLISAVDF 133
+ H++IV + +V Y M+ ++G L I G L D A + Q++ +
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAYVAPEV 191
H + HRD+KP+N+L+D + LK+ DFG+ + L Q GT Y +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN---HVLGTVQYFSPEQ 183
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP-----WFSS 246
+ D DI+S G++LY +L G PF + VS+ K +
Sbjct: 184 AKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 247 EARRLITKLLDPNPNSR 263
+I + + + +R
Sbjct: 243 SLSNVILRATEKDKANR 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 12/269 (4%)
Query: 2 ATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG 61
S+ +G + R G Y L R++G G VY A + + +A+K++ +
Sbjct: 17 RGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPV 76
Query: 62 MMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVA 120
+++RE ++ H+V +H+ ++Y M L+ G +L + + G L A
Sbjct: 77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA 136
Query: 121 RVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLH 178
+Q+ SA+D H+ G HRD+KPEN+L+ D + DFG+ + E L Q G
Sbjct: 137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG--- 193
Query: 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238
T GT Y+APE S+ +ADI++ +LY L G P+Q D + M I
Sbjct: 194 NTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAI 251
Query: 239 KCP----PWFSSEARRLITKLLDPNPNSR 263
P P +I + + NP R
Sbjct: 252 PRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 76/314 (24%), Positives = 123/314 (39%), Gaps = 72/314 (22%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--------REIS 71
KYE +G GTF +V+ AR+ +TG+ +A+K KV+ ME K REI
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVL----MENEKEGFPITALREIK 68
Query: 72 VMKMVKHKHIVELHEVMASKS--------KIYFAM-----DLVKGGELFNKIAKGRLRED 118
+++++KH+++V L E+ +K+ IY DL L + + +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNV-LVKFTLS 124
Query: 119 VARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLL 177
+ Q L++ + + H + HRD+K N+L+ DG LK+ DFGL+ AFS
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 178 HTTC-GTPAYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 234
+T T Y PE++ + Y G D+W G I+ + Q + I
Sbjct: 185 YTNRVVTLWYRPPELLLGERD-Y-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 235 R-------------------GDFKCPPW-------------FSSEARRLITKLLDPNPNS 262
+ + A LI KLL +P
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 263 RIAISKIMESSWFK 276
RI + +F
Sbjct: 303 RIDSDDALNHDFFW 316
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 77/312 (24%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIK--------REI 70
+YE +G G + KV+ AR+L+ G+ +A+K +V ++ + RE+
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALK-----RVR----VQTGEEGMPLSTIREV 62
Query: 71 SVMKMVK---HKHIVELHEV-----MASKSKIYFAM-----DLVKGGELFNKIAKGRLRE 117
+V++ ++ H ++V L +V ++K+ DL +K+ + +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPT 119
Query: 118 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGL 176
+ + QL+ +DF HS V HRDLKP+N+L+ G +K+ DFGL+ +S +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--- 176
Query: 177 LHTTCGTPA-----YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 231
T Y APEV+ + Y D+WS G I + F+ + V
Sbjct: 177 ------TSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 229
Query: 232 KIYR-----------GDFKCP----------------PWFSSEARRLITKLLDPNPNSRI 264
KI D P + L+ K L NP RI
Sbjct: 230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 289
Query: 265 AISKIMESSWFK 276
+ + +F+
Sbjct: 290 SAYSALSHPYFQ 301
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 53/252 (21%), Positives = 111/252 (44%), Gaps = 15/252 (5%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
+G+ +G G+F VY + +A+K++ ++ K E+ V++ +H +I
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
+ + ++ +G L++ ++ + +Q +D+ H++ +
Sbjct: 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD- 198
HRDLK N+ L ED +K+ DFGL+ G+ ++APEVI + +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 199 -GAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFK-----CPPWFSSEARRL 251
++D+++ G++LY L+ G LP+ + +N + + RG +RL
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 252 ITKLLDPNPNSR 263
+ + L + R
Sbjct: 262 MAECLKKKRDER 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 59/274 (21%), Positives = 117/274 (42%), Gaps = 23/274 (8%)
Query: 27 LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELH 85
+G G + V + +G+ MA+K + + +Q+ ++ V M+ +IV+ +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 86 EVMASKSKIYFAMDLVKGG-----ELFNKIAKGRLREDVARVYFQQLISAVDFCHS-RGV 139
+ + + M+L+ + + + E++ + A++ +
Sbjct: 88 GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----SKK 195
HRD+KP N+LLD GN+K+ DFG+S L G Y+APE I S++
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD-----FKCPPWFSSEAR 249
GYD ++D+WS G+ LY L G P+ +++ ++ +GD FS
Sbjct: 205 GYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFI 263
Query: 250 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 283
+ L + + R ++++ + + V
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-43
Identities = 68/289 (23%), Positives = 135/289 (46%), Gaps = 17/289 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+++ LG G++ VY A + +TG+ +A+K V + + ++I +EIS+M+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFN--KIAKGRLREDVARVYFQQLISAVDFCHSR 137
H+V+ + + ++ M+ G + + ++ L ED Q + +++ H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSA--FSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
HRD+K N+LL+ +G+ K+ DFG++ K+ +T GTP ++APEVI +
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR----NTVIGTPFWMAPEVIQEI 200
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLI 252
GY+ ADIWS G+ + G P+ D + + I F+ P +S +
Sbjct: 201 GYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259
Query: 253 TKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPE 301
+ L +P R +++++ + + + ++ E K +Q
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQES 308
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-43
Identities = 61/261 (23%), Positives = 102/261 (39%), Gaps = 36/261 (13%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-------GMMEQIK 67
++ G+YE+ + HG +YLA + V G+ V+K
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAM 127
Query: 68 REISVMKMVKHKHIVELHEV-----MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV 122
E + V H IV++ Y M+ V G L + +L A
Sbjct: 128 AERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIA 186
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
Y +++ A+ + HS G+ + DLKPEN++L E+ LK+ D G + + G L G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS---RINSFGYL---YG 239
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 242
TP + APE++ + DI++ G L L + + K
Sbjct: 240 TPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD--PVLKTYD 295
Query: 243 WFSSEARRLITKLLDPNPNSR 263
+ RL+ + +DP+P R
Sbjct: 296 SY----GRLLRRAIDPDPRQR 312
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-42
Identities = 55/270 (20%), Positives = 118/270 (43%), Gaps = 28/270 (10%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
E+G ++G G F +VY R +A++++ ++ + ++ KRE+ + +H+++
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENV 91
Query: 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYF--QQLISAVDFCHSRGV 139
V S + L KG L++ + ++ DV + Q+++ + + H++G+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLS---AFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
H+DLK +N+ D +G + +TDFGL + +++ L G ++APE+I +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 197 YDGA--------KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------DFKCPP 242
D +D+++ G I Y L A PF+ ++ ++ G
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 243 WFSSEARRLITKLLDPNPNSRIAISKIMES 272
++ R +K+M+
Sbjct: 271 EI----SDILLFCWAFEQEERPTFTKLMDM 296
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-42
Identities = 62/246 (25%), Positives = 108/246 (43%), Gaps = 11/246 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E LG G V+ + +G MA K++ + IK + QI RE+ V+ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
IV + S +I M+ + GG L +++ K GR+ E + +I + + +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 139 -VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
+ HRD+KP N+L++ G +K+ DFG+S L D + ++ GT +Y++PE + Y
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVGTRSYMSPERLQGTHY 207
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257
++DIWS G+ L + G P + + R L
Sbjct: 208 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 258 PNPNSR 263
+SR
Sbjct: 267 FGMDSR 272
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-42
Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 17/269 (6%)
Query: 8 GGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK 67
G P+ L +YELG +LG G ++V+LAR+L+ + +A+KV+ D + +
Sbjct: 1 GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 68 REISVMKMVKHKHIVELHEV----MASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARV 122
RE + H IV +++ + Y M+ V G L + + G + A
Sbjct: 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL----SAFSEHLKQDGLLH 178
A++F H G+ HRD+KP N+++ +KV DFG+ + + Q
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA--- 177
Query: 179 TTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238
GT Y++PE + A++D++S G +LY +L G PF D+ VS+ + R D
Sbjct: 178 AVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 239 KCP----PWFSSEARRLITKLLDPNPNSR 263
P S++ ++ K L NP +R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-42
Identities = 64/270 (23%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG--MMEQIKREISVMKMVKHK 79
G +LG G F + + +TG+ M MK ++I+ +E+ VM+ ++H
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMK-----ELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC---- 134
++++ V+ ++ F + +KGG L ++ ++ + Q +S A D
Sbjct: 68 NVLKFIGVLYKDKRLNFITEYIKGGTLRG-----IIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 135 --HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------------LKQDGLLHTT 180
HS + HRDL N L+ E+ N+ V DFGL+ +T
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM-----YRKIYR 235
G P ++APE+I+ + YD K D++S G++L ++ D +M R
Sbjct: 183 VGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 236 GDF--KCPPWFSSEARRLITKLLDPNPNSR 263
CPP F + + D +P R
Sbjct: 242 RYCPPNCPPSF----FPITVRCCDLDPEKR 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-41
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 21/256 (8%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM-MEQIKREISVMKMVKHKH 80
L ++G G F KVY A + G +A+K D + +E +++E + M+KH +
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVY 140
I+ L V + + M+ +GG L ++ R+ D+ + Q+ +++ H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 141 ---HRDLKPENLLLDEDG--------NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
HRDLK N+L+ + LK+TDFGL+ + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAP 183
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGD-FKCPPWFSSE 247
EVI + +D+WS GV+L+ LL G +PF+ D + Y P
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 248 ARRLITKLLDPNPNSR 263
+L+ +P+P+SR
Sbjct: 243 FAKLMEDCWNPDPHSR 258
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 63/279 (22%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHK 79
E LG G + V R++ +G+ MA+K + + +++ ++ + M+ V
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 80 HIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAK--GRLREDVARVYFQQLISAVDFCH 135
V + + + ++ M+L+ + + ++ + ED+ ++ A++ H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 136 S-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-- 192
S V HRD+KP N+L++ G +K+ DFG+S +L D G Y+APE I
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINP 183
Query: 193 --SKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFKCPP-----WF 244
++KGY K+DIWS G+ + L P+ +++ P F
Sbjct: 184 ELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPADKF 239
Query: 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVV 283
S+E ++ L N R ++M+ +F K
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 51/281 (18%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVV----GKDKVIKVGMMEQIKREISVMKMVK 77
E + +G G F V+ R ++ +A+K + + + + ++ +RE+ +M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG--------RLR--EDVARVYFQQL 127
H +IV+L + M+ V G+L++++ +LR D+A
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL------ 133
Query: 128 ISAVDFCHSRG--VYHRDLKPENLLLDEDG-----NLKVTDFGLSAFSEHLKQDGLLHTT 180
+++ ++ + HRDL+ N+ L KV DFGLS S H +
Sbjct: 134 --GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGL 186
Query: 181 CGTPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY------RK 232
G ++APE I + Y KAD +S +ILY +L G PF + + + +
Sbjct: 187 LGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
Query: 233 IYRGDF--KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
R CPP R +I +P R S I++
Sbjct: 246 GLRPTIPEDCPPRL----RNVIELCWSGDPKKRPHFSYIVK 282
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 24/293 (8%)
Query: 19 GKYELGRMLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
G YEL ++G G V LAR TG+ + ++ + + M+ ++ E+ V K+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGG---ELFNKIAKGRLREDVARVYFQQLISAVDF 133
H +IV + ++++ + G +L + E Q ++ A+D+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTC----GTPAYVA 188
H G HR +K ++L+ DG + ++ + H ++ ++H +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 189 PEVI--SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS 246
PEV+ + +GYD AK+DI+S G+ L G +PF+D M + G P
Sbjct: 204 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT---VP---- 255
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQ 299
L+ P ++ S+ + +S S + + +
Sbjct: 256 ---CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-41
Identities = 67/298 (22%), Positives = 124/298 (41%), Gaps = 22/298 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+ R +GHG+F VY AR+++ + +A+K + + I +E+ ++ ++H
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRG 138
+ ++ + + M+ G ++ K L+E + + + HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS---KK 195
+ HRD+K N+LL E G +K+ DFG ++ ++ GTP ++APEVI +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILAMDEG 228
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRLI 252
YDG K D+WS G+ L P + N +S I + + + W S R +
Sbjct: 229 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFV 286
Query: 253 TKLLDPNPNSRIAISKIMESSWFKKSAPKVVIT-------KQEMEFEADKSSKQPETL 303
L P R +++ + + P VI E + + K + L
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKIL 344
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 50/262 (19%), Positives = 97/262 (37%), Gaps = 39/262 (14%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
L +++ R G + +KV+ K + E +++ H +
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 81 IVELHEVMASKSKIYFA--MDLVKGGELFNKIAKGRLRE-----------DVARVYFQQL 127
++ + S + + G L+N + +G D+AR
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR------ 122
Query: 128 ISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
+ F H+ + L ++++DED +++ + FS PA
Sbjct: 123 --GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-FSFQSP------GRMYAPA 173
Query: 186 YVAPEVISKKGYDGA--KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--KCP 241
+VAPE + KK D AD+WS V+L+ L+ +PF D + + + K+ P
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233
Query: 242 PWFSSEARRLITKLLDPNPNSR 263
P S +L+ ++ +P R
Sbjct: 234 PGISPHVSKLMKICMNEDPAKR 255
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 32/293 (10%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVK 77
G +EL ++G+GT+ +VY R+++TG+ A+KV+ + E+IK+EI+++K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 78 HKHIVELHE------VMASKSKIYFAMDLVKGG---ELFNKIAKGRLREDVARVYFQQLI 128
H++I + +++ M+ G +L L+E+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC-GTPAYV 187
+ H V HRD+K +N+LL E+ +K+ DFG+SA L + T GTP ++
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWM 196
Query: 188 APEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP 242
APEVI+ YD K+D+WS G+ + G P D + + I R P
Sbjct: 197 APEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---AP 252
Query: 243 -----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEME 290
+S + + I L N + R A ++M+ + + + + Q +
Sbjct: 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKD 305
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-40
Identities = 84/322 (26%), Positives = 136/322 (42%), Gaps = 74/322 (22%)
Query: 6 SNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ 65
+ G G DRP + Y +++G+G+F VY A+ +G+ +A+K V +DK K
Sbjct: 43 TPGQGPDRPQEV--SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----- 95
Query: 66 IKREISVMKMVKHKHIVELHEVMASKS------KIYFAM-----DLVKGGELFNKIAKGR 114
RE+ +M+ + H +IV L S + + + + +++ AK
Sbjct: 96 --RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQT 152
Query: 115 LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLS-AFSEHLK 172
L ++Y QL ++ + HS G+ HRD+KP+NLLLD D LK+ DFG +
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 209
Query: 173 QDGLLHTTCGTP--AYV------APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQD 223
G P +Y+ APE+I Y + D+WS G +L LL G F
Sbjct: 210 ---------GEPNVSYICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPG 259
Query: 224 DNIVSMYRKIYR-----------------GDFKCPPW------------FSSEARRLITK 254
D+ V +I + +FK P EA L ++
Sbjct: 260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 319
Query: 255 LLDPNPNSRIAISKIMESSWFK 276
LL+ P +R+ + S+F
Sbjct: 320 LLEYTPTARLTPLEACAHSFFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-39
Identities = 70/300 (23%), Positives = 132/300 (44%), Gaps = 57/300 (19%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
Y +++G+G+F V+ A+ +++ + +A+K V +DK RE+ +M++VKH
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHP 92
Query: 80 HIVELHEVMASKS------KIYFAM-----DLVKGGELFNKIAKGRLREDVARVYFQQLI 128
++V+L S + + + + + K K + + ++Y QL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLL 151
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAY 186
++ + HS G+ HRD+KP+NLLLD G LK+ DFG + + + C + Y
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---AGEPNVSYIC-SRYY 207
Query: 187 VAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR---------- 235
APE+I Y DIWS G ++ L+ G F ++ + +I +
Sbjct: 208 RAPELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 236 -------GDFKCPPW------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
+ K P +A LI++LL+ P++R+ + + +F
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 38/258 (14%), Positives = 79/258 (30%), Gaps = 38/258 (14%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
+ +G+Y L G + + A + + +A+ V V+ ++++ +
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+ + + +V+ +++ + ++GG L R Q L +A D
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRA-MQSLAAAADAA 145
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
H GV P + + DG++ + PA +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA---- 179
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-------PWFSSE 247
+ DI G LY LL P + + S R P +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 248 ARRLITKLLDPNPNSRIA 265
+ + + + R A
Sbjct: 236 ISAVAARSVQGDGGIRSA 253
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 71/327 (21%), Positives = 122/327 (37%), Gaps = 79/327 (24%)
Query: 20 KYE-LGRMLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+E G +G GT+ VY A+ + K A+K + G+ REI++++ +
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLREL 75
Query: 77 KHKHIVELHEVMASKS--KIYFAM-----DLVK----GGELFNKIAKGRLREDVARVYFQ 125
KH +++ L +V S + K++ DL +L + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGN----LKVTDFGLS-AFSEHLKQDGLLHTT 180
Q++ + + H+ V HRDLKP N+L+ +G +K+ D G + F+ LK L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP--LADLD 193
Query: 181 CG--TPAYVAPEVI--SKKGYDGAKADIWSCGVILYVLLAG-------------FLPFQD 223
T Y APE++ ++ Y A DIW+ G I LL P+
Sbjct: 194 PVVVTFWYRAPELLLGARH-YTKA-IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 224 D------------------------NIVSMYRKIYRGDFKCP----------PWFSSEAR 249
D ++ + R + S+A
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 250 RLITKLLDPNPNSRIAISKIMESSWFK 276
L+ KLL +P RI + M+ +F
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 53/208 (25%), Positives = 110/208 (52%), Gaps = 19/208 (9%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H 78
Y+L R LG G +++V+ A N+ + + +K+ +K ++IKREI +++ ++
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 90
Query: 79 KHIVELHEVM---ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 135
+I+ L +++ S++ + F ++ + L + R Y +++ A+D+CH
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVN--NTDFKQLYQ-TLTDYDIRFYMYEILKALDYCH 147
Query: 136 SRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-S 193
S G+ HRD+KP N+++D E L++ D+GL+ F ++ + + + PE++
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVD 204
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPF 221
+ YD + D+WS G +L ++ PF
Sbjct: 205 YQMYDYS-LDMWSLGCMLASMIFRKEPF 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 54/289 (18%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVM 73
+Y +G G + V A + +A+K K+ E + REI ++
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--------KISPFEHQTYCQRTLREIKIL 79
Query: 74 KMVKHKHIVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI 128
+H++I+ +++++ + + +Y DL+ +L+ + L D + Q++
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV 187
+ + HS V HRDLKP NLLL+ +LK+ DFGL+ G L T Y
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 188 APEVI-SKKGYDGAKADIWSCGVILYVLLAG---F-----------------LPFQDD-- 224
APE++ + KGY + DIWS G IL +L+ F P Q+D
Sbjct: 199 APEIMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 225 NIVSMYRKIY--------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 264
I+++ + Y + + P S+A L+ K+L NP+ RI
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 80/328 (24%), Positives = 134/328 (40%), Gaps = 65/328 (19%)
Query: 1 MATSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV 60
M + N+ D+R ++++ RM G GTF V L + TG S+A+K V +D +
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR- 63
Query: 61 GMMEQIKREISVMKM---VKHKHIVELHEVMASKSK-----IYFA-------MDLVKGGE 105
RE+ +M+ + H +IV+L + + IY L +
Sbjct: 64 ------NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCR 117
Query: 106 LFNKIAKGRLREDVARVYFQQLISAVDFCH--SRGVYHRDLKPENLLLD-EDGNLKVTDF 162
+ + + + +V+ QLI ++ H S V HRD+KP N+L++ DG LK+ DF
Sbjct: 118 NYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 163 GLS-AFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLP 220
G + S + + C + Y APE+I + Y A DIWS G I ++ G
Sbjct: 177 GSAKKLS---PSEPNVAYIC-SRYYRAPELIFGNQHYTTA-VDIWSVGCIFAEMMLGEPI 231
Query: 221 FQDDN----------------------IVSMYRKIYRGDFKCPPW----------FSSEA 248
F+ DN + + + + K PW + EA
Sbjct: 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEA 291
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFK 276
L++ LL P R+ + + +F
Sbjct: 292 YDLLSALLQYLPEERMKPYEALCHPYFD 319
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 56/294 (19%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVK 77
+Y + LG G V+ A + K +A+K K++ ++ REI +++ +
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66
Query: 78 HKHIVELHEVMASKSK--------------IYFAMDLVKGGELFNKIAKGRLREDVARVY 123
H +IV++ E++ +Y + + +L N + +G L E+ AR++
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLF 125
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLS-AFSEHLKQDGLLHTTC 181
QL+ + + HS V HRDLKP NL ++ ED LK+ DFGL+ H G L
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 182 GTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAG---F-----------------LP 220
T Y +P ++ S Y A D+W+ G I +L G F +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 221 FQDD--NIVSMYRKIYRGDFKCP--------PWFSSEARRLITKLLDPNPNSRI 264
++D ++S+ R D P P S EA + ++L +P R+
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 75/340 (22%), Positives = 129/340 (37%), Gaps = 70/340 (20%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME------QIKREISVM 73
++L +LG G + V A + TG+ +A+K K+ + + REI ++
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--------KIEPFDKPLFALRTLREIKIL 63
Query: 74 KMVKHKHIVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLI 128
K KH++I+ + + S +Y +L+ +L I+ L +D + + Q +
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPAY 186
AV H V HRDLKP NLL++ + +LKV DFGL G +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 187 V------APEVI-SKKGYDGAKADIWSCGVILYVLLAG--FLPFQD-------------- 223
V APEV+ + Y A D+WSCG IL L P +D
Sbjct: 183 VATRWYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 224 -------DNIVSMYRKIY---RGDFKCPPWF------SSEARRLITKLLDPNPNSRIAIS 267
I S + Y + P + + L+ ++L +P RI
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 268 KIMESSWFKK--------SAPKVVITKQEMEFEADKSSKQ 299
+ +E + + + + E + + + +
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTK 341
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 72/292 (24%), Positives = 122/292 (41%), Gaps = 65/292 (22%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVK 77
Y +G G + V A + ++G+ +A+K + + I ++ RE+ ++K ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQ 81
Query: 78 HKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131
H++++ L +V S Y M + +L KI + E+ + Q++ +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYV--- 187
+ HS GV HRDLKP NL ++ED LK+ DFGL+ + YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG------------YVVTR 187
Query: 188 ---APEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--------- 234
APEVI S Y+ DIWS G I+ +L G F+ + + +I
Sbjct: 188 WYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 235 ---------------------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 264
R DF P S +A L+ K+L+ + + R+
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 81/388 (20%), Positives = 140/388 (36%), Gaps = 99/388 (25%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY LG+ LG G+F V ++++GK A+K V +D K RE+ +MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHV 60
Query: 80 HIVELHEVMASKSK--------------------------------------IYFAMDLV 101
+I++L + + + M+ V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 102 KGGELFNKI-----AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDG 155
L + + + ++ +Y QL AV F HS G+ HRD+KP+NLL++ +D
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI-SKKGYDGAKADIWSCGVILYVL 214
LK+ DFG + + + C + Y APE++ Y + D+WS G + L
Sbjct: 180 TLKLCDFGSAKKLI--PSEPSVAYIC-SRFYRAPELMLGATEYTPS-IDLWSIGCVFGEL 235
Query: 215 LAGFLPFQ-------------------DDNIVSM---YRKIYRGDFKCPPWFS------- 245
+ G F + ++ M Y ++ K W
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNA 305
S A L+ ++L P+ RI + M +F + + K
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFD-----------HLRNSYESEVKNNSNFPH 344
Query: 306 FHIISLSEGFDLSPLFEEKKRAEREELR 333
++ + F+ SP E L
Sbjct: 345 GVNQNIPQLFNFSP--YELSIIPGNVLN 370
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 43/228 (18%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVMKM 75
+YE+ ++G G++ V A + + +A+K K+++V ++I REI+++
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNR 108
Query: 76 VKHKHIVELHEVMASKS-----KIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLIS 129
+ H H+V++ +++ K ++Y +++ + L E + L+
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA--- 185
V + HS G+ HRDLKP N L+++D ++KV DFGL+ + L +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 186 ---------------YV------APEVI-SKKGYDGAKADIWSCGVIL 211
+V APE+I ++ Y A D+WS G I
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIGCIF 274
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 68/297 (22%), Positives = 120/297 (40%), Gaps = 63/297 (21%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKM 75
+Y+ + +G G V A + +++A+K K+ + + RE+ +MK
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 76 VKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
V HK+I+ L V + +Y M+L+ L ++ + L + Q++
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLC 138
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ HS G+ HRDLKP N+++ D LK+ DFGL + ++ T Y AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAP 195
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---------------- 233
EVI GY DIWS G I+ ++ G + F + + + K+
Sbjct: 196 EVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 234 --------------------------YRGDFKCPPWFSSEARRLITKLLDPNPNSRI 264
+ D + +S+AR L++K+L + + RI
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 50/285 (17%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVK 77
+Y+ +G G + V A + +TG +A+K + + +I ++ RE+ ++K +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMK 86
Query: 78 HKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131
H++++ L +V +Y L+ G +L N + +L +D + Q++ +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
+ HS + HRDLKP NL ++ED LK+ DFGL+ + T Y APE+
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEI 200
Query: 192 I-SKKGYDGAKADIWSCGVILYVLLAG--FLPFQD--------------------DNIVS 228
+ + Y+ DIWS G I+ LL G P D I S
Sbjct: 201 MLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 229 MYRKIY--------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 264
+ Y + +F + A L+ K+L + + RI
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 68/337 (20%), Positives = 130/337 (38%), Gaps = 68/337 (20%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKM 75
+Y+ + +G G V A + +++A+K K+ + + RE+ +MK
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 76 VKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
V HK+I+ L V + +Y M+L+ L ++ + L + Q++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLC 175
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ HS G+ HRDLKP N+++ D LK+ DFGL + ++ T Y AP
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYYRAP 232
Query: 190 EVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---------------- 233
EVI GY DIWS G I+ ++ + F + + + K+
Sbjct: 233 EVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 234 --------------------------YRGDFKCPPWFSSEARRLITKLLDPNPNSRIAIS 267
+ D + +S+AR L++K+L +P RI++
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 268 KIMESSWFKK-----SAPKVVITKQEMEFEADKSSKQ 299
++ + + + + + + +
Sbjct: 352 DALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 388
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 50/285 (17%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVK 77
Y + +G G + V A + +TG +A+K + + + ++ RE+ ++K ++
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMR 82
Query: 78 HKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131
H++++ L +V Y M + G +L + +L ED + Q++ +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 132 DFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
+ H+ G+ HRDLKP NL ++ED LK+ DFGL+ + D + T Y APEV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 196
Query: 192 I-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY---------------- 234
I + Y DIWS G I+ ++ G F+ + + ++I
Sbjct: 197 ILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 235 --------------RGDFKCP-PWFSSEARRLITKLLDPNPNSRI 264
+ DF S A L+ K+L + R+
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 54/292 (18%), Positives = 109/292 (37%), Gaps = 49/292 (16%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI 81
L +G G + +V+ G+++A+K+ + E+ M++H++I
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE----KSWFRETELYNTVMLRHENI 64
Query: 82 VEL----HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 137
+ S ++++ + G L++ + L + S + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 138 --------GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL--HTTCGTPAYV 187
+ HRDLK +N+L+ ++G + D GL+ + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 188 APEVISKKGYDGA-----KADIWSCGVILYVLLAGF----------LPFQDDN-----IV 227
APEV+ + + DIW+ G++L+ + PF D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 228 SMYRKIYRGDFKCPP----WFSSEARRLITKLL----DPNPNSRIAISKIME 271
M + + + P WFS + KL+ NP++R+ +I +
Sbjct: 245 DMRKVVCVDQQR-PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 57/297 (19%), Positives = 108/297 (36%), Gaps = 33/297 (11%)
Query: 3 TSNSNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM 62
S+ G + +L + G F V+ A+ + +A+K+
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQD----KQ 61
Query: 63 MEQIKREISVMKMVKHKHIVEL----HEVMASKSKIYFAMDLVKGGELF-----NKIA-K 112
Q + E+ + +KH++I++ + ++ + G L N ++
Sbjct: 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWN 121
Query: 113 GRLR--EDVAR--VYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168
E +AR Y + I + H + HRD+K +N+LL + + DFGL+
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA----KADIWSCGVILYVLLAGFLPFQDD 224
E K G H GT Y+APEV+ + D+++ G++L+ L + D
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA--D 239
Query: 225 NIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRI-------AISKIMESSW 274
V Y + + P ++ K P + + +E W
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 58/247 (23%), Positives = 110/247 (44%), Gaps = 26/247 (10%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ +YE+ +++G G+F +V A + + + +A+K+V +K Q EI +++ +
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHL 150
Query: 77 KHK------HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQL 127
+ + +++ + E ++ I +L+ L+ I K + + + R + +
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 128 ISAVDFCHSRGVYHRDLKPENLLLDEDG--NLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
+ +D H + H DLKPEN+LL + G +KV DFG S + ++T +
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRF 264
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPW 243
Y APEVI Y D+WS G IL LL G+ ++ + G
Sbjct: 265 YRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP--SQK 321
Query: 244 FSSEARR 250
++R
Sbjct: 322 LLDASKR 328
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 50/240 (20%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
+Y L R LG G F+ V+LA+++ +AMK+V DKV E + EI +++
Sbjct: 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQ 70
Query: 75 MVK-----------HKHIVELHEVMASKSKIYFAMDLVKGG--------------ELFNK 109
V HI++L + +F G L K
Sbjct: 71 RVNDADNTKEDSMGANHILKLLD--------HFNHKGPNGVHVVMVFEVLGENLLALIKK 122
Query: 110 IAKGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDE------DGNLKVTDF 162
+ + +QL+ +D+ H R G+ H D+KPEN+L++ +K+ D
Sbjct: 123 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222
G + + + + T Y +PEV+ + ADIWS +++ L+ G F+
Sbjct: 183 GNACWYDEH-----YTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFE 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 57/293 (19%), Positives = 103/293 (35%), Gaps = 54/293 (18%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--------QIKREIS 71
Y + R + G++ V + G +A+K V + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 72 VMKMVKHKHIVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKGR--LREDVARVYF 124
++ H +I+ L ++ + +Y +L+ +L I R + + +
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
++ + H GV HRDL P N+LL ++ ++ + DF L + D
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL---AREDTADANKTHYVTHR 197
Query: 185 AYVAPEVI-SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---------- 233
Y APE++ KG+ D+WS G ++ + F+ + KI
Sbjct: 198 WYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 234 ----------------YRGDFKCPPWF------SSEARRLITKLLDPNPNSRI 264
+ W A LI K+L+ NP RI
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVI--KVGMMEQIKREISVMKM 75
Y + ++G G++ VYLA + T K++A+K V + + +I K +I REI+++
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-----RILREITILNR 81
Query: 76 VKHKHIVELHEVMASKSK-----IYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLIS 129
+K +I+ L++++ +Y +++ +L L E+ + L+
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL--SAFSEHLKQDGLLHTTCGTPA-- 185
+F H G+ HRDLKP N LL++D ++KV DFGL + SE P
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 186 ----------YV------APEVI-SKKGYDGAKADIWSCGVILYVLLAG 217
+V APE+I ++ Y + DIWS G I LL
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWSTGCIFAELLNM 248
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 54/327 (16%), Positives = 112/327 (34%), Gaps = 49/327 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HK 79
+L ++G G + VY L + +A+KV + E ++ ++ H
Sbjct: 16 KLLELIGRGRYGAVYKGS-LD-ERPVAVKV------FSFANRQNFINEKNIYRVPLMEHD 67
Query: 80 HIVEL-----HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+I + + M+ G L ++ + + + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 135 HS---------RGVYHRDLKPENLLLDEDGNLKVTDFGLS------AFSEHLKQDGLLHT 179
H+ + HRDL N+L+ DG ++DFGLS ++D +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 180 TCGTPAYVAPEVI------SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI 233
GT Y+APEV+ + D+++ G+I + + V Y+
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 234 YRGDFKCPPWF-------SSEARRL-ITKLLDPNPNSRIAISKIMESSWFKK-----SAP 280
++ + P F S E +R + N + ++ + +E W + +A
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 281 KVVITKQEMEFEADKSSKQPETLNAFH 307
E+ +++ T + H
Sbjct: 308 XAEERMAELMMIWERNKSVSPTAHHHH 334
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 74/332 (22%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVI--KVGMMEQIKREISVMK- 74
KYEL + LG G + V+ + + +TG+ +A+K + + + REI ++
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-----RTFREIMILTE 64
Query: 75 MVKHKHIVELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVD 132
+ H++IV L V+ + + +Y D + +L I L + QLI +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 133 FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPA------ 185
+ HS G+ HRD+KP N+LL+ + ++KV DFGLS +F + + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 186 ------YV------APEVI-SKKGYDGAKADIWSCGVILYVLLAG---F----------- 218
YV APE++ Y D+WS G IL +L G F
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKG-IDMWSLGCILGEILCGKPIFPGSSTMNQLER 242
Query: 219 ---------------------------------LPFQDDNIVSMYRKIYRGDFKCPPWFS 245
+ + + K +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302
Query: 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
EA L+ KLL NPN RI+ + ++ +
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 60/315 (19%), Positives = 126/315 (40%), Gaps = 53/315 (16%)
Query: 4 SNSNGGGDDRPTLLH----GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK 59
++G G P L+ L +G G F +V+ + G+ +A+K+ +
Sbjct: 23 MTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-- 78
Query: 60 VGMMEQIKREISVMKMVKHKHIVEL----HEVMASKSKIYFAMDLVKGGELFNKIAKGRL 115
+ EI M++H++I+ ++ + ++++ D + G LF+ + + +
Sbjct: 79 --RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV 136
Query: 116 REDVARVYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167
+ S + H + HRDLK +N+L+ ++G + D GL+
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 168 SEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGA-----KADIWSCGVILYVLLAGF-- 218
+ D + GT Y+APEV+ +ADI++ G++ + +
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
Query: 219 --------LPFQ-----DDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLL----D 257
LP+ D ++ M + + + P W S EA R++ K++
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWY 315
Query: 258 PNPNSRIAISKIMES 272
N +R+ +I ++
Sbjct: 316 ANGAARLTALRIKKT 330
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 61/318 (19%), Positives = 125/318 (39%), Gaps = 59/318 (18%)
Query: 4 SNSNGGGDDRPTLLH----GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK 59
S S+G G P L+ + ++ + +G G + +V++ + + G+ +A+KV +
Sbjct: 18 SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK-WR-GEKVAVKVFFTTEE-- 73
Query: 60 VGMMEQIKREISVMKMVKHKHIVEL----HEVMASKSKIYFAMDLVKGGELFNKIAKGRL 115
+ EI +++H++I+ + S +++Y D + G L++ + L
Sbjct: 74 --ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL 131
Query: 116 REDVARVYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167
+S + H+ + HRDLK +N+L+ ++G + D GL+
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
Query: 168 SEHLKQ--DGLLHTTCGTPAYVAPEVISKKGYDGA-----KADIWSCGVILYVLLAGF-- 218
D +T GT Y+ PEV+ + AD++S G+IL+ +
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
Query: 219 --------LPFQ-----DDNIVSMYRKIYR-----------GDFKCPPWFSSEARRLITK 254
LP+ D + M + +C +L+T+
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTE 307
Query: 255 LLDPNPNSRIAISKIMES 272
NP SR+ ++ ++
Sbjct: 308 CWAHNPASRLTALRVKKT 325
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 28/250 (11%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM 75
+YE+ ++G G+F +V A + + +A+K++ K + Q + E+ ++++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLEL 106
Query: 76 VKH------KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQ 126
+ +IV L ++ + +++ L++ + R ++ R + QQ
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 127 LISAVDFCHSR--GVYHRDLKPENLLLDEDGN--LKVTDFGLSAFSEHLKQDGLLHTTCG 182
+ +A+ F + + H DLKPEN+LL +K+ DFG S+ + ++
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQ 220
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKC 240
+ Y +PEV+ YD A D+WS G IL + G F N V KI G
Sbjct: 221 SRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP-- 277
Query: 241 PPWFSSEARR 250
P +A +
Sbjct: 278 PAHILDQAPK 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 67/292 (22%), Positives = 116/292 (39%), Gaps = 60/292 (20%)
Query: 4 SNSNGGGDD-------RP-TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVV-GK 54
N GDD + LL+ + + R +G GTF +V L +++ K A+KVV
Sbjct: 12 ENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI 71
Query: 55 DKVIKVGMMEQIKREISVMKMVKH-----KHIVELHEVMASKSKIYFAMDLVKGGELFNK 109
K K E ++K +++ +IV+ H + + + G L+
Sbjct: 72 KK-----YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEI 125
Query: 110 IAKGRLR---EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----------- 155
I + + ++Y +++ A+++ + H DLKPEN+LLD+
Sbjct: 126 ITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185
Query: 156 --------------NLKVTDFGLSAF-SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
+K+ DFG + F S++ + T Y APEVI G+D +
Sbjct: 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVS 239
Query: 201 KADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI--YRGDFKCPPWFSSEARR 250
+D+WS G +L L G L F+ + + P EA +
Sbjct: 240 -SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPI--PKNMLYEATK 288
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 78/346 (22%), Positives = 123/346 (35%), Gaps = 98/346 (28%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSM-AMKVV-GKDKVIKVGMMEQIKREISVM 73
L +YE+ LG GTF KV + GKS A+K++ K E + EI+V+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-----YREAARLEINVL 70
Query: 74 KMVKHK------HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYF 124
K +K K V + + + A +L+ G F + + + R
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-------------------LKVTDFGLS 165
QL A+ F H + H DLKPEN+L ++V DFG S
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S 188
Query: 166 AFSEHLKQDGLLHTTCGTPAYV------APEVISKKGYDGAKADIWSCGVILYVLLAGFL 219
A +H HTT V PEVI + G+ D+WS G IL+ GF
Sbjct: 189 ATFDHEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFT 237
Query: 220 PFQ-DDNI--------------VSMYRKIYRGDF---KCPPWFSSEARR----------- 250
FQ +N M + + + W + +
Sbjct: 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLK 297
Query: 251 ---------------LITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
L+ ++L+ +P RI +++ + +F P+
Sbjct: 298 SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 33/263 (12%)
Query: 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVM 73
H LG +G G F +V+ R +A+K + + +K +E ++
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKS------CRETLPPDLKAKFLQEARIL 166
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVD 132
K H +IV L V K IY M+LV+GG+ LR + AR+ + L+ D
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-----FLRTEGARLRVKTLLQMVGD 221
Query: 133 FC------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
S+ HRDL N L+ E LK++DFG+S + DG+ + G
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQV 277
Query: 187 ----VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKC 240
APE ++ Y +++D+WS G++L+ G P+ + + + +G C
Sbjct: 278 PVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336
Query: 241 PPWFSSEARRLITKLLDPNPNSR 263
P RL+ + P R
Sbjct: 337 PELCPDAVFRLMEQCWAYEPGQR 359
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 72/384 (18%), Positives = 123/384 (32%), Gaps = 146/384 (38%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+G+Y + R LG G F+ V+L+ ++Q K +AMKVV + E EI ++K V
Sbjct: 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSV 90
Query: 77 K--------HKHIVEL-----------------HEVMASKSKIYFAMDLVKGGELFNKIA 111
+ + +V+L EV+ L+K N
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG--------HHLLKWIIKSNY-- 140
Query: 112 KGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLL------------------- 151
L + QQ++ +D+ H++ + H D+KPEN+LL
Sbjct: 141 -QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 152 ------------------------------DEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181
E +K+ D G + + T
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTED 253
Query: 182 GTP-AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ---------DDNIVSM-- 229
Y + EV+ GY+ ADIWS + + L G F+ D++ +++
Sbjct: 254 IQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 230 ---------------YRKIY---RGDFK----CPPWFSSEAR---------------RLI 252
Y K + +GD K PW E +
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL 372
Query: 253 TKLLDPNPNSRIAISKIMESSWFK 276
+L+ P R ++ + W
Sbjct: 373 LPMLELIPEKRATAAECLRHPWLN 396
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 68/274 (24%), Positives = 103/274 (37%), Gaps = 60/274 (21%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSM-AMKVV-GKDKVIKVGMMEQIKREISVM 73
+L +YE+ LG G F KV + + G A+K+V D+ E + EI V+
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-----YCEAARSEIQVL 65
Query: 74 KMVKHK------HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYF 124
+ + V++ E I +L+ G ++ I + D R
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 125 QQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-------------------LKVTDFGLS 165
Q+ +V+F HS + H DLKPEN+L + +KV DFG +
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA 184
Query: 166 AF-SEHLKQDGLLHTTCGTPAYV------APEVISKKGYDGAKADIWSCGVILYVLLAGF 218
+ EH H+T V APEVI G+ D+WS G IL GF
Sbjct: 185 TYDDEH-------HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGF 231
Query: 219 LPFQDDNIVSMYRKIYR--GDFKCPPWFSSEARR 250
F + + R G P + R+
Sbjct: 232 TVFPTHDSKEHLAMMERILGPL--PKHMIQKTRK 263
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
+ ++LG G F VY + G+ + + V + K ++ + E VM V
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASV 74
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH- 135
+ H+ L + S + L+ G L + +RE + Q L +++C
Sbjct: 75 DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLD-----YVREHKDNIGSQYL---LNWCVQ 125
Query: 136 ---------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P 184
R + HRDL N+L+ ++K+TDFGL+ L + + G P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVP 182
Query: 185 -AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
++A E I + Y ++D+WS GV ++ ++ G P+
Sbjct: 183 IKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDG 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 33/241 (13%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 79
+ LG G + +VY K ++ V K +K ME + +E +VMK +KH
Sbjct: 223 TMKHKLGGGQYGEVYEG----VWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHP 276
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC--- 134
++V+L V + Y + + G L LRE + V L+ A
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNL-----LDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 135 ---HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAP 189
+ HR+L N L+ E+ +KV DFGL S + D AP
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGL---SRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 190 EVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-----FKCPPW 243
E ++ + K+D+W+ GV+L+ + G P+ ++ +Y + + CP
Sbjct: 389 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 447
Query: 244 F 244
Sbjct: 448 V 448
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 61/276 (22%), Positives = 103/276 (37%), Gaps = 42/276 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVK 77
+ + LG G F V + R + V V K ++ E ++ REI ++K ++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV---KKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 78 HKHIVELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 134
H +IV+ V S + + M+ + G L + L++ R+ +L+ C
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL-----RDYLQKHKERIDHIKLLQYTSQIC 124
Query: 135 ------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV- 187
++ HRDL N+L++ + +K+ DFGL ++ L QD P
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL---TKVLPQDKEFFKV-KEPGESP 180
Query: 188 ----APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW 243
APE +++ + +D+WS GV+LY L F +
Sbjct: 181 IFWYAPESLTESKFS-VASDVWSFGVVLYEL------FTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 244 FSSEARRLITKL-----LDPNPNSRIAISKIMESSW 274
LI L L I IM W
Sbjct: 234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECW 269
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 61/276 (22%), Positives = 104/276 (37%), Gaps = 42/276 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVK 77
+ + LG G F V + R + V V K ++ E ++ REI ++K ++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAV---KKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 78 HKHIVELHEV--MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 134
H +IV+ V A + + M+ + G L + L++ R+ +L+ C
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL-----RDYLQKHKERIDHIKLLQYTSQIC 155
Query: 135 ------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV- 187
++ HRDL N+L++ + +K+ DFGL ++ L QD + P
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL---TKVLPQDKEYYKV-KEPGESP 211
Query: 188 ----APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW 243
APE +++ + +D+WS GV+LY L F +
Sbjct: 212 IFWYAPESLTESKFS-VASDVWSFGVVLYEL------FTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 244 FSSEARRLITKL-----LDPNPNSRIAISKIMESSW 274
LI L L I IM W
Sbjct: 265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECW 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 37/238 (15%)
Query: 19 GKYE-------LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--RE 69
GK+ + +G G F V+L +A+K I+ G M + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKT------IREGAMSEEDFIEE 53
Query: 70 ISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
VM + H +V+L+ V ++ I + ++ G L + LR + L+
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD-----YLRTQRGLFAAETLLG 108
Query: 130 -AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
+D C V HRDL N L+ E+ +KV+DFG++ F D ++ G
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTG 164
Query: 183 T--PA-YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
T P + +PEV S Y +K+D+WS GV+++ V G +P+++ + + I G
Sbjct: 165 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 37/223 (16%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIK------REISVMK 74
L LG G+F V + +GK++++ V K +K ++ Q + RE++ M
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAV----KCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+ H++++ L+ V + +L G L + RLR+ L +
Sbjct: 77 SLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLD-----RLRKHQGHFLLGTL---SRYA 127
Query: 135 H----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT- 183
S+ HRDL NLLL +K+ DFGL + D
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP--QNDDHYVMQEHRK 185
Query: 184 -P-AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
P A+ APE + + + +D W GV L+ + G P+
Sbjct: 186 VPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 52/234 (22%), Positives = 97/234 (41%), Gaps = 35/234 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
+ ++LG G F VY + G+ + + V + K ++ + E VM V
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASV 74
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH- 135
+ H+ L + S + L+ G L + +RE + Q L +++C
Sbjct: 75 DNPHVCRLLGI-CLTSTVQLITQLMPFGCLLD-----YVREHKDNIGSQYL---LNWCVQ 125
Query: 136 ---------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P 184
R + HRDL N+L+ ++K+TDFGL+ L + + G P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVP 182
Query: 185 -AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
++A E I + Y ++D+WS GV ++ ++ G P+ + + +G
Sbjct: 183 IKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMVK 77
+++G G F +VY + + V + K +K G E+ + E +M
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI---KTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH- 135
H +I+ L V++ + + ++ G L LRE QL+
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGAL-----DKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 136 -----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV--- 187
+ HRDL N+L++ + KV+DFGLS E +TT G +
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWT 217
Query: 188 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
APE IS + + + +D+WS G++++ V+ G P+ +
Sbjct: 218 APEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 19 GKYE-------LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--RE 69
G E L + LG G F V L + + +A+K+ IK G M + + +E
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKM------IKEGSMSEDEFFQE 53
Query: 70 ISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
M + H +V+ + V + + IY + + G L N LR + QL+
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN-----YLRSHGKGLEPSQLLE 108
Query: 130 -AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG 182
D C S HRDL N L+D D +KV+DFG++ + D ++ G
Sbjct: 109 MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVG 164
Query: 183 T--PA-YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
T P + APEV Y +K+D+W+ G++++ V G +P+
Sbjct: 165 TKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 37/232 (15%)
Query: 12 DRPTLLHGKYE-------LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME 64
L +G +E + LG G F V + + +A+K+ IK G M
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKM------IKEGSMS 62
Query: 65 QIK--REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV 122
+ + E VM + H+ +V+L+ V + I+ + + G L N LRE R
Sbjct: 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN-----YLREMRHRF 117
Query: 123 YFQQLIS-AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175
QQL+ D C S+ HRDL N L+++ G +KV+DFGLS + D
Sbjct: 118 QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DD 173
Query: 176 LLHTTCGT--PA-YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
++ G+ P + PEV+ + +K+DIW+ GV+++ + G +P++
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-IKREISVMKMVKHKH 80
+L + +G G F V L G +A+K IK Q E SVM ++H +
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSN 75
Query: 81 IVELHEV-MASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFCH-- 135
+V+L V + K +Y + + G L + LR + + L+ ++D C
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD-----YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 136 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV---A 188
HRDL N+L+ ED KV+DFGL+ + + G L P V A
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTA 182
Query: 189 PEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
PE + +K + K+D+WS G++L+ + G +P+ + + ++ +G
Sbjct: 183 PEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 32/230 (13%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK--REISVMKMVKH 78
+ LG G + +VY K ++ V V K +K ME + +E +VMK +KH
Sbjct: 16 TMKHKLGGGQYGEVYEGV----WKKYSLTVAV---KTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFCH- 135
++V+L V + Y + + G L + LRE + V L+ A
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVSAVVLLYMATQISSA 123
Query: 136 -----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-YV 187
+ HRDL N L+ E+ +KV DFGLS G P +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWT 179
Query: 188 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
APE ++ + K+D+W+ GV+L+ + G P+ ++ +Y + +
Sbjct: 180 APESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMVK 77
+ LG G F V L R G + V V K ++ +Q + REI ++K +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAV---KQLQHSGPDQQRDFQREIQILKALH 82
Query: 78 HKHIVELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 134
IV+ V + + M+ + G L + L+ AR+ +L+ + C
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL-----RDFLQRHRARLDASRLLLYSSQIC 137
Query: 135 ------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV- 187
SR HRDL N+L++ + ++K+ DFGL+ L + P
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA----KLLPLDKDYYVVREPGQSP 193
Query: 188 ----APEVISKKGYDGAKADIWSCGVILY 212
APE +S + ++D+WS GV+LY
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVLY 221
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 23 LGRMLGHGTFAKVYLAR-NLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVK 77
+ +++G G F +V R L + K +++ + K +KVG E+ +R E S+M
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAI----KTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH-- 135
H +I+ L V+ + + ++ G L + LR+ A+ QL V
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF-----LRKHDAQFTVIQL---VGMLRGI 156
Query: 136 --------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
G HRDL N+L++ + KV+DFGL E +TT G +
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIPI 214
Query: 188 ---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
+PE I+ + + + +D+WS G++L+ V+ G P+ +
Sbjct: 215 RWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 34/221 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
+ +++G G +V R L+ + V + K +K G E+ + E S+M
Sbjct: 52 HIEKIIGSGDSGEVCYGR-LRVPGQRDVPVAI---KALKAGYTERQRRDFLSEASIMGQF 107
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH- 135
H +I+ L V+ + ++ G L LR + QL+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT-----FLRTHDGQFTIMQLV---GMLRG 159
Query: 136 ---------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY 186
G HRDL N+L+D + KV+DFGLS E +TT G
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIP 217
Query: 187 V---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
+ APE I+ + + + +D+WS GV+++ VL G P+ +
Sbjct: 218 IRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 56/235 (23%), Positives = 93/235 (39%), Gaps = 44/235 (18%)
Query: 15 TLLHGKYE-------LGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQI 66
++ +Y L R+LG G F +VY K + V V K K
Sbjct: 1 SMGGPQYGIAREDVVLNRILGEGFFGEVYEGV-YTNHKGEKINVAV---KTCKKDCTLDN 56
Query: 67 K----REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV 122
K E +MK + H HIV+L ++ + + M+L GEL + L + +
Sbjct: 57 KEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGH-----YLERNKNSL 110
Query: 123 YFQQLISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172
L+ + S HRD+ N+L+ +K+ DFGLS + E
Sbjct: 111 KVLTLV---LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE--- 164
Query: 173 QDGLLHTTCGT--P-AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
D + T P +++PE I+ + + +D+W V ++ +L G PF
Sbjct: 165 -DEDYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFW 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 79
L LG G F +V++ +A+K +K G M +E VMK ++H+
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIKT------LKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC----- 134
+V+L+ V S+ IY + + G L L+ + + + +L VD
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSL-----LDFLKGETGK--YLRLPQLVDMAAQIAS 374
Query: 135 -----HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--V 187
HRDL+ N+L+ E+ KV DFGL + ++ +
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWT 431
Query: 188 APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
APE + K+D+WS G++L + G +P+ + ++ RG
Sbjct: 432 APEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 30/228 (13%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 79
L LG G F +V++ T + K +K G M +E VMK ++H+
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTRVAI-------KTLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC--- 134
+V+L+ V S+ IY + + G L + L+ + QL+ A
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLD-----FLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 135 ---HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAP 189
HRDL+ N+L+ E+ KV DFGL + ++ + AP
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGL---ARLIEDNEYTARQGAKFPIKWTAP 350
Query: 190 EVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
E + K+D+WS G++L + G +P+ + ++ RG
Sbjct: 351 EAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-IKREISVMKMVKHKH 80
+L + +G G F V L G +A+K IK Q E SVM ++H +
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSN 247
Query: 81 IVELHEV-MASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFC--- 134
+V+L V + K +Y + + G L LR + + L+ ++D C
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSL-----VDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 135 ---HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA-YVAPE 190
HRDL N+L+ ED KV+DFGL+ + + G L P + APE
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPE 356
Query: 191 VISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
+ +K + K+D+WS G++L+ + G +P+ + + ++ +G
Sbjct: 357 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
ELGR +G G F V+ + ++ A+ V + K K + ++ +E M+
Sbjct: 18 ELGRCIGEGQFGDVHQGI-YMSPENPALAVAI---KTCKNCTSDSVREKFLQEALTMRQF 73
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFCH 135
H HIV+L V +++ ++ M+L GEL + L+ + LI A
Sbjct: 74 DHPHIVKLIGV-ITENPVWIIMELCTLGEL-----RSFLQVRKYSLDLASLILYAYQLST 127
Query: 136 ------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--PA-Y 186
S+ HRD+ N+L+ + +K+ DFGLS + E D + P +
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME----DSTYYKASKGKLPIKW 183
Query: 187 VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
+APE I+ + + + +D+W GV ++ +L+ G PFQ
Sbjct: 184 MAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQG 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 36/231 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 79
+L LG G F +V++ +A+K +K G M E ++MK ++H+
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVKS------LKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE-DVARVYFQQLIS-AVDFCH-- 135
+V L+ V ++ IY + ++ G L + L+ ++ +L+ A
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVD-----FLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 136 ----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH----LKQDGLLHTTCGTPA-Y 186
R HRDL+ N+L+ + + K+ DFGL+ E ++ P +
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------PIKW 176
Query: 187 VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
APE I+ + K+D+WS G++L ++ G +P+ + + + RG
Sbjct: 177 TAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 49/234 (20%), Positives = 92/234 (39%), Gaps = 35/234 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
++LG G F V+ + G+S+ + V + KVI+ Q + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCI---KVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH- 135
H HIV L + S + + G L + +R+ + Q L +++
Sbjct: 73 DHAHIVRLLGL-CPGSSLQLVTQYLPLGSLLD-----HVRQHRGALGPQLL---LNWGVQ 123
Query: 136 ---------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P 184
G+ HR+L N+LL ++V DFG++ L D P
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTP 180
Query: 185 -AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
++A E I Y ++D+WS GV ++ ++ G P+ + + + +G
Sbjct: 181 IKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 32/210 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
+ R LG G F KV L R G + +V V K +K +EI +++ +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAV---KSLKPESGGNHIADLKKEIEILRNL 80
Query: 77 KHKHIVELHEV--MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDF 133
H++IV+ + + I M+ + G L K L ++ ++ +Q + AV
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSL-----KEYLPKNKNKINLKQQLKYAVQI 135
Query: 134 C------HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
C SR HRDL N+L++ + +K+ DFGL+ + + T
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT----KAIETDKEYYTVKDDRDS 191
Query: 188 -----APEVISKKGYDGAKADIWSCGVILY 212
APE + + + +D+WS GV L+
Sbjct: 192 PVFWYAPECLMQSKFY-IASDVWSFGVTLH 220
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
ELGR +G G F V+ + ++ AM V + K K + ++ +E M+
Sbjct: 393 ELGRCIGEGQFGDVHQGI-YMSPENPAMAVAI---KTCKNCTSDSVREKFLQEALTMRQF 448
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH- 135
H HIV+L V +++ ++ M+L GEL + L+ + LI + +
Sbjct: 449 DHPHIVKLIGV-ITENPVWIIMELCTLGELRS-----FLQVRKFSLDLASLI---LYAYQ 499
Query: 136 ---------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG-TPA 185
S+ HRD+ N+L+ + +K+ DFGLS + ++ + G P
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPI 556
Query: 186 -YVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
++APE I+ + + + +D+W GV ++ +L+ G PFQ
Sbjct: 557 KWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQG 595
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK--REISVMKMVKHK 79
+L + LG G F +V++A + K K +K G M E +VMK ++H
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTKVAV-------KTMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYF-QQLISAVDFCHS 136
+V+LH V +K IY + + G L F K +G + + F Q+ + F
Sbjct: 244 KLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY--VAPEVISK 194
R HRDL+ N+L+ K+ DFGL+ ++ + APE I+
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 195 KGYDGAKADIWSCGVILY 212
+ K+D+WS G++L
Sbjct: 360 GSFT-IKSDVWSFGILLM 376
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
+ R LG G F KV L T V V K +K Q + +EI +++ +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAV---KALKADAGPQHRSGWKQEIDILRTL 90
Query: 77 KHKHIVELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
H+HI++ + M+ V G L + + + + ++ QQ+ + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYL 150
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH------LKQDGLLHTTCGTP-AYV 187
H++ HRDL N+LLD D +K+ DFGL+ +++DG P +
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFWY 204
Query: 188 APEVISKKGYDGAKADIWSCGVILY 212
APE + + + +D+WS GV LY
Sbjct: 205 APECLKEYKFY-YASDVWSFGVTLY 228
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 42/239 (17%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
++G G F VY L + V K + E +MK
Sbjct: 28 HFNEVIGRGHFGCVYHGT-LLDNDGKKIHCAV---KSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 77 KHKHIVELHEVMA-SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 134
H +++ L + S+ + +K G+L + +R + + LI +
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVA 138
Query: 135 H------SRGVYHRDLKPENLLLDEDGNLKVTDFGLS-------AFSEHLKQDGLLHTTC 181
S+ HRDL N +LDE +KV DFGL+ +S H K L
Sbjct: 139 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---- 194
Query: 182 GTPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
P V A E + + + K+D+WS GV+L+ ++ G P+ D N + + +G
Sbjct: 195 --P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 52/232 (22%), Positives = 86/232 (37%), Gaps = 35/232 (15%)
Query: 11 DDRPTLLHGKYELGRM-LGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK-- 67
D + L + + LG G F V K + + + KV+K G +
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI----KVLKQGTEKADTEE 56
Query: 68 --REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ 125
RE +M + + +IV L V + M++ GG L L +
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHK-----FLVGKREEIPVS 110
Query: 126 QLISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175
+ + H + HRDL N+LL K++DFGLS D
Sbjct: 111 NV---AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG--ADDS 165
Query: 176 LLHTTCGT--P-AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
P + APE I+ + + +++D+WS GV ++ L G P++
Sbjct: 166 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 58/250 (23%), Positives = 93/250 (37%), Gaps = 39/250 (15%)
Query: 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK---- 67
R LL ELG G F V K + + + KV+K G +
Sbjct: 333 KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAI----KVLKQGTEKADTEEMM 384
Query: 68 REISVMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQL 127
RE +M + + +IV L V + M++ GG L L + +
Sbjct: 385 REAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHK-----FLVGKREEIPVSNV 438
Query: 128 ISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177
+ H + HR+L N+LL K++DFGLS D
Sbjct: 439 ---AELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG--ADDSYY 493
Query: 178 HTTCGT--P-AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKI 233
P + APE I+ + + +++D+WS GV ++ L G P++ + I
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
Query: 234 YRGD-FKCPP 242
+G +CPP
Sbjct: 553 EQGKRMECPP 562
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 47/221 (21%), Positives = 83/221 (37%), Gaps = 38/221 (17%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK-----REISVMKMV 76
+ LG G F V K + V V K++K + E +VM+ +
Sbjct: 21 EDKELGSGNFGTVKKGY--YQMKKVVKTVAV---KILKNEANDPALKDELLAEANVMQQL 75
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH- 135
+ +IV + + M++ + G L + + R V + + ++ H
Sbjct: 76 DNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR------HVKDKNI---IELVHQ 125
Query: 136 ---------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT--P 184
HRDL N+LL K++DFGLS + P
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR--ADENYYKAQTHGKWP 183
Query: 185 -AYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD 223
+ APE I+ + +K+D+WS GV+++ G P++
Sbjct: 184 VKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK- 77
K+ LGR +G G+F ++YL N+QT + +A+K+ Q+ E + ++++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQG 61
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKG---GELFNKIAKGRLREDVARVYFQQLISAVDFC 134
I + MDL+ G +LFN ++ + V + Q+I+ V+F
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFV 119
Query: 135 HSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAF------SEHLKQDGLLHTTCGTPA 185
HS+ HRD+KP+N L+ + + DFGL+ +H+ + T GT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-GTAR 178
Query: 186 YVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQDDNIVSM---YRKIYR 235
Y + V + G + + D+ S G +L L G LP+Q + Y KI
Sbjct: 179 YAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 62/243 (25%), Positives = 94/243 (38%), Gaps = 41/243 (16%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK-----REISVMKM 75
LGRMLG G F V A+ L+ +KV V K++K ++ RE + MK
Sbjct: 26 TLGRMLGKGEFGSVREAQ-LKQEDGSFVKVAV---KMLKADIIASSDIEEFLREAACMKE 81
Query: 76 VKHKHIVEL------HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS 129
H H+ +L + +K G+L + R+ E+ + Q L+
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 130 -AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLL 177
VD SR HRDL N +L ED + V DFGLS L
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 178 HTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKI 233
P V A E ++ Y +D+W+ GV ++ ++ G P+ +Y +
Sbjct: 202 ------P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
Query: 234 YRG 236
G
Sbjct: 253 IGG 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 29/235 (12%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+Y LGR +G G+F +YL ++ G+ +A+K+ Q+ E + KM++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQG 63
Query: 79 -KHIVELHEVMASKSKIYFAMDLVKG---GELFNKIAKGRLREDVARVYFQQLISAVDFC 134
I + A M+L+ G +LFN ++ + V + Q+IS +++
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLL-ADQMISRIEYI 121
Query: 135 HSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTT-------CGTP 184
HS+ HRD+KP+N L+ + + DFGL+ ++ H GT
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYRENKNLTGTA 179
Query: 185 AYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQ---DDNIVSMYRKIYR 235
Y + + + G + + D+ S G +L G LP+Q Y +I
Sbjct: 180 RYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 33/238 (13%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVK 77
+ +G+ +G G F ++ L +NL T + +A+K+ Q+ E K +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGS 63
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGG----ELFNKIAKGRLREDVARVYFQQLISAVDF 133
I +++ ++L+ G +LF+ + + V + QLIS +++
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMI-AIQLISRMEY 120
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLK-----VTDFGLSAFSEHLKQDGLLH-------TTC 181
HS+ + +RD+KPEN L+ GN + DF L+ E++ + H +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA--KEYIDPETKKHIPYREHKSLT 178
Query: 182 GTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQ---DDNIVSMYRKIYR 235
GT Y++ + + G + + D+ + G + L G LP+Q D + Y+KI
Sbjct: 179 GTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 48/237 (20%), Positives = 95/237 (40%), Gaps = 31/237 (13%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVK 77
Y++GR +G G+F ++ NL + +A+K + Q++ E K +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 64
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKG---GELFNKIAKGRLREDVARVYFQQLISAVDFC 134
I ++ +DL+ G +L + + + VA +Q+++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMA-AKQMLARVQSI 122
Query: 135 HSRGVYHRDLKPENLLL----DEDGN-LKVTDFGLSAFSEHLKQDGLLH-------TTCG 182
H + + +RD+KP+N L+ ++ N + V DFG+ + H G
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHIPYREKKNLSG 180
Query: 183 TPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQ---DDNIVSMYRKIYR 235
T Y++ + + G + + D+ + G + L G LP+Q Y +I
Sbjct: 181 TARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 46/254 (18%), Positives = 81/254 (31%), Gaps = 54/254 (21%)
Query: 22 ELGRMLGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMK 74
LG GTF K++ G+ +V + KV+ + S+M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLL---KVLDKAHRNYSESFFEAASMMS 67
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDF 133
+ HKH+V + V + + VK G L L+++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY-----LKKNKNCINILWKLEVAKQL 122
Query: 134 CH------SRGVYHRDLKPENLLLDEDGNL--------KVTDFGLSAFSEHLKQDGLLHT 179
+ H ++ +N+LL + + K++D G+S +D
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--PKDI---- 176
Query: 180 TCGTPAY------VAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQD-DN--IVSM 229
V PE I D WS G L+ + G P D+ +
Sbjct: 177 ------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 230 YRKIYRGDFKCPPW 243
Y ++ P
Sbjct: 231 YEDRHQLP--APKA 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 51/235 (21%), Positives = 89/235 (37%), Gaps = 34/235 (14%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKMV 76
++G G F VY L + V K + E +MK
Sbjct: 92 HFNEVIGRGHFGCVYHGT-LLDNDGKKIHCAV---KSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 77 KHKHIVELHEVMA-SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 134
H +++ L + S+ + +K G+L + +R + + LI +
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-----RNFIRNETHNPTVKDLIGFGLQVA 202
Query: 135 H------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCG------ 182
S+ HRDL N +LDE +KV DFGL+ + D + + T
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRG 236
A E + + + K+D+WS GV+L+ ++ G P+ D N + + +G
Sbjct: 263 M----ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 53/267 (19%), Positives = 102/267 (38%), Gaps = 43/267 (16%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVG--MMEQIK--REISVMKMV 76
R++G G F VY ++ + K + M + RE +M+ +
Sbjct: 24 HSDRVIGKGHFGVVYHGE-YIDQAQNRIQCAI---KSLSRITEMQQVEAFLREGLLMRGL 79
Query: 77 KHKHIVELHEV-MASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS-AVDFC 134
H +++ L + + + + + + G+L +R + LIS +
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-----LQFIRSPQRNPTVKDLISFGLQVA 134
Query: 135 H------SRGVYHRDLKPENLLLDEDGNLKVTDFGLS-------AFSEHLKQDGLLHTTC 181
+ HRDL N +LDE +KV DFGL+ +S + L
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL---- 190
Query: 182 GTPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD 237
P V A E + + K+D+WS GV+L+ +L G P++ + + + +G
Sbjct: 191 --P--VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
Query: 238 -FKCPPWFSSEARRLITKLLDPNPNSR 263
P + +++ + + +P R
Sbjct: 246 RLPQPEYCPDSLYQVMQQCWEADPAVR 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 52/220 (23%), Positives = 82/220 (37%), Gaps = 46/220 (20%)
Query: 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMV-K 77
++G G F +V AR + G M + K +K + E+ V+ +
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAI----KRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQL 127
H +I+ L + +Y A++ G L A + + QQL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 128 ISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH--LKQDG 175
+ F + HRDL N+L+ E+ K+ DFGLS E K G
Sbjct: 145 LH---FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 176 LLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
L P V A E ++ Y +D+WS GV+L+
Sbjct: 202 RL------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 58/242 (23%), Positives = 94/242 (38%), Gaps = 40/242 (16%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKV-VGKDKVIKVGMMEQIKR-----EISVMKM 75
LG++LG G F V L+ ++KV V K +K+ Q + E + MK
Sbjct: 37 ILGKILGEGEFGSVMEGN-LKQEDGTSLKVAV---KTMKLDNSSQREIEEFLSEAACMKD 92
Query: 76 VKHKHIVEL-----HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLIS- 129
H +++ L K + +K G+L + RL + Q L+
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 130 AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQDGLLH 178
VD +R HRDL N +L +D + V DFGLS + +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211
Query: 179 TTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIY 234
P V A E ++ + Y +K+D+W+ GV ++ + G P+ MY +
Sbjct: 212 -----P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 235 RG 236
G
Sbjct: 264 HG 265
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 46/225 (20%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
G+ LG G F KV A AM V V K++K + E+ V+
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAV---KMLKPSAHLTEREALMSELKVLSY 82
Query: 76 V-KHKHIVELHEVMASKSKIYFAMDLVKGGEL------------FNKIAKGRLREDVARV 122
+ H +IV L + G+L +K + + +D +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 123 YFQQLIS-------AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH--- 170
+ L+S + F S+ HRDL N+LL K+ DFGL+ ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 171 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
+K + L P V APE I Y ++D+WS G+ L+
Sbjct: 203 VKGNARL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 43/215 (20%)
Query: 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELH 85
+LG G F KVY R L G +A+K + +++ G Q + E+ ++ M H++++ L
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 86 -------------EVMASKSKIYFAMDLVKGGELFN-----KIAKGRLREDVAR--VYFQ 125
MA+ S + + + +IA G AR Y
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG-----SARGLAYLH 148
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT---CG 182
D C + + HRD+K N+LLDE+ V DFGL+ L H T G
Sbjct: 149 ------DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRG 197
Query: 183 TPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG 217
T ++APE +S G K D++ GV+L L+ G
Sbjct: 198 TIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITG 231
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 44/237 (18%), Positives = 86/237 (36%), Gaps = 43/237 (18%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
++ LG+ +G G F +YLA + A VV K + + G + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVEYQENG---PLFSELKFYQRVAK 92
Query: 79 KHIVELHEVMASKSK------IYFAMDLVKGGE---------------LFNKIAKGRL-R 116
K ++ + KG + + G +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFKK 150
Query: 117 EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT--DFGLSAF------S 168
V ++ +++ +++ H H D+K NLLL +V D+GLS
Sbjct: 151 STVLQL-GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 169 EHLKQD-GLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQD 223
+ +++ H GT + + + + KG ++D+ G + L G LP++
Sbjct: 210 KQYQENPRKGHN--GTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 42/221 (19%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMV 76
L R LG G F KV+LA + M V V K +K + K RE ++ +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAV---KALKDPTLAARKDFQREAELLTNL 74
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQQ 126
+H+HIV+ + V + + +K G+L + G+ R+ + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 127 LIS-AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH-----LKQD 174
++ A S+ HRDL N L+ + +K+ DFG+S +
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 175 GLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
+L P + PE I + + ++D+WS GVIL+
Sbjct: 195 TML------P--IRWMPPESIMYRKFT-TESDVWSFGVILW 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 52/219 (23%), Positives = 85/219 (38%), Gaps = 38/219 (17%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK----REISVMKMV- 76
+ G+ LG G F KV A GK A+ V K++K K E+ +M +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAV-KMLKSTAHADEKEALMSELKIMSHLG 107
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFN--------KIAKGRLREDVARVYFQQLI 128
+H++IV L + + G+L N + + L+
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 129 S-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS----AFSEHLKQ-DGL 176
+ F S+ HRD+ N+LL K+ DFGL+ S ++ + +
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 177 LHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
L P V APE I Y ++D+WS G++L+
Sbjct: 228 L------P--VKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 51/230 (22%)
Query: 22 ELGRMLGHGTFAKVYLARNLQ-TGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
LG+ LG G F KV A G++ V V K++K E +V+K
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAV---KMLKENASPSELRDLLSEFNVLKQ 82
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGEL------------------FNKIAKGRLRE 117
V H H+++L+ + + ++ K G L ++ +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 118 DVARVYFQQLIS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFS 168
D + LIS A + + HRDL N+L+ E +K++DFGLS +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 169 EH---LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
E + G + P V A E + Y ++D+WS GV+L+
Sbjct: 203 EDSYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 57/233 (24%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
E G++LG G F KV A + ++++V V K++K + E+ +M
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV---KMLKEKADSSEREALMSELKMMTQ 104
Query: 76 V-KHKHIVELHEVMASKSKIYFAMDLVKGGEL-----------------FNKIAKGRLRE 117
+ H++IV L IY + G+L + + E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 118 DVARVYFQQLISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLS-- 165
D+ + F+ L+ F + + HRDL N+L+ +K+ DFGL+
Sbjct: 165 DLNVLTFEDLLC---FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 166 AFSEHL---KQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
S+ + + L P V APE + + Y K+D+WS G++L+
Sbjct: 222 IMSDSNYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 4e-15
Identities = 65/264 (24%), Positives = 102/264 (38%), Gaps = 63/264 (23%)
Query: 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKR----EISVMKMVKHK 79
G +G G F VY + ++A+K + I ++K+ EI VM +H+
Sbjct: 36 GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHE 90
Query: 80 HIVELH-------------EVMASKSKIYFAMDLVKGGELF----NKIAKGRLREDVARV 122
++VEL M + S + L L KIA+G A
Sbjct: 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG-----AAN- 144
Query: 123 YFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-- 180
++F H HRD+K N+LLDE K++DFGL+ SE T
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK---FAQTVMTSR 194
Query: 181 -CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF----QDDNIVSMYRKIYR 235
GT AY+APE + G K+DI+S GV+L ++ G + ++ + +I
Sbjct: 195 IVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED 252
Query: 236 GDFKCPPWFSSEARRLITKLLDPN 259
+ I +D
Sbjct: 253 E------------EKTIEDYIDKK 264
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 54/224 (24%), Positives = 85/224 (37%), Gaps = 45/224 (20%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
+LG+ LG G F +V A + V V K++K G E+ ++
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV---KMLKEGATHSEHRALMSELKILIH 86
Query: 76 V-KHKHIVELHEV-MASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVY 123
+ H ++V L + ++ K G L F +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 124 FQQLIS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH---L 171
+ LI + F SR HRDL N+LL E +K+ DFGL+ + +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 172 KQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
K D L P + APE I + Y ++D+WS GV+L+
Sbjct: 207 KGDARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 46/225 (20%)
Query: 22 ELGRMLGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVM 73
LG+ LG G F +V +A + A+ V V K++K E+ E+ +M
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAV---KMLKDDATEKDLSDLVSEMEMM 94
Query: 74 KMV-KHKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARV 122
KM+ KHK+I+ L +Y ++ G L + + R ++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 123 YFQQLIS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH--- 170
F+ L+S + S+ HRDL N+L+ E+ +K+ DFGL+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 171 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
+G L P V APE + + Y ++D+WS GV+++
Sbjct: 215 KTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 22 ELGRMLGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVM 73
LG+ LG G F +V LA + + KV V K++K E+ E+ +M
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV---KMLKSDATEKDLSDLISEMEMM 128
Query: 74 KMV-KHKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARV 122
KM+ KHK+I+ L +Y ++ G L + + ++
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 123 YFQQLIS-AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH----- 170
+ L+S A S+ HRDL N+L+ ED +K+ DFGL+ H
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 171 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
+G L P V APE + + Y ++D+WS GV+L+
Sbjct: 249 KTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 44/225 (19%), Positives = 74/225 (32%), Gaps = 49/225 (21%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
LG F KVY V + K +K ++ E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAI---KTLKDKAEGPLREEFRHEAMLRAR 68
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARVYFQ 125
++H ++V L V+ + G+L + + R + +
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 126 QLISAVDFCH----------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH----- 170
+ S V H+DL N+L+ + N+K++D GL
Sbjct: 129 DFV---HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 171 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
L + LL P + APE I + +DIWS GV+L+
Sbjct: 186 LLGNSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVLW 221
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 46/225 (20%)
Query: 22 ELGRMLGHGTFAKVYLAR---NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVM 73
LG+ LG G F +V +A + A+ V V K++K E+ E+ +M
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV---KMLKDDATEKDLSDLVSEMEMM 140
Query: 74 KMV-KHKHIVELHEVMASKSKIYFAMDLVKGGEL----------FNKIAKGRLREDVARV 122
KM+ KHK+I+ L +Y ++ G L + + R ++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 123 YFQQLIS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSE---H 170
F+ L+S + S+ HRDL N+L+ E+ +K+ DFGL+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 171 LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
+G L P V APE + + Y ++D+WS GV+++
Sbjct: 261 KTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 47/221 (21%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
+ R LG G+F VY +V + K + + + E SVMK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI---KTVNEAASMRERIEFLNEASVMKE 84
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLRE---------DVARVYFQQ 126
H+V L V++ M+L+ G+L K LR +A +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPAMANNPVLAPPSLSK 139
Query: 127 LIS-AVD------FCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS--AFSEH---LKQD 174
+I A + + ++ HRDL N ++ ED +K+ DFG++ +
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 175 GLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
GLL P V +PE + + +D+WS GV+L+
Sbjct: 200 GLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVLW 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 52/214 (24%), Positives = 82/214 (38%), Gaps = 33/214 (15%)
Query: 22 ELGRMLGHGTFAKVY--LARNLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMK 74
L R LGHG F +VY + S ++V V K + EQ + E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPS-PLQVAV---KTLPEVCSEQDELDFLMEALIIS 88
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARV-YFQQLIS-AVD 132
H++IV V + M+L+ GG+L + + + R R L+ A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 133 FCH------SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTTCGT 183
HRD+ N LL G K+ DFG++ + + G
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAS---YYRKGG 203
Query: 184 PAYV-----APEVISKKGYDGAKADIWSCGVILY 212
A + PE + + +K D WS GV+L+
Sbjct: 204 CAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 51/217 (23%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK---REISVMKMV 76
L LG G F KV+LA + + M V V K +K + RE ++ M+
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV---KALKEASESARQDFQREAELLTML 100
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGEL---------FNKIAKGRLREDVARVYFQQL 127
+H+HIV V + + ++ G+L K+ G + QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 128 IS-AVDFCH------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
++ A HRDL N L+ + +K+ DFG+S D +
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TD---YYR 215
Query: 181 CGTPAYV-----APEVISKKGYDGAKADIWSCGVILY 212
G + PE I + + ++D+WS GV+L+
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLW 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 39/252 (15%), Positives = 89/252 (35%), Gaps = 47/252 (18%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME-QIKREISV-MKMV 76
+++L +Y A T + + +K+ + ++ E + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDS-GPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100
Query: 77 KHKHIVELHEVMASKS----KIYF-----------AMDLVKG---GELFNKIAKGRL-RE 117
K + + ++ ++ + + G + K L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 118 DVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT--DFGLS---------- 165
V +V +L+ A++F H H ++ EN+ +D + +VT +G +
Sbjct: 160 SVLQV-ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA-KADIWSCGVILYVLLAGFLPFQD- 223
A+ E + H G +++ + KG + ++D+ S G + L GFLP+ +
Sbjct: 219 AYVEGSRSP---HE--GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271
Query: 224 --DNIVSMYRKI 233
+ M +K
Sbjct: 272 LPNTEDIMKQKQ 283
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 45/250 (18%), Positives = 89/250 (35%), Gaps = 43/250 (17%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME--QIKREISVMKMV 76
+++G +G G F +YLA + +S+ V+KV + + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADM-NSSESVGSDA---PCVVKVEPSDNGPLFTELKFYQRA 90
Query: 77 KHKHIVELHEVMASKS-----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQ------ 125
++ K + + K G+ + + R D+ ++Y
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFS 150
Query: 126 ---------QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT--DFGLSAF------S 168
+++ +++ H H D+K NLLL+ +V D+GL+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 169 EHLKQD-GLLHTTCGTPAYVAPEVISKKGYD-GAKADIWSCGVILYVLLAGFLPFQD--- 223
+ D H GT + + + + G + D+ G + L G LP++D
Sbjct: 211 KAYAADPKRCHD--GTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266
Query: 224 DNIVSMYRKI 233
D KI
Sbjct: 267 DPKYVRDSKI 276
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-13
Identities = 28/191 (14%), Positives = 58/191 (30%), Gaps = 47/191 (24%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ-----IKREISVMK 74
K + +G G F +V+ +A+K++ + V Q I EI + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 75 MV---------KHKHIVELHEV------------------------------MASKSKIY 95
+ + + + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDED 154
++ GG ++ A+ QL +++ + HRDL N+LL +
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 155 GNLKVTDFGLS 165
K+
Sbjct: 199 SLKKLHYTLNG 209
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 50/213 (23%), Positives = 83/213 (38%), Gaps = 31/213 (14%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
L R LGHG F +VY + + ++V V K + EQ + E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV---KTLPEVCSEQDELDFLMEALIISK 130
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVY-FQQLIS-AVDF 133
H++IV V + ++L+ GG+L + + + R R L+ A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 134 CH------SRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
HRD+ N LL G K+ DFG++ + + + G
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--RDIYRAG---YYRKGGC 245
Query: 185 AYV-----APEVISKKGYDGAKADIWSCGVILY 212
A + PE + + +K D WS GV+L+
Sbjct: 246 AMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLW 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 47/230 (20%), Positives = 79/230 (34%), Gaps = 51/230 (22%)
Query: 22 ELGRMLGHGTFAKVYLAR-NLQTGKSMAMKV-VGKDKVIKVGMMEQIK----REISVMKM 75
E R +G G F +V+ AR V V K++K ++ RE ++M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAALMAE 106
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGEL------------FNKIAKGRLREDVARVY 123
+ +IV+L V A + + + G+L +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 124 FQQLISAVDFCH-------------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170
+S + R HRDL N L+ E+ +K+ DFGLS
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 171 -----LKQDGLLHTTCGTPAYV---APEVISKKGYDGAKADIWSCGVILY 212
+ + P + PE I Y ++D+W+ GV+L+
Sbjct: 227 ADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 66/266 (24%), Positives = 109/266 (40%), Gaps = 69/266 (25%)
Query: 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
++GHG F KVY L+ G +A+K + G+ E + EI + +H H+V L
Sbjct: 45 FLIGHGVFGKVYKGV-LRDGAKVALKRRTPES--SQGIEE-FETEIETLSFCRHPHLVSL 100
Query: 85 H-------------EVMAS---KSKIYFAMDLVKGGELFNKIA---KGRLR--EDVARVY 123
+ M + K +Y G ++ + RL AR
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLY--------GSDLPTMSMSWEQRLEICIGAAR-- 150
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTT-- 180
+ + H+R + HRD+K N+LLDE+ K+TDFG+S +E H +
Sbjct: 151 ------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE----LDQTHLSTV 200
Query: 181 -CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG------FLPFQDDNIVSMYRKI 233
GT Y+ PE KG K+D++S GV+L+ +L LP + N+ +
Sbjct: 201 VKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 234 YRGDFKCPPWFSSEARRLITKLLDPN 259
+ + +++DPN
Sbjct: 260 HN-------------NGQLEQIVDPN 272
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 7/90 (7%)
Query: 126 QLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
Q+ ++F SR HRDL N+LL E +K+ DFGL+ + +D
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKDPDYVRKGDARL 257
Query: 186 YV---APEVISKKGYDGAKADIWSCGVILY 212
+ APE I + Y ++D+WS GV+L+
Sbjct: 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 27/169 (15%), Positives = 55/169 (32%), Gaps = 10/169 (5%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMV- 76
+LG+ LG G F +V A K+ + V K++K G + E+ ++ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV-KMLKEGATHSEHRALMSELKILIHIG 83
Query: 77 KHKHIVELHEVM-ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH 135
H ++V L + ++ K G L + R + + Y +
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---RSKRNEFVPYKTKGARFRQGKD 140
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTP 184
G DLK + + + F ++++
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 27/175 (15%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGK--SMAMKV-------VGKDKVIKVGMMEQIKREIS 71
+G ++ G A V+ A + GK +MA+K+ K G R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 72 VMKMVK------HKHIVELHEVMASKSKIYF------AMDLVKGGEL----FNKIAKGRL 115
+ V +++ E S + Y M+ + EL ++ +
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 116 REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170
DV ++ + + + H DL N++ + + D G + H
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTLRH 221
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 441 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.42 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 98.15 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 98.09 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 97.99 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.63 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.48 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 97.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.3 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.45 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.84 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.74 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-69 Score=524.35 Aligned_cols=262 Identities=33% Similarity=0.621 Sum_probs=243.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.|+|||||++++++.+.+.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44679999999999999999999999999999999987765555567889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||||+||+|++++.+ +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999976 889999999999999999999999999999999999999999999999999998765444455
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 255 (441)
...+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+...++.+|.++.+.+|..+++++++||.+|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 66788999999999999988884 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCHHH------HhcCcccCccC
Q 013522 256 LDPNPNSRIAISK------IMESSWFKKSA 279 (441)
Q Consensus 256 L~~dP~~R~t~~e------il~hpwf~~~~ 279 (441)
|++||++|||++| |++||||+...
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 9999999999988 58999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-68 Score=510.67 Aligned_cols=258 Identities=45% Similarity=0.829 Sum_probs=223.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 48999999999999999999999999999999999887665555677899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|||| +|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... ...
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CCc
Confidence 9999 6799999865 7899999999999999999999999999999999999999999999999999976432 334
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 256 (441)
..+.+|||.|+|||++.+.+|++.++|||||||++|+|++|++||.+.+...++..+..+.+++|.++|+++++||.+||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 247 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHS
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 56789999999999999988888899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCccC
Q 013522 257 DPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++||++|||++|+++||||+...
T Consensus 248 ~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp CSSGGGSCCHHHHHHCHHHHTTC
T ss_pred cCChhHCcCHHHHHcCcccccCC
Confidence 99999999999999999998654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-66 Score=511.70 Aligned_cols=258 Identities=25% Similarity=0.455 Sum_probs=233.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
..+|++++.||+|+||+||+|++..+|+.||||++.+..... .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 356999999999999999999999999999999998654332 35678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||||+||+|.+++..+++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999986432 23445
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~ 254 (441)
.+.||||.|||||++.+.+| +.++|||||||++|+|++|++||.+.+....+..+..+.. +.+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 67899999999999988888 4899999999999999999999999999988888877643 2334589999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
||+.||++|||++|+|+||||++..++
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 999999999999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-66 Score=512.77 Aligned_cols=259 Identities=29% Similarity=0.560 Sum_probs=229.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... ....+.+.+|+.+|+.|+|||||++++++.+.+.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999999876643 34567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 98 MDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||||+||+|++++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--V 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--H
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--c
Confidence 999999999999964 35799999999999999999999999999999999999999999999999999865431 1
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARRLIT 253 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~ 253 (441)
....+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+++.++..+.+ +.+..+|+++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 234567899999999999988885 899999999999999999999999999999999988876 456789999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+||++||++|||++|+|+||||++...
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999976443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-65 Score=512.57 Aligned_cols=258 Identities=24% Similarity=0.441 Sum_probs=234.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999865433 235688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||||.||+|.+++..+++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 9999999999999989999999999999999999999999999999999999999999999999999986432 23445
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~~ 254 (441)
.+.||||.|||||++.+..|+ .++|||||||++|+|++|++||.+.+....+..+..+.. ..+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 678999999999999988884 899999999999999999999999999988888877643 3445689999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
||+.||++|||+.|+|+||||++..++
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-66 Score=500.74 Aligned_cols=256 Identities=36% Similarity=0.658 Sum_probs=227.2
Q ss_pred CCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
++|++++.||+|+||+||+|++. .+++.||+|++.+..... .....+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 67999999999999999999984 468899999998765432 22346789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+|||||+||+|++++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 99999999999999976 8899999999999999999999999999999999999999999999999999975432 23
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
....+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+++.++.++.+.+|+.+|+++++||.+
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 445678999999999999988886 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 255 LLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 255 ~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
||++||++||| ++|+++||||+..
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999998 5899999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-64 Score=482.43 Aligned_cols=255 Identities=23% Similarity=0.469 Sum_probs=222.7
Q ss_pred cccCCe-EEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 013522 16 LLHGKY-ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS---- 90 (441)
Q Consensus 16 ~~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---- 90 (441)
...+|| ++.+.||+|+||+||+|++..++..||+|++....... ...+.+.+|+.+|+.|+|||||++++++.+
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 345677 78899999999999999999999999999998765433 456789999999999999999999999865
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCC-CCCeEEeecCccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDE-DGNLKVTDFGLSA 166 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~-~~~vkl~DFGla~ 166 (441)
...+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 3568999999999999999976 78999999999999999999999998 999999999999984 7899999999997
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHHcCCCC--CCCC
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDFK--CPPW 243 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~--~~~~ 243 (441)
... .....+.+|||.|||||++.+ +| +.++|||||||+||+|+||++||.+. +...++..+..+..+ ++..
T Consensus 181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eCC----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 532 345567899999999999865 56 48999999999999999999999764 455666666665432 3556
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+++++++||.+||+.||++|||++++|+||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 8899999999999999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-63 Score=488.31 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=223.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.+.|++.++||+|+||+||+|++..+|+.||||+++++... .+|+.+|+.|+|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999876432 3799999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999976 8899999999999999999999999999999999999999988 59999999998654322111
Q ss_pred ---cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHHH
Q 013522 176 ---LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEAR 249 (441)
Q Consensus 176 ---~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~ 249 (441)
...+.||||.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+...++.++..+.. ..|+.+++++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 22346899999999999988885 899999999999999999999999888778888887765 35778999999
Q ss_pred HHHHHhcCCCCCCCCCHHHH-------------hcCcccCccC
Q 013522 250 RLITKLLDPNPNSRIAISKI-------------MESSWFKKSA 279 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~ei-------------l~hpwf~~~~ 279 (441)
+||.+||++||++|||+.|+ ++|||+.+..
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999999999997 5799987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-61 Score=495.17 Aligned_cols=393 Identities=33% Similarity=0.613 Sum_probs=311.2
Q ss_pred CCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
...+.+..++|.+++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+
T Consensus 8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34566788999999999999999999999999999999999987654333456789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+.+|+||||+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999999999976 679999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEAR 249 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 249 (441)
......+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...++.++..+.+..|..+++++.
T Consensus 168 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 244 (476)
T 2y94_A 168 ---DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244 (476)
T ss_dssp ---TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHH
T ss_pred ---ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHH
Confidence 23445678999999999999988887789999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCccCCccccchh--------hhh----------hhhc--------cCCCCcc--
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQ--------EME----------FEAD--------KSSKQPE-- 301 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~~~~~~~--------~~~----------~~~~--------~~~~~~~-- 301 (441)
+||.+||..||.+|||+.++++||||+...+....... +.. .... .....+.
T Consensus 245 ~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 324 (476)
T 2y94_A 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAV 324 (476)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC-----------------------
T ss_pred HHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHH
Confidence 99999999999999999999999999765332111000 000 0000 0000000
Q ss_pred -------------ccchhh---------------------hhccCC--CC----CCChhh-----HHhhHHHhhhhcccc
Q 013522 302 -------------TLNAFH---------------------IISLSE--GF----DLSPLF-----EEKKRAEREELRFAT 336 (441)
Q Consensus 302 -------------~~~~~~---------------------~~~~~~--~~----~l~~~~-----~~~~~~~~~~~~~~~ 336 (441)
....+- ....+. .. .+.... ....+..+..+++.+
T Consensus 325 ~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s 404 (476)
T 2y94_A 325 AYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRS 404 (476)
T ss_dssp --------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEE
T ss_pred HHHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCcc
Confidence 000000 000000 00 000000 001123356678888
Q ss_pred cCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEecCceEEEEEEccCCChhhh
Q 013522 337 TRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEY 406 (441)
Q Consensus 337 ~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~ 406 (441)
+.++.+++..+..+++.+|+.|+..+ +.|++....+.....+.|.+++|++.+..+||||++..|+.++|
T Consensus 405 ~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~ 475 (476)
T 2y94_A 405 QSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475 (476)
T ss_dssp CSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred CCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence 99999999999999999999999755 77999764333344567999999999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=487.52 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=225.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------ 90 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 90 (441)
+.++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.|+|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 34689999999999999999999999999999999976543 23456778899999999999999999999864
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+.+|+|||||. |+|++++.. +++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 367999999996 579999976 789999999999999999999999999999999999999999999999999997643
Q ss_pred cc--ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-------
Q 013522 170 HL--KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC------- 240 (441)
Q Consensus 170 ~~--~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------- 240 (441)
.. .......+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+..+.+..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 223455678999999999999887777899999999999999999999999999888877775421111
Q ss_pred ------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 241 ------------------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 241 ------------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+.+++++.+||.+||.+||++|||+.|+|+||||++..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 124689999999999999999999999999999998643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=498.52 Aligned_cols=260 Identities=31% Similarity=0.493 Sum_probs=229.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHH---HHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK---REISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+..++|++++.||+|+||+||+|++..+|+.||||++.+...........+. +++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3457899999999999999999999999999999999876543333333333 4466777889999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+|||||+||+|++++.+ +++++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~- 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK- 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC-
Confidence 99999999999999999976 8899999999999999999999999999999999999999999999999999975432
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---cHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
....+.||||.|||||++.+...++.++|||||||+||+|++|.+||.+. +...+...+....+.+|..+|+++
T Consensus 345 ---~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a 421 (689)
T 3v5w_A 345 ---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421 (689)
T ss_dssp ---CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred ---CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHH
Confidence 34567899999999999975433458999999999999999999999764 445677888888999999999999
Q ss_pred HHHHHHhcCCCCCCCCC-----HHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRIA-----ISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t-----~~eil~hpwf~~~~ 279 (441)
++||.+||+.||.+|++ +++|++||||+...
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 99999999999999998 79999999998643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-60 Score=469.69 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=211.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 91 (441)
.+.++|++++.||+|+||+||+|++. .+++.||+|.+.+.. ...++.+|+.+|+.+ +||||+++++++.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 36789999999999999999999875 467899999986543 235688999999998 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~~~ 170 (441)
+++|+|||||+||+|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999999984 59999999999999999999999999999999999999877 7999999999975432
Q ss_pred cc--------------------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC-
Q 013522 171 LK--------------------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD- 223 (441)
Q Consensus 171 ~~--------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~- 223 (441)
.. ......+.+|||.|+|||++.+.++++.++||||+||++|+|++|++||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 112345678999999999998877667999999999999999999999954
Q ss_pred CcHHHHHHHHHc--------------------------------------CCC----------------CCCCCCCHHHH
Q 013522 224 DNIVSMYRKIYR--------------------------------------GDF----------------KCPPWFSSEAR 249 (441)
Q Consensus 224 ~~~~~~~~~i~~--------------------------------------~~~----------------~~~~~~~~~~~ 249 (441)
.+.......|.. ... ...+.+|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 333333332211 000 11134789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+||++||++||++|||++|+|+||||++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-60 Score=457.05 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=203.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----- 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----- 92 (441)
.++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 356999999999999999999999999999999997653 2344578999999999999999999999987544
Q ss_pred -------EEEEEEeccCCCchHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEee
Q 013522 93 -------KIYFAMDLVKGGELFNKIAK-GR---LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 161 (441)
Q Consensus 93 -------~~~lv~E~~~gg~L~~~i~~-~~---l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~D 161 (441)
.+|+|||||.||+|.+++.. +. .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999976 33 45567899999999999999999999999999999999999999999
Q ss_pred cCccccccccccC----------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-HHHH
Q 013522 162 FGLSAFSEHLKQD----------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMY 230 (441)
Q Consensus 162 FGla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~~~~ 230 (441)
||+|+........ ....+.||||.|||||++.+.+|+ .++|||||||++|+|++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 9999865432211 123456899999999999988885 89999999999999996 8865432 2334
Q ss_pred HHHHcCCCC-CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 231 RKIYRGDFK-CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 231 ~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
..+....++ .++..++.+.+||.+||++||++|||+.++++||||++.
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 444443322 112356778999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=455.27 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=223.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
.+-.++|.+.+.||+|+||+||+|++. .++..||||++... .....+.+.+|+.+|++|+|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 445578999999999999999999875 36789999999654 2345678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 99999999999999999999964 3589999999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443322233456799999999999988875 99999999999999998 999999999999999988
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 235 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
.+. ++.|+.+|+++.+||.+||+.||++|||+.+| ++|++
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 875 46788899999999999999999999999999 45664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-59 Score=487.88 Aligned_cols=257 Identities=31% Similarity=0.573 Sum_probs=234.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.|+|||||+++++|.+.+.+|+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999976532 345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC--CCeEEeecCccccccccc
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED--GNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~--~~vkl~DFGla~~~~~~~ 172 (441)
|||||.||+|++++.. +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 679999999999999999999999999999999999999854 899999999998643
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEA 248 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 248 (441)
......+.|||+.|+|||++.+.+| +.++|||||||+||+|++|.+||.+.+..+.+..+..+.+.++ +.+|+++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 3445667899999999999998888 4899999999999999999999999999999999998877665 4589999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
++||.+||+.||.+|||+.|+|+||||+....
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999987544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=454.43 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=214.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
-..+|.+.+.||+|+||+||+|++. .+++.||||++... .....+.+.+|+.+|++|+|||||++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3457899999999999999999875 36889999999654 234567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 92 SKIYFAMDLVKGGELFNKIAK----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
+.+|+|||||+||+|.+++.. +++++.++..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 999999999999999999864 3589999999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.+||+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443333344567899999999999988875 99999999999999999 999999999888888888
Q ss_pred cC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 235 RG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 235 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+ .++.|+.+++++.+||.+||+.||++|||+.+|+++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 76 467788899999999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=448.87 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=207.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+++-.+++++++.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 4555678999999999999999999863 3599999865433 33456789999999999999999999998754 56
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
+|||||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 8999999999999999964 67999999999999999999999999999999999999999999999999999876544
Q ss_pred ccCCcccccccCCCccchhhhhccC--CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHHcCCC-----CCCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY-RKIYRGDF-----KCPPW 243 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~-~~i~~~~~-----~~~~~ 243 (441)
.......+.+||+.|||||++.+.. .++.++|||||||+||||+||+.||.+.+..... ..+..+.. ..++.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 4444566789999999999997432 2358999999999999999999999886654444 34444321 23456
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++++.+||.+||+.||++|||+.+++++
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=448.76 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=225.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
..+-...+++.+.||+|+||+||+|++. .+++.||||++.... .....+.+.+|+.+|++++|||||++++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3455678999999999999999999864 467899999996543 223457899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL 151 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl 151 (441)
.+.+.+|+|||||++|+|.+++.. +.+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 999999999999999999999953 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHH
Q 013522 152 DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMY 230 (441)
Q Consensus 152 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~ 230 (441)
++++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+..++.
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999866544444455677899999999999988875 99999999999999998 89999999999999
Q ss_pred HHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 231 RKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 231 ~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..+..+. .+.|+.+++++.+|+.+||+.||++|||+.+|+++
T Consensus 258 ~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8888775 46788899999999999999999999999999865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=441.82 Aligned_cols=260 Identities=39% Similarity=0.777 Sum_probs=241.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+|+.||+|++.+... .....+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 456899999999999999999999999999999999987654 3345678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||++||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.... ..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~---~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS---SS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC---CC
Confidence 99999999999999965 789999999999999999999999999999999999999999999999999987543 23
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
......+||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+...+...+..+.+..|..+++++.+||++
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 45567889999999999999888888999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||..||.+|||+.++++||||+...
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=442.66 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=217.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMA 89 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~ 89 (441)
+-.++|++++.||+|+||+||+|++..+ ++.||||.+..... ....+.+.+|+.+|++++| ||||++++++.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4457899999999999999999998654 36899999975432 2345779999999999965 99999999986
Q ss_pred e-CCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe
Q 013522 90 S-KSKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL 151 (441)
Q Consensus 90 ~-~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl 151 (441)
+ .+.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 5 4578999999999999999963 237899999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcH-HHH
Q 013522 152 DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI-VSM 229 (441)
Q Consensus 152 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~-~~~ 229 (441)
++++.+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+. ..+
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999865432222234466899999999999988875 99999999999999998 9999988654 445
Q ss_pred HHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 230 YRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 230 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
...+..+ .++.|+.+++++.+||.+||+.||++|||+.+|++|
T Consensus 298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5555555 467788899999999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=439.25 Aligned_cols=263 Identities=33% Similarity=0.621 Sum_probs=232.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
..+..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 345678999999999999999999999999999999999876554445567888999999988 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 99999999999999999976 7899999999999999999999999999999999999999999999999999874222
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 251 (441)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+...++..+..+...+|.++++++.+|
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 254 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 22345677899999999999888774 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCH------HHHhcCcccCccC
Q 013522 252 ITKLLDPNPNSRIAI------SKIMESSWFKKSA 279 (441)
Q Consensus 252 i~~~L~~dP~~R~t~------~eil~hpwf~~~~ 279 (441)
|++||+.||.+||++ .++++||||+...
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 999999999999998 8999999998643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=431.09 Aligned_cols=260 Identities=33% Similarity=0.641 Sum_probs=237.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987654333456788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCC
Confidence 9999999999999976 7799999999999999999999999999999999999999999999999999874221 233
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 255 (441)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+..+...+|..+++++++||.+|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 4567889999999999988777 589999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCC-----CHHHHhcCcccCccC
Q 013522 256 LDPNPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 256 L~~dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
|+.||++|| ++.++++||||+...
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 999999999 999999999998643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=425.08 Aligned_cols=258 Identities=34% Similarity=0.726 Sum_probs=237.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765433345678889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 99999999999999976 679999999999999999999999999999999999999999999999999997533
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
....+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++..+...+|+.+++++.+||.+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 158 DVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp SCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 234567899999999999887774 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCcccCccC
Q 013522 255 LLDPNPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
||..||.+|| +++++++||||+...
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999 999999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=429.40 Aligned_cols=263 Identities=32% Similarity=0.566 Sum_probs=236.5
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
.....+.++|++++.||+|+||+||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 3445688999999999999999999999999999999999987654221 1356889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----CeEEeecC
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFG 163 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~----~vkl~DFG 163 (441)
.+.+.+|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999999999976 6799999999999999999999999999999999999998877 79999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC--
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-- 241 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 241 (441)
++..... .......+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+....+..+..+.+.++
T Consensus 165 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 240 (361)
T 2yab_A 165 LAHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240 (361)
T ss_dssp SCEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred CceEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 9975432 334556789999999999988777 4899999999999999999999999999999999998887765
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 --PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 --~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+++.+++||.+||.+||.+|||+.++++||||+..
T Consensus 241 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 4689999999999999999999999999999999854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=438.07 Aligned_cols=261 Identities=40% Similarity=0.793 Sum_probs=234.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 46689999999999999999999999999999999997654433334567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||+ +|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~---~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---G 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---S
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---C
Confidence 999999 6789998865 7899999999999999999999999999999999999999999999999999975432 3
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+...+...+..+.+..|..+++++.+||++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 34567789999999999988877778999999999999999999999988776666666667778889999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
||.+||.+|||+.++++||||+...+
T Consensus 242 ~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 242 MIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp TSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HcCCChhHCcCHHHHHhChhhccCCc
Confidence 99999999999999999999986543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=430.44 Aligned_cols=263 Identities=32% Similarity=0.590 Sum_probs=236.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
.....++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 345678999999999999999999999999999999999876543334567788999999876 9999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 99999999999999999986 7899999999999999999999999999999999999999999999999999874321
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 251 (441)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...++..+..+...+|.++++++++|
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 2234567789999999999988777 48999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHH-HHhcCcccCccC
Q 013522 252 ITKLLDPNPNSRIAIS-KIMESSWFKKSA 279 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~-eil~hpwf~~~~ 279 (441)
|.+||..||++||++. ++++||||+...
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 9999999999999998 999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=435.34 Aligned_cols=263 Identities=30% Similarity=0.591 Sum_probs=232.1
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
..+-.++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 345567899999999999999999999999999999999877655444556788999999877 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~-- 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-- 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--
Confidence 99999999999999999976 789999999999999999999999999999999999999999999999999987422
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------cHHHHHHHHHcCCCCCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------NIVSMYRKIYRGDFKCPP 242 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~~~ 242 (441)
.......+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||... ....++..+......+|.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred cCCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 23344567899999999999998877 48999999999999999999999632 344577888889999999
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCcccCccC
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAI------SKIMESSWFKKSA 279 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~------~eil~hpwf~~~~ 279 (441)
.+++++++||++||+.||.+||++ ++|++||||+...
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 999999999999999999999995 7999999998643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=426.08 Aligned_cols=258 Identities=34% Similarity=0.674 Sum_probs=238.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999998765444445678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 99999999999999986 7899999999999999999999999999999999999999999999999999975432
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+...++.++..+...+|..+++++.+||.+
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23467899999999999887774 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCcccCccC
Q 013522 255 LLDPNPNSRIA-----ISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~t-----~~eil~hpwf~~~~ 279 (441)
||+.||.+||+ +++|++||||+...
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 99999999998 99999999998643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=427.62 Aligned_cols=262 Identities=31% Similarity=0.573 Sum_probs=236.5
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
..+..++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 345678999999999999999999999999999999999876544444567788999999988 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 99999999999999999986 7899999999999999999999999999999999999999999999999999874221
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 251 (441)
......+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.+...++.++..+...+|..+++++.+|
T Consensus 174 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 251 (353)
T 2i0e_A 174 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI 251 (353)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 2234567789999999999988777 58999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 252 ITKLLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 252 i~~~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
|.+||..||.+||+ +.++++||||+..
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999995 6999999999854
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=422.71 Aligned_cols=261 Identities=31% Similarity=0.598 Sum_probs=234.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
+..++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999887665556677899999999988 899999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--T
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--C
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999874221 2
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC---------CcHHHHHHHHHcCCCCCCCCC
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---------DNIVSMYRKIYRGDFKCPPWF 244 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~ 244 (441)
.....+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.. .+...++..+......+|..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 334567789999999999988777 5899999999999999999999975 344567778888888999999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCH------HHHhcCcccCccC
Q 013522 245 SSEARRLITKLLDPNPNSRIAI------SKIMESSWFKKSA 279 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~------~eil~hpwf~~~~ 279 (441)
++++++||.+||+.||.+||++ .++++||||+...
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 9999999999999999999995 8999999997643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=413.34 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=229.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 567899999999999999999999999999999999765432 34678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 97 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||+.||+|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--cccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999875432 2233
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLIT 253 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~ 253 (441)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....|..+++.+.+||.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence 456689999999999988877 48999999999999999999999988776655555433 33456678999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+||+.||++|||+.++++||||+...+
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHccCChhHCcCHHHHhhChhhcccCc
Confidence 999999999999999999999986543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-54 Score=429.44 Aligned_cols=264 Identities=28% Similarity=0.536 Sum_probs=235.9
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
...+..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34566789999999999999999999999999999999998765544455678899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 99999999999999999986 679999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCcccccccCCCccchhhhhcc--CCCCCcccHHHHHHHHHHHhhCCCCCCC---CcHHHHHHHHHcCCCCCCCCCCH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDFKCPPWFSS 246 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~ 246 (441)
......+.+||+.|+|||++... ...+.++|||||||++|+|++|..||.. .....+...+......+|..+++
T Consensus 167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 167 -RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp -TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 23445678899999999999642 2235889999999999999999999974 44566777778888889999999
Q ss_pred HHHHHHHHhcCCCCCCCCC-HHHHhcCcccCccC
Q 013522 247 EARRLITKLLDPNPNSRIA-ISKIMESSWFKKSA 279 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t-~~eil~hpwf~~~~ 279 (441)
++.+||.+||+.||.+||+ ++++++||||+...
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 9999999999999999998 89999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=423.69 Aligned_cols=273 Identities=38% Similarity=0.664 Sum_probs=219.9
Q ss_pred CCCCCCCCCCCCC-CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC
Q 013522 1 MATSNSNGGGDDR-PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79 (441)
Q Consensus 1 m~~~~~~~~~~~~-~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp 79 (441)
|+......++... .....++|++++.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.+++.++||
T Consensus 1 m~~~~~~~~p~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp 76 (361)
T 3uc3_A 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHP 76 (361)
T ss_dssp ----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCT
T ss_pred CCCCCCCCCCCCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCC
Confidence 4444444444333 344568999999999999999999999999999999999765433 25688999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC--
Q 013522 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-- 156 (441)
Q Consensus 80 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~-- 156 (441)
||+++++++.+.+.+|+||||+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 77 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~ 156 (361)
T 3uc3_A 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR 156 (361)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCC
T ss_pred CCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCce
Confidence 999999999999999999999999999999975 78999999999999999999999999999999999999987765
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHH
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRK 232 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~ 232 (441)
+||+|||+|.... ........+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+ .......
T Consensus 157 ~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 233 (361)
T 3uc3_A 157 LKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233 (361)
T ss_dssp EEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH
T ss_pred EEEeecCcccccc---ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 9999999987422 22234556799999999999988887666999999999999999999998743 3455666
Q ss_pred HHcCCCCCCC--CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 233 IYRGDFKCPP--WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 233 i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+.......|. .+++++.+||.+||..||.+|||+.++++||||.+..+
T Consensus 234 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 7766666665 47999999999999999999999999999999976543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=426.07 Aligned_cols=263 Identities=35% Similarity=0.604 Sum_probs=229.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH-HHhCCCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV-MKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~ 92 (441)
+....++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 44567899999999999999999999999999999999988766554455667778877 57789999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~- 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE- 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-
Confidence 99999999999999999976 7799999999999999999999999999999999999999999999999999874322
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRL 251 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 251 (441)
......+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+...++.++......+|+.+++++++|
T Consensus 192 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 192 -HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHL 269 (373)
T ss_dssp -CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHH
T ss_pred -CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHH
Confidence 23345678999999999999887774 8999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCH----HHHhcCcccCccC
Q 013522 252 ITKLLDPNPNSRIAI----SKIMESSWFKKSA 279 (441)
Q Consensus 252 i~~~L~~dP~~R~t~----~eil~hpwf~~~~ 279 (441)
|.+||+.||.+||++ .++++||||+...
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 999999999999997 6999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=417.51 Aligned_cols=261 Identities=34% Similarity=0.616 Sum_probs=226.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 678999999999999999999999999999999999755432 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 9999999999999986 579999999999999999999999999999999999999999999999999998665444444
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCCC--CCCCHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP--PWFSSEARRLI 252 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~~~~~~~li 252 (441)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 5567789999999999988877778899999999999999999999876543 33344444443333 34899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+||..||++|||+.++++||||+...
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=434.37 Aligned_cols=261 Identities=36% Similarity=0.668 Sum_probs=231.7
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
....+.++|++++.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 3456788999999999999999999999999999999999876543 244677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC---CCCCeEEeecCccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFS 168 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~---~~~~vkl~DFGla~~~ 168 (441)
..|+||||+.||+|++.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999999875 7799999999999999999999999999999999999998 4578999999999754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----CC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WF 244 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~ 244 (441)
.. ........+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+...++..+..+.+.+|. .+
T Consensus 164 ~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 164 EG--EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp CT--TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cC--CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 43 2233456789999999999988777 48999999999999999999999999999999999988776653 57
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
++++.+||.+||++||++|||+.++|+||||+.
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=416.10 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=230.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.+.++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 36789999999999999999999999999999999986442 33467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC--CCCeEEeecCcccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~--~~~vkl~DFGla~~~~~~ 171 (441)
+||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 99999999999999976 46999999999999999999999999999999999999987 78999999999976432
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 247 (441)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+...++ +.++++
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 334456789999999999987655 5899999999999999999999999999999999988887765 368999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+||.+||..||.+|||+.++++||||++.
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=415.87 Aligned_cols=264 Identities=35% Similarity=0.640 Sum_probs=225.1
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
.+..+..++|++.+.||+|+||+||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||++++++
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 345567789999999999999999999985 689999999998654322 2234567899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
+.+.+.+|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999999999975 779999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCH
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSS 246 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 246 (441)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|+.+++
T Consensus 170 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 246 (327)
T 3a62_A 170 ESIH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCH
T ss_pred cccc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence 4322 2223456789999999999988776 589999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCC-----CHHHHhcCcccCcc
Q 013522 247 EARRLITKLLDPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
++++||.+||..||.+|| ++.++++||||+..
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999999 88999999999854
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=411.68 Aligned_cols=261 Identities=37% Similarity=0.670 Sum_probs=224.0
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc-----------------------hhhHHHHHHHH
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----------------------VGMMEQIKREI 70 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~Ei 70 (441)
..+..++|++.+.||+|+||+||+|++..+++.||+|++....... ....+.+.+|+
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 3456789999999999999999999999999999999997654321 11235688999
Q ss_pred HHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCc
Q 013522 71 SVMKMVKHKHIVELHEVMAS--KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPEN 148 (441)
Q Consensus 71 ~il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~N 148 (441)
.+|+.++||||+++++++.+ ...+|+||||+.+++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 88 AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999999986 6789999999999999998877889999999999999999999999999999999999
Q ss_pred EEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCC--CCCcccHHHHHHHHHHHhhCCCCCCCCcH
Q 013522 149 LLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNI 226 (441)
Q Consensus 149 ILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~~ll~G~~Pf~~~~~ 226 (441)
||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999875432 2223455689999999999876542 35789999999999999999999999988
Q ss_pred HHHHHHHHcCCCCCC--CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 227 VSMYRKIYRGDFKCP--PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 227 ~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
......+.......| +.+++++.+||.+||+.||++|||+.++++||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 888888877766554 46899999999999999999999999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=417.56 Aligned_cols=248 Identities=19% Similarity=0.289 Sum_probs=196.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS----K 93 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~ 93 (441)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+..++|||||++++++.+++ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 46799999999999999999998 789999999965421 1223345677777899999999999997653 6
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 94 IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~--------gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
+|||||||+||+|.+++...+++++.+..++.|++.||+|||++ ||+||||||+|||++.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999998899999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccc--CCcccccccCCCccchhhhhccCC-----CCCcccHHHHHHHHHHHhhCCCCCCCC--------------
Q 013522 166 AFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGY-----DGAKADIWSCGVILYVLLAGFLPFQDD-------------- 224 (441)
Q Consensus 166 ~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~~ll~G~~Pf~~~-------------- 224 (441)
+....... .....+.+||+.|+|||++.+... .+.++|||||||+||||+||.+||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 122345689999999999975421 246899999999999999997765321
Q ss_pred -cHHHHHHHHHcCC--CCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 225 -NIVSMYRKIYRGD--FKCPPW-----FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 225 -~~~~~~~~i~~~~--~~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....+...+.... +.+|.. .++.+.+|+.+||+.||++|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 2234444444332 233332 2246789999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=432.24 Aligned_cols=263 Identities=33% Similarity=0.538 Sum_probs=231.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34578999999999999999999999999999999997654333233456789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
+||||++||+|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....... ..
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EE
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999997543211 11
Q ss_pred cccccccCCCccchhhhhccCC---CCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCC--CCCCHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGY---DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP--PWFSSEA 248 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~---~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~ 248 (441)
...+.+||+.|+|||++.+.+. .+.++|||||||++|+|++|.+||.+.+....+.++..+. ..+| ..+++++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 2346789999999999986552 3589999999999999999999999999999999887642 3444 4689999
Q ss_pred HHHHHHhcCCCCCC--CCCHHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNS--RIAISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~--R~t~~eil~hpwf~~~~ 279 (441)
++||.+||..+|.+ |+++++|++||||+...
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 99999999999999 99999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=421.54 Aligned_cols=259 Identities=36% Similarity=0.678 Sum_probs=232.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 345677899999999999999999999999999999999876543 3456789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEeecCcccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSE 169 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~DFGla~~~~ 169 (441)
.|+||||+.||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999999975 6799999999999999999999999999999999999998654 59999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCC
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFS 245 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~ 245 (441)
. .......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+...++..+..+.+.+|. .++
T Consensus 183 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (362)
T 2bdw_A 183 D---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258 (362)
T ss_dssp T---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSC
T ss_pred C---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 2 2334567899999999999887774 8999999999999999999999999999999999888776653 479
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+++.+||.+||..||++|||+.++|+||||..
T Consensus 259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=412.67 Aligned_cols=262 Identities=33% Similarity=0.588 Sum_probs=233.6
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
....+.++|++++.||+|+||+||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 84 (326)
T 2y0a_A 5 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84 (326)
T ss_dssp BCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345677899999999999999999999999999999999986543221 13578999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----CeEEeecCc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGL 164 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~----~vkl~DFGl 164 (441)
+....|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999999999976 6799999999999999999999999999999999999999887 799999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC---
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--- 241 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 241 (441)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++
T Consensus 165 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 165 AHKIDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 240 (326)
T ss_dssp CEECCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CeECCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc
Confidence 975432 233456789999999999987776 4899999999999999999999999988888888887776654
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 -PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 -~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 4689999999999999999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=433.50 Aligned_cols=261 Identities=33% Similarity=0.638 Sum_probs=227.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 45568899999999999999999999999999999999876544444556788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 999999999999999976 779999999999999999999998 9999999999999999999999999999874322
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+...+...+......+|..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 2234556789999999999988777 589999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCcccCcc
Q 013522 253 TKLLDPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 253 ~~~L~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
.+||++||.+|| |+.++++||||+..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999999 99999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=401.79 Aligned_cols=266 Identities=44% Similarity=0.811 Sum_probs=230.5
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+.+..++|++++.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34566789999999999999999999999999999999999765433334467889999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999999975 7799999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARR 250 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 250 (441)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....|..+++.+.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22344567999999999998877766899999999999999999999999998888999988888889999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 251 LITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
||.+||+.||.+|||+.++++||||++..+
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 999999999999999999999999986553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=401.92 Aligned_cols=257 Identities=31% Similarity=0.529 Sum_probs=218.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999986653 2345577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.| ++.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 157 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCSC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--cccc
Confidence 99987 55555543 7799999999999999999999999999999999999999999999999999975432 2233
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCC-CCCCcHHHHHHHHHcC--C----------------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYRG--D---------------- 237 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~--~---------------- 237 (441)
....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+... .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45667999999999998777567999999999999999987776 5666666666555331 0
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 -----------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...++.+++++++||.+||+.||++|||++++++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011234788999999999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=409.18 Aligned_cols=263 Identities=29% Similarity=0.444 Sum_probs=218.1
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.....+.++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 345568899999999999999999999984 689999999975532 223457788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999999986 78887765 459999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCC--------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFK-------- 239 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~-------- 239 (441)
. ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ...
T Consensus 171 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 I--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp S--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred C--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 2 2233455679999999999987555569999999999999999999999876655544444321 000
Q ss_pred --------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 --------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 --------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+.+++++.+||.+||++||++|||+.++++||||++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1234678999999999999999999999999999998654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=417.71 Aligned_cols=260 Identities=34% Similarity=0.644 Sum_probs=226.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
...+.++|++.+.||+|+||+||+|++..+|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3467789999999999999999999999999999999997543221 11357789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC---eEEeecC
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFG 163 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~---vkl~DFG 163 (441)
+.+|+|||||.|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999999888753 24899999999999999999999999999999999999987665 9999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC--
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP-- 241 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 241 (441)
++..... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ...+..+..+....+
T Consensus 179 ~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 179 VAIQLGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp TCEECCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred ceeEecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 9975443 1223456789999999999988777 589999999999999999999998864 456677777776654
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 242 --PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 242 --~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+.+++++++||.+||..||++|||+.++++||||+.
T Consensus 255 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 468999999999999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=401.65 Aligned_cols=260 Identities=33% Similarity=0.660 Sum_probs=233.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
....++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34568999999999999999999999999999999999765544434467789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+.+++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999998864332
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.+||.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred -ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 22345679999999999987665 5899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+||+.||.+|||+.++++||||+...
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHhccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999999997644
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-53 Score=428.84 Aligned_cols=264 Identities=29% Similarity=0.520 Sum_probs=229.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999976543333334458899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ..
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~ 230 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GT 230 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SC
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-CC
Confidence 9999999999999976 68999999999999999999999999999999999999999999999999999654321 11
Q ss_pred CcccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCC---CCC
Q 013522 175 GLLHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPP---WFS 245 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~---~~~ 245 (441)
......+||+.|+|||++.. ....+.++|||||||++|+|++|++||.+.+..+.+.++... .+.+|. .++
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 310 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence 12344689999999999972 233368999999999999999999999999999888888653 345554 489
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHHHHhcCcccCccCCc
Q 013522 246 SEARRLITKLLDPNPNS--RIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~--R~t~~eil~hpwf~~~~~~ 281 (441)
+++++||++||..+|++ |++++++++||||+.....
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 99999999999999988 9999999999999865443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=419.83 Aligned_cols=263 Identities=28% Similarity=0.419 Sum_probs=213.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKS- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~- 92 (441)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++.+.. ........+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 456789999999999999999999999999999999986543 23345677889999999997 999999999997544
Q ss_pred -EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 -KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 -~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+. ++|...+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999997 58999998888999999999999999999999999999999999999999999999999999754321
Q ss_pred -------------------ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHH
Q 013522 172 -------------------KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK 232 (441)
Q Consensus 172 -------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 232 (441)
.........+||++|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122345678999999999998755556999999999999999999999999887776666
Q ss_pred HHcCC-C----------------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 013522 233 IYRGD-F----------------------------------------------KCPPWFSSEARRLITKLLDPNPNSRIA 265 (441)
Q Consensus 233 i~~~~-~----------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t 265 (441)
+...- . ..+..+++++.+||.+||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 54210 0 011256889999999999999999999
Q ss_pred HHHHhcCcccCccC
Q 013522 266 ISKIMESSWFKKSA 279 (441)
Q Consensus 266 ~~eil~hpwf~~~~ 279 (441)
+.++|+||||+...
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=398.83 Aligned_cols=261 Identities=36% Similarity=0.687 Sum_probs=236.0
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.....++|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 44566899999999999999999999999999999999976544333445788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
.|+||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 9999999999999999976 7799999999999999999999999999999999999999999999999999864332
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLI 252 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 252 (441)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|+.+++++++||
T Consensus 167 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (284)
T 2vgo_A 167 --LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243 (284)
T ss_dssp --SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred --cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHH
Confidence 22345679999999999987766 489999999999999999999999999888888999888899999999999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+||..||.+|||+.++++||||+...
T Consensus 244 ~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 244 SKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999999997543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=394.27 Aligned_cols=260 Identities=35% Similarity=0.675 Sum_probs=232.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
+.+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 45789999999999999999999999999999999999766543 34567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC---eEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~---vkl~DFGla~~~~~ 170 (441)
|+||||+.|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999988875 77999999999999999999999999999999999999987665 99999999875432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 246 (441)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....| ..+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 233445679999999999988776 5899999999999999999999999999888888888776554 35799
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++.+||.+||++||++|||+.++++||||++..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 999999999999999999999999999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=398.59 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=214.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|++ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 68999999999765432 233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~ 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--cccc
Confidence 99986 89988875 6799999999999999999999999999999999999999999999999999875432 1223
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC----------------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF---------------- 238 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~---------------- 238 (441)
....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+. ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 345679999999999977655569999999999999999999999988776666555331 00
Q ss_pred -----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 239 -----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 239 -----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
..++.+++++.+||.+||+.||++|||+.++++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 012347899999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=421.79 Aligned_cols=263 Identities=29% Similarity=0.518 Sum_probs=227.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998654433334456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~- 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG- 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence 99999999999999976 479999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccccCCCccchhhhhc------cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCC---C
Q 013522 174 DGLLHTTCGTPAYVAPEVISK------KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP---P 242 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~---~ 242 (441)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+....+.++.... ..+| .
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 296 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence 112235689999999999974 1223589999999999999999999999999988888887532 3333 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCcccCccCC
Q 013522 243 WFSSEARRLITKLLDPNPNSR---IAISKIMESSWFKKSAP 280 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R---~t~~eil~hpwf~~~~~ 280 (441)
.+++++++||++||. +|.+| ++++++++||||+....
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 799999999999999 99998 59999999999986543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=414.47 Aligned_cols=262 Identities=23% Similarity=0.400 Sum_probs=219.4
Q ss_pred cccCCeEEeeeeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 16 LLHGKYELGRMLGHG--TFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G--~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
...++|++++.||+| +||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456799999999999 9999999999999999999999876543 3556788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999999975 5699999999999999999999999999999999999999999999999998754322
Q ss_pred cc-----cCCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-----
Q 013522 171 LK-----QDGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----- 238 (441)
Q Consensus 171 ~~-----~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----- 238 (441)
.. ........+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+.......+..+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 1122334579999999999987 344 5899999999999999999999987654443333222111
Q ss_pred -----------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 239 -----------------------------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 239 -----------------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+.+..+++++.+||.+||++||++|||+.++|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 134457899999999999999999999999999999986
Q ss_pred cC
Q 013522 278 SA 279 (441)
Q Consensus 278 ~~ 279 (441)
..
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 54
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=429.99 Aligned_cols=261 Identities=35% Similarity=0.633 Sum_probs=234.7
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
....+.++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34568889999999999999999999999999999999998766544455678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla~~~ 168 (441)
..|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999875 789999999999999999999999999999999999999 46789999999998754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWF 244 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~ 244 (441)
.. .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+.......+..+.+.++ ..+
T Consensus 180 ~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (484)
T 3nyv_A 180 EA---SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254 (484)
T ss_dssp CC---CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGS
T ss_pred cc---ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccC
Confidence 32 334566789999999999976 45 5899999999999999999999999999999999988876543 348
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++++++||.+||++||.+|||+.++|+||||+..
T Consensus 255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999999999754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=400.72 Aligned_cols=262 Identities=32% Similarity=0.577 Sum_probs=233.6
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
....+.++|++++.||+|+||+||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp BCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678899999999999999999999999999999999976543221 13577999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----CeEEeecCc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGL 164 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~----~vkl~DFGl 164 (441)
+.+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999999999976 6789999999999999999999999999999999999999888 799999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC---
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--- 241 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 241 (441)
+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 166 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 166 AHEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CEECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred ceecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 875432 233455679999999999987766 5899999999999999999999999998888888888776665
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 -PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 -~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+++.+.+||.+||.+||++|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 4689999999999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=394.50 Aligned_cols=263 Identities=32% Similarity=0.571 Sum_probs=238.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998776555556778999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+||||+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999876 77999999999999999999999999999999999999999999999999998754321 2
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|..+++.+.+||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 23345679999999999987666 58999999999999999999999999988888889888888999999999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
||+.||++|||+.++++||||.....+
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HcccChhhCcCHHHHhhChheecCCcC
Confidence 999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=411.58 Aligned_cols=258 Identities=28% Similarity=0.535 Sum_probs=229.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3456899999999999999999999999999999999976532 2345788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC--CCCeEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~--~~~vkl~DFGla~~~~~ 170 (441)
|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999999975 46999999999999999999999999999999999999974 46799999999975432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 246 (441)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++ ..+++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 334456689999999999987766 4899999999999999999999999988888888887766544 35799
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++.+||.+||+.||.+|||+.++++||||+...
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=442.96 Aligned_cols=261 Identities=31% Similarity=0.578 Sum_probs=237.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 94 (441)
+..++|++++.||+|+||+||+|++..+++.||||++.+.........+.+..|..++..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999876544444567788999999988 799999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+.||+|.+++.. +++++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 999999999999999986 8899999999999999999999999999999999999999999999999999974322 2
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLIT 253 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~ 253 (441)
.....+.+||+.|+|||++.+..| +.++|||||||+||+|++|.+||.+.+..+++..|......+|..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 334567899999999999988877 5899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCH-----HHHhcCcccCccC
Q 013522 254 KLLDPNPNSRIAI-----SKIMESSWFKKSA 279 (441)
Q Consensus 254 ~~L~~dP~~R~t~-----~eil~hpwf~~~~ 279 (441)
+||+.||.+||++ ++|++||||+...
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 9999999999998 9999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=392.51 Aligned_cols=255 Identities=37% Similarity=0.637 Sum_probs=230.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.+.++|++.+.||+|+||+||+|.+..++..+|+|++...... ..+.+.+|+.+++.++||||+++++++.+....|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 4678999999999999999999999999999999999765432 3568899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCcccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla~~~~~~ 171 (441)
+||||+.|++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~-- 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-- 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc--
Confidence 99999999999998875 779999999999999999999999999999999999999 788899999999987543
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~ 247 (441)
........+||+.|+|||++.+. .+.++|||||||++|+|++|..||...+.......+..+....|. .+++.
T Consensus 161 -~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 161 -PGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp -TTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred -CccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 23344567899999999998654 468999999999999999999999999998999999888877765 58999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+||.+||++||.+|||+.++++||||++.
T Consensus 238 ~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=426.05 Aligned_cols=261 Identities=36% Similarity=0.625 Sum_probs=229.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch----------hhHHHHHHHHHHHHhCCCCCcceE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----------GMMEQIKREISVMKMVKHKHIVEL 84 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l 84 (441)
..+.++|++++.||+|+||+||+|++..+++.||+|++.+...... ...+.+.+|+.+|+.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3577899999999999999999999999999999999986543221 335678999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEe
Q 013522 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVT 160 (441)
Q Consensus 85 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~ 160 (441)
++++.+...+|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999999875 7899999999999999999999999999999999999999876 69999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 240 (441)
|||+|..... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+...+...+..+.+.+
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999976442 334566789999999999874 45 589999999999999999999999999999999999988766
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 241 P----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 241 ~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+ +.+++++++||++||++||.+|||+.++|+||||+....
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 5 468999999999999999999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=402.45 Aligned_cols=262 Identities=32% Similarity=0.576 Sum_probs=238.8
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
..++|++++.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999987765555667889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--cc
Confidence 9999999999999876 77999999999999999999999999999999999999999999999999998754321 22
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 255 (441)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|..+++.+.+||.+|
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 3445679999999999987766 589999999999999999999999998888888888888899999999999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 256 LDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
|+.||++|||+.++++||||.....+
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ccCChhHCcCHHHHhcCccccCCCcc
Confidence 99999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=431.87 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=233.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 55678999999999999999999999999999999998765444445677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+||||+.||+|.+++.. + .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~--- 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--- 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc---
Confidence 99999999999999975 2 39999999999999999999999999999999999999999999999999997543
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
........+||+.|+|||++.+..|. .++|||||||++|+|++|..||... ....+...+......+|..+++++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cCccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 22334567899999999999887764 8999999999999999999999875 346677778888888899999999
Q ss_pred HHHHHHhcCCCCCCCC-----CHHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
++||.+||+.||.+|| ++.++++||||+...
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 9999999999999999 799999999998643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=408.90 Aligned_cols=253 Identities=32% Similarity=0.628 Sum_probs=223.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++.+... ...+|+.++.++ +||||+++++++.+...
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 4577899999999999999999999999999999999976543 234688888887 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-C---CeEEeecCccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-G---NLKVTDFGLSAFS 168 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~---~vkl~DFGla~~~ 168 (441)
+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999999976 679999999999999999999999999999999999998543 3 4999999999754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC---CcHHHHHHHHHcCCCCCC----
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDFKCP---- 241 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~~---- 241 (441)
.. ......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.. .+...+...+..+.+..+
T Consensus 171 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 171 RA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp BC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred cC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 32 23345678899999999999877664 899999999999999999999975 466778888888877654
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+.+++++++||++||..||++|||+.++++||||..
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 458999999999999999999999999999999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=397.95 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=216.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 35799999999999999999999999999999999866542 23445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--ccc
Confidence 9999999999998875 6799999999999999999999999999999999999999999999999999975442 222
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------------
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------------- 236 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 236 (441)
.....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3456689999999999987555569999999999999999999999988766555443221
Q ss_pred --CCCCC----------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 --DFKCP----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 --~~~~~----------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+.+ +.+++++.+||.+||++||.+|||+.++++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 01111 34788999999999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=403.65 Aligned_cols=258 Identities=29% Similarity=0.473 Sum_probs=207.5
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++++.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 4689999999999999999999999999999999976542 22346788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 98 MDLVKGGELFNKIAK-------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
|||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999985 89988864 3489999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC----------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF---------- 238 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~---------- 238 (441)
........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 --PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 1223456689999999999987555568999999999999999999999998877766665431 00
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 239 ----------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 239 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
..+..+++++.+||.+||++||++|||+.++++||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 011246889999999999999999999999999999987543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=398.23 Aligned_cols=262 Identities=32% Similarity=0.600 Sum_probs=219.2
Q ss_pred CccccCCeEEe-eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013522 14 PTLLHGKYELG-RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK 91 (441)
Q Consensus 14 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 91 (441)
...+.++|++. +.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++++ +||||+++++++.+.
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 34577899995 789999999999999999999999999976532 3356788999999985 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC---eEEeecCcccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGLSAF 167 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~---vkl~DFGla~~ 167 (441)
+.+|+||||+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999976 77999999999999999999999999999999999999998776 99999999875
Q ss_pred cccccc-----CCcccccccCCCccchhhhhc-----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCc------------
Q 013522 168 SEHLKQ-----DGLLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDN------------ 225 (441)
Q Consensus 168 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~------------ 225 (441)
...... .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 432111 122345679999999999975 334 488999999999999999999997753
Q ss_pred ---HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 226 ---IVSMYRKIYRGDFKCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 226 ---~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...+...+..+...+| ..+++.+++||.+||+.||.+|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2456677777777766 35899999999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=405.77 Aligned_cols=262 Identities=28% Similarity=0.437 Sum_probs=212.7
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.....++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 45677899999999999999999999999999999999976543 22345667899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-----CCCCeEEeecCcccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-----EDGNLKVTDFGLSAF 167 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-----~~~~vkl~DFGla~~ 167 (441)
+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 99999876 6799999999999999999999999999999999999994 445599999999976
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCC-----
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKC----- 240 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~----- 240 (441)
... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .+..
T Consensus 187 ~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 442 1233455678999999999987665579999999999999999999999998877766665432 1100
Q ss_pred ----C-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 241 ----P-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 241 ----~-------------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+ ..+++++.+||.+||++||++|||+.++++||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 0 11678999999999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=427.68 Aligned_cols=261 Identities=27% Similarity=0.456 Sum_probs=233.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45578999999999999999999999999999999998765544445678889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999999864 3599999999999999999999999999999999999999999999999999975432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~ 246 (441)
. .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+. +...+...+......+|+.+++
T Consensus 342 ~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 342 G--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp T--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 1 2223456899999999999887774 8999999999999999999999875 4567788888888889999999
Q ss_pred HHHHHHHHhcCCCCCCCCC-----HHHHhcCcccCccC
Q 013522 247 EARRLITKLLDPNPNSRIA-----ISKIMESSWFKKSA 279 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t-----~~eil~hpwf~~~~ 279 (441)
++.+||.+||+.||.+||+ +++|++||||+...
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 9999999999999999996 58999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-52 Score=395.61 Aligned_cols=259 Identities=32% Similarity=0.654 Sum_probs=206.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999765443334467899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+.+++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--~~ 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--HE 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--CC
Confidence 999999999999976 56999999999999999999999999999999999999999999999999998754322 12
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHh
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKL 255 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 255 (441)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+|
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHH
T ss_pred cceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHH
Confidence 2345679999999999987665 589999999999999999999999877666666666667778888999999999999
Q ss_pred cCCCCCCCCCHHHHhcCcccCccC
Q 013522 256 LDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 256 L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|..||++|||+.++++||||....
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC---
T ss_pred cccCHhhCCCHHHHhcCccccCCC
Confidence 999999999999999999997543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=425.67 Aligned_cols=261 Identities=34% Similarity=0.627 Sum_probs=229.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
...+.++|++++.||+|+||+||+|++..+++.||+|++.+..... .....+.+|+.+|+.++||||+++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 4468899999999999999999999999999999999997654322 335788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC---CCCCeEEeecCcccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~---~~~~vkl~DFGla~~~~ 169 (441)
+|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999998865 7899999999999999999999999999999999999995 45579999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFS 245 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~ 245 (441)
. .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+...+...+..+.+.++ ..++
T Consensus 176 ~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 176 Q---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp C---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred C---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 2 234456789999999999875 35 5899999999999999999999999999999999988876543 2479
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+++++||.+||.+||.+|||+.++|+||||+....
T Consensus 251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 99999999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=397.23 Aligned_cols=254 Identities=25% Similarity=0.463 Sum_probs=225.7
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
.|+..+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48899999999999999999999999999999976543 235678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
|+.|++|.+++...++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cccccc
Confidence 999999999998888999999999999999999999999999999999999999999999999998754331 223345
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHhc
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---CPPWFSSEARRLITKLL 256 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~~L 256 (441)
.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.....+ .+..+++.+.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 689999999999987766 48999999999999999999999998887777777665432 23457899999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCccC
Q 013522 257 DPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+.||++|||+.++++||||....
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGCC
T ss_pred cCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999997644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=389.83 Aligned_cols=261 Identities=34% Similarity=0.616 Sum_probs=227.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.++|++++.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 567899999999999999999999999999999999765432 345788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999999976 579999999999999999999999999999999999999999999999999997654433334
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCCC--CCCCHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP--PWFSSEARRLI 252 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~~~~~~~li 252 (441)
.....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 4556789999999999988777668899999999999999999999876543 33344444333333 35899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+||..||++|||+.++++||||+...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=397.21 Aligned_cols=261 Identities=26% Similarity=0.436 Sum_probs=214.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCC---CCCcceEEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVK---HKHIVELHEVM 88 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~ 88 (441)
+.++.++|++++.||+|+||+||+|++..+++.||+|++...... .......+.+|+.+++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 456788999999999999999999999999999999999754321 1112345678888877764 99999999999
Q ss_pred EeCC-----EEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEe
Q 013522 89 ASKS-----KIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 89 ~~~~-----~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
.... .+++||||+.| +|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 68999999975 999999763 38999999999999999999999999999999999999999999999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--C
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--F 238 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~ 238 (441)
|||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+......++.... .
T Consensus 163 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eCccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999975432 334456789999999999988777 489999999999999999999999988877776664321 0
Q ss_pred C-------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 K-------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 ~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+ ..+.+++.+.+||.+||++||++|||+.++|+||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0 1134788999999999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=423.23 Aligned_cols=257 Identities=27% Similarity=0.469 Sum_probs=213.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 35689999999999999999999999999999999997653 2334567889999999999999999999999654
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..+|+||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 468999999976 57776654 49999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------- 236 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 236 (441)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+....+.++.+.
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345667899999999999988775 8999999999999999999999998877766665431
Q ss_pred ---------C-----CCCCCCC---------------CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 ---------D-----FKCPPWF---------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ---------~-----~~~~~~~---------------~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. ..++..+ ++++++||.+||.+||++|||++|+|+||||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0 0001001 46799999999999999999999999999998543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=424.48 Aligned_cols=256 Identities=36% Similarity=0.631 Sum_probs=223.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.+.++|++++.||+|+||+||+|++..++..||+|++.+..... .....+.+|+.+++.++||||+++++++.+...+|
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45668999999999999999999999999999999998765332 23567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC---CCeEEeecCcccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---GNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~---~~vkl~DFGla~~~~~~ 171 (441)
+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~- 191 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN- 191 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence 99999999999998865 789999999999999999999999999999999999999764 4599999999976543
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 247 (441)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+...+...+..+.+.++ +.+++.
T Consensus 192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 233456789999999999864 45 5899999999999999999999999999999999988876654 248999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+++||.+||++||.+|||+.++|+||||+.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=409.47 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=216.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 35689999999999999999999999999999999996543 2334567889999999999999999999999765
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999998889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-----------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF----------- 238 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 238 (441)
. .....+||++|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 244568999999999998744456899999999999999999999999887766655533100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 --------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 --------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...+..++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12245689999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=403.76 Aligned_cols=256 Identities=37% Similarity=0.656 Sum_probs=210.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..+.++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 456788999999999999999999999999999999997543 235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~DFGla~~~~~ 170 (441)
|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999976 67999999999999999999999999999999999999975 88999999999875432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCCC----CCCC
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP----PWFS 245 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~~ 245 (441)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ..+..+.......+ +.++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ---ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 233456789999999999987766 58999999999999999999999776544 46677777655443 3578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++.+||.+||..||++|||+.++++||||....
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999999998643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=403.68 Aligned_cols=254 Identities=37% Similarity=0.701 Sum_probs=204.7
Q ss_pred ccCCeEEe---eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 013522 17 LHGKYELG---RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKS 92 (441)
Q Consensus 17 ~~~~y~i~---~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~ 92 (441)
+.++|++. +.||+|+||+||+|.+..+++.||+|++.+. ....+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 45678886 7899999999999999999999999999654 2457789999999997 999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEeecCccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFS 168 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~DFGla~~~ 168 (441)
..|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999976 6799999999999999999999999999999999999998766 7999999999754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc-------HHHHHHHHHcCCCCCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN-------IVSMYRKIYRGDFKCP 241 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~~~~~~~~ 241 (441)
.. ......+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+ .......+..+.+.++
T Consensus 160 ~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 160 PP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 32 22345567899999999999887774 89999999999999999999997643 3567788888877665
Q ss_pred C----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 242 P----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 242 ~----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. .+++++++||.+||.+||.+|||+.++++||||+...
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 3 4899999999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=390.56 Aligned_cols=257 Identities=32% Similarity=0.587 Sum_probs=221.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+..+.++|++.+.||+|+||+||+|.+..++..+|+|++...... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 345788999999999999999999999999999999999765432 235788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCcc
Q 013522 94 IYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLS 165 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla 165 (441)
.|+||||+.|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999998853 579999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC---C
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP---P 242 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---~ 242 (441)
..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ .
T Consensus 175 ~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 175 ELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred eecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence 75443 233456679999999999864 44 5899999999999999999999999988887777766554443 2
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+++++.+||.+||++||++|||+.++++||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 37899999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=404.46 Aligned_cols=264 Identities=33% Similarity=0.538 Sum_probs=224.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
.+.++|++++.||+|+||+||+|++..+++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4678999999999999999999999999999999999765432 23456789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 013522 94 IYFAMDLVKGGELFNKIAK-----------------------------------------GRLREDVARVYFQQLISAVD 132 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-----------------------------------------~~l~~~~~~~~~~qll~aL~ 132 (441)
.|+||||++||+|.+++.. ..+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998851 12367888999999999999
Q ss_pred HHhhcCcEeccCCCCcEEeCCCC--CeEEeecCccccccccccCC--cccccccCCCccchhhhhcc-CCCCCcccHHHH
Q 013522 133 FCHSRGVYHRDLKPENLLLDEDG--NLKVTDFGLSAFSEHLKQDG--LLHTTCGTPAYVAPEVISKK-GYDGAKADIWSC 207 (441)
Q Consensus 133 ylH~~gi~HrDLkp~NILl~~~~--~vkl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSl 207 (441)
|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998777 89999999998654322221 24566799999999999752 334589999999
Q ss_pred HHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 208 GVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 208 Gvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||++|+|++|..||.+.+.......+.......+. .+++++.+||.+||++||.+|||+.++++||||+...
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999999888888888777654432 3789999999999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=402.10 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=221.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----- 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 90 (441)
...++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 3568999999999999999999999999999999999765432 2334567799999999999999999999977
Q ss_pred ---CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 91 ---KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 91 ---~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
.+.+|+||||+.| +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4578999999976 77777765 67999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCC
Q 013522 166 AFSEHLK--QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW 243 (441)
Q Consensus 166 ~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 243 (441)
....... ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.......++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7654222 22334566799999999999876555799999999999999999999999988877766664422111111
Q ss_pred --------------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 244 --------------------------------FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 244 --------------------------------~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
.++.+.+||.+||+.||++|||+.++++||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 2677999999999999999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=411.09 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=212.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK--- 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--- 91 (441)
-.+.++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 457889999999999999999999999999999999997543 2334567899999999999999999999999766
Q ss_pred --CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
..+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 57999999996 599999987 56999999999999999999999999999999999999999999999999999865
Q ss_pred cccccC--------------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-----------
Q 013522 169 EHLKQD--------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG----------- 217 (441)
Q Consensus 169 ~~~~~~--------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G----------- 217 (441)
...... ......+||++|+|||++......+.++|||||||++|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 432211 2346778999999999976555556999999999999999984
Q ss_pred CCCCCCCcH-----------------HHHHH------------------------HHHcCCCCCC-------CCCCHHHH
Q 013522 218 FLPFQDDNI-----------------VSMYR------------------------KIYRGDFKCP-------PWFSSEAR 249 (441)
Q Consensus 218 ~~Pf~~~~~-----------------~~~~~------------------------~i~~~~~~~~-------~~~~~~~~ 249 (441)
.++|.+.+. ..... .+.......+ +.+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 444444320 11111 1111111111 45799999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+||++||+.||++|||++++|+||||+....
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999999999999986543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=403.36 Aligned_cols=253 Identities=25% Similarity=0.442 Sum_probs=219.3
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----HKHIVELHEV 87 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~ 87 (441)
.+.++.++|++++.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.+. ||||++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 45678899999999999999999999999999999999996432 33567788999999996 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-----------
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE----------- 153 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~----------- 153 (441)
+...+..|+||||+ |++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 99999999999999 88999999763 4999999999999999999999999999999999999975
Q ss_pred --------------CCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCC
Q 013522 154 --------------DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL 219 (441)
Q Consensus 154 --------------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~ 219 (441)
++.+||+|||+|..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCC
Confidence 78899999999975332 23456799999999999888774 89999999999999999999
Q ss_pred CCCCCcHHHHHHHHHcCCCCCCC----------------------------------------------CCCHHHHHHHH
Q 013522 220 PFQDDNIVSMYRKIYRGDFKCPP----------------------------------------------WFSSEARRLIT 253 (441)
Q Consensus 220 Pf~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~li~ 253 (441)
||...+.......+.....+.|. ..++.+.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 99988777666655443222221 12367889999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccC
Q 013522 254 KLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+||++||.+|||+.++|+||||+
T Consensus 338 ~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999995
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=418.26 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=200.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----- 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 90 (441)
.+.++|++++.||+|+||+||+|++..+++.||||++.+.. ......+++.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 45689999999999999999999999999999999996543 233456788999999999999999999999843
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
...+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 5689999886 679999999999999999999999999999999999999999999999999998654
Q ss_pred ccccC-------------------------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh--------
Q 013522 170 HLKQD-------------------------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-------- 216 (441)
Q Consensus 170 ~~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-------- 216 (441)
..... ......+||++|+|||++......+.++|||||||+||+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 22111 134566899999999987655545699999999999999998
Q ss_pred ---CCCCCCCCcH--------------------HHHHHHHHc--CC--------------------C---------CCCC
Q 013522 217 ---GFLPFQDDNI--------------------VSMYRKIYR--GD--------------------F---------KCPP 242 (441)
Q Consensus 217 ---G~~Pf~~~~~--------------------~~~~~~i~~--~~--------------------~---------~~~~ 242 (441)
|.+||.+.+. ......+.. +. . ...+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777766431 111111110 00 0 0123
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..++++.+||++||..||++|||++++|+||||+...
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 4689999999999999999999999999999998654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=406.06 Aligned_cols=255 Identities=31% Similarity=0.543 Sum_probs=224.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV-----GMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
.+.++|++.+.||+|+||+||+|++..+++.||+|++........ .....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 466899999999999999999999999999999999987653221 123456789999999999999999999999
Q ss_pred CCEEEEEEeccCCC-chHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 KSKIYFAMDLVKGG-ELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 ~~~~~lv~E~~~gg-~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.+..++||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999776 99999986 57999999999999999999999999999999999999999999999999999754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
.. .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..... ........|..+++++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHHH
Confidence 32 33445678999999999999888877899999999999999999999976432 2334455677789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+||.+||++||++|||+.++++||||+...
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999999999999999999998644
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=403.16 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=222.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
+.++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 3479999999999999999999999999999999997432 234457888999999999999999999999765
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
...|+||||+.| +|.+++..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 478999999975 9999999888999999999999999999999999999999999999999999999999999865433
Q ss_pred cc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC----------
Q 013522 172 KQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF---------- 238 (441)
Q Consensus 172 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~---------- 238 (441)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+... .+
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 223456689999999999876665569999999999999999999999887766555544321 00
Q ss_pred --------------C-----CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 --------------K-----CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 --------------~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. .++.+++++.+||.+||++||++|||+.++|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 0 1245789999999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=395.95 Aligned_cols=264 Identities=33% Similarity=0.621 Sum_probs=228.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceEEEEE--EeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKHKHIVELHEVM--ASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~ 92 (441)
.+.++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 36789999999999999999999999999999999997654321 23457899999999999999999999998 4456
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..|+||||+.++ |.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999886 6666653 679999999999999999999999999999999999999999999999999997654
Q ss_pred ccccCCcccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
............||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+..+....|..+++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 433344445667999999999997643 3357899999999999999999999999999999999999989999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
.+||.+||..||.+|||+.++++||||+....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=389.83 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=224.1
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
-.+.++.++|++++.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 34677899999999999999999999999999999999999776555556678899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+..|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999999999976 7799999999999999999999999999999999999999999999999999976443
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-----CCCCCC
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-----CPPWFS 245 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~~ 245 (441)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......+......+ .++.++
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp ------------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred cc-ccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence 21 122345679999999999988776 48899999999999999999999998877766666555432 245689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999999999999999999666666666643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=400.47 Aligned_cols=265 Identities=28% Similarity=0.453 Sum_probs=224.2
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+..+.++|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp CCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred CCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 45677899999999999999999999999999999999999876555555667899999999999999999999998654
Q ss_pred C----EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 92 S----KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 92 ~----~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
. ..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3 45999999999999999975 789999999999999999999999999999999999999999999999999997
Q ss_pred cccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----
Q 013522 167 FSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP---- 241 (441)
Q Consensus 167 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 241 (441)
........ ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 54432211 22334679999999999988776 4899999999999999999999999888777766666554332
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+.+++++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 458999999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=405.35 Aligned_cols=255 Identities=32% Similarity=0.539 Sum_probs=221.0
Q ss_pred ccCCeEE--eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 17 LHGKYEL--GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 17 ~~~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
+...|++ .+.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4456766 6789999999999999999999999999976532 3456889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe--CCCCCeEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl--~~~~~vkl~DFGla~~~~~ 170 (441)
|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998864 469999999999999999999999999999999999999 5677899999999976432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 246 (441)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+..+ +.+++
T Consensus 242 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 ---REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ---TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ---ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 233455679999999999977655 5899999999999999999999999998888888888776554 45899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++++||.+||++||.+|||+.++++||||+..
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=409.02 Aligned_cols=252 Identities=33% Similarity=0.610 Sum_probs=209.9
Q ss_pred cccCCeEEe-eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEe---
Q 013522 16 LLHGKYELG-RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMAS--- 90 (441)
Q Consensus 16 ~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~--- 90 (441)
.+.++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 456778887 7999999999999999999999999998643 3567888887 45689999999999876
Q ss_pred -CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEeecC
Q 013522 91 -KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFG 163 (441)
Q Consensus 91 -~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~DFG 163 (441)
...+|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 6689999999999999999976 25999999999999999999999999999999999999998 7889999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH----HHHHHHHcCCCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDFK 239 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~~ 239 (441)
++.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.. .....+..+.+.
T Consensus 210 ~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 210 FAKETT---SHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cccccC---CCCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 997543 22345678899999999999877774 8999999999999999999999775432 245566666665
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 CP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 ~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+| ..+++++.+||.+||..||++|||+.++++||||....
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 54 35899999999999999999999999999999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=386.11 Aligned_cols=259 Identities=34% Similarity=0.629 Sum_probs=227.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
++.++|++++.||+|+||+||+|++..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 466889999999999999999999999999999999976543221 13578999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----CeEEeecCcccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAF 167 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~----~vkl~DFGla~~ 167 (441)
..|+||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999999999999975 7799999999999999999999999999999999999998877 799999999875
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PW 243 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~ 243 (441)
... ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ +.
T Consensus 162 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T 3bhy_A 162 IEA---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN 237 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ccC---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence 432 223345679999999999987766 5899999999999999999999999988888888877766554 46
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+++.+.+||.+||..||++|||+.++++||||+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 78999999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=384.77 Aligned_cols=257 Identities=19% Similarity=0.287 Sum_probs=218.7
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK 91 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 91 (441)
....+.++|++.+.||+|+||+||+|++..+++.||+|++....... .....+.+|+.++..+ +||||+++++++.+.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 45567789999999999999999999999999999999997654332 3456788999999999 999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC------------
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED------------ 154 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~------------ 154 (441)
+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999999974 569999999999999999999999999999999999999844
Q ss_pred -------CCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH
Q 013522 155 -------GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV 227 (441)
Q Consensus 155 -------~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~ 227 (441)
..+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 4799999999875432 22346999999999998765556799999999999999999988765543
Q ss_pred HHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 228 SMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 228 ~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
...+..+. ...|+.+++++.+||.+||+.||++|||+.++++||||....
T Consensus 237 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 237 --WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp --HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred --HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 33444444 356778999999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=392.35 Aligned_cols=256 Identities=39% Similarity=0.733 Sum_probs=226.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..+.++|++.+.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence 45778999999999999999999999999999999999765322 235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla~~~~~ 170 (441)
|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~- 160 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ- 160 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC-
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC-
Confidence 999999999999999875 789999999999999999999999999999999999999 778899999999987432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 246 (441)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+...++ +.+++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 161 ---NGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp ---CBTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred ---CCccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 223455679999999999987766 4899999999999999999999999988888888888765443 45789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++.+||.+||..||++|||+.++++||||+..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=400.15 Aligned_cols=258 Identities=33% Similarity=0.606 Sum_probs=227.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMV-KHKHIVELHEVMAS 90 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~ 90 (441)
+.++|++.+.||+|+||.||+|++..+|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 457899999999999999999999999999999999765321 112356788999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999999976 679999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCccchhhhhcc-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC---
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP--- 241 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 241 (441)
. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+....+
T Consensus 252 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 252 P---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred C---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 2 2344567899999999998643 2235789999999999999999999999888888888888776554
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 242 -PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 242 -~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
..+++.+.+||.+||+.||++|||+.++++||||++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357899999999999999999999999999999973
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=399.19 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=211.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 6899999999999999999999999999999999654321 11123457999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~ 156 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKT 156 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Cccc
Confidence 99975 89888875 4599999999999999999999999999999999999999999999999999875432 2233
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCC---------------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFK--------------- 239 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~--------------- 239 (441)
....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+. .+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 445678999999999987555569999999999999999999999998877766665431 100
Q ss_pred -------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 -------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 -------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.++.+++++.+||.+||++||.+|||+.++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 1124688999999999999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=397.62 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=218.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
-...++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3456899999999999999999999999999999999976543 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999999888764 67999999999999999999999999999999999999999999999999999754332
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-----------------
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG----------------- 236 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~----------------- 236 (441)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 233455679999999999987655568999999999999999999999988766555444321
Q ss_pred --CCCC------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 --DFKC------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 --~~~~------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.... .+.+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0111 12468999999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=385.45 Aligned_cols=265 Identities=31% Similarity=0.529 Sum_probs=228.9
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc------chhhHHHHHHHHHHHHhCC-CCCcceE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI------KVGMMEQIKREISVMKMVK-HKHIVEL 84 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l 84 (441)
.....+.++|++.+.||+|+||+||+|++..+|+.||+|++...... .....+.+.+|+.+++++. ||||+++
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 33456789999999999999999999999999999999999765321 1123567889999999995 9999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecC
Q 013522 85 HEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163 (441)
Q Consensus 85 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFG 163 (441)
++++.+....|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999999999976 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhc-----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISK-----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 238 (441)
++..... .......+||+.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+..+..
T Consensus 170 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 170 FSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred chhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9875432 233456679999999999862 22335899999999999999999999999988888888887766
Q ss_pred CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 KCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 ~~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+ +.+++.+.+||.+||..||.+|||+.++++||||++..
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 247 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 544 24789999999999999999999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=393.84 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=227.6
Q ss_pred CccccCCeEEe-eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013522 14 PTLLHGKYELG-RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK 91 (441)
Q Consensus 14 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 91 (441)
...+.++|.+. +.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 45688899998 8999999999999999999999999999765432 23456788999999999 569999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEeecCcc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLS 165 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~DFGla 165 (441)
...|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999999999864 67999999999999999999999999999999999999988 789999999999
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP---- 241 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---- 241 (441)
..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......+
T Consensus 182 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 257 (327)
T 3lm5_A 182 RKIGH---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred cccCC---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence 75432 223445689999999999987776 4899999999999999999999999988888887776654443
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
..+++.+.+||.+||++||.+|||+.++++||||+.....
T Consensus 258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 3578999999999999999999999999999999875433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=391.79 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=208.7
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~ 92 (441)
...+.++|++.+.||+|+||+||+|++..+|+.||||++....... ........|+..+. ..+||||+++++++.+.+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 4566789999999999999999999999999999999986544332 22334445555554 459999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999999 6689888865 5699999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC--CCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF--KCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 248 (441)
.......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+... ...+..+.. ..+..+++++
T Consensus 210 ---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 210 ---AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHH
T ss_pred ---CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHH
Confidence 233455679999999999875 45 5899999999999999999766655332 233333332 2345689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+||.+||++||++|||+.++++||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=395.65 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=223.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999999866544445567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||+. |+|.+.+. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----- 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----
Confidence 99997 57888775 36799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC--CCCCCCHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--CPPWFSSEARRL 251 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~l 251 (441)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+..+..+ .+..+++.+.+|
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 235679999999999853 233358999999999999999999999988877766666655433 245689999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
|.+||+.||++|||+.++++||||....++
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999999765543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=385.64 Aligned_cols=275 Identities=24% Similarity=0.415 Sum_probs=231.8
Q ss_pred CCCCCCCCCCCCC---CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC
Q 013522 1 MATSNSNGGGDDR---PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77 (441)
Q Consensus 1 m~~~~~~~~~~~~---~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~ 77 (441)
|+.+....+.... ......+|++++.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++
T Consensus 1 ~~~~~~~~~~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~ 78 (303)
T 3a7i_A 1 MAHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCD 78 (303)
T ss_dssp ------------CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCC
Confidence 5555544432222 234567899999999999999999999999999999999765432 34678999999999999
Q ss_pred CCCcceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCe
Q 013522 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL 157 (441)
Q Consensus 78 hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~v 157 (441)
||||+++++++.+....|+||||+.|++|.+++..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 79 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 158 (303)
T 3a7i_A 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 158 (303)
T ss_dssp CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE
T ss_pred CCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCE
Confidence 99999999999999999999999999999999998899999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC
Q 013522 158 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD 237 (441)
Q Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 237 (441)
||+|||++...... ........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+..+.
T Consensus 159 kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (303)
T 3a7i_A 159 KLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235 (303)
T ss_dssp EECCCTTCEECBTT--BCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred EEeecccceecCcc--ccccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC
Confidence 99999998754332 1223456799999999999877664 89999999999999999999999888777766665554
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 238 -FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 238 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
...+..+++.+.+||.+||..||.+|||+.++++||||.....
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 3456678999999999999999999999999999999976543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=395.84 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=214.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKSK 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~ 93 (441)
+..++|++++.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|+.+|+.++| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999998 5789999999976543 23456788999999999976 999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+|+|||+ .+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999994 57899999976 6799999999999999999999999999999999999996 6789999999998655433
Q ss_pred cCCcccccccCCCccchhhhhc----------cCCCCCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHcC--CCC
Q 013522 173 QDGLLHTTCGTPAYVAPEVISK----------KGYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFK 239 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~----------~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~~ 239 (441)
........+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.... .......+... ...
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 3334456789999999999965 1334589999999999999999999998743 33344444433 345
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+|...++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 6777889999999999999999999999999999998543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=395.41 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=211.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--- 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 92 (441)
.+.++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45678999999999999999999999999999999997654 2345678999999999999999999999985543
Q ss_pred ------------------------------------------------------EEEEEEeccCCCchHHHHhcC----C
Q 013522 93 ------------------------------------------------------KIYFAMDLVKGGELFNKIAKG----R 114 (441)
Q Consensus 93 ------------------------------------------------------~~~lv~E~~~gg~L~~~i~~~----~ 114 (441)
..|+|||||.|++|.+++... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 389999999999999999863 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc----------CCcccccccCC
Q 013522 115 LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ----------DGLLHTTCGTP 184 (441)
Q Consensus 115 l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~----------~~~~~~~~gt~ 184 (441)
.++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 56667899999999999999999999999999999999999999999999976543221 12234567999
Q ss_pred CccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC-CCCCCHHHHHHHHHhcCCCCCCC
Q 013522 185 AYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC-PPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 185 ~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R 263 (441)
.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+.....+. +...++++.+||.+||++||++|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999988777 5899999999999999998776532 223333344433221 22357888999999999999999
Q ss_pred CCHHHHhcCcccCc
Q 013522 264 IAISKIMESSWFKK 277 (441)
Q Consensus 264 ~t~~eil~hpwf~~ 277 (441)
||+.++++||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=398.90 Aligned_cols=260 Identities=28% Similarity=0.411 Sum_probs=215.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..++|++++.||+|+||+||+|++..+|+.||+|++....... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4688999999999999999999999999999999997543221 11234678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-- 164 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-- 164 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC--
Confidence 999999986 88888875 4689999999999999999999999999999999999999999999999999976432
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCC---C-------
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFK---C------- 240 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~---~------- 240 (441)
........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+... ... +
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence 2234456789999999999976655568999999999999999999999998887777666542 110 0
Q ss_pred ----------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 241 ----------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 241 ----------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+.+++++.+||.+||..||++|||+.++++||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 134578999999999999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=403.07 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=216.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASKSKI 94 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~ 94 (441)
...+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|+.++ ||||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999854 89999999976543 3345678999999999996 59999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 568899999976 6789999999999999999999999999999999999995 58999999999986544333
Q ss_pred CCcccccccCCCccchhhhhcc----------CCCCCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHcC--CCCC
Q 013522 174 DGLLHTTCGTPAYVAPEVISKK----------GYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DFKC 240 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~~~ 240 (441)
.......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ...+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 3334567899999999999752 234589999999999999999999998753 33445555554 3456
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|.+.++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 788899999999999999999999999999999997543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=402.56 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=203.7
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK---- 91 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---- 91 (441)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 35689999999999999999999999999999999996543 2334567888999999999999999999999654
Q ss_pred --CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 --SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 --~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
...|+|+||+ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999988889999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--C----------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D---------- 237 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~---------- 237 (441)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.+. .
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2345689999999999987555568999999999999999999999998876666555331 0
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 -----------FKC--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 -----------~~~--------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... .+..++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 001 124688999999999999999999999999999998643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=407.68 Aligned_cols=261 Identities=34% Similarity=0.645 Sum_probs=212.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-----VGMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
+..+.++|++.+.||+|+||+||+|.+..+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3456789999999999999999999999999999999998754321 11223578999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEeecCc
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGL 164 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~DFGl 164 (441)
. .+..|+||||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5 4568999999999999999875 7799999999999999999999999999999999999997654 499999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-HHHHHHHHcCCCCCC
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNI-VSMYRKIYRGDFKCP 241 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~~ 241 (441)
|..... .....+.+||+.|+|||++.+ ....+.++|||||||++|+|++|.+||..... ..+...+..+....+
T Consensus 289 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 289 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred ceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 986442 334556789999999999853 22335789999999999999999999976533 344556666665543
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 ----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 ----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+.+++.+.+||.+||++||++|||+.++++||||+..
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 3579999999999999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=381.16 Aligned_cols=254 Identities=22% Similarity=0.440 Sum_probs=218.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----KS 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~ 92 (441)
-...|++.+.||+|+||+||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 345689999999999999999999999999999999765543 3456788999999999999999999999865 46
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeC-CCCCeEEeecCccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLD-EDGNLKVTDFGLSAFS 168 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~-~~~~vkl~DFGla~~~ 168 (441)
.+|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999987 78999999999999999999999999 99999999999998 7899999999998643
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHHcCCC--CCCCCCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDF--KCPPWFS 245 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~--~~~~~~~ 245 (441)
. .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||... +....+..+..+.. ..+...+
T Consensus 183 ~----~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred c----ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 3 233455679999999998864 34 58999999999999999999999874 44455555554432 2345578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
+++.+||.+||+.||.+|||+.++++||||++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=405.10 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=216.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC------CCCCcceEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV------KHKHIVELHEV 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~ 87 (441)
...+..+|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 3567789999999999999999999999999999999997543 3346777899888877 57899999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC--eEEeec
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--LKVTDF 162 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~--vkl~DF 162 (441)
+.....+|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999999996 589999875 34899999999999999999999999999999999999999987 999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC----
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---- 238 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---- 238 (441)
|+|.... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 247 G~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 247 GSSCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp TTCEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9986432 23456789999999999998877 5899999999999999999999999887666554432100
Q ss_pred ----------------C---------------------------------------CCCCCCHHHHHHHHHhcCCCCCCC
Q 013522 239 ----------------K---------------------------------------CPPWFSSEARRLITKLLDPNPNSR 263 (441)
Q Consensus 239 ----------------~---------------------------------------~~~~~~~~~~~li~~~L~~dP~~R 263 (441)
. ++...++.+.+||.+||++||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 0 011237889999999999999999
Q ss_pred CCHHHHhcCcccCccCC
Q 013522 264 IAISKIMESSWFKKSAP 280 (441)
Q Consensus 264 ~t~~eil~hpwf~~~~~ 280 (441)
||+.|+|+||||+...+
T Consensus 401 pta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRLP 417 (429)
T ss_dssp CCHHHHHTSTTTC----
T ss_pred CCHHHHhCChhhccCCC
Confidence 99999999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=399.43 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=210.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS--- 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 92 (441)
.+.++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 356899999999999999999999999999999999976432 3345677889999999999999999999997654
Q ss_pred ---EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 ---KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ---~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..|+||||+.| +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999975 7888876 459999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC---------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--------- 240 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 240 (441)
. .......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234567899999999999887774 89999999999999999999999988877776665431110
Q ss_pred ---------------------------CC------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 241 ---------------------------PP------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 241 ---------------------------~~------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|. ..++++++||.+||+.||++|||+.++++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0146789999999999999999999999999997543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=396.66 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=221.5
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+.+..++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 4566789999999999999999999999999999999997653 33456789999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.|+||||+.|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999999976 7899999999999999999999996 9999999999999999999999999998754321
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHH--------------------
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR-------------------- 231 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~-------------------- 231 (441)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+......
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 2345679999999999988766 489999999999999999999998766543322
Q ss_pred ----------------------HHHcCCC-CCC-CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 232 ----------------------KIYRGDF-KCP-PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 232 ----------------------~i~~~~~-~~~-~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+..... ..+ ..+++++.+||.+||++||++|||+.++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 2222221 122 23788999999999999999999999999999998643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=399.26 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=212.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----- 90 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----- 90 (441)
...++|++++.||+|+||+||+|++..+|+.||+|++..+... ..+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567999999999999999999999999999999998755322 2379999999999999999999843
Q ss_pred ---------------------------------CCEEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHH
Q 013522 91 ---------------------------------KSKIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVD 132 (441)
Q Consensus 91 ---------------------------------~~~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ 132 (441)
...+++||||+.| +|.+.+.. +.+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 77666642 67999999999999999999
Q ss_pred HHhhcCcEeccCCCCcEEeC-CCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHH
Q 013522 133 FCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVIL 211 (441)
Q Consensus 133 ylH~~gi~HrDLkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil 211 (441)
|||++||+||||||+|||++ .++.+||+|||+|..... .......+||+.|+|||++.+....+.++||||+||++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999998 678999999999975432 23345667999999999998766556999999999999
Q ss_pred HHHhhCCCCCCCCcHHHHHHHHHcC-----------------CCC------------CCCCCCHHHHHHHHHhcCCCCCC
Q 013522 212 YVLLAGFLPFQDDNIVSMYRKIYRG-----------------DFK------------CPPWFSSEARRLITKLLDPNPNS 262 (441)
Q Consensus 212 ~~ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~~~~~~~li~~~L~~dP~~ 262 (441)
|+|++|.+||.+.+..+....+.+. ... +|..+++++.+||.+||++||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999998877666655431 011 34557899999999999999999
Q ss_pred CCCHHHHhcCcccCcc
Q 013522 263 RIAISKIMESSWFKKS 278 (441)
Q Consensus 263 R~t~~eil~hpwf~~~ 278 (441)
|||+.++++||||+..
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 313 RINPYEAMAHPFFDHL 328 (383)
T ss_dssp SCCHHHHHTSGGGHHH
T ss_pred CCCHHHHhcCHHHHHH
Confidence 9999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=386.57 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=216.8
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE---
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA--- 89 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--- 89 (441)
.+..+.++|++++.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 34568899999999999999999999999999999999987542 345678899999999999999999999873
Q ss_pred -----------eCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-CCCCe
Q 013522 90 -----------SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNL 157 (441)
Q Consensus 90 -----------~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-~~~~v 157 (441)
+....|+||||+. |+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4478999999997 5999999988999999999999999999999999999999999999997 56789
Q ss_pred EEeecCccccccccc-cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC
Q 013522 158 KVTDFGLSAFSEHLK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG 236 (441)
Q Consensus 158 kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 236 (441)
||+|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654221 1223445678999999999876555568999999999999999999999988876666555432
Q ss_pred CCC------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 DFK------------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ~~~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... .++.+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 110 1245799999999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=395.84 Aligned_cols=260 Identities=33% Similarity=0.585 Sum_probs=224.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
.++|++++.||+|+||+||+|++. .+++.||+|++.+.... .....+.+.+|+.+|+.+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999985 58999999999764321 112235567899999999 6999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.+|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999999976 78999999999999999999999999999999999999999999999999999754322
Q ss_pred ccCCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhhCCCCCCCC----cHHHHHHHHHcCCCCCCCCCCH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRKIYRGDFKCPPWFSS 246 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~ 246 (441)
........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+.......|+.+++
T Consensus 213 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (355)
T 1vzo_A 213 -ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291 (355)
T ss_dssp -GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCH
Confidence 12233456899999999999753 23458899999999999999999999743 4456667777778888899999
Q ss_pred HHHHHHHHhcCCCCCCCC-----CHHHHhcCcccCcc
Q 013522 247 EARRLITKLLDPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
.+.+||.+||..||.+|| |+.++++||||+..
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999999999999999999 99999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=391.06 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=220.1
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-- 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 91 (441)
...+.++|++.+.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3457789999999999999999999999999999999996432 234456788999999999999999999998654
Q ss_pred ---CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 ---SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ---~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
...|+||||+. ++|.+.+..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 67999999997 58999998888999999999999999999999999999999999999999999999999999765
Q ss_pred cccccC--------CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc--CC-
Q 013522 169 EHLKQD--------GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--GD- 237 (441)
Q Consensus 169 ~~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~- 237 (441)
...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.. +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 432111 1123457999999999987655556899999999999999999999998876554443321 00
Q ss_pred ---------------------CC--------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 ---------------------FK--------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 ---------------------~~--------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.. .++.+++++.+||.+||..||++|||+.++++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 1245789999999999999999999999999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=380.79 Aligned_cols=259 Identities=30% Similarity=0.521 Sum_probs=226.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKI 94 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~ 94 (441)
..++|++++.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 357899999999999999999999999999999999865432 3456789999999999999999999998854 6789
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcC-----cEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 95 YFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~g-----i~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999964 24999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC-CCCCC
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPW 243 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 243 (441)
+...... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...+...+..+.. ..|..
T Consensus 163 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNHD--TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeeccc--cccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 8754321 112335679999999999987766 4899999999999999999999999988888888887765 56778
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++++.++|.+||+.||.+|||+.++++|+|+....
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999999999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=396.11 Aligned_cols=259 Identities=24% Similarity=0.514 Sum_probs=227.9
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh--------------hHHHHHHHHHHHHhCCCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG--------------MMEQIKREISVMKMVKHK 79 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~hp 79 (441)
.....++|++++.||+|+||+||+|++ +|+.||+|++......... ..+.+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 445678999999999999999999999 9999999999765432211 127899999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcE
Q 013522 80 HIVELHEVMASKSKIYFAMDLVKGGELFNK------IAK---GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENL 149 (441)
Q Consensus 80 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~---~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NI 149 (441)
||+++++++.+.+..|+||||+.|++|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 653 579999999999999999999999 9999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-H
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNI-V 227 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~-~ 227 (441)
|++.++.+||+|||++..... .......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999999999999999875432 234556799999999999876 4543489999999999999999999998776 7
Q ss_pred HHHHHHHcCCCCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 228 SMYRKIYRGDFKCP-------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 228 ~~~~~i~~~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.....+..+....| +.+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 78888888877776 6689999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=383.05 Aligned_cols=260 Identities=30% Similarity=0.445 Sum_probs=221.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
....++|++++.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 4567899999999999999999999999999999999865432 3357888999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998864 679999999999999999999999999999999999999999999999999876432211
Q ss_pred cCCcccccccCCCccchhhhh----ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCC
Q 013522 173 QDGLLHTTCGTPAYVAPEVIS----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---CPPWFS 245 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~ 245 (441)
.......||+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+.....+ .+..++
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccC
Confidence 1223457999999999984 2233358999999999999999999999998887777777665433 355689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+.+||.+||..||.+|||+.++++||||+...
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=385.46 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=216.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
..+..++|++.+.||+|+||+||+|++ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 356678999999999999999999987 788999999976543 23456788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 94 IYFAMDLVKGGELFNKIAKGR----LREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~~----l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
.|+||||+.||+|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999998633 999999999999999999999999 99999999999999999999999999875
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHH--cCCCCCCCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY--RGDFKCPPWFS 245 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~ 245 (441)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. ......|..++
T Consensus 189 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T 3p86_A 189 KAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred cccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 3321 222345679999999999988776 589999999999999999999999988877776663 34556788899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhc--CcccCc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIME--SSWFKK 277 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~~ 277 (441)
+.+.+||.+||..||.+|||+.++++ .+|++.
T Consensus 266 ~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999987 455543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=385.60 Aligned_cols=252 Identities=25% Similarity=0.463 Sum_probs=212.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMAS--KSK 93 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~ 93 (441)
..++|++++.||+|+||+||+|++..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999986432 367889999999997 9999999999987 678
Q ss_pred EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCccccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~ 172 (441)
.++||||+.+++|.+++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT--
T ss_pred eEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC--
Confidence 9999999999999998854 89999999999999999999999999999999999999777 899999999975432
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHH-------------HHHHHcCCC
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSM-------------YRKIYRGDF 238 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~-------------~~~i~~~~~ 238 (441)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +.... ...+.....
T Consensus 184 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 233456789999999999987555569999999999999999999999543 22111 111222222
Q ss_pred CC------------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 KC------------------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 ~~------------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.. +..+++++.+||.+||++||.+|||+.++|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11 122789999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=381.05 Aligned_cols=259 Identities=34% Similarity=0.622 Sum_probs=228.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
...+.++|++++.||+|+||+||+|++..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 456788999999999999999999999999999999999765432 2345788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeEEeecCcccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLKVTDFGLSAFSE 169 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vkl~DFGla~~~~ 169 (441)
.|+||||+.+++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999998865 7899999999999999999999999999999999999997644 69999999987543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCC
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFS 245 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~ 245 (441)
. ........||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+.......+..+....+ ..++
T Consensus 176 ~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp C---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred C---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 2 2233455689999999998754 4 5899999999999999999999999998888888888765543 4589
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+++.+||.+||.+||.+|||+.++++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=388.63 Aligned_cols=261 Identities=34% Similarity=0.651 Sum_probs=216.5
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
+..+.++|++.+.||+|+||+||+|++..+++.||+|++...... .......+.+|+.+++.++||||+++++++
T Consensus 5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 455778999999999999999999999999999999999765431 112234578999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC---eEEeecCc
Q 013522 89 ASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVTDFGL 164 (441)
Q Consensus 89 ~~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~---vkl~DFGl 164 (441)
.... .|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7665 8999999999999999875 67999999999999999999999999999999999999987765 99999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCCC
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP 241 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~ 241 (441)
+..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .+...+..+....+
T Consensus 164 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 164 SKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp CEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred ceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 875432 222345679999999999852 233358999999999999999999999765432 34445555555443
Q ss_pred ----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 242 ----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 242 ----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
..+++.+.+||.+||..||++|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 4579999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=381.13 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=203.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.++...++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 35678999999999999999999999999999999999755322 22334455566668889999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 77776642 5799999999999999999999998 9999999999999999999999999998754
Q ss_pred cccccCCcccccccCCCccchhhhh---ccCCCCCcccHHHHHHHHHHHhhCCCCCCC-Cc-HHHHHHHHHcCCCCCC-C
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQD-DN-IVSMYRKIYRGDFKCP-P 242 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~-~~~~~~~i~~~~~~~~-~ 242 (441)
.. .......+||+.|+|||++. .....+.++|||||||++|+|++|..||.. .. .......+.......+ .
T Consensus 161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 33 22334457999999999972 333345899999999999999999999985 23 3333334444444433 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 68999999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=388.53 Aligned_cols=268 Identities=23% Similarity=0.364 Sum_probs=205.2
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
....+..++|++++.||+|+||+||+|++..++. .||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3445677899999999999999999999877765 89999997654332 4467899999999999999999999999
Q ss_pred EeCCEE------EEEEeccCCCchHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 89 ASKSKI------YFAMDLVKGGELFNKIAKG-------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 89 ~~~~~~------~lv~E~~~gg~L~~~i~~~-------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
...... ++||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 9999999999999998641 589999999999999999999999999999999999999999
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999999976544332233344557889999999988776 489999999999999999 999999988888777777
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCcccCccCCc
Q 013522 235 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIA-------ISKIMESSWFKKSAPK 281 (441)
Q Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t-------~~eil~hpwf~~~~~~ 281 (441)
.+. ...++.+++++.+||.+||+.||.+||| +++++.|||+......
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 654 5667789999999999999999999999 7888999999865443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=387.55 Aligned_cols=267 Identities=27% Similarity=0.464 Sum_probs=199.1
Q ss_pred CCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
..+..+..++|++.+.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEES
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 345667789999999999999999999999899999999998654321 235678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEee
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK---------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 161 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~---------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~D 161 (441)
.+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 9999999999999999999862 4589999999999999999999999999999999999999999999999
Q ss_pred cCccccccccc---cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC
Q 013522 162 FGLSAFSEHLK---QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF 238 (441)
Q Consensus 162 FGla~~~~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 238 (441)
||++....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 244 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence 99987543221 112234567999999999997633345899999999999999999999988766555444443322
Q ss_pred C----------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 K----------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 ~----------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. .+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 1 2245788999999999999999999999999999998643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=383.67 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=216.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe---
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMAS--- 90 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--- 90 (441)
....++|++++.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 3467899999999999999999999999999999999975432 236788999999998 89999999999977
Q ss_pred ---CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 91 ---KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 91 ---~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
.+..|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 5689999999999999999975 5699999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK- 239 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 239 (441)
+...... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 176 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (326)
T 2x7f_A 176 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 253 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred ceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence 8754321 122345679999999999862 223358899999999999999999999988877666666554332
Q ss_pred -CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 -CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 -~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+..+++.+.+||.+||..||.+|||+.++++||||+...
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 2456899999999999999999999999999999998644
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=398.97 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=210.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS- 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 92 (441)
+.....+|++++.||+|+||+||+|++..+++ +|+|.+...... ..+|+.+|+.++||||+++++++....
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 34566789999999999999999999977766 888887654322 237999999999999999999995543
Q ss_pred -----EEEEEEeccCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-CCCCeEEeec
Q 013522 93 -----KIYFAMDLVKGGELFNKIA----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDF 162 (441)
Q Consensus 93 -----~~~lv~E~~~gg~L~~~i~----~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-~~~~vkl~DF 162 (441)
.+|+||||+.++.+..... .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 3889999998754333221 36799999999999999999999999999999999999999 7899999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC------
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------ 236 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------ 236 (441)
|+|+.... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.+.
T Consensus 187 G~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99975432 233446679999999999987665569999999999999999999999998876666555431
Q ss_pred -----------CCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 -----------DFK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 -----------~~~------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... +++.+++++.+||.+||++||.+|||+.++++||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 001 2344789999999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=407.60 Aligned_cols=248 Identities=18% Similarity=0.260 Sum_probs=205.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS---VMKMVKHKHIVELH-------EV 87 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~ 87 (441)
.++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 478999999999999999999999999999999998665545556788999995 45555899999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCchHHHHhc-CCCCH-------HHHHHHHHHHHHHHHHHhhcCcEec
Q 013522 88 MASKSK-----------------IYFAMDLVKGGELFNKIAK-GRLRE-------DVARVYFQQLISAVDFCHSRGVYHR 142 (441)
Q Consensus 88 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~-~~l~~-------~~~~~~~~qll~aL~ylH~~gi~Hr 142 (441)
+.+.+. .|+||||+ +|+|.+++.. +.+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776542 89999999 6799999975 44555 7888899999999999999999999
Q ss_pred cCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhcc-----------CCCCCcccHHHHHHHH
Q 013522 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-----------GYDGAKADIWSCGVIL 211 (441)
Q Consensus 143 DLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~~DiwSlGvil 211 (441)
||||+|||++.++.+||+|||+|.... ......+| +.|+|||++.+. .+ +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 999999999999999999999987422 23456678 999999999877 56 5899999999999
Q ss_pred HHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 212 YVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 212 ~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
|+|++|..||.+.+.......+. ..++.+++++.+||.+||+.||++|||+.++++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999998766544333332 234568999999999999999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=379.88 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=218.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
....++|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 4567889999999999999999999999999999999976532 35788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||+.|++|.+++. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 99999999999999986 367999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC---CCCCCCCCHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEAR 249 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~ 249 (441)
........||+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.... ...+..+++.+.
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred -ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence 1223456799999999999877664 88999999999999999999999887766555554443 233556899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 250 RLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+||.+||..||.+|||+.++++||||+....
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 9999999999999999999999999986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=392.32 Aligned_cols=255 Identities=22% Similarity=0.412 Sum_probs=221.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL-------QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHE 86 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 86 (441)
....++|++++.||+|+||+||+|++. .++..||+|++.... .....+.+.+|+.+|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345678999999999999999999975 345679999997553 234567899999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcE
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENL 149 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NI 149 (441)
++.+.+.+|+||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 999999999999999999999999752 378999999999999999999999999999999999
Q ss_pred EeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHH
Q 013522 150 LLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVS 228 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~ 228 (441)
|++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999985543332233344567899999999988776 489999999999999999 999999988888
Q ss_pred HHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 229 MYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 229 ~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+...+..+. ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 877777664 45677899999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=393.65 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=205.1
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.......++|++.+.||+|+||+||+|++..+|+.||+|++....... ....+++..++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 334566789999999999999999999999999999999986654322 3556788888999999999999999654
Q ss_pred CE-------EEEEEeccCCCchHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHh--hcCcEeccCCCCcEEeCC-CCC
Q 013522 92 SK-------IYFAMDLVKGGELFNKI----AK-GRLREDVARVYFQQLISAVDFCH--SRGVYHRDLKPENLLLDE-DGN 156 (441)
Q Consensus 92 ~~-------~~lv~E~~~gg~L~~~i----~~-~~l~~~~~~~~~~qll~aL~ylH--~~gi~HrDLkp~NILl~~-~~~ 156 (441)
.. +++||||+.++ |...+ .. ..+++..++.++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 33 89999999875 44333 22 56899999999999999999999 999999999999999997 899
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG 236 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 236 (441)
+||+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.+.
T Consensus 171 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99999999975443 233445679999999999977665579999999999999999999999998877766665431
Q ss_pred C--------------------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 D--------------------------------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ~--------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. ...+...++++.+||.+||++||.+|||+.++++||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0 011122567899999999999999999999999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=393.08 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=215.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI- 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 94 (441)
.+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 367899999999999999999999999999999999976432 334567888999999999999999999999877654
Q ss_pred -----EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 95 -----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 95 -----~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
|+||||+. ++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEcccc-ccHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 588877754 49999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD------------ 237 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 237 (441)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 196 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred c-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 23456799999999999874445689999999999999999999999988766665553310
Q ss_pred -------------C------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 -------------F------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 -------------~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. ..++.+++.+.+||.+||++||++|||+.++++||||+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0 01235689999999999999999999999999999998543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=398.45 Aligned_cols=251 Identities=30% Similarity=0.441 Sum_probs=208.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK----- 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----- 91 (441)
...+|++++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999875432 233799999999999999999998532
Q ss_pred -CEEEEEEeccCCCchHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCc
Q 013522 92 -SKIYFAMDLVKGGELFNKIA-----KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGL 164 (441)
Q Consensus 92 -~~~~lv~E~~~gg~L~~~i~-----~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGl 164 (441)
..+++||||+.+ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999986 5655553 2679999999999999999999999999999999999999965 5689999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--------
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG-------- 236 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------- 236 (441)
++.... .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+.+..+.+.
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975432 223445689999999999977644568999999999999999999999998766655554321
Q ss_pred ---------CCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 ---------DFK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 ---------~~~------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.+. +++.+++++.+||.+||.+||.+|||+.++++||||+..
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 234568999999999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=387.23 Aligned_cols=256 Identities=24% Similarity=0.419 Sum_probs=213.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS- 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 92 (441)
...+.++|++.+.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 346778999999999999999999999999999999999765432 23567789999999999999999999998765
Q ss_pred -EEEEEEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe----CCCCCeEEeecC
Q 013522 93 -KIYFAMDLVKGGELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFG 163 (441)
Q Consensus 93 -~~~lv~E~~~gg~L~~~i~~~----~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl----~~~~~vkl~DFG 163 (441)
..|+||||+.|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 889999999999999999752 39999999999999999999999999999999999999 778889999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhc-------cCCCCCcccHHHHHHHHHHHhhCCCCCCCC----cHHHHHHH
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISK-------KGYDGAKADIWSCGVILYVLLAGFLPFQDD----NIVSMYRK 232 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~----~~~~~~~~ 232 (441)
++..... .......+||+.|+|||++.. ....+.++|||||||++|+|++|..||... .......+
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CceecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 9975433 233456679999999999863 233458999999999999999999999642 23445555
Q ss_pred HHcCCCC-------------------CC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 233 IYRGDFK-------------------CP------PWFSSEARRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 233 i~~~~~~-------------------~~------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
+..+.+. .| ..+++.+.+||++||+.||++|||++|+|+||=
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 5443321 11 123467889999999999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=395.22 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=224.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
.+..++|++++.||+|+||+||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556889999999999999999999 45578899999996432 2344567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC---CeE
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG---NLK 158 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~---~vk 158 (441)
+....|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999975 2489999999999999999999999999999999999999655 499
Q ss_pred EeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC
Q 013522 159 VTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD 237 (441)
Q Consensus 159 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 237 (441)
|+|||+|+...............||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999765443333444566789999999999887764 89999999999999998 999999999988888887765
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 238 -FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 238 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
...|..+++.+.+||.+||+.||.+|||+.+++++.|+.
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 455677999999999999999999999999999998864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=384.65 Aligned_cols=256 Identities=28% Similarity=0.433 Sum_probs=216.3
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEE-cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC------CcceE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARN-LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK------HIVEL 84 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l 84 (441)
..+.++.++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 45677889999999999999999999998 5688999999996432 3456788999999988765 49999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC--------
Q 013522 85 HEVMASKSKIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------- 153 (441)
Q Consensus 85 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-------- 153 (441)
++++.+.+..|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 88999999753 5899999999999999999999999999999999999987
Q ss_pred -----------CCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCC
Q 013522 154 -----------DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQ 222 (441)
Q Consensus 154 -----------~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~ 222 (441)
++.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCC
Confidence 66899999999875332 2345679999999999988777 489999999999999999999999
Q ss_pred CCcHHHHHHHHHcCCCCC--------------------------------------------CCCCCHHHHHHHHHhcCC
Q 013522 223 DDNIVSMYRKIYRGDFKC--------------------------------------------PPWFSSEARRLITKLLDP 258 (441)
Q Consensus 223 ~~~~~~~~~~i~~~~~~~--------------------------------------------~~~~~~~~~~li~~~L~~ 258 (441)
..+.......+.....+. +...++++.+||.+||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 877665444332211111 111246788999999999
Q ss_pred CCCCCCCHHHHhcCcccCcc
Q 013522 259 NPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 259 dP~~R~t~~eil~hpwf~~~ 278 (441)
||.+|||+.++++||||+..
T Consensus 316 dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHH
Confidence 99999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=400.05 Aligned_cols=259 Identities=26% Similarity=0.400 Sum_probs=197.6
Q ss_pred cccCCeEE-eeeecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 013522 16 LLHGKYEL-GRMLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-- 90 (441)
Q Consensus 16 ~~~~~y~i-~~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-- 90 (441)
.+.+.|++ +++||+|+||+||+|++. .+++.||+|++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 45677888 568999999999999976 5788999999975533 2467899999999999999999999954
Q ss_pred CCEEEEEEeccCCCchHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe----CCCCC
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGN 156 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl----~~~~~ 156 (441)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 7789999999975 78887752 249999999999999999999999999999999999999 67789
Q ss_pred eEEeecCccccccccc-cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH--------
Q 013522 157 LKVTDFGLSAFSEHLK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-------- 227 (441)
Q Consensus 157 vkl~DFGla~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-------- 227 (441)
+||+|||+|....... ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999998654321 1233456789999999999987665679999999999999999999999765431
Q ss_pred -HHHHHHHc--CCCCCC------------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 013522 228 -SMYRKIYR--GDFKCP------------------------------------PWFSSEARRLITKLLDPNPNSRIAISK 268 (441)
Q Consensus 228 -~~~~~i~~--~~~~~~------------------------------------~~~~~~~~~li~~~L~~dP~~R~t~~e 268 (441)
.....+.. +.+... ...++.+.+||.+||.+||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 22222221 111100 012678999999999999999999999
Q ss_pred HhcCcccCccCC
Q 013522 269 IMESSWFKKSAP 280 (441)
Q Consensus 269 il~hpwf~~~~~ 280 (441)
+|+||||.....
T Consensus 331 ~L~hp~f~~~~~ 342 (405)
T 3rgf_A 331 AMQDPYFLEDPL 342 (405)
T ss_dssp HHTSGGGTSSSC
T ss_pred HhcChhhccCCC
Confidence 999999987543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=371.59 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=221.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
..+-.++|++.+.||+|+||+||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 4556689999999999999999999986 5778999999765432 3578899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999975 56999999999999999999999999999999999999999999999999999754332
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEAR 249 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 249 (441)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ ....|..+++.+.
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 160 QY-TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 237 (269)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred cc-ccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHH
Confidence 21 12334557888999999987776 489999999999999999 99999999988888888776 3455667899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
++|.+||+.||++|||+.++++|
T Consensus 238 ~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCcccCcCHHHHHHH
Confidence 99999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=382.41 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=220.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
..+..++|++.+.||+|+||+||+|++..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999986655 49999997543 23445788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999999964 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCC-cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCC
Q 013522 169 EHLKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFS 245 (441)
Q Consensus 169 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 245 (441)
....... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..++
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 4322211 1223346788999999987766 489999999999999999 99999999888888888776 455677899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+.+||.+||..||.+|||+.++++
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=385.98 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=215.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK-- 93 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-- 93 (441)
.+.++|.+.+.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 356899999999999999999999999999999999976432 33456788999999999999999999999977654
Q ss_pred ----EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 94 ----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 94 ----~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.|+||||+. ++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEecccc-CCHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999997 588887754 49999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC-------------
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------- 236 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 236 (441)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.+.
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 2345679999999999987445568999999999999999999999988776655544321
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 ------------------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
....++.+++++.+||.+||..||++|||+.++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 011234578999999999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=387.26 Aligned_cols=263 Identities=33% Similarity=0.567 Sum_probs=188.7
Q ss_pred CCCCCCCCCCCccccCCeEEee-eecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcc
Q 013522 4 SNSNGGGDDRPTLLHGKYELGR-MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 82 (441)
Q Consensus 4 ~~~~~~~~~~~~~~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv 82 (441)
+....++......+.++|++.+ .||+|+||+||+|++..+|+.||+|++.... ....+....++.++||||+
T Consensus 13 ~~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~ 85 (336)
T 3fhr_A 13 EVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIV 85 (336)
T ss_dssp -------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBC
T ss_pred cccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChH
Confidence 3444556666677899999965 6999999999999999999999999986532 1222333346778999999
Q ss_pred eEEEEEEe----CCEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-
Q 013522 83 ELHEVMAS----KSKIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED- 154 (441)
Q Consensus 83 ~l~~~~~~----~~~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~- 154 (441)
++++++.. ...+|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165 (336)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS
T ss_pred HHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC
Confidence 99999976 55689999999999999999762 59999999999999999999999999999999999999864
Q ss_pred --CCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH---
Q 013522 155 --GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM--- 229 (441)
Q Consensus 155 --~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~--- 229 (441)
+.+||+|||++.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....
T Consensus 166 ~~~~~kl~Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG 240 (336)
T ss_dssp TTCCEEECCCTTCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred CCceEEEeccccceecc----ccccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh
Confidence 459999999987543 223456789999999999976666 4889999999999999999999977654433
Q ss_pred -HHHHHcCCCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 230 -YRKIYRGDFKCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 230 -~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
...+..+....| ..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 222333333332 3589999999999999999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=385.85 Aligned_cols=256 Identities=31% Similarity=0.567 Sum_probs=223.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCC--CCCcceEEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVK--HKHIVELHEVM 88 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~ 88 (441)
...+.++|++++.||+|+||+||+|++..+++.||+|++........ .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 45688999999999999999999999999999999999976543221 11245668999999996 59999999999
Q ss_pred EeCCEEEEEEeccCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-CCCCeEEeecCcc
Q 013522 89 ASKSKIYFAMDLVKG-GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFGLS 165 (441)
Q Consensus 89 ~~~~~~~lv~E~~~g-g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-~~~~vkl~DFGla 165 (441)
.+.+..++||||+.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999986 899999975 7899999999999999999999999999999999999999 7789999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCC
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFS 245 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 245 (441)
..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+ .+..+....+..++
T Consensus 198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~ 267 (320)
T 3a99_A 198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS 267 (320)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence 75432 234456799999999999888776788999999999999999999997643 34456667788899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++.+||.+||+.||.+|||+.++++||||+...
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999999999999999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=389.10 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=211.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc--------chhhHHHHHHHHHHHHhCCCCCcceEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--------KVGMMEQIKREISVMKMVKHKHIVELHE 86 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 86 (441)
..+.++|++++.||+|+||+||+|.+. +|+.||+|++...... .....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 356789999999999999999999985 4999999999654321 2223578999999999999999999999
Q ss_pred EEEe-----CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEE
Q 013522 87 VMAS-----KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 87 ~~~~-----~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
++.. ...+|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9844 347899999997 588888875 46999999999999999999999999999999999999999999999
Q ss_pred eecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---
Q 013522 160 TDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--- 236 (441)
Q Consensus 160 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--- 236 (441)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999874332 233445679999999999987555569999999999999999999999998876666555321
Q ss_pred ---------------------CCC--------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 237 ---------------------DFK--------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 237 ---------------------~~~--------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
... .++.+++.+.+||.+||++||.+|||+.++++||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 000 12346889999999999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=376.61 Aligned_cols=255 Identities=28% Similarity=0.499 Sum_probs=210.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------ 90 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 90 (441)
+.++|++++.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 567899999999999999999999999999999999643 2345788999999999999999999998865
Q ss_pred -------CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEee
Q 013522 91 -------KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTD 161 (441)
Q Consensus 91 -------~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~D 161 (441)
.+..|+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 4678999999999999999975 3578899999999999999999999999999999999999999999999
Q ss_pred cCccccccccc------------cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHH
Q 013522 162 FGLSAFSEHLK------------QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVS 228 (441)
Q Consensus 162 FGla~~~~~~~------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~ 228 (441)
||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||.. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987543211 11233456799999999999876555689999999999999998 5543 34445
Q ss_pred HHHHHHcCCCCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 229 MYRKIYRGDFKCPP----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 229 ~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
....+......+|+ ..++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 66666666555544 456779999999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=373.46 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=211.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
|.....||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 3334499999999999999999999999999976532 3456789999999999999999999999999999999999
Q ss_pred cCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-CCCeEEeecCccccccccccCC
Q 013522 101 VKGGELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-DGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 101 ~~gg~L~~~i~~~----~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~ 175 (441)
++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++...... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--CC
Confidence 9999999999752 4678999999999999999999999999999999999987 899999999998754322 22
Q ss_pred cccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCcHH--HHHH-HHHcCCCCCCCCCCHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDNIV--SMYR-KIYRGDFKCPPWFSSEARRL 251 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~~~~~~~l 251 (441)
......||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...... .... .........|..+++++.+|
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHH
Confidence 234567999999999997643 2358999999999999999999999754322 2222 23344556778899999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 252 ITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
|.+||+.||++|||+.++++||||+...
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=393.71 Aligned_cols=252 Identities=26% Similarity=0.466 Sum_probs=208.7
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--------CCCcceEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--------HKHIVELH 85 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~ 85 (441)
+..+.++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 4577899999999999999999999999999999999996542 34567889999999985 78899999
Q ss_pred EEEE----eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCC--
Q 013522 86 EVMA----SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDG-- 155 (441)
Q Consensus 86 ~~~~----~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~-- 155 (441)
+++. +...+|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9987 566899999999 5567666653 4699999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------------CeEEeecCccccccccccCCcccccccCCCccc
Q 013522 156 -----------------------------------------------NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188 (441)
Q Consensus 156 -----------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 188 (441)
.+||+|||+|..... .....+||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccC
Confidence 799999999975432 2345679999999
Q ss_pred hhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc------HHHHHHHHHc--CC-----------------------
Q 013522 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN------IVSMYRKIYR--GD----------------------- 237 (441)
Q Consensus 189 PE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~------~~~~~~~i~~--~~----------------------- 237 (441)
||++.+..+. .++|||||||++|+|++|..||...+ .......+.. +.
T Consensus 262 PE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999888774 89999999999999999999997643 1122222111 00
Q ss_pred -----------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 238 -----------------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 238 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
...+...++.+.+||.+||++||++|||+.++|+||||+
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011222346788999999999999999999999999996
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=387.67 Aligned_cols=258 Identities=24% Similarity=0.414 Sum_probs=226.2
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQT-------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 83 (441)
....+..++|++++.||+|+||+||+|++..+ +..||+|++.... .......+.+|+.+++.+ +||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34567788999999999999999999997543 3579999997553 234567889999999999 9999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCC
Q 013522 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146 (441)
Q Consensus 84 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp 146 (441)
+++++.+.+..|+||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 999999999999999999999999999753 389999999999999999999999999999999
Q ss_pred CcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCc
Q 013522 147 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDN 225 (441)
Q Consensus 147 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~ 225 (441)
+|||++.++.+||+|||+|................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999986554333334455668899999999987766 489999999999999999 999999999
Q ss_pred HHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 226 IVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 226 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
...+...+..+ ....|..+++++.+||.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88888888776 345677899999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=371.67 Aligned_cols=256 Identities=20% Similarity=0.339 Sum_probs=221.3
Q ss_pred CCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 10 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
+...+.+..++|++++.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 34556777889999999999999999999885 6778999999765432 357889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
+.+..|+||||+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999999999976 6799999999999999999999999999999999999999999999999999975
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFS 245 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 245 (441)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..++
T Consensus 170 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T 3gen_A 170 VLDDEY-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247 (283)
T ss_dssp BCCHHH-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cccccc-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCC
Confidence 433221 12234457888999999987776 589999999999999998 999999998888888887764 44566789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.+.+||.+||+.||.+|||+.++++|
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999999876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=383.02 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=223.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
....++|++++.||+|+||+||+|++. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 345678999999999999999999987 455899999997543 2345678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccC
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK-------------------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDL 144 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~-------------------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDL 144 (441)
+.+..|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 99999999999999999999975 56899999999999999999999999999999
Q ss_pred CCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCC
Q 013522 145 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQD 223 (441)
Q Consensus 145 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~ 223 (441)
||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999976543332233445678999999999988776 489999999999999999 9999999
Q ss_pred CcHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 224 DNIVSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 224 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.......+..+.. ..|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 988888888877754 5677899999999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=382.74 Aligned_cols=257 Identities=30% Similarity=0.596 Sum_probs=212.6
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhC----CCCCcceEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMV----KHKHIVELHE 86 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~hpnIv~l~~ 86 (441)
...+.++|++++.||+|+||+||+|++..+++.||+|++........ .....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 46788999999999999999999999999999999999976543221 1223456799999988 8999999999
Q ss_pred EEEeCCEEEEEEec-cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC-CCCCeEEeecC
Q 013522 87 VMASKSKIYFAMDL-VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD-EDGNLKVTDFG 163 (441)
Q Consensus 87 ~~~~~~~~~lv~E~-~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~-~~~~vkl~DFG 163 (441)
++.+.+..++|||| +.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999999 789999999976 6799999999999999999999999999999999999999 78999999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW 243 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 243 (441)
++..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+......++..
T Consensus 186 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~ 255 (312)
T 2iwi_A 186 SGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAH 255 (312)
T ss_dssp SCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTT
T ss_pred hhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCccc
Confidence 9875442 234556799999999999887776668999999999999999999997643 344566778888
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+++.+.+||.+||+.||++|||+.++++||||+....
T Consensus 256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 9999999999999999999999999999999986543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=393.74 Aligned_cols=253 Identities=17% Similarity=0.189 Sum_probs=195.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC--CCCCcceEE-------EEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV--KHKHIVELH-------EVMA 89 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~ 89 (441)
..|++++.||+|+||+||+|++..+|+.||+|++...........+.+++|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999887654445567788886555544 699988755 5554
Q ss_pred eC-----------------CEEEEEEeccCCCchHHHHhc--CCCCHHHH------HHHHHHHHHHHHHHhhcCcEeccC
Q 013522 90 SK-----------------SKIYFAMDLVKGGELFNKIAK--GRLREDVA------RVYFQQLISAVDFCHSRGVYHRDL 144 (441)
Q Consensus 90 ~~-----------------~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~------~~~~~qll~aL~ylH~~gi~HrDL 144 (441)
.. ..+|+||||+. |+|.+++.. ..+++... ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 799999975 33444444 566799999999999999999999
Q ss_pred CCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCC
Q 013522 145 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQ 222 (441)
Q Consensus 145 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~ 222 (441)
||+|||++.++.+||+|||+|..... ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999975432 2224567799999999976 455 589999999999999999999998
Q ss_pred CCcHHH--HHHH-----HHcCCCCC--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 223 DDNIVS--MYRK-----IYRGDFKC--PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 223 ~~~~~~--~~~~-----i~~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+..... .+.. .....+.+ ++.+++.+.+||.+||++||++|||+.++++||||++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 764321 0000 01112222 34689999999999999999999999999999999753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=375.19 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=217.2
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc-CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEE-
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL-QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMA- 89 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~- 89 (441)
....++|++++.||+|+||+||+|++. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 345689999999999999999999995 678999999997543221 1223456788777766 8999999999987
Q ss_pred ----eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeec
Q 013522 90 ----SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 90 ----~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DF 162 (441)
.....++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 5678999999998 599999875 34999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--C---
Q 013522 163 GLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D--- 237 (441)
Q Consensus 163 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~--- 237 (441)
|++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred cccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 998754422 23445679999999999987766 48999999999999999999999998877766665431 0
Q ss_pred ----------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 ----------------------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..+++.+++.+++||.+||..||.+|||+.++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 012345789999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=387.36 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=214.1
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CC-----CcceEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HK-----HIVELHEV 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~ 87 (441)
+..+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+ +|++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 4567899999999999999999999999999999999997542 34567888999998885 55 49999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHh--hcCcEeccCCCCcEEeC--CCCCeEEe
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCH--SRGVYHRDLKPENLLLD--EDGNLKVT 160 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH--~~gi~HrDLkp~NILl~--~~~~vkl~ 160 (441)
+...+..|+||||+.| +|.+++.. +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999999965 99999875 45899999999999999999999 57999999999999995 47789999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC 240 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 240 (441)
|||+|..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 204 DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 204 DFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred eccCceeccc-----ccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999975432 23467899999999999887774 89999999999999999999999988777666654311000
Q ss_pred ------------------------------------CCC----------------------------CCHHHHHHHHHhc
Q 013522 241 ------------------------------------PPW----------------------------FSSEARRLITKLL 256 (441)
Q Consensus 241 ------------------------------------~~~----------------------------~~~~~~~li~~~L 256 (441)
++. .++++++||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 000 0137899999999
Q ss_pred CCCCCCCCCHHHHhcCcccCcc
Q 013522 257 DPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++||++|||+.++|+||||+..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=389.44 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=220.6
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.+.+-.++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+|+.++||||+++++++.+.+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34455678999999999999999999999999999999986542 2234557889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
.+|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999975 4699999999999999999999999999999999999999999999999999875332
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 248 (441)
...........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111111122345778999999987766 489999999999999998 99999998887777777665 456778899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||+.||++|||+.++++
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=387.24 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=216.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
.+..++|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 4567899999999999999999999 45677899999997543 223456789999999999 799999999999
Q ss_pred EeCC-EEEEEEeccCCCchHHHHhcCC-----------------------------------------------------
Q 013522 89 ASKS-KIYFAMDLVKGGELFNKIAKGR----------------------------------------------------- 114 (441)
Q Consensus 89 ~~~~-~~~lv~E~~~gg~L~~~i~~~~----------------------------------------------------- 114 (441)
.+.+ .+++||||+.||+|.+++....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8754 4899999999999999997522
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCccccc
Q 013522 115 --------------LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT 180 (441)
Q Consensus 115 --------------l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 180 (441)
+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 889999999999999999999999999999999999999999999999999755433222234456
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH-HHHHHHHcC-CCCCCCCCCHHHHHHHHHhcC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-SMYRKIYRG-DFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~ 257 (441)
.||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.. .....+..+ ....|..+++++.++|.+||+
T Consensus 256 ~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 789999999999887764 89999999999999998 99999886543 333344433 456678899999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 013522 258 PNPNSRIAISKIMES 272 (441)
Q Consensus 258 ~dP~~R~t~~eil~h 272 (441)
.||.+|||+.++++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=376.48 Aligned_cols=257 Identities=22% Similarity=0.341 Sum_probs=222.4
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
......++|++++.||+|+||+||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34566789999999999999999999983 456899999997543 23456788999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEec
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAKG-------------------------RLREDVARVYFQQLISAVDFCHSRGVYHR 142 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~~-------------------------~l~~~~~~~~~~qll~aL~ylH~~gi~Hr 142 (441)
+.+.+..|+||||+.|++|.+++... .+++..+..++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 99999999999999999999999752 28899999999999999999999999999
Q ss_pred cCCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCC
Q 013522 143 DLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPF 221 (441)
Q Consensus 143 DLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf 221 (441)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875543222222334567889999999987766 489999999999999999 99999
Q ss_pred CCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 222 QDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 222 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.+...+...+..+. ...|..+++++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9988877777776654 45677899999999999999999999999999865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=380.16 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=213.8
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCC-cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC------cceEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTG-KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH------IVELH 85 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~ 85 (441)
.+..+.++|++.+.||+|+||+||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 45678899999999999999999999998777 689999996532 34567889999999997766 99999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe-----------
Q 013522 86 EVMASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----------- 151 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl----------- 151 (441)
+++...+..|+||||+ +++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 5677777754 369999999999999999999999999999999999999
Q ss_pred --------CCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC
Q 013522 152 --------DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD 223 (441)
Q Consensus 152 --------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~ 223 (441)
+.++.+||+|||++..... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||..
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCC
Confidence 5678999999999975332 23456799999999999887774 899999999999999999999998
Q ss_pred CcHHHHHHHHHcCCCCCC--------------------------------------------CCCCHHHHHHHHHhcCCC
Q 013522 224 DNIVSMYRKIYRGDFKCP--------------------------------------------PWFSSEARRLITKLLDPN 259 (441)
Q Consensus 224 ~~~~~~~~~i~~~~~~~~--------------------------------------------~~~~~~~~~li~~~L~~d 259 (441)
.+.......+.....+.| ...++++.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 776654443322111111 112357889999999999
Q ss_pred CCCCCCHHHHhcCcccCcc
Q 013522 260 PNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 260 P~~R~t~~eil~hpwf~~~ 278 (441)
|++|||+.++++||||+..
T Consensus 322 P~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 322 PAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp TTTSCCHHHHTTSGGGGGC
T ss_pred hhhCcCHHHHhcChhhcCC
Confidence 9999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=365.13 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=219.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+..++|++.+.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456689999999999999999999875 6778999999765432 35788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999999999975 459999999999999999999999999999999999999999999999999987543321
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~ 250 (441)
. .......||+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+.. ..|..+++.+.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 1 112334567789999999877664 88999999999999999 9999999888888888777654 446678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 013522 251 LITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~h 272 (441)
+|.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=364.74 Aligned_cols=250 Identities=27% Similarity=0.486 Sum_probs=207.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
+-.++|++.+.||+|+||+||+|.+ +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 3457899999999999999999998 58999999987653322 23357789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---cEeccCCCCcEEeCC--------CCCeEEeecC
Q 013522 95 YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG---VYHRDLKPENLLLDE--------DGNLKVTDFG 163 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~g---i~HrDLkp~NILl~~--------~~~vkl~DFG 163 (441)
|+||||+.|++|.+++..+++++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999998888999999999999999999999999 999999999999986 6789999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--CCCC
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCP 241 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~~ 241 (441)
++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... .+.|
T Consensus 162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccc----cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 98754332 2235579999999999987766 589999999999999999999999988777776666554 3556
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 242 PWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 242 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7789999999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=373.90 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=224.2
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
...+..++|++.+.||+|+||+||+|++. .+++.||+|++.... .......+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34677889999999999999999999886 467889999997543 22345678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 156 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~-----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~ 156 (441)
+.+.+..|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 9999999999999999999999864 35689999999999999999999999999999999999999999
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHc
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYR 235 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 235 (441)
+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 99999999976543322223344567899999999987766 489999999999999999 8999999988888888777
Q ss_pred CCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 236 GDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 236 ~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.. ..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 654 4577899999999999999999999999999886
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=374.96 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=211.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 3468999999999999999999999999999999988543 2345678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||+.|++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999976 6799999999999999999999999999999999999999999999999999976533221
Q ss_pred CC------------cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH-----HHHHHHcC
Q 013522 174 DG------------LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS-----MYRKIYRG 236 (441)
Q Consensus 174 ~~------------~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~-----~~~~i~~~ 236 (441)
.. ...+.+||+.|+|||++.+..+. .++|||||||++|+|++|..||....... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--
Confidence 11 11256799999999999887764 89999999999999999999986532110 001111
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 237 DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....|+.+++.+.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12346778899999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=370.86 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=210.6
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
......++|++.+.||+|+||+||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 34456789999999999999999999999999999999997665444455678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999986 77999999999999999999999999999999999999999999999999998754432
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC---CCCCCCCHHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF---KCPPWFSSEA 248 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~ 248 (441)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...+...+..... ..++.+++.+
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred c-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 1 122345679999999999987666 4899999999999999999999999887755555544332 2356789999
Q ss_pred HHHHHHhcCCCCCCCC-CHHHHhc
Q 013522 249 RRLITKLLDPNPNSRI-AISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~-t~~eil~ 271 (441)
.++|.+||+.||++|| |++++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 7888764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=379.55 Aligned_cols=262 Identities=20% Similarity=0.281 Sum_probs=220.2
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEE-----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 86 (441)
....+..++|++++.||+|+||+||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 3445678899999999999999999999 55688899999996432 2344567889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC---C
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAKG--------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---G 155 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~~--------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~---~ 155 (441)
++.+....|+||||+.|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999999753 38899999999999999999999999999999999999954 4
Q ss_pred CeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHH
Q 013522 156 NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234 (441)
Q Consensus 156 ~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 234 (441)
.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 599999999875543333333445668999999999987776 489999999999999998 999999988888888777
Q ss_pred cCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 235 RGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
.+. ...+..+++.+.+||.+||..||.+|||+.+++++.|+.
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 664 455677999999999999999999999999999998874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=367.63 Aligned_cols=253 Identities=18% Similarity=0.278 Sum_probs=214.3
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASK 91 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~ 91 (441)
...++.++|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+|+.+++.+ +||||+++++++.+.
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 456788999999999999999999999999999999999865432 23577899999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC-----eEEeecCc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-----LKVTDFGL 164 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~-----vkl~DFGl 164 (441)
...|+||||+ |++|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999 9999999985 46999999999999999999999999999999999999988776 99999999
Q ss_pred cccccccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---cHHHHHHHHHcC
Q 013522 165 SAFSEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---NIVSMYRKIYRG 236 (441)
Q Consensus 165 a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~ 236 (441)
+......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +....+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9865432221 12356679999999999987776 58999999999999999999999873 334444444332
Q ss_pred CC-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 237 DF-----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 237 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.. ..++.+++++.+||.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21 1234689999999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=378.71 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=212.4
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
.++.++|++++.||+|+||+||+|++..+|+.||+|++...... +.+.+|+.+++.+ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 45678999999999999999999999999999999998755322 3578999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC-----eEEeecCccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN-----LKVTDFGLSA 166 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~-----vkl~DFGla~ 166 (441)
.|+||||+ |++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 9999999984 67999999999999999999999999999999999999998887 9999999998
Q ss_pred cccccccCC-----cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC---CcHHHHHHHHHcCCC
Q 013522 167 FSEHLKQDG-----LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD---DNIVSMYRKIYRGDF 238 (441)
Q Consensus 167 ~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~ 238 (441)
......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 644322111 2346789999999999988777 5899999999999999999999987 444455555544333
Q ss_pred CCC-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 239 KCP-----PWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 239 ~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..| ..++ ++.++|.+||..||.+||++.++++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 222 2244 9999999999999999999998875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=368.14 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=209.4
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
...+..++|++++.||+|+||+||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3567789999999999999999999998654 4579999986542 2345678899999999999999999999984
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
.+..|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 5678999999999999999975 3699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFS 245 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 245 (441)
..... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.|+.++
T Consensus 166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (281)
T 1mp8_A 166 MEDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 243 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCC
T ss_pred cCccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCC
Confidence 54321 112234457889999999987776 489999999999999996 999999888777777776654 46678899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.+.++|.+||..||++|||+.+++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=377.40 Aligned_cols=254 Identities=20% Similarity=0.351 Sum_probs=210.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
....++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 345678999999999999999999998888765 666664322 22345788999999999999999999999987
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.. .++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 65 7899999999999999975 56999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 246 (441)
.............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...+...+..+. .+.|+.++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 54333333344557889999999988777 489999999999999999 999999988777777766653 566778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=378.42 Aligned_cols=254 Identities=19% Similarity=0.330 Sum_probs=215.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcE----EEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKS----MAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
....++|++.+.||+|+||+||+|++..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34567999999999999999999999888876 66666643321 122345678999999999999999999986
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.+..++||||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 4568999999999999999975 57999999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 246 (441)
.............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI 244 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred CcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence 54443344456678889999999987776 489999999999999999 99999998877777777766 3556777899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+||.+||..||.+|||+.+++++
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=369.92 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=213.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTG-------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
.+..++|++.+.||+|+||+||+|++..++ ..||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999998877 479999996543 2345789999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC--------e
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN--------L 157 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~--------v 157 (441)
+.+.+..|+||||+.|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999863 3999999999999999999999999999999999999998887 9
Q ss_pred EEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcHHHHHHHHHcC
Q 013522 158 KVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYRG 236 (441)
Q Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~ 236 (441)
||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| .+||...+... .......
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~ 233 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED 233 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence 9999999864322 23456899999999998744456899999999999999995 55565555444 3344455
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 237 DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
....|...++++.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 667777789999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=370.54 Aligned_cols=256 Identities=22% Similarity=0.372 Sum_probs=209.9
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
.+..+..++|++++.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3456778999999999999999999999 56789999999986542 3445788999999999999999999999
Q ss_pred EEe--CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecC
Q 013522 88 MAS--KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163 (441)
Q Consensus 88 ~~~--~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFG 163 (441)
+.. ...+|+||||+.|++|.+++.. .++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 854 4568999999999999999976 459999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH---------------
Q 013522 164 LSAFSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV--------------- 227 (441)
Q Consensus 164 la~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~--------------- 227 (441)
++......... .......|++.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99865432211 12234457888999999988777 48999999999999999999998754321
Q ss_pred -HHHHHHHc-CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 -SMYRKIYR-GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 -~~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.....+.. ...+.|..+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 12222222 345667789999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=374.98 Aligned_cols=258 Identities=22% Similarity=0.404 Sum_probs=221.9
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNL-------QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 83 (441)
....+..++|++++.||+|+||+||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 345667789999999999999999999986 467789999997543 234567889999999999 8999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCC
Q 013522 84 LHEVMASKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146 (441)
Q Consensus 84 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp 146 (441)
+++++.+.+..|+||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 999999999999999999999999999753 388999999999999999999999999999999
Q ss_pred CcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCc
Q 013522 147 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDN 225 (441)
Q Consensus 147 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~ 225 (441)
+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999975443222222334457889999999987666 489999999999999999 999999998
Q ss_pred HHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 226 IVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 226 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
...+...+..+. ...|..+++++.++|.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 888887777664 45677899999999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=371.20 Aligned_cols=261 Identities=24% Similarity=0.414 Sum_probs=212.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASKS 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~ 92 (441)
.+..++|++++.||+|+||+||+|.+. +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 345667999999999999999999984 589999999976543 2345678999999999997 599999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
..|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9999999 557899999976 67999999999999999999999999999999999999964 89999999999865443
Q ss_pred ccCCcccccccCCCccchhhhhcc----------CCCCCcccHHHHHHHHHHHhhCCCCCCCCc-HHHHHHHHHcC--CC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKK----------GYDGAKADIWSCGVILYVLLAGFLPFQDDN-IVSMYRKIYRG--DF 238 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~--~~ 238 (441)
.........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+... ..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 333334466799999999998652 234589999999999999999999998753 33334444443 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+|...++++.+||.+||..||.+|||+.++++||||+...
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 56777899999999999999999999999999999998643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=378.53 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=216.5
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEV 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 87 (441)
..+-.++|++++.||+|+||+||+|++. .++..||+|++..... ....+.+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3455678999999999999999999973 4667899999975432 23356789999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEecc
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAKG------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRD 143 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~~------------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrD 143 (441)
+...+..|+||||++||+|.+++... .+++..+..++.||+.||.|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999999999999752 278999999999999999999999999999
Q ss_pred CCCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCC
Q 013522 144 LKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQ 222 (441)
Q Consensus 144 Lkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~ 222 (441)
|||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999976544332223345568899999999988776 489999999999999998 999998
Q ss_pred CCcHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 223 DDNIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 223 ~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
+.+.......+... ....|..+++++.+||.+||..||.+|||+.+++++..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 87654444444333 34557789999999999999999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=365.04 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=213.2
Q ss_pred CCCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhh----HHHHHHHHHHHHhCCCCCcceE
Q 013522 9 GGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGM----MEQIKREISVMKMVKHKHIVEL 84 (441)
Q Consensus 9 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~~Ei~il~~l~hpnIv~l 84 (441)
.....+....++|++.+.||+|+||+||+|++..+++.||+|++.......... .+.+.+|+.+++.++||||+++
T Consensus 9 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp ---CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred cchhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 334456678899999999999999999999999999999999997654332211 2678999999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCC----
Q 013522 85 HEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGN---- 156 (441)
Q Consensus 85 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~---- 156 (441)
++++.+.. ++||||+.+++|.+.+.. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence 99997666 699999999999998864 56999999999999999999999999 999999999999988876
Q ss_pred -eEEeecCccccccccccCCcccccccCCCccchhhhhcc-CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH--HHHH
Q 013522 157 -LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS--MYRK 232 (441)
Q Consensus 157 -vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~--~~~~ 232 (441)
+||+|||++.... .......||+.|+|||++... ...+.++|||||||++|+|++|..||...+... ....
T Consensus 167 ~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 167 CAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 9999999987432 234456799999999998432 223578999999999999999999998754332 2333
Q ss_pred HHcC--CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 233 IYRG--DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 233 i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+... ....|..+++.+.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3333 34567789999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=375.73 Aligned_cols=251 Identities=18% Similarity=0.233 Sum_probs=205.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-- 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-- 92 (441)
.+-.++|++++.||+|+||+||+|++ .++.||+|++.... .......+|+.+++.++||||+++++++.+..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 34567899999999999999999998 48999999996543 23345667999999999999999999998743
Q ss_pred --EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc----------CcEeccCCCCcEEeCCCCCeEEe
Q 013522 93 --KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR----------GVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 93 --~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~----------gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
.+|+||||+++|+|.+++..+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred CceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 479999999999999999988899999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCC----CCCcccHHHHHHHHHHHhhCCCCCCCCc-----------
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY----DGAKADIWSCGVILYVLLAGFLPFQDDN----------- 225 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~~~DiwSlGvil~~ll~G~~Pf~~~~----------- 225 (441)
|||+|...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999976554433334455789999999999976322 2357899999999999999999997532
Q ss_pred -----HHHHHHHHHcCCC--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 226 -----IVSMYRKIYRGDF--KCPPW-----FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 226 -----~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
...+...+..... ..+.. .++++.+||.+||+.||++|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233333322221 11111 2345999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=383.38 Aligned_cols=254 Identities=26% Similarity=0.487 Sum_probs=209.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----------CCCcce
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----------HKHIVE 83 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~ 83 (441)
....++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.++ ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 445689999999999999999999999999999999997543 23467889999999886 899999
Q ss_pred EEEEEEeCC----EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeC---
Q 013522 84 LHEVMASKS----KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLD--- 152 (441)
Q Consensus 84 l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~--- 152 (441)
+++++...+ .+++||||+ |++|.+++.. +.+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999997654 899999999 8899999975 4599999999999999999999998 999999999999995
Q ss_pred ---CCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH---
Q 013522 153 ---EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI--- 226 (441)
Q Consensus 153 ---~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~--- 226 (441)
..+.+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 344799999999975432 2345579999999999988776 5899999999999999999999986542
Q ss_pred ---HHHHHHHH------------------------------------------cCCCCCCCCCCHHHHHHHHHhcCCCCC
Q 013522 227 ---VSMYRKIY------------------------------------------RGDFKCPPWFSSEARRLITKLLDPNPN 261 (441)
Q Consensus 227 ---~~~~~~i~------------------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~ 261 (441)
......+. .....+++.+++++.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 11111111 112233344567899999999999999
Q ss_pred CCCCHHHHhcCcccCccC
Q 013522 262 SRIAISKIMESSWFKKSA 279 (441)
Q Consensus 262 ~R~t~~eil~hpwf~~~~ 279 (441)
+|||+.++++||||+...
T Consensus 324 ~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred ccCCHHHHhhChhhhccc
Confidence 999999999999998654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=372.92 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=218.3
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHE 86 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 86 (441)
......++|++++.||+|+||+||+|++ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3456678999999999999999999985 45778999999975532 23457899999999999 9999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCC
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAKG-------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~ 147 (441)
++.+.+..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 999999999999999999999999753 3899999999999999999999999999999999
Q ss_pred cEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcH
Q 013522 148 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI 226 (441)
Q Consensus 148 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~ 226 (441)
|||++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+...
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999976544332223345568889999999987766 489999999999999998 9999988664
Q ss_pred HHHHHHH-HcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 227 VSMYRKI-YRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 227 ~~~~~~i-~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
....... ..+ ....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4333333 332 334466789999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=365.78 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=224.1
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+.+..++|++.+.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 356677889999999999999999999999999999999997543 2457888999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
+..|+||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999999975 45899999999999999999999999999999999999999999999999999764
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 246 (441)
.... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|..+++
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 4221 122334557889999999988776 489999999999999999 99999998877777776665 4556778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+.+||.+||..||.+|||+.++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=375.63 Aligned_cols=254 Identities=20% Similarity=0.352 Sum_probs=210.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEE----EEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSM----AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
.+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 345689999999999999999999999888876 555553322 22346788999999999999999999999987
Q ss_pred CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.. .++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 65 7899999999999999975 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 246 (441)
.............||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+...+...+..+. .+.|+.+++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 543333334455678899999999887774 89999999999999999 999999988877777776654 566778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+||.+||..||.+|||+.++++.
T Consensus 247 ~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 247 DVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=360.80 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=216.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-- 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-- 91 (441)
..+..++|++.+.||+|+||+||+|++ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 455678999999999999999999998 5899999999765432 34457799999999999999999999999877
Q ss_pred CEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
...++||||++||+|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 7899999999999999999863 4899999999999999999999999 9999999999999999999999998865
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCC--CcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CCCCCC
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG--AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DFKCPP 242 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~--~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~ 242 (441)
.. ......||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ....|+
T Consensus 162 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 162 SF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp TT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred ee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 32 123457899999999998765542 3799999999999999999999998887776666544 345677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+++++.++|.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 89999999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=371.88 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=217.8
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEE--EEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSM--AMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA 89 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 89 (441)
-+.+-.++|++.+.||+|+||+||+|++..++..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 34556689999999999999999999999898865 999886432 223456788999999999 9999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAKG-----------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD 152 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~~-----------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~ 152 (441)
+.+..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 999999999999999999999753 589999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHH
Q 013522 153 EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYR 231 (441)
Q Consensus 153 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 231 (441)
.++.+||+|||++..... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+......
T Consensus 177 ~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp GGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 999999999999874322 122234457889999999987766 489999999999999998 999999999888888
Q ss_pred HHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 232 KIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 232 ~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+..+ ....|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 87766 345667789999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=367.92 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=199.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+|+.||+|++...... ......+.++..+++.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 4557899999999999999999999999999999999765432 223344555666788899999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
+||||+ ++.+...... +.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 999999 5555555543 6799999999999999999999995 999999999999999999999999999875432
Q ss_pred cCCcccccccCCCccchhhhhc----cCCCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHHcCCCC-CC--CCC
Q 013522 173 QDGLLHTTCGTPAYVAPEVISK----KGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRGDFK-CP--PWF 244 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~-~~--~~~ 244 (441)
.......+||+.|+|||++.. ....+.++|||||||++|+|++|..||.. .+.......+..+..+ .| ..+
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred -CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence 223345679999999999952 22335899999999999999999999987 4445555666555433 23 347
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 999999999999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=366.58 Aligned_cols=256 Identities=22% Similarity=0.443 Sum_probs=201.3
Q ss_pred CCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 10 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
....+.+..++|++++.||+|+||+||+|++. ..||+|++..... .....+.+.+|+.+++.++||||++++++.
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 34556788999999999999999999999863 3599999975543 334567899999999999999999999965
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
.....++||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 55678999999999999999964 5699999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCCcccccccCCCccchhhhh---ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCC----
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFK---- 239 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~---- 239 (441)
..............||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.. .....+..+...
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred cccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 55433344455678999999999986 3333 57899999999999999999999875443 444444444332
Q ss_pred -CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 240 -CPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 240 -~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+..+++.+.+||.+||..||.+|||+.++++
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 23467899999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=359.16 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=219.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+-.++|++.+.||+|+||+||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 44578999999999999999999985 6788999999765432 367889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 99999999999999975 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRL 251 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l 251 (441)
........||+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|..+++.+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 112234457889999999987776 489999999999999999 999999998888888887764 44566789999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 013522 252 ITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~h 272 (441)
|.+||+.||++|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=362.09 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=218.9
Q ss_pred cccCCeEEee-eecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGR-MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+..++|.+.. .||+|+||+||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4567788887 9999999999999864 467889999997643 234567899999999999999999999999 556
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 78999999999999999964 5699999999999999999999999999999999999999999999999999976532
Q ss_pred ccc-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 013522 171 LKQ-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 247 (441)
Q Consensus 171 ~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 247 (441)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|+.++++
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 241 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence 211 112234457899999999987666 489999999999999998 999999988888887777764 5667889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
+.+||.+||..||++|||+.+++++.+
T Consensus 242 l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 242 LYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=365.15 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=212.6
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
.+......+|++++.||+|+||+||+|+ +..+++.||+|++..... ......+.+|+.+++.++||||++++++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 3445566789999999999999999999 567899999999975532 2345788999999999999999999999
Q ss_pred EEeC--CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecC
Q 013522 88 MASK--SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFG 163 (441)
Q Consensus 88 ~~~~--~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFG 163 (441)
+.+. ..+|+||||+.|++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 9876 679999999999999999954 679999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC---------------cHH
Q 013522 164 LSAFSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD---------------NIV 227 (441)
Q Consensus 164 la~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~---------------~~~ 227 (441)
++......... .......||+.|+|||++.+..+. .++|||||||++|+|++|..|+... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 99765432211 223455688899999999887664 8899999999999999999886432 122
Q ss_pred HHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 SMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.....+..+ ..+.|+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 233333333 45567889999999999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.31 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=193.7
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS-VMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~ 92 (441)
.....++|++++.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+. +++.++||||+++++++.+.+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 45667899999999999999999999999999999999976532 223345556665 777889999999999999999
Q ss_pred EEEEEEeccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhc-CcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 93 KIYFAMDLVKGGELFNKIA------KGRLREDVARVYFQQLISAVDFCHSR-GVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~------~~~l~~~~~~~~~~qll~aL~ylH~~-gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
..|+||||+.| +|.+++. .+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999986 7777765 46799999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhh----ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCC-
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVIS----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFK- 239 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~- 239 (441)
..... ........||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+.. .....+..+..+
T Consensus 174 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3aln_A 174 GQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249 (327)
T ss_dssp CC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred eeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 75432 22233457999999999983 3444 58999999999999999999999875432 222222222221
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 240 CP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 240 ~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.+ ..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 22 3578999999999999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=371.72 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=217.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGK-----SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEV 87 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~ 87 (441)
.....++|++++.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34566889999999999999999999977665 79999997543 223467889999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK---------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD 152 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~---------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~ 152 (441)
+.+.+..|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999999999999863 3579999999999999999999999999999999999999
Q ss_pred CCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHH
Q 013522 153 EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYR 231 (441)
Q Consensus 153 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 231 (441)
.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999999976543322223344567889999999988776 489999999999999998 999998866544444
Q ss_pred HHHcC--CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 232 KIYRG--DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 232 ~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+... ....|..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 43332 344567789999999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=368.33 Aligned_cols=256 Identities=19% Similarity=0.295 Sum_probs=214.0
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTG----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
..+...+|++.+.||+|+||+||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4566789999999999999999999986553 359999997543 2334567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
+.+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999975 5799999999999999999999999999999999999999999999999999976
Q ss_pred ccccccCC-cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCC
Q 013522 168 SEHLKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWF 244 (441)
Q Consensus 168 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 244 (441)
........ ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 275 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence 54322111 1223346788999999987766 489999999999999998 99999998888888887766 45567778
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+.+||.+||+.||.+|||+.+++++
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=369.92 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=213.9
Q ss_pred CCCccccCCe-EEeeeecccCceEEEEEEE----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEE
Q 013522 12 DRPTLLHGKY-ELGRMLGHGTFAKVYLARN----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHE 86 (441)
Q Consensus 12 ~~~~~~~~~y-~i~~~LG~G~fg~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~ 86 (441)
..+.++.++| ++++.||+|+||+||++.+ ..+++.||+|++.... .....+.+.+|+.+++.++||||+++++
T Consensus 23 g~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (318)
T 3lxp_A 23 GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKG 100 (318)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEE
Confidence 3456788888 9999999999999988764 4578999999997653 2345678999999999999999999999
Q ss_pred EEEe--CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 87 VMAS--KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 87 ~~~~--~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
++.+ ...+|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 9987 47899999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred cccccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH---------------H
Q 013522 165 SAFSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------------S 228 (441)
Q Consensus 165 a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~---------------~ 228 (441)
+......... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||...... .
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9765432111 123345688899999999877664 8999999999999999999999764322 1
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 229 MYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 229 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
....+..+ ..+.|..+++++.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22223332 34567789999999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=361.54 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=207.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++.+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45678999999999999999999999999999999998655445556778999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999998863 5689999999999999999999999999999999999999999999999999875443
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC--cHHHHHHHHHcCCCCC--CCCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD--NIVSMYRKIYRGDFKC--PPWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~--~~~~~~ 246 (441)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. +.......+.....+. +..+++
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred C--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 2 222345679999999999987766 48999999999999999999999764 3445556666554432 246899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++.+||.+||..||.+|||+.+++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=361.82 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=216.6
Q ss_pred CCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 013522 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS 90 (441)
Q Consensus 11 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~ 90 (441)
...+..+.++|++.+.||+|+||.||+|++..+++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp CCCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 3445678889999999999999999999999999999999997543 246689999999999999999998854
Q ss_pred ----------------CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe
Q 013522 91 ----------------KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL 151 (441)
Q Consensus 91 ----------------~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl 151 (441)
...+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 4568999999999999999964 579999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHH
Q 013522 152 DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR 231 (441)
Q Consensus 152 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~ 231 (441)
+.++.+||+|||++..... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||... .....
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~ 229 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFT 229 (284)
T ss_dssp EETTEEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHH
T ss_pred cCCCCEEECcchhheeccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHH
Confidence 9999999999999875432 223445679999999999987766 58999999999999999999987532 23334
Q ss_pred HHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 232 KIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 232 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+..+ ..++.+++.+.+||.+||..||.+|||+.++++++|.-.
T Consensus 230 ~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 DLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred Hhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 44433 346678999999999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=366.41 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=208.1
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+..++|++++.||+|+||+||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 456789999999999999999998765 556899999976543 2344677899999999999999999999997655
Q ss_pred -----EEEEEEeccCCCchHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEe
Q 013522 93 -----KIYFAMDLVKGGELFNKIA-------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 93 -----~~~lv~E~~~gg~L~~~i~-------~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
..|+||||+.+++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999983 2469999999999999999999999999999999999999999999999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CC
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DF 238 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~ 238 (441)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ ..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 9999976543322223344567889999999987766 489999999999999999 99999998887777777766 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 239 KCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 239 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
..|..+++.+.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5677899999999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=361.37 Aligned_cols=258 Identities=22% Similarity=0.388 Sum_probs=208.1
Q ss_pred CCCCCCCCCCCC--CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC
Q 013522 1 MATSNSNGGGDD--RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78 (441)
Q Consensus 1 m~~~~~~~~~~~--~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h 78 (441)
|+.|.+...... ...+..++|++.+.||+|+||+||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++|
T Consensus 1 mg~s~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h 73 (278)
T 1byg_A 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRH 73 (278)
T ss_dssp --------------CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCC
T ss_pred CCCCccchhhhhhccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCC
Confidence 666655444332 2356678999999999999999999998 58899999986543 34678899999999999
Q ss_pred CCcceEEEEEEeC-CEEEEEEeccCCCchHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC
Q 013522 79 KHIVELHEVMASK-SKIYFAMDLVKGGELFNKIAKG---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED 154 (441)
Q Consensus 79 pnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~ 154 (441)
|||+++++++.+. +..|+||||+.+++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 74 ~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 153 (278)
T 1byg_A 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED 153 (278)
T ss_dssp TTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC
Confidence 9999999997544 5789999999999999999752 38999999999999999999999999999999999999999
Q ss_pred CCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHH
Q 013522 155 GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKI 233 (441)
Q Consensus 155 ~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 233 (441)
+.+||+|||++...... .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+
T Consensus 154 ~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 227 (278)
T 1byg_A 154 NVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227 (278)
T ss_dssp SCEEECCCCC-----------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred CcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998753321 234468899999999987766 489999999999999998 99999988877777777
Q ss_pred HcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 234 YRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 234 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..+ ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 228 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 665 34567789999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=369.36 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=215.9
Q ss_pred ccccCCeEEeeeecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
....++|++++.||+|+||+||+|++ ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 45668999999999999999999985 3577899999997553 223456789999999999 799999999998
Q ss_pred EeCC-EEEEEEeccCCCchHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEE
Q 013522 89 ASKS-KIYFAMDLVKGGELFNKIAKGR-----------------LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 150 (441)
Q Consensus 89 ~~~~-~~~lv~E~~~gg~L~~~i~~~~-----------------l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NIL 150 (441)
...+ .+|+||||+.|++|.+++.... +++..+..++.||+.||.|||++||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 5999999999999999997632 789999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHH-H
Q 013522 151 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIV-S 228 (441)
Q Consensus 151 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~-~ 228 (441)
++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 99999999999999975543222223345668999999999988776 489999999999999998 99999876533 3
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 229 MYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 229 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
....+..+ ....|..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34444443 356677899999999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.79 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=208.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.+..++|++.+.||+|+||+||+|++. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 445678999999999999999999986 467789999996542 234567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
...|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999999999976 469999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCC-cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 013522 170 HLKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246 (441)
Q Consensus 170 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 246 (441)
...... ......+|+.|+|||++.+..+. .++|||||||++|+|++ |..||...+.......+..+ ..+.+..+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 322111 11223457889999999887764 89999999999999998 99999998888888777665 3445667899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+.+||.+||+.||.+|||+.++++
T Consensus 278 ~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=360.89 Aligned_cols=253 Identities=20% Similarity=0.306 Sum_probs=214.4
Q ss_pred cccCCeEEee-eecccCceEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGR-MLGHGTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~-~LG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+-.++|++.+ .||+|+||+||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 4457899998 999999999999954 56788999999976532 224467899999999999999999999999 567
Q ss_pred EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999986 56999999999999999999999999999999999999999999999999998754322
Q ss_pred ccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHH
Q 013522 172 KQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEA 248 (441)
Q Consensus 172 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 248 (441)
... .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.+
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 11223446789999999987766 489999999999999999 999999988888887777664 45677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.++|.+||+.||.+|||+.++++
T Consensus 250 ~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 250 YDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=381.90 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=217.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
..+..++|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. .+.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 4566788999999999999999999985 577899999976432 3578899999999999999999999986 567
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 8999999999999999975 3689999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 248 (441)
... .......+|+.|+|||++....+ +.++|||||||+||+|++ |..||.+.+..+....+..+ ..+.|..+++++
T Consensus 337 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 414 (454)
T 1qcf_A 337 NEY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 414 (454)
T ss_dssp HHH-HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred Cce-eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 211 11223446788999999987776 489999999999999999 99999998888888777765 456677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||..||++|||+.+|++
T Consensus 415 ~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 415 YNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=384.18 Aligned_cols=270 Identities=22% Similarity=0.330 Sum_probs=198.5
Q ss_pred CCCCCCCCCCCCC---CccccC--CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh
Q 013522 1 MATSNSNGGGDDR---PTLLHG--KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM 75 (441)
Q Consensus 1 m~~~~~~~~~~~~---~~~~~~--~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~ 75 (441)
||++.+....... ..+..+ +|++.+.||+|+||+||. ....+|+.||||++...... .+.+|+.+|+.
T Consensus 1 M~ss~s~~~~~~~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~ 73 (432)
T 3p23_A 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRE 73 (432)
T ss_dssp -----------------CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHH
T ss_pred CCCCcccccCcCcccCCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHh
Confidence 7766665543322 223333 599999999999999764 33468999999999654332 34589999999
Q ss_pred C-CCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC
Q 013522 76 V-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD 152 (441)
Q Consensus 76 l-~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~ 152 (441)
+ +||||+++++++.+....|+|||||. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 74 l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~ 152 (432)
T 3p23_A 74 SDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152 (432)
T ss_dssp SCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEEC
T ss_pred ccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEe
Confidence 9 89999999999999999999999996 5999999763 456667789999999999999999999999999999995
Q ss_pred CC-----CCeEEeecCcccccccccc-CCcccccccCCCccchhhhhcc--CCCCCcccHHHHHHHHHHHhh-CCCCCCC
Q 013522 153 ED-----GNLKVTDFGLSAFSEHLKQ-DGLLHTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLA-GFLPFQD 223 (441)
Q Consensus 153 ~~-----~~vkl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~~ll~-G~~Pf~~ 223 (441)
.+ ..+||+|||+|........ .......+||+.|+|||++.+. ...+.++|||||||++|+|++ |..||..
T Consensus 153 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp CCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 32 3578999999976543211 1234456799999999999742 223578999999999999999 9999977
Q ss_pred CcHHHHHHHHHcCCCCC---CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 224 DNIVSMYRKIYRGDFKC---PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 224 ~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.........+....... +...+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 233 SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp TTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred hhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 65544333322222221 12245668999999999999999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=357.77 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=214.3
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcC---CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
...+..++|++.+.||+|+||+||+|++.. ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 445677899999999999999999999754 34469999997653 2344678999999999999999999999986
Q ss_pred eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
+. ..|+||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 56899999999999999975 4599999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFS 245 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~ 245 (441)
..... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ ..+.|..++
T Consensus 163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (281)
T 3cc6_A 163 IEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP 240 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred ccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence 44321 112234557889999999987776 489999999999999998 99999877666666666554 455677799
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.+.+||.+||..||++|||+.+++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=359.15 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=208.2
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM-ASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 93 (441)
..+.++|++++.||+|+||+||+|++..+|+.||+|++...... +.+.+|+.+++.++|++++..+..+ .....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 34678999999999999999999999999999999998765432 3688999999999988866655554 67788
Q ss_pred EEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCccccc
Q 013522 94 IYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla~~~ 168 (441)
.|+||||+ +++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 899999997 3679999999999999999999999999999999999999 48889999999999765
Q ss_pred cccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCCCCC
Q 013522 169 EHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKC 240 (441)
Q Consensus 169 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~ 240 (441)
...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+ ....+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 432221 12345679999999999988776 589999999999999999999998632 222333333322222
Q ss_pred -----CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 241 -----PPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 241 -----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 3668999999999999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=380.84 Aligned_cols=244 Identities=23% Similarity=0.436 Sum_probs=213.0
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-E
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS-K 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~ 93 (441)
.+-.++|++.+.||+|+||+||+|.+ +|+.||||++.... ..+.+.+|+.+|++++||||+++++++.... .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 45567899999999999999999998 57899999997543 2467889999999999999999999987655 7
Q ss_pred EEEEEeccCCCchHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK-G--RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-~--~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+|+||||+.+|+|.+++.. + .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999975 3 379999999999999999999999999999999999999999999999999874322
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 248 (441)
......+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+
T Consensus 342 -----~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 342 -----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 415 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHH
T ss_pred -----cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 12234678999999999887764 89999999999999998 99999988777777777766 456788899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||..||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=354.87 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=216.7
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.+.+..++|++++.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 35667789999999999999999999974 667899999975432 24678899999999999999999999864 5
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..|+||||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 68999999999999999975 269999999999999999999999999999999999999999999999999997644
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 247 (441)
... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++.
T Consensus 161 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 161 DNE-YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238 (279)
T ss_dssp SSC-EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred Ccc-cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHH
Confidence 321 112234457889999999987666 489999999999999999 999999988888887777663 4556778999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+||.+||..||++|||+.++++
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=372.45 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=210.2
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++.+.||+|+||+||+|++ .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3568999999999999999999996 478999999986543 234678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 96 FAMDLVKGGELFNKIAKG-----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~-----~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+||||+.||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999999652 489999999999999999999999999999999999999999999999999976443
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH-------HHHHHcCCC-----
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM-------YRKIYRGDF----- 238 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~-------~~~i~~~~~----- 238 (441)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ......+..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 333333455679999999999987776 4899999999999999999999976432111 111111111
Q ss_pred -----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCc
Q 013522 239 -----KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESS 273 (441)
Q Consensus 239 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hp 273 (441)
..++..+..+.+++.+||+.||++|||+.+++++.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11222456789999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=388.22 Aligned_cols=252 Identities=22% Similarity=0.378 Sum_probs=220.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
..+-..+|++.+.||+|+||+||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.+...
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 45566789999999999999999999999999999999975532 25678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999999975 4589999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHHH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEA 248 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 248 (441)
.. ........+++.|+|||++.+..+ +.++|||||||+||+|++ |..||.+.+.......+..+ ....|..+++.+
T Consensus 371 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 448 (495)
T 1opk_A 371 DT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 448 (495)
T ss_dssp CC-EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred Cc-eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 111223446788999999987766 489999999999999999 99999998877777776655 345677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||+.||.+|||+.++++
T Consensus 449 ~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 449 YELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=359.53 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=202.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM-ASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 93 (441)
..+.++|++++.||+|+||+||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+..+ ...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 34678999999999999999999999999999999987655432 3577899999999988777666554 77889
Q ss_pred EEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCccccc
Q 013522 94 IYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla~~~ 168 (441)
.++||||+ +++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 899999997 3679999999999999999999999999999999999999 78899999999999865
Q ss_pred cccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHHcCCCCC
Q 013522 169 EHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI---VSMYRKIYRGDFKC 240 (441)
Q Consensus 169 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~~ 240 (441)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+. ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 433221 12345679999999999988776 5899999999999999999999976432 12222332222222
Q ss_pred C-----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 241 P-----PWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 241 ~-----~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
| ..+++++.+||.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 2 567999999999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=361.53 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=207.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQ-TGK--SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.+..++|++++.||+|+||+||+|++.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456789999999999999999998643 333 6999999766544445678899999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
. .++||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 8899999999999999975 569999999999999999999999999999999999999999999999999987654
Q ss_pred ccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC--CCCCCCCC
Q 013522 170 HLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKCPPWFS 245 (441)
Q Consensus 170 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~ 245 (441)
..... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .+.+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 32211 12234567889999999987766 489999999999999999 999999998888888887654 34456789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+++.++|.+||..||.+|||+.++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=380.80 Aligned_cols=254 Identities=24% Similarity=0.428 Sum_probs=210.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS- 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 92 (441)
+..+.++|++.+.||+|+||+||+|++..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 346778999999999999999999999999999999999765432 23567789999999999999999999998755
Q ss_pred -EEEEEEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe----CCCCCeEEeecC
Q 013522 93 -KIYFAMDLVKGGELFNKIAKG----RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL----DEDGNLKVTDFG 163 (441)
Q Consensus 93 -~~~lv~E~~~gg~L~~~i~~~----~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl----~~~~~vkl~DFG 163 (441)
..|+||||+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 789999999999999999752 39999999999999999999999999999999999999 777789999999
Q ss_pred ccccccccccCCcccccccCCCccchhhhhcc-------CCCCCcccHHHHHHHHHHHhhCCCCCCC----CcHHHHHHH
Q 013522 164 LSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK-------GYDGAKADIWSCGVILYVLLAGFLPFQD----DNIVSMYRK 232 (441)
Q Consensus 164 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~DiwSlGvil~~ll~G~~Pf~~----~~~~~~~~~ 232 (441)
++..... .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.. ........+
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CceEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 9976443 2234456799999999998652 1224789999999999999999999964 233455555
Q ss_pred HHcCCCC-------------------CC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 233 IYRGDFK-------------------CP------PWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 233 i~~~~~~-------------------~~------~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+..+.+. .| ..+++.+.+||.+||+.||++|||+.+++++
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 5554321 11 1134578899999999999999999998654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.15 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=212.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI- 94 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~- 94 (441)
-+|++.+.||+|+||+||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 357888999999999999999766554 79999986532 334567889999999999999999999999776655
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999986 568999999999999999999999999999999999999999999999999997543322
Q ss_pred --cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHH
Q 013522 173 --QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEA 248 (441)
Q Consensus 173 --~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 248 (441)
.........||+.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+. ...|..+++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence 1223345568999999999987776 489999999999999999 566677777766666666654 45677789999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||+.||.+|||+.++++
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=358.26 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=210.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM-ASKSK 93 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~ 93 (441)
..+|++.+.||+|+||+||+|++..++ ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 457999999999999999999975443 368999986532 334567899999999999999999999985 45678
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
.|+||||+.||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999975 56899999999999999999999999999999999999999999999999999754332
Q ss_pred cc--CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC-CCCCCCCHH
Q 013522 172 KQ--DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF-KCPPWFSSE 247 (441)
Q Consensus 172 ~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~ 247 (441)
.. ........||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+.. ..|..+++.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 122334567889999999988776 489999999999999999 7788888777777777766654 346678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.++|.+||+.||.+|||+.++++
T Consensus 261 l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 261 LYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=356.07 Aligned_cols=250 Identities=20% Similarity=0.339 Sum_probs=201.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEe-
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMAS- 90 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~- 90 (441)
...+.++|++.+.||+|+||+||+|++ +++.||+|++.... ...+.+|.+++.. ++||||+++++++..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 356788999999999999999999998 79999999986432 3455667777766 799999999998654
Q ss_pred ---CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hcCcEeccCCCCcEEeCCCCCeEE
Q 013522 91 ---KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH--------SRGVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 91 ---~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH--------~~gi~HrDLkp~NILl~~~~~vkl 159 (441)
...+|+||||+.+|+|.+++..+.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356899999999999999999888999999999999999999999 999999999999999999999999
Q ss_pred eecCccccccccccC--CcccccccCCCccchhhhhccCCC-----CCcccHHHHHHHHHHHhhC----------CCCCC
Q 013522 160 TDFGLSAFSEHLKQD--GLLHTTCGTPAYVAPEVISKKGYD-----GAKADIWSCGVILYVLLAG----------FLPFQ 222 (441)
Q Consensus 160 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~-----~~~~DiwSlGvil~~ll~G----------~~Pf~ 222 (441)
+|||+|......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999754332111 112345799999999999765332 2589999999999999999 88885
Q ss_pred CCc----HHHHHHHHHcCC---CCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 223 DDN----IVSMYRKIYRGD---FKCPPW-----FSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 223 ~~~----~~~~~~~i~~~~---~~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
... ............ ...|+. +++.+.+||.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 431 222233332221 222221 3467999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=368.61 Aligned_cols=253 Identities=16% Similarity=0.175 Sum_probs=200.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcC---CCcEEEEEEeecccccch--------hhHHHHHHHHHHHHhCCCCCcceEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQ---TGKSMAMKVVGKDKVIKV--------GMMEQIKREISVMKMVKHKHIVELH 85 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~--------~~~~~~~~Ei~il~~l~hpnIv~l~ 85 (441)
..++|++++.||+|+||+||+|++.. ++..+|+|++........ .....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34689999999999999999999987 788999999976532110 0123466789999999999999999
Q ss_pred EEEEe----CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC--CeE
Q 013522 86 EVMAS----KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG--NLK 158 (441)
Q Consensus 86 ~~~~~----~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~--~vk 158 (441)
+++.. ....|+||||+ |++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 78899999999 9999999976 5799999999999999999999999999999999999999887 999
Q ss_pred EeecCccccccccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC--CcHHHHHH
Q 013522 159 VTDFGLSAFSEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD--DNIVSMYR 231 (441)
Q Consensus 159 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~--~~~~~~~~ 231 (441)
|+|||++......... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999765432211 12245679999999999987766 5899999999999999999999965 22222222
Q ss_pred HHHcCCCCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 232 KIYRGDFKCP---------PWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 232 ~i~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.........| ..+++++.+||.+||..||++|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111111122 268899999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=364.88 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=214.1
Q ss_pred CCCCCccc-cCCeEEeeeecccCceEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceE
Q 013522 10 GDDRPTLL-HGKYELGRMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84 (441)
Q Consensus 10 ~~~~~~~~-~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l 84 (441)
+....+++ .++|++++.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~ 89 (327)
T 3lxl_A 13 ACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKY 89 (327)
T ss_dssp ----CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEE
Confidence 33344444 4689999999999999999999 56789999999997543 3445678999999999999999999
Q ss_pred EEEEE--eCCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEe
Q 013522 85 HEVMA--SKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 85 ~~~~~--~~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
++++. +....|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~ 169 (327)
T 3lxl_A 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIA 169 (327)
T ss_dssp EEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEc
Confidence 99886 56779999999999999999975 569999999999999999999999999999999999999999999999
Q ss_pred ecCccccccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcH-------------
Q 013522 161 DFGLSAFSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNI------------- 226 (441)
Q Consensus 161 DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~------------- 226 (441)
|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3lxl_A 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248 (327)
T ss_dssp CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred ccccceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence 99999765432211 12334568889999999987766 5899999999999999999999865433
Q ss_pred --HHHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 227 --VSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 227 --~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
......+..+ ..+.|+.+++.+.+||.+||++||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2223333333 345677899999999999999999999999999654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=365.47 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=205.7
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA----SKS 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~ 92 (441)
..++|++++.||+|+||+||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 4568999999999999999999999999999999986542 345678899999999999999999999986 345
Q ss_pred EEEEEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
..|+||||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999999999998864 5699999999999999999999999999999999999999999999999999865
Q ss_pred ccccccCC-------cccccccCCCccchhhhhccCC--CCCcccHHHHHHHHHHHhhCCCCCCCCcH--HHHHHHHHc-
Q 013522 168 SEHLKQDG-------LLHTTCGTPAYVAPEVISKKGY--DGAKADIWSCGVILYVLLAGFLPFQDDNI--VSMYRKIYR- 235 (441)
Q Consensus 168 ~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~--~~~~~DiwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~- 235 (441)
........ ......||+.|+|||++.+... .+.++|||||||++|+|++|..||..... ......+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 263 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc
Confidence 43211110 1124458999999999875432 25899999999999999999999954211 011112222
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 236 GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
...+.++.+++.+.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 2234456789999999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.46 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=213.4
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.+.+..++|++.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345667889999999999999999999864 46799999976542 24678999999999999999999999876 6
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
..|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999964 469999999999999999999999999999999999999999999999999997644
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 247 (441)
... ........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|+.+++.
T Consensus 332 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 332 DNE-YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred CCc-eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 211 112233457788999999987776 489999999999999999 99999998888888887766 45667889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+||.+||+.||++|||+.++++
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=365.30 Aligned_cols=250 Identities=30% Similarity=0.457 Sum_probs=187.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEE-------
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMA------- 89 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~------- 89 (441)
..+|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 458999999999999999999999999999999986543 244567889999999995 999999999984
Q ss_pred -eCCEEEEEEeccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeCCCCCeEEeec
Q 013522 90 -SKSKIYFAMDLVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLDEDGNLKVTDF 162 (441)
Q Consensus 90 -~~~~~~lv~E~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~~~~~vkl~DF 162 (441)
....+++||||+. |+|.+++.. +.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 3456899999996 588888753 67999999999999999999999999 999999999999999999999999
Q ss_pred CccccccccccC----------CcccccccCCCccchhhhh---ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH
Q 013522 163 GLSAFSEHLKQD----------GLLHTTCGTPAYVAPEVIS---KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM 229 (441)
Q Consensus 163 Gla~~~~~~~~~----------~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~ 229 (441)
|++......... ......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 999765432211 1122556999999999983 3334 5899999999999999999999987655433
Q ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 230 YRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 230 ~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
..... ..+.+...++.+.+||.+||+.||.+|||+.+++++-+
T Consensus 262 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 32211 23334567888999999999999999999999998743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=376.42 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=199.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~ 92 (441)
...+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+|+.+ +||||+++++++.+.+
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 34567788889999999999998754 4689999999986532 35678999999876 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC----------
Q 013522 93 KIYFAMDLVKGGELFNKIAKGRL--------REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED---------- 154 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~~l--------~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~---------- 154 (441)
.+|+|||||. |+|.+++..... ++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 599999986432 223456799999999999999999999999999999754
Q ss_pred ---CCeEEeecCccccccccccC--CcccccccCCCccchhhhhc------cCCCCCcccHHHHHHHHHHHhh-CCCCCC
Q 013522 155 ---GNLKVTDFGLSAFSEHLKQD--GLLHTTCGTPAYVAPEVISK------KGYDGAKADIWSCGVILYVLLA-GFLPFQ 222 (441)
Q Consensus 155 ---~~vkl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~------~~~~~~~~DiwSlGvil~~ll~-G~~Pf~ 222 (441)
+.+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 47999999999865432211 12345689999999999965 1334689999999999999999 999998
Q ss_pred CCcHHHHHHHHHcCCCCCCC-------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 223 DDNIVSMYRKIYRGDFKCPP-------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 223 ~~~~~~~~~~i~~~~~~~~~-------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+..... ..+..+....+. .+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 765433 234444433322 235789999999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=370.41 Aligned_cols=252 Identities=16% Similarity=0.188 Sum_probs=199.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC-----CcEEEEEEeecccccchh--------hHHHHHHHHHHHHhCCCCCcceE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQT-----GKSMAMKVVGKDKVIKVG--------MMEQIKREISVMKMVKHKHIVEL 84 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l 84 (441)
.++|++++.||+|+||+||+|.+..+ ++.||+|++......... ......+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34999999999999999999998764 588999998765321000 01234456667788899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC--CCCC
Q 013522 85 HEVMASK----SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD--EDGN 156 (441)
Q Consensus 85 ~~~~~~~----~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~--~~~~ 156 (441)
++++... ...|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 5689999999 9999999975 6799999999999999999999999999999999999999 8899
Q ss_pred eEEeecCccccccccccCC-----cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHH
Q 013522 157 LKVTDFGLSAFSEHLKQDG-----LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMY 230 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~ 230 (441)
+||+|||+|.......... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999997654332211 1244569999999999988776 58999999999999999999999853211 111
Q ss_pred HHHH---cCCC-------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 231 RKIY---RGDF-------KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 231 ~~i~---~~~~-------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.... .... -.+..+++++.++|..||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110 0000 012467899999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=354.90 Aligned_cols=234 Identities=30% Similarity=0.571 Sum_probs=194.4
Q ss_pred CCccccCCeEEe-eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHH-HhCCCCCcceEEEEEEe
Q 013522 13 RPTLLHGKYELG-RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM-KMVKHKHIVELHEVMAS 90 (441)
Q Consensus 13 ~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~ 90 (441)
....+.++|.+. +.||+|+||+||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 345567888887 7899999999999999999999999998643 3567888888 66799999999999987
Q ss_pred ----CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEe
Q 013522 91 ----KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVT 160 (441)
Q Consensus 91 ----~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~ 160 (441)
...+|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 7789999999999999999975 25999999999999999999999999999999999999998 7889999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHH----HHcC
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRK----IYRG 236 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~----i~~~ 236 (441)
|||++..... ..+ +.++|||||||++|+|++|..||.+.+....... +..+
T Consensus 163 Dfg~a~~~~~------------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETTG------------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECTT------------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred cccccccccc------------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 9999863221 123 4789999999999999999999987655433211 1222
Q ss_pred CCCCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 DFKCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
....| ..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 33333 45899999999999999999999999999999997643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=363.27 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=200.8
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC--CCCCcceEEEEEEeC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV--KHKHIVELHEVMASK 91 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~ 91 (441)
...+.++|++.+.||+|+||+||+|++ +++.||+|++.... .....+|..++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 356778999999999999999999998 58999999986432 23445566666554 999999999999887
Q ss_pred ----CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CcEeccCCCCcEEeCCCCCeEE
Q 013522 92 ----SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR--------GVYHRDLKPENLLLDEDGNLKV 159 (441)
Q Consensus 92 ----~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~--------gi~HrDLkp~NILl~~~~~vkl 159 (441)
...|+||||+.||+|.+++....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999988899999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccccccCC--cccccccCCCccchhhhhccCCCCC-----cccHHHHHHHHHHHhhC----------CCCCC
Q 013522 160 TDFGLSAFSEHLKQDG--LLHTTCGTPAYVAPEVISKKGYDGA-----KADIWSCGVILYVLLAG----------FLPFQ 222 (441)
Q Consensus 160 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~-----~~DiwSlGvil~~ll~G----------~~Pf~ 222 (441)
+|||++.......... .....+||+.|+|||++.+..+... ++|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999996543322111 1235679999999999987665432 38999999999999999 77775
Q ss_pred CC-----cHHHHHHHHHcC--CCCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 223 DD-----NIVSMYRKIYRG--DFKCPP-----WFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 223 ~~-----~~~~~~~~i~~~--~~~~~~-----~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.. ........+... ....|. .+++++.+||.+||+.||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 43 122222222222 222332 245679999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=363.52 Aligned_cols=244 Identities=14% Similarity=0.193 Sum_probs=202.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcC--------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcce------
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQ--------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVE------ 83 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------ 83 (441)
.++|++.+.||+|+||+||+|++.. +++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4799999999999999999999987 4889999998754 25779999999999999988
Q ss_pred ---------EEEEEEe-CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEE
Q 013522 84 ---------LHEVMAS-KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 150 (441)
Q Consensus 84 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NIL 150 (441)
+++++.. ....|+||||+ |++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777766 78999999999 9999999975 57999999999999999999999999999999999999
Q ss_pred eCCCC--CeEEeecCccccccccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC
Q 013522 151 LDEDG--NLKVTDFGLSAFSEHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD 223 (441)
Q Consensus 151 l~~~~--~vkl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~ 223 (441)
++.++ .+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 8999999999765433211 12244579999999999987766 5899999999999999999999987
Q ss_pred Cc--HHHHHHH---HHcCCCCCC------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 224 DN--IVSMYRK---IYRGDFKCP------PWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 224 ~~--~~~~~~~---i~~~~~~~~------~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.. ...+... +......++ ..+++.+.+||.+||..||++|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 3222222 222222222 246899999999999999999999999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=367.19 Aligned_cols=246 Identities=16% Similarity=0.241 Sum_probs=202.7
Q ss_pred cccCCeEEeeeecccCceEEEEE-----EEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceEEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLA-----RNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEV 87 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~ 87 (441)
+..++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 44578999999999999999999 467889999999986542 356778888888887 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC--------
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIA------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-------- 153 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~------~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-------- 153 (441)
+...+..|+||||+.||+|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 999999999999999999999996 356999999999999999999999999999999999999998
Q ss_pred ---CCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHH
Q 013522 154 ---DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY 230 (441)
Q Consensus 154 ---~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~ 230 (441)
++.+||+|||+|...............+||+.|+|||++.+..| +.++|||||||++|+|++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 89999999999976554444445567789999999999988876 4899999999999999999999965432100
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 231 RKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 231 ~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.....-...+.++.+.+++..||+.+|.+|++..+.+.+
T Consensus 294 ---~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 ---KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ---EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ---eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000111122457789999999999999999765555443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=368.12 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=202.8
Q ss_pred CeEEeeeecccCceEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA-SKSKIY 95 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~ 95 (441)
+|++.+.||+|+||+||+|++..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+..|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 5899999999999999999976443 468999986432 3345678999999999999999999999864 456889
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999999975 4588999999999999999999999999999999999999999999999999975432211
Q ss_pred C--CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 174 D--GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 174 ~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
. .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+. ...|..+++.+.
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 11233457889999999988776 489999999999999999 788998877666666666654 345677999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 013522 250 RLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~eil~h 272 (441)
++|.+||..||++|||+.+++++
T Consensus 327 ~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 327 EVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=358.26 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=204.5
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMD 99 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E 99 (441)
|..++.||+|+||+||+|.+ +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999996 788999999975432 223456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 100 LVKGGELFNKIAK----GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 100 ~~~gg~L~~~i~~----~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999863 458999999999999999999999999999999999999999999999999987654333222
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH----HHHHHHHcCCC-----------CC
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV----SMYRKIYRGDF-----------KC 240 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~-----------~~ 240 (441)
.....+||+.|+|||++.+. + +.++|||||||++|+|++|..||...... .+...+..... ..
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 33456799999999998754 4 58999999999999999999999875432 22222222211 11
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 241 PPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 241 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+...++.+.++|.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 22345678999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.39 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=210.8
Q ss_pred ccCCeEEee-eecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 17 LHGKYELGR-MLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 17 ~~~~y~i~~-~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
..++|.+.+ .||+|+||+||+|.+. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++.+ +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 345566666 8999999999999876 356679999997643 22346789999999999999999999999976 56
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
+|+||||+.||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 8999999999999999964 56999999999999999999999999999999999999999999999999999764322
Q ss_pred ccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHH
Q 013522 172 KQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEA 248 (441)
Q Consensus 172 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 248 (441)
... .......+|+.|+|||++.+..+. .++|||||||+||+|++ |..||.+.+..+....+..+. ...|+.+++++
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 111 112233467899999999877774 89999999999999998 999999988888888887764 56778899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||..||++|||+.++++
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=353.63 Aligned_cols=241 Identities=26% Similarity=0.427 Sum_probs=199.5
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
-.++|++.+.||+|+||+||+|++ .++.||+|++... ...+.+.+|+.+++.++||||+++++++.+ ..|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 346899999999999999999998 5789999998643 235678899999999999999999998864 4789
Q ss_pred EEeccCCCchHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh---cCcEeccCCCCcEEeCCCCC-eEEeecCccccc
Q 013522 97 AMDLVKGGELFNKIAKG----RLREDVARVYFQQLISAVDFCHS---RGVYHRDLKPENLLLDEDGN-LKVTDFGLSAFS 168 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~----~l~~~~~~~~~~qll~aL~ylH~---~gi~HrDLkp~NILl~~~~~-vkl~DFGla~~~ 168 (441)
||||++|++|.+++... .++...+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999999863 37899999999999999999999 89999999999999998887 799999998743
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHHcC-CCCCCCCCC
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN--IVSMYRKIYRG-DFKCPPWFS 245 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~-~~~~~~~~~ 245 (441)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+..+ ....+..++
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred cc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence 32 2234569999999999987766 489999999999999999999997542 23333334333 345567789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.+.+||.+||+.||.+|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=380.54 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=218.4
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+.+..++|++.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3455677899999999999999999999864 46799999976542 24678999999999999999999999876
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
..+|+||||+.+|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 678999999999999999974 46999999999999999999999999999999999999999999999999999764
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 246 (441)
..... .......+++.|+|||++....+ +.++|||||||+||+|++ |..||.+.+..+....+..+ ..+.|..+++
T Consensus 414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 491 (535)
T 2h8h_A 414 EDNEY-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 491 (535)
T ss_dssp CCHHH-HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCce-ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 32111 11223446788999999987776 489999999999999999 99999998888888887766 3566788999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
.+.+||.+||+.||++|||+.+|++.
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=361.28 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=206.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++.+.||+|+||+||+|++ .+|+.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 4678999999999999999999985 578999999997654321 1236889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhc---CcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 96 FAMDLVKGGELFNKIAKG-----RLREDVARVYFQQLISAVDFCHSR---GVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~-----~l~~~~~~~~~~qll~aL~ylH~~---gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
+||||+.||+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 183 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183 (326)
T ss_dssp EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence 999999999999999752 389999999999999999999999 999999999999999999999999999976
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHHHHcCCC-----
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDF----- 238 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~----- 238 (441)
.... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ..........+..
T Consensus 184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 5422 2233445569999999999987766 589999999999999999999995211 0001111111110
Q ss_pred ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcc
Q 013522 239 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSW 274 (441)
Q Consensus 239 ----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpw 274 (441)
..++..++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111112467899999999999999999999998855
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=383.65 Aligned_cols=248 Identities=20% Similarity=0.323 Sum_probs=209.6
Q ss_pred eEE-eeeecccCceEEEEEEE--cCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 21 YEL-GRMLGHGTFAKVYLARN--LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 21 y~i-~~~LG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
+.+ .+.||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ +..++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 444 34899999999999955 45678999999976532 23456789999999999999999999999965 458899
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc-CC
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~ 175 (441)
|||+.+|+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........ ..
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999999999976 6799999999999999999999999999999999999999999999999999986543221 11
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLIT 253 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 253 (441)
......||+.|+|||++.+..+. .++|||||||++|+|++ |..||.+.+.......+..+. ...|..+++++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22334578899999999887774 89999999999999998 999999999888888887764 5668889999999999
Q ss_pred HhcCCCCCCCCCHHHHhc
Q 013522 254 KLLDPNPNSRIAISKIME 271 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~ 271 (441)
+||..||++|||+.++++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=356.44 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=210.4
Q ss_pred CCccccCCeEEeeeecccCceEEEEEE----EcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLAR----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVM 88 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~ 88 (441)
+.....++|++++.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 111 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVC 111 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 445667789999999999999999999 45689999999997542 34567899999999999999999999998
Q ss_pred EeCC--EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 89 ASKS--KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 89 ~~~~--~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
...+ .+++||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 6543 78999999999999999976 4599999999999999999999999999999999999999999999999999
Q ss_pred cccccccccC-CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH----------------
Q 013522 165 SAFSEHLKQD-GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV---------------- 227 (441)
Q Consensus 165 a~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~---------------- 227 (441)
+......... .......+++.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 9765432211 11233457888999999987766 48999999999999999999998653211
Q ss_pred HHHHHHHc-CCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 228 SMYRKIYR-GDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 228 ~~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+...+.. ...+.|+.+++++.+||.+||..||++|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11222222 245567789999999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=357.74 Aligned_cols=258 Identities=19% Similarity=0.304 Sum_probs=196.2
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHH--HHhCCCCCcceEEEEEEe-
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISV--MKMVKHKHIVELHEVMAS- 90 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i--l~~l~hpnIv~l~~~~~~- 90 (441)
+.+-.++|++++.||+|+||+||+|++ +++.||+|++.... ...+..|..+ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 455678999999999999999999987 78999999996543 2233344444 456899999999986542
Q ss_pred ----CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---------CcEeccCCCCcEEeCCCCCe
Q 013522 91 ----KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR---------GVYHRDLKPENLLLDEDGNL 157 (441)
Q Consensus 91 ----~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~---------gi~HrDLkp~NILl~~~~~v 157 (441)
...+|+||||++||+|.+++.....++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 33689999999999999999988889999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccccc------cCCcccccccCCCccchhhhhccC------CCCCcccHHHHHHHHHHHhhCCCCCCCC-
Q 013522 158 KVTDFGLSAFSEHLK------QDGLLHTTCGTPAYVAPEVISKKG------YDGAKADIWSCGVILYVLLAGFLPFQDD- 224 (441)
Q Consensus 158 kl~DFGla~~~~~~~------~~~~~~~~~gt~~y~APE~l~~~~------~~~~~~DiwSlGvil~~ll~G~~Pf~~~- 224 (441)
||+|||++....... ........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999997643211 122234567999999999997621 2236799999999999999997665321
Q ss_pred c-----------------HHHHHHHHHc--CCCCCCCC------CCHHHHHHHHHhcCCCCCCCCCHHHHh------cCc
Q 013522 225 N-----------------IVSMYRKIYR--GDFKCPPW------FSSEARRLITKLLDPNPNSRIAISKIM------ESS 273 (441)
Q Consensus 225 ~-----------------~~~~~~~i~~--~~~~~~~~------~~~~~~~li~~~L~~dP~~R~t~~eil------~hp 273 (441)
. .......+.. ....+|.. +++++.+||.+||+.||++|||+.+++ -++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 1111111111 12233333 334799999999999999999999994 467
Q ss_pred ccCccC
Q 013522 274 WFKKSA 279 (441)
Q Consensus 274 wf~~~~ 279 (441)
|-++..
T Consensus 320 ~~~~~~ 325 (336)
T 3g2f_A 320 WERNKS 325 (336)
T ss_dssp CCC---
T ss_pred HHhccc
Confidence 766543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=357.80 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=211.4
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
...+..++|++++.||+|+||+||+|++.. .+|+|++...... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345667899999999999999999999843 4999999754322 123345778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..++||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999999999986 3599999999999999999999999999999999999998 68999999999875432
Q ss_pred cc---cCCcccccccCCCccchhhhhcc--------CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC
Q 013522 171 LK---QDGLLHTTCGTPAYVAPEVISKK--------GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK 239 (441)
Q Consensus 171 ~~---~~~~~~~~~gt~~y~APE~l~~~--------~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 239 (441)
.. .........||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+.......+..+..+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 21 22334455699999999999752 22358899999999999999999999999888888877776543
Q ss_pred C--CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 240 C--PPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 240 ~--~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
. +..+++++.++|.+||..||.+|||+.++++
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3 2357899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.70 Aligned_cols=250 Identities=19% Similarity=0.342 Sum_probs=206.5
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--VKHKHIVELHEVMASKS 92 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~ 92 (441)
..+.++|++.+.||+|+||+||+|++ +|+.||+|++... ....+.+|+.+++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 45678999999999999999999998 6899999998643 23567789999887 79999999999998776
Q ss_pred ----EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hcCcEeccCCCCcEEeCCCCCeEEe
Q 013522 93 ----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCH--------SRGVYHRDLKPENLLLDEDGNLKVT 160 (441)
Q Consensus 93 ----~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH--------~~gi~HrDLkp~NILl~~~~~vkl~ 160 (441)
..|+||||+.+|+|.+++....+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 8999999999999999999888999999999999999999999 8999999999999999999999999
Q ss_pred ecCccccccccccC--CcccccccCCCccchhhhhccCCCC-----CcccHHHHHHHHHHHhhC----------CCCCCC
Q 013522 161 DFGLSAFSEHLKQD--GLLHTTCGTPAYVAPEVISKKGYDG-----AKADIWSCGVILYVLLAG----------FLPFQD 223 (441)
Q Consensus 161 DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~-----~~~DiwSlGvil~~ll~G----------~~Pf~~ 223 (441)
|||++......... ......+||+.|+|||++.+..... .++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999754432111 0234557999999999997653221 579999999999999999 789866
Q ss_pred C-----cHHHHHHHHHcCCC--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 224 D-----NIVSMYRKIYRGDF--KCPPW-----FSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 224 ~-----~~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
. ....+...+..... ..|.. .++.+.+||.+||+.||++|||+.++++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 4 23444444433322 22321 23578999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=371.52 Aligned_cols=245 Identities=18% Similarity=0.282 Sum_probs=200.6
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCC---------CCCc
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----KVGMMEQIKREISVMKMVK---------HKHI 81 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnI 81 (441)
+..++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 7899999999876431 2234578889999999885 8888
Q ss_pred ceEEEEEE------------------------------eCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013522 82 VELHEVMA------------------------------SKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAV 131 (441)
Q Consensus 82 v~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL 131 (441)
+++++++. +.+.+|+||||+.+|++.+.+.++.+++..++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 88877653 268899999999999888888778899999999999999999
Q ss_pred HHHh-hcCcEeccCCCCcEEeCCCC--------------------CeEEeecCccccccccccCCcccccccCCCccchh
Q 013522 132 DFCH-SRGVYHRDLKPENLLLDEDG--------------------NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190 (441)
Q Consensus 132 ~ylH-~~gi~HrDLkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 190 (441)
+||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999887 899999999986542 2458999999999
Q ss_pred hhhccCCCCCcccHHHHHHH-HHHHhhCCCCCCCCcH-HHHHHHHHcC-CCC--C----CCCCCHHHHHHHHHhcCCCCC
Q 013522 191 VISKKGYDGAKADIWSCGVI-LYVLLAGFLPFQDDNI-VSMYRKIYRG-DFK--C----PPWFSSEARRLITKLLDPNPN 261 (441)
Q Consensus 191 ~l~~~~~~~~~~DiwSlGvi-l~~ll~G~~Pf~~~~~-~~~~~~i~~~-~~~--~----~~~~~~~~~~li~~~L~~dP~ 261 (441)
++.+.. +.++||||+|++ .+++++|..||.+... ......+... ... . ++.+++++++||++||++|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998665 589999998777 7788999999955322 2233333321 111 1 1236789999999999987
Q ss_pred CCCCHHHHh-cCcccC
Q 013522 262 SRIAISKIM-ESSWFK 276 (441)
Q Consensus 262 ~R~t~~eil-~hpwf~ 276 (441)
|+.++| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=368.25 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=208.6
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMASKSK 93 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~ 93 (441)
..+.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.|+| ++|..+..++.....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 35778999999999999999999999999999999998755432 357799999999977 566666677788899
Q ss_pred EEEEEeccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEe---CCCCCeEEeecCccccc
Q 013522 94 IYFAMDLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl---~~~~~vkl~DFGla~~~ 168 (441)
.|+||||+ |++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999999 899999997 4679999999999999999999999999999999999999 68899999999999865
Q ss_pred cccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCCC--
Q 013522 169 EHLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDF-- 238 (441)
Q Consensus 169 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~-- 238 (441)
...... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+.. ....+.++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 432221 12236789999999999988776 489999999999999999999998743 3333443332221
Q ss_pred ---CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 239 ---KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 239 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.++..+++++.+||.+||..||++||++.+|++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999998754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=370.89 Aligned_cols=247 Identities=19% Similarity=0.240 Sum_probs=195.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcc----------------
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIV---------------- 82 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv---------------- 82 (441)
.|++++.||+|+||+||+|++..+|+.||||++...........+.+++|+.+++.++| +|..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 48899999999999999999999999999999875443333346789999999999987 2211
Q ss_pred -----eEEEEEEe-----CCEEEEEEeccCCCchHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccC
Q 013522 83 -----ELHEVMAS-----KSKIYFAMDLVKGGELFNKIA--------KGRLREDVARVYFQQLISAVDFCHSRGVYHRDL 144 (441)
Q Consensus 83 -----~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~--------~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDL 144 (441)
.+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||+|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11121221 22467778876 579998885 234778888999999999999999999999999
Q ss_pred CCCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhh----------ccCCCCCcccHHHHHHHHHHH
Q 013522 145 KPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS----------KKGYDGAKADIWSCGVILYVL 214 (441)
Q Consensus 145 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~----------~~~~~~~~~DiwSlGvil~~l 214 (441)
||+|||++.++.+||+|||+++..... ..+.+| +.|+|||++. +..+ +.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHH
Confidence 999999999999999999998754332 456788 9999999994 2233 4799999999999999
Q ss_pred hhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 215 LAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 215 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++|+.||...+.......+.. ....+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 311 ltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999988766544443333 223578999999999999999999999999999999753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=379.92 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=214.3
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCC---CcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.+..++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 35567899999999999999999998654 4579999886432 3345578999999999999999999999985 4
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
+..|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 668999999999999999975 368999999999999999999999999999999999999999999999999997643
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 247 (441)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .+.|+.+++.
T Consensus 543 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCc-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 321 112234457889999999987776 489999999999999997 999999988888888877654 5678889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+||.+||..||.+|||+.++++
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=390.72 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=206.7
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--- 90 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--- 90 (441)
+....++|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3455699999999999999999999999999999999986542 33456788999999999999999999999755
Q ss_pred ---CCEEEEEEeccCCCchHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC---eEEe
Q 013522 91 ---KSKIYFAMDLVKGGELFNKIAK-G---RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN---LKVT 160 (441)
Q Consensus 91 ---~~~~~lv~E~~~gg~L~~~i~~-~---~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~---vkl~ 160 (441)
.+..|+||||+.||+|.+++.. + .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 6778999999999999999976 2 5899999999999999999999999999999999999997775 9999
Q ss_pred ecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHH---------
Q 013522 161 DFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR--------- 231 (441)
Q Consensus 161 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~--------- 231 (441)
|||++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........+.
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999976432 233456789999999999987776 489999999999999999999997653322110
Q ss_pred H-----HHcCCC------CCC----CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 232 K-----IYRGDF------KCP----PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 232 ~-----i~~~~~------~~~----~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
. ...+.. +.| +.+++.+.+||.+||.+||++|||+.++++||||+.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 011111 111 225678999999999999999999999999999964
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=343.59 Aligned_cols=228 Identities=15% Similarity=0.197 Sum_probs=193.9
Q ss_pred CCc-cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 13 RPT-LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 13 ~~~-~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
.+. ++.++|++.+.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR 103 (286)
T ss_dssp TTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence 344 7889999999999999999999999999999999999876555455667899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
+..|+||||+.|++|.+++..+. ...++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------- 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------- 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------
T ss_pred CcEEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------
Confidence 99999999999999999997764 5667889999999999999999999999999999999999999985542
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHH---HHHcCCCC----CCCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYR---KIYRGDFK----CPPWF 244 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~~----~~~~~ 244 (441)
++| .+.++|||||||++|+|++|+.||.+.+...... +...+... .++.+
T Consensus 176 ---------------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T 3uqc_A 176 ---------------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232 (286)
T ss_dssp ---------------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTS
T ss_pred ---------------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCC
Confidence 332 3588999999999999999999998765432110 11112111 23568
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
++++.+||.+||+.||.+| |+.++++.
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 9999999999999999999 99999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=381.96 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=203.4
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcC-CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQ-TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+.++.++|++.+.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 45678999999999999999999999976 78999999986532 2344567889999999999999999999998765
Q ss_pred E-----EEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 93 K-----IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 93 ~-----~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
. .|+||||+.|++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 5 7999999999999988766 79999999999999999999999999999999999999875 999999999875
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC--CCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFS 245 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~ 245 (441)
... ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+..... .... ....+
T Consensus 231 ~~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~ 294 (681)
T 2pzi_A 231 INS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLKTY 294 (681)
T ss_dssp TTC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CCTTCHHHHHC
T ss_pred ccc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCccccccc--------ccccccccccC
Confidence 432 1456799999999999765 3 689999999999999999999987632110 0000 01136
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+.+.+||.+||++||.+||+..+.+.|+|+.
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 7899999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.65 Aligned_cols=230 Identities=12% Similarity=0.111 Sum_probs=160.5
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeeccccc-------chhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 013522 26 MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-------KVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 26 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++.|++|.+..++....|+.+|+|++.+.... .....+.+.+|+++|+++ .|+||+++++++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788888888888889999999999875432 123456799999999999 799999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||+|++|.++|.+ +++++. .++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCcc
Confidence 999999999999987 667654 5899999999999999999999999999999999999999999975443 2234
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 256 (441)
..+.+||+.|+|||++.+.. ..++|+||+|++++.+.++..|+ ...+... |.. ...+..+...++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-RWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHTS----CGG-GCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchh--------HHHhhcC----CCC-CCcHHHHHHHHh
Confidence 56789999999999997643 36799999999999887764443 1111111 110 112456677777
Q ss_pred CCCCCCCCCHHHHhcCccc
Q 013522 257 DPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf 275 (441)
..+|..|+.......++|.
T Consensus 461 ~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 461 KKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp TGGGSCCGGGSSCCHHHHH
T ss_pred CCCCCCCCChhhhccchhH
Confidence 7888888777666666665
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=244.87 Aligned_cols=131 Identities=37% Similarity=0.700 Sum_probs=116.5
Q ss_pred CccccchhhhhccCCCCCCChhhHHhhHHHhhhhcccccCCchhhHHHHHHHHHHcCcEEEeecCeEEEEeeecCCccce
Q 013522 299 QPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKL 378 (441)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 378 (441)
.|..+|||++|++|+|+|||+||+......++++||+|+.|++.++++|+++|+.++|+|+++++++++++..+|+||.|
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l 82 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL 82 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence 46789999999999999999999765432356799999999999999999999999999999888999999999999999
Q ss_pred EEEEEEEEecCceEEEEEEccCCChhhhHHHhhhhhhhhhccceeccccccc
Q 013522 379 AINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWMSTADNP 430 (441)
Q Consensus 379 ~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~~~~l~~~l~div~~~~~~~~ 430 (441)
++.+|||+|+|+++||||+|++||++||++||. +||++|+||||+|+++..
T Consensus 83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~-~Lr~~L~diV~~~~~~~~ 133 (143)
T 2ehb_D 83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSKLENIIWRATEGIP 133 (143)
T ss_dssp EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHH-HHHHHSTTTBCC------
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHH-HHHHHhhcceecCCCCCc
Confidence 999999999999999999999999999999765 899999999999999764
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=226.34 Aligned_cols=122 Identities=30% Similarity=0.474 Sum_probs=107.9
Q ss_pred CccccchhhhhccCCCCCCChhhHHhhHHHhhhhcccccCCchhhHHHHHHHHHHcCcEEEeecCeEEEEeeecCCccce
Q 013522 299 QPETLNAFHIISLSEGFDLSPLFEEKKRAEREELRFATTRPASSVISRFEEVAKAVKFNVKTSESRVRLQGQESGRKGKL 378 (441)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 378 (441)
.|..+|||++|++|+|+|||+||++..+ .++++||+|+.||+.++++|+++|+.++|+|++++++ ++..+|+||.|
T Consensus 2 ~~~~lNAFdiIs~S~g~dLSgLFe~~~~-~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l 77 (123)
T 2zfd_B 2 GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNF 77 (123)
T ss_dssp --CCCCHHHHHHTSTTSSSGGGGGGGCS-SCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTE
T ss_pred CcccccHHHHHHHCcCCCchHhcCcccc-cccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccE
Confidence 3567999999999999999999976432 3568999999999999999999999999999988875 77788999999
Q ss_pred EEEEEEEEecCceEEEEEEccCCChhhhHHHhhhhhhhhhccceec
Q 013522 379 AINADIFAVTPSLLVVEVKKDNGDTLEYNQFCSNELRPALKDIVWM 424 (441)
Q Consensus 379 ~~~~~i~~~~~~~~~v~~~~~~Gd~le~~~~~~~~l~~~l~div~~ 424 (441)
++.+|||||+|+++||||+|++||++||++||+++||++|+||||+
T Consensus 78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~ 123 (123)
T 2zfd_B 78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE 123 (123)
T ss_dssp EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence 9999999999999999999999999999999988999999999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=268.43 Aligned_cols=189 Identities=18% Similarity=0.170 Sum_probs=146.0
Q ss_pred EEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG-----MMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
...+.||+|+||+||+|.. .++.+++|........... ..+++.+|+.+|++++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3457899999999999954 6789999987654332211 24568999999999999999955555556777799
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC-
Q 013522 97 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG- 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~- 175 (441)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999998 99999999998654322111
Q ss_pred ----cccccccCCCccchhhhhc--cCCCCCcccHHHHHHHHHHHhhCCCCCC
Q 013522 176 ----LLHTTCGTPAYVAPEVISK--KGYDGAKADIWSCGVILYVLLAGFLPFQ 222 (441)
Q Consensus 176 ----~~~~~~gt~~y~APE~l~~--~~~~~~~~DiwSlGvil~~ll~G~~Pf~ 222 (441)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+-+.++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 2346789999999999976 5564 67899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-27 Score=224.48 Aligned_cols=148 Identities=16% Similarity=0.241 Sum_probs=118.5
Q ss_pred CeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---------------hhHHHHHHHHHHHHhCCCCCcceE
Q 013522 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---------------GMMEQIKREISVMKMVKHKHIVEL 84 (441)
Q Consensus 20 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l 84 (441)
.|++++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|+.++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 355669999999999999999 8899999999965332110 134678899999999994 445
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 85 HEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 85 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
++++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 554433 45699999999999988 422 23557999999999999999999999999999999 99999999999
Q ss_pred cccccccccCCcccccccCCCccchhhhhc
Q 013522 165 SAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194 (441)
Q Consensus 165 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 194 (441)
|. .+..|.|||.+.+
T Consensus 239 a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SV---------------EVGEEGWREILER 253 (282)
T ss_dssp CE---------------ETTSTTHHHHHHH
T ss_pred Ce---------------ECCCCCHHHHHHH
Confidence 86 3556899998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8.5e-23 Score=193.39 Aligned_cols=139 Identities=18% Similarity=0.222 Sum_probs=109.5
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcE--EEEEEeecccccc---------------------hhhHHHHHHHHHHHHhCC
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKS--MAMKVVGKDKVIK---------------------VGMMEQIKREISVMKMVK 77 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 77 (441)
|++.+.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998788999 9999975432110 011236889999999998
Q ss_pred CCCc--ceEEEEEEeCCEEEEEEeccCC-C----chHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCcEeccCCCCcE
Q 013522 78 HKHI--VELHEVMASKSKIYFAMDLVKG-G----ELFNKIAKGRLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENL 149 (441)
Q Consensus 78 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH-~~gi~HrDLkp~NI 149 (441)
|++| ..+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| ++||+||||||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 8764 444443 246899999942 3 56655432 335578899999999999999 99999999999999
Q ss_pred EeCCCCCeEEeecCcccc
Q 013522 150 LLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 150 Ll~~~~~vkl~DFGla~~ 167 (441)
|++. .++|+|||+|..
T Consensus 203 Ll~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 203 MYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EESS--SEEECCCTTCEE
T ss_pred EEcC--cEEEEECccccc
Confidence 9988 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-20 Score=187.39 Aligned_cols=138 Identities=17% Similarity=0.250 Sum_probs=102.2
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc-----------chhhH--------HHHHHHHHHHHhCCCCCc
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI-----------KVGMM--------EQIKREISVMKMVKHKHI 81 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----------~~~~~--------~~~~~Ei~il~~l~hpnI 81 (441)
|+++..||.|+||.||+|.+ .+|+.||||+++..... ..... -...+|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999997 57999999998643211 00000 112457777777765554
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC-----
Q 013522 82 VELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN----- 156 (441)
Q Consensus 82 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~----- 156 (441)
.-..-+.... .++||||+.|++|..... ...+..++.||+.+|.|||++||+||||||.|||++++|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3221111222 379999999988876532 2345678999999999999999999999999999988773
Q ss_pred -----eEEeecCccc
Q 013522 157 -----LKVTDFGLSA 166 (441)
Q Consensus 157 -----vkl~DFGla~ 166 (441)
+.|+||+.+.
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8999999775
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.7e-13 Score=129.12 Aligned_cols=140 Identities=16% Similarity=0.132 Sum_probs=113.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 96 (441)
.+.|++...+|.|+++.||++.. .++.+++|+....... ....+.+|+.+++.+. +..+.+++++..+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 46799999999999999999985 4689999998643211 1235889999999984 6788899999999999999
Q ss_pred EEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 013522 97 AMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS---------------------------------------- 136 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~---------------------------------------- 136 (441)
||||++|.+|.+... +......++.++..+|+.||+
T Consensus 88 v~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999999877632 222345788899999999998
Q ss_pred -------------------cCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 137 -------------------RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 137 -------------------~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
.+++|+|++|.||++++++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.9e-12 Score=121.16 Aligned_cols=135 Identities=14% Similarity=0.145 Sum_probs=103.0
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH--IVELHEVMASKSKIY 95 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~ 95 (441)
...|.+....+.|+.+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+..+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 45677766555777799999964 567889999975431 235778999999885444 566899888888899
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG------------------------------------- 138 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~g------------------------------------- 138 (441)
+||||++|.+|. .. ... ...++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 999999998884 21 122 2356778888888888743
Q ss_pred ---------------------cEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 139 ---------------------VYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 139 ---------------------i~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
++|+|++|.||++++++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=122.35 Aligned_cols=140 Identities=17% Similarity=0.333 Sum_probs=107.0
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEee--cccccchhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CEEE
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVG--KDKVIKVGMMEQIKREISVMKMVK--HKHIVELHEVMASK---SKIY 95 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~~~ 95 (441)
-.+.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+++.|. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 457799999999999986 34678888775 32211 12356889999999997 45688899988776 4589
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS--------------------------------------- 136 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~--------------------------------------- 136 (441)
+||||++|..+.+... ..++......++.+++..|+.||+
T Consensus 118 ~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999999987754322 237788889999999999999997
Q ss_pred -------------------cCcEeccCCCCcEEeCCCCC--eEEeecCcccc
Q 013522 137 -------------------RGVYHRDLKPENLLLDEDGN--LKVTDFGLSAF 167 (441)
Q Consensus 137 -------------------~gi~HrDLkp~NILl~~~~~--vkl~DFGla~~ 167 (441)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999998764 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=8.6e-12 Score=120.20 Aligned_cols=181 Identities=17% Similarity=0.217 Sum_probs=122.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCC--cceEEEEEEeCC---EEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKH--IVELHEVMASKS---KIYFA 97 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lv 97 (441)
.+.++.|....||.+. ..+++|+-... .....+.+|..+|+.+ .+.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3558999999999864 46888885422 2356789999999887 3333 345555443333 35899
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-----------------------------------------
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS----------------------------------------- 136 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~----------------------------------------- 136 (441)
||+++|.+|.+... ..++..+...++.|+...|+.||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988875433 347788888899999999999886
Q ss_pred -----------------cCcEeccCCCCcEEeCC--CCCeEEeecCccccccccccCCcccccccCCCc---cchhhh--
Q 013522 137 -----------------RGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAY---VAPEVI-- 192 (441)
Q Consensus 137 -----------------~gi~HrDLkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y---~APE~l-- 192 (441)
..++|+|++|.||++++ ++.+.|+||+.+...+.... ......+ ..|+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence 13799999999999998 45678999998864322110 0001111 223221
Q ss_pred --hccCCCC---------CcccHHHHHHHHHHHhhCCCCC
Q 013522 193 --SKKGYDG---------AKADIWSCGVILYVLLAGFLPF 221 (441)
Q Consensus 193 --~~~~~~~---------~~~DiwSlGvil~~ll~G~~Pf 221 (441)
...+... ...+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111110 1268999999999999998776
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=99.00 E-value=2.2e-09 Score=88.20 Aligned_cols=86 Identities=13% Similarity=0.205 Sum_probs=74.5
Q ss_pred cccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEec-CceEEEEEEccCCChhhhHHHh
Q 013522 333 RFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFC 410 (441)
Q Consensus 333 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~ 410 (441)
.-+|..+|.+++..|+++++++|+.++.++ +.+++.......++.+.|.+||+++. +++++|+|+|.+||++.|+++|
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc 111 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIA 111 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHH
Confidence 346788999999999999999999999876 67888874444567899999999995 8999999999999999999998
Q ss_pred hhhhhhhhc
Q 013522 411 SNELRPALK 419 (441)
Q Consensus 411 ~~~l~~~l~ 419 (441)
. +|.+.|+
T Consensus 112 ~-~il~~L~ 119 (120)
T 3ose_A 112 S-KIANELK 119 (120)
T ss_dssp H-HHHHHCC
T ss_pred H-HHHHHhc
Confidence 7 6777664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.3e-07 Score=91.00 Aligned_cols=133 Identities=19% Similarity=0.217 Sum_probs=96.2
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEe
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK---HIVELHEVMA-SKSKIYFAMD 99 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E 99 (441)
.+.++.|....||+. |..+++|+-.. ......+.+|..+|+.|.+. .+.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 356788999999988 56788887421 23456889999999999652 3556666664 4456789999
Q ss_pred ccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 013522 100 LVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSR------------------------------------------ 137 (441)
Q Consensus 100 ~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~------------------------------------------ 137 (441)
|++|..+.+..- ..++......+..++...|+.||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988866322 2345556666666666666666642
Q ss_pred ------------------CcEeccCCCCcEEeCC---CCCe-EEeecCcccc
Q 013522 138 ------------------GVYHRDLKPENLLLDE---DGNL-KVTDFGLSAF 167 (441)
Q Consensus 138 ------------------gi~HrDLkp~NILl~~---~~~v-kl~DFGla~~ 167 (441)
.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 4554 8999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.6e-07 Score=86.77 Aligned_cols=131 Identities=15% Similarity=0.224 Sum_probs=96.5
Q ss_pred cccCc-eEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCc
Q 013522 28 GHGTF-AKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGE 105 (441)
Q Consensus 28 G~G~f-g~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~gg~ 105 (441)
..|.. +.||+......+..+.+|+-.. .....+.+|..+|+.|. +--+.+++.++.+.+..|+|||+++|.+
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 33444 4799988777778899998643 23567889999999884 3346788899999999999999999988
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------------
Q 013522 106 LFNKIAKGRLREDVARVYFQQLISAVDFCHS------------------------------------------------- 136 (441)
Q Consensus 106 L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~------------------------------------------------- 136 (441)
+.+..... ......+..++...|.-||+
T Consensus 107 ~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 107 AFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 77655432 12233455566666666663
Q ss_pred ---------cCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 137 ---------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 137 ---------~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877677999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=5.5e-07 Score=89.71 Aligned_cols=80 Identities=10% Similarity=0.104 Sum_probs=50.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccc-cch---hhHHHHHHHHHHHHhCCC--CC-cceEEEEEEeCCEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKV-IKV---GMMEQIKREISVMKMVKH--KH-IVELHEVMASKSKIYF 96 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~l 96 (441)
.+.||.|.++.||++....+++.+++|....... ... ...+++..|..+|+.+.. |. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4689999999999997655678999998653211 000 123456789999987742 33 4456644 3445689
Q ss_pred EEeccCCCc
Q 013522 97 AMDLVKGGE 105 (441)
Q Consensus 97 v~E~~~gg~ 105 (441)
||||+.|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=4.6e-07 Score=74.27 Aligned_cols=85 Identities=13% Similarity=0.186 Sum_probs=70.8
Q ss_pred ccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEec-CceEEEEEEccCCChhhhHHHhh
Q 013522 334 FATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQFCS 411 (441)
Q Consensus 334 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~~~ 411 (441)
.+|..++.+++..+..+++++++.|+.++ +.+++.......+..+.|.+||+.+. .+++.|+|+|.+||...|+++|.
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~ 112 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIAS 112 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHH
Confidence 35677899999999999999999999744 66888663333456789999999994 78999999999999999999997
Q ss_pred hhhhhhhc
Q 013522 412 NELRPALK 419 (441)
Q Consensus 412 ~~l~~~l~ 419 (441)
+|-..|+
T Consensus 113 -~IL~eLk 119 (126)
T 1v5s_A 113 -KIANELK 119 (126)
T ss_dssp -HHHHHTT
T ss_pred -HHHHHHh
Confidence 5666665
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=5.3e-07 Score=88.34 Aligned_cols=86 Identities=13% Similarity=0.164 Sum_probs=57.2
Q ss_pred EEeeee-cccCceEEEEEEEc--C----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeC
Q 013522 22 ELGRML-GHGTFAKVYLARNL--Q----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H--KHIVELHEVMASK 91 (441)
Q Consensus 22 ~i~~~L-G~G~fg~Vy~a~~~--~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~ 91 (441)
...+.| +.|....+|+.... . ++..+++|+..............+.+|+.+|+.|. + ..+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 89999999998753 1 26678899865432000000135678999988884 2 3567788877655
Q ss_pred ---CEEEEEEeccCCCchH
Q 013522 92 ---SKIYFAMDLVKGGELF 107 (441)
Q Consensus 92 ---~~~~lv~E~~~gg~L~ 107 (441)
+..|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999986654
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=2e-06 Score=68.07 Aligned_cols=88 Identities=13% Similarity=0.270 Sum_probs=71.9
Q ss_pred hhhcccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEecCceEEEEEEccCC-------
Q 013522 330 EELRFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNG------- 401 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~G------- 401 (441)
......|...+.+++..+-.+.+.+|+.|+..+ +.|++....+.....+.|.+++|++.+..+|+||++..|
T Consensus 8 W~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~ 87 (106)
T 4eai_A 8 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGG 87 (106)
T ss_dssp EEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSS
T ss_pred ceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCC
Confidence 334456778899999999999999999999755 889988743333456789999999999999999999999
Q ss_pred -ChhhhHHHhhhhhhhhh
Q 013522 402 -DTLEYNQFCSNELRPAL 418 (441)
Q Consensus 402 -d~le~~~~~~~~l~~~l 418 (441)
.+++|-++|.+ +-..|
T Consensus 88 ~~~~~F~d~ca~-li~~l 104 (106)
T 4eai_A 88 SHTIEFFEMCAN-LIKIL 104 (106)
T ss_dssp CHHHHHHHHHHH-HHHHC
T ss_pred cCcEeHHHHHHH-HHHHH
Confidence 49999999974 55444
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=4.8e-06 Score=80.51 Aligned_cols=134 Identities=13% Similarity=0.126 Sum_probs=79.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----HKHIVELH-E--VMASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 95 (441)
.+.|+.|..+.||++.. ++..+++|+.... ...+..|..+++.|. .|.++... + +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 35567778899999986 3345899998652 133445556555442 35444310 0 123467889
Q ss_pred EEEeccCCCchH--------------HHHhc--CCC--C-----------HH--------H-------------------
Q 013522 96 FAMDLVKGGELF--------------NKIAK--GRL--R-----------ED--------V------------------- 119 (441)
Q Consensus 96 lv~E~~~gg~L~--------------~~i~~--~~l--~-----------~~--------~------------------- 119 (441)
++|||++|.++. ..+.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 101 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHh-------------hcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 120 ----ARVYFQQLISAVDFCH-------------SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 120 ----~~~~~~qll~aL~ylH-------------~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
...+..++..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1112223344566665 3579999999999999888899999999764
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.3e-05 Score=67.24 Aligned_cols=75 Identities=8% Similarity=0.199 Sum_probs=60.0
Q ss_pred hhcccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEecCceEEEEEEccCCChhh
Q 013522 331 ELRFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLE 405 (441)
Q Consensus 331 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 405 (441)
.....|+..+.+++..+..+.+.+|+.||+.+ +.|++....+.....+.|.+++|++.++.+||||++..||+-|
T Consensus 6 hLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 6 HLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 34456777899999999999999999999766 7899887443322357899999999999999999999998755
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=2.1e-05 Score=66.89 Aligned_cols=77 Identities=8% Similarity=0.173 Sum_probs=62.2
Q ss_pred hhhhcccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEecCceEEEEEEccCCChhh
Q 013522 329 REELRFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLE 405 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 405 (441)
|......|+..+.+++..+-.+.+.+|+.||+.+ +.|++....+.....+.|.+++|++.++.+||||++..||+-|
T Consensus 18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e 95 (173)
T 2y8l_A 18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 95 (173)
T ss_dssp EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence 4556677888899999999999999999999866 7799987433222357899999999999999999999998755
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=97.99 E-value=4.7e-05 Score=61.85 Aligned_cols=78 Identities=14% Similarity=0.198 Sum_probs=58.6
Q ss_pred hhhcccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEecCceEEEEEEccCCChhhhH
Q 013522 330 EELRFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLEYN 407 (441)
Q Consensus 330 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le~~ 407 (441)
...-..|+..+.+++..+-.+.+.+++.||..+ +.|++..........+.+.+++|++.+..+|+||+...||..|+.
T Consensus 8 W~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~ 86 (130)
T 4eag_A 8 WHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG 86 (130)
T ss_dssp EEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred eeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence 334456777789999999999999999999765 788888644444445689999999999999999999999965544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=9.2e-05 Score=71.22 Aligned_cols=75 Identities=8% Similarity=0.198 Sum_probs=60.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEec
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK---HKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+.+.+....+..|+||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46789999999999985 5678889987543 2467889999998883 35688888888888899999999
Q ss_pred cCCCch
Q 013522 101 VKGGEL 106 (441)
Q Consensus 101 ~~gg~L 106 (441)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=1.5e-05 Score=66.22 Aligned_cols=90 Identities=10% Similarity=0.159 Sum_probs=71.6
Q ss_pred hhhhcccccCCchhhHHHHHHHHHHcCcEEEee---------c-CeEEEEeeecCC-----ccceEEEEEEEEecCceEE
Q 013522 329 REELRFATTRPASSVISRFEEVAKAVKFNVKTS---------E-SRVRLQGQESGR-----KGKLAINADIFAVTPSLLV 393 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~ 393 (441)
|......|+..+.+++..+-.+.+.+|+.|+.. + +.|++....+.. ...+.|.+++|++.++.+|
T Consensus 12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL 91 (137)
T 2qrd_A 12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM 91 (137)
T ss_dssp CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence 455667788899999999999999999999976 5 668887643321 2357899999999999999
Q ss_pred EEEEccCCC---------------h----hhhHHHhhhhhhhhhc
Q 013522 394 VEVKKDNGD---------------T----LEYNQFCSNELRPALK 419 (441)
Q Consensus 394 v~~~~~~Gd---------------~----le~~~~~~~~l~~~l~ 419 (441)
|||+..+|+ . +.|-++|. .|-..|.
T Consensus 92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca-~Li~eLa 135 (137)
T 2qrd_A 92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCA-MLVCKLF 135 (137)
T ss_dssp EEEEEEEEEESCC-------------CCCTTHHHHHH-HHHHHHH
T ss_pred EEEEecCCccccccCccccccCCccccccccHHHHHH-HHHHHHh
Confidence 999999999 5 89999987 4655553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.88 E-value=4.8e-05 Score=76.27 Aligned_cols=32 Identities=22% Similarity=0.445 Sum_probs=28.2
Q ss_pred hhcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 135 H~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
+...++|+|++|.|||++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999998876 99999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00025 Score=63.80 Aligned_cols=120 Identities=19% Similarity=0.136 Sum_probs=79.1
Q ss_pred chHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh-hcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccccc
Q 013522 105 ELFNKIAK--GRLREDVARVYFQQLISAVDFCH-SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTC 181 (441)
Q Consensus 105 ~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH-~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 181 (441)
+|.+.+.. ++++|+++|.++.|.+.+|.-+- .+.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 68888864 78999999999999999987762 12222344567899999999988774 2211 1
Q ss_pred cCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcCC
Q 013522 182 GTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 182 gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~ 258 (441)
....+.|||... ...+.+.=|+|||+++|..+--.+| ..-+..+|+.+.+||..|...
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 233466888753 2334778899999999987732111 112345899999999999866
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.0001 Score=71.18 Aligned_cols=134 Identities=13% Similarity=0.145 Sum_probs=71.2
Q ss_pred eeecccCceE-EEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEecc
Q 013522 25 RMLGHGTFAK-VYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKSKIYFAMDLV 101 (441)
Q Consensus 25 ~~LG~G~fg~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~~ 101 (441)
+.|+.|+... +|+... .+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4566665554 666653 2366777776543210 234567777776632 23556666543333 7899999
Q ss_pred CCCchHHHHhcCC---------------------------CCHHHHH-------H-HH------------HHHHHHHHHH
Q 013522 102 KGGELFNKIAKGR---------------------------LREDVAR-------V-YF------------QQLISAVDFC 134 (441)
Q Consensus 102 ~gg~L~~~i~~~~---------------------------l~~~~~~-------~-~~------------~qll~aL~yl 134 (441)
.|..+.+.+.... +...... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 7766544332110 1111110 0 00 0111122222
Q ss_pred ------hhcCcEeccCCCCcEEeCCC----CCeEEeecCcccc
Q 013522 135 ------HSRGVYHRDLKPENLLLDED----GNLKVTDFGLSAF 167 (441)
Q Consensus 135 ------H~~gi~HrDLkp~NILl~~~----~~vkl~DFGla~~ 167 (441)
+...++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23579999999999999874 6799999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00011 Score=70.11 Aligned_cols=131 Identities=14% Similarity=0.131 Sum_probs=74.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLV- 101 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~- 101 (441)
.+.|+.|....+|++ ..+.+|+....... .-...+|+.+++.+...++ .+++.+. .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999999 56888987543111 1123468888877642222 4555543 33347899999
Q ss_pred CCCchHHH------------------Hhc-C-CCC-----HHHHHHHHHH--------------HHHHHHHHh-------
Q 013522 102 KGGELFNK------------------IAK-G-RLR-----EDVARVYFQQ--------------LISAVDFCH------- 135 (441)
Q Consensus 102 ~gg~L~~~------------------i~~-~-~l~-----~~~~~~~~~q--------------ll~aL~ylH------- 135 (441)
.|.++... +.. . .++ ...+..+..+ +...+..+.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66544210 011 0 010 1111122111 111111111
Q ss_pred -hcCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 136 -SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 136 -~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
...++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 5667899999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00024 Score=68.03 Aligned_cols=136 Identities=13% Similarity=0.169 Sum_probs=77.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----HKHIVELH-E--VMASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~-~--~~~~~~~~~ 95 (441)
.+.|+.|....+|++... + ..+++|+..... ..+.+..|+.+++.|. -|.++... + +....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES-S-CCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC-C-ccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 466788988999999862 3 368899886521 1134567787777663 23333210 0 112346789
Q ss_pred EEEeccCCCchHH--------------HHhc--CCC--------CHHHHHHHH---------------HHHHHHHHHHhh
Q 013522 96 FAMDLVKGGELFN--------------KIAK--GRL--------REDVARVYF---------------QQLISAVDFCHS 136 (441)
Q Consensus 96 lv~E~~~gg~L~~--------------~i~~--~~l--------~~~~~~~~~---------------~qll~aL~ylH~ 136 (441)
++++|++|..+.. .+.. ..+ ....-...+ ..+...+.++++
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999864311 1111 001 100000000 113344555542
Q ss_pred -------cCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 137 -------RGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 137 -------~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
.+++|+|++|.|||++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999877656899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00028 Score=70.98 Aligned_cols=74 Identities=11% Similarity=0.170 Sum_probs=50.7
Q ss_pred eeeecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~ 95 (441)
.+.|+.|....||++.... ++..+.+|+..... ..+.+.+|..+++.|...++ .++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4678889999999998643 35789999884321 11345579999988853333 567766542 3
Q ss_pred EEEeccCCCch
Q 013522 96 FAMDLVKGGEL 106 (441)
Q Consensus 96 lv~E~~~gg~L 106 (441)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00032 Score=69.25 Aligned_cols=134 Identities=14% Similarity=0.161 Sum_probs=82.6
Q ss_pred eeecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l 96 (441)
+.|..|-...+|++.... +++.+.+|+.... . .....+.+|..+++.|. +.-..++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 567778888999998642 3578999986331 1 12456678999998884 3223566766543 28
Q ss_pred EEeccCCCchHH--------------HH---hc-----CC-CC--HHHHHHHHHHHHH-------------------HHH
Q 013522 97 AMDLVKGGELFN--------------KI---AK-----GR-LR--EDVARVYFQQLIS-------------------AVD 132 (441)
Q Consensus 97 v~E~~~gg~L~~--------------~i---~~-----~~-l~--~~~~~~~~~qll~-------------------aL~ 132 (441)
||||++|.+|.. .+ .. ++ .. ...+.+++.++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865421 11 11 11 11 3455666655432 233
Q ss_pred HHh----h----cCcEeccCCCCcEEeCCC----CCeEEeecCccc
Q 013522 133 FCH----S----RGVYHRDLKPENLLLDED----GNLKVTDFGLSA 166 (441)
Q Consensus 133 ylH----~----~gi~HrDLkp~NILl~~~----~~vkl~DFGla~ 166 (441)
.|. . ..++|+|+.+.||+++.+ +.+.|+||..|.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 1 359999999999999876 789999999876
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00057 Score=58.67 Aligned_cols=89 Identities=11% Similarity=0.116 Sum_probs=68.4
Q ss_pred hhhhcccccCCchhhHHHHHHHHHHcCcEEEee----cCeEEEEeeecC---------CccceEEEEEEEEecCceEEEE
Q 013522 329 REELRFATTRPASSVISRFEEVAKAVKFNVKTS----ESRVRLQGQESG---------RKGKLAINADIFAVTPSLLVVE 395 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~v~ 395 (441)
|......++..+.+++..+..+.+.+|+.||+. -+.|++....+. ....+.|.+++|++.++.+|||
T Consensus 50 kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLD 129 (179)
T 3t4n_A 50 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 129 (179)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEE
T ss_pred eeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEE
Confidence 344556677888999999999999999999975 367888752211 1134789999999999999999
Q ss_pred EEccCC----------------------ChhhhHHHhhhhhhhhhc
Q 013522 396 VKKDNG----------------------DTLEYNQFCSNELRPALK 419 (441)
Q Consensus 396 ~~~~~G----------------------d~le~~~~~~~~l~~~l~ 419 (441)
|+ ..| ..+.|-++|. .|--.|.
T Consensus 130 fk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca-~LI~eLa 173 (179)
T 3t4n_A 130 FK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTT-KLIMELA 173 (179)
T ss_dssp EE-EEEEECC----------------CCCCHHHHHHHH-HHHHHHH
T ss_pred EE-eccccccccccccccccccccccccCCccHHHHHH-HHHHHHH
Confidence 99 777 6788999887 4655553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00043 Score=67.90 Aligned_cols=75 Identities=12% Similarity=0.115 Sum_probs=45.3
Q ss_pred eeeecccCceEEEEEEEcC--------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 013522 24 GRMLGHGTFAKVYLARNLQ--------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKI 94 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 94 (441)
.+.|+.|....+|++.... .+..+.+|+...... .......|..+++.+...+ +.+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4678888889999998643 136888998754311 1112457888888774333 44666554 22
Q ss_pred EEEEeccCCCch
Q 013522 95 YFAMDLVKGGEL 106 (441)
Q Consensus 95 ~lv~E~~~gg~L 106 (441)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00079 Score=64.59 Aligned_cols=134 Identities=14% Similarity=0.149 Sum_probs=78.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCC--CcceEEEE-----EEeCCEEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK--HIVELHEV-----MASKSKIYFA 97 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lv 97 (441)
..|+ |....||.+.. .+|+.+++|+...... ....+..|..+++.|... .+.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998764 4566799999863321 134667788888776321 23333332 2235677899
Q ss_pred EeccCCCchH-----------H---HHhc----C------CCCHHH----H------------------HHHHHHHHHHH
Q 013522 98 MDLVKGGELF-----------N---KIAK----G------RLREDV----A------------------RVYFQQLISAV 131 (441)
Q Consensus 98 ~E~~~gg~L~-----------~---~i~~----~------~l~~~~----~------------------~~~~~qll~aL 131 (441)
|+|++|..+. . .+.. . ..+... . ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 0 0110 0 011110 0 11112222222
Q ss_pred HHH----hhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 132 DFC----HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 132 ~yl----H~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
.-+ ....++|+|++|.||+++ + .+.|+||+.+.
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 222 234689999999999998 4 89999999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0014 Score=61.80 Aligned_cols=79 Identities=13% Similarity=0.097 Sum_probs=55.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC---CCcceEEEEEEeCCEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH---KHIVELHEVMASKSKIY 95 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~ 95 (441)
.+..-++.+|.|..+.||+.+. .+|+.|.+|+-...... ....+..|...|+.|.- --+.+.+.+. . -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ce
Confidence 4556678899999999999985 67899999986543221 12357789999998842 2344555542 2 37
Q ss_pred EEEeccCCCc
Q 013522 96 FAMDLVKGGE 105 (441)
Q Consensus 96 lv~E~~~gg~ 105 (441)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0021 Score=65.00 Aligned_cols=75 Identities=11% Similarity=0.186 Sum_probs=49.2
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-VELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~ 102 (441)
.+.|+.|-...+|++.....+..+.+|+...... ... ...+|..+++.|...++ .++++.+. + ..|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 4678889999999998754457899998753211 111 12589999998865544 56777663 2 25999999
Q ss_pred CCch
Q 013522 103 GGEL 106 (441)
Q Consensus 103 gg~L 106 (441)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0022 Score=62.19 Aligned_cols=31 Identities=16% Similarity=0.381 Sum_probs=27.9
Q ss_pred cCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 137 ~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
.+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0094 Score=59.58 Aligned_cols=75 Identities=12% Similarity=0.202 Sum_probs=48.7
Q ss_pred eeeecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQT-------GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 95 (441)
.+.|..|-...+|++..... +..+.+++..... ...-...+|..+++.+. +.-..++++.+. + +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--C
Confidence 45677888899999987421 5789999864321 11112357888888874 322455665432 2 7
Q ss_pred EEEeccCCCch
Q 013522 96 FAMDLVKGGEL 106 (441)
Q Consensus 96 lv~E~~~gg~L 106 (441)
.|+||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.45 E-value=0.24 Score=48.83 Aligned_cols=30 Identities=33% Similarity=0.535 Sum_probs=25.6
Q ss_pred CcEeccCCCCcEEe------CCCCCeEEeecCcccc
Q 013522 138 GVYHRDLKPENLLL------DEDGNLKVTDFGLSAF 167 (441)
Q Consensus 138 gi~HrDLkp~NILl------~~~~~vkl~DFGla~~ 167 (441)
.++|+|+.+.|||+ ++++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999999864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.84 E-value=2.4 Score=37.86 Aligned_cols=82 Identities=15% Similarity=0.080 Sum_probs=63.2
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhcCcEeccCCCCcEEeCCCC
Q 013522 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVD-FCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 77 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~-ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
.||++ -..+-.+.+.+.+.++.-+++.-+..++ .++..+.++++.+|+.... ++ ..-+|--|+|+||++|.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCC
Confidence 68888 4555577888888888776665555553 4788888888888887665 44 4456778999999999999
Q ss_pred CeEEeecCc
Q 013522 156 NLKVTDFGL 164 (441)
Q Consensus 156 ~vkl~DFGl 164 (441)
.++|.-.|+
T Consensus 122 ~p~i~hRGi 130 (219)
T 4ano_A 122 EPFFLHVGV 130 (219)
T ss_dssp CEEESCCEE
T ss_pred cEEEEEcCC
Confidence 999998886
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.37 E-value=1.7 Score=38.67 Aligned_cols=85 Identities=16% Similarity=0.267 Sum_probs=63.3
Q ss_pred CCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC
Q 013522 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG 155 (441)
Q Consensus 76 l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~ 155 (441)
..||+++.. .+-.+.+.+.+.++.-..+.=+..++ .++....++++.+|+....++ ..=+|--|+|+||+++.++
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 368999876 67777777777777665443344443 377888888999888877443 4446778999999999999
Q ss_pred CeEEeecCcc
Q 013522 156 NLKVTDFGLS 165 (441)
Q Consensus 156 ~vkl~DFGla 165 (441)
.+++.--|+-
T Consensus 117 ~p~i~~RGik 126 (215)
T 4ann_A 117 LPIAKTRGLQ 126 (215)
T ss_dssp CEEESCCEET
T ss_pred CEEEEEccCc
Confidence 9999988863
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.74 E-value=0.078 Score=53.54 Aligned_cols=64 Identities=9% Similarity=0.151 Sum_probs=18.3
Q ss_pred EEeeeecccCceEEEEEEEcCCCcEEEE------EEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 22 ELGRMLGHGTFAKVYLARNLQTGKSMAM------KVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
.+.+.|| ||.||.|........||+ |........ ......+.+|..+++.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence 3455676 999999998765568888 654332221 123345778889999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 441 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-91 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-86 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-86 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-83 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-81 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-80 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-80 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-79 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-77 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-77 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-76 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-76 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-76 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-74 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-74 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-73 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-72 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-72 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-70 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-69 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-67 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-64 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-63 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-61 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-49 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-45 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-24 | |
| d1ul7a_ | 102 | d.129.6.1 (A:) Map/microtubule affinity-regulating | 4e-07 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (701), Expect = 6e-91
Identities = 89/261 (34%), Positives = 147/261 (56%), Gaps = 6/261 (2%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+E+GR LG G F VYLAR Q+ +A+KV+ K ++ K G+ Q++RE+ + ++H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+I+ L+ +++Y ++ G ++ ++ K + E Y +L +A+ +CHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V HRD+KPENLLL G LK+ DFG S + T CGT Y+ PE+I + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
K D+WS GV+ Y L G PF+ + Y++I R +F P + + AR LI++LL
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 259 NPNSRIAISKIMESSWFKKSA 279
NP+ R + +++E W ++
Sbjct: 242 NPSQRPMLREVLEHPWITANS 262
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (674), Expect = 2e-86
Identities = 86/259 (33%), Positives = 145/259 (55%), Gaps = 2/259 (0%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
++ G++LG G+F+ V LAR L T + A+K++ K +IK + + RE VM + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
V+L+ K+YF + K GEL I K G E R Y +++SA+++ H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ HRDLKPEN+LL+ED ++++TDFG + + ++ GT YV+PE++++K
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
+D+W+ G I+Y L+AG PF+ N +++KI + ++ P F +AR L+ KLL
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 259 NPNSRIAISKIMESSWFKK 277
+ R+ ++ K
Sbjct: 248 DATKRLGCEEMEGYGPLKA 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (672), Expect = 2e-86
Identities = 93/267 (34%), Positives = 150/267 (56%), Gaps = 6/267 (2%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
++L + LG G + +V LA N T +++A+K+V + + E IK+EI + KM+ H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSR 137
+++V+ + + Y ++ GGELF++I + E A+ +F QL++ V + H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
G+ HRD+KPENLLLDE NLK++DFGL+ + ++ LL+ CGT YVAPE++ ++ +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 198 DGAKADIWSCGVILYVLLAGFLPF-QDDNIVSMYRKIYRGDFKCPPW--FSSEARRLITK 254
D+WSCG++L +LAG LP+ Q + Y PW S L+ K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPK 281
+L NP++RI I I + W+ K K
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (655), Expect = 1e-83
Identities = 73/265 (27%), Positives = 133/265 (50%), Gaps = 9/265 (3%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
KY +G G VY A ++ TG+ +A++ + + K E I EI VM+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRG 138
+IV + +++ M+ + GG L + + + + E ++ + A++F HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V HRD+K +N+LL DG++K+TDFG A + T GTP ++APEV+++K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITKL 255
K DIWS G++ ++ G P+ ++N + I + + P S+ R + +
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 256 LDPNPNSRIAISKIMESSWFKKSAP 280
LD + R + ++++ + K + P
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 9e-81
Identities = 73/270 (27%), Positives = 131/270 (48%), Gaps = 14/270 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+E+ LG G F KVY A+N +T A KV+ +E EI ++ H +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPN 70
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRG 138
IV+L + ++ ++ ++ GG + + + L E +V +Q + A+++ H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI----SK 194
+ HRDLK N+L DG++K+ DFG+SA + + + GTP ++APEV+ SK
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD---FKCPPWFSSEARRL 251
KAD+WS G+ L + P + N + + KI + + P +SS +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKKSAPK 281
+ K L+ N ++R S++++ + + K
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (633), Expect = 5e-80
Identities = 62/290 (21%), Positives = 122/290 (42%), Gaps = 13/290 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+ R +GHG+F VY AR+++ + +A+K + + I +E+ ++ ++H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELF-NKIAKGRLREDVARVYFQQLISAVDFCHSRG 138
+ ++ + + M+ G ++ K L+E + + + HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--SKKG 196
+ HRD+K N+LL E G +K+ DFG ++ ++ GTP ++APEVI +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW--FSSEARRLITK 254
K D+WS G+ L P + N +S I + + +S R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 255 LLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLN 304
L P R +++ + + P VI ++ + ++ + L
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVI--MDLIQRTKDAVRELDNLQ 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 249 bits (636), Expect = 7e-80
Identities = 71/269 (26%), Positives = 128/269 (47%), Gaps = 15/269 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
++ Y++ LG G F V+ TG+ K + + +K EIS+M +
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQL 83
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFC 134
H ++ LH+ K ++ ++ + GGELF++IA ++ E Y +Q +
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 135 HSRGVYHRDLKPENLLLD--EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
H + H D+KPEN++ + + ++K+ DFGL + L D ++ T T + APE++
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGL---ATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEA 248
++ D+W+ GV+ YVLL+G PF ++ + + + R D++ S EA
Sbjct: 201 DREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKK 277
+ I LL P R+ + +E W K
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 248 bits (634), Expect = 1e-79
Identities = 82/266 (30%), Positives = 125/266 (46%), Gaps = 15/266 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
Y++ LG G F V+ TG + A K V E +++EI M +++H
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHP 83
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSR 137
+V LH+ +++ + + GGELF K+A ++ ED A Y +Q+ + H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 138 GVYHRDLKPENLLL--DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
H DLKPEN++ LK+ DFGL+A HL + T GT + APEV K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK----CPPWFSSEARRL 251
G D+WS GV+ Y+LL+G PF +N R + D+ S + +
Sbjct: 201 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 252 ITKLLDPNPNSRIAISKIMESSWFKK 277
I KLL +PN+R+ I + +E W
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 239 bits (612), Expect = 3e-77
Identities = 87/277 (31%), Positives = 136/277 (49%), Gaps = 20/277 (7%)
Query: 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV------GMMEQIKREIS 71
+ YE +LG G + V + T K A+K++ + E +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 72 VMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLIS 129
+++ V H +I++L + + + + DL+K GELF+ + K L E R + L+
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAP 189
+ H + HRDLKPEN+LLD+D N+K+TDFG S L L CGTP+Y+AP
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAP 178
Query: 190 EVISKKGYD-----GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--FKCPP 242
E+I D G + D+WS GVI+Y LLAG PF + M R I G+ F P
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 243 W--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
W +S + L+++ L P R + + +F++
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 3e-77
Identities = 77/268 (28%), Positives = 132/268 (49%), Gaps = 17/268 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
YE+ +G G++ + R GK + K + + + + + E+++++ +KH
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 80 HIVELHEVMASKS--KIYFAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVD 132
+IV ++ + ++ +Y M+ +GG+L + I K L E+ QL A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 133 FCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYV 187
CH R V HRDLKP N+ LD N+K+ DFGL+ H GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYM 181
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-KCPPWFSS 246
+PE +++ Y+ K+DIWS G +LY L A PF + + KI G F + P +S
Sbjct: 182 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 247 EARRLITKLLDPNPNSRIAISKIMESSW 274
E +IT++L+ R ++ +I+E+
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 1e-76
Identities = 82/260 (31%), Positives = 137/260 (52%), Gaps = 6/260 (2%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHK 79
+ L +MLG G+F KV+LA +T + A+K + KD V+ +E E V+ + +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCHSRG 138
+ + +K ++F M+ + GG+L I + + A Y ++I + F HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ +RDLK +N+LLD+DG++K+ DFG+ + D +T CGTP Y+APE++ + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
D WS GV+LY +L G PF + ++ I + P W EA+ L+ KL
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 259 NPNSRI-AISKIMESSWFKK 277
P R+ I + F++
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 6e-76
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 16/274 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
L+ KY + LG G F V+ + K+ K V +K+EIS++ +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIA 58
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFC 134
+H++I+ LHE S ++ + + G ++F +I L E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 135 HSRGVYHRDLKPENLLLDEDGN--LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
HS + H D++PEN++ + +K+ +FG + LK P Y APEV
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVH 175
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEA 248
D+WS G ++YVLL+G PF + + I ++ S EA
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKV 282
+ +LL SR+ S+ ++ W K+ +V
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 237 bits (605), Expect = 7e-76
Identities = 102/304 (33%), Positives = 158/304 (51%), Gaps = 17/304 (5%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ Y+ +LG G F++V LA + +T K +A+K + K + G ++ EI+V+ +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKI 64
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
KH +IV L ++ S +Y M LV GGELF++I KG E A Q++ AV + H
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 136 SRGVYHRDLKPENLLL---DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI 192
G+ HRDLKPENLL DED + ++DFGLS +L T CGTP YVAPEV+
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 181
Query: 193 SKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEA 248
++K Y D WS GVI Y+LL G+ PF D+N ++ +I + +++ S A
Sbjct: 182 AQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKS---SKQPETLNA 305
+ I L++ +P R + ++ W Q + + K+ SK + NA
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNA 300
Query: 306 FHII 309
++
Sbjct: 301 TAVV 304
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 234 bits (599), Expect = 6e-75
Identities = 88/263 (33%), Positives = 155/263 (58%), Gaps = 12/263 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+++ R LG G+F +V+L R+ G+ AMKV+ K+ V+++ +E E ++ +V H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHSRGV 139
I+ + +I+ MD ++GGELF+ R VA+ Y ++ A+++ HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 140 YHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDG 199
+RDLKPEN+LLD++G++K+TDFG + + + +T CGTP Y+APEV+S K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYN- 179
Query: 200 AKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDPN 259
D WS G+++Y +LAG+ PF D N + Y KI + + PP+F+ + + L+++L+ +
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 260 PNSRIA-----ISKIMESSWFKK 277
+ R+ + WFK+
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 7e-75
Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 18/268 (6%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMME---QIKREISVM 73
L +Y++G +LG G F VY + +A+K V KD++ G + ++ E+ ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 74 KMVKHKH--IVELHEVMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLIS 129
K V ++ L + ++ + + +G L+E++AR +F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 130 AVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
AV CH+ GV HRD+K EN+L+D + G LK+ DFG A + D + GT Y
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSP 177
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248
PE I Y G A +WS G++LY ++ G +PF+ D +I RG SSE
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231
Query: 249 RRLITKLLDPNPNSRIAISKIMESSWFK 276
+ LI L P+ R +I W +
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 2e-74
Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 53/314 (16%)
Query: 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM 75
L +E LG G V+ + +G MA K++ + IK + QI RE+ V+
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60
Query: 76 VKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFC 134
+IV + S +I M+ + GG L + K GR+ E + +I + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 135 HSR-GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
+ + HRD+KP N+L++ G +K+ DFG+S D + ++ GT +Y++PE +
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPW------- 243
Y ++DIWS G+ L + G P + + M+ GD P
Sbjct: 177 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 244 ----------------------------------FSSEARRLITKLLDPNPNSRIAISKI 269
FS E + + K L NP R + ++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 270 MESSWFKKSAPKVV 283
M ++ K+S + V
Sbjct: 296 MVHAFIKRSDAEEV 309
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 8e-74
Identities = 86/263 (32%), Positives = 141/263 (53%), Gaps = 9/263 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
++ ++LG GTF KV L R TG+ AMK++ K+ +I + E V++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDFCHSRG 138
+ L + ++ F M+ GGELF +++ E+ AR Y +++SA+++ HSR
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V +RD+K ENL+LD+DG++K+TDFGL + T CGTP Y+APEV+ Y
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
D W GV++Y ++ G LPF + + ++ I + + P S EA+ L+ LL
Sbjct: 184 -RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 259 NPNSRIA-----ISKIMESSWFK 276
+P R+ ++ME +F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 9e-73
Identities = 62/274 (22%), Positives = 127/274 (46%), Gaps = 19/274 (6%)
Query: 15 TLLHGKY-ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM 73
G++ + +G G+F VY + +T +A + K+ K ++ K E ++
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEML 62
Query: 74 KMVKHKHIVELHEVMASKSK----IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLI 128
K ++H +IV ++ S K I +L+ G L + + ++ V R + +Q++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 129 SAVDFCHSRG--VYHRDLKPENLLL-DEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPA 185
+ F H+R + HRDLK +N+ + G++K+ D GL+ K+ GTP
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPE 178
Query: 186 YVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRG--DFKCPP 242
++APE+ +K YD D+++ G+ + + P+ + N +YR++ G
Sbjct: 179 FMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236
Query: 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
E + +I + N + R +I ++ ++F+
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 3e-72
Identities = 59/275 (21%), Positives = 118/275 (42%), Gaps = 16/275 (5%)
Query: 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
G+ +G+ +G G+F VY + +A+K++ + + K E+ V++ +
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTR 62
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCH 135
H +I+ + ++ +G L++ + + + +Q +D+ H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVI--S 193
++ + HRDLK N+ L ED +K+ DFGL+ G+ ++APEVI
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------KCPPWFSSE 247
K ++D+++ G++LY L+ G LP+ + N + + K
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 248 ARRLITKLLDPNPNSRIAISKIMES-SWFKKSAPK 281
+RL+ + L + R +I+ S +S PK
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 3e-72
Identities = 87/287 (30%), Positives = 146/287 (50%), Gaps = 18/287 (6%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI---KVGMMEQIKREISVMKMV 76
Y+ G LG G FA V R TG A K + K + + E I+RE+S++K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLISAVDFCH 135
+H +++ LHEV +K+ + ++LV GGELF+ + K L E+ A + +Q+++ V + H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 136 SRGVYHRDLKPENLLLDEDG----NLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEV 191
S + H DLKPEN++L + +K+ DFGL+ + GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 192 ISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK----CPPWFSSE 247
++ + +AD+WS GVI Y+LL+G PF D + +++ S+
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEM--EFE 292
A+ I +LL +P R+ I ++ W K + ++ +FE
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 226 bits (577), Expect = 4e-72
Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 11/273 (4%)
Query: 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM 73
P+ L +YELG +LG G ++V+LAR+L+ + +A+KV+ D + +RE
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 74 KMVKHKHIVELHEVMASKSK----IYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLI 128
+ H IV +++ +++ Y M+ V G L + + G + A
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA-FSEHLKQDGLLHTTCGTPAYV 187
A++F H G+ HRD+KP N+++ +KV DFG++ ++ GT Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PW 243
+PE D A++D++S G +LY +L G PF D+ VS+ + R D P
Sbjct: 182 SPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
S++ ++ K L NP +R + M + +
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 224 bits (572), Expect = 3e-70
Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 16/268 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK--- 77
+ + R++G G F +VY R TGK AMK + K ++ E ++ +V
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS 136
IV + + K+ F +DL+ GG+L +++ G E R Y ++I ++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
R V +RDLKP N+LLDE G+++++D GL+ H + GT Y+APEV+ K
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGV 181
Query: 197 YDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARRLIT 253
+ AD +S G +L+ LL G PF+ + R + P FS E R L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 254 KLLDPNPNSRIAISK-----IMESSWFK 276
LL + N R+ + ES +F+
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (561), Expect = 7e-69
Identities = 90/264 (34%), Positives = 144/264 (54%), Gaps = 12/264 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+++ + LG G+F +V L ++ ++G AMK++ K KV+K+ +E E +++ V
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG 138
+V+L S +Y M+ V GGE+F+ + + GR E AR Y Q++ ++ HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ +RDLKPENLL+D+ G ++VTDFG + G T CGTP +APE+I KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLDP 258
D W+ GV++Y + AG+ PF D + +Y KI G + P FSS+ + L+ LL
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 259 NPNSRIA-----ISKIMESSWFKK 277
+ R ++ I WF
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-67
Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 32/288 (11%)
Query: 13 RPTLLHGKYE-LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS 71
+ + Y+ ++LG G KV N +T + A+K++ + +RE+
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 56
Query: 72 VM-KMVKHKHIVELHEV----MASKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVY 123
+ + + HIV + +V A + + M+ + GGELF++I E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSEHLKQDGLLHTT 180
+ + A+ + HS + HRD+KPENLL + LK+TDFG F++ L T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLTTP 173
Query: 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---- 236
C TP YVAPEV+ + YD D+WS GVI+Y+LL G+ PF ++ +++ +
Sbjct: 174 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 237 --DFKCPPW--FSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280
+F P W S E + LI LL P R+ I++ M W +S
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-67
Identities = 68/321 (21%), Positives = 128/321 (39%), Gaps = 42/321 (13%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+Y +G G + V A + +A+K + + ++ REI ++ +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 79 KHIVELHEVMASKS----KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
++I+ +++++ + + K + + + G +L+ + L D + Q++ + +
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT-CGTPAYVAPEVIS 193
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ T T Y APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI-------------------- 233
DIWS G IL +L+ F + + I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 234 YRGDFKCP-----------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK----S 278
P P S+A L+ K+L NP+ RI + + + + ++ S
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 279 APKVVITKQEMEFEADKSSKQ 299
+ + + E D K+
Sbjct: 306 DEPIAEAPFKFDMELDDLPKE 326
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 70/286 (24%), Positives = 110/286 (38%), Gaps = 33/286 (11%)
Query: 22 ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI--KVGMMEQIKREISVMKMVKHK 79
E LG G FA VY AR+ T + +A+K + K G+ REI +++ + H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHSRG 138
+I+ L + KS I D ++ L + Y + +++ H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
+ HRDLKP NLLLDE+G LK+ DFGL+ + T Y APE++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------------------- 238
G D+W+ G IL LL D+ + +I+
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 239 --------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
+ LI L NP +RI ++ ++ +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-64
Identities = 56/258 (21%), Positives = 111/258 (43%), Gaps = 19/258 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+ +L + +G G F V L G +A+K + D + E SVM ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHS 60
Query: 80 HIVELHEVMA-SKSKIYFAMDLVKGGELFNKI---AKGRLREDVARVYFQQLISAVDFCH 135
++V+L V+ K +Y + + G L + + + L D + + A+++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
HRDL N+L+ ED KV+DFGL+ + + T + APE + +K
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 175
Query: 196 GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLIT 253
+ K+D+WS G++L+ + + G +P+ + + ++ +G P ++
Sbjct: 176 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 254 KLLDPNPNSRIAISKIME 271
+ R + ++ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-63
Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 44/302 (14%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
KYE +G GTF +V+ AR+ +TG+ +A+K V + K G REI +++++KH
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKH 68
Query: 79 KHIVELHEVMAS--------KSKIYFAMDLVKGGELFNKI-AKGRLREDVARVYFQQLIS 129
+++V L E+ + K IY D + + + Q L++
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 130 AVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD--GLLHTTCGTPAYV 187
+ + H + HRD+K N+L+ DG LK+ DFGL+ K T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 188 APEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----- 242
PE++ + G D+W G I+ + Q + I + P
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 243 ---------------------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWF 275
A LI KLL +P RI + +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 276 KK 277
Sbjct: 309 WS 310
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 87/342 (25%), Positives = 138/342 (40%), Gaps = 58/342 (16%)
Query: 6 SNGGGDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ 65
+ G G DRP + Y +++G+G+F VY A+ +G+ +A+K V +DK
Sbjct: 9 TPGQGPDRPQEV--SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RF 59
Query: 66 IKREISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGEL----FNKIAKGRL 115
RE+ +M+ + H +IV L S + + +D V AK L
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 116 REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNL-KVTDFGLSAFSEHLKQD 174
++Y QL ++ + HS G+ HRD+KP+NLLLD D + K+ DFG + L +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRG 176
Query: 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIY 234
+ + Y APE+I + D+WS G +L LL G F D+ V +I
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 235 RG----------------------DFKCPPW-------FSSEARRLITKLLDPNPNSRIA 265
+ K PW EA L ++LL+ P +R+
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
Query: 266 ISKIMESSWFKK------SAPKVVITKQEMEFEADKSSKQPE 301
+ S+F + P T F + S P
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 7e-63
Identities = 53/259 (20%), Positives = 95/259 (36%), Gaps = 9/259 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQT---GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK 77
L LG G+F V S+A+K + D + + M+ RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 78 HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCH 135
H++++ L+ V+ + + +L G L +++ K G Y Q+ + +
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 136 SRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
S+ HRDL NLLL +K+ DFGL ++ P K
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 196 GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD--FKCPPWFSSEARRLI 252
+D W GV L+ + G P+ N + KI + P + ++
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248
Query: 253 TKLLDPNPNSRIAISKIME 271
+ P R + +
Sbjct: 249 VQCWAHKPEDRPTFVALRD 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 8e-63
Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 34/289 (11%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
++ +G GT+ VY ARN TG+ +A+K + D + G+ REIS++K + H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 80 HIVELHEVMASKSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLISAVDFCHSR 137
+IV+L +V+ +++K+Y + + + + A + + + Y QL+ + FCHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
V HRDLKP+NLL++ +G +K+ DFGL+ T Y APE++ Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 198 DGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------------------- 238
DIWS G I ++ F D+ + +I+R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 239 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
K P + R L++++L +PN RI+ + +F+
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-62
Identities = 69/323 (21%), Positives = 132/323 (40%), Gaps = 47/323 (14%)
Query: 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
+ Y + +G G + V A + +TG +A+K + + + ++ RE+ ++K +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHM 74
Query: 77 KHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISA 130
+H++++ L +V Y M + G +L + +L ED + Q++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 131 VDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPE 190
+ + H+ G+ HRDLKP NL ++ED LK+ DFGL+ + D + T Y APE
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPE 188
Query: 191 VISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF------ 244
VI DIWS G I+ ++ G F+ + + ++I + P F
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 245 -------------------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKK-- 277
S A L+ K+L + R+ + + +F+
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
Query: 278 -SAPKVVITKQEMEFEADKSSKQ 299
+ + + K + F+ +
Sbjct: 309 DTEDEPQVQKYDDSFDDVDRTLD 331
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 201 bits (511), Expect = 3e-62
Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 34/288 (11%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KY +G GT+ VY A+N G++ A+K + +K G+ REIS++K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFN-KIAKGRLREDVARVYFQQLISAVDFCHSRG 138
+IV+L++V+ +K ++ + + + +G L A+ + QL++ + +CH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V HRDLKP+NLL++ +G LK+ DFGL+ T Y AP+V+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 199 GAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF-------------------- 238
DIWS G I ++ G F + +I+R
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 239 ---------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277
L++K+L +PN RI + +E ++FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-62
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 34/284 (11%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV----GMMEQIKREISVM-K 74
E G++LG G F KV A K+ V K++K E + E+ +M +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSSEREALMSELKMMTQ 96
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK---------------------- 112
+ H++IV L IY + G+L N +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 113 --GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170
L + + Q+ ++F + HRDL N+L+ +K+ DFGL+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSM 229
+ ++APE + + Y K+D+WS G++L+ + + G P+ + +
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 230 YRKIYRGDFK--CPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ K+ + FK P + + E ++ + R + +
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-61
Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 15/273 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVI-KVGMMEQIKREISVMKM 75
+EL ++LG G + KV+L R + TGK AMKV+ K ++ K E + E V++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 76 VKHK-HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKG-RLREDVARVYFQQLISAVDF 133
++ +V LH +++K++ +D + GGELF +++ R E ++Y +++ A++
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
H G+ +RD+K EN+LLD +G++ +TDFGLS + + V
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 194 KKGYDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFSSEAR 249
D WS GV++Y LL G PF D + R+I + + P S+ A+
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 250 RLITKLLDPNPNSRIA-----ISKIMESSWFKK 277
LI +LL +P R+ +I E +F+K
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 67/319 (21%), Positives = 130/319 (40%), Gaps = 45/319 (14%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+Y+ +G G + V A + +TG +A+K + + + ++ RE+ ++K +KH+
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 80 HIVELHEVMASKSKI-----YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
+++ L +V + + + + G +L N + +L +D + Q++ + +
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISK 194
HS + HRDLKP NL ++ED LK+ DFGL+ ++ T Y APE++
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLN 192
Query: 195 KGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWF---------- 244
+ DIWS G I+ LL G F + + + I R
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 245 ---------------------SSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA---P 280
+ A L+ K+L + + RI ++ + ++F +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 281 KVVITKQEMEFEADKSSKQ 299
+ V + FE+
Sbjct: 313 EPVADPYDQSFESRDLLID 331
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 6e-61
Identities = 50/265 (18%), Positives = 110/265 (41%), Gaps = 11/265 (4%)
Query: 25 RMLGHGTFAKVYLA--RNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIV 82
+ LG G F V + + K++A+K++ K++ + +++ E +VM+ + + +IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 83 ELHEVMASKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYH 141
+ + M++ + G L + + +++ Q+ + + H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 142 RDLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGA 200
RDL N+LL K++DFGLS A + APE I+ + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 201 KADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 258
K+D+WS GV+++ + G P++ + + +G+ CP E L+
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 259 NPNSRIAISKIME--SSWFKKSAPK 281
+ +R + + +++ +
Sbjct: 250 DVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-60
Identities = 52/257 (20%), Positives = 111/257 (43%), Gaps = 15/257 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ LG G F V + + +A+K++ + + + ++ E VM + H+
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRG 138
+V+L+ V + I+ + + G L N + + R + + + A+++ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEVISKKG 196
HRDL N L+++ G +KV+DFGL S ++ D + + PEV+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGL---SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 197 YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITK 254
+ +K+DIW+ GV+++ + + G +P++ I +G P S + ++
Sbjct: 178 FS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236
Query: 255 LLDPNPNSRIAISKIME 271
+ R ++
Sbjct: 237 CWHEKADERPTFKILLS 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 1e-60
Identities = 61/283 (21%), Positives = 127/283 (44%), Gaps = 13/283 (4%)
Query: 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREIS 71
D+ + + LG G + +VY + ++A+K + +D + +E+ +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAA 65
Query: 72 VMKMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIA---KGRLREDVARVYFQQLI 128
VMK +KH ++V+L V + Y + + G L + + + + V Q+
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
SA+++ + HRDL N L+ E+ +KV DFGLS + A
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTA 184
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLL-AGFLPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246
PE ++ + K+D+W+ GV+L+ + G P+ ++ +Y + + + P
Sbjct: 185 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 247 EARRLITKLLDPNPNSRIAISKIMES--SWFKKSAPKVVITKQ 287
+ L+ NP+ R + ++I ++ + F++S+ + K+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 15/269 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
L LG G F +V++ T + +A+K + + E +E VMK ++H+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR---EDVARVYFQQLISAVDFCHS 136
+V+L+ V+ S+ IY + + G L + + + Q+ S + +
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
HRDL+ N+L+ E+ KV DFGL+ E + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 197 YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITK 254
+ K+D+WS G++L L G +P+ + ++ RG CPP L+ +
Sbjct: 191 FT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 255 LLDPNPNSRIAISKIME--SSWFKKSAPK 281
P R + +F + P+
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 57/264 (21%), Positives = 105/264 (39%), Gaps = 14/264 (5%)
Query: 27 LGHGTFAKVYLARNLQTGKSM--AMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVEL 84
LG G F V K + A+KV+ + + E++ RE +M + + +IV L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 85 HEVMASKSKIYFAMDLVKGGELFNKI--AKGRLREDVARVYFQQLISAVDFCHSRGVYHR 142
V + M++ GG L + + + Q+ + + + HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 143 DLKPENLLLDEDGNLKVTDFGLS-AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAK 201
DL N+LL K++DFGLS A + APE I+ + + ++
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192
Query: 202 ADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPN 259
+D+WS GV ++ L+ G P++ + I +G +CPP E L++
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 260 PNSRIAISKI---MESSWFKKSAP 280
R + M + ++ ++
Sbjct: 253 WEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-60
Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 34/292 (11%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
KYE +G GT+ V+ A+N +T + +A+K V D G+ REI ++K +KHK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGEL-FNKIAKGRLREDVARVYFQQLISAVDFCHSRG 138
+IV LH+V+ S K+ + + G L ++ + + QL+ + FCHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V HRDLKP+NLL++ +G LK+ +FGL+ T Y P+V+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 199 GAKADIWSCGVILYVLLAGFLP-FQDDNIVSMYRKIYRGDF------------------- 238
D+WS G I L P F +++ ++I+R
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 239 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAP 280
P ++ R L+ LL NP RI+ + ++ +F P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 6e-60
Identities = 55/292 (18%), Positives = 112/292 (38%), Gaps = 6/292 (2%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKH 78
++ ++LG G F VY + G+ + + V K + ++I E VM V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR-EDVARVYFQQLISAVDFCHSR 137
H+ L + + + + G L + Q+ +++ R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 138 GVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGY 197
+ HRDL N+L+ ++K+TDFGL+ +++ ++A E I + Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 198 DGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKL 255
++D+WS GV ++ L+ G P+ + + +G+ PP + + ++ K
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 256 LDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFH 307
+ +SR +++ P+ + Q E S A
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALM 301
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 7e-60
Identities = 54/263 (20%), Positives = 107/263 (40%), Gaps = 15/263 (5%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQ----IKREISVMKMV 76
++ +++G G F +V GK + K +K G E+ E S+M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI---KTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 77 KHKHIVELHEVMASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDFC 134
H +++ L V+ + + + ++ G L F + G+ + + + + +
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 135 HSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT---CGTPAYVAPEV 191
HRDL N+L++ + KV+DFGLS F E D + + APE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 192 ISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEAR 249
I + + +D+WS G++++ +++ G P+ D + I + P S
Sbjct: 205 IQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 250 RLITKLLDPNPNSRIAISKIMES 272
+L+ + N R +I+ +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-59
Identities = 56/255 (21%), Positives = 109/255 (42%), Gaps = 11/255 (4%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH 80
+ +G G F V+L +A+K + + + + E E VM + H
Sbjct: 7 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 81 IVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLR--EDVARVYFQQLISAVDFCHSRG 138
+V+L+ V ++ I + ++ G L + + R + + + +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 139 VYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYD 198
V HRDL N L+ E+ +KV+DFG++ F Q T + +PEV S Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 199 GAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITKLL 256
+K+D+WS GV+++ + + G +P+++ + + I G P S+ +++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 257 DPNPNSRIAISKIME 271
P R A S+++
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-59
Identities = 71/295 (24%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQT-GKSMAMKVVGKDKVIKVGMMEQIKREISVMKM--- 75
+YE +G G + KV+ AR+L+ G+ +A+K V + + + GM RE++V++
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66
Query: 76 VKHKHIVELHEVMAS-----KSKIYFAMDLVKGG--ELFNKIAKGRLREDVARVYFQQLI 128
+H ++V L +V ++K+ + V +K+ + + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 129 SAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVA 188
+DF HS V HRDLKP+N+L+ G +K+ DFGL+ + T Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG------------ 236
PEV+ + Y D+WS G I + F+ + V KI
Sbjct: 184 PEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 237 ---------------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
K + L+ K L NP RI+ + +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-59
Identities = 57/279 (20%), Positives = 106/279 (37%), Gaps = 24/279 (8%)
Query: 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVM 73
P L + ++G G F +V AR + G M + + E+ V+
Sbjct: 5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 64
Query: 74 -KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK-----------------GRL 115
K+ H +I+ L + +Y A++ G L + + K L
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 116 REDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175
+ + +D+ + HRDL N+L+ E+ K+ DFGLS E +
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK- 183
Query: 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIY 234
++A E + +D+WS GV+L+ +++ G P+ +Y K+
Sbjct: 184 --TMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 235 RG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272
+G + P E L+ + P R + ++I+ S
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-58
Identities = 55/257 (21%), Positives = 108/257 (42%), Gaps = 13/257 (5%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHK 79
+L LG G F +V++ +A+K + + + + E ++MK ++H+
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 80 HIVELHEVMASKSKIYFAMDLVKGGELFNKI---AKGRLREDVARVYFQQLISAVDFCHS 136
+V L+ V+ ++ IY + ++ G L + + + +L + Q+ + F
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
R HRDL+ N+L+ + + K+ DFGL+ E + + APE I G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAI-NYG 185
Query: 197 YDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLITK 254
K+D+WS G++L ++ G +P+ + + + RG P E +L+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 255 LLDPNPNSRIAISKIME 271
P R +
Sbjct: 246 CWKERPEDRPTFDYLRS 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-58
Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 8/257 (3%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKS-MAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+ ELGR +G G F V+ + +A+ + + E+ +E M+ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS 136
HIV+L V+ +++ ++ M+L GEL + + L +Y QL +A+ + S
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKG 196
+ HRD+ N+L+ + +K+ DFGLS + E ++APE I+ +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRR 185
Query: 197 YDGAKADIWSCGVILY-VLLAGFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITK 254
+ +D+W GV ++ +L+ G PFQ + +I G+ PP L+TK
Sbjct: 186 FTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 255 LLDPNPNSRIAISKIME 271
+P+ R +++
Sbjct: 245 CWAYDPSRRPRFTELKA 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (477), Expect = 6e-57
Identities = 56/284 (19%), Positives = 102/284 (35%), Gaps = 35/284 (12%)
Query: 20 KYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
E R +G G F +V+ AR + +A+K++ ++ M +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-------------------- 114
+ +IV+L V A + + + G+L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 115 -----LREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169
L +Q+ + + + R HRDL N L+ E+ +K+ DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFL-PFQDDNIVS 228
++ PE I Y ++D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 229 MYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ + G+ CP E L+ P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 187 bits (476), Expect = 1e-56
Identities = 65/299 (21%), Positives = 124/299 (41%), Gaps = 53/299 (17%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-H 78
Y+L R LG G +++V+ A N+ + + +K+ +K ++IKREI +++ ++
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 89
Query: 79 KHIVELHEVMASKSK--IYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS 136
+I+ L +++ + V + L + R Y +++ A+D+CHS
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHS 147
Query: 137 RGVYHRDLKPENLLLD-EDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKK 195
G+ HRD+KP N+++D E L++ D+GL+ F + + + PE++
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDY 204
Query: 196 GYDGAKADIWSCGVILYVLLAGFLPFQDDN--------------IVSMYRKIYRGDFKCP 241
D+WS G +L ++ PF + +Y I + + +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 242 PWF------------------------SSEARRLITKLLDPNPNSRIAISKIMESSWFK 276
P F S EA + KLL + SR+ + ME +F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 183 bits (464), Expect = 3e-55
Identities = 47/273 (17%), Positives = 96/273 (35%), Gaps = 26/273 (9%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
Y++GR +G G+F ++ NL + +A+K + Q++ E K++
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 79 -KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGR-LREDVARVYFQQLISAVDFCHS 136
I ++ +DL+ GR + +Q+++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 137 RGVYHRDLKPENLLLDE-----DGNLKVTDFGLSAF-----SEHLKQDGLLHTTCGTPAY 186
+ + +RD+KP+N L+ + V DFG+ F ++ GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 187 VAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVS---MYRKIYRGDFKCPPW 243
++ + + D+ + G + L G LP+Q + Y +I P
Sbjct: 180 MSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 244 -----FSSEARRLITKLLDPNPNSRIAISKIME 271
F E + + + ++ +
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-55
Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 30/288 (10%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKS-------MAMKVVGKDKVIKVGMM 63
D R L + LG+ LG G F +V LA + K +A+K++ D K +
Sbjct: 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DL 62
Query: 64 EQIKREISVMKMV-KHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI------------ 110
+ E+ +MKM+ KHK+I+ L +Y ++ G L +
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122
Query: 111 -----AKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
+ +L Q+ +++ S+ HRDL N+L+ ED +K+ DFGL+
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDD 224
H+ ++APE + + Y ++D+WS GV+L+ + G P+
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 225 NIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ +++ + G P ++E ++ P+ R +++E
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 7e-55
Identities = 52/280 (18%), Positives = 102/280 (36%), Gaps = 27/280 (9%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
+Y LGR +G G+F +YL ++ G+ +A+K+ Q+ E + KM++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQG 61
Query: 79 KH-IVELHEVMASKSKIYFAMDLVKGGELF-NKIAKGRLREDVARVYFQQLISAVDFCHS 136
I + A M+L+ + + Q+IS +++ HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 137 RGVYHRDLKPENLL---LDEDGNLKVTDFGLSAFSEHLKQDGLLH-----TTCGTPAYVA 188
+ HRD+KP+N L + + + DFGL+ + + GT Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 189 PEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK--------C 240
+ D+ S G +L G LP+Q + +K R K
Sbjct: 182 INTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 PPWFSSEARRLITKLLDPNPNSRI---AISKIMESSWFKK 277
+ SE + + + + ++ + + ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 58/289 (20%), Positives = 108/289 (37%), Gaps = 31/289 (10%)
Query: 11 DDRPTLLHGKYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQ 65
D + + G+ LG G F KV A ++A+K++ + E
Sbjct: 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREA 72
Query: 66 IKREISVMKMVK-HKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK------------ 112
+ E+ V+ + H +IV L + G+L N + +
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 113 -------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165
L + + Q+ + F S+ HRDL N+LL K+ DFGL+
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDD 224
++ + ++APE I ++D+WS G+ L+ L + G P+
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 225 NIVSMYRKIYRGDFK--CPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ S + K+ + F+ P +E ++ D +P R +I++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-53
Identities = 75/346 (21%), Positives = 136/346 (39%), Gaps = 59/346 (17%)
Query: 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKRE 69
GD T+L +Y+ + +G G V A + +++A+K + + + ++ RE
Sbjct: 9 GDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRE 66
Query: 70 ISVMKMVKHKHIVELHEVMASKSK------IYFAMDLVKGGELFNKIAKGRLREDVARVY 123
+ +MK V HK+I+ L V + +Y M+L+ ++ + L +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYL 124
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183
Q++ + HS G+ HRDLKP N+++ D LK+ DFGL+ + ++ T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 181
Query: 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPW 243
Y APEVI GY DIWS G I+ ++ + F + + + K+ P
Sbjct: 182 RYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 244 F------------------------------------------SSEARRLITKLLDPNPN 261
F +S+AR L++K+L +P
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 262 SRIAISKIMESSWFKK---SAPKVVITKQEMEFEADKSSKQPETLN 304
RI++ ++ + A Q + + D+ E
Sbjct: 301 KRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-53
Identities = 48/258 (18%), Positives = 99/258 (38%), Gaps = 8/258 (3%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGK--DKVIKVGMMEQIKREISVMKMVKH 78
+++G G F +VY + + V K E +M H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 79 KHIVELHEVMASKSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHS 136
+I+ L V++ + + ++ G L + + G + + + + + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 137 RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT-TCGTPAYVAPEVISKK 195
HRDL N+L++ + KV+DFGLS E + + + APE IS +
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 196 GYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSEARRLIT 253
+ +D+WS G++++ ++ G P+ + + + + I G P S +L+
Sbjct: 189 KFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMM 247
Query: 254 KLLDPNPNSRIAISKIME 271
+ R + I+
Sbjct: 248 QCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-53
Identities = 59/262 (22%), Positives = 109/262 (41%), Gaps = 13/262 (4%)
Query: 20 KYELGRMLGHGTFAKVYLARNLQTGKS---MAMKVVGKDKVIKVGMMEQIKREISVMKMV 76
++G G F VY L A+K + +++ +G + Q E +MK
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85
Query: 77 KHKHIVELHEV-MASKSKIYFAMDLVKGGEL--FNKIAKGRLREDVARVYFQQLISAVDF 133
H +++ L + + S+ + +K G+L F + + Q+ + F
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTT--CGTPAYVAPEV 191
S+ HRDL N +LDE +KV DFGL+ + D + + T ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 192 ISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249
+ + K+D+WS GV+L+ L+ G P+ D N + + +G P +
Sbjct: 206 L-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264
Query: 250 RLITKLLDPNPNSRIAISKIME 271
++ K P R + S+++
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVS 286
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-51
Identities = 54/271 (19%), Positives = 100/271 (36%), Gaps = 21/271 (7%)
Query: 20 KYELGRMLGHGTFAKVYLARN-----LQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
K + R LG G+F VY + +A+K V + + + E SVMK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78
Query: 75 MVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKI-----------AKGRLREDVARVY 123
H+V L V++ M+L+ G+L + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 124 FQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGT 183
++ + + ++ HRDL N ++ ED +K+ DFG++
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 184 PAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRGD-FKCP 241
+++PE + + +D+WS GV+L+ + P+Q + + R + G P
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 242 PWFSSEARRLITKLLDPNPNSRIAISKIMES 272
L+ NP R + +I+ S
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-50
Identities = 57/278 (20%), Positives = 109/278 (39%), Gaps = 28/278 (10%)
Query: 20 KYELGRMLGHGTFAKVYLAR-----NLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
+ +LG+ LG G F +V A T +++A+K++ K+ + ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIH 72
Query: 75 MVKHKHIVELHEVMASK-SKIYFAMDLVKGGELFNKI-----------------AKGRLR 116
+ H ++V L + ++ K G L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 117 EDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176
+ Y Q+ ++F SR HRDL N+LL E +K+ DFGL+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYR 235
++APE I + Y ++D+WS GV+L+ + + P+ I + + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 236 GD--FKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271
+ P + + E + + P+ R S+++E
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-49
Identities = 50/294 (17%), Positives = 109/294 (37%), Gaps = 47/294 (15%)
Query: 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH 78
L +G G F +V+ + G+ +A+K+ + + EI M++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE----RSWFREAEIYQTVMLRH 56
Query: 79 KHIVELHEVM----ASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFC 134
++I+ + ++++ D + G LF+ + + + + S +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 135 HS--------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ--DGLLHTTCGTP 184
H + HRDLK +N+L+ ++G + D GL+ + D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 185 AYVAPEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPF---------------QDD 224
Y+APEV+ K +ADI++ G++ + + D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 225 NIVSMYRKIYRG--DFKCPPWFSS-----EARRLITKLLDPNPNSRIAISKIME 271
++ M + + P + S +++ + N +R+ +I +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (404), Expect = 1e-45
Identities = 68/378 (17%), Positives = 123/378 (32%), Gaps = 91/378 (24%)
Query: 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK 74
+Y L R LG G F+ V+LA+++ +AMK+V DKV E + EI +++
Sbjct: 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQ 64
Query: 75 MVKH-----------KHIVELHEVMASKSKIYFAMDLVKGG------ELFNKIAKGRLRE 117
V HI++L + K + +V L K +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 118 DVARVYFQQLISAVDFC-HSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQDG 175
+ +QL+ +D+ G+ H D+KPEN+L++ + ++ D
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMY----- 230
+ T Y +PEV+ + ADIWS +++ L+ G F+ D S
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 231 -------------------------------------------RKIYRGDFKCPPWFSSE 247
+ +K + E
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSAPKVVITKQEMEFEADKSSKQPETLNAFH 307
++ +L +P R ++ W K + + + P+
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG-------------MEEIRVPDREL--- 347
Query: 308 IISLSEGFDLSPLFEEKK 325
G D+ FEE +
Sbjct: 348 ---YGSGSDIPGWFEEVR 362
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.6 bits (237), Expect = 9e-24
Identities = 33/204 (16%), Positives = 67/204 (32%), Gaps = 25/204 (12%)
Query: 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKD-------KVIKVGMMEQIKREISVM 73
+G+++G G + V+ + + +K K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 74 KMVKHKHIVELHEVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDF 133
+ + + +L + K + ++ EL + R+R + ++ V
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLM--ELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 134 CHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVIS 193
+ RG+ H DL N+L+ E+G + + DF S +L I
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--------RNII 169
Query: 194 ---KKGYDGAKADIWSCGVILYVL 214
+ Y + DI S I +L
Sbjct: 170 TYFSRTY-RTEKDINS--AIDRIL 190
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 45.9 bits (109), Expect = 4e-07
Identities = 10/82 (12%), Positives = 29/82 (35%), Gaps = 2/82 (2%)
Query: 336 TTRPASSVISRFEEVAKAVKFNVKTSES-RVRLQGQESGRKGKLAINADIFAV-TPSLLV 393
++ S ++ +V A + + E + + + + ++ + SL
Sbjct: 17 SSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNG 76
Query: 394 VEVKKDNGDTLEYNQFCSNELR 415
V K+ +G ++ + S
Sbjct: 77 VRFKRISGTSIAFKNIASKIAN 98
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 441 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.29 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 97.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.32 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 97.26 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 97.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.78 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-65 Score=485.88 Aligned_cols=255 Identities=35% Similarity=0.683 Sum_probs=237.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999876554445567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CCc
Confidence 999999999999976 789999999999999999999999999999999999999999999999999997543 233
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 256 (441)
....+||+.|+|||++.+.+|+ .++|||||||+||+|++|++||.+.+...++.++.++.+.+|+.+|+++++||.+||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 4567899999999999988774 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHhcCcccCc
Q 013522 257 DPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 257 ~~dP~~R~t~~eil~hpwf~~ 277 (441)
++||++|||++|+|+||||+.
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-65 Score=486.41 Aligned_cols=261 Identities=34% Similarity=0.616 Sum_probs=227.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ...+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 457899999999999999999999999999999999866432 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 97 AMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
|||||+||+|++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999999976 679999999999999999999999999999999999999999999999999998766544455
Q ss_pred cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHHcCCCCCC--CCCCHHHHHHH
Q 013522 176 LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIYRGDFKCP--PWFSSEARRLI 252 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~~~~~~~li 252 (441)
...+.+||+.|+|||++.+..+++.++|||||||++|+|++|++||...+.. ..+..+.......+ +.+++++++||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 5677899999999999998888778899999999999999999999775443 33344444433333 35899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 253 TKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 253 ~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.+||+.||++|||++|+++||||++..
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-65 Score=488.60 Aligned_cols=262 Identities=33% Similarity=0.623 Sum_probs=236.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
...++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+.+.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 34468999999999999999999999999999999998765544456678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+|||||+||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999875 88999999999999999999999999999999999999999999999999999876554444
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+...++.++.++.+.+|..+++++++||.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 556677899999999999988774 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHHH------HhcCcccCcc
Q 013522 255 LLDPNPNSRIAISK------IMESSWFKKS 278 (441)
Q Consensus 255 ~L~~dP~~R~t~~e------il~hpwf~~~ 278 (441)
||++||++|||++| +++||||+..
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999988 5889999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-64 Score=481.65 Aligned_cols=256 Identities=28% Similarity=0.480 Sum_probs=229.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 35899999999999999999999999999999999765432 346789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 98 MDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||||+||+|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... .....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999986432 23345
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---CCCCCCCCCHHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---DFKCPPWFSSEARRLITK 254 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~ 254 (441)
...+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+.......+... .+..|+.+++++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 677899999999999988774 8999999999999999999999988877666655543 334567799999999999
Q ss_pred hcCCCCCCCCCHHHHhcCcccCccC
Q 013522 255 LLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
||++||++|||+.|+|+||||+...
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HccCChhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999997543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-63 Score=485.90 Aligned_cols=260 Identities=33% Similarity=0.644 Sum_probs=240.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++++.||+|+||+||+|++..+|+.||||++.+.........+++.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 34578999999999999999999999999999999998776554456788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD 174 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 174 (441)
+|||||+||+|++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 99999999999999986 7899999999999999999999999999999999999999999999999999975432 23
Q ss_pred CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q 013522 175 GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITK 254 (441)
Q Consensus 175 ~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 254 (441)
....+.+|||.|+|||++.+.+| +.++|||||||++|+|++|++||.+.+...++..+..+.+.+|..+|+++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 44567899999999999998888 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 255 LLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 255 ~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
||++||.+|++ ++++++||||+..
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999994 8999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-62 Score=474.52 Aligned_cols=258 Identities=36% Similarity=0.690 Sum_probs=216.1
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
..+.++|++++.||+|+||+||+|++..+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++.+++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 346788999999999999999999999999999999998765432 345688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC---CCCCeEEeecCccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD---EDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~---~~~~vkl~DFGla~~~~~ 170 (441)
|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ +++.+||+|||+|....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~- 161 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED- 161 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc-
Confidence 999999999999999976 7899999999999999999999999999999999999995 57899999999997543
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCH
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSS 246 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 246 (441)
......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+.......+.++....+ +.+|+
T Consensus 162 --~~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 238 (307)
T d1a06a_ 162 --PGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD 238 (307)
T ss_dssp -------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --CCCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCH
Confidence 23445678899999999999988775 899999999999999999999999999999999988876543 46899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
++++||.+||++||++|||++|+++||||+..
T Consensus 239 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-62 Score=474.58 Aligned_cols=255 Identities=35% Similarity=0.740 Sum_probs=236.8
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999999999999999998765544455788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|||.||+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CB
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----cc
Confidence 99999999999876 6789999999999999999999999999999999999999999999999999976432 34
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhcC
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLLD 257 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~ 257 (441)
.+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+.+.++..+...+|+.++++++++|.+||.
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 567899999999999888875 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccCccC
Q 013522 258 PNPNSRI-----AISKIMESSWFKKSA 279 (441)
Q Consensus 258 ~dP~~R~-----t~~eil~hpwf~~~~ 279 (441)
+||.+|+ |++++++||||++..
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred hCHHhccccchhhHHHHHcCcccccCC
Confidence 9999996 999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-62 Score=470.99 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=226.8
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.+.|++++.||+|+||+||+|++..+|+.||+|++.+... ...+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 3579999999999999999999999999999999976532 3356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCC
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDG 175 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 175 (441)
||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~ 165 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 165 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence 999999999999754 56999999999999999999999999999999999999999999999999999754322 12
Q ss_pred cccccccCCCccchhhhh-----ccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC---CCCCCCHH
Q 013522 176 LLHTTCGTPAYVAPEVIS-----KKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK---CPPWFSSE 247 (441)
Q Consensus 176 ~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~ 247 (441)
...+.+||+.|+|||++. +.+| +.++|||||||++|+|++|.+||.+.+..+.+.++..+..+ .|+.+|++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 344678999999999984 2334 58999999999999999999999998888888888877543 35678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++||.+||++||++|||++|+++||||+...
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999997543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-61 Score=465.92 Aligned_cols=260 Identities=33% Similarity=0.584 Sum_probs=234.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV---GMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+.++|++++.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.+.
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4467899999999999999999999999999999999987654321 2367899999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC----CeEEeecCccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG----NLKVTDFGLSA 166 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~----~vkl~DFGla~ 166 (441)
+.+|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999976 7899999999999999999999999999999999999998876 49999999997
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----C
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----P 242 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~ 242 (441)
... ......+.+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+..+.+..+..+...++ +
T Consensus 166 ~~~---~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 166 KID---FGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp ECT---TSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hcC---CCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 543 2344567789999999999987766 5999999999999999999999999999999999998877665 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 243 WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 243 ~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
.+|+++++||++||++||++|||++++++||||+..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 689999999999999999999999999999999854
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-62 Score=464.93 Aligned_cols=254 Identities=30% Similarity=0.542 Sum_probs=217.4
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS--KSKIY 95 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~ 95 (441)
.++|++++.||+|+||+||+|++..+|+.||+|++...... ....+.+.+|+.+|++++||||+++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 46799999999999999999999999999999999876543 3456778999999999999999999999864 45689
Q ss_pred EEEeccCCCchHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcC-----cEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 96 FAMDLVKGGELFNKIAK-----GRLREDVARVYFQQLISAVDFCHSRG-----VYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-----~~l~~~~~~~~~~qll~aL~ylH~~g-----i~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999853 56999999999999999999999977 999999999999999999999999999
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCC-CCCCC
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFK-CPPWF 244 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~ 244 (441)
+.... ......+.+|||.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..++..++..+.+. .|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 86543 22344567899999999999888775 8999999999999999999999999999999999888764 56779
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCccc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWF 275 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf 275 (441)
|+++.+||.+||++||++|||++|+++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-61 Score=474.14 Aligned_cols=256 Identities=31% Similarity=0.567 Sum_probs=232.2
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYF 96 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l 96 (441)
+.++|++++.||+|+||+||+|++..+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 55799999999999999999999999999999999976532 345778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC--CCCeEEeecCccccccccc
Q 013522 97 AMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE--DGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 97 v~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~--~~~vkl~DFGla~~~~~~~ 172 (441)
|||||+||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~--- 177 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 177 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC---
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc---
Confidence 9999999999999953 67999999999999999999999999999999999999964 5789999999997543
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSEA 248 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~ 248 (441)
......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+..+.+..+..+.+..+ +.+|+++
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 33445678899999999999988875 899999999999999999999999999999999988877655 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++||.+||.+||++|||++|+|+||||+...
T Consensus 257 ~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-61 Score=468.06 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=227.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999999999999999998776655556678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|||.||+|..++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... .
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence 99999999776654 7799999999999999999999999999999999999999999999999999975432 3
Q ss_pred cccccCCCccchhhhhcc--CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC--CCCCCHHHHHHHH
Q 013522 178 HTTCGTPAYVAPEVISKK--GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC--PPWFSSEARRLIT 253 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~--~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~li~ 253 (441)
...+||+.|+|||++.+. +.++.++|||||||++|+|++|..||.+.+......++..+..+. +..+|+++++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 456899999999999642 223589999999999999999999999988888887777765443 3458999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCcccCccCC
Q 013522 254 KLLDPNPNSRIAISKIMESSWFKKSAP 280 (441)
Q Consensus 254 ~~L~~dP~~R~t~~eil~hpwf~~~~~ 280 (441)
+||++||++|||++++|+||||....+
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 999999999999999999999976543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-61 Score=475.27 Aligned_cols=255 Identities=35% Similarity=0.696 Sum_probs=237.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47899999999999999999999999999999999876655555677899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
|||+.||+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~-----~~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----SC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-----cc
Confidence 999999999999976 789999999999999999999999999999999999999999999999999997543 23
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 256 (441)
..+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+...++.++..+.+..|+.+++++.+||++||
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred cccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHh
Confidence 4567899999999999988775 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----CHHHHhcCcccCcc
Q 013522 257 DPNPNSRI-----AISKIMESSWFKKS 278 (441)
Q Consensus 257 ~~dP~~R~-----t~~eil~hpwf~~~ 278 (441)
++||.+|+ |++++++||||+..
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hhCHHhccccccccHHHHHcCccccCC
Confidence 99999995 99999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-61 Score=474.12 Aligned_cols=257 Identities=27% Similarity=0.533 Sum_probs=233.0
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+|+.+|++++||||+++++++.+++.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356789999999999999999999999999999999976542 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeC--CCCCeEEeecCcccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLD--EDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~--~~~~vkl~DFGla~~~~~~ 171 (441)
+|||||+||+|++.+.. .++++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~-- 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC--
Confidence 99999999999998865 4699999999999999999999999999999999999998 56899999999998643
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCC----CCCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCP----PWFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~ 247 (441)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+..+..+.+.+| +.+|++
T Consensus 181 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 181 -PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp -TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred -CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 34456678899999999999888774 899999999999999999999999999999999988877655 468999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+++||.+||++||.+|||+.|+|+||||+...
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-61 Score=455.93 Aligned_cols=253 Identities=23% Similarity=0.468 Sum_probs=220.3
Q ss_pred ccCCe-EEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----C
Q 013522 17 LHGKY-ELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS----K 91 (441)
Q Consensus 17 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~ 91 (441)
..+|| ++.+.||+|+||+||+|++..+++.||+|.+...... ....+.+.+|+++|++++|||||++++++.+ .
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 45667 7888999999999999999999999999999876543 3446789999999999999999999999865 4
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC--cEeccCCCCcEEeC-CCCCeEEeecCcccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRG--VYHRDLKPENLLLD-EDGNLKVTDFGLSAF 167 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~g--i~HrDLkp~NILl~-~~~~vkl~DFGla~~ 167 (441)
..+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+|+.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 568999999999999999976 78999999999999999999999998 99999999999996 578999999999975
Q ss_pred ccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHHcCCCC--CCCCC
Q 013522 168 SEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDD-NIVSMYRKIYRGDFK--CPPWF 244 (441)
Q Consensus 168 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~--~~~~~ 244 (441)
.. .....+.+|||.|+|||++.+ +| +.++|||||||++|+|++|+.||.+. +...++..+..+..+ ++..+
T Consensus 165 ~~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 165 KR----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp CC----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred cc----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccC
Confidence 32 234557789999999999865 46 58999999999999999999999765 455666677665432 34558
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
++++++||.+||++||++|||++|+|+||||+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 89999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-61 Score=470.87 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=218.5
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
+..++|++++.||+|+||+||+|++..+|+.||+|++.+.. .....+++.+|+.+|+.++|||||++++++.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45789999999999999999999999999999999997653 2345678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 96 FAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
+|||||+||+|.+++.+ +++++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence 99999999999999975 789999999999999999999997 5999999999999999999999999999986543
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH------------------------
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM------------------------ 229 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~------------------------ 229 (441)
....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+....
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred -CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 223467899999999999988875 899999999999999999999976543211
Q ss_pred ------------------HHHHHcCCC-CCCC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 230 ------------------YRKIYRGDF-KCPP-WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 230 ------------------~~~i~~~~~-~~~~-~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
...+....+ ..|. .+|+++++||.+||++||++|||++|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 111111111 1111 257899999999999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-61 Score=467.27 Aligned_cols=256 Identities=32% Similarity=0.607 Sum_probs=233.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMK-MVKHKHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~lv 97 (441)
++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999999999999999998765444445566777777765 68999999999999999999999
Q ss_pred EeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 98 MDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||||+||+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--cccc
Confidence 999999999999976 7899999999999999999999999999999999999999999999999999975432 2334
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHHHHHHHHhc
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEARRLITKLL 256 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L 256 (441)
....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+...++.++..+.+.+|..+|+++++||.+||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHS
T ss_pred ccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhc
Confidence 5567899999999999988885 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHH-HHhcCcccCc
Q 013522 257 DPNPNSRIAIS-KIMESSWFKK 277 (441)
Q Consensus 257 ~~dP~~R~t~~-eil~hpwf~~ 277 (441)
++||++|||+. ++++||||+.
T Consensus 239 ~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTT
T ss_pred ccCCCCCcCHHHHHHhCchhcc
Confidence 99999999995 8999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-60 Score=453.08 Aligned_cols=258 Identities=31% Similarity=0.556 Sum_probs=230.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccch------hhHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKV------GMMEQIKREISVMKMVK-HKHIVELHEVMA 89 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~ 89 (441)
+.++|++++.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+|++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 35799999999999999999999999999999999987654321 23456889999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
+++.+|+|||||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999965 88999999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCcccccccCCCccchhhhhcc-----CCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC-
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKK-----GYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP- 242 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~- 242 (441)
.. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|++||.+.+.......+..+....+.
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 43 3344667899999999999642 23367899999999999999999999999999999999888765433
Q ss_pred ---CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 243 ---WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 243 ---~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
.+|+++++||.+||++||++|||++|+|+||||++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 58999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-60 Score=463.71 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=231.3
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIY 95 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 95 (441)
.+.+||++++.||+|+||+||+|++..+|+.||+|++.+... ....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 367899999999999999999999999999999999976532 2356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC--CCeEEeecCcccccccc
Q 013522 96 FAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED--GNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~--~~vkl~DFGla~~~~~~ 171 (441)
+|||||+||+|++++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999999999999975 379999999999999999999999999999999999999854 479999999987543
Q ss_pred ccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----CCCHH
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP----WFSSE 247 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~ 247 (441)
......+.+||+.|+|||.+.+..|. .++|||||||++|+|++|..||.+.+....+.++.++.+.+|. .+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 23445677899999999999887764 8999999999999999999999999999999999998877764 68999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
+++||.+||++||++|||++|+++||||++.
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-60 Score=468.62 Aligned_cols=257 Identities=31% Similarity=0.494 Sum_probs=223.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHH---HHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIK---REISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~---~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.++|++++.||+|+||+||+|++..+|+.||||++.+...........+. +|+.+++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 47899999999999999999999999999999999765543322223333 457777888999999999999999999
Q ss_pred EEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~ 173 (441)
|+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999985442
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCCCCCCCCCCHHHHH
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDFKCPPWFSSEARR 250 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 250 (441)
......+||+.|+|||++.+...++.++|||||||+||+|++|..||.+.+ ...+...+.......|+.+|+++++
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 234567899999999999765545689999999999999999999998654 3345555566677788889999999
Q ss_pred HHHHhcCCCCCCCCC-----HHHHhcCcccCcc
Q 013522 251 LITKLLDPNPNSRIA-----ISKIMESSWFKKS 278 (441)
Q Consensus 251 li~~~L~~dP~~R~t-----~~eil~hpwf~~~ 278 (441)
||.+||++||++||| ++++++||||+..
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999999999 7999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-60 Score=453.29 Aligned_cols=253 Identities=32% Similarity=0.592 Sum_probs=224.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchh---hHHHHHHHHHHHHhCC--CCCcceEEEEEEeC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVG---MMEQIKREISVMKMVK--HKHIVELHEVMASK 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~ 91 (441)
+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ ||||+++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 568999999999999999999999999999999999876543211 1234668999999986 89999999999999
Q ss_pred CEEEEEEeccCC-CchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCC-CCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKG-GELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDED-GNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~g-g~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~-~~vkl~DFGla~~~ 168 (441)
+..|+||||+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999986 578888765 789999999999999999999999999999999999999855 78999999999754
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCCCCCHHH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPPWFSSEA 248 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 248 (441)
. .....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...+ .+.++...+++.+|+++
T Consensus 162 ~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~ 231 (273)
T d1xwsa_ 162 K----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC 231 (273)
T ss_dssp C----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred c----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHH
Confidence 3 2345677899999999999988887788999999999999999999998643 46677888999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 249 RRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
++||++||++||++|||++|+++||||++..
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=446.27 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=219.6
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
++|++++.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 689999999999999999999999999999999976543 2234568889999999999999999999999999999999
Q ss_pred eccCCCchHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIA--KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~--~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.|+.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... ....
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cccc
Confidence 9997754433333 25699999999999999999999999999999999999999999999999999976432 2334
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC----------------
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF---------------- 238 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~---------------- 238 (441)
....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+......++... .+
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 556789999999999988888889999999999999999999999988877666555321 00
Q ss_pred CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccCCc
Q 013522 239 KC-----------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSAPK 281 (441)
Q Consensus 239 ~~-----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~~~ 281 (441)
.. .+.+++++++||.+||.+||++|||++|+++||||++...+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00 12357899999999999999999999999999999875543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-59 Score=451.00 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=215.7
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 013522 23 LGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIK--VGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDL 100 (441)
Q Consensus 23 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 100 (441)
.++.||+|+||+||+|++..+|+.||||++....... ......+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999999999999999997654321 12235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcccc
Q 013522 101 VKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHT 179 (441)
Q Consensus 101 ~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 179 (441)
+.|+++...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ......+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Ccccccc
Confidence 999887777764 6799999999999999999999999999999999999999999999999999975433 2234456
Q ss_pred cccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCC--C------------------C
Q 013522 180 TCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGD--F------------------K 239 (441)
Q Consensus 180 ~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~------------------~ 239 (441)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+...++.+.. + .
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 7899999999999876666799999999999999999999999998888777765320 0 0
Q ss_pred C--------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 240 C--------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 240 ~--------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
. .+.+++++.+||.+||++||++|||++|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0 124678999999999999999999999999999998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=453.03 Aligned_cols=254 Identities=33% Similarity=0.589 Sum_probs=215.6
Q ss_pred CccccCCeEEee-eecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHh-CCCCCcceEEEEEEe-
Q 013522 14 PTLLHGKYELGR-MLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKM-VKHKHIVELHEVMAS- 90 (441)
Q Consensus 14 ~~~~~~~y~i~~-~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~- 90 (441)
...+.++|++.. .||+|+||+||+|++..+|+.||||++.+. ..+.+|+.++.+ ++||||++++++|.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 344568899875 699999999999999999999999998643 357789998654 589999999999976
Q ss_pred ---CCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEee
Q 013522 91 ---KSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTD 161 (441)
Q Consensus 91 ---~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~D 161 (441)
...+|+|||||+||+|++++.. .++++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 4679999999999999999975 36999999999999999999999999999999999999986 45799999
Q ss_pred cCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHH----HHHHHcCC
Q 013522 162 FGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSM----YRKIYRGD 237 (441)
Q Consensus 162 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~ 237 (441)
||+|+.... .....+.+|||.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+.... ...+..+.
T Consensus 158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred cceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 999975443 3445678899999999999888775 899999999999999999999987654433 33344455
Q ss_pred CCCCC----CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 238 FKCPP----WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 238 ~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
+.+|. .+|+++++||++||++||++|||+.++++||||.+..
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 55553 4799999999999999999999999999999997543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.9e-58 Score=436.85 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=220.7
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS- 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~- 92 (441)
|+.+.+||++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++...+
T Consensus 2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 5678899999999999999999999999999999999998776655566778999999999999999999999997654
Q ss_pred ---EEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 93 ---KIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 93 ---~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
.+|+|||||+|++|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+...
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 48999999999999999875 78999999999999999999999999999999999999999999999999998654
Q ss_pred cccc-cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC----CCC
Q 013522 169 EHLK-QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC----PPW 243 (441)
Q Consensus 169 ~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~ 243 (441)
.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+...++....... ++.
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp C----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 3322 22345567899999999999887775 89999999999999999999999999888888877765543 356
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccC
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMESSWFK 276 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 276 (441)
+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 899999999999999999999544445566653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3e-57 Score=435.03 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=218.2
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+||++++.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.+|++++||||+++++++.+.+..|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 69999999999999999999985 889999999976643 2334578999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
||+.++.+...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|...... ....
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 157 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKY 157 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--cccc
Confidence 99998877777764 78999999999999999999999999999999999999999999999999999764432 2234
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--CC-----------------
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--DF----------------- 238 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~----------------- 238 (441)
....|++.|+|||.+.+..+.+.++||||+||++|+|++|++||.+.+..+...++... .+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 45579999999999988777789999999999999999999999998877666655321 00
Q ss_pred ----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCc
Q 013522 239 ----------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKK 277 (441)
Q Consensus 239 ----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 277 (441)
..++.+++++++||++||++||++|||+.|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112346889999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-57 Score=435.36 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=215.3
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCC-CcEEEEEEeecccccchhhHHHHHHHHHHHHhC---CCCCcceEEEEEEe--
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQT-GKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV---KHKHIVELHEVMAS-- 90 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-- 90 (441)
..++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.| +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 468999999999999999999999765 6779999997654322 2223456788887766 79999999999853
Q ss_pred ---CCEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 91 ---KSKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 91 ---~~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
...+|++|||+.++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3578999999998876544433 66999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC--C------
Q 013522 166 AFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--D------ 237 (441)
Q Consensus 166 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~------ 237 (441)
..... .....+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|.+||.+.+..+...++... .
T Consensus 164 ~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 164 RIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 75432 2345677899999999999988885 8999999999999999999999998887777666431 0
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 238 -------------------FKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 238 -------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
..++..+++.+++||.+||++||++|||+.|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 01234578999999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=442.78 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=217.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS---- 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 92 (441)
+.++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 67899999999999999999999999999999999976543 3455678999999999999999999999997654
Q ss_pred --EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 --KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 --~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
.+|+||||+ |.+|...+..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6688888888899999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCC------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDF------------ 238 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------ 238 (441)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T d1cm8a_ 173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248 (346)
T ss_dssp ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence 2345678999999999998877778999999999999999999999998876655444322100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 239 -------------------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 239 -------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
..++.+++++.+||.+||.+||++|||+.|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1234578999999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=435.78 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=215.3
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------- 90 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------- 90 (441)
.+||++++.||+|+||+||+|++..+|+.||||++.++... .....++.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 58999999999999999999999999999999999766543 2345678899999999999999999999854
Q ss_pred -CCEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 91 -KSKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 91 -~~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
...+|+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3568999999988766555443 67999999999999999999999999999999999999999999999999999765
Q ss_pred cccc--cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCCCC----
Q 013522 169 EHLK--QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKCPP---- 242 (441)
Q Consensus 169 ~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~---- 242 (441)
.... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.......++
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 4322 2234456789999999999987655568999999999999999999999988877666555432111110
Q ss_pred ----------------------------CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 243 ----------------------------WFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 243 ----------------------------~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
..++++++||.+||++||++|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 0267889999999999999999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-56 Score=430.66 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=221.4
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+++-.++|++++.||+|+||+||+|++..+|+.||||++..+.. ..+++.+|+.+|+.++|||||++++++.++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 3456677899999999999999999999999999999999976543 246789999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
+.+|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999999864 56899999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCC-CCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGF-LPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~-~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 246 (441)
... .........||+.|+|||++.+..|+ .++|||||||++|+|++|. +||.+.+...++..+..+ .++.|+.+++
T Consensus 166 ~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 243 (287)
T d1opja_ 166 TGD-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243 (287)
T ss_dssp CSS-SSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCC-CceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchH
Confidence 432 11222344589999999999988875 8999999999999999965 456666777776666655 4567788999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 247 EARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
++.+||.+||+.||++|||++++++
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-57 Score=430.39 Aligned_cols=254 Identities=22% Similarity=0.407 Sum_probs=208.9
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSK 93 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 93 (441)
+++-.++|++++.||+|+||+||+|++. ..||||++...... ....+.+.+|+.+|++++||||+++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 3556789999999999999999999853 36999999765433 345678999999999999999999999875 456
Q ss_pred EEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccc
Q 013522 94 IYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHL 171 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~ 171 (441)
+|+|||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 8999999999999999964 66999999999999999999999999999999999999999999999999999876554
Q ss_pred ccCCcccccccCCCccchhhhhccC--CCCCcccHHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHHcCCC-----CCCCC
Q 013522 172 KQDGLLHTTCGTPAYVAPEVISKKG--YDGAKADIWSCGVILYVLLAGFLPFQDDNIVS-MYRKIYRGDF-----KCPPW 243 (441)
Q Consensus 172 ~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~~-----~~~~~ 243 (441)
.......+.+||+.|+|||++.+.. ..+.++|||||||+||||+||+.||.+.+... +...+..+.. ..+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 4444556778999999999996432 23589999999999999999999998865543 4444444422 23556
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 244 FSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 244 ~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++++.+||.+||+.||++|||+.+|+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-57 Score=439.66 Aligned_cols=254 Identities=21% Similarity=0.350 Sum_probs=216.8
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCc-----EEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGK-----SMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMA 89 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~ 89 (441)
+-.++|++++.||+|+||+||+|++..+++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 445789999999999999999999876554 699999865432 23346788999999988 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCC
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAKG------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLK 145 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~~------------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLk 145 (441)
+.+.+|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+|||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999999999999642 37899999999999999999999999999999
Q ss_pred CCcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCC
Q 013522 146 PENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDD 224 (441)
Q Consensus 146 p~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~ 224 (441)
|+|||++.++.+||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||+||+|+| |.+||.+.
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999865544333344567799999999999888774 89999999999999997 89999887
Q ss_pred cHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 225 NIVSMYRKIYRG--DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 225 ~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+....+.++... .++.|..+|+++++||.+||+.||++|||+++|++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 665555555444 345678899999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=422.35 Aligned_cols=247 Identities=23% Similarity=0.381 Sum_probs=209.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
.+|++++.||+|+||+||+|++. +++.||||++...... .+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999985 6778999999765432 367899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 99999999999865 568999999999999999999999999999999999999999999999999997654322 122
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 254 (441)
.....||+.|+|||++.+..|+ .++|||||||++|||+| |.+||...+...+...+..+. ...|..+++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3446799999999999988875 89999999999999999 688888888888888887764 45577789999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 013522 255 LLDPNPNSRIAISKIMES 272 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~h 272 (441)
||+.||++|||+++|++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-56 Score=424.28 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=222.2
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
..+++-.++|++++.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 345566789999999999999999999984 678899999976543 24678999999999999999999998754
Q ss_pred CEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFS 168 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~ 168 (441)
+.+|+|||||++|+|.+++.. .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 567999999999999998764 36999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCH
Q 013522 169 EHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSS 246 (441)
Q Consensus 169 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~ 246 (441)
.... ........||+.|+|||++.+..| +.++|||||||++|+|+| |.+||...+.......+..+ ....|+.+++
T Consensus 160 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 160 EDNE-YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (272)
T ss_dssp SSSC-EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-cccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChH
Confidence 4321 122345679999999999987777 489999999999999999 56777788888888888776 4556788999
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc--CcccC
Q 013522 247 EARRLITKLLDPNPNSRIAISKIME--SSWFK 276 (441)
Q Consensus 247 ~~~~li~~~L~~dP~~R~t~~eil~--hpwf~ 276 (441)
++.+||.+||+.||++|||++++++ |+||.
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999999999999999999999988 78875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-56 Score=436.35 Aligned_cols=261 Identities=25% Similarity=0.411 Sum_probs=217.1
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS---- 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 92 (441)
+..||++++.||+|+||+||+|++..+|+.||||++.+.. .....+++.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4578999999999999999999999999999999997643 3345678899999999999999999999997653
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
..+++++|+.||+|++++..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 23444556679999999998889999999999999999999999999999999999999999999999999997654332
Q ss_pred c-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC---------------
Q 013522 173 Q-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG--------------- 236 (441)
Q Consensus 173 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------- 236 (441)
. .......+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 234566789999999999977766679999999999999999999999887765444333210
Q ss_pred ----------CC------CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 ----------DF------KCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 ----------~~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
.. ...+.+++++++||.+||++||++|||+.++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00 01235688999999999999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-55 Score=427.00 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=209.9
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCc---EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGK---SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
+-.++|++.+.||+|+||+||+|++..+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 445789999999999999999999987765 58888876543 2344567999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
.+|+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999998875 5699999999999999999999999999999999999999999999999999986543
Q ss_pred cccCCc---ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCC
Q 013522 171 LKQDGL---LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFS 245 (441)
Q Consensus 171 ~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 245 (441)
...... .....||+.|+|||++.+..|+ .++|||||||+||||+| |.+||.+.+..++...+..+. ++.|..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 322211 1224579999999999887775 89999999999999998 899999999888888887764 56677899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 246 SEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++.+||.+||+.||++|||+.+|+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-56 Score=424.96 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=219.9
Q ss_pred cCCeEEeee-ecccCceEEEEEEEcC--CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRM-LGHGTFAKVYLARNLQ--TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~-LG~G~fg~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.++|.+... ||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+.+|++++|||||++++++.+ +.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 356888885 9999999999998764 45579999997543 23456789999999999999999999999865 458
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
|+|||||+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999999864 579999999999999999999999999999999999999999999999999998654322
Q ss_pred c-CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHH
Q 013522 173 Q-DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEAR 249 (441)
Q Consensus 173 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 249 (441)
. .......+||+.|+|||++.+..++ .++|||||||++|||+| |..||.+.+..++...+.++. ++.|+.+|+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 242 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 242 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 1223456789999999999887774 89999999999999998 999999988888888888774 567889999999
Q ss_pred HHHHHhcCCCCCCCCCHHHH---hcCcccC
Q 013522 250 RLITKLLDPNPNSRIAISKI---MESSWFK 276 (441)
Q Consensus 250 ~li~~~L~~dP~~R~t~~ei---l~hpwf~ 276 (441)
+||.+||+.||++|||+.+| |+|+|+.
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999888 6677764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-55 Score=419.97 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=222.3
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+||++++.||+|+||+||+|++..+|+.||||++..... ......++.+|+.+|+.++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 689999999999999999999999999999999976653 3456788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCcc
Q 013522 99 DLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGLL 177 (441)
Q Consensus 99 E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 177 (441)
|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~~ 158 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSCC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Cccc
Confidence 99999999888876 68999999999999999999999999999999999999999999999999999764432 2233
Q ss_pred cccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCC-CCCcHHHHHHHHHcC--------------------
Q 013522 178 HTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPF-QDDNIVSMYRKIYRG-------------------- 236 (441)
Q Consensus 178 ~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~-------------------- 236 (441)
....+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+......++...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 44567889999999988877779999999999999999999885 555555555554321
Q ss_pred ---------CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 237 ---------DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 237 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
....++.+++.+.+||++||++||++|||++|+|+||||++-
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011223468899999999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=424.94 Aligned_cols=248 Identities=19% Similarity=0.341 Sum_probs=210.9
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 013522 25 RMLGHGTFAKVYLARNL--QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAMDLVK 102 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 102 (441)
+.||+|+||+||+|.+. .+++.||||++..... .....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999864 4567899999975543 334567899999999999999999999999654 5789999999
Q ss_pred CCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccccccc-CCccccc
Q 013522 103 GGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQ-DGLLHTT 180 (441)
Q Consensus 103 gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~ 180 (441)
||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999976 6799999999999999999999999999999999999999999999999999976433221 1123345
Q ss_pred ccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHhcCC
Q 013522 181 CGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITKLLDP 258 (441)
Q Consensus 181 ~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~ 258 (441)
.||+.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+..++...+.++. ++.|+.+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 69999999999988776 489999999999999998 999999998888888888764 567888999999999999999
Q ss_pred CCCCCCCHHHH---hcCccc
Q 013522 259 NPNSRIAISKI---MESSWF 275 (441)
Q Consensus 259 dP~~R~t~~ei---l~hpwf 275 (441)
||++|||+++| |+|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 99999999998 466665
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=416.95 Aligned_cols=247 Identities=21% Similarity=0.361 Sum_probs=221.7
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKIYFAM 98 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~ 98 (441)
+.|+++++||+|+||+||+|++ .+++.||||++.+.... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5789999999999999999998 47889999999876543 367899999999999999999999999999999999
Q ss_pred eccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccCCc
Q 013522 99 DLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQDGL 176 (441)
Q Consensus 99 E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 176 (441)
||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Ccee
Confidence 99999999999754 67999999999999999999999999999999999999999999999999999765432 2223
Q ss_pred ccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Q 013522 177 LHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARRLITK 254 (441)
Q Consensus 177 ~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~ 254 (441)
....+||+.|+|||++.+..|+ .++|||||||++|+|+| |+.||.+.+..++..++..+. ...|..+++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3456799999999999988875 89999999999999998 899999999999999998864 45677899999999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 013522 255 LLDPNPNSRIAISKIMES 272 (441)
Q Consensus 255 ~L~~dP~~R~t~~eil~h 272 (441)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=430.08 Aligned_cols=252 Identities=30% Similarity=0.424 Sum_probs=211.6
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------C
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------K 91 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~ 91 (441)
.-+|+.++.||+|+||+||+|++..+|+.||||++.++... ..+|+.+|++++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 34799999999999999999999999999999999765432 2379999999999999999999853 3
Q ss_pred CEEEEEEeccCCCchHHHH---h-cCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCccc
Q 013522 92 SKIYFAMDLVKGGELFNKI---A-KGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSA 166 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i---~-~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~ 166 (441)
.++|+|||||.++.+.... . ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 4689999999876433332 2 25799999999999999999999999999999999999999875 89999999987
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcC----------
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRG---------- 236 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------- 236 (441)
.... .....+.+||+.|+|||++.+...++.++||||+||++|+|++|..||...+....+..+.+.
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 5432 334566789999999999887666679999999999999999999999988777666555321
Q ss_pred -------CCC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCccC
Q 013522 237 -------DFK------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKSA 279 (441)
Q Consensus 237 -------~~~------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~~ 279 (441)
... ..+.+++++.+||.+||++||++|||+.|+|+||||++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 111 1234789999999999999999999999999999997643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=427.08 Aligned_cols=260 Identities=32% Similarity=0.582 Sum_probs=224.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEc---CCCcEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNL---QTGKSMAMKVVGKDKVIK-VGMMEQIKREISVMKMVKH-KHIVELHEVMASK 91 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~ 91 (441)
-.++|++++.||+|+||+||+|++. .+|+.||||++.+..... ....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 3488999999999999999999974 478999999997654322 2234568899999999976 8999999999999
Q ss_pred CEEEEEEeccCCCchHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK-GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~-~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..+|++|||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999976 7899999999999999999999999999999999999999999999999999975543
Q ss_pred cccCCcccccccCCCccchhhhhccC-CCCCcccHHHHHHHHHHHhhCCCCCCCCc----HHHHHHHHHcCCCCCCCCCC
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKG-YDGAKADIWSCGVILYVLLAGFLPFQDDN----IVSMYRKIYRGDFKCPPWFS 245 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~ 245 (441)
. ......+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+ ...+........++.|..++
T Consensus 182 ~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 182 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred c-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 2 233455678999999999997654 34678999999999999999999997754 33445555667778888999
Q ss_pred HHHHHHHHHhcCCCCCCCC-----CHHHHhcCcccCc
Q 013522 246 SEARRLITKLLDPNPNSRI-----AISKIMESSWFKK 277 (441)
Q Consensus 246 ~~~~~li~~~L~~dP~~R~-----t~~eil~hpwf~~ 277 (441)
+++.+||.+||++||.+|| |++|+++||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=434.06 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=218.2
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK-----S 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~ 92 (441)
.+||++++.||+|+||+||+|++..+|+.||||++.+... .....+++.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 5899999999999999999999999999999999986543 334567789999999999999999999998633 3
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
..+++++|+.||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 446667788899999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHcCCCCC------------
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYRGDFKC------------ 240 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------------ 240 (441)
...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 34567899999999998888777899999999999999999999999988776666654321111
Q ss_pred -------------------CCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 241 -------------------PPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 241 -------------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
...+++++++||++||.+||++|||+.|+|+||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12468999999999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=415.38 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=219.2
Q ss_pred CCCCCccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 013522 10 GDDRPTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMA 89 (441)
Q Consensus 10 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~ 89 (441)
+...+.+-.++|++++.||+|+||+||+|++..+ +.||||++...... .+.+.+|+.+|++++|||||++++++.
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 3445566678999999999999999999998654 67999999765432 367899999999999999999999985
Q ss_pred eCCEEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 90 SKSKIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 90 ~~~~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
+ +.+|+||||+++|+|..++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhh
Confidence 4 567999999999999988864 569999999999999999999999999999999999999999999999999997
Q ss_pred cccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCC
Q 013522 167 FSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWF 244 (441)
Q Consensus 167 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~ 244 (441)
..... ........+||+.|+|||++.+..++ .++|||||||++|+|++ |.+|+...+..++...+..+ ..+.|+.+
T Consensus 162 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 239 (285)
T d1fmka3 162 LIEDN-EYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred hccCC-CceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCccc
Confidence 65432 22233456799999999999888774 89999999999999999 56667777888888887766 45678889
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc--CcccCcc
Q 013522 245 SSEARRLITKLLDPNPNSRIAISKIME--SSWFKKS 278 (441)
Q Consensus 245 ~~~~~~li~~~L~~dP~~R~t~~eil~--hpwf~~~ 278 (441)
++++++||.+||+.||++|||+++|++ ++||...
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999999987 8898754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=414.57 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=209.8
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASK 91 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 91 (441)
++-.++|++++.||+|+||+||+|++..++ ..||||.+.... .....+.+.+|+.+|++++||||+++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 345679999999999999999999987554 468888875432 3345678999999999999999999999985 5
Q ss_pred CEEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 92 SKIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 92 ~~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
+.+|+||||+++|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999998764 579999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 247 (441)
.. ........+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+++.++..+. .+.|+.+|++
T Consensus 160 ~~-~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 237 (273)
T d1mp8a_ 160 DS-TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred CC-cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 32 22233456789999999999887775 89999999999999997 899999999888888888775 5678889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+.+||.+||+.||++|||+.+|++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.1e-54 Score=421.10 Aligned_cols=250 Identities=24% Similarity=0.459 Sum_probs=209.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMAS--KSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~~ 94 (441)
.++|++++.||+|+||+||+|++..+|+.||||++.... .+++.+|+.+|+.++ ||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 468999999999999999999999999999999986532 467889999999995 9999999999974 4569
Q ss_pred EEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCC-CeEEeecCcccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDG-NLKVTDFGLSAFSEHLKQ 173 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 173 (441)
|+|||||.+++|.... +++++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~--- 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--- 182 (328)
T ss_dssp EEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT---
T ss_pred eEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC---
Confidence 9999999999997764 4699999999999999999999999999999999999998765 599999999986443
Q ss_pred CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHH-------------cCCCC
Q 013522 174 DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV-SMYRKIY-------------RGDFK 239 (441)
Q Consensus 174 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~-------------~~~~~ 239 (441)
.......+||+.|+|||.+.+....+.++||||+||++|+|++|..||...... .....+. .....
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 334567789999999999987766679999999999999999999999764321 1111110 00000
Q ss_pred ------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 240 ------------------------CPPWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 240 ------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
....+++++++||++||.+||++|||++|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 112368899999999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=421.16 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=211.9
Q ss_pred CCeEEeeeecccCceEEEEEEEcCCCc----EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 19 GKYELGRMLGHGTFAKVYLARNLQTGK----SMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 19 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.+|++++.||+|+||+||+|++..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988887 47777775432 223467899999999999999999999999865 56
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++++||+.+|+|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788899999999998875 579999999999999999999999999999999999999999999999999998765433
Q ss_pred cCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCC-CCCCCCCCHHHHH
Q 013522 173 QDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGD-FKCPPWFSSEARR 250 (441)
Q Consensus 173 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 250 (441)
.........||+.|+|||++.+..| +.++|||||||++|||+| |.+||.+.+..++...+..+. ++.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 3334445568999999999988877 489999999999999998 899999988878887777765 5678889999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCc
Q 013522 251 LITKLLDPNPNSRIAISKIMESS 273 (441)
Q Consensus 251 li~~~L~~dP~~R~t~~eil~hp 273 (441)
||.+||..||++|||+.+|++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999884
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=409.04 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=209.4
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCC----cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTG----KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
-...|++.+.||+|+||+||+|.+..++ ..||||.+..... ......+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 3467999999999999999999987655 4699999965432 234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
..++||||+.++++.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999998865 6799999999999999999999999999999999999999999999999999986543
Q ss_pred cccCC-cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 013522 171 LKQDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247 (441)
Q Consensus 171 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 247 (441)
..... ......||+.|+|||++.+..++ .++|||||||++|||++ |.+||...+..+++..+..+ .++.|..+++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence 32221 23345689999999999887775 89999999999999998 46667777777888877766 35667789999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 248 ARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.+||.+||+.||++|||+.+|++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=425.69 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=205.6
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS------ 90 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------ 90 (441)
+.++|++++.||+|+||+||+|++..+|+.||||++.+... ......++.+|+.+|+.++||||++++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 45889999999999999999999999999999999987654 33456788999999999999999999999953
Q ss_pred CCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccc
Q 013522 91 KSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEH 170 (441)
Q Consensus 91 ~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~ 170 (441)
...+|+|||||.|+ +.+.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++....
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchH-HHHhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 47899999999775 444443 4699999999999999999999999999999999999999999999999999875443
Q ss_pred cccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHHHc---------------
Q 013522 171 LKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKIYR--------------- 235 (441)
Q Consensus 171 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 235 (441)
.......+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++..
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 334456789999999999988776 4889999999999999999999998876665554432
Q ss_pred -------CCCCCC--------------------CCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCcccCcc
Q 013522 236 -------GDFKCP--------------------PWFSSEARRLITKLLDPNPNSRIAISKIMESSWFKKS 278 (441)
Q Consensus 236 -------~~~~~~--------------------~~~~~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 278 (441)
...... ...++++.+||++||.+||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 111000 0135678999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=410.07 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=222.4
Q ss_pred CCCccccCCeEEeeeecccCceEEEEEEEcCCC-------cEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcce
Q 013522 12 DRPTLLHGKYELGRMLGHGTFAKVYLARNLQTG-------KSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVE 83 (441)
Q Consensus 12 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~ 83 (441)
..+.+-.++|++++.||+|+||.||+|++..++ ..||||++.++.. ......+.+|...+.++ +|||||+
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 345667789999999999999999999976554 4799999976542 33457788899988888 8999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCC
Q 013522 84 LHEVMASKSKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKP 146 (441)
Q Consensus 84 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp 146 (441)
+++++.++..+|+|||||.+|+|.+++.. .++++..+..++.||+.||+|||++||+||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 99999999999999999999999999964 2489999999999999999999999999999999
Q ss_pred CcEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCc
Q 013522 147 ENLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDN 225 (441)
Q Consensus 147 ~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~ 225 (441)
+|||++.++.+||+|||++...............+||+.|+|||.+.+..|+ .++|||||||++|+|++ |.+||.+.+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999999877665555556677899999999999888775 99999999999999998 799999999
Q ss_pred HHHHHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 226 IVSMYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 226 ~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
...++..+..+ .++.|.++++++.+||.+||++||++|||+.++++
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 98888888776 45678889999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-53 Score=410.76 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=220.7
Q ss_pred cCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS 92 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 92 (441)
.++|++++.||+|+||+||+|++. .+++.||||++.... .....+++.+|+.+|+.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 467999999999999999999975 356789999987543 2344678999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCC
Q 013522 93 KIYFAMDLVKGGELFNKIAKG-------------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~-------------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~ 147 (441)
..+++|||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 999999999999999998631 3788999999999999999999999999999999
Q ss_pred cEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcH
Q 013522 148 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNI 226 (441)
Q Consensus 148 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~ 226 (441)
|||+|.++.+||+|||+|+............+.+||+.|+|||.+.+..|+ .++|||||||++|||++| .+||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999866554444555677899999999999988875 899999999999999998 578999999
Q ss_pred HHHHHHHHcCCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 227 VSMYRKIYRGDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 227 ~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.++...+.++.. +.|..+++++.+||.+||+.||++|||+.+|++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999888764 457789999999999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=408.15 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=206.9
Q ss_pred cCCeEEeeeecccCceEEEEEEEcCC-C--cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 013522 18 HGKYELGRMLGHGTFAKVYLARNLQT-G--KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKSKI 94 (441)
Q Consensus 18 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~ 94 (441)
.++|++.+.||+|+||+||+|++..+ + ..||||++.+.........+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 46799999999999999999986533 3 3689999987665555667889999999999999999999999976 467
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLK 172 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~ 172 (441)
++||||+.+|++.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999988764 679999999999999999999999999999999999999999999999999998654332
Q ss_pred cCC-cccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcCCC--CCCCCCCHHH
Q 013522 173 QDG-LLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRGDF--KCPPWFSSEA 248 (441)
Q Consensus 173 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 248 (441)
... .....+|++.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+..+...++.+... +.|+.+|+++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 222 2334567889999999988766 588999999999999998 8999999999999888877644 5567799999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 013522 249 RRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 249 ~~li~~~L~~dP~~R~t~~eil~ 271 (441)
.+||.+||..||++|||+.+|++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=402.58 Aligned_cols=246 Identities=23% Similarity=0.419 Sum_probs=210.3
Q ss_pred CccccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 013522 14 PTLLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KS 92 (441)
Q Consensus 14 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~ 92 (441)
+.+-.++|++++.||+|+||.||+|++ +|..||||+++++. ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 345667899999999999999999998 57899999997543 34678999999999999999999999854 56
Q ss_pred EEEEEEeccCCCchHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcccccc
Q 013522 93 KIYFAMDLVKGGELFNKIAK---GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSE 169 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~---~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~ 169 (441)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 68999999999999999965 248999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHHcC-CCCCCCCCCHH
Q 013522 170 HLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNIVSMYRKIYRG-DFKCPPWFSSE 247 (441)
Q Consensus 170 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 247 (441)
. ...+.++|+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+...+...+..+ .+++|+.++++
T Consensus 155 ~-----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 155 S-----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred C-----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 2 2345578999999999988777 599999999999999998 89999998888888888765 56778889999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 248 ARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 248 ~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+++||.+||+.||.+|||+.+++++
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=409.96 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=205.7
Q ss_pred ccccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 013522 15 TLLHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVM 88 (441)
Q Consensus 15 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~ 88 (441)
.+-.++|++++.||+|+||+||+|++.. +++.||||++..... ....+.+.+|+.++.++ +||||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3456789999999999999999999754 457899999865432 23456677788877766 789999999988
Q ss_pred EeC-CEEEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEE
Q 013522 89 ASK-SKIYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLL 150 (441)
Q Consensus 89 ~~~-~~~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NIL 150 (441)
... ..+++|||||+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 654 568999999999999999863 24889999999999999999999999999999999999
Q ss_pred eCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcHH-H
Q 013522 151 LDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIV-S 228 (441)
Q Consensus 151 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~~-~ 228 (441)
++.++.+||+|||+|+............+.+||+.|+|||++.+..+ +.++|||||||++|+|++| .+||.+.+.. .
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999986554444444556789999999999988777 5999999999999999986 6788776543 3
Q ss_pred HHHHHHcC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 229 MYRKIYRG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 229 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
....+..+ .++.|+.+++++.+||.+||+.||++|||+.++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44444444 456678899999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-53 Score=408.54 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=215.0
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcE--EEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKS--MAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHEVMASKSK 93 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~ 93 (441)
-.++|++.+.||+|+||+||+|++..+|.. ||||.+.... .....+.+.+|+.+|+++ +||||+++++++.+.+.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 346899999999999999999999888875 6677765332 223456789999999998 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC
Q 013522 94 IYFAMDLVKGGELFNKIAK-----------------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 156 (441)
Q Consensus 94 ~~lv~E~~~gg~L~~~i~~-----------------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~ 156 (441)
+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999999999999853 46899999999999999999999999999999999999999999
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcHHHHHHHHHc
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYR 235 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~ 235 (441)
+||+|||+|+.... .......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+++..+..
T Consensus 166 ~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 166 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEccccccccccc---cccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 99999999975433 2223456799999999999888774 899999999999999996 568999999999988877
Q ss_pred C-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 236 G-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 236 ~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
+ .++.|..+++++.+||.+||+.||++|||+.+|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6 456677899999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=406.19 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=225.4
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNLQ-----TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEV 87 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~ 87 (441)
.+++-.++|++++.||+|+||+||+|.+.. ++..||||++++.. .......+.+|+.++++++||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356777999999999999999999999853 45789999997543 23345678999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCC
Q 013522 88 MASKSKIYFAMDLVKGGELFNKIAK-----------GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGN 156 (441)
Q Consensus 88 ~~~~~~~~lv~E~~~gg~L~~~i~~-----------~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~ 156 (441)
+......++||||+.+|+|.+++.. ..++...+..++.|++.||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 9999999999999999999998853 23688999999999999999999999999999999999999999
Q ss_pred eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhC-CCCCCCCcHHHHHHHHHc
Q 013522 157 LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAG-FLPFQDDNIVSMYRKIYR 235 (441)
Q Consensus 157 vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~ 235 (441)
+||+|||+|+..............+||+.|+|||.+.+..+. .++|||||||++|+|++| .+||.+.+....+..+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999876554444444556799999999999888775 899999999999999998 689999999998888887
Q ss_pred CCC-CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 236 GDF-KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 236 ~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
+.. +.|+.+++.+.+||.+||+.||++|||+.+|++
T Consensus 251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 654 567889999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=403.83 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=218.7
Q ss_pred CCccccCCeEEeeeecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCcceEEE
Q 013522 13 RPTLLHGKYELGRMLGHGTFAKVYLARNL-----QTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMV-KHKHIVELHE 86 (441)
Q Consensus 13 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~ 86 (441)
.+.+-.++|++++.||+|+||+||+|++. .+++.||||++..... ......+.+|+.+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45566789999999999999999999863 4677999999976542 34456788999999999 6999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCC
Q 013522 87 VMASKSKIYFAMDLVKGGELFNKIAKG-------------------RLREDVARVYFQQLISAVDFCHSRGVYHRDLKPE 147 (441)
Q Consensus 87 ~~~~~~~~~lv~E~~~gg~L~~~i~~~-------------------~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~ 147 (441)
++.+....|+|||||++|+|.+++... .+++..+..++.||+.||+|||++|++||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 999999999999999999999998642 4889999999999999999999999999999999
Q ss_pred cEEeCCCCCeEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhh-CCCCCCCCcH
Q 013522 148 NLLLDEDGNLKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLA-GFLPFQDDNI 226 (441)
Q Consensus 148 NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~-G~~Pf~~~~~ 226 (441)
|||++.++.+|++|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|+| |.+||...+.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987654433334455689999999999987766 589999999999999998 7777877666
Q ss_pred HHHHHHHH-cC-CCCCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 227 VSMYRKIY-RG-DFKCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 227 ~~~~~~i~-~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
...+.++. .+ .+..|..+++++.+||.+||++||++|||+.+|++
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55444443 33 34456778999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=390.07 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=205.4
Q ss_pred EEeeeecccCceEEEEEEEcCCC---cEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 013522 22 ELGRMLGHGTFAKVYLARNLQTG---KSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMAS-KSKIYFA 97 (441)
Q Consensus 22 ~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv 97 (441)
.+.++||+|+||+||+|++..++ ..||||.+++. ......+++.+|+.+|++++||||+++++++.+ +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999987654 36999998643 234556889999999999999999999999865 5689999
Q ss_pred EeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCccccccccccC-
Q 013522 98 MDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLSAFSEHLKQD- 174 (441)
Q Consensus 98 ~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 174 (441)
||||++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999999875 45778889999999999999999999999999999999999999999999999865432211
Q ss_pred -CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCC-CcHHHHHHHHHcC-CCCCCCCCCHHHHHH
Q 013522 175 -GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQD-DNIVSMYRKIYRG-DFKCPPWFSSEARRL 251 (441)
Q Consensus 175 -~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~-~~~~~~~~~~~~~~l 251 (441)
.......||+.|+|||.+....+ +.++|||||||++|||++|..||.. .+...+...+..+ .+..|+.+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 22334568999999999988777 5999999999999999997666644 4455566666665 445678899999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 013522 252 ITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 252 i~~~L~~dP~~R~t~~eil~h 272 (441)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-50 Score=386.79 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=203.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKH-IVELHEVMASKSKI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~ 94 (441)
.+.+||++++.||+|+||+||+|++..+|+.||||++...... +.+.+|+++++.++|+| |+.++.++.+.+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3567899999999999999999999999999999998765322 35778999999998766 55556667888999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC---CCCeEEeecCcccccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE---DGNLKVTDFGLSAFSE 169 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~---~~~vkl~DFGla~~~~ 169 (441)
++||||+.+ +|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+...
T Consensus 79 ~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999999954 66665543 67999999999999999999999999999999999999864 4579999999998765
Q ss_pred ccccC-----CcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHHHHHHHH---HcCC----
Q 013522 170 HLKQD-----GLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIVSMYRKI---YRGD---- 237 (441)
Q Consensus 170 ~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~~~~---- 237 (441)
..... ....+.+||+.|+|||++.+.+++ .++|||||||++|+|++|..||...........+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 43221 223456799999999999988774 8999999999999999999999875543332221 1111
Q ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCCCHHH---HhcCcccCc
Q 013522 238 -FKCPPWFSSEARRLITKLLDPNPNSRIAISK---IMESSWFKK 277 (441)
Q Consensus 238 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e---il~hpwf~~ 277 (441)
...++.+|+++.+||.+||..||++||++.+ +|+|+|.+.
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1124568999999999999999999999875 467777644
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-49 Score=380.40 Aligned_cols=249 Identities=18% Similarity=0.277 Sum_probs=208.4
Q ss_pred cccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 013522 16 LLHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-KHIVELHEVMASKSKI 94 (441)
Q Consensus 16 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~ 94 (441)
++.++|++++.||+|+||+||+|++..+|+.||||++..... ...+++|+++++.|.| +||+.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 567899999999999999999999999999999999865432 2357789999999965 8999999999999999
Q ss_pred EEEEeccCCCchHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCC-----CCCeEEeecCcccc
Q 013522 95 YFAMDLVKGGELFNKIAK--GRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDE-----DGNLKVTDFGLSAF 167 (441)
Q Consensus 95 ~lv~E~~~gg~L~~~i~~--~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~-----~~~vkl~DFGla~~ 167 (441)
|+||||+ |++|.+.+.. ..++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 6799998865 56999999999999999999999999999999999999974 56899999999987
Q ss_pred cccccc-----CCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHHcCCC-
Q 013522 168 SEHLKQ-----DGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDN---IVSMYRKIYRGDF- 238 (441)
Q Consensus 168 ~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~- 238 (441)
...... .....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.. ....+.++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 543221 1234456899999999999987774 89999999999999999999997543 3333333322211
Q ss_pred ----CCCCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 013522 239 ----KCPPWFSSEARRLITKLLDPNPNSRIAISKIME 271 (441)
Q Consensus 239 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 271 (441)
..++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123568899999999999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=382.61 Aligned_cols=250 Identities=19% Similarity=0.297 Sum_probs=195.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHIVELHEVMASKS---- 92 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---- 92 (441)
+..+|.+.+.||+|+||+||+|++ +|+.||||++..+.. .....+.|+..+..++||||+++++++.+.+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 356899999999999999999997 789999999864421 1122334555666789999999999997654
Q ss_pred EEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------cCcEeccCCCCcEEeCCCCCeEEeecCc
Q 013522 93 KIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS--------RGVYHRDLKPENLLLDEDGNLKVTDFGL 164 (441)
Q Consensus 93 ~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~--------~gi~HrDLkp~NILl~~~~~vkl~DFGl 164 (441)
.+|+|||||++|+|.+++.+..+++.....++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 68999999999999999998889999999999999999999996 6999999999999999999999999999
Q ss_pred ccccccccc--CCcccccccCCCccchhhhhccCC-----CCCcccHHHHHHHHHHHhhCCCCCCC--------------
Q 013522 165 SAFSEHLKQ--DGLLHTTCGTPAYVAPEVISKKGY-----DGAKADIWSCGVILYVLLAGFLPFQD-------------- 223 (441)
Q Consensus 165 a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiwSlGvil~~ll~G~~Pf~~-------------- 223 (441)
+........ .......+||+.|+|||++.+... .+.++|||||||+||||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 986543221 123345789999999999875432 24679999999999999999887732
Q ss_pred -CcHHHHHHHHHcCCC--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 013522 224 -DNIVSMYRKIYRGDF--KCPPW-----FSSEARRLITKLLDPNPNSRIAISKIMES 272 (441)
Q Consensus 224 -~~~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~R~t~~eil~h 272 (441)
............... .+|.. ....+.+|+.+||+.||++|||+.||+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122333333333322 22222 12358899999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-47 Score=379.97 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=199.4
Q ss_pred Ccccc-CCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-----------CCCc
Q 013522 14 PTLLH-GKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-----------HKHI 81 (441)
Q Consensus 14 ~~~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnI 81 (441)
+..+. +||+++++||+|+||+||+|++..+|+.||||+++++. ...+.+.+|+.+++.++ ||||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 44443 68999999999999999999999999999999997653 23467788999988875 5789
Q ss_pred ceEEEEEE--eCCEEEEEEeccCCCchHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh-cCcEeccCCCCcEEeCCC
Q 013522 82 VELHEVMA--SKSKIYFAMDLVKGGELFNKIA----KGRLREDVARVYFQQLISAVDFCHS-RGVYHRDLKPENLLLDED 154 (441)
Q Consensus 82 v~l~~~~~--~~~~~~lv~E~~~gg~L~~~i~----~~~l~~~~~~~~~~qll~aL~ylH~-~gi~HrDLkp~NILl~~~ 154 (441)
+++++++. .....+++++++..+....... ...+++..++.++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 99998875 4567777887776654433322 2579999999999999999999998 899999999999999876
Q ss_pred CC------eEEeecCccccccccccCCcccccccCCCccchhhhhccCCCCCcccHHHHHHHHHHHhhCCCCCCCCcHH-
Q 013522 155 GN------LKVTDFGLSAFSEHLKQDGLLHTTCGTPAYVAPEVISKKGYDGAKADIWSCGVILYVLLAGFLPFQDDNIV- 227 (441)
Q Consensus 155 ~~------vkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiwSlGvil~~ll~G~~Pf~~~~~~- 227 (441)
+. ++++|||.|..... .....+||+.|+|||++.+.+|+ .++||||+||++++|++|+.||...+..
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 54 99999999874332 23567899999999999988885 8999999999999999999999754321
Q ss_pred -----HHHHH---HH---------cC------------------------------CCCCCCCCCHHHHHHHHHhcCCCC
Q 013522 228 -----SMYRK---IY---------RG------------------------------DFKCPPWFSSEARRLITKLLDPNP 260 (441)
Q Consensus 228 -----~~~~~---i~---------~~------------------------------~~~~~~~~~~~~~~li~~~L~~dP 260 (441)
..... +. .. ....++..++++.+||.+||++||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11100 00 00 001112235789999999999999
Q ss_pred CCCCCHHHHhcCcccCcc
Q 013522 261 NSRIAISKIMESSWFKKS 278 (441)
Q Consensus 261 ~~R~t~~eil~hpwf~~~ 278 (441)
.+|||++|+|+||||++.
T Consensus 317 ~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTCBCHHHHHTCGGGTTC
T ss_pred hHCcCHHHHhcCcccCCC
Confidence 999999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4.1e-27 Score=210.78 Aligned_cols=137 Identities=18% Similarity=0.268 Sum_probs=109.4
Q ss_pred eEEeeeecccCceEEEEEEEcCCCcEEEEEEeeccccc---------------chhhHHHHHHHHHHHHhCCCCCcceEE
Q 013522 21 YELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVI---------------KVGMMEQIKREISVMKMVKHKHIVELH 85 (441)
Q Consensus 21 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~ 85 (441)
|.+++.||+|+||+||+|++ .+|+.||||+++..... .........+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 57899999999999999998 57899999987532111 001123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcEeccCCCCcEEeCCCCCeEEeecCcc
Q 013522 86 EVMASKSKIYFAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHSRGVYHRDLKPENLLLDEDGNLKVTDFGLS 165 (441)
Q Consensus 86 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~~gi~HrDLkp~NILl~~~~~vkl~DFGla 165 (441)
++.. .+++|||+.+..+.. ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+|
T Consensus 81 ~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred EecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 7642 279999999866543 4556678899999999999999999999999999999865 5999999998
Q ss_pred cccc
Q 013522 166 AFSE 169 (441)
Q Consensus 166 ~~~~ 169 (441)
....
T Consensus 150 ~~~~ 153 (191)
T d1zara2 150 VEVG 153 (191)
T ss_dssp EETT
T ss_pred ccCC
Confidence 6543
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.29 E-value=6.3e-12 Score=98.14 Aligned_cols=87 Identities=14% Similarity=0.201 Sum_probs=77.2
Q ss_pred hcccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEec-CceEEEEEEccCCChhhhHHH
Q 013522 332 LRFATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVT-PSLLVVEVKKDNGDTLEYNQF 409 (441)
Q Consensus 332 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~~~~~~Gd~le~~~~ 409 (441)
...+|..+|++++..|+++++++|+.+++++ +.++++...++.++.+.|.+||+++. +++++|+|+|.+||+++|+++
T Consensus 13 v~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l 92 (102)
T d1ul7a_ 13 MKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNI 92 (102)
T ss_dssp CCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHH
T ss_pred eecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHH
Confidence 3457888999999999999999999998765 77999998888899999999999995 799999999999999999999
Q ss_pred hhhhhhhhhc
Q 013522 410 CSNELRPALK 419 (441)
Q Consensus 410 ~~~~l~~~l~ 419 (441)
|. +|-..|+
T Consensus 93 ~~-~il~~l~ 101 (102)
T d1ul7a_ 93 AS-KIANELK 101 (102)
T ss_dssp HH-HHHHHCC
T ss_pred HH-HHHHhcc
Confidence 87 5655553
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=2.7e-08 Score=90.87 Aligned_cols=142 Identities=15% Similarity=0.122 Sum_probs=98.9
Q ss_pred ccCCeEEeeeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013522 17 LHGKYELGRMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIY 95 (441)
Q Consensus 17 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 95 (441)
+...|++.+..+.++.+.||+.. .+++.+.+|........ ....+.+|...++.+. +--+.+++.+..+++..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45678888877667778999886 36677888887644321 2335678888888773 434677888888899999
Q ss_pred EEEeccCCCchHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------
Q 013522 96 FAMDLVKGGELFNKIAKGRLREDVARVYFQQLISAVDFCHS--------------------------------------- 136 (441)
Q Consensus 96 lv~E~~~gg~L~~~i~~~~l~~~~~~~~~~qll~aL~ylH~--------------------------------------- 136 (441)
+||++++|.++.+...... ....++.++...++.||+
T Consensus 87 lv~~~l~G~~~~~~~~~~~----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEEecccccccccccccc----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 9999999987765543221 122233344444444442
Q ss_pred --------------------cCcEeccCCCCcEEeCCCCCeEEeecCcccc
Q 013522 137 --------------------RGVYHRDLKPENLLLDEDGNLKVTDFGLSAF 167 (441)
Q Consensus 137 --------------------~gi~HrDLkp~NILl~~~~~vkl~DFGla~~ 167 (441)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1379999999999998776667999998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.24 E-value=3.5e-06 Score=75.90 Aligned_cols=78 Identities=14% Similarity=0.215 Sum_probs=54.3
Q ss_pred eEEeeeecccC-ceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEE
Q 013522 21 YELGRMLGHGT-FAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH--KHIVELHEVMASKSKIYFA 97 (441)
Q Consensus 21 y~i~~~LG~G~-fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv 97 (441)
++... +..|. -+.||+... .++..+.+|...... ...+..|...|+.|.. -.+.+++.+..+++..|+|
T Consensus 13 ~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 13 YDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp CEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 44433 34444 468999885 456678889764432 2346788888887742 3367788888888899999
Q ss_pred EeccCCCch
Q 013522 98 MDLVKGGEL 106 (441)
Q Consensus 98 ~E~~~gg~L 106 (441)
|++++|.++
T Consensus 85 ~~~i~G~~~ 93 (255)
T d1nd4a_ 85 LGEVPGQDL 93 (255)
T ss_dssp EECCSSEET
T ss_pred EEeeecccc
Confidence 999998665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=6.3e-06 Score=79.66 Aligned_cols=81 Identities=12% Similarity=0.146 Sum_probs=50.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeecc-cccc---hhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQTGKSMAMKVVGKD-KVIK---VGMMEQIKREISVMKMVK-H--KHIVELHEVMASKSKIYF 96 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~---~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l 96 (441)
.+.||.|....||++.+..+++.+++|.-... +... ....++...|...|+.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998777889999965321 1100 012345667888888763 2 345566654 4445578
Q ss_pred EEeccCCCch
Q 013522 97 AMDLVKGGEL 106 (441)
Q Consensus 97 v~E~~~gg~L 106 (441)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.90 E-value=2.6e-05 Score=62.84 Aligned_cols=72 Identities=7% Similarity=0.192 Sum_probs=59.7
Q ss_pred ccccCCchhhHHHHHHHHHHcCcEEEeec-CeEEEEeeecCCccceEEEEEEEEecCceEEEEEEccCCChhh
Q 013522 334 FATTRPASSVISRFEEVAKAVKFNVKTSE-SRVRLQGQESGRKGKLAINADIFAVTPSLLVVEVKKDNGDTLE 405 (441)
Q Consensus 334 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~~~~~~Gd~le 405 (441)
+.++..+.+++..+..+.++||+.||+.+ +.|++..........+.|..++|++.+..+||||+...|+-.|
T Consensus 5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e 77 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 77 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence 45677889999999999999999999766 8899998544445567899999999999999999999998655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.32 E-value=0.00059 Score=65.26 Aligned_cols=74 Identities=9% Similarity=0.091 Sum_probs=51.3
Q ss_pred eeeecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 013522 24 GRMLGHGTFAKVYLARNLQ-------TGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVK-HKHIVELHEVMASKSKIY 95 (441)
Q Consensus 24 ~~~LG~G~fg~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~ 95 (441)
++.|+.|-.-.+|++.... ..+.|.+++..... . .-...+|..+++.+. +.-..++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678899999999998643 34567788775321 1 234668999999885 4334577777643 6
Q ss_pred EEEeccCCCch
Q 013522 96 FAMDLVKGGEL 106 (441)
Q Consensus 96 lv~E~~~gg~L 106 (441)
+|+||+.|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999988544
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=97.26 E-value=0.00044 Score=54.39 Aligned_cols=86 Identities=12% Similarity=0.206 Sum_probs=62.6
Q ss_pred cccccCCchhhHHHHHHHHHHcCcEEEeec----------CeEEEEeeec-----CCccceEEEEEEEEecCceEEEEEE
Q 013522 333 RFATTRPASSVISRFEEVAKAVKFNVKTSE----------SRVRLQGQES-----GRKGKLAINADIFAVTPSLLVVEVK 397 (441)
Q Consensus 333 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~~-----~~~~~l~~~~~i~~~~~~~~~v~~~ 397 (441)
...|+..+-+++..+-.+.+++|+.|++-+ +.|++....+ +...-+.+.+++|++.++.+||||+
T Consensus 6 GIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK 85 (127)
T d2qrda1 6 GVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVK 85 (127)
T ss_dssp SEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEE
T ss_pred ccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEc
Confidence 345778899999999999999999998644 5688875322 1123467899999999999999998
Q ss_pred c------cCC-------------ChhhhHHHhhhhhhhhhc
Q 013522 398 K------DNG-------------DTLEYNQFCSNELRPALK 419 (441)
Q Consensus 398 ~------~~G-------------d~le~~~~~~~~l~~~l~ 419 (441)
- ..+ .+.+|-++|. .|--.|.
T Consensus 86 ~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a-~LI~qL~ 125 (127)
T d2qrda1 86 SNGYKDIYSHPERTADHGMDDLKSSFPFLDLCA-MLVCKLF 125 (127)
T ss_dssp EEEEEESCC-------------CCCTTHHHHHH-HHHHHHH
T ss_pred cCCcccccCCccccccCccccccCCccHHHHHH-HHHHHHh
Confidence 2 221 2466888886 4555553
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=97.12 E-value=0.00046 Score=57.14 Aligned_cols=71 Identities=11% Similarity=0.110 Sum_probs=52.2
Q ss_pred hhhhcccccCCchhhHHHHHHHHHHcCcEEEeec----CeEEEEeeec---------CCccceEEEEEEEEecCceEEEE
Q 013522 329 REELRFATTRPASSVISRFEEVAKAVKFNVKTSE----SRVRLQGQES---------GRKGKLAINADIFAVTPSLLVVE 395 (441)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v~ 395 (441)
|.....-|+..+-+++..+-++.+++|+.|++.+ +.|++....+ .....+.|.+++|+|.++.+|||
T Consensus 45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD 124 (171)
T d2qlva1 45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD 124 (171)
T ss_dssp CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence 4666777899999999999999999999998654 6688875221 11123678999999999999999
Q ss_pred EEcc
Q 013522 396 VKKD 399 (441)
Q Consensus 396 ~~~~ 399 (441)
|+-+
T Consensus 125 FK~~ 128 (171)
T d2qlva1 125 FKFD 128 (171)
T ss_dssp EEEE
T ss_pred EecC
Confidence 9853
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.08 E-value=0.00068 Score=63.03 Aligned_cols=69 Identities=13% Similarity=0.237 Sum_probs=45.7
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCc-----ceE--EEEEEeCCEEEEEEeccCCC
Q 013522 32 FAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKHKHI-----VEL--HEVMASKSKIYFAMDLVKGG 104 (441)
Q Consensus 32 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l--~~~~~~~~~~~lv~E~~~gg 104 (441)
--.||.+.. .+|+.|++|+.+.... ..+++..|...+..|...+| +.. -..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999985 6888999999865432 24668889888887742222 111 11234567889999999874
Q ss_pred c
Q 013522 105 E 105 (441)
Q Consensus 105 ~ 105 (441)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.78 E-value=0.003 Score=57.88 Aligned_cols=135 Identities=14% Similarity=0.119 Sum_probs=72.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-----CCcceEE---EEEEeCCEEEE
Q 013522 25 RMLGHGTFAKVYLARNLQTGKSMAMKVVGKDKVIKVGMMEQIKREISVMKMVKH-----KHIVELH---EVMASKSKIYF 96 (441)
Q Consensus 25 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l~---~~~~~~~~~~l 96 (441)
+.|..|---+.|+... ++..+++|++..... .+.+..|+.+|..|.. |..+... .+.......+.
T Consensus 24 ~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHT--TKDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEECC---EEEEEEEE--SSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ecCCCCcccCeEEEEE--CCCcEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 4455677788999886 334589999865321 2355667777776632 2222210 01223456677
Q ss_pred EEeccCCCchHH--------------HHh---c---C----CCCH------------------HHHHHHHHHHHHHHHHH
Q 013522 97 AMDLVKGGELFN--------------KIA---K---G----RLRE------------------DVARVYFQQLISAVDFC 134 (441)
Q Consensus 97 v~E~~~gg~L~~--------------~i~---~---~----~l~~------------------~~~~~~~~qll~aL~yl 134 (441)
++.+..|..... .+. . . .... ......+..+...+.-.
T Consensus 97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (316)
T d2ppqa1 97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 176 (316)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence 777776643210 000 0 0 0001 11111222222333332
Q ss_pred h----hcCcEeccCCCCcEEeCCCCCeEEeecCccc
Q 013522 135 H----SRGVYHRDLKPENLLLDEDGNLKVTDFGLSA 166 (441)
Q Consensus 135 H----~~gi~HrDLkp~NILl~~~~~vkl~DFGla~ 166 (441)
+ ..|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 177 ~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 177 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2 2589999999999999988777899999875
|